{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nThe 5.000 % senior notes that mature in April 2030 kept a nearly‑unchanged carrying amount of about **$606 million** from fiscal 2022 through fiscal 2024 (the same $606 million figure is reported as of Oct 30 2022, Oct 29 2023 and Nov 3 2024).  Because this tranche is included in the “Thereafter” column of the “Future Principal Payments of Debt” schedule—​$36.8 billion of scheduled repayments beyond 2029—it represents a stable, long‑dated fixed‑rate component of AVGO’s capital structure.  The flat exposure shows that AVGO’s debt‑management strategy has been to **extend maturities and lock in low‑cost financing** (e.g., issuing new senior notes and term‑loan facilities) while using cash flows and asset‑sale proceeds to retire higher‑cost or near‑term obligations, thereby maintaining a consistent, long‑term debt profile rather than expanding or shrinking this particular note.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims the carrying amount was 'nearly-unchanged' at '$606 million' from fiscal 2022 through 2024, but the ground truth explicitly states it DECREASED from $1,086 million in 2022 to $606 million in 2023, then remained at $606 million in 2024. This is a significant $480 million reduction in the first year, representing a 44% decrease. (1) QUANTITATIVE ACCURACY FAILURE: The LLM completely misses the 2022 figure of $1,086 million and incorrectly characterizes the progression as 'nearly-unchanged' when there was a substantial one-year decline. The claim that the figure was '$606 million as of Oct 30 2022' is factually incorrect—the ground truth shows $1,086 million for 2022. (2) MULTI-HOP REASONING FAILURE: The LLM fails to properly synthesize the three-year progression. It should have identified: 2022: $1,086M → 2023: $606M (major reduction) → 2024: $606M (stable). Instead, it presents a false narrative of consistency. (3) DEBT MANAGEMENT STRATEGY MISCHARACTERIZATION: The ground truth indicates 'deliberate debt reduction strategy' with 'actively managing outstanding obligations.' The LLM's interpretation of 'extending maturities and locking in low-cost financing while retiring higher-cost obligations' may be partially reasonable strategy discussion, but it's built on the false premise that this particular note remained flat, when in fact it was actively reduced by $480 million. (4) CONTEXTUAL ISSUES: While the LLM provides additional context about the debt schedule and capital structure, this contextual information cannot compensate for the fundamental factual error about the year-over-year progression. The answer demonstrates a misreading or misunderstanding of the source data regarding the 2022 baseline figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 504,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nMetLife has consistently reinsured 59 % of the closed‑block liabilities through a modified‑coinsurance agreement with an unaffiliated reinsurer in 2022, 2023 and 2024, accounting for the arrangement under the deposit method and offsetting the deposit payable against the recoverable.  The 2023‑24 risk‑transfer with Global Atlantic added a large, separate layer of reinsurance (≈ $10.3 bn of recoverables and a $770 m net cost) but left the 59 % cession rate unchanged, indicating a deliberate long‑term strategy to maintain a stable, predictable transfer of a fixed share of closed‑block risk while preserving capital and dividend expectations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of MetLife's modified coinsurance strategy with mostly accurate information. STRENGTHS: (1) Correctly identifies the consistent 59% reinsurance rate across 2022-2023-2024, matching ground truth exactly; (2) Accurately notes the deposit method of accounting and offset treatment; (3) Correctly identifies the unaffiliated third-party reinsurer relationship; (4) Appropriately synthesizes the multi-hop information about strategy consistency despite market changes; (5) The reference to Global Atlantic's 2023-24 reinsurance layer (~$10.3bn recoverables, $770m net cost) adds relevant context not in ground truth but appears factually grounded. WEAKNESSES: (1) The LLM answer omits the specific comparison of total net ceded reinsurance recoverables growth ($6.3B in 2021 to $17.6B in 2024) that the ground truth emphasizes as key evidence of strategy consistency; (2) Does not explicitly mention the 59.25% figure for 2022 (ground truth shows 59.25% vs 59% vs 59%), though this is a minor precision issue since the answer rounds to 59%; (3) The phrase 'deposit payable' is slightly imprecise terminology - ground truth refers to 'deposit liability' and 'deposit recoverable' with offset rights, not 'payable'; (4) The answer adds interpretation about 'preserving capital and dividend expectations' which, while reasonable, goes slightly beyond what the ground truth explicitly states about the strategy. QUANTITATIVE VERIFICATION: The 59% figure is correct across all three years (59.25% rounds to 59%). The Global Atlantic figures ($10.3bn, $770m) cannot be verified against ground truth but appear internally consistent. The omission of the $6.3B-to-$17.6B growth comparison is a notable gap in demonstrating the full scope of the strategy's context. MULTI-HOP REASONING: The answer successfully synthesizes information about the modified coinsurance agreement, the closed block, accounting treatment, and strategic implications across multiple years. The connection between stable cession rates and deliberate strategy is sound. Overall, this is a solid answer with minor omissions and terminology precision issues, but the core facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 592,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil posts under master‑netting arrangements tied to its investments, advances and long‑term receivables fell sharply—from **$1.49 billion in 2022 to $0.80 billion in 2023 and then to $0.49 billion in 2024**.  This steady decline shows that the company is requiring less external security for its derivative positions, suggesting that it is managing derivative exposure with fewer offsetting trades or higher‑quality counterparties, thereby reducing the amount of collateral it must set aside.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494 million, $800 million, and $491 million respectively. The format conversion from millions to billions is appropriate and accurate. COMPLETENESS: The answer addresses all required elements - the three-year trend, the specific collateral amounts, and interpretation of what the trend suggests about derivative exposure management. ENTITY ACCURACY: Correctly identifies ExxonMobil, the specific collateral type (master netting arrangements related to Investments, advances and long-term receivables), and all three fiscal years (2022-2024). REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the consistent downward trend across all three years and provides logical interpretation that this reflects improved derivative exposure management. The explanation about 'fewer offsetting trades or higher-quality counterparties' provides reasonable context for why collateral requirements would decrease. SEMANTIC EQUIVALENCE: The LLM's interpretation that the decline 'suggests a strategic reduction in derivative exposure or improved offsetting mechanisms' aligns well with the ground truth's characterization of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' Minor difference: The LLM provides slightly more detailed interpretation (mentioning 'fewer offsetting trades or higher-quality counterparties') which adds value without contradicting the ground truth. No calculation errors, no missing data points, and the narrative flow is clear and professional.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 479,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 were carried at **$622 million** at the end of fiscal 2022 (and again at the end of fiscal 2023) but had been **fully retired – the balance fell to $0** by the end of fiscal 2024, as shown in the debt tables of the 2022‑2024 10‑K filings (pages 101‑105 for 2022 and pages 79‑83 for 2023‑2024).  \n\nThis reduction reflects Broadcom’s deliberate **de‑risking of near‑term maturities**, using cash on hand and proceeds from newer senior‑note issuances to retire the 3.625 % issue early, thereby extending the average debt profile and optimizing interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All financial figures are correct - $622 million for fiscal 2022 and 2023, and $0 for fiscal 2024. The progression is accurately captured. The page references (101-105 for 2022, 79-83 for 2023-2024) add credibility though cannot be independently verified here. ENTITY ACCURACY: Correctly identifies AVGO/Broadcom, the 3.625% notes, October 2024 maturity date, and all relevant fiscal years. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the key transition point (between 2023 and 2024). DEBT MANAGEMENT STRATEGY: The LLM provides more detailed strategic context than the ground truth, explaining the 'de-risking of near-term maturities' and mentioning use of 'cash on hand and proceeds from newer senior-note issuances.' This represents sound financial analysis and interpretation, though the ground truth uses more neutral language ('addressed this specific liability'). SEMANTIC EQUIVALENCE: The LLM's characterization of 'fully retired' and 'balance fell to $0' is semantically equivalent to the ground truth's 'no longer listed any outstanding principal' and 'fully repaid or refinanced.' The LLM's additional strategic interpretation about extending the average debt profile and optimizing interest expense is reasonable inference from the facts but goes slightly beyond what the ground truth explicitly states. This is a minor enhancement rather than an error. MINOR CONSIDERATION: The LLM uses 'Broadcom' while the question uses 'AVGO' - both are correct references to the same company, so this is not an error. Overall, the answer is factually correct, complete, well-reasoned, and provides appropriate context for understanding the company's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 496,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue grew steadily from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, reflecting a roughly 5 % increase each year. This upward trajectory—driven by expanding backlogs for Arleigh Burke‑class destroyers, Expeditionary Sea Base ships, and the John Lewis‑class oilers—shows that GD is consolidating its position as a core U.S. naval shipbuilder, leveraging new capacity investments and a robust pipeline to capture the next wave of surface‑warfare construction.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct revenue figures across all three years. Verification: $2,561M (2022) correctly converted to $2.56B; $2,698M (2023) correctly converted to $2.70B; $2,819M (2024) correctly converted to $2.82B. The format variation (millions to billions) is appropriate and acceptable. The year-over-year growth calculations are approximately correct: 2022-2023 shows ~5.4% growth ($137M/$2,561M), and 2023-2024 shows ~4.5% growth ($121M/$2,698M), supporting the stated 'roughly 5% increase each year' characterization. The answer correctly identifies the Marine Systems division context and provides relevant supporting details about specific ship programs (Arleigh Burke-class destroyers, Expeditionary Sea Base ships, John Lewis-class oilers) that demonstrate understanding of GD's naval shipbuilding portfolio. The multi-hop synthesis is sound: the answer connects revenue growth data to strategic positioning and market dynamics. Minor deduction: The original answer focuses on 'sustained growth and strategic emphasis' while the LLM adds interpretive details about capacity investments and market positioning that, while reasonable and contextually appropriate, go slightly beyond what the ground truth explicitly states. However, this represents appropriate elaboration rather than factual error. The answer fully addresses the three-year trajectory question and provides meaningful insight into GD's naval shipbuilding positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 410,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares kept the same rights—one vote per share and full dividend participation—but the cash dividend per share rose each year, from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024.  Ownership‑voting percentages remained essentially unchanged (public investors ≈ 89‑90 % of equity and voting power, the Mastercard Foundation ≈ 10 % of each), showing that the shareholder‑governance structure has stayed stable despite modest shifts in the composition of owners.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dividend per share numbers ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) and ownership percentages (public investors ≈89-90%, Mastercard Foundation ≈10%) that are NOT present in the ground truth answer. The ground truth explicitly states that A Class shares had 'standard dividend rights' with 'no changes to these rights over the period,' indicating dividend amounts were NOT a focus of the original answer. The LLM appears to have fabricated or hallucinated these specific financial figures without verification against the actual SEC filings. Additionally, the ground truth makes no mention of ownership-voting percentages or the Mastercard Foundation's stake, yet the LLM introduces these details as if they were part of the documented governance structure. While the LLM correctly identifies that voting rights (one vote per share) remained stable and that the governance structure showed stability, it fundamentally misrepresents the scope and nature of the answer by adding unverified quantitative claims. The core insight about stability is preserved, but the introduction of specific unverified numbers (dividend amounts and ownership percentages) represents a significant factual error that could mislead users. The answer conflates dividend AMOUNTS (which may have changed) with dividend RIGHTS (which the ground truth says remained constant). This is a critical distinction the LLM failed to maintain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 405,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nFrom 2022 to 2023, General Dynamics’ surface‑ship revenue climbed from **$2.06 billion to $2.56 billion** (≈ 25 % growth), and in 2024 it edged higher to **$2.70 billion** (≈ 5 % growth). This steady increase—driven by a growing backlog of Arleigh Burke‑class destroyers, Flight III DDG‑51 ships, and replenishment Oilers—signals that the company is well‑positioned in the Navy’s surface‑warfare portfolio and benefiting from expanding production and modernization programs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three years: (1) 2022: LLM states $2.06 billion vs. ground truth $2,561 million ($2.561 billion) - a 20% understatement; (2) 2023: LLM states $2.56 billion vs. ground truth $2,698 million ($2.698 billion) - a 5% understatement; (3) 2024: LLM states $2.70 billion vs. ground truth $2,819 million ($2.819 billion) - a 4% understatement. The LLM appears to have confused or misreported the 2022 figure as $2.06B when it should be $2.561B. CALCULATION ERRORS: The LLM calculates 2022-2023 growth as ~25%, but the correct calculation is ($2,698M - $2,561M) / $2,561M = 5.3%. The LLM calculates 2023-2024 growth as ~5%, but the correct calculation is ($2,819M - $2,698M) / $2,698M = 4.5%. Both growth rate calculations are significantly wrong. POSITIVE ASPECTS: The LLM correctly identifies the upward trend direction and appropriately mentions relevant naval programs (Arleigh Burke-class destroyers, Flight III DDG-51, replenishment oilers), demonstrating contextual understanding of the industry. The reasoning about positioning in naval defense is sound and relevant. However, the systematic understatement of revenue figures across all years and the incorrect growth calculations represent fundamental quantitative failures that severely undermine the answer's reliability for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 394,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nBetween 2022 and 2024 Linde kept the vast majority of its industrial‑gas sales under long‑term supply agreements and repeatedly highlighted that these contracts “provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers.”  In the 2023 and 2024 MD&A the company noted that “cost‑pass‑through” – i.e., the contractual billing of energy‑cost variances to on‑site customers – modestly reduced sales but had “minimal impact on operating profit,” underscoring that the long‑term contract model was used deliberately to shield earnings from energy‑price swings.  This consistent reliance signals that Linde’s cash‑flow strategy is built around contract‑driven cost recovery, allowing it to maintain stable cash generation even when energy markets fluctuate.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the consistent reliance on long-term contracts across 2022-2024 period; (2) Accurately captures the key benefit of 'stability in cash flow and ability to pass through changes in energy and feedstock costs'; (3) Properly synthesizes multi-hop information by noting that cost-pass-through had 'minimal impact on operating profit' while reducing sales, demonstrating understanding of the nuanced financial mechanics; (4) Correctly interprets the strategic intent - that this is a deliberate approach to shield earnings from energy-price volatility; (5) Appropriately concludes that the consistency signals a deliberate cash-flow strategy. MINOR CONSIDERATIONS: (1) The LLM provides slightly more granular detail about the 2023-2024 MD&A disclosures regarding cost-pass-through mechanics than the ground truth explicitly states, but this is consistent with the ground truth's characterization and adds helpful context rather than contradicting it; (2) The phrasing 'vast majority' is appropriately cautious language that aligns with the ground truth's emphasis on consistent reliance without claiming 100% coverage. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022-2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects contractual structure to financial outcomes (cash flow stability, earnings protection, cost recovery). The logical chain is sound and matches the ground truth's reasoning. SEMANTIC EQUIVALENCE: The LLM's phrasing 'contract-driven cost recovery' and 'shield earnings from energy-price swings' conveys the same strategic intent as the ground truth's 'financial resilience and operational certainty over short-term pricing flexibility.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 531,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nFrom 2022 through 2024 GD kept non‑economic accounting changes—such as goodwill impairments and other one‑time adjustments—out of its ROIC calculation, using the same definition of net operating profit after taxes and average invested capital each year. This consistent exclusion shows that the company treats ROIC as a pure, core‑performance metric that isolates the return generated by its ongoing business, without the distortion of non‑recurring accounting items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024. The LLM provides specific examples (goodwill impairments and one-time adjustments) that illustrate the types of non-economic items excluded, which adds helpful detail without contradicting the ground truth. The reasoning is sound: both answers recognize this consistent exclusion as evidence of GD's stable methodology and its view that such items distort core operational performance measurement. The LLM's characterization of ROIC as a 'pure, core-performance metric' and its emphasis on isolating returns from 'ongoing business' without 'non-recurring accounting items' semantically matches the ground truth's assertion that GD 'views non-economic accounting changes as irrelevant to its underlying business performance' and has 'institutionalized this principle.' No quantitative errors are present (no specific numbers were required to answer this question). The multi-hop synthesis is correct: the answer properly connects the consistent treatment across three years to the broader insight about GD's performance measurement philosophy. Minor: The LLM could have been slightly more explicit about the 'institutionalization' aspect mentioned in the ground truth, but this is a very minor omission that doesn't materially affect the answer's quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 408,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings, UnitedHealth repeatedly disclosed in the “Commitments and contingencies” notes that **no material amounts were accrued, paid or charged to income for service‑level guarantees** in any of those years.  This consistent, immaterial impact shows that the company’s contractual performance obligations have been met without generating significant financial liabilities, reflecting a well‑controlled risk‑management environment and a stable, reliable record of fulfilling its service‑level commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core finding that UnitedHealth Group consistently disclosed immaterial amounts for service level guarantee obligations across 2022-2024. The key factual claims are correct: no material amounts were accrued, paid, or charged to income in any of the three years. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either the original or LLM answer, so this dimension is fully satisfied. The temporal scope (2022-2024) is correctly identified. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop reasoning: it identifies the pattern of immateriality across three years, correctly attributes this to the company's risk management controls and contractual performance, and draws the appropriate inference about consistency and reliability. The reasoning chain is sound and logically structured. (4) ENTITY ACCURACY: UnitedHealth Group is correctly identified, the financial metric (service level guarantees) is accurate, and the disclosure location (Commitments and contingencies notes) is appropriately referenced. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('no material amounts were accrued, paid or charged to income') is semantically equivalent to the ground truth's 'none of the amounts accrued, paid, or charged to income...were material.' The interpretation that this reflects 'well-controlled risk-management environment' and 'stable, reliable record' directly parallels the ground truth's assessment of 'strong risk management controls and contractual performance.' Minor differences in wording ('well-controlled' vs 'strong,' 'stable, reliable record' vs 'avoiding significant financial penalties') represent stylistic variation rather than factual divergence. The answer fully addresses the multi-part question regarding evolution, pattern, and implications for risk management effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 539,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue grew from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, reflecting a steady double‑digit increase in the segment’s backlog of destroyers (Flight III DDG‑51), auxiliary ships (ESB and T‑AO‑205) and related lifecycle services. This upward trajectory signals that GD is deliberately expanding its high‑value, complex surface‑combatant and support‑ship portfolio, positioning the company as a core, long‑term supplier within the U.S. Navy’s modernization and fleet‑renewal strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. Ground truth shows: 2022: $2,328M, 2023: $2,698M, 2024: $2,819M. LLM states: 2022: $2.56B ($2,560M), 2023: $2.70B ($2,700M), 2024: $2.82B ($2,820M). The 2022 figure is off by $232 million (9.9% error), 2023 is off by $2 million (0.07% - acceptable), and 2024 is off by $1 million (0.04% - acceptable). The 2022 error is substantial and represents a material misstatement of the baseline year. CALCULATION VERIFICATION: The LLM claims 'steady double-digit increase' but the actual year-over-year growth rates are: 2022-2023: 15.9%, 2023-2024: 4.5%. While 2022-2023 is double-digit, 2023-2024 is not, making the characterization partially inaccurate. MULTI-HOP REASONING: The LLM correctly synthesizes the trend (growth from 2022-2024) and provides relevant context about specific ship types (DDG-51 Flight III, ESB, T-AO-205) and strategic positioning. The reasoning about GD's role in naval modernization is sound and contextually appropriate. ENTITY ACCURACY: Company (General Dynamics), segment (Marine Systems), and time period (2022-2024) are correctly identified. SEMANTIC EQUIVALENCE: The qualitative assessment about strategic positioning and naval defense alignment matches the ground truth intent, though the LLM adds more specific ship-type details. OVERALL ASSESSMENT: While the LLM demonstrates good understanding of the strategic context and provides relevant qualitative analysis, the quantitative errors—particularly the 2022 baseline figure—are significant enough to warrant a low correctness score. Financial accuracy is paramount in SEC filing analysis, and a $232M discrepancy in the starting year is material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 479,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company (EIC) from an internal captive unit to a “held‑for‑sale” business.  In 2022 the subsidiary was classified as held‑for‑sale (with $541 million of assets and $378 million of liabilities as of Dec 31 2023) and a $109 million loss was recorded in 2023 earnings;  in 2024 GE completed the sale to Riverstone International Holdings for $120 million cash, removing the remaining assets and liabilities from its balance sheet and concluding the divestiture.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant chronological error that undermines accuracy. The ground truth clearly states that in 2022, EIC was disclosed as a captive insurer with $0.2 billion in net claim reserves, and only by 2023 was it classified as 'held for sale.' However, the LLM states 'In 2022 the subsidiary was classified as held‑for‑sale,' which is factually incorrect. The LLM appears to have conflated the 2022 disclosure with the 2023 held-for-sale classification. All other quantitative data is correct: the $541 million assets, $378 million liabilities (as of Dec 31, 2023), $109 million loss in 2023, and $120 million sale price to Riverstone in 2024 are accurate. The multi-hop synthesis of the three-year progression is mostly sound, and the answer correctly identifies the strategic shift from operational ownership to divestiture. However, the misstatement about when the held-for-sale classification occurred is a material error in a multi-hop question that requires precise temporal sequencing. The answer also omits the initial 2022 disclosure detail about the $0.2 billion net claim reserves, which provides important context about the company's financial position at the starting point. The reasoning about the divestiture process and its conclusion is logically sound, but the chronological inaccuracy prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 376,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2021 onward ConocoPhillips ran a staged “monetization” of its CVE common shares, completing the final 91 million‑share sale in the first quarter of 2022 and using the cash proceeds to fund part of its share‑repurchase program.  After the CVE proceeds were exhausted, the board enlarged the buy‑back authorization—from $25 bn to $45 bn in October 2022 and then to $65 bn in October 2024—while increasingly financing repurchases with operating cash flow, enabling the company to retire an additional ~50 million shares in 2023‑24 (total shares repurchased rising to 433 million at a cost of $34.3 bn by year‑end 2024).  This progression shows that the company’s capital‑allocation strategy shifted from relying on a one‑time asset‑sale cash infusion to a disciplined, cash‑driven policy of returning excess capital to shareholders through opportunistic equity retirements, while maintaining ample authorization for future buy‑backs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with excellent multi-hop synthesis and reasoning. STRENGTHS: (1) Correctly identifies the 91 million CVE shares sold in Q1 2022 and their application to repurchases; (2) Accurately states the final repurchase totals: 433 million shares at $34.3 billion by end of 2024; (3) Correctly identifies the authorization increases: $25bn to $45bn in October 2022, then to $65bn in October 2024; (4) Provides superior contextual analysis by explaining the strategic shift from asset-sale funding to operating cash flow financing; (5) Correctly notes approximately 50 million additional shares retired in 2023-24; (6) Excellent multi-hop reasoning connecting CVE monetization → initial repurchase funding → authorization expansion → cash flow-driven strategy. MINOR ISSUES: (1) The ground truth states the $45 billion authorization was already in place when CVE proceeds were applied, but the LLM implies the authorization was increased from $25bn to $45bn in October 2022 as a response to CVE exhaustion—this is a subtle timing/causality issue that may reflect different interpretations of the filing data; (2) The ground truth mentions 383 million shares repurchased at $29 billion by end of 2023, which the LLM does not explicitly state (though the 433 million total by 2024 is correct); (3) The LLM's statement about 'after CVE proceeds were exhausted' is reasonable inference but not explicitly confirmed in ground truth. QUANTITATIVE VERIFICATION: All key numbers check out—91M shares, 433M total, $34.3B cost, authorization amounts and dates. The ~50M additional shares calculation (433M - 383M = 50M) is mathematically sound. The answer provides richer strategic insight than the ground truth while maintaining factual accuracy on all verifiable metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 489,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure **exactly 59 % of the closed‑block** with an unaffiliated third‑party under a **modified coinsurance agreement**, and each year it accounted for the arrangement using the **deposit method**—offsetting the deposit liability against the deposit‑recoverable. This unchanged percentage and consistent deposit‑method accounting show that MetLife’s long‑term risk‑transfer strategy is to **incrementally shift a stable, pre‑determined slice of closed‑block risk to a third party while retaining the remainder on its books**, preserving capital and limiting volatility without a fundamental change in how the risk is managed. (Based on MET 10‑K pages 212‑216 (2022), 225‑229 (2023) and 202‑206 (2024).)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) Quantitative accuracy is excellent - the 59% reinsurance percentage is correctly stated and consistently applied across 2022-2024, matching the ground truth values (59.25% in 2022 rounds to 59%, 59% in 2023, 59% in 2024). (2) The accounting treatment is correctly identified as the deposit method with offset between deposit liability and deposit recoverable, consistent with ground truth. (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three years and identifies the unaffiliated third-party reinsurer. (4) The strategic interpretation is accurate - the answer correctly characterizes this as a stable, predetermined risk transfer strategy focused on longevity risk management. (5) Entity identification is correct (MetLife, closed block, modified coinsurance agreement). (6) The answer appropriately addresses all parts of the multi-part question: evolution (showing consistency), percentage of closed block reinsured, accounting treatment, and strategic implications. (7) Contextual relevance is high - the answer directly addresses what the consistency reveals about long-term risk transfer strategy. MINOR CONSIDERATIONS: The phrase 'exactly 59%' is slightly imprecise given that 2022 was 59.25%, though this is a very minor point and the rounding is reasonable for practical purposes. The answer's characterization of the strategy as 'incrementally shift' could be interpreted as suggesting change, but in context it clearly means maintaining a stable shift, which aligns with the ground truth's emphasis on consistency. The citation of specific page numbers adds credibility and demonstrates source verification. Overall, this is a high-quality answer that accurately synthesizes multi-hop information and provides sound strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 506,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe data show that the share of purchases made with Target’s co‑branded credit product (the Target MasterCard, later renamed the Target Circle Card) slipped steadily from about 20 percent of all transactions in the 2022‑2023 fiscal years to roughly 18.6 percent in 2024 (down from the ≈23 percent peak recorded in 2019). This ongoing decline suggests that consumer engagement with Target’s financial products has been gradually weakening, likely reflecting market saturation, competition from other payment options, or reduced incentive to use the RedCard discount.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall downward trend in penetration rates and provides reasonable qualitative analysis about consumer engagement weakening. The answer appropriately addresses the multi-part question about evolution and implications. The reasoning about market saturation and competition is sound and relevant.\n\nCRITICAL ERRORS: (1) The LLM states penetration was 'about 20 percent' in 2022-2023, but ground truth shows 20.5% in 2022 and 19.8% in 2023 - these are distinct values that should not be conflated. (2) The LLM provides a 2019 comparison point (≈23%) that is not in the ground truth answer and appears to be unsourced information, which violates the requirement to stick to provided data. (3) The LLM uses imprecise language ('roughly 18.6 percent') when the ground truth specifies exactly 18.6% for 2024.\n\nQUANTITATIVE ACCURACY ISSUES: While the 2024 figure (18.6%) is correct, the treatment of 2022-2023 data is imprecise and conflates two distinct years. The introduction of the 2019 baseline (23%) without ground truth support is problematic for a multi-hop question requiring synthesis of specific filing data.\n\nQUALITATIVE STRENGTHS: The reasoning about rebranding (RedCard to Target Circle Card) and its failure to reverse decline is sound. The analysis of underlying causes (market saturation, competition, reduced incentive) is logical and well-reasoned.\n\nMULTI-HOP SYNTHESIS: The answer demonstrates understanding that this requires tracking a metric across three fiscal years and connecting it to business strategy changes, but the execution is weakened by imprecise numbers and unsourced comparisons.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 454,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the PMI 10‑K filings show that Colgate‑Palmolive Co. stays in the PMI Peer Group used for the cumulative‑shareholder‑return graph, with no indication that it was added or removed in any year. This steady inclusion reveals that PMI’s strategic benchmarking relies on a stable set of global consumer‑product companies—chosen for comparable size, market presence and consumer‑focused portfolios—rather than altering the peer group annually.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that Colgate-Palmolive remained consistently in PMI's Peer Group from 2022-2024 with no additions or removals; (2) Accurately references the peer group's use in cumulative shareholder return graphs; (3) Correctly identifies the selection criteria (global presence, consumer products focus, comparable size/market capitalization); (4) Properly synthesizes the multi-hop information showing consistency across three years; (5) Appropriately interprets what this consistency reveals about PMI's benchmarking approach (stable methodology rather than annual changes). Quantitative accuracy is perfect—no numeric errors, dates are correct (2022-2024 period), and no calculations are required. The reasoning is sound and demonstrates proper multi-hop synthesis across multiple 10-K filings. Minor observation: The LLM answer uses slightly different phrasing ('cumulative-shareholder-return graph' vs. the ground truth's more general 'comparative benchmarking'), but this is semantically equivalent and actually more specific. The LLM also emphasizes 'no indication that it was added or removed in any year' which is a slightly stronger statement than the ground truth's 'remained consistently included,' but this is a reasonable interpretation of the same underlying fact. The answer fully addresses both parts of the question: (1) how the classification evolved (it didn't—remained consistent), and (2) what this reveals about PMI's strategic approach (stable, not reactive). No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 441,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nAMD’s revenue‑recognition framework for development and IP‑licensing arrangements kept the same core test from 2022 through 2024: it first determines whether the IP license is distinct (both capable of being distinct and distinct in the context of the agreement).  If the license is not distinct, it is combined with the development services and revenue is recognized over time; if the license is distinct, revenue is recognized at a point in time when the customer can benefit from the license.  The 2023 and 2024 filings merely refined the wording of this guidance—no substantive change to the criteria or timing of revenue recognition was introduced—demonstrating a consistent accounting approach across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing AMD's revenue recognition policy for development and IP licensing agreements from 2022-2024. STRENGTHS: (1) Correctly identifies the core two-part test for distinctness (capable of being distinct AND distinct in context), which is the fundamental framework; (2) Accurately describes the bifurcation logic: non-distinct licenses combined with development services recognized over time, distinct licenses recognized at point in time; (3) Correctly notes the consistency across all three years (2022-2024); (4) Properly identifies that refinements were wording-only, not substantive changes; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the absence of variable consideration estimates across the three years, which the ground truth specifically highlights as evidence of stable and uniform accounting policy. This is a notable detail that strengthens the conclusion about consistency; (2) The phrase 'when the customer can benefit from the license' in the LLM answer is slightly less precise than the ground truth's 'when the customer could benefit from the license' (modal verb difference), though semantically equivalent. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the evolution (or lack thereof) in AMD's accounting approach. The reasoning that wording refinements do not constitute substantive policy changes is sound and demonstrates proper multi-hop synthesis. OVERALL ASSESSMENT: The answer is factually correct and addresses the core question comprehensively, with only a minor omission regarding variable consideration that would have strengthened the completeness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 488,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the disclosed PMI Peer Group—used for the shareholder‑return performance graph and benchmarking—continues to list **Colgate‑Palmolive Co.** in each year. This unchanged inclusion shows that PMI treats Colgate‑Palmolive as a direct peer within its broader consumer‑products competitive set, reinforcing a strategic framing of PMI as a diversified consumer‑brand company that competes with large non‑tobacco consumer products firms as well as other tobacco companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Colgate-Palmolive's inclusion in PM's peer group across 2022-2024. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive was consistently included across all three years (2022, 2023, 2024) - matching the ground truth; (2) Accurately characterizes this as 'unchanged inclusion' showing consistency in PM's benchmarking methodology; (3) Properly synthesizes the multi-hop information by connecting the peer group consistency to strategic implications about PM's competitive positioning; (4) Correctly identifies the peer group's use in shareholder-return performance graphs and benchmarking; (5) Appropriately notes that this reflects PM's strategic framing as a diversified consumer-brand company competing with both tobacco and non-tobacco consumer products firms. MINOR CONSIDERATIONS: (1) The LLM answer uses 'PMI' (Philip Morris International ticker) while the ground truth uses 'PM' - both are correct references to the same company, representing acceptable variation; (2) The LLM answer adds slightly more context about PM's competitive positioning (mentioning both tobacco and non-tobacco competitors) compared to the ground truth, which is a reasonable elaboration that enhances rather than detracts from accuracy; (3) Both answers convey the same core insight about consistency and strategic relevance. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; no calculations required; entity identification (Colgate-Palmolive Co., PM/PMI) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information about peer group composition across three years and connects this to strategic implications about competitive positioning - the reasoning is sound and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 495,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings AMD continued to treat combined development‑service and IP‑licensing arrangements as one or more performance obligations and to evaluate whether the IP license is distinct. If the license is **not** distinct, it is combined with the development service and revenue is recognized **over time** as the service is performed; if the license **is** distinct, it is accounted for as a separate performance obligation and revenue is recognized **at a point in time** when the customer gains the ability to benefit from the license. The language was refined in 2023‑2024 to emphasize that no variable‑consideration estimates apply and that revenue recognition timing is governed by the transfer of control, but the underlying model for performance obligations and timing remained the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core policy framework for combined development and IP licensing agreements across 2022-2024; (2) Accurately describes the two-criterion test for distinctness (capable of being distinct AND distinct in context); (3) Correctly states that non-distinct licenses are combined with development services and recognized over time, while distinct licenses are recognized at a point in time; (4) Properly notes the absence of variable consideration estimates; (5) Accurately captures the consistency of the underlying model across the three-year period; (6) Appropriately identifies that language refinements occurred in 2023-2024 while emphasizing the stability of the core accounting treatment. MINOR CONSIDERATIONS: The LLM answer adds interpretive language about 'transfer of control' governing revenue recognition timing, which is a reasonable accounting principle but goes slightly beyond what the ground truth explicitly states. However, this is not factually incorrect—it represents a reasonable elaboration consistent with ASC 606 revenue recognition standards. The answer correctly emphasizes that despite any language refinements, the fundamental policy remained consistent, which is the core finding. NO QUANTITATIVE ERRORS: There are no numbers, dates, percentages, or calculations to verify, and the temporal references (2022-2024, 2023-2024) are all accurate. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and correctly identifies the evolution (or lack thereof) in the policy. The reasoning is sound and logically structured. The answer fully addresses the question's focus on how the policy 'evolved' by correctly noting that it remained consistent while acknowledging minor language refinements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 511,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips completed the paced sale of its remaining 91 million CVE shares in early 2022 and used those proceeds to fund part of its buy‑back program, then accelerated repurchases in 2023 (e.g., 48.6 million shares bought that year) and, in 2024, raised the board‑approved authorization to $65 bn and executed a total of 433 million shares repurchased for $34.3 bn since the program’s inception. This multi‑year progression shows that the company is deliberately scaling a cash‑driven shareholder‑return strategy—first leveraging the CVE monetization proceeds and then expanding buy‑backs as cash flow and market conditions allow—reflecting a disciplined capital‑allocation focus on returning excess cash to investors while maintaining flexibility for future investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of ConocoPhillips' capital allocation strategy and correctly identifies most key facts and figures. STRENGTHS: (1) Correctly states 91 million CVE shares sold in early 2022; (2) Accurately cites the $65 billion board authorization in 2024; (3) Correctly reports 433 million total shares repurchased for $34.3 billion by year-end 2024; (4) Properly synthesizes the multi-hop connection between CVE monetization and share repurchase funding; (5) Provides sound reasoning about the company's disciplined capital allocation strategy. WEAKNESSES: (1) The LLM states '48.6 million shares bought that year' for 2023, which appears to be a specific annual figure not verified in the ground truth (ground truth only provides cumulative figures: 383 million shares at $29 billion through end of 2023); (2) Missing the explicit statement that cumulative repurchases reached 383 million shares at $29 billion by end of 2023, which is important context for understanding the progression; (3) The phrasing 'since the program's inception' for the 433 million/34.3 billion figures could be clearer—these are cumulative through 2024, not just 2024 activity. CALCULATION VERIFICATION: The numbers provided (91M CVE shares, $65B authorization, 433M shares, $34.3B cost) all match ground truth. The 48.6M figure for 2023 is not contradicted but also not confirmed in the ground truth provided. MULTI-HOP REASONING: The answer correctly synthesizes the connection between CVE monetization (2022) and its application to share repurchases, and traces the evolution through 2024. The logic about 'cash-driven shareholder-return strategy' is sound and well-reasoned. SEMANTIC EQUIVALENCE: The answer conveys the essential information and strategic narrative effectively, though with minor gaps in cumulative context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 499,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 to 2024 Honeywell’s competitive exposure moved from volume‑driven, commoditized segments—particularly Warehouse & Workflow Solutions and Productivity Solutions & Services, which posted double‑digit organic sales declines and a 17 % drop in segment profit in 2023—to a reshaped portfolio that isolates those vulnerable businesses and concentrates on higher‑margin, technology‑focused units (Industrial Automation, Energy & Sustainability Solutions, Aerospace Technologies).  The 2023‑2024 realignment, including the announced spin‑off of Advanced Materials and the creation of separate Industrial Automation and Energy & Sustainability reporting segments, reflects mounting market pressures such as new entrants, pricing and commoditization risks, and macro‑economic volatility, prompting Honeywell to reposition, divest and refocus its strategy on differentiated growth areas.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misaligns with the ground truth in multiple critical ways: (1) ENTITY MISMATCH: The ground truth specifically identifies Honeywell Building Technologies, Safety and Productivity Solutions, Building Automation, and Industrial Automation as the segments with competitive landscape concerns. The LLM introduces 'Warehouse & Workflow Solutions' and 'Productivity Solutions & Services' which are not mentioned in the ground truth as having competitive landscape disclosures. (2) QUANTITATIVE ERRORS: The LLM cites specific metrics ('double-digit organic sales declines' and '17% drop in segment profit in 2023') that are not present in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be fabricated or from unrelated sources. (3) STRATEGIC NARRATIVE DIVERGENCE: The ground truth focuses on Honeywell's disclosed concerns about 'new market entrants and new technologies' leading to 'product commoditization' across a 3-year period. The LLM shifts the narrative to portfolio restructuring, spin-offs, and segment realignment—while these may be real strategic responses, they are not the focus of the ground truth answer about competitive landscape exposure evolution. (4) MISSING CORE ANALYSIS: The LLM fails to address the key ground truth finding: the consistent and expanding concern about competitive pressures from 2022-2024, with specific language about new entrants and technologies threatening differentiation. Instead, it pivots to business unit performance and portfolio actions. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about 'exposure to changes in the competitive landscape' across segments from 2022-2024. The ground truth synthesizes this by tracking consistent risk language across years and segments. The LLM attempts a different synthesis (portfolio performance and restructuring) that doesn't directly address the competitive landscape exposure question. The answer demonstrates some understanding of Honeywell's strategic challenges but fundamentally misses the specific competitive landscape disclosure trends that form the basis of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 581,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares consistently retained **one vote per share** and continued to carry dividend rights.  The cash dividend per share rose each year—$2.04 in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting structure remained unchanged.  This three‑year stability demonstrates a deliberate governance strategy that preserves shareholder‑level control (one‑vote‑per‑share) while progressively increasing cash returns, reinforcing investor confidence and a steady, predictable equity‑holder policy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The original answer explicitly states only that A Class shares carry 'dividend rights' without specifying actual dividend amounts or their year-over-year changes. The LLM appears to have fabricated these specific numbers, which is a serious factual error. CORRECT ELEMENTS: The LLM correctly identifies that A Class shares maintained one vote per share across all three years (2022-2024) with no changes, which matches the ground truth. The characterization of this as a 'stable governance strategy' is semantically aligned with the ground truth's statement about 'stable governance and capital structure strategy.' REASONING ISSUES: While the LLM's logic about stability demonstrating deliberate governance strategy is reasonable, it goes beyond what the ground truth supports by adding interpretive claims about 'progressively increasing cash returns' and 'reinforcing investor confidence' without evidentiary basis in the provided ground truth. MULTI-HOP SYNTHESIS: The answer fails to properly synthesize information—it conflates the stability of voting/dividend RIGHTS (which is what the ground truth addresses) with actual dividend PAYMENTS (which the LLM introduces without source). The question asks about 'dividend and voting rights...evolve' and what 'consistency reveals,' not about actual dividend payment amounts. The LLM misinterprets the scope of the question by introducing unverified financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 436,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s total‑return‑swap exposure tied to deferred compensation went from a **$92 million loss recorded in operating expenses in FY 2022** to **gains of $58 million in FY 2023 and $91 million in FY 2024**, showing a reversal from a drag on earnings to an increasingly positive contribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million. The multi-hop synthesis is sound, correctly tracking the evolution across three fiscal years and identifying the key reversal from loss to gains. The answer properly characterizes the financial exposure through Total Return Swaps-Deferred Compensation and accurately describes the trajectory from 'a drag on earnings to an increasingly positive contribution.' The wording differs slightly from the ground truth (e.g., 'went from' vs 'shifted significantly from') but conveys identical semantic meaning. The answer addresses all parts of the question: the specific amounts, the years involved (2022-2024), and the overall trend/evolution. The reasoning about the reversal from net cost to net benefit is logically sound and well-supported by the numbers. Minor deduction from perfect score only due to slightly different phrasing in the characterization, though this does not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 311,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from a single $2 billion reserve created after the 2021 creation of LTL Management LLC to a multi‑phase bankruptcy strategy—filing the original LTL Chapter 11 case in late 2021, seeing that case dismissed in 2023, then launching a second “LTL 2” filing and, in 2024, establishing a new “pre‑packaged” Chapter 11 plan through the Red River Talc LLC that would fund a $6.5 billion present‑value trust over 25 years to resolve the talc claims.  At the same time the company shifted from relying on litigation defenses to negotiating multi‑state settlements, culminating in a June 2024 agreement with 42 states and the District of Columbia and a total talc‑related reserve of roughly $11–13 billion (nominal) to cover probable losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) TIMELINE ERROR - LLM states original LTL Chapter 11 filed in 'late 2021' but ground truth indicates 2022 as the establishment year with bankruptcy filing. This is a significant chronological error. (2) RESERVE AMOUNTS - LLM introduces $6.5 billion present-value trust and $11-13 billion nominal total reserves that are NOT mentioned in the ground truth. The ground truth only references the $2 billion reserve established in 2022. These appear to be fabricated numbers not supported by the original answer. (3) RED RIVER TALC LLC - LLM introduces 'Red River Talc LLC' and 'pre-packaged Chapter 11 plan' concepts that do not appear in the ground truth at all. This represents hallucination of entities and structures. (4) PARTIAL ACCURACY - LLM correctly identifies: the 2023 Third Circuit reversal, LTL 2 re-filing, 42 states + DC settlement in 2024, and the shift from bankruptcy-focused to dual strategy approach. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize the evolution across years, it does so by introducing unsupported financial figures and entities, undermining the reliability of the synthesis. The core narrative structure is partially correct but contaminated with inaccurate details. (6) GROUND TRUTH ADHERENCE - The original answer is more conservative and specific, limiting claims to what can be verified. The LLM answer expands significantly beyond the ground truth with unsubstantiated claims about reserve amounts and bankruptcy structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 415,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 showed a flat balance of roughly **$495 million** at the end of fiscal 2022, continued to be $495 million at the end of fiscal 2023, and remained $495 million as of the FY 2024 reporting date (Nov 3 2024) — the same figure disclosed in the “2017 Senior Notes – fixed rate” table. This unchanged, relatively small position indicates that Broadcom is treating this legacy tranche as a stable, long‑term funding source that it plans to hold to maturity and settle with cash or broader refinancing, rather than actively issuing, retiring, or refinancing it early, reflecting a conservative debt‑management approach for this specific instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $495 million is stated consistently for fiscal years 2022, 2023, and 2024, matching the ground truth exactly. The date reference (January 2025 maturity, Nov 3 2024 FY2024 reporting date) is accurate. No calculation errors present. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the principal balance across three fiscal years, (2) the specific instrument identification (3.125% notes due January 2025), and (3) interpretation of debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) correctly identified, fiscal years 2022-2024 properly referenced, and the specific debt instrument accurately characterized. REASONING QUALITY: The LLM correctly synthesizes that the constant $495 million balance across three years indicates no retirement, issuance, or early refinancing activity. The interpretation that this reflects a conservative, hold-to-maturity approach is sound and goes slightly beyond the ground truth by adding context about settlement strategy (cash or broader refinancing). SEMANTIC EQUIVALENCE: The LLM's phrasing 'flat balance,' 'unchanged,' and 'stable funding source' conveys the same meaning as the ground truth's 'remained constant' and 'consistent approach.' The additional detail about treating it as a 'legacy tranche' and 'conservative debt-management approach' adds valuable context without contradicting the ground truth. MINOR OBSERVATION: The LLM references a '2017 Senior Notes – fixed rate' table, which provides source documentation but is not explicitly mentioned in the ground truth. This adds credibility without introducing inaccuracy. Overall, the answer demonstrates strong multi-hop synthesis across three fiscal years and provides accurate financial data with sound interpretive reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 512,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nThe $500 million 3.50 % senior note maturing on June 15 2025 showed a steep rise in its effective borrowing cost: 3.20 % in fiscal 2022 (as reported in the 2022 filing), ≈ 6.38 % in fiscal 2023, and ≈ 6.66 % in fiscal 2024. This upward progression indicates that Cisco’s debt‑service expenses have risen substantially over the period, reflecting higher market interest rates and the impact of related hedging adjustments on the note’s effective yield.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three effective interest rate figures are correct - 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024). The maturity date (June 15, 2025) and coupon rate (3.50%) are accurate. The principal amount ($500 million) is correctly identified. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) identifies the specific note, (2) traces the evolution across all three fiscal years, (3) provides interpretation of the trend. ENTITY ACCURACY: Cisco is correctly identified, fiscal years are properly sequenced, and the financial metrics are appropriately labeled. REASONING QUALITY: The LLM correctly synthesizes the upward progression and provides sound interpretation - the explanation that this reflects \"higher market interest rates and the impact of related hedging adjustments\" is a reasonable and contextually appropriate explanation for the effective rate increase beyond the stated coupon rate. MINOR CONSIDERATIONS: The use of \"≈\" (approximately) before 6.38% and 6.66% is slightly imprecise since these appear to be exact figures from the filings, though this is a very minor stylistic issue. The answer adds helpful context about debt-service expenses and hedging adjustments, which enhances understanding without introducing inaccuracy. The semantic meaning aligns perfectly with the ground truth - both convey that effective rates rose substantially from 3.20% to 6.38% to 6.66%, indicating deteriorating financing terms. No calculation errors detected. The multi-hop synthesis across three fiscal years is executed correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 453,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior and subordinated notes held roughly $30.8 bn at the end of 2022, edged up to $31.2 bn in 2023, and then slipped to $30.7 bn by the end of 2024. The modest 2023 rise reflected incremental issuance, while the 2024 decline—driven by a pull‑back in floating‑rate senior debt and a slight shift toward longer‑dated subordinated issuance—shows a deliberate de‑leveraging and a move to lock in more stable, fixed‑rate funding amid rising rates. This progression reveals Capital One’s capital‑structure strategy is focused on maintaining a relatively flat debt base while optimizing the mix toward longer‑term, fixed‑rate instruments to manage interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers that are essential to answering this question. (1) WRONG 2022 FIGURE: LLM states '$30.8 bn' for 2022, but ground truth shows $27.219 billion—a $3.6 billion discrepancy (13% error). This is a major error for the starting point of a 3-year progression analysis. (2) CORRECT 2023 FIGURE: LLM states '$31.2 bn' which matches ground truth of $31.248 billion (acceptable rounding). (3) CORRECT 2024 FIGURE: LLM states '$30.7 bn' which matches ground truth of $30.696 billion (acceptable rounding). (4) MISSING CRITICAL INTEREST RATE DATA: The ground truth explicitly provides weighted average interest rates (2.76% in 2022, 4.48% in 2023, 4.84% in 2024), which are central to understanding the 'interest rate positioning' aspect of the question. The LLM answer completely omits these specific percentages, instead offering only vague references to 'fixed-rate' vs 'floating-rate' without quantification. (5) REASONING QUALITY: While the LLM correctly identifies the strategic shift toward fixed-rate instruments and interest-rate risk management, the analysis is undermined by the incorrect 2022 baseline. The characterization of the progression as 'modest 2023 rise' and 'relatively flat debt base' is contradicted by the actual 15% increase from 2022 to 2023 ($27.2B to $31.2B). (6) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the relationship between debt levels and interest rate changes across the three years. The ground truth shows a clear correlation: as rates rose, Capital One shifted to fixed-rate financing, which is a key strategic insight missing from the LLM's analysis. The LLM's statement about 'maintaining a relatively flat debt base' is factually incorrect given the substantial 2022-2023 increase. SUMMARY: The answer demonstrates partial understanding of capital structure strategy but fails on fundamental quantitative accuracy (wrong 2022 baseline) and omits critical interest rate metrics that directly address the 'interest rate positioning' component of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 568,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the proportion of U.S. Treasury and agency securities in the Company’s U.S. pension‑plan fixed‑income portfolio dropped from **about 40 %** (as reported for 2022) to **roughly 30 %** by the end of 2023 and again in 2024.  This pull‑back from Treasuries signals that Colgate‑Palmolive is rebalancing its pension fund toward a more diversified mix of government, corporate and other bonds—likely to broaden income sources, manage interest‑rate exposure, and better align the portfolio with long‑term funding and return objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All numerical values are correct - 40% in 2022, 30% in 2023, and 30% in 2024. The percentages match the ground truth exactly. ENTITY ACCURACY: Correctly identifies Colgate-Palmolive, U.S. pension plan, fixed-income portfolio, and U.S. treasury/agency securities. Time periods (2022-2024) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes the evolution of allocations across three years and connects this to strategic implications. The reasoning about rebalancing toward diversified bonds is sound and matches the ground truth's interpretation. SEMANTIC EQUIVALENCE: The LLM's explanation of the shift as 'rebalancing its pension fund toward a more diversified mix of government, corporate and other bonds' is semantically equivalent to the ground truth's 'strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds.' The LLM adds slightly more detail about the motivations (broadening income sources, managing interest-rate exposure, aligning with long-term objectives) which enhances the answer without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM uses 'roughly 30%' and 'about 40%' which appropriately conveys the approximate nature of the percentages. The phrasing 'pull-back from Treasuries' is a clear, colloquial way to describe the reduction. No calculation errors detected. The answer fully addresses both parts of the question: the evolution of allocations AND what it suggests about pension fund strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 440,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company (EIC) from a **held‑for‑sale captive insurer**—carrying roughly **$541 million of assets and $378 million of liabilities** (with modest net claim reserves of $0.2–0.3 billion) and classified in the 2022 “business held for sale” tables—to a **signed sale agreement in Q2 2023** (targeting completion in H1 2024) and finally to a **completed disposal in Q2 2024** for **$120 million of cash**, which required a **$109 million loss** on the transaction.  \n\nThis progression underscores GE’s **strategic pivot away from non‑core, low‑margin insurance operations** and its intent to **streamline the portfolio, off‑load legacy captive structures, and concentrate resources on its core industrial, energy and aviation businesses**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative arc (2022 held-for-sale status → 2023 signed agreement with $109M loss → 2024 completed sale for $120M) and accurately captures the strategic rationale (divesting non-core insurance operations to focus on industrial/aerospace). However, there are significant quantitative accuracy issues: (1) The LLM introduces asset ($541M) and liability ($378M) figures that are NOT present in the ground truth answer and cannot be verified against it. These appear to be fabricated or sourced from unverified filing data. (2) The LLM states the sale agreement was signed in 'Q2 2023' with completion targeted for 'H1 2024,' but the ground truth only confirms the sale was 'completed in 2024' without specifying quarters. (3) The LLM characterizes EIC as 'held-for-sale' in 2022, but the ground truth indicates it was disclosed as a 'captive property and casualty insurance subsidiary' in 2022 and only classified as 'held for sale' by 2023. This is a material mischaracterization of the 2022 status. The core financial figures that ARE verifiable ($0.2B net claim reserves, $109M loss, $120M sale price) are correct. The multi-hop reasoning is sound—the answer successfully synthesizes the three-year progression and connects it to strategic intent. However, the introduction of unverified balance sheet figures ($541M assets, $378M liabilities) and the temporal misplacement of the 'held-for-sale' classification in 2022 represent factual errors that reduce confidence in the answer's reliability. The qualitative assessment of strategic direction is appropriate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 445,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to present the $4.45 % Notes due 2044 in the “Long‑term debt” section, reproducing the same issuance language from the 2014 officer’s certificate and showing no material change to the instrument’s terms. This consistent, year‑over‑year disclosure signals that Apple treats the 2044 notes as a stable, low‑cost component of its capital structure, using long‑dated, fixed‑rate bonds to lock in financing at favorable rates and maintain a predictable, diversified debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.45% Notes due 2044 and accurately references the May 6, 2014 Officer's Certificate date. It correctly notes the consistent year-over-year disclosure across 2022, 2023, and 2024 filings. The percentage (4.45%) and maturity year (2044) are accurate. The core factual claim about stable, unchanged disclosure is correct.\n\nWEAKNESSES: (1) QUANTITATIVE: The LLM states '$4.45%' which is a formatting error - it should be '4.45%' (the dollar sign is incorrect for a percentage rate). This is a minor but notable error. (2) QUALITATIVE/REASONING: The LLM adds interpretive analysis ('low-cost component,' 'lock in financing at favorable rates,' 'predictable, diversified debt profile') that goes beyond what the ground truth supports. The ground truth explicitly states the pattern 'suggests a stable long-term capital structure and no material changes or retirements' - it does NOT characterize the notes as 'low-cost' or make claims about Apple's strategic intent to 'lock in financing at favorable rates.' These are reasonable inferences but represent unsupported speculation beyond the filing disclosures. (3) COMPLETENESS: The LLM adequately addresses the multi-year pattern evolution and the strategic implications, matching the ground truth's scope. (4) MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three years and identifies the consistent pattern, which is appropriate for the multi-hop nature of the question.\n\nCRITICAL ISSUE: The '$4.45%' formatting error and the addition of unsupported strategic characterizations (calling it 'low-cost,' claiming it's used to 'lock in financing at favorable rates') represent departures from the factual ground truth. The ground truth is more conservative, stating only that consistency 'suggests' stability without making claims about Apple's strategic motivations or the relative cost of the instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 519,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nThe carrying value of Capital One’s senior and subordinated notes fell from $31.2 bn in 2022 to $30.7 bn in 2023 and remained essentially flat at $30.7 bn in 2024, signaling a deliberate de‑leveraging and a more stable capital structure. This reduction reflects a strategic shift toward limiting new long‑term debt while keeping the weighted‑average interest rate on the remaining notes steady around 2.8‑3.0%, underscoring a focus on affordable financing amid a higher‑for‑longer rate environment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors across all key metrics:\n\n(1) QUANTITATIVE ERRORS - CRITICAL:\n- 2022 carrying value: LLM states $31.2bn, but ground truth is $27,219 million ($27.2bn). This is a $4 billion error (15% overstatement).\n- 2023 carrying value: LLM states $30.7bn, but ground truth is $31,248 million ($31.2bn). This is a $500 million error in the opposite direction.\n- 2024 carrying value: LLM correctly states $30.7bn ($30,696 million), but this is the only correct number.\n- The LLM completely inverts the trend: claims values fell from 2022-2023, when they actually INCREASED by ~$4 billion.\n- Weighted-average interest rate: LLM states 2.8-3.0%, but ground truth shows 2.76% (2022) to 4.84% (2024). The LLM understates the 2024 rate by nearly 2 percentage points and misses the dramatic 2.08 percentage point increase.\n\n(2) MULTI-HOP REASONING FAILURE:\n- The LLM fundamentally misunderstands the capital structure evolution. Ground truth shows a net increase of ~$3.5 billion over three years, indicating EXPANSION, not de-leveraging.\n- The LLM incorrectly characterizes this as \"deliberate de-leveraging\" when the data shows the opposite.\n- The LLM fails to recognize the strategic shift from floating-rate to fixed-rate debt that occurred during the rising rate environment.\n\n(3) STRATEGIC INTERPRETATION ERROR:\n- Ground truth correctly identifies a strategic move toward longer-term fixed-rate financing to lock in rates during a rising rate environment.\n- LLM incorrectly suggests the company was limiting new long-term debt and maintaining \"affordable financing,\" which contradicts the actual increase in debt and rising interest rates.\n- The LLM's narrative about \"steady\" interest rates around 2.8-3.0% is factually wrong; rates nearly doubled to 4.84%.\n\n(4) ENTITY AND CONTEXT ACCURACY:\n- Company identification (Capital One/COF) is correct.\n- Time period (2022-2024) is correct.\n- However, the interpretation of what the data means is completely inverted.\n\nThe LLM answer demonstrates a fundamental failure to accurately extract and synthesize the financial data from the source documents, resulting in an answer that contradicts the ground truth on nearly every quantitative and qualitative dimension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 610,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nAcross the three fiscal years Adobe moved Frame.io from a newly‑acquired, stand‑alone collaboration hub (2022) to a tightly‑woven element of the Creative Cloud ecosystem—first by embedding it in Premiere Pro and After Effects for frame‑accurate review (2023), and then by extending that native integration to additional Creative Cloud apps such as Photoshop, Lightroom and Workfront, and making it a core component of Adobe GenStudio for end‑to‑end content creation and publishing (2024). This evolution positioned Frame.io as the collaborative backbone that links video, design and marketing workflows within Adobe’s cloud‑based creative platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: All core facts are accurate - Frame.io's 2022 status as a newly-acquired standalone product, its 2023 positioning as a cloud-native collaboration platform with integration into Premiere Pro and After Effects, and its 2024 expansion to Photoshop, Lightroom, Workfront, and Adobe GenStudio. The answer correctly identifies the progression of integration depth and strategic emphasis. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable. The years (2022, 2023, 2024) are correctly referenced. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and multiple product integrations, correctly tracing the evolution from standalone product to ecosystem-integrated platform. The reasoning chain is logical and complete. (4) ENTITY ACCURACY: All entities are correctly identified - Adobe, Frame.io, Creative Cloud, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and Adobe GenStudio are all properly named and contextualized. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different but semantically equivalent language compared to the ground truth. For example, 'cloud-native creative collaboration platform' (ground truth) is conveyed as 'collaboration hub' and 'collaborative backbone' (LLM), which captures the same concept. The LLM's characterization of Frame.io as 'the collaborative backbone that links video, design and marketing workflows' adds interpretive value while remaining faithful to the ground truth. Minor difference: The ground truth mentions Frame.io was 'listed as a registered trademark' in 2022, while the LLM describes it as 'newly-acquired, stand-alone collaboration hub' - both are accurate but emphasize different aspects of the 2022 status. The LLM's framing is arguably more substantive for understanding the product's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 544,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nLowe’s repeatedly cites the 4.550 % Notes due April 5 2049—first created in the 2019 Fifteenth Supplemental Indenture and continued to appear in its 2022‑2024 filing exhibits—showing that the company treats this long‑dated, fixed‑rate tranche as a core pillar of its capital structure. By keeping the 2049 maturity visible in each annual filing, Lowe’s is deliberately extending the average life of its debt, locking in financing at a known rate for the next two‑plus decades and reducing near‑term refinancing risk while maintaining flexibility to layer newer, shorter‑term borrowings around it. This pattern reflects a strategy of managing the debt‑maturity profile through a “laddered” approach that emphasizes a stable, long‑term funding base to support sustained growth and cash‑flow predictability.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Lowe's debt management strategy and correctly identifies key elements of the ground truth. STRENGTHS: (1) Correctly identifies the 4.550% Notes due April 5, 2049 with accurate percentage and date; (2) Accurately notes the notes' consistent appearance across 2022-2024 filings; (3) Correctly interprets this as indicating no early redemption or refinancing during the period; (4) Properly characterizes the strategy as emphasizing long-term stability and predictability; (5) Adds valuable context about the 2019 Fifteenth Supplemental Indenture origin and the 'laddered' debt approach. MINOR ISSUES: (1) The LLM introduces the concept of a 'laddered' debt approach and mentions 'newer, shorter-term borrowings' which, while logically sound and consistent with typical debt management practices, goes slightly beyond what the ground truth explicitly states. The ground truth mentions 'other notes with shorter maturities' but doesn't explicitly characterize this as a deliberate laddering strategy; (2) The phrase 'two-plus decades' is accurate (2049 is approximately 25 years from 2024) but represents a minor extrapolation beyond the filing data itself. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the strategic implications of consistent inclusion without modification. The reasoning about interest rate risk management and refinancing risk reduction is sound and aligns with the ground truth's emphasis on stability. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth—that Lowe's maintains this debt as a stable, long-term component of its capital structure without modification—though with somewhat more elaborate strategic framing. The answer is contextually appropriate and directly addresses the question about capital structure strategy and debt maturity profile management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 528,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nBroadcom’s 3.125 % senior notes maturing in January 2025 carried a carrying‑value of about **$495 million** at the end of fiscal 2022, and that figure remained essentially unchanged through fiscal 2023 and fiscal 2024 (the same $495 million was reported as of the 2024 and 2023 year‑ends).  This flat trajectory shows that the company is not aggressively paying down this specific tranche; instead it is being held to maturity (or refinanced as part of broader debt‑management actions such as the 2023‑24 term‑loan and senior‑note repayments), reflecting a strategy of managing cash flows and rolling newer debt rather than directly retiring the 3.125 % notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $495 million outstanding principal balance for the 3.125% notes due January 2025 across all three fiscal years (2022, 2023, 2024). (2) The numeric values are accurate and properly formatted. (3) The LLM correctly recognizes the stability/consistency of the balance across the period. (4) The company name (Broadcom) and debt instrument details are correct.\n\nWEAKNESSES: (1) The LLM introduces speculative reasoning about 'broader debt-management actions such as the 2023-24 term-loan and senior-note repayments' that goes beyond what the ground truth states. The ground truth simply notes the stability indicates 'a deliberate debt management strategy' without speculating about other debt actions. (2) The phrase 'held to maturity (or refinanced as part of broader debt-management actions)' presents alternatives that aren't grounded in the specific data about this instrument. (3) The LLM's interpretation about 'rolling newer debt rather than directly retiring the 3.125% notes' adds inference not explicitly supported by the ground truth, which focuses on the preservation of this specific liability. (4) The ground truth emphasizes 'no repayments or additional issuances' as the key finding, while the LLM shifts focus to broader debt management strategy speculation.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year trend (2022-2024) and identifies the consistency. However, it overextends by introducing external debt management actions not directly tied to this specific instrument's data.\n\nSEMANTIC EQUIVALENCE: While the core finding (stable $495M balance) is correct, the interpretation diverges. The ground truth emphasizes deliberate preservation of this liability; the LLM emphasizes it being 'held to maturity' with speculation about refinancing and broader debt actions. These are subtly different strategic interpretations.\n\nCALCULATIONS: No calculations required; the answer correctly reports the same $495M figure across three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 545,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nAcross the three filings IBM moved from a bare‑bones line‑item listing of the 0.950% Notes due 2025 in the 2022 long‑term‑debt schedule (pp. 28‑32) to a 2023 footnote that added detail on the notes’ callable feature, covenant compliance and the re‑classification of a portion as current as they approached maturity (pp. 18‑22). By the 2024 filing the notes were explicitly named in the securities‑registration table and discussed as part of IBM’s broader strategy to manage maturing debt and extend the average tenor of its long‑term financing (pp. 1‑5). This progression shows a shift from passive disclosure to an active, transparent capital‑structure strategy that emphasizes proactive debt‑maturity management and greater investor visibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and diverges substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific page numbers (pp. 28-32 for 2022, pp. 18-22 for 2023, pp. 1-5 for 2024) that cannot be verified and appear fabricated. These page references are presented as facts but lack grounding in actual filings. (2) FACTUAL INACCURACIES: The ground truth establishes that the 0.950% Notes due 2025 were listed on the NYSE under ticker IBM25B in 2024, representing a shift to active market visibility. The LLM answer completely omits this critical fact and instead discusses callable features, covenant compliance, and debt-maturity management strategies that are not mentioned in the ground truth. (3) MISSING KEY INFORMATION: The LLM fails to mention the May 2017 Form 8-K reference that appears consistently across 2022-2023 filings, which is a core element of the ground truth narrative. The NYSE listing under IBM25B ticker is entirely absent from the LLM response. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize a progression narrative (2022→2023→2024), it does so by inventing details rather than accurately synthesizing the actual evolution described in the ground truth. The narrative about 'callable features' and 'covenant compliance' appears to be hallucinated content not supported by the ground truth. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes a transition from 'disclosure to active market visibility and tradability,' while the LLM emphasizes 'passive disclosure to active capital-structure strategy' with focus on debt-maturity management. These are fundamentally different narratives. The LLM answer reads plausibly but is factually incorrect on multiple dimensions, particularly regarding the NYSE listing and specific disclosure details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 497,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe Public Company Accounting Oversight Board (PCAOB) firm identification number for KPMG LLP that is disclosed in the 2022, 2023 and 2024 Form 10‑K filings is 185, and this number has remained unchanged across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key elements of the question. (1) CORRECTNESS: The PCAOB firm identification number of 185 for KPMG LLP is accurately stated, and the claim that it remained consistent across 2022, 2023, and 2024 filings matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: The numeric value (185) is correct with no calculation errors. (3) MULTI-HOP REASONING: The answer correctly synthesizes information across three separate years (2022, 2023, 2024) and properly identifies the consistency pattern across all three periods. (4) ENTITY ACCURACY: KPMG LLP is correctly identified, the PCAOB is correctly referenced, and all three fiscal years are properly cited. (5) COMPLETENESS: The answer addresses both parts of the question - identifying the specific number (185) and confirming its consistency across all three years. The only minor difference from the ground truth is stylistic: the LLM uses 'Form 10-K filings' while the ground truth simply says 'filings,' but this is a negligible semantic variation that adds appropriate context. The answer is clear, accurate, and directly responsive to the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 331,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s Fixed Unsecured Senior Debt moved from a low‑coupon, longer‑dated issuance profile (weighted‑average rates ≈ 2.9 % with maturities to 2032 and a carrying value of roughly $20 bn) to a modestly lower average rate of about 2.76 % in 2023 but with larger issuances, and then to a markedly higher‑rate issuance in 2024 (weighted‑average ≈ 4.8 %, maturities extending to 2035 and a carrying value near $27 bn).  This evolution shows the firm deliberately lengthening the debt horizon and shifting to higher‑fixed‑rate funding to lock in financing as interest rates rose, reflecting a more defensive capital‑structure stance that prioritises stability and liquidity amid a higher‑rate macro environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core trend (increase in Fixed Unsecured Senior Debt from ~$20bn to ~$27bn, with weighted-average rates rising from ~2.9% to ~4.8%), captures the strategic intent (lengthening debt horizon, locking in higher rates amid rising rate environment), and provides sound qualitative reasoning about defensive capital structure positioning. The semantic interpretation of the multi-year evolution is accurate and well-articulated.\n\nWEAKNESSES & ERRORS: (1) QUANTITATIVE INACCURACY - The LLM introduces a 2023 intermediate data point (weighted-average rate of ~2.76%) that is NOT in the ground truth answer. The ground truth only provides 2022 and 2024 data points. This appears to be fabricated or inferred data not supported by the original filing information. (2) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM provides more narrative detail than the ground truth, it adds unsupported specifics (maturity dates to 2032 and 2035, the 2023 intermediate rate) that cannot be verified against the provided ground truth. (3) PRECISION ISSUE - The ground truth states the 2024 rate as 4.84%, while the LLM rounds to 4.8%. While minor, this is a rounding that slightly reduces precision.\n\nVERIFICATION: Ground truth numbers: 2022: $19,975M → 2024: $26,930M (LLM says ~$20bn to ~$27bn - acceptable format variation); 2022 rate: 2.91% (LLM says ≈2.9% - acceptable); 2024 rate: 4.84% (LLM says ≈4.8% - acceptable rounding). However, the 2023 intermediate data point (2.76%) is NOT in the ground truth and represents either fabrication or unsupported inference.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between debt issuance amounts, interest rates, and macroeconomic conditions. The logic connecting rising rates to fixed-rate debt strategy is sound. However, the introduction of unsupported intermediate data undermines the reliability of the multi-hop synthesis.\n\nJUSTIFICATION: The answer demonstrates good qualitative understanding and mostly correct quantitative data for the 2022-2024 endpoints, but the insertion of unverified 2023 data and specific maturity dates reduces correctness. The core insight is right, but the execution includes fabricated details that violate strict factual accuracy standards for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 613,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nAMD’s disclosures for 2022, 2023 and 2024 all describe the same revenue‑recognition framework for development‑plus‑IP and pure‑IP arrangements: the license is tested for distinctness, bundled with development services when it is not distinct (revenue recognized over time), and recognized at a point in time when the license alone is sold; no variable‑consideration estimates are used and payment terms are treated as normal trade receivables. This unchanged methodology indicates that AMD is deliberately monetizing its IP through clear, performance‑based licensing contracts that generate predictable, point‑in‑time cash flows, underscoring a long‑term strategy of extracting steady value from its intellectual‑property portfolio rather than relying on complex, contingent or variable‑payment schemes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent revenue recognition methodology across 2022-2024, including the distinctness testing framework; (2) Accurately captures that licenses bundled with development services are recognized over time while standalone licenses are recognized at a point in time; (3) Correctly notes the absence of variable consideration estimates; (4) Properly synthesizes the multi-hop information about AMD's strategic approach to IP monetization; (5) The characterization of AMD's strategy as 'deliberate,' 'stable,' and 'mature' aligns with the ground truth's assessment of consistency implying a 'stable and deliberate strategic approach.' MINOR CONSIDERATIONS: (1) The LLM adds interpretive language about 'predictable, point-in-time cash flows' and 'extracting steady value' which, while logically sound and consistent with the methodology described, goes slightly beyond the explicit ground truth statement that consistency 'indicates a mature and well-defined policy framework.' However, this additional interpretation is reasonable and not contradictory. (2) The mention of 'payment terms are treated as normal trade receivables' is a reasonable inference from standard accounting practices but is not explicitly stated in the ground truth. This is a minor elaboration that doesn't contradict the source material. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022, 2023, 2024) and connects the consistent methodology to strategic implications about IP monetization, demonstrating sound multi-hop reasoning. SEMANTIC EQUIVALENCE: The LLM's phrasing 'unchanged methodology' and 'deliberately monetizing' conveys the same meaning as the ground truth's 'consistent' and 'stable and deliberate strategic approach.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 554,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s senior‑and‑subordinated notes rose modestly to **$31.2 bn in 2023** (up from **$30.8 bn in 2022**) but pulled back to **$30.7 bn in 2024**.  The change reflects a deliberate de‑leveraging and interest‑rate repositioning: the firm issued new fixed‑rate senior notes in 2023 at still‑relatively low yields (the weighted‑average rate on fixed senior debt edging up only to **4.48 %**), but in 2024 it began retiring higher‑cost floating‑rate notes and trimmed total long‑term debt from **$49.9 bn to $45.6 bn**, while the average fixed‑rate on senior debt climbed to **4.84 %**, signaling a shift toward longer‑dated, higher‑yielding fixed financing to match the rising rate environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: (1) 2022 baseline is WRONG - LLM states '$30.8 bn in 2022' but ground truth shows $27,219 million ($27.2 bn). This is a ~$3.6 billion error on the starting point. (2) 2023 figure is approximately correct at $31.2 bn vs. $31,248 million ground truth (minor rounding acceptable). (3) 2024 figure is correct at $30.7 bn vs. $30,696 million. (4) Fixed rate progression: LLM states 4.48% for 2023 but ground truth shows 4.45% - minor but incorrect. LLM correctly identifies 4.84% for 2024. (5) MAJOR OMISSION: LLM completely fails to mention the floating-rate debt reduction, which is a KEY insight in the ground truth. Ground truth explicitly notes floating unsecured senior debt fell from $1,709M (2022) to $349M (2023) to $0 (2024) - this is central to understanding the capital structure strategy. LLM mentions 'retiring higher-cost floating-rate notes' vaguely but provides no actual numbers. (6) The introduction of total long-term debt figures ($49.9bn to $45.6bn) is NOT in the ground truth and appears to be extraneous information that muddies the analysis. (7) REASONING QUALITY: LLM's interpretation about 'de-leveraging' and 'interest-rate repositioning' is reasonable but lacks the specific evidence about floating-rate elimination that drives the actual strategy. The characterization of 2023 rates as 'still-relatively low yields' contradicts the ground truth narrative of rising rates. MULTI-HOP SYNTHESIS: LLM fails to properly synthesize the three-year progression with the floating-rate debt elimination story, which is essential to answering the question about capital structure strategy. The answer reads as partially informed but contains fundamental numerical errors on the baseline year and omits critical strategic details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 484,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nFrom 2022 to 2023 the carrying amount of Capital One’s fixed‑rate unsecured senior notes jumped from **$24.1 bn to $27.2 bn**, while the weighted‑average interest rate stayed essentially unchanged at **≈ 4.45 %**. In 2024 the balance slipped modestly to **$26.9 bn**, and the weighted‑average rate rose a little to **about 4.8 %**.  \n\nThis pattern shows that COF expanded its long‑term senior debt in 2023 at a stable low cost, then trimmed the outstanding balance in 2024 while allowing the average rate to drift upward—consistent with a strategy of extending maturities and locking in longer‑dated funding as market rates increase, while keeping the overall cost of debt relatively controlled.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 carrying value. Ground truth states $19,975 million in 2022, but LLM reports $24.1 billion ($24,100 million)—a discrepancy of approximately $4.1 billion or 20.5%. This is a major error that undermines the entire analysis. The 2023 figure of $27.2 billion is correct, and the 2024 figure of $26.9 billion is correct. However, the 2022 baseline error is critical because it distorts the trend analysis. WEIGHTED-AVERAGE INTEREST RATE ERRORS: The LLM states the rate 'stayed essentially unchanged at ≈ 4.45%' from 2022 to 2023, but ground truth shows it rose from 2.91% in 2022 to 4.45% in 2023—a significant 154 basis point increase, not 'essentially unchanged.' The 2024 rate of approximately 4.8% is correct. This mischaracterization of the 2022-2023 rate movement is a substantial error. REASONING QUALITY: The LLM's interpretation that COF 'expanded its long-term senior debt in 2023 at a stable low cost' is contradicted by the actual data showing rates rose significantly from 2.91% to 4.45%. The characterization of 4.45% as 'stable low cost' is misleading given the context of rising rates. The overall strategic interpretation about extending maturities and locking in longer-dated funding is reasonable, but it's based on incorrect premises about the rate stability. MULTI-HOP SYNTHESIS: The answer attempts to synthesize carrying values and rates across three years, but the fundamental data errors prevent sound multi-hop reasoning. The comparison logic is present but built on incorrect numbers. COMPLETENESS: The answer addresses all parts of the question (carrying value evolution, weighted-average rate evolution, and strategic implications), but the execution is flawed due to data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 490,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s guidance on revenue recognition for development‑plus‑IP deals and for pure IP licenses was essentially unchanged across the three filings. In the 2022 10‑K (Note 2, pp. 57‑61), 2023 10‑K (Note 2, pp. 62‑66) and 2024 10‑K (Note 2, pp. 61‑65) the company states that when a contract bundles development services and a license, the license is evaluated for distinctness; if it is **not** distinct the services and license are combined as a single performance obligation and revenue is recognized over time, but if the license **is** distinct it is treated as a separate performance obligation and revenue is recognized at a point in time when the customer can benefit. Standalone IP licenses are likewise recognized at a point in time when the customer obtains the right to use the IP. The documents note that no material variable‑consideration estimates apply to either type of arrangement, indicating a consistent policy from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Strengths: (1) Correctly identifies the core policy consistency across 2022-2024 with no material changes; (2) Accurately describes the distinctness test framework - non-distinct licenses combined with development services recognized over time, distinct licenses as separate performance obligations recognized at point in time; (3) Correctly notes standalone IP licenses recognized at point in time; (4) Accurately states no variable consideration estimates apply to either arrangement type; (5) Provides specific document references (Note 2, page ranges) that demonstrate multi-hop synthesis across three years of filings; (6) Uses precise technical language matching SEC filing terminology (\"performance obligation,\" \"distinctness,\" \"point in time\"). Quantitative accuracy is perfect - all dates (2022, 2023, 2024) and document references are correct. The multi-hop reasoning is sound, synthesizing information across three separate 10-K filings to demonstrate policy consistency. Minor observation: The LLM answer is slightly more detailed and technical than the ground truth (explaining the distinctness logic more explicitly), but this adds value without contradicting the original answer. The semantic equivalence is strong - both answers convey that AMD's policy remained stable and consistent across the three-year period with the same treatment of combined vs. standalone arrangements. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 409,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nBetween 2022 and 2024, COF’s short‑term borrowings fell sharply from **$883 million (2022) to $538 million (2023)** and edged up only slightly to **$562 million in 2024**, while its long‑term debt **peaked at $49.3 billion in 2023** before **declining to $45.0 billion in 2024**.  \n\nThis three‑year pattern shows that the firm reduced its reliance on volatile short‑term wholesale funding, temporarily expanded longer‑dated borrowing to capture relatively lower rates in 2023, and then **de‑leveraged by paying down a sizable portion of that long‑term debt in 2024**—a clear strategy to lower interest‑rate exposure and strengthen balance‑sheet resilience amid a rising rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally misrepresent COF's debt structure and evolution:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Short-term borrowings: LLM claims $883M (2022), $538M (2023), $562M (2024). Ground truth shows these are minor components of total debt, not the primary focus.\n   - Long-term debt: LLM states $49.3B (2023) and $45.0B (2024), but ground truth shows total short-term borrowings + long-term debt was $48.715B (2023) and $45.551B (2024). The LLM's $49.3B figure is close but appears to isolate only long-term debt, missing the complete picture.\n   - MISSING CRITICAL DATA: The LLM completely omits the weighted-average interest rates (2.76% in 2022, 4.48% in 2023, 4.84% in 2024), which are essential to answering the question about interest rate exposure.\n   - The 2022 total debt figure is not provided by LLM, making it impossible to verify the starting point.\n\n2. MULTI-HOP SYNTHESIS FAILURE:\n   - The ground truth explicitly states total debt was $43.086B (2022) → $48.715B (2023) → $45.551B (2024). The LLM's numbers don't align with this trajectory.\n   - The LLM fails to synthesize the interest rate component with the debt levels, which is central to understanding the debt management strategy.\n   - The question specifically asks about interest rate exposure, which the LLM completely ignores.\n\n3. REASONING QUALITY:\n   - While the LLM's narrative about de-leveraging and reducing short-term reliance is plausible, it's built on incomplete/incorrect data.\n   - The interpretation about 'capturing lower rates in 2023' contradicts the ground truth showing rates ROSE from 2.76% to 4.48% in 2023.\n   - The strategic narrative doesn't account for the actual interest rate environment reflected in the weighted-average rates.\n\n4. COMPLETENESS:\n   - The answer addresses debt evolution but fails to adequately address interest rate exposure, which is explicitly part of the question.\n   - Missing the 2022 baseline total debt figure ($43.086B) prevents proper trend analysis.\n   - No mention of weighted-average interest rates at all.\n\n5. ENTITY/METRIC ACCURACY:\n   - Correctly identifies COF and the 2022-2024 period.\n   - Correctly identifies short-term borrowings and long-term debt as relevant metrics.\n   - FAILS to identify or discuss weighted-average interest rates on long-term debt, a critical metric for the question.\n\nThe LLM answer demonstrates partial understanding of debt management concepts but fails on factual accuracy and omits essential data required to fully answer the question about interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 699,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nAMD’s core revenue‑recognition principle—recognizing revenue when control of the promised goods or services transfers—has remained unchanged from 2022 through 2024. What evolved in the filings is a clearer articulation of how development‑plus‑IP arrangements are split into performance obligations: the company now explicitly evaluates whether the IP licence is “distinct” (i.e., both capable of being distinct and distinct in the contract context). If the licence is **not** distinct, the development service and licence are combined into a **single performance obligation** and revenue is recognized **over time**; if the licence **is** distinct (or when the arrangement involves a standalone IP licence), it is treated as a **separate performance obligation** and revenue is recognized **at a point in time**. Thus, the 2023‑2024 disclosures sharpen the distinction between combined arrangements (single, over‑time obligation) and standalone licences (separate, point‑in‑time obligation), but the underlying methodology has not materially changed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of AMD's revenue recognition policy evolution. STRENGTHS: (1) Correctly identifies the core principle that remained unchanged from 2022-2024; (2) Accurately describes the distinction framework between combined arrangements (single performance obligation, over-time recognition) and standalone licenses (separate performance obligation, point-in-time recognition); (3) Properly articulates the 'distinctness' test (capable of being distinct AND distinct in contract context); (4) Correctly notes that the underlying methodology did not materially change, with 2023-2024 providing clearer articulation; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the variable consideration aspect that the ground truth emphasizes—specifically that AMD consistently stated no variable consideration estimates were associated with these arrangements across all three years. This is a notable omission since the ground truth explicitly states 'There was no material change in the treatment of variable consideration across the three years'; (2) The LLM answer frames the evolution as a 'sharpening' of distinction rather than emphasizing the consistency/stability of the policy, though it does conclude with 'underlying methodology has not materially changed'; (3) The ground truth mentions the business context shift (Gaming segment emphasis in 2023-2024), which the LLM answer does not address, though this is a minor contextual detail. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and correctly identifies the key distinction between combined vs. standalone arrangements. The reasoning is sound and logically structured. The answer appropriately addresses the core question about policy evolution while maintaining accuracy about the consistency of the underlying framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 526,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe fact that the **Certificate of Designations of Series B Convertible Participating Preferred Stock** is repeatedly listed as a primary exhibit in the 2022, 2023 and 2024 10‑K filings shows that the instrument remains formally authorized, outstanding, and integral to Visa’s capital framework. Its continual appearance signals that the rights, preferences and conversion terms attached to the Series B preferred shares have not been retired or materially altered, underscoring a stable and ongoing reliance on this financing component within Visa’s overall equity structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core concept that the Certificate of Designations of Series B Convertible Participating Preferred Stock appears consistently across Visa's 2022, 2023, and 2024 filings, and appropriately concludes this indicates stability and ongoing relevance. However, there are significant gaps in specificity compared to the ground truth: (1) The LLM fails to cite the specific exhibit numbers (4.5 for 2022, 4.4 for 2023 and 2024) that are crucial evidence of the claim. (2) The LLM does not reference the consistent filing date of June 21, 2016, which is a key factual detail that strengthens the argument about the instrument's static nature. (3) The LLM uses more general language ('formally authorized, outstanding, integral') rather than the more precise ground truth language about 'no modifications required or implemented' and 'same terms and conditions.' (4) The reasoning is sound but less rigorous—the ground truth explicitly connects the identical exhibit numbers and filing dates to the conclusion about stability, while the LLM makes the same conclusion without citing these specific supporting details. The LLM answer is not incorrect in its core assertion, but it lacks the documentary evidence and specificity that would make it fully credible and complete. The multi-hop synthesis is present but underdeveloped, missing the quantitative/documentary anchors that validate the qualitative conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 400,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nRTX’s ownership in the International Aero Engines AG has remained a 49.5 % equity stake, but its **program‑share interest stayed at 61 %** (net of sub‑collaborator allocations it was 57 % of IAE and 51 % of the IAE LLC joint venture).  The 2022 filing first disclosed these percentages; the 2023 filing reiterated them and highlighted that Pratt & Whitney is the primary beneficiary of both IAE and IAE LLC; and the 2024 filing added that the company holds a 59 % program‑share and ownership in IAE LLC and is exposed to **contingent flight‑hour payments to Rolls‑Royce that are capitalised as collaboration intangibles**, underscoring a multi‑year cash‑flow exposure.  \n\nTogether, the progression shows that Pratt & Whitney has positioned itself as the **strategic lead and primary economic driver of the V2500 engine programme**, using its program‑share to capture the bulk of program revenues and cost recoveries while limiting its direct equity risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core percentages: 49.5% ownership interest, 61% program share interest, and 57% net program share interest after sub-collaborator participation. These match the ground truth exactly. The answer also correctly notes consistency across 2022-2024 and identifies Pratt & Whitney as the primary beneficiary. The mention of IAE LLC with 59% program-share and 51% net interest adds detail not in the ground truth but appears factually grounded.\n\nWEAKNESSES: (1) The ground truth emphasizes that RTX's stake and economic exposure remained CONSISTENT across all three years (2022-2024), indicating NO strategic repositioning. The LLM answer, while mentioning consistency, introduces new elements (contingent flight-hour payments, collaboration intangibles) that shift focus away from the core finding of stability. (2) The LLM's conclusion that P&W positioned itself as 'strategic lead and primary economic driver' goes beyond what the ground truth states. The ground truth explicitly says the consistency 'suggests that RTX did not alter its strategic positioning,' which is more conservative and accurate. (3) The LLM introduces the concept of 'contingent flight-hour payments to Rolls-Royce' which, while potentially accurate from filings, is not mentioned in the ground truth and may represent over-interpretation or synthesis from different filing sections. (4) The framing of 'limiting its direct equity risk' while capturing bulk of revenues is an inference not explicitly supported by the ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years (2022, 2023, 2024) and does track the progression of disclosures. However, it conflates 'what was disclosed' with 'what changed,' when the ground truth's key insight is that nothing materially changed in the stake/exposure metrics themselves.\n\nQUANTITATIVE VERIFICATION: All percentages cited (49.5%, 61%, 57%, 59%, 51%) appear accurate based on ground truth. No calculation errors detected.\n\nSEMANTIC ISSUE: The ground truth's conclusion is about STABILITY and NO CHANGE in strategic positioning. The LLM's conclusion emphasizes P&W's 'strategic lead' role, which is a different narrative emphasis and potentially misleading about what the multi-year progression actually indicates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 616,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nAcross fiscal years 2022‑2024 Medtronic kept the same Non‑Employee Director Deferred Unit Award Agreement, only updating the exhibit reference to reflect amendments to the underlying 2008/2013 Stock Plans; the vesting schedule and deferred‑unit structure were unchanged. This consistency shows a deliberate long‑term compensation strategy that aligns director interests with sustained shareholder value rather than short‑term cash payouts.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures the core finding that Medtronic maintained consistency in the Non-Employee Director Deferred Unit Award Agreement across 2022-2024, which aligns with the ground truth. However, there are significant issues with accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the three fiscal years (2022, 2023, 2024)\n2. Accurately states the agreement remained unchanged in structure\n3. Correctly notes the vesting schedule and deferred-unit structure were unchanged\n4. Appropriately interprets this as a deliberate long-term compensation strategy\n5. The semantic meaning about consistency and shareholder alignment is sound\n\nCRITICAL ERRORS:\n1. FACTUAL INACCURACY: The LLM states the agreement was \"only updating the exhibit reference to reflect amendments to the underlying 2008/2013 Stock Plans.\" The ground truth explicitly states the agreement was tied to the 2008 plan specifically, NOT the 2013 plan. The ground truth notes that \"despite broader updates and amendments to other award agreements under the 2013 plan,\" the deferred unit award remained tied to the 2008 plan. This is a material distinction the LLM misrepresents.\n2. INCOMPLETE EXHIBIT CITATION: The ground truth provides specific exhibit numbers (10.41 for 2022, 10.52 for both 2023 and 2024), which the LLM omits entirely. While not critical, these details support the factual claim.\n3. MISSING KEY CONTEXT: The ground truth emphasizes that the 2008 plan origin was maintained \"without transitioning them to newer plan versions,\" which is a crucial distinction. The LLM's mention of \"amendments to the underlying 2008/2013 Stock Plans\" obscures this key finding.\n4. VAGUE LANGUAGE: The LLM says \"only updating the exhibit reference\" but doesn't clarify what remained constant versus what changed, creating ambiguity about whether the plan itself changed.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes that consistency across three years indicates a deliberate strategy, but fails to properly distinguish between the 2008 plan (which remained constant for directors) and the 2013 plan (which had broader updates). This is a multi-hop synthesis error.\n\nOVERALL: The answer is directionally correct but contains a material factual error regarding plan attribution (2008 vs. 2013) and lacks the specificity and precision of the ground truth. The interpretation is reasonable but built on incomplete/inaccurate premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 649,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nLockheed Martin kept the notional size of its variable‑rate interest‑rate swaps essentially unchanged – $1.3 billion at the end of 2022, 2023 and again at 31 December 2024 (as disclosed in Note 15 – Fair Value Measurements and the 2024 ITEM 7A discussion).  While the company’s total debt grew from roughly $16.8 billion (2022) to $21.6 billion (2024), the swap notional stayed flat, indicating a deliberate, steady‑state hedging approach that protects a consistent portion of its fixed‑rate borrowing without scaling the hedge proportionally as debt levels rose.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that LMT's notional amount of interest rate swaps was $500 million in 2022, then increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. The LLM answer incorrectly claims the notional amount was $1.3 billion at the end of 2022, which is factually wrong. This is a major quantitative error that undermines the entire response. The LLM states 'the swap notional stayed flat' from 2022-2024, when in reality there was a significant 160% increase from 2022 to 2023 ($500M to $1.3B), followed by stability from 2023-2024. The LLM's characterization of the strategy as 'steady-state hedging' and 'flat' is therefore incorrect and misses the key insight from the ground truth: that there was a strategic shift and tripling of exposure from 2022 to 2023. While the LLM correctly identifies that debt grew from $16.8B to $21.6B and makes a reasonable observation about proportional hedging, this contextual analysis cannot compensate for the fundamental error in the core data points. The LLM failed to capture the evolution and progression that the question specifically asks about, instead presenting a false narrative of consistency across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 367,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie’s charter kept the same director‑removal language: stockholders may remove directors only “for cause,” the board alone can fill vacancies, and any amendment to those provisions requires the affirmative vote of holders of at least 80 % of the voting stock (plus the Delaware §203‑based 15 %‑ownership lock‑up). Because this language is unchanged across the three annual reports, the company has maintained a consistent, board‑protective governance framework that deliberately makes it harder for an acquirer to oust or replace incumbent directors, signalling a steady strategic posture that prioritizes takeover defense and the preservation of board control.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis across the three-year period (2022-2024). Key strengths: (1) Correctly identifies the consistent 'for cause' removal provision across all three years; (2) Accurately cites the 80% supermajority voting requirement for amendments; (3) Correctly references Delaware §203 anti-takeover statute and the 15% ownership threshold; (4) Properly synthesizes the multi-hop reasoning that consistency across three years indicates deliberate, stable governance strategy; (5) Accurately characterizes the strategic posture as prioritizing takeover defense and board control preservation. The answer goes slightly beyond the ground truth by explicitly mentioning the Delaware §203 mechanism and the 15% lock-up provision, which adds specificity and demonstrates deeper knowledge without contradicting the original answer. The 80% supermajority figure is presented accurately. The reasoning about what consistency suggests (board-protective framework, deliberate anti-takeover strategy) aligns perfectly with the ground truth's characterization. Minor consideration: The LLM answer is more detailed and technical than the ground truth, but this represents enhancement rather than error. All entities (AbbVie, stockholders, board, directors) are correctly identified. The temporal synthesis (2022-2024 consistency) is properly executed. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 402,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term cash‑equivalent allocation fell from **$21 million in 2022** to **$10 million in 2023** and stayed at that level through **2024**.  The pull‑back from money‑market funds and time deposits indicates the company is relying less on these ultra‑conservative, interest‑earning vehicles and is instead managing liquidity through larger cash balances and other short‑term investments, a prudent stance given the volatility in its operating cash flows.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect: (1) QUANTITATIVE ERRORS: The LLM states money market funds and time deposits were '$21 million in 2022' and '$10 million in 2023', but the ground truth shows the opposite sequence: $12 million in 2022, $21 million in 2023, and $10 million in 2024. The LLM has reversed the 2022 and 2023 figures. Additionally, the LLM claims the allocation 'stayed at that level through 2024' at $10 million, which happens to be correct for 2024, but only by coincidence given the reversed prior years. (2) INCOMPLETE SYNTHESIS: The LLM fails to provide the complete three-year trend required by the question. It only addresses 2022-2023 transition and 2024, missing the critical intermediate year data point that shows the peak at $21 million in 2023. (3) MISSING CONTEXT: The ground truth includes important context about overall cash and equivalents fluctuations ($8,449M in 2022 → $9,201M in 2023 → $5,524M in 2024), which the LLM completely omits. This context is essential for understanding the liquidity strategy evolution. (4) REASONING FLAW: The LLM's interpretation that the company is 'relying less on these ultra-conservative, interest-earning vehicles' is partially correct for the 2023-2024 decline, but this reasoning doesn't account for the initial increase from 2022 to 2023, which the LLM got backwards. The multi-hop synthesis across three years is fundamentally broken due to the reversed figures. (5) SEMANTIC ISSUES: While the LLM's general commentary about liquidity management is reasonable, it's built on incorrect data, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 457,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie’s charter kept the identical “removal‑for‑cause” language – shareholders may eliminate a director only for cause – and retained the other anti‑takeover features (a classified, three‑year staggered board, a ban on calling special meetings, and an 80 % super‑majority vote to amend director‑related provisions, plus Section 203 of the DGCL).  The lack of any substantive change signals that AbbVie is deliberately maintaining a stable board structure and a strong legal shield against hostile bids, underscoring a long‑term strategy to deter hostile takeovers by preserving board control and making a forced acquisition difficult.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of AbbVie's governance provisions. STRENGTHS: (1) Correctly identifies the core provision that stockholders may only remove directors for cause, matching the ground truth exactly; (2) Accurately notes the consistency of this provision across 2022-2024 with no substantive changes; (3) Properly synthesizes the multi-hop information by connecting the removal-for-cause provision to the broader anti-takeover defense strategy; (4) Correctly identifies and lists complementary governance mechanisms (classified three-year staggered board, ban on special meetings, 80% super-majority vote requirement, Section 203 of DGCL); (5) Accurately interprets the strategic implication that this consistency reflects a deliberate, long-term strategy to deter hostile takeovers and maintain board stability. QUANTITATIVE ACCURACY: The 80% super-majority threshold is correctly stated, and the three-year staggered board structure is accurately referenced. No numerical errors detected. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail about the complementary governance mechanisms than the ground truth (explicitly listing the 80% threshold and Section 203 reference), which adds value without contradicting the original answer. The semantic meaning is fully aligned with the ground truth - both convey that AbbVie maintained consistent removal-for-cause provisions as part of a deliberate anti-takeover strategy. The reasoning is sound and the multi-hop synthesis across years and governance mechanisms is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 445,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from a future‑node concept to a production‑ready differentiator. In 2022 the company introduced PowerVia as the back‑side power‑delivery solution for the upcoming Intel 18A node (targeted for 2025), positioning it alongside RibbonFET to boost density and performance‑per‑watt. By 2023 the narrative broadened: PowerVia became a core element of Intel’s IDM 2.0 and IFS strategy, with plans to offer the technology to external foundry customers and to integrate it into the Intel 18A “Panther Lake” platform. In 2024 Intel moved to high‑volume manufacturing of Panther Lake on Intel 18A, making PowerVia the first commercial implementation of backside power delivery and cementing it as a strategic pillar for Intel’s advanced‑node roadmap and its goal of leading in density, performance and supply‑chain resilience.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) TIMELINE CONTRADICTION: The ground truth explicitly states that in 2022 Intel 'first introduced PowerVia as part of its future process and packaging technologies' with no specific node assignment, yet the LLM claims in 2022 PowerVia was 'introduced as the back-side power-delivery solution for the upcoming Intel 18A node.' This is a fundamental misrepresentation of the 2022 positioning. (2) NODE ASSIGNMENT ERROR: The ground truth indicates PowerVia was positioned for Intel 20A in 2023, then shifted to Intel 18A in 2024. The LLM incorrectly assigns Intel 18A to 2022, skipping the 20A intermediate step entirely and misrepresenting the 'strategic pivot from initial introduction to realignment within a more refined roadmap' that the ground truth emphasizes. (3) MISSING KEY DETAIL: The ground truth's core insight about the evolution is the shift from 20A (2023) to 18A (2024), which the LLM completely omits. This is not a minor detail but central to understanding Intel's strategic recalibration. (4) SPECULATIVE ADDITIONS: The LLM introduces details like 'Panther Lake' platform and 'IDM 2.0 and IFS strategy' that are not mentioned in the ground truth, suggesting extrapolation beyond the source material. (5) CORRECT ELEMENTS: The LLM does correctly identify PowerVia as a backside power delivery solution, correctly notes the 2025 HVM timeline for 18A, and appropriately characterizes the strategic importance. However, these correct elements cannot offset the fundamental chronological and node-assignment errors. The multi-hop reasoning fails because it doesn't accurately synthesize the progression across the three-year period as documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 488,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nMDT’s expected‑volatility input to the Black‑Scholes model rose modestly each year—from **23.0 % in fiscal 2022 to 24.1 % in fiscal 2023 and 24.3 % in fiscal 2024**—reflecting the company’s practice of blending historical price swings with implied market volatility. This multi‑year upward trend indicates that MDT is deliberately incorporating greater expected price variability (and thus higher option‑fair‑value estimates) into its valuation of non‑qualified stock options, signaling a more conservative, market‑responsive approach to option pricing over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides specific volatility percentages (23.0%, 24.1%, 24.3%) that cannot be verified against the ground truth and appear to be fabricated. The ground truth makes NO mention of these specific numerical values. The LLM's core claim about an 'upward trend' in volatility percentages is unsupported by the provided ground truth. METHODOLOGY ACCURACY: The LLM correctly identifies that MDT used a blended approach combining historical and implied volatility, which aligns with the ground truth's description of the evolution from 2022-2024. However, the LLM misrepresents the timeline and nature of this evolution. FACTUAL DISCREPANCIES: (1) Ground truth states 2022 used ONLY historical volatility (no implied volatility), but LLM implies blending occurred throughout the period. (2) Ground truth indicates the blended approach began in 2023, not 2022. (3) The specific percentage values (23.0%, 24.1%, 24.3%) are not mentioned in the ground truth and appear to be hallucinated. MULTI-HOP REASONING: The LLM fails to properly synthesize the methodological shift from pure historical to hybrid approach. Instead, it focuses on quantitative trends that aren't supported by the source material. SEMANTIC ISSUES: While the LLM correctly identifies the general concept of moving toward market-responsive valuation, it does so by inventing specific numbers rather than accurately describing the qualitative evolution documented in the ground truth. The answer demonstrates partial understanding of the methodology change but fundamentally fails on factual accuracy by introducing unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 447,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a planned feature of the cancelled Intel 20A node to the cornerstone of its next‑generation Intel 18A process, which is slated for high‑volume manufacturing in 2025 (e.g., the Panther Lake client family).  The company repeatedly emphasized that PowerVia—paired with RibbonFET—will deliver up to 15 % performance‑per‑watt gains and will be a differentiator for Intel’s IDM 2.0 roadmap and its foundry services, positioning the technology as a central pillar of Intel’s advanced‑process strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of PowerVia technology across 2022-2024. STRENGTHS: (1) All key numeric values are correct: 15% performance-per-watt improvement, 2025 HVM timeline, Panther Lake processor family. (2) Correctly identifies the strategic pivot from Intel 20A to Intel 18A while maintaining PowerVia as central. (3) Accurately captures the pairing of PowerVia with RibbonFET. (4) Properly contextualizes PowerVia's role in IDM 2.0 and foundry services strategy. (5) Multi-hop reasoning is sound—synthesizing the 2022 introduction, 2023 commitment, and 2024 cancellation/pivot correctly. MINOR GAPS: (1) The answer does not explicitly mention that PowerVia was 'first introduced in 2022' or provide the chronological progression as clearly as the ground truth (which states 'first introduced in 2022,' 'reiterated in 2023,' 'disclosed in 2024'). The LLM answer implies this progression but doesn't explicitly state the 2022 introduction date. (2) The ground truth emphasizes PowerVia as an 'industry-first backside power delivery solution designed to optimize signal transmission'—the LLM answer omits this technical characterization, though it's not essential to answering the core question about strategic evolution. (3) The ground truth explicitly notes the 'Intel 3' comparison baseline for the 15% improvement; the LLM answer provides the percentage but not the baseline comparison. These are relatively minor omissions that don't significantly detract from the core answer's accuracy. The LLM successfully captures the essential narrative: PowerVia evolved from a planned Intel 20A feature to a cornerstone of Intel 18A, with consistent emphasis on its performance benefits and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 486,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom 2022 through 2024 Medtronic kept the expected option life essentially steady (≈ 6 years, edging to 6.1 yr in 2024), but it revised the other Black‑Scholes inputs each year: the risk‑free rate rose sharply from 0.90 % (2022) to 0.33 % (2023) and then to 4.16 % (2024), volatility edged up from 23.0 % to 24.2 %, and the dividend yield increased from 1.95 % to 2.36 % and 3.18 %.  This trajectory shows the company is progressively incorporating higher current interest rates and a modestly higher expected price swing into its valuation, while assuming employee exercise behavior remains roughly a six‑year horizon, reflecting a data‑driven adjustment to macro‑economic conditions and observed market trends.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numerical data that contradicts the ground truth. Specifically: (1) Risk-free rate direction is REVERSED - LLM claims it 'rose sharply from 0.90% (2022) to 0.33% (2023)' which is a DECREASE, not a rise. The LLM then claims it went to 4.16% in 2024, creating an internally inconsistent narrative. (2) The ground truth makes NO mention of specific percentage values for risk-free rates, volatility, or dividend yields - these numbers appear to be fabricated or misattributed. (3) MISSING KEY INFORMATION: The LLM completely fails to address the most important evolution mentioned in the ground truth - the shift from using ONLY historical volatility in 2022 to incorporating IMPLIED VOLATILITY from market-traded options in 2023-2024. This is the central finding about the company's 'more sophisticated and market-informed approach.' (4) The LLM provides specific numerical details (23.0% volatility, 1.95% dividend yield, etc.) that cannot be verified against the ground truth and appear to be hallucinated. (5) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that the Black-Scholes model was used consistently, it fails to capture the qualitative shift toward market-based volatility estimation, which is the core insight about the company's strategic evolution. (6) The LLM's conclusion about 'macro-economic conditions' is reasonable but doesn't address the actual methodological change from historical to implied volatility. The answer demonstrates poor multi-hop reasoning by focusing on numerical details that may be incorrect rather than the documented methodological evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 453,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of collateral the company must post under master‑netting arrangements fell sharply – from **$1.49 billion in 2022 to $0.80 billion in 2023 and $0.49 billion in 2024**.  This decline shows that ExxonMobil is needing less external margin to support its derivative positions, reflecting more efficient management of its derivative exposure (e.g., stronger credit standing, tighter counter‑party relationships and greater use of netting), which reduces the cash tied up in collateral and lightens the balance‑sheet burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024). The format variation ($1.49B vs $1,494M) is acceptable and properly handled. The declining trend is accurately captured. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in collateral amounts from 2022-2024, and (2) what this trend suggests about derivative exposure management. ENTITY ACCURACY: Correctly identifies ExxonMobil, the correct metric ('Other assets, including intangibles - net' collateral under master netting arrangements), and the correct time period (2022-2024). REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting the numerical decline to strategic implications. The interpretation that declining collateral reflects 'more efficient management of derivative exposure' is semantically equivalent to the ground truth's 'strategic reduction in derivative-related exposure or active management of margin requirements.' The LLM adds specific mechanisms (stronger credit standing, tighter counterparty relationships, greater use of netting) that provide reasonable explanatory depth. MINOR CONSIDERATIONS: The ground truth mentions 'lower volatility in commodity markets or a shift in hedging strategies' as potential drivers, while the LLM focuses on operational efficiency factors. Both interpretations are valid and complementary rather than contradictory. The LLM's explanation about reducing cash tied up in collateral and lightening balance-sheet burden is a logical extension of the data that adds value without contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 471,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of NEE’s gas‑linked options was essentially flat at about $100 million (asset) while the liability side edged up from $97 million to $102 million, signalling a modest deterioration in the net position.  The valuation assumptions also changed: implied volatilities narrowed from a 20‑233 % range with a 50 % weighted average in 2022‑23 to a tighter 15‑150 % range with a 52 % weighted average in 2024, and implied correlations rose from roughly 57 % to about 99 %.  Together, these shifts show that NEE is deliberately reducing exposure to volatile gas‑price swings and moving toward a more conservative, hedge‑oriented stance on gas derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth across multiple dimensions: (1) ASSET VALUES: Ground truth shows assets declined from $356M (2022) → $100M (2023) → $100M (2024). LLM claims assets were 'essentially flat at about $100 million' throughout, completely missing the $356M starting point in 2022. This is a critical omission of the most important trend. (2) LIABILITY VALUES: Ground truth shows liabilities declined from $347M (2022) → $97M (2023) → $102M (2024). LLM only mentions the 2023-2024 movement ($97M to $102M) and misses the dramatic $347M starting point in 2022. (3) IMPLIED VOLATILITY: Ground truth clearly states weighted average volatility was 36% in 2022, 50% in 2023, and 52% in 2024 - showing an INCREASE in volatility over time. LLM claims volatility 'narrowed from 20-233% range with 50% weighted average in 2022-23 to 15-150% range with 52% weighted average in 2024' - this is internally contradictory (claiming narrowing while showing 52% in both periods) and contradicts ground truth (36% in 2022, not 50%). The range figures (20-233%, 15-150%) appear fabricated and are not in the ground truth. (4) CORRELATION DATA: LLM introduces implied correlations (57% to 99%) that are not mentioned in the ground truth at all, suggesting hallucination. (5) INTERPRETATION ERROR: LLM concludes NEE is 'reducing exposure to volatile gas-price swings' when the ground truth actually shows volatility INCREASED from 36% to 52%, contradicting this conclusion. The multi-hop synthesis is fundamentally broken - the LLM failed to correctly identify the massive 2022-2023 decline in both assets and liabilities, which is the core story of how exposure evolved. The answer demonstrates poor data retrieval and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 491,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 35A that SPG holds kept the same terms: a $750 million face amount (shown as $750,000 k), a fixed 2.65 % coupon, an annual debt‑service charge of $19.875 million (shown as $19,875 k), and a maturity date of July 15, 2030.  \n\nThis consistency indicates that SPG’s long‑term debt strategy is to lock in low‑cost, long‑dated unsecured financing and extend the maturity profile of its capital structure, thereby reducing refinancing risk and preserving liquidity while maintaining a relatively stable debt composition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental unit conversion error that invalidates the core numerical claims. The ground truth states face amount of $750,000 and annual debt service of $19,875 (in thousands, as indicated by the 'k' notation). The LLM incorrectly interprets these as $750 million and $19.875 million respectively, representing a 1,000x magnitude error. This is a severe factual mistake that undermines the entire answer. VERIFICATION: Ground truth: $750,000 (face amount) and $19,875 (annual debt service). LLM claims: $750 million face amount and $19.875 million annual debt service. These are NOT equivalent - the LLM misread the scale of the numbers. ADDITIONAL ISSUES: (1) The LLM introduces information not in the ground truth (2.65% coupon, July 15, 2030 maturity date) without verification against the original filing data. While these details might be accurate, they represent information beyond what was provided in the ground truth answer. (2) The LLM's interpretation of the notation '$750,000 k' as '$750 million' is incorrect - the 'k' suffix typically means thousands, so $750,000k would be $750 million, but the ground truth explicitly states '$750,000' as the face amount figure, not '$750,000k'. MULTI-HOP REASONING: The reasoning about SPG's debt strategy (locking in low-cost financing, extending maturity profile, reducing refinancing risk) is logically sound and well-articulated, but it's built on incorrect numerical foundations. COMPLETENESS: The answer addresses the evolution question and provides strategic interpretation, but the numerical foundation is fatally flawed. The consistency observation is correct in concept but wrong in magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 468,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing products at the heart of its growth story—highlighting them in the “four sustainable competitive advantages” and reporting double‑digit revenue and profit gains for Embedded Processing in 2022 and modest growth in 2023—but the segment’s momentum stalled in 2024, with revenue falling 25 % and operating profit dropping 65 % (profit margin collapsing from ~30 % to ~14 %).  This three‑year trajectory shows that while embedded processing remains a strategic pillar, TI is now tempering its near‑term focus to protect cash flow and align investments with broader analog‑and‑embedded diversification, underscoring a long‑term positioning that relies on a balanced portfolio and manufacturing scale rather than sustained rapid expansion of any single segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific financial metrics (25% revenue decline, 65% profit decline, margin collapse from ~30% to ~14% in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states that embedded processing emphasis 'remained unchanged' from 2022-2023 and 'continued to reinforce' in 2024, with NO mention of performance deterioration or segment momentum stalling. The LLM appears to have fabricated or conflated data from other segments or sources. Critical issues: (1) The ground truth describes a STABLE, CONSISTENT strategic emphasis across all three years with identical language used in 2022-2023. The LLM contradicts this by claiming 'momentum stalled in 2024' with dramatic declines. (2) No financial performance metrics (revenue growth rates, profit margins, decline percentages) are mentioned in the ground truth, yet the LLM provides specific numbers without source verification. (3) The ground truth's conclusion emphasizes 'stable, long-term strategy' and 'consistent emphasis,' while the LLM concludes the company is 'tempering its near-term focus' and shifting to 'balanced portfolio diversification'—a fundamentally different interpretation. (4) The LLM's narrative about 'protecting cash flow' and 'aligning investments with broader analog-and-embedded diversification' is not supported by the ground truth. The LLM answer demonstrates significant factual divergence from the knowledge graph source material, introducing unverified performance data and mischaracterizing the strategic consistency that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 435,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast layered shared‑data options inside its bundled Xfinity packages, moving from a basic choice of unlimited, shared‑data or per‑GB plans in 2022 to offering prepaid unlimited data under the NOW brand in 2023 and, by 2024, embedding shared‑data tiers within both residential and prepaid bundles while extending interest‑free device financing up to 48 months for international customers.  This evolution positions shared‑data plans as a flexible, low‑cost add‑on that can be paired with broadband, video and wireless services, giving customers a wider range of payment choices—including unlimited, shared, per‑gigabyte, prepaid and financing options—within the same bundled offering.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) TIMELINE INACCURACY - The LLM states NOW brand prepaid unlimited was introduced in 2023, but ground truth indicates this occurred in 2024. This is a significant factual error in a timeline-focused question. (2) UNSUPPORTED CLAIMS - The LLM introduces details NOT in the ground truth: 'extending interest-free device financing up to 48 months for international customers' and 'residential and prepaid bundles' positioning. Ground truth only mentions 24-month device financing in 2022-2023, with no mention of 48-month terms or international customer specifics. (3) PARTIAL ACCURACY - The LLM correctly identifies: shared data plans as core offering across all years, unlimited/shared/per-GB options in 2022, NOW brand prepaid introduction, and the general evolution toward more flexible options. (4) SEMANTIC ISSUES - The phrasing 'moving from...in 2022 to offering prepaid unlimited data under the NOW brand in 2023' directly contradicts ground truth which places NOW introduction in 2024. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize evolution across years, it introduces fabricated details and misplaces key timeline events, undermining the reliability of the synthesis. The core narrative of expanding options is correct, but the execution contains material factual errors that would mislead readers about when specific offerings were introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 388,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 Mastercard’s Class A Treasury‑Stock balance grew from **$51.354 bn** to **$60.429 bn** (2022 → 2023) and then to **$71.431 bn** by the end of 2024, reflecting purchases of **≈ $9.1 bn** in 2023 and **≈ $11.0 bn** in 2024.  This accelerating buy‑back activity shows that the company is increasingly allocating a larger share of its cash flow to repurchasing its own shares—reducing outstanding shares and boosting per‑share earnings—rather than using the cash for other investments or debt reduction.  The trend therefore signals a capital‑allocation strategy that prioritizes returning capital to shareholders through equity‑based repurchases while maintaining confidence in future cash generation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental errors in the treasury stock figures. The ground truth shows treasury stock values as NEGATIVE numbers (in parentheses): $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. These negative values represent accumulated treasury stock purchases (a contra-equity account). The LLM incorrectly reports these as positive values ($51.354 bn, $60.429 bn, $71.431 bn), fundamentally misrepresenting the accounting treatment. Additionally, the LLM cites $51.354 bn for 2022, which doesn't match either the ground truth figure of $(36,658) million or any logical conversion. The calculated buyback amounts of ~$9.1 bn and ~$11.0 bn are also incorrect when derived from the wrong base numbers. CORRECT INTERPRETATION: The ground truth shows treasury stock increased in absolute value from $36.658 billion to $60.429 billion to $71.431 billion (in negative/parenthetical form), representing cumulative buybacks of approximately $23.771 billion from 2022-2023 and $11.002 billion from 2023-2024. QUALITATIVE ASSESSMENT: The LLM's reasoning about capital allocation strategy and shareholder returns is conceptually sound and well-articulated. The interpretation that increasing treasury stock reflects confidence and shareholder-focused capital allocation is correct. However, this correct reasoning is built on fundamentally incorrect numbers, making the overall answer misleading despite good analytical framework. The answer demonstrates understanding of what treasury stock buybacks signify but fails on the core factual accuracy required for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 456,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRevenue from Repair and other services fell modestly from **$1.169 billion in 2022 to $1.132 billion in 2023** and then **held steady at $1.132 billion in 2024**. This slight dip followed by a flat‑line pattern indicates that the company’s service business has largely plateaued, with growth now being driven more by new ship‑building and construction activities rather than expanding repair income.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and proper number formatting. All key numbers are accurate: $1.169 billion (2022), $1.132 billion (2023), and $1.132 billion (2024). The format conversion from millions to billions is correct and acceptable. The multi-hop synthesis is sound, correctly identifying the revenue trajectory across three years and recognizing the pattern of decline followed by stabilization. The reasoning about stagnation/plateau is logically sound and matches the ground truth interpretation. However, there are minor differences: (1) The LLM does not explicitly calculate or mention the 3.2% overall decline from 2022 to 2024 that the ground truth specifies, though the characterization of 'slight dip' is semantically equivalent. (2) The LLM adds interpretive commentary about 'growth being driven more by new ship-building and construction activities' which goes beyond the ground truth answer and introduces information not explicitly verified in the provided context. This additional interpretation, while potentially insightful, represents a slight overreach beyond what can be confirmed from the specific data points. The core answer is correct and well-structured, addressing all parts of the question with accurate numbers and sound reasoning about the service business trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 377,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nAcross the three years the company’s residential‑mortgage‑backed‑securities (RMBS) position grew only modestly – amortized cost rose from **$845 million in 2022 to $862 million in 2023** (and remained roughly at that level in 2024), while fair value increased from **$757 million to $810 million** over the same period.  The unrealized‑loss exposure fell sharply from **about $89 million in 2022 to $60 million in 2023** (and stayed near that level in 2024), reflecting fewer price‑related losses and a shorter‑duration, higher‑quality portfolio.  This multi‑year trend shows CVS has been deliberately trimming the interest‑rate‑sensitive, loss‑prone segment of its RMBS holdings, positioning the asset class as a relatively stable, income‑generating exposure with limited downside risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across nearly all quantitative metrics and contradicts the ground truth on multiple critical dimensions: (1) FAIR VALUE NUMBERS: Ground truth shows fair values of $629M (2022), $614M (2023), and $71M (2024). LLM claims $757M (2022) and $810M (2023) - these are completely wrong and represent a 20%+ discrepancy. (2) UNREALIZED LOSSES: Ground truth shows $10M (2022), $60M (2023), and implies continued losses in 2024. LLM claims $89M (2022) declining to $60M (2023) - the 2022 figure is wrong by nearly 9x. (3) AMORTIZED COST: LLM provides amortized cost figures ($845M, $862M) that are not mentioned in the ground truth and appear to be fabricated or from a different source. (4) DIRECTIONAL NARRATIVE: Ground truth emphasizes a SHARP DECLINE in fair value from $629M to $71M (88% reduction), indicating aggressive de-risking. LLM incorrectly characterizes this as 'modest growth' in amortized cost and improving unrealized losses, which contradicts the actual trajectory. (5) STRATEGIC INTERPRETATION: While both answers suggest de-risking, the LLM's characterization of 'fewer price-related losses' and 'stable, income-generating exposure' is misleading given the massive fair value decline and increased unrealized losses in 2023. The LLM appears to have confused or conflated different metrics (amortized cost vs. fair value) and provided numbers that do not match the ground truth data. This is a critical failure on a quantitative financial question where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 421,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nLinde’s on‑site supply agreements remained long‑term “total‑requirement” contracts (typically 10‑20 years) that include minimum purchase volumes and built‑in price‑escalation provisions indexed to commodity, inflation and energy‑price benchmarks.  From 2022 through 2024 the company refined the variable‑pricing component—linking price adjustments to those market indices and incorporating inflation‑driven escalators—while still treating the variable portion as constrained and recognizing revenue only when the amount became measurable, a practice reflected in the growth of estimated future minimum‑purchase revenue from roughly $48 bn to $58 bn.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core contractual structure correctly (10-20 year on-site contracts with minimum purchase requirements and price escalation provisions) and accurately identifies the evolution toward greater transparency in variable pricing mechanisms from 2022-2024. The qualitative description of pricing indices (commodity, inflation, energy benchmarks) and the constraint on variable components aligns well with the ground truth. However, there is a critical quantitative accuracy issue: the LLM introduces specific dollar figures ($48bn to $58bn for estimated future minimum-purchase revenue) that are NOT present in the original ground truth answer. The ground truth makes no mention of these specific revenue figures or their growth trajectory. This represents an unsupported quantitative claim that cannot be verified against the provided ground truth. The LLM correctly identifies the ASC 606 revenue recognition framework and the practical expedient for measuring progress, though the ground truth explicitly mentions this while the LLM only implies it through the revenue recognition discussion. The multi-hop reasoning is sound in synthesizing the 3-year evolution and connecting contract structure to revenue recognition practices. The answer is well-structured and contextually relevant to the question about contractual evolution, but the introduction of unverified financial metrics significantly undermines quantitative credibility. The semantic equivalence is generally strong for the qualitative aspects, but the quantitative additions create a factual accuracy problem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 438,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra’s net notional exposure to forward gas contracts fell sharply – from about 1.3 trillion MMBtu (a short position) to 1.452 trillion MMBtu in 2023 and then to 1.131 trillion MMBtu in 2024 – and the fair‑value net position dropped from roughly $300 million (2023) to $250 million (2024). This contraction in both volume and fair‑value exposure shows that the company is deliberately scaling back its natural‑gas price risk, moving toward a more regulated, lower‑volatility earnings profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. CRITICAL ISSUES: (1) WRONG METRIC: The LLM discusses 'notional exposure in MMBtu' (volume/quantity metric), but the ground truth answer addresses 'fair-value net position' in dollars (asset/liability metric). These are completely different measures. (2) WRONG NUMBERS FOR 2022: Ground truth shows $160M net exposure in 2022; LLM claims '1.3 trillion MMBtu (a short position)' which is a volume measure, not a dollar value. (3) WRONG 2023 FIGURE: Ground truth shows $300M in 2023; LLM states 'roughly $300 million (2023)' which happens to match but is presented alongside incorrect MMBtu volumes. (4) CORRECT 2024 FIGURE: LLM correctly states $250M for 2024, matching ground truth. (5) INCOMPLETE 2022 DATA: LLM completely omits the 2022 fair-value position ($160M), failing to establish the baseline for the 3-year trend analysis. (6) CONFUSED ANALYSIS: The LLM conflates notional volume exposure (MMBtu) with fair-value exposure (dollars), creating a nonsensical comparison. The ground truth clearly shows: 2022=$160M, 2023=$300M (increase), 2024=$250M (decrease). The LLM's narrative about 'scaling back' and 'moving toward regulated, lower-volatility earnings' may be reasonable interpretation, but it's built on incorrect quantitative foundations. The answer demonstrates a fundamental misunderstanding of which metric to track and provides mostly wrong numbers for the critical 2022-2023 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 409,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nAcross the three filings Broadcom’s framing of industrial fiber‑optic products moved from a simple “industrial‑end‑market” listing toward a strategic, cross‑segment enabler.  \n\n- **2022 (AVGO 10‑K, pp. 8‑12)** – Industrial fiber optics appear only as one item in the “Industrial End Markets” table, grouped with optocouplers, motion encoders, LEDs and Ethernet ICs and described as serving factory automation, power, medical, defense and automotive applications.  \n- **2023 (AVGO 10‑K, pp. 3‑7)** – After the VMware merger, the language expands: the company positions its optical‑component suite as part of a broader “Industrial & Automotive” offering that underpins high‑speed, secure connectivity for industrial IoT and edge‑computing use cases, and ties it to its Ethernet PHY and custom‑silicon platforms.  \n- **2024 (AVGO 10‑K, pp. 3‑7)** – The narrative elevates industrial fiber optics to a core pillar of Broadcom’s industrial portfolio, highlighting its role in AI‑driven factory automation, renewable‑energy systems and autonomous‑vehicle communications, and integrating it with the company’s expanded Ethernet, ASIC and connectivity solutions.  \n\nThus, the positioning evolved from a peripheral product line to a central, cross‑selling component that supports Broadcom’s wider industrial and automotive market strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth:\n\n1. ENTITY ERROR: The LLM repeatedly refers to 'Broadcom' when the company is 'AVGO' (Broadcom Inc.). While Broadcom is the parent company name, the 10-K filings are filed under AVGO ticker, and the ground truth specifically uses AVGO. This is a critical entity identification error.\n\n2. FACTUAL INACCURACY - 2022 POSITIONING: The ground truth states Industrial Fiber Optics was described as part of 'a broad variety of industrial products' serving multiple applications (industrial automation, power generation, medical systems, defense, aerospace, automotive). The LLM claims it appeared 'only as one item in the Industrial End Markets table' - this mischaracterizes the scope and breadth of the 2022 description.\n\n3. FACTUAL INACCURACY - 2023 POSITIONING: The ground truth indicates Industrial Fiber Optics was 'listed among key product offerings' alongside optocouplers, sensors, motion encoders, and LED devices. The LLM claims the language 'expands' to position it as part of a broader 'Industrial & Automotive' offering tied to 'industrial IoT and edge-computing use cases' and 'Ethernet PHY and custom-silicon platforms.' This narrative of expansion and strategic elevation is NOT supported by the ground truth, which shows consistent positioning.\n\n4. FACTUAL INACCURACY - 2024 POSITIONING: The ground truth states the product 'remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs.' The LLM claims it was 'elevated to a core pillar' with emphasis on 'AI-driven factory automation' and 'autonomous-vehicle communications.' The ground truth explicitly states there was 'no significant expansion or contraction relative to other product lines,' directly contradicting the LLM's narrative of elevation and strategic expansion.\n\n5. CORE CONCLUSION ERROR: The LLM concludes the positioning 'evolved from a peripheral product line to a central, cross-selling component.' The ground truth explicitly states 'The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio.' These conclusions are fundamentally opposed.\n\n6. MISSING CONTEXT: The LLM mentions the VMware merger in 2023, which is not addressed in the ground truth and may be introducing external context not supported by the filing analysis.\n\nThe LLM answer fundamentally misinterprets the evolution as one of strategic elevation and expansion when the ground truth indicates stability and consistent positioning. This is a major reasoning error in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 716,
        "total_tokens": 2310
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Unsecured Notes – 31B showed no change in size or cost: the notes remained a **$750 million (face amount) fixed‑rate tranche at a 3.25 % coupon**, which produced a **consistent annual debt‑service expense of about $24.4 million (≈$24,375 k)** each year.  This stability indicates that SPG is deliberately **maintaining a low‑cost, medium‑term fixed‑rate debt position** rather than issuing new notes or refinancing, using the 31B tranche as a steady component of its long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: the $750 million face amount, 3.25% interest rate, and $24,375,000 annual debt service are accurately stated across all three years (2022-2024). The LLM appropriately converts the annual debt service to '$24.4 million (≈$24,375 k)' which is a valid format variation and shows proper understanding of the magnitude. The multi-hop synthesis is sound—the model correctly identifies that the notes remained unchanged across the three-year period and draws a logical conclusion about SPG's debt strategy. The characterization of this as a 'stable long-term debt strategy' with 'no refinancing or restructuring' aligns perfectly with the ground truth. The LLM adds interpretive value by describing it as a 'low-cost, medium-term fixed-rate debt position' and noting it serves as a 'steady component of its long-term capital structure,' which represents reasonable financial analysis rather than factual error. The answer fully addresses both parts of the question: (1) how the obligations evolved (they didn't), and (2) what this reveals about strategy (stability and deliberate positioning). Minor deduction only because the LLM's interpretation of 'medium-term' is not explicitly confirmed in the ground truth, though it's a reasonable inference from the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 380,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ U.S. defined‑contribution expense rose each year – $70 million in 2022, $75 million in 2023 and $76 million in 2024 – showing a consistent upward trend.  This steady increase indicates that the company is progressively expanding its investment in employee retirement benefits through the defined‑contribution plans.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all three years' expense figures ($70M in 2022, $75M in 2023, $76M in 2024) and accurately characterizes the trend as a consistent upward progression. The quantitative data is entirely accurate with no calculation errors. However, the answer has one notable omission: it does not include the specific percentage increase calculation (8.6% from 2022 to 2024) that was provided in the ground truth answer. The LLM's characterization of the trend as 'progressively expanding investment' is semantically equivalent to the ground truth's 'steady and slightly growing commitment,' though the ground truth's phrasing of 'steady' better captures the modest nature of the increases (only $1M per year). The LLM successfully synthesizes the multi-hop information across three fiscal years and correctly interprets what the trend indicates about the company's employee retirement benefits strategy. The answer is well-structured and addresses the core question effectively, but the missing percentage metric represents an incomplete response to the original question which explicitly asked about the 3-year trend and what it indicates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 329,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has kept the same treatment of non‑economic accounting items in its ROIC calculation throughout 2022‑2024.  In each year’s filing the company explicitly states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance,” and the same definition of net operating profit after taxes and average invested capital is applied in the 2022, 2023 and 2024 ROIC tables.  This consistent exclusion shows that GD evaluates management performance on the basis of underlying, cash‑generating operating profitability rather than one‑time accounting adjustments, making ROIC a stable, comparable metric across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: The answer correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, matching the ground truth. The core finding of consistency is accurate. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) QUALITATIVE ACCURACY: The LLM answer provides superior detail compared to the ground truth by: (a) explicitly quoting the company's language about excluding goodwill impairments and non-economic accounting changes, (b) specifying that the same definition of net operating profit after taxes and average invested capital was applied across years, and (c) explaining the methodology's purpose (evaluating management on cash-generating operating profitability). The reasoning is sound and demonstrates proper multi-hop synthesis across three years of filings. (4) ENTITY ACCURACY: GD is correctly identified, the three-year period (2022-2024) is correct, and ROIC is the correct metric. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth (consistent exclusion indicating stable methodology) while providing additional supporting detail and context. The explanation of why this consistency matters (stable, comparable metric; focus on underlying cash-generating profitability) is logically sound and enhances understanding. Minor deduction from perfect score only because the LLM provides interpretive detail beyond what can be verified from the ground truth statement, though this detail appears reasonable and consistent with the stated facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 493,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nCVS’s Separate‑Accounts assets slipped from $3.31 billion at the end of 2022 to $3.20 billion at the end of 2023 (and stayed roughly at that level through 2024), with the decline driven mainly by lower U.S. corporate‑security holdings and net outflows, while cash and collective‑trust positions edged higher.  The modest, sustained contraction indicates that CVS is gradually reshaping its long‑term insurance investment book toward more liquid, lower‑risk assets and trimming exposure to higher‑yield but more volatile securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth data. Specific issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 value as '$3.31 billion' when ground truth shows $5,087 million ($5.087 billion) - a massive discrepancy of $1.776 billion or 35% understatement. The LLM also states 2023 as '$3.20 billion' when ground truth shows $3,250 million ($3.250 billion) - a minor understatement but still incorrect. The 2024 figure of roughly $3.20 billion is also inaccurate compared to ground truth's $3,311 million. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to capture the critical 2023 decline pattern. Ground truth shows a dramatic 36% drop from 2022 ($5,087M) to 2023 ($3,250M), followed by a modest 1.9% recovery in 2024 ($3,311M). The LLM incorrectly characterizes this as a 'modest, sustained contraction' starting from 2022, missing the sharp 2023 cliff entirely. (3) REASONING ERROR: The LLM's explanation about 'lower U.S. corporate-security holdings and net outflows' and 'gradually reshaping' suggests a gradual trend, when the data shows a sudden, significant devaluation in 2023 followed by stabilization - a very different narrative. (4) ENTITY/METRIC ACCURACY: While CVS is correctly identified, the Separate Accounts Assets figures are materially wrong, making all downstream analysis unreliable. The ground truth interpretation of 'strategic reduction or market-driven devaluation' is more accurate than the LLM's 'gradual reshaping' characterization. This is a fundamental failure to accurately report and synthesize multi-year financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 449,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nTarget’s Credit Card Program Agreement with TD Bank USA, N.A. was first updated in the period under review by a **Third Amendment executed on November 1 2022** (see Exhibit 10.21.3+ in the 2024 Form 10‑K), which revised several program terms and conditions.  This was followed by a **Letter Agreement dated March 8 2023** (Exhibit 10.21.4+) that further modified the arrangement, after which no additional amendments are disclosed in the 2024 filing, marking the latest contractual milestone through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims a 'Third Amendment executed on November 1, 2022' exists, but the ground truth explicitly states the second amendment was dated November 19, 2019 - there is no mention of a third amendment or November 1, 2022 date in the ground truth. The LLM also introduces a 'Letter Agreement dated March 8, 2023' that is not mentioned in the ground truth at all. (2) QUANTITATIVE ACCURACY: The dates provided by the LLM (November 1, 2022 and March 8, 2023) do not match the ground truth dates (October 22, 2012 for original agreement, February 24, 2015 for first amendment, November 19, 2019 for second amendment). The LLM appears to have fabricated specific dates and amendment numbers. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the actual evolution of the agreement across 2022-2024. The ground truth shows the agreement maintained continuity with amendments from 2015 and 2019 being referenced through 2024, not new amendments in 2022-2023. (4) ENTITY ACCURACY: While the company names are correct (Target Corporation and TD Bank USA, N.A.), the contractual milestones and amendments are fundamentally wrong. The LLM's claim that 'no additional amendments are disclosed in the 2024 filing' contradicts the ground truth which explicitly lists the November 19, 2019 amendment as being disclosed in 2024. The answer demonstrates hallucination of specific dates and amendment numbers rather than accurate synthesis of the actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 435,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022‑2024 Linde transformed rare‑gas production from a marginal co‑product into a strategic growth pillar by investing in advanced separation technologies (e.g., membrane and VPSA) and engineering‑driven on‑site plant designs that simultaneously yield oxygen, nitrogen, argon and rare gases.  These streams are now tightly integrated with Linde’s broader portfolio—linked to engineering contracts, hydrogen and low‑carbon gas projects, and specialty‑gas markets—creating cross‑selling opportunities across its industrial‑gases and engineering segments.  Capital spending and long‑term minimum‑purchase on‑site contracts have risen to support this differentiated, integrated approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Linde's rare gases evolution from 2022-2024 and correctly identifies key technological and strategic elements. STRENGTHS: (1) Accurately captures the shift from rare gases as marginal co-products to strategic growth pillar; (2) Correctly identifies specific technologies (VPSA, membrane separation) mentioned in ground truth; (3) Properly synthesizes the integration aspect across product lines and segments; (4) Accurately reflects the emphasis on on-site delivery and long-term contracts; (5) Correctly notes the connection to hydrogen and low-carbon gas projects as part of broader portfolio integration. WEAKNESSES: (1) The LLM answer does not explicitly mention specific rare gases (krypton, neon, xenon) that are highlighted in the ground truth as examples of Linde's leadership; (2) Does not explicitly reference the 2023 emphasis on proprietary technologies and price escalation clauses in contracts, though the general concept of long-term contracts is captured; (3) The phrase 'marginal co-product' is an inference not explicitly stated in ground truth, though semantically reasonable; (4) Missing explicit reference to the 'non-cryogenic air separation technologies' leadership claim from 2024. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is not directly testable. The temporal progression (2022-2024) is correctly maintained. MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the progression from product-centric to technology/integration-driven approach. The connection between technological innovation and market expansion is logically sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—both describe evolution toward technology-driven, integrated positioning. The LLM's framing of 'cross-selling opportunities' effectively captures the integration concept. Overall, this is a strong answer that captures the essential narrative but omits some specific details and examples present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 572,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nFrom 2022 to 2024 the amount of collateral the company posted under master‑netting arrangements that backs its **advances to equity‑company counterparties fell sharply – from about $1.49 billion in 2022 to $0.80 billion in 2023 and then to roughly $0.49 billion in 2024**.  This downward trend shows that ExxonMobil has been **reducing the amount of security it must set aside to offset derivative positions tied to those equity‑company relationships**, indicating a **decline in the outstanding derivative liabilities (or a lower reliance on such collateral) associated with its equity‑company exposures**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024). The LLM properly converted the ground truth values ($1,494M → $1.49B, $800M → $0.80B, $491M → $0.49B), which is an acceptable format variation. The downward trend is accurately captured. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) how the collateral evolved from 2022-2024 with specific year-over-year figures, and (b) what the trend suggests about derivative liability exposure. (3) ENTITY ACCURACY: ExxonMobil is correctly identified, the time period (2022-2024) is correct, and the financial metrics (collateral under master netting arrangements, advances to equity companies, derivative liabilities) are all properly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly connects the declining collateral amounts to reduced derivative exposure and interprets this as de-risking or portfolio optimization, which aligns with the ground truth's characterization of 'strategic reduction in exposure' and 'de-risking or portfolio optimization efforts.' The explanation that lower collateral requirements reflect 'decline in outstanding derivative liabilities (or lower reliance on such collateral)' is logically sound and semantically equivalent to the ground truth. (5) MINOR OBSERVATION: The LLM's phrasing 'collateral the company posted' and 'security it must set aside' provides slightly more interpretive detail than the ground truth, but this adds helpful context without introducing inaccuracy. The answer is comprehensive, well-structured, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 475,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral PPAs rose only modestly—from roughly 92 % of capacity (as reported for the 2021/2022 period) to about 94 % by the end of 2023 and it stayed at that level in 2024.  The remaining capacity is now increasingly sold into spot markets or hedged with shorter‑term (typically < 3‑year) bilateral contracts that protect a portion of expected revenue.  This pattern shows that NEER continues to lock in the bulk of its earnings through long‑term contracts while using limited short‑term hedges to manage price risk and retain flexibility in competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of NEER's long-term bilateral contract strategy. QUANTITATIVE ACCURACY: All key percentages are correct—92% in 2022, 94% in 2023 and 2024. The LLM correctly identifies the modest increase (2 percentage points) and maintains accurate numerical references throughout. Minor note: The LLM references '2021/2022 period' which is slightly imprecise wording compared to ground truth's cleaner '2022' reference, but this does not constitute a factual error. QUALITATIVE ACCURACY: The LLM successfully synthesizes the multi-hop information about NEER's risk mitigation strategy across three years. It correctly identifies that: (1) long-term bilateral contracts dominate the portfolio, (2) remaining capacity uses spot markets or shorter-term hedges, (3) this reflects a deliberate strategy balancing stability with flexibility. The reasoning is sound and logically connects the trend data to strategic implications. COMPLETENESS: The answer addresses all components of the multi-part question—the evolution of reliance (92%→94%), the trend (steady increase), and what it suggests about risk mitigation strategy (revenue stability, price risk management, flexibility retention). SEMANTIC EQUIVALENCE: The LLM's explanation of 'shorter-term (typically < 3-year) bilateral contracts' and 'spot markets' aligns with the ground truth's reference to 'shorter-term bilateral contracts as a hedge.' The characterization of the strategy as emphasizing 'revenue stability and risk mitigation' matches the ground truth's assessment. ENTITY ACCURACY: NEER is correctly identified, years are accurate, and financial metrics (net generating capacity percentages) are properly referenced. The only minor weakness is the slightly awkward phrasing of '2021/2022 period' rather than simply '2022,' but this does not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 512,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 continued to show a flat $495 million outstanding from the end of fiscal 2022 through fiscal 2024 (the same $495 million reported as of Oct 29 2023 and Nov 3 2024).  Because no reduction is noted, the company is effectively holding the tranche to maturity and using newer borrowings—such as the 2023 Term Loans and the October/July 2024 senior‑note issuances—to refinance and extend its overall maturity profile, rather than actively retiring this specific legacy debt.  This reflects a debt‑management strategy that prioritizes rolling newer, larger‑scale financing while letting the 3.125 % notes amortize on their scheduled 2025 principal‑payment date.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the $495 million outstanding principal balance remaining constant from fiscal 2022 through fiscal 2024. The numeric values are accurate, and the date references (Oct 29 2023 and Nov 3 2024) are appropriately specific. The answer correctly identifies the 3.125% notes due January 2025 and accurately characterizes the lack of principal reduction over the three-year period. The multi-hop reasoning is sound, synthesizing information about AVGO's debt management strategy by connecting the static balance of this specific instrument to broader refinancing activities (2023 Term Loans, October/July 2024 senior-note issuances). The LLM answer goes slightly beyond the ground truth by providing more detailed context about the company's overall debt strategy, explaining that AVGO is using newer borrowings to extend maturity profile while letting the 3.125% notes reach their scheduled maturity. This additional context is logical and consistent with the ground truth's suggestion of refinancing or using cash reserves. The semantic meaning aligns well with the original answer—both conclude that no amortization occurred and the company is managing this debt through refinancing rather than active retirement. Minor differences: the LLM uses slightly more sophisticated language ('roll newer, larger-scale financing' vs. 'refinance or use cash reserves') but conveys equivalent meaning. The answer fully addresses all parts of the question regarding the evolution of the balance and what it reveals about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 441,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Unsecured Notes 37B remained essentially unchanged: each filing lists a fixed 2.25 % coupon, a $700 million face amount and a maturity date of January 15 2032, with the same $15,750 k annual debt‑service figure disclosed in 2022, 2023 and 2024.  The lack of any rate, size or term modification over the three‑year span shows that SPG is deliberately locking in low‑cost, long‑dated unsecured financing and is not seeking to refinance or restructure this tranche, reflecting a strategy of maintaining a stable, predictable capital structure with extended maturities to manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2.25% interest rate, $700 million face amount, January 15, 2032 maturity date, and the $15,750k annual debt-service figure are all accurate and properly formatted. The answer correctly identifies that these terms remained unchanged across all three years (2022-2024), which is the core factual requirement. The multi-hop synthesis is sound - the model successfully tracked the same instrument across three separate filings and identified the consistency pattern. The reasoning about debt strategy is well-articulated and semantically equivalent to the ground truth: both answers recognize that the stability indicates a deliberate strategy of maintaining predictable financing costs with extended maturities. The LLM answer adds slightly more detail by explicitly mentioning the annual debt-service figure and explicitly stating SPG is 'not seeking to refinance or restructure,' which provides additional context without contradicting the ground truth. The only minor distinction is that the ground truth emphasizes alignment with 'real estate portfolio' cash flows while the LLM emphasizes 'interest-rate risk management' - both are valid strategic interpretations of the same underlying fact pattern. No calculation errors, no factual inaccuracies, and all entities (Simon Property Group, the specific notes instrument, years, and metrics) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 405,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom 2022 through 2024 the property tables list Melaka, Malaysia with an “X” only under the **Analog** column and no “X” under **Embedded Processing** in each year’s disclosure (the site is noted as partly leased/owned in 2022 and marked with an asterisk/ double‑asterisk in later years).  This consistent designation shows that TI’s Melaka campus has remained dedicated solely to analog‑chip manufacturing over the three‑year span, with no shift or expansion into embedded‑processing production.  The unchanged footprint therefore reveals that the company’s strategic focus at Melaka is firmly on scaling its analog portfolio—leveraging the location’s cost and supply‑chain advantages—while embedded processing continues to be served from other sites.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All factual claims are correct - Melaka, Malaysia is accurately identified with 'X' under Analog only across 2022-2024, with no Embedded Processing designation in any year. (2) The multi-hop synthesis is sound: the answer correctly identifies the 3-year progression (2022→2023→2024) and accurately characterizes it as 'unchanged' or 'consistent.' (3) Entity accuracy is perfect: Texas Instruments (TXN) correctly identified, Melaka location correct, product categories (Analog vs Embedded Processing) correctly distinguished. (4) The reasoning is logical and well-articulated: the answer correctly infers from the consistent 'X' pattern that TI maintains a targeted, analog-only strategy at Melaka. (5) Additional contextual details are appropriately included (lease/ownership status, asterisk notations) without detracting from core answer. (6) The conclusion about strategic focus on analog capabilities and leveraging cost/supply-chain advantages is a reasonable inference from the data pattern. MINOR CONSIDERATIONS: The LLM adds interpretive commentary about 'scaling analog portfolio' and 'cost and supply-chain advantages' that goes slightly beyond what the ground truth explicitly states, though these are reasonable inferences from the consistent operational pattern. The ground truth is more conservative in its language ('suggests a targeted investment') while the LLM is slightly more assertive ('firmly on scaling'). This is a minor stylistic difference that does not constitute a factual error. All core facts match perfectly between the two answers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 447,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard tied its multi‑layered security model to the rollout of real‑time payment rails, first scaling real‑time clearing and settlement to 13 markets (2023) and then extending those rails into new jurisdictions—including a joint‑venture launch in China (2024) and the Alias‑Based Remittances platform that streamlines cross‑border disbursements.  With each geographic expansion the company deepened collaboration among issuers, acquirers, governments and standards bodies, added fraud‑scoring and tokenization services to its distributed architecture, and introduced programmatic safeguards such as Mastercard Receivables Manager and enhanced virtual‑card controls to protect the growing volume of instantaneous, cross‑border transactions across more than 200 countries.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - LLM states '13 markets (2023)' which matches ground truth, but then claims expansion 'into new jurisdictions' without specifying the 2022 baseline of 12 markets. The ground truth explicitly states 12 markets in 2022 and 13 in 2023 - a single market expansion, not the dramatic scaling implied by LLM's narrative. (2) UNSUPPORTED CLAIMS - LLM introduces 'Alias-Based Remittances platform' and 'Mastercard Receivables Manager' which do NOT appear in the ground truth. These are factually unverifiable additions that inflate the answer with potentially incorrect information. (3) GEOGRAPHIC SCOPE INFLATION - LLM claims 'more than 200 countries' which is not mentioned in ground truth and appears to be generic boilerplate rather than specific to the 2022-2024 evolution being asked about. (4) MISSING KEY DETAILS - LLM fails to clearly articulate the 2022 baseline (12 markets) and the incremental nature of expansion. Ground truth emphasizes the progression: 12→13 markets with specific security mechanisms (fraud scoring, tokenization, EMV standards, third-party risk integration). (5) CHINA EXPANSION - Both answers correctly identify the 2024 China joint venture, but LLM doesn't adequately explain how this required scaling the security framework specifically. CORRECT ELEMENTS: LLM correctly identifies the 2023 expansion to 13 markets, the China 2024 joint venture, the emphasis on fraud-scoring and tokenization services, and the multi-stakeholder collaboration model. The semantic connection between geographic expansion and security evolution is present. However, the introduction of unverified products and the lack of precise market count progression significantly undermines accuracy. The answer reads more like marketing copy than a precise synthesis of filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 494,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nBetween 2022 and 2024 General Dynamics grew the Canadian LAV build‑rate from about **360 vehicles in 2022 to 399 in 2023 and to 449 in 2024** (the 2024 figure also includes an additional 66 LRSS‑equipped units).  This upward trajectory shows that GD is deliberately scaling up and sustaining its LAV program for Canada, treating the contract as a strategic growth area and investing in new variants and upgrades.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct production volumes for all three years (360 units in 2022, 399 in 2023, and 449 in 2024). The core numbers match the ground truth exactly. The answer properly identifies the upward trajectory and correctly synthesizes the multi-hop information about General Dynamics' LAV program evolution across the 2022-2024 period. The reasoning about strategic focus and commitment is sound and well-supported by the production data. One minor addition in the LLM answer is the mention of '66 LRSS-equipped units' in 2024, which is not present in the ground truth answer. While this additional detail doesn't contradict the ground truth and may represent supplementary information from the source documents, it goes slightly beyond what was confirmed in the original answer. The LLM's interpretation that this represents 'deliberate scaling up' and 'treating the contract as a strategic growth area' aligns well with the ground truth's characterization of 'consistent and growing strategic emphasis.' The semantic equivalence is strong - both answers convey the same fundamental message about expanding production and strategic commitment. The answer is well-structured, addresses all parts of the question, and provides appropriate context about what the progression indicates about company strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 377,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nThe pension‑plan’s exposure to hedge‑fund limited‑partnerships grew modestly but consistently: $225 million in 2022 → $252 million in 2023 → $280 million in 2024 (an approximate 25 % rise over the three‑year period). This upward trajectory suggests that CVS is deliberately increasing its allocation to alternative‑asset strategies—using hedge‑fund LP interests to enhance returns and diversify the plan’s portfolio while staying within its broader target‑allocation framework.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data across all three years. Ground truth values: 2022=$214M, 2023=$225M, 2024=$252M. LLM values: 2022=$225M, 2023=$252M, 2024=$280M. The LLM has shifted all values upward and misaligned them to wrong years. Specifically: (1) The 2022 figure is wrong ($225M vs $214M - off by $11M or 5.1%), (2) The 2023 figure is wrong ($252M vs $225M - off by $27M or 12%), (3) The 2024 figure is wrong ($280M vs $252M - off by $28M or 11.1%). The calculated percentage increase is also incorrect: LLM claims ~25% growth, but ground truth shows 17.8% growth [(252-214)/214 = 17.8%]. The LLM's calculation of 25% would be approximately correct for their stated numbers [(280-225)/225 = 24.4%], but those numbers are wrong. The multi-hop reasoning about CVS's strategy is qualitatively reasonable (discussing deliberate allocation increases and portfolio diversification), but this reasoning is built on incorrect foundational data. The answer fails the primary requirement of factual accuracy on all three data points and the calculated metric. This is a complete failure on quantitative accuracy despite reasonable qualitative framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 338,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe Target MasterCard Credit‑Card penetration fell steadily from ≈ 20.5 % of all purchases in the fiscal year ended January 2022 to ≈ 19.8 % in 2023 and ≈ 18.6 % in 2024 (the company reports overall “RedCard” penetration of 20.5 %, 19.8 % and 18.6 % for those three years).  This modest decline indicates that while the card continues to be used by a meaningful share of shoppers, its growth has plateaued and even slipped slightly, pointing to slower consumer adoption or increasing competition rather than expanding engagement with Target’s financial products.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN KEY METRIC: The LLM reports 2024 penetration as 18.6%, but the ground truth states it was 17.8%. This is a significant factual error on the primary quantitative measure being evaluated. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The discrepancy of 0.8 percentage points is material when discussing trend analysis and represents a ~4.5% understatement of the decline. CORRECT ELEMENTS: The LLM correctly identifies the overall declining trend, properly attributes this to RedCard penetration data, and provides sound qualitative reasoning about what the decline suggests (slower adoption, competition, plateaued growth). The semantic interpretation of the trend is appropriate. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the penetration decline to broader implications about consumer behavior and market dynamics. The explanation that 'while RedCard sales increased in dollar terms, total sales grew even faster' is implied but not explicitly stated in the LLM answer, though the conclusion about dilution is reasonable. COMPLETENESS: The answer addresses the evolution question and provides interpretation of what the trend suggests, meeting the multi-part requirement. However, the quantitative error undermines the credibility of the analysis. The 0.8 percentage point difference between reported (18.6%) and actual (17.8%) 2024 figures is not a minor rounding variation - it represents a material misstatement of the data point that is central to evaluating the trend's severity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 426,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value exposure recorded for FPL Cost Recovery Clauses rose from $16 million to $12 million and then to $38 million, with the net position expanding even though the observable‑input component stayed small and turned increasingly negative (≈$(6) million in 2022, ≈$(8)‑$(12) million in 2023‑2024).  At the same time the unobservable‑input contribution grew from roughly $16 million to about $24 million, showing a marked shift toward greater reliance on internal, non‑observable assumptions for the estimate.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022 Total Fair Value: LLM states $16 million, but ground truth is $1 million. This is a 1,500% error.\n   - 2023 Total Fair Value: LLM states $12 million, which matches ground truth. CORRECT.\n   - 2024 Total Fair Value: LLM states $38 million, which matches ground truth. CORRECT.\n   - 2022 Observable Inputs: LLM states \"≈$(6) million\" (negative), ground truth is -$5 million. Close but imprecise.\n   - 2022 Unobservable Inputs: LLM states \"roughly $16 million\", ground truth is +$6 million. This is a 167% error.\n   - 2023 Observable Inputs: LLM states \"≈$(8)-(12) million\", ground truth is -$12 million. Partially correct range.\n   - 2023 Unobservable Inputs: LLM states \"about $24 million\", ground truth is +$24 million. CORRECT.\n   - 2024 Observable Inputs: LLM states positive contribution but ground truth shows +$4 million. Direction correct but magnitude unclear in LLM statement.\n   - 2024 Unobservable Inputs: LLM does not explicitly state this; ground truth is +$34 million. MISSING.\n\n2. MULTI-HOP SYNTHESIS ISSUES:\n   - The LLM failed to correctly synthesize the 2022 baseline figures, which cascades through the entire analysis.\n   - The LLM correctly identified the trend toward greater reliance on unobservable inputs, but the supporting numbers are wrong.\n   - The LLM did not provide the complete breakdown for 2024 (missing unobservable inputs contribution of $34 million).\n\n3. SEMANTIC/REASONING ISSUES:\n   - The LLM's statement that \"the net position expanding\" is correct in concept for 2023-2024, but the 2022 baseline error undermines the entire trajectory analysis.\n   - The conclusion about \"marked shift toward greater reliance on internal, non-observable assumptions\" is directionally correct but based on incorrect numbers.\n\n4. COMPLETENESS:\n   - The answer addresses the evolution from 2022-2024 but with significant numerical errors.\n   - Missing explicit statement of 2024 unobservable inputs contribution ($34 million).\n   - The answer does not fully capture the complete fair value composition for all three years.\n\nThe most damaging error is the 2022 total fair value ($16M vs. $1M), which represents a fundamental misreading of the data and undermines the credibility of the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 642,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Nike’s competitive edge versus Anta was reinforced by a dual focus on high‑tech product innovation and deep‑level brand engagement.  While Anta has continued to grow its domestic market share in China with cost‑effective, performance‑oriented releases, Nike accelerated the rollout of its flagship cushioning and digital‑first platforms (Air, Zoom, React, Flyknit, FlyEase, Adapt) and expanded its athlete‑centric, social‑media‑driven marketing and direct‑to‑consumer retail network, thereby strengthening consumer connection and brand affinity worldwide.  This sustained innovation‑and‑engagement strategy has helped Nike maintain its position as the global leader in athletic footwear and apparel despite Anta’s rising presence.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific product names (Air, Zoom, React, Flyknit, FlyEase, Adapt) that are NOT mentioned in the ground truth. This represents fabrication of details not supported by the source material. (2) UNSUPPORTED CLAIMS - The statement about 'Anta has continued to grow its domestic market share in China with cost-effective, performance-oriented releases' is not present in the ground truth and appears to be inferred/invented. (3) INCOMPLETE SYNTHESIS - The ground truth explicitly documents a TEMPORAL EVOLUTION: 2022 (emphasis on quality, performance, reliability, style/design), 2023 (elevated 'innovation and development' ahead of performance), and 2024 (further solidified innovation focus + digital experiences/social media/athlete endorsements). The LLM answer collapses this three-year progression into a generic statement about 'dual focus' without capturing the strategic shift over time. (4) MISSING KEY DETAILS - The ground truth emphasizes that Anta's competitive threat comes through 'localized and digitally native strategies,' which the LLM answer does not adequately address. (5) CORRECT ELEMENTS - The LLM correctly identifies: Nike as global leader, Anta as named competitor, innovation as key differentiator, digital engagement/social media as important, athlete endorsements as part of strategy, and the overall competitive dynamic. However, these correct elements are undermined by the fabricated product details and incomplete temporal analysis. The answer reads more like general industry knowledge than a synthesis of specific filing information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 455,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nFrom the 2022, 2023 and 2024 proxy tables the number of shares still available for future issuance under the 2003 Director Compensation Plan fell – roughly 1.8 million shares were left in 2022, about 1.75 million in 2023 and just under 1.73 million by 2024.  This steady decline shows the plan’s reserve is being exhausted and that Texas Instruments is shifting its director‑compensation funding to newer, shareholder‑approved equity plans (e.g., the 2024 Long‑Term Incentive Plan) rather than relying on the 2003 plan for future grants.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific share availability numbers (1.8M in 2022, 1.75M in 2023, 1.73M in 2024) that cannot be verified against the ground truth, which does not provide these specific figures. This is a critical issue for a quantitative question. The ground truth indicates the plan was 'no longer listed among those with remaining shares available for future issuance' by 2023, which contradicts the LLM's claim of 1.75M shares available in 2023. The LLM's statement that shares were 'still available for future issuance' in 2023-2024 appears inconsistent with the ground truth's assertion that the plan was no longer listed as having remaining shares by 2023. The qualitative reasoning about the shift toward newer plans (2024 LTIP, 2018 Director Plan) is sound and aligns with the ground truth's narrative of a 'strategic shift toward updated incentive structures.' The LLM correctly identifies the trend as a decline/phase-out and appropriately characterizes this as a shift to newer compensation vehicles. However, the specific numerical claims lack verification and may be inaccurate based on the ground truth's statement that the plan was no longer listed with available shares by 2023. The answer demonstrates good understanding of the overall trend but fails on quantitative precision, which is essential for this type of financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 378,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA layered data‑driven services onto its advertising offering by first modernizing the network (2022 – rolling out 2 Gbps downstream speeds and DOCSIS 4.0 while virtualizing core network functions), then adding streaming‑centric ad products such as the prepaid NOW broadband tier and the Xumo Stream Box that integrate DTC‑streaming commissions (2023), and finally consolidating a programmatic marketplace that unifies linear, digital and OTT inventory across X1, Sky Q and the ad‑supported NOW tier with advanced audience‑targeting, measurement and marketplace tools (2024).  These steps brought a unified, cloud‑based technology stack, richer data‑driven targeting capabilities, and expanded marketplace solutions that let advertisers buy and measure ads across the company’s full suite of video and streaming platforms.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The answer references specific technical specifications (2 Gbps downstream speeds, DOCSIS 4.0) and product names (Xumo Stream Box, NOW broadband tier, X1, Sky Q) that are not mentioned in the ground truth and appear to conflate CMCSA's network infrastructure evolution with advertising service evolution. (2) ENTITY/PRODUCT CONFUSION: The ground truth focuses on advertising technology, tools, data-driven services, and marketplace solutions. The LLM answer incorrectly emphasizes network modernization (DOCSIS 4.0, virtualizing core network functions) which is infrastructure, not advertising service evolution. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: The ground truth clearly states the evolution involved: 2022 - technology/tools/data-driven services for advertisers; 2023 - deeper integration of data-driven services with cloud-based platforms and integrated search; 2024 - enhanced digital advertising tools and strengthened representation agreements. The LLM answer instead discusses streaming products, prepaid tiers, and programmatic marketplace consolidation without mentioning the representation agreements or the specific cloud-based platform and search functionality enhancements noted in the ground truth. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution of advertising services across the three-year period. Instead, it created a narrative about network infrastructure and streaming product launches that doesn't match the ground truth's focus on advertising technology and data-driven service integration. (5) SEMANTIC MISMATCH: While the LLM answer does mention 'cloud-based technology stack' and 'data-driven targeting capabilities,' these are presented in a context of programmatic marketplace consolidation rather than the integration of data-driven services into the advertising ecosystem as stated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 545,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the amortized cost of CVS’s commercial mortgage‑backed securities fell from $1.17 bn to $1.07 bn, and fair value declined from $1.02 bn to $0.98 bn, while unrealized losses narrowed from $155 m to $100 m. The 2024 filing shows a comparable modest exposure and essentially unchanged unrealized losses, indicating the company has reduced its CMBS position and now carries a lower market‑risk profile in this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all years. Specific errors: (1) 2022: LLM states amortized cost of $1.17bn and fair value of $1.02bn, but ground truth shows fair value of $574M with $12M unrealized losses - a massive discrepancy (LLM's numbers are roughly 1.8x larger). (2) 2023: LLM claims fair value of $0.98bn with $100M unrealized losses, but ground truth shows fair value of $675M - again, LLM's figure is significantly overstated. (3) 2024: LLM vaguely references 'comparable modest exposure and essentially unchanged unrealized losses' without providing specific numbers, while ground truth clearly states CMBS holdings fell to just $6M with no significant unrealized losses. The LLM appears to have confused or conflated CMBS data with other asset classes or misread the source documents entirely. The directional narrative (reduction in exposure, de-risking) is partially aligned with ground truth, but the quantitative foundation is completely wrong. The LLM failed to provide the critical 2024 figures that are essential to answering the question about the 2022-2024 evolution. Multi-hop synthesis is inadequate because the underlying numbers are incorrect, making any conclusions unreliable. The answer demonstrates a fundamental failure in quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 393,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, Target repeatedly lists “merchandise and other discounts” as part of its Compensation and Benefits package, using essentially the same language and without disclosing any change in discount rate or eligibility. This consistent inclusion—alongside comparable wage, health, retirement and tuition‑assistance benefits—indicates that Target treats the employee discount as a stable, core element of its broader benefits strategy focused on reinforcing engagement, retention and the company’s purpose of helping families enjoy everyday life.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps in addressing the multi-year progression question. While it correctly identifies that merchandise discounts were consistently mentioned across 2022-2024 filings and avoids fabricating specific discount rates, it fundamentally fails to capture the evolution that the ground truth describes. The ground truth explicitly documents a clear progression: (1) 2022: discounts listed with $15/hour minimum wage; (2) 2023: wage range expanded to $15-$24/hour with enhanced financial wellness benefits (401(k) matching, tuition reimbursement); (3) 2024: discounts within expanded ecosystem including mental health services and virtual healthcare. The LLM answer states discounts were presented 'without disclosing any change in discount rate or eligibility' and uses 'essentially the same language,' which contradicts the ground truth's documented evolution in how benefits were framed and contextualized. The LLM correctly identifies that discounts remained a 'stable, core element' but misses the critical multi-hop synthesis: the question asks about how the SCOPE AND VALUE evolved, and the ground truth shows evolution not in the discount itself but in its positioning within an increasingly comprehensive benefits package. The LLM's conclusion about 'reinforcing engagement, retention' is reasonable but generic and doesn't capture the strategic shift toward 'holistic employee well-being' with modern benefits layering. The answer demonstrates incomplete document synthesis—it appears to acknowledge consistency without recognizing the contextual evolution across the three years. Quantitative accuracy is adequate (no false numbers), but qualitative accuracy is weak because the multi-hop reasoning fails to identify and articulate the documented progression in benefits strategy framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 495,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nFrom 2022 to 2024 Linde’s risk‑factor disclosures moved from a brief mention that “cultural challenges associated with integrating employees from the acquired company” could pose a problem, to a more detailed focus that places cultural integration alongside control harmonisation, system alignment and foreign‑market risks, and even describes concrete mitigation steps such as cross‑cultural training and retention programmes.  This progression shows that Linde now treats cultural compatibility as a core strategic priority—embedding it in due‑diligence, integration planning and governance—to proactively manage the cross‑border integration risks that can erode synergies and financial performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2022-2024) and company (Linde). (2) No quantitative errors detected - no specific numbers, dates, or calculations are present in either answer to verify. (3) The LLM captures the general evolution of Linde's discussion of cultural challenges from brief mentions to more detailed treatment. (4) The answer correctly identifies that cultural integration became increasingly framed as a strategic priority. WEAKNESSES: (1) SIGNIFICANT DIVERGENCE FROM GROUND TRUTH: The LLM introduces specific mitigation strategies (cross-cultural training, retention programmes, due diligence, governance frameworks) that are NOT mentioned in the original answer. The ground truth makes no reference to these concrete mitigation steps. (2) FRAMING DIFFERENCE: The ground truth emphasizes a progression from operational concerns (2022) → broader regulatory/compliance context (2023) → financial outcomes focus (2024). The LLM presents a different narrative: brief mention → detailed focus on control harmonization, system alignment, and foreign-market risks. These are not the same progression. (3) MISSING KEY INSIGHT: The ground truth specifically notes that by 2024, Linde framed cultural challenges in terms of 'strategic risk management and financial outcomes rather than just operational hurdles.' The LLM captures the financial performance angle but misses the specific 2023 regulatory/compliance expansion mentioned in ground truth. (4) UNSUPPORTED CLAIMS: The LLM's reference to 'concrete mitigation steps' and specific governance approaches cannot be verified against the ground truth and may represent hallucination or over-interpretation. (5) INCOMPLETE SYNTHESIS: While the LLM addresses the evolution question, it doesn't accurately capture the three-year progression pattern described in the original answer. The multi-hop reasoning is partially sound but based on a different interpretation of the source material than what the ground truth indicates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 541,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nExxonMobil’s collateral that is pledged under master‑netting arrangements fell sharply—from **$1.49 billion in 2022 to $0.49 billion in 2024**, a decline of about **$1.0 billion (≈ 67 %)**.  Because this collateral is netted against the derivative assets recorded in “Notes and accounts receivable – net,” the drop signals that the company is relying less on external security to offset derivative positions and is instead managing its derivative exposure through internal netting, stronger credit positioning, and possibly reduced notional exposure.  The trend therefore points to a more streamlined and lower‑risk approach to handling its derivative book.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metrics and trend. STRENGTHS: (1) Numbers are accurate - correctly states $1.49 billion (2022) and $0.49 billion (2024), matching the ground truth values of $1,494M and $491M respectively. Format variation ($1.49B vs $1,494M) is acceptable. (2) Calculation is correct - the $1.0 billion decline and 67% percentage decrease are mathematically accurate. (3) Multi-hop synthesis is sound - the answer correctly connects the collateral decline to derivative exposure management and internal netting mechanisms. (4) The interpretation about strategic reduction and improved offsetting aligns with the ground truth's suggestion about 'strategic reduction in derivative exposure or improved offsetting mechanisms.' (5) The answer appropriately addresses both parts of the question: the change from 2022 to 2024 AND what the trend suggests. MINOR WEAKNESSES: (1) The answer omits the intermediate 2023 data point ($800M/$0.8B), which the ground truth explicitly includes. While not critical since the question asks about 2022-2024 change, including the three-year progression would have been more complete. (2) The reasoning about 'internal netting, stronger credit positioning, and possibly reduced notional exposure' goes slightly beyond what can be definitively concluded from the collateral data alone, though it represents reasonable inference. The answer is well-structured, uses appropriate financial terminology, and provides sound analytical interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 432,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform moved from a primarily internal, posture‑assessment tool for mainframe security into a centrally‑integrated component of Broadcom’s broader cybersecurity strategy.  In 2022 it delivered risk scores and remediation suggestions that could be consumed by in‑house SIEMs, but by 2023 Broadcom added native APIs and pre‑built connectors that let the platform feed data directly into external SOAR and ticketing systems, automating workflow‑driven remediation.  By 2024 the platform was positioned as a cross‑stack, zero‑trust enablement layer—leveraging AI‑driven threat intelligence from Symantec/Carbon Black, offering unified visibility across mainframe, cloud and edge environments, and aligning remediation actions with the company’s broader cybersecurity framework for holistic risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth: (1) ENTITY ERROR: The answer refers to 'Broadcom' and 'Symantec/Carbon Black' as if they are AVGO's own products/divisions, but the ground truth clearly identifies this as AVGO's (Broadcom's) Security Insights Platform - the LLM conflates external acquisitions with platform capabilities. (2) FABRICATED DETAILS: The LLM claims that by 2023 'Broadcom added native APIs and pre-built connectors' and by 2024 the platform was 'leveraging AI-driven threat intelligence from Symantec/Carbon Black' - these specific technical enhancements are NOT mentioned in the ground truth and appear to be hallucinated. (3) SCOPE MISALIGNMENT: The ground truth describes the platform's evolution in terms of positioning within AVGO's portfolio (standalone → integrated with cybersecurity portfolio → part of expanded mainframe suite with Cybersecurity/AIOps/DevOps), while the LLM invents a technical evolution narrative (internal tool → APIs/connectors → zero-trust enablement) that is not supported by the source material. (4) MISSING CORE FACTS: The LLM fails to mention the key 2024 evolution - that the platform became contextualized within an expanded mainframe software suite including Cybersecurity, AIOps, and DevOps. (5) MISCHARACTERIZATION: The ground truth emphasizes strategic portfolio alignment and regulatory compliance positioning; the LLM emphasizes technical integration details that are not in the ground truth. The answer demonstrates fundamental misunderstanding of what actually evolved (strategic positioning vs. technical capabilities) and introduces unsupported technical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 462,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the “Unsecured Notes – 32B” issue kept the same structural terms: a fixed face amount of **$750 million** and a **3.38 % coupon**, with maturity on **June 15, 2027** (see SPG 10‑K 2022 p. 51; SPG 10‑K 2023 p. 51; SPG 10‑K 2024 p. 51).  Its proportion of total consolidated unsecured debt stayed roughly 3½‑4 % (≈ $750 M of the $20‑$21 B unsecured pool), indicating a stable, long‑dated fixed‑rate component in the capital structure.  This underscores SPG’s long‑term debt‑management approach of locking in low‑to‑mid‑range rates and extending maturities to reduce refinancing risk while maintaining a predictable, low‑cost funding base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - face amount of $750 million, interest rate of 3.38%, maturity date of June 15, 2027. The LLM also provides additional context by noting the debt represents approximately 3.5-4% of total consolidated unsecured debt ($20-21B pool), which is a reasonable estimate and adds analytical depth. COMPLETENESS: The answer addresses all three years (2022, 2023, 2024) and correctly identifies that terms remained unchanged throughout the period. ENTITY ACCURACY: SPG (Simon Property Group) is correctly identified, the specific debt instrument (Unsecured Notes - 32B) is accurate, and all fiscal years are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and draws appropriate conclusions about debt management strategy - specifically that SPG maintained stable terms, locked in favorable rates, and reduced refinancing risk. The reasoning is sound and logically connects the stable debt terms to strategic implications. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'locking in low-to-mid-range rates and extending maturities to reduce refinancing risk' is semantically equivalent to the ground truth's 'stable long-term debt strategy' and 'maintain original terms without early redemption or restructuring.' MINOR CONSIDERATIONS: The LLM provides slightly more analytical context (debt proportion, capital structure implications) than the ground truth, which enhances rather than detracts from the answer. The citation format (page references) adds credibility. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 458,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen accelerated its fiber‑to‑the‑premises rollout—moving from a few pilot zones to a nationwide footprint that now reaches a sizable share of Comcast’s market and can deliver symmetrical multi‑gigabit speeds.  This expansion has been coupled with bundled packages that combine high‑speed fiber internet with Lumen’s video (streaming) and voice services, directly competing with Comcast’s traditional broadband‑plus‑video bundles and pressuring the cable operator to speed up its own fiber upgrades and bundling strategies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE PROBLEMS: The LLM introduces specific claims about 'nationwide footprint,' 'sizable share of Comcast's market,' and 'symmetrical multi-gigabit speeds' that are not present in the ground truth and cannot be verified from the provided knowledge graph. These appear to be fabricated details. (2) FACTUAL ACCURACY: The ground truth indicates Lumen was 'noted as part of a group' in 2022 and 'explicitly called out' in 2023 for fiber deployment, but the LLM's characterization of 'accelerated' rollout 'from pilot zones to nationwide footprint' is not supported by the source material. The ground truth uses more measured language ('consistent,' 'possibly intensifying') rather than the LLM's more dramatic escalation narrative. (3) MULTI-HOP REASONING: While the LLM correctly identifies the three-year period (2022-2024) and mentions fiber expansion and bundling, it fails to accurately synthesize the actual competitive evolution described in the ground truth. The ground truth shows a gradual, consistent threat; the LLM portrays an acceleration narrative without evidence. (4) MISSING NUANCE: The ground truth emphasizes that Lumen was part of a competitive group and that the threat was 'consistent and possibly intensifying,' but the LLM presents definitive claims about market share and speed capabilities that exceed what the knowledge graph supports. (5) SEMANTIC DIVERGENCE: While both answers address fiber expansion and bundling, the LLM's specific claims about 'nationwide footprint' and market impact are not grounded in the provided ground truth and represent unsupported extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 478,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nThe penetration rate of Target’s branded payment cards fell steadily from **≈20.5 % in fiscal 2022** to **≈18.6 % in fiscal 2023** and further to **≈17.8 % in fiscal 2024 (ended Feb 1 2025)**.  This downward trend indicates that the loyalty‑driven 5 % discount incentive for using RedCards/Target Circle Cards is losing traction, suggesting the current payment‑loyalty strategy is becoming less effective at driving incremental sales.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES (Primary Problem): The LLM provides incorrect penetration rates for fiscal 2023. Ground truth shows 19.8% for 2023, but LLM states ≈18.6% for fiscal 2023. This is a material discrepancy of 1.2 percentage points. The 2022 figure (20.5%) and 2024 figure (17.8%) are correct. The calculation of the overall trend direction is correct (downward), but the intermediate year data is wrong, which undermines the accuracy of the multi-hop analysis. QUALITATIVE ACCURACY: The LLM correctly identifies the downward trend and provides reasonable interpretation about the loyalty strategy's effectiveness. The reasoning about the 5% RedCard discount losing traction is logical and contextually appropriate, though this specific detail about the discount rate is not explicitly verified against the ground truth provided. The fiscal year end date reference (Feb 1, 2025) adds helpful context. COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates and what the trend suggests about strategy effectiveness. However, the incorrect 2023 figure creates a gap in the completeness of accurate data synthesis. MULTI-HOP REASONING: The model correctly synthesizes the three-year trend and connects it to strategic implications, but the factual error in the middle year weakens the reliability of this synthesis. The conclusion about declining effectiveness is sound given the downward trend, but is based on partially incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 410,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nChevron’s exposure to the Republic of Congo from 2022‑2024 was limited to a non‑operated 31.5 % interest in the offshore Haute Mer permit and a 15.75 % stake in the Lianzi block, which were accounted for in its African upstream portfolio (Business Environment and Outlook, p. 31, 2022 10‑K; Note 15, p. 77).  The company made only modest exploration‑and‑evaluation outlays on these blocks and did not treat them as core growth assets, focusing instead on higher‑return projects elsewhere; this stance was underscored by the sale of the two interests in early 2025 (Noteworthy Developments, p. 41, 2024 10‑K), signalling a strategic withdrawal while retaining the country only as a passive, non‑operated holding.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key quantitative details but has some timing and completeness issues. STRENGTHS: (1) Correctly identifies the 31.5% nonoperated interest in Haute Mer permit and 15.75% interest in Lianzi - these percentages match the ground truth exactly. (2) Accurately characterizes the assets as non-operated holdings in the African upstream portfolio. (3) Correctly identifies the divestiture as a strategic exit/withdrawal. (4) Properly synthesizes the multi-hop information about Chevron's evolving engagement. WEAKNESSES: (1) TIMING DISCREPANCY: The LLM states the sale occurred in 'early 2025' based on the 2024 10-K, but the ground truth indicates the sale was completed by 2024, not early 2025. This is a material timing error that affects the narrative of evolution through 2024. (2) MISSING KEY INVESTMENT DATA: The ground truth explicitly mentions Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa including the Republic of Congo in 2023. The LLM dismisses this as 'modest exploration-and-evaluation outlays' without quantifying or acknowledging the $0.7 billion investment figure, which represents a significant omission of concrete financial data. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes the evolution from 'active investment and development' (2022-2023) to 'divestiture' (2024), showing a clear progression. The LLM downplays the 2023 investment phase by characterizing holdings as never being 'core growth assets,' which understates the actual capital commitment made. (4) MISSING 2022 CONTEXT: The ground truth notes that in 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating strategic importance at that time. The LLM does not establish this baseline. The answer is directionally correct about the strategic exit but fails to fully capture the investment-to-divestiture evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 539,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s gas‑related option book grew in size but remained a small net‑liability: the “options ‑ primarily gas” line showed assets of roughly $100 million and liabilities of about $102 million in both 2023 and 2024 (down from a near‑break‑even $9 million net asset in 2021), while the accompanying forward‑gas contracts expanded from about $191 million of assets (2021) to $377 million of assets (2023) and $296 million of assets (2024).  At the same time the range of implied volatilities used to price those options fell from a 17 %‑295 % spread in 2021 to roughly 15 %‑150 % by 2024, reflecting higher market‑expected price swings and higher option premiums.  Together, the rising fair‑value of forward gas positions and the increasingly volatile volatility inputs show that NEE has been deliberately scaling up its hedging of gas‑price risk—using more options and forwards to manage exposure as market volatility intensified.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across multiple dimensions:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - 2022 Fair Values: Ground truth states $356M assets/$347M liabilities. LLM completely omits 2022 data and incorrectly references 2021 ($9M net asset, $191M forward assets) which is outside the requested 2022-2024 timeframe.\n   - 2023 Fair Values: Ground truth states $100M assets/$97M liabilities. LLM correctly states $100M assets/$102M liabilities for 2023-2024 but misses the critical 2023 liabilities figure of $97M.\n   - 2024 Fair Values: Ground truth states $100M assets/$102M liabilities. LLM correctly states these figures but only for 2023-2024 combined discussion.\n   - Implied Volatilities: Ground truth provides specific averages (36% in 2022, 50% in 2023, 52% in 2024). LLM provides volatility ranges (17%-295% in 2021, 15%-150% by 2024) which are different metrics entirely and outside the requested period.\n\n2. MULTI-HOP REASONING FAILURE:\n   - The question specifically asks about evolution from 2022-2024. The LLM introduces 2021 data (not requested) and fails to establish the critical 2022 baseline.\n   - The LLM misinterprets the question's focus on options volatility by discussing forward contracts extensively, which are a separate instrument not central to the ground truth answer.\n   - The LLM's conclusion about \"deliberately scaling up hedging\" contradicts the ground truth's finding of \"strategic de-risking\" from 2022 to 2023.\n\n3. ENTITY/METRIC CONFUSION:\n   - Ground truth focuses on \"options primarily tied to gas\" with implied volatility metrics.\n   - LLM conflates options with forward-gas contracts and uses volatility ranges instead of implied volatility averages.\n   - The LLM discusses forward contracts ($191M→$377M→$296M) which are not the primary focus of the ground truth answer.\n\n4. SEMANTIC MISALIGNMENT:\n   - Ground truth narrative: Sharp reduction 2022→2023, stabilization 2023→2024, de-risking strategy.\n   - LLM narrative: Growth in options book, scaling up hedging, intensified volatility management.\n   - These represent opposite strategic interpretations.\n\n5. MISSING CRITICAL INSIGHTS:\n   - The ground truth's key finding that fair values dropped from $356M/$347M (2022) to $100M/$97M (2023) is completely absent from the LLM answer.\n   - The ground truth's observation about implied volatility increasing from 36% to 50% then moderating to 52% is replaced with volatility range data.\n   - The strategic de-risking conclusion is inverted in the LLM response.\n\nThe LLM answer appears to reference different data points (possibly from a different section of the filing or different years) and fundamentally misinterprets both the quantitative trajectory and strategic implications of NextEra's gas options positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 754,
        "total_tokens": 2209
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nFrom 2022 to 2024 Nike moved FlyEase from a peripheral entry in a long list of “Nike Air, Zoom, Free, Dri‑FIT, FlyEase…” technologies to a highlighted element of its innovation narrative, explicitly tying the platform to the company’s push for inclusive, high‑performance product design.  This shift shows that FlyEase has transitioned from an experimental capability to a strategic pillar of Nike’s innovation strategy, underscoring the firm’s focus on accessibility‑driven performance as a growth driver across its footwear and apparel categories.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of FlyEase's evolution from 2022 to 2024. Both answers correctly identify the progression: (1) initial introduction/peripheral positioning in 2022, (2) expanded integration in 2023, and (3) established core role by 2024. The LLM answer accurately captures the key insight that FlyEase transitioned from experimental/newly introduced to a strategic pillar/foundational element. The specific characterization of the 2022 positioning as 'peripheral entry in a long list' is semantically equivalent to the ground truth's 'listing it alongside other technologies,' and both convey the same hierarchical positioning. The LLM answer adds valuable context about 'inclusive, high-performance product design' and 'accessibility-driven performance as a growth driver,' which aligns with and enriches the ground truth's emphasis on 'integration into various categories and consumer applications.' The multi-hop reasoning is sound—correctly synthesizing the three-year progression and drawing the appropriate conclusion about strategic importance. Minor deduction: The LLM answer doesn't explicitly mention the 2023 intermediate step as clearly as the ground truth does, instead jumping more directly from 2022 to the overall 2024 positioning. However, the implicit acknowledgment of the progression ('moved from...to...') captures the temporal evolution. No quantitative errors detected—no specific numbers, dates, or calculations are present in either answer, so quantitative accuracy is not a limiting factor. The answer is appropriately contextualized and directly addresses the question about evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 466,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 35A series stayed exactly the same: a $750 million (face) tranche carrying a fixed 2.65 % coupon, requiring an annual debt‑service payment of about $19.9 million and maturing on July 15, 2030.  No increase, amendment, or repayment of this note was reported in any of the 2022, 2023 or 2024 10‑K filings.  \n\nThis unchanged, long‑dated, low‑cost unsecured debt illustrates SPG’s deliberate strategy of locking in inexpensive financing for an extended horizon, thereby reducing refinancing risk and preserving liquidity for other growth and investment opportunities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental and severe factual error that undermines the entire response. The ground truth states the face amount is $750,000 (seven hundred fifty thousand dollars), but the LLM claims it is $750 million (seven hundred fifty million dollars) - a 1,000x overstatement. This is not a minor formatting difference; it represents a massive misrepresentation of SPG's actual debt obligation. The annual debt service is correctly stated as approximately $19.9 million in the LLM answer, which is consistent with the ground truth's $19,875 (the LLM rounded to $19.9M, which is reasonable rounding). However, this creates an internal inconsistency: if the face amount were truly $750 million at 2.65%, the annual debt service would be approximately $19.875 million, which matches the stated figure. The ground truth's $19,875 annual payment on a $750,000 face amount yields an effective rate of 2.65%, confirming the ground truth is correct. The LLM's claim of $750 million is mathematically inconsistent with the stated annual debt service of $19.9 million unless the interest rate were dramatically different. All other facts are correct: the 2.65% interest rate, the July 15, 2030 maturity date, the consistency across 2022-2024, and the strategic interpretation about locking in low-cost financing. The reasoning about SPG's debt strategy is sound and well-articulated. However, the magnitude error on the principal amount is so severe that it fundamentally misrepresents the company's financial obligations and cannot be overlooked, regardless of the quality of the strategic analysis provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 447,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nAcross 2022‑2024 Texas Instruments repeatedly placed embedded‑processing products alongside analog chips as one of the two core pillars of its business, citing them as key elements of the four sustainable competitive advantages that drive its strategy.  While embedded‑processing revenue rose modestly in 2022, slipped in 2023 and fell sharply in 2024, the company kept investing in capacity (e.g., the Lehi fab) and R&D, emphasizing that the segment’s cash‑generating power is essential to growing free‑cash‑flow per share.  This consistent positioning shows that TI’s long‑term growth strategy is not to chase short‑term sales spikes but to leverage the high‑margin, cash‑rich analog and embedded‑processing businesses to deliver sustained free‑cash‑flow growth for shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic positioning of embedded processing products alongside analog chips as dual pillars of TI's business model across 2022-2024. It accurately captures the connection to the four competitive advantages and the emphasis on free cash flow per share as the ultimate objective. The reasoning about long-term strategy versus short-term sales fluctuations is sound and well-articulated. The mention of specific investments (Lehi fab) and R&D commitment adds credible detail.\n\nWEAKNESSES: The LLM introduces specific revenue trend claims (\"rose modestly in 2022, slipped in 2023 and fell sharply in 2024\") that are NOT present in the ground truth answer. These quantitative assertions about revenue movements cannot be verified against the original answer and represent unsupported factual claims. The ground truth makes no mention of specific revenue trends or the Lehi fab investment - these appear to be inferences or external knowledge not grounded in the provided context. This is problematic because the evaluation criteria emphasize strict accuracy on numbers and facts.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects strategic positioning to the free cash flow per share objective, matching the ground truth's core logic. However, the addition of unverified revenue data and specific capital projects weakens the answer's reliability.\n\nKEY ISSUE: The LLM answer goes beyond the ground truth by making specific claims about revenue trends and capital investments that cannot be confirmed. While these may be factually accurate in TI's actual filings, they are not supported by the ground truth provided, which focuses on strategic narrative consistency rather than specific financial metrics or investment details. This represents a factual accuracy risk that prevents a higher score despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 523,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved Marvel from a generic indefinite‑lived trademark listed alongside ESPN and Pixar to a **top‑level “Marvel” tile on Disney+**, promoting Marvel movies, series and related content as a primary navigation entry and retaining that prominence in 2024; this evolution shows that the company is using Marvel’s IP as a **strategic lever to acquire and retain DTC subscribers**, as reflected by the continued capitalization of Marvel‑related intangible assets and the equity‑based compensation expenses tied to Marvel‑focused programming.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic evolution of Marvel from 2022-2024, accurately noting the transition to a top-level tile on Disney+ and the continued recognition as an indefinite-lived intangible asset. The reasoning about using Marvel as a strategic lever for DTC subscriber acquisition and retention is sound and aligns with the ground truth. The multi-hop synthesis across years and strategic/financial dimensions is logically coherent.\n\nWEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The LLM fails to include the specific Disney+ subscriber figure of 123 million as of September 28, 2024, which is explicitly mentioned in the ground truth and provides concrete evidence of the financial impact of this strategy. This is a significant omission for a question focused on 'financial strategy in driving subscriber growth.' (2) INCOMPLETE CONTEXT: The LLM does not mention the ESPN+ tile launch plan for early fiscal 2025, which the ground truth identifies as part of a 'broader strategy' showing how Marvel's approach was being replicated across other platforms. (3) VAGUE REFERENCE: The mention of 'equity-based compensation expenses tied to Marvel-focused programming' in the LLM answer is not substantiated in the ground truth and appears to be an inference not directly supported by the filing data. (4) MISSING TEMPORAL DETAIL: The ground truth emphasizes the 2023 transition as a 'key differentiator in the competitive DTC market,' which the LLM mentions but doesn't emphasize as strongly.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects strategic positioning to financial strategy, but the synthesis is incomplete without the subscriber growth metrics that directly demonstrate the financial impact.\n\nNUMERIC VERIFICATION: No specific numbers are provided in the LLM answer, so no calculation errors exist, but the omission of the 123 million subscriber figure is a material gap given the question's explicit focus on 'driving subscriber growth.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 550,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure about 59 % of its closed block through a modified‑coinsurance agreement with an external reinsurer.  In 2022 the arrangement was accounted for under the deposit method, with the deposit and recoverable offset on the balance sheet, whereas after the November 2023 risk‑transfer transaction the company expanded the modified‑coinsurance to separate‑account products and recorded a much larger reinsurance‑recoverable balance (≈ $10.3 bn in 2023 and $17.6 bn of net ceded recoverables in 2024, 84 % of which was held by the five largest reinsurers).  Consequently, the percentage of the closed block covered remained roughly constant, but the associated recoverable balances grew substantially and were now disclosed as sizable, partially unsecured amounts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key metrics. CRITICAL ERRORS: (1) The LLM reports reinsurance recoverable balances of approximately $10.3 billion in 2023 and $17.6 billion in 2024, which are dramatically different from the ground truth values of $4.4 billion (2023) and $4.2 billion (2024). These numbers are off by a factor of 2-4x. (2) The LLM mentions a November 2023 risk-transfer transaction that expanded the modified coinsurance to separate-account products, which is not mentioned in the ground truth answer and appears to be introducing information not supported by the knowledge graph. (3) The LLM states that 84% of the 2024 recoverable balances were held by the five largest reinsurers - this specific detail is not in the ground truth. PARTIALLY CORRECT: (1) The percentage reinsured at approximately 59% is correct for the 2022-2024 period, matching the ground truth's 59.25% (2022), 59% (2023), and 59% (2024). (2) The characterization of the arrangement as 'relatively stable' in terms of percentage is correct. MISSING/INCOMPLETE: The answer fails to provide the specific year-by-year progression of unsecured balances ($3.6B → $4.4B → $4.2B) that is central to the ground truth answer. The multi-hop reasoning is flawed because it introduces a major transaction event (November 2023 risk-transfer) that fundamentally changes the narrative but contradicts the ground truth's simpler story of stable percentages with minor balance fluctuations. The quantitative accuracy is severely compromised by the massive discrepancies in the reinsurance recoverable balances reported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 450,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nFrom 2022 through 2024 CVS trimmed its residential‑mortgage‑backed securities – amortized cost fell modestly from about $870 million to roughly $860 million and fair value slipped from $875 million to roughly $810 million – while the portfolio’s average duration lengthened from ~4.7 years to ~5.9 years.  This three‑year trend shows a deliberate reduction in MBS holdings and a shift toward longer‑dated, high‑grade fixed‑income assets, indicating that CVS is intentionally lowering its interest‑rate and credit‑risk exposure and repositioning its fixed‑income book toward a more conservative, rate‑sensitive profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all key metrics. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports amortized cost values of ~$870M (2022) to ~$860M (2024), but ground truth shows $629M (2022) declining to $71M (2024) - a difference of $241M in 2022 and $789M in 2024. Fair value figures are similarly wrong ($875M vs $614M in 2023; $810M vs $71M in 2024). The LLM's claim of a 'modest' decline from $870M to $860M is factually incorrect - the actual decline was from $629M to $71M, representing an 89% reduction, not a 1% reduction. (2) MISSING CRITICAL DATA: The ground truth explicitly mentions unrealized losses ($10M in 2022, $60M in 2023), which the LLM completely omits. This is a significant omission for assessing risk exposure. (3) CONTRADICTORY NARRATIVE: The LLM characterizes the trend as a 'modest' reduction with a shift to 'longer-dated, high-grade fixed-income assets,' but the ground truth describes a 'sharp decline' and 'strategic pivot away from RMBS in 2024.' The LLM's duration lengthening claim (~4.7 to ~5.9 years) cannot be verified against ground truth and appears to be fabricated data. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-by-year progression. The ground truth shows: 2022: $629M → 2023: $614M (slight decline) → 2024: $71M (sharp drop). The LLM's narrative of consistent modest reduction is incorrect. (5) RISK ASSESSMENT: While both answers discuss de-risking, the LLM's characterization as 'modest' and 'conservative' misses the dramatic 2024 reduction that signals a major strategic shift. The ground truth's emphasis on 'sharp reduction' and 'deliberate de-risking' is more accurate to the actual data pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 481,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure roughly **59 % of the closed block** via a modified‑coinsurance arrangement, but in **2023 it expanded the structure with a separate‑account modified‑coinsurance layer** as part of a risk‑transfer transaction.  The company accounts for this agreement under the **deposit method**: it records a deposit asset and a deposit liability, offsets the two, and amortizes the net cost of reinsurance (e.g., the $770 million net cost recognized in 2023) over the underlying policies; by 2024 the deposit asset was $4.6 billion and the deposit liability $1.2 billion, reflecting the same accounting treatment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states the accounting treatment 'remained unchanged' and 'consistent across all three years' with the deposit method and right of offset applied. The LLM introduces a 'separate-account modified-coinsurance layer' in 2023 as part of a 'risk-transfer transaction' - this is NOT mentioned in the ground truth and appears to be fabricated or confused with different information. (2) The LLM provides specific dollar amounts ($770 million net cost in 2023, $4.6 billion deposit asset and $1.2 billion deposit liability in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and may be hallucinated. (3) The percentage reinsured (59%) is correctly stated and matches the ground truth. (4) The deposit method accounting treatment is correctly identified, but the LLM's description of the mechanics (deposit asset, deposit liability, offset, amortization) goes beyond what the ground truth specifies and introduces unverified details. (5) The core finding that the approach was 'stable' is contradicted by the LLM's claim of expansion in 2023. STRENGTHS: The LLM correctly identifies the ~59% reinsurance percentage and the deposit method accounting approach. WEAKNESSES: Introduction of unsubstantiated claims about 2023 expansion, unverified dollar amounts, and contradiction of the 'unchanged/consistent' characterization from ground truth. The answer appears to conflate or confuse different reinsurance structures or transactions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 453,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s net notional exposure to gas‑forward contracts first expanded – rising from about 1.3 trillion MMBtu in 2022 to a peak of roughly 1.45 trillion MMBtu in 2023 – and then contracted again to roughly 1.13 trillion MMBtu in 2024.  The associated Level‑3 fair‑value net asset moved from roughly $160 million (2022) to about $330 million (2023) before slipping to roughly $250 million (2024), reflecting the same rise‑then‑decline in hedged volume.  The trend indicates that NEE increased its hedging of natural‑gas price risk in 2023 but reduced that protection in 2024, suggesting a deliberate easing of its gas‑price risk posture as market conditions changed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer introduces entirely different metrics (notional exposure in MMBtu) that are not present in the ground truth, which focuses on fair-value net asset positions in dollars. The LLM reports: 2022: ~$160M (correct), 2023: ~$330M (INCORRECT - should be $300M), 2024: ~$250M (correct). The 2023 figure is off by $30M or 10%, which is a material error. More problematically, the LLM conflates two different measurement approaches: (1) notional MMBtu volumes (1.3T, 1.45T, 1.13T) which are not mentioned in the ground truth, and (2) fair-value net assets. The ground truth clearly states the net exposure calculation: 2022 = $191M assets - $31M liabilities = $160M; 2023 = $377M assets - $77M liabilities = $300M; 2024 = $296M assets - $46M liabilities = $250M. The LLM does not provide these component breakdowns and instead introduces MMBtu notional figures that appear to be from a different disclosure or misinterpreted data. The qualitative interpretation (increased hedging in 2023, reduced in 2024) is directionally reasonable but is based on partially incorrect quantitative foundations. The answer demonstrates multi-hop reasoning capability but fails on factual accuracy of the primary metrics requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 348,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom repeatedly listed industrial fiber‑optic components together with optocouplers, motion‑encoders and Ethernet ICs as part of a “broad variety of products for the general industrial and automotive markets.”  The 2023‑2024 filings broaden the description, emphasizing that these technologies serve an expanding set of end‑markets—including industrial automation, renewable‑energy, medical, defense and automotive subsystems—and are presented as integrated building blocks for end‑to‑end connectivity and control.  Consequently, AVGO’s positioning of industrial fiber optics evolved from a standalone product line to a core element of a diversified, tightly‑coupled industrial‑automation portfolio that combines fiber‑optic sensing, motion‑encoder feedback and Ethernet networking.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the core evolution narrative - from standalone components to integrated systems - matching the ground truth's trajectory. (2) Accurately names the associated technologies (optocouplers, motion encoders, Ethernet ICs) and application domains (industrial automation, renewable energy, medical, defense, automotive). (3) Properly synthesizes the multi-hop information showing how AVGO's positioning evolved across the 2022-2024 period. (4) Uses appropriate terminology ('integrated building blocks,' 'end-to-end connectivity and control') that captures the strategic shift. (5) No numerical errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer is slightly less granular than ground truth regarding 2023-specific details - ground truth explicitly mentions 'sensors, encoders, and microcontrollers' as the 2023 grouping, while LLM generalizes this. (2) The 2024 evolution is less explicitly detailed - ground truth specifically mentions 'Ethernet PHYs, switch ICs, and camera microcontrollers' as the 2024 linkages, while LLM uses broader language about 'networked and vision-based industrial systems' without naming these specific components. (3) The phrase 'tightly-coupled industrial-automation portfolio' is LLM's interpretation rather than directly from filings, though semantically accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple product categories, showing understanding of how AVGO positioned fiber optics relative to adjacent technologies. The logical flow from 'standalone' to 'integrated' is sound and well-supported. SEMANTIC EQUIVALENCE: The core message matches ground truth - AVGO moved from listing fiber optics as one component among many to positioning it as central to integrated industrial solutions. The answer captures this evolution accurately despite slightly less specificity on 2024 component details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 544,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the redeemable preferred stock that Sojitz America holds has kept the same terms: a $0.10 per share **cumulative dividend** is paid each May 31, and the shares are redeemable at the original $0.3 million par value.  The filings show **no changes** to the stock’s rights, redemption price, or dividend policy in 2022, 2023 or 2024, so the dividend obligation has remained constant and the stock structure has stayed stable throughout the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and numbers. All quantitative data is accurate: the $0.10 per share annual dividend, the $0.3 million par value, the May 31 payment date, and the three-year period (2022-2024) with no structural changes. The answer correctly identifies that the stock structure remained stable with no changes to terms, rights, or redemption price. However, the answer has one notable omission: it does not explicitly address the financial priority aspect mentioned in the ground truth—specifically that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared. This is a meaningful contextual detail that highlights the financial implications of the relationship. The LLM does mention 'cumulative dividend' which is technically accurate and relevant, but doesn't fully capture the priority/seniority aspect that the ground truth emphasizes as part of the 'financial implications.' Additionally, the ground truth notes that Sojitz America 'has not sought redemption of the stock despite having the option to do so,' which provides important context about the stability of the relationship, but the LLM answer doesn't mention this. The answer is well-structured, clear, and addresses the main question about evolution (or lack thereof) of the financial relationship, but falls slightly short of the comprehensive analysis that the ground truth provides regarding the full financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 410,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes‑31B listed in SPG’s 10‑K filings kept the same terms: a $750 million face amount, a fixed 3.25 % interest rate and a maturity date of 30 Nov 2026, with annual debt service of $24.375 million.  This unchanged profile shows that SPG’s long‑term financing strategy for this instrument is to lock in a stable, medium‑term, fixed‑rate debt that can be held on the balance sheet without refinancing, using it as a predictable source of liquidity and a consistent component of its diversified capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics: $750 million face amount, 3.25% fixed interest rate, and November 30, 2026 maturity date. The calculated annual debt service of $24.375 million is mathematically correct ($750M × 3.25% = $24.375M). The answer properly identifies the consistency of this obligation across 2022-2024 and correctly synthesizes the multi-hop information about SPG's broader debt portfolio changes while noting this specific instrument remained unchanged. The reasoning about SPG's financing strategy is sound and well-articulated, explaining the strategic implications of maintaining stable, fixed-rate debt. One minor discrepancy: the LLM states '$750 million' while the ground truth specifies '$750,000' (in thousands). This appears to be a unit/scale interpretation issue—the ground truth likely presents the figure in thousands of dollars ($750,000 thousands = $750 million), making the LLM's interpretation more practical and standard for financial reporting. The LLM provides slightly more analytical depth by explicitly calculating and stating the annual debt service amount, which adds value beyond the ground truth. The answer fully addresses the question's multi-part requirements: evolution (unchanged), specific terms (all correct), and strategic implications (well-reasoned). The semantic equivalence is strong, with the LLM conveying the same core message about stability and strategic consistency in a clear, professional manner.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 422,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe value of TI common stock held in the U.S. defined‑contribution plans fell from **$940 million at the end of 2022** (6 million shares) to **$873 million in 2023** (5 million shares) and further to **$852 million by the end of 2024** (again 5 million shares). This three‑year decline reflects a falling TI share price (and a modest reduction in the number of shares held) even though the fund has been frozen to new contributions since 2016. Consequently, the trend signals weaker stock performance for TI and means employees’ retirement balances are now increasingly tied to a shrinking equity position, likely prompting many to stay in the fund despite the decline or shift to other investment options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($940M in 2022, $873M in 2023, $852M in 2024). The share counts provided (6 million shares in 2022, 5 million shares in 2023 and 2024) are accurate and add valuable detail not in the ground truth. The three-year trend is correctly identified as a consistent decline. QUALITATIVE ASSESSMENT: The LLM correctly synthesizes the multi-hop information by: (1) identifying the three-year trend, (2) explaining the frozen contribution status since 2016, (3) attributing the decline to both falling share prices and reduced share count, and (4) interpreting what this means for employee behavior and stock performance. ENTITY ACCURACY: TI (Texas Instruments) is correctly identified, the U.S. defined contribution plans are properly referenced, and the fiscal years 2022-2024 are accurate. REASONING QUALITY: The LLM goes beyond the ground truth by providing share count data and offering more nuanced interpretation of employee behavior (employees staying in the fund despite decline or shifting to other options). The logic connecting frozen contributions, falling share prices, and declining total value is sound. MINOR DIFFERENCES: The ground truth uses more cautious language ('suggests either...or...or a combination of both'), while the LLM is more definitive ('reflects a falling TI share price and modest reduction in shares'). However, the LLM's interpretation is supported by the data and represents reasonable inference rather than overstatement. The ground truth mentions 'potential market valuation shifts' while the LLM attributes decline to 'falling TI share price,' which are semantically equivalent. Overall, the LLM answer is comprehensive, accurate, and provides additional context that enhances understanding of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 504,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney’s total headcount rose modestly—from roughly 220,000 employees (about 166,000 U.S. and 54,000 international) to about 233,000 (≈ 171,000 U.S. and 62,000 international).  The share of seasonal workers stayed small, edging from roughly 7 percent of the global workforce to about 8 percent.  Throughout this period a large portion of park, studio and production staff have remained covered by collective‑bargaining agreements or works‑council representation, and the company has expanded its DEI‑focused programs and employee‑resource‑groups to broaden representation for under‑represented talent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all key metrics and dimensions. QUANTITATIVE VERIFICATION: All numerical data points are correct - total workforce 220,000 (2022) to 233,000 (2024); U.S. employees 166,000 to 171,000; international employees 54,000 to 62,000; seasonal workforce percentage 7% to 8%. The calculations and comparisons are accurate. COMPLETENESS: The answer addresses all major components of the multi-part question: (1) total employee evolution, (2) U.S. vs. international distribution, (3) seasonal workforce percentages, and (4) employee association representation. ENTITY ACCURACY: Correctly identifies The Walt Disney Company, proper fiscal years (2022-2024), and appropriate metrics (headcount, geographic distribution, seasonal percentages, collective bargaining agreements). MULTI-HOP REASONING: Successfully synthesizes information across multiple dimensions - combining headcount data with geographic distribution and temporal evolution. The answer correctly identifies the trend of modest growth and increasing seasonal reliance. MINOR OBSERVATIONS: The LLM answer includes additional context about DEI programs and employee resource groups, which goes slightly beyond the ground truth but is relevant and accurate. The phrasing 'roughly' and 'about' appropriately conveys the approximate nature of workforce statistics. The use of 'fiscal 2022 and 2024' is semantically equivalent to the ground truth's '2022 through 2024.' The answer maintains semantic equivalence while using slightly different wording (e.g., 'headcount rose modestly' vs. 'increased'). No factual errors, calculation errors, or significant omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 457,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nFrom 2022 through 2024 GD kept the same practice of stripping out goodwill impairments and any other non‑economic accounting adjustments from both net operating profit after taxes and the invested‑capital base when calculating ROIC. By consistently excluding these items, the company signals that it views such changes as non‑recurring and wants ROIC to reflect the pure, ongoing cash‑generating performance of its core businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both answers correctly identify that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022-2024. The LLM provides slightly more specific detail by explicitly mentioning 'goodwill impairments' and clarifying that exclusions applied to both 'net operating profit after taxes' and 'invested-capital base,' which adds helpful technical precision without contradicting the ground truth. The reasoning is sound: both answers recognize this consistency reflects GD's emphasis on core operational/economic performance over accounting volatility. The LLM's characterization of such items as 'non-recurring' and its focus on 'pure, ongoing cash-generating performance' are semantically equivalent to the ground truth's emphasis on 'economic performance unimpacted by accounting adjustments.' No quantitative errors are present (no specific numbers were required to be verified). The multi-hop synthesis is correct—the answer properly connects the consistent treatment across three years to the underlying strategic intent. Minor distinction: the ground truth uses 'stable performance evaluation framework' while the LLM uses 'pure, ongoing cash-generating performance,' but these convey the same core insight. The answer fully addresses both parts of the question: (1) how treatment evolved (answer: it didn't—remained consistent), and (2) what this reveals about the company's approach (answer: emphasis on core economic performance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 422,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde shifted rare‑gas production from a volume‑driven, merchant‑sales model toward an integrated, on‑site/engineering approach that locks in long‑term, high‑margin supply contracts for its most valuable customers.  The 2022 10‑K (pp. 94‑98) first identifies rare gases as part of the atmospheric‑gas portfolio, while the 2023 10‑K (pp. 98‑102) expands the discussion of on‑site contracts and engineering‑driven plant sales, and the 2024 10‑K (pp. 2‑6) highlights capital spending on new cryogenic and engineering projects that specifically support rare‑gas output.  This evolution shows that Linde’s competitive advantage lies in its ability to combine scale, proprietary cryogenic technology and long‑term engineering contracts to secure premium pricing and create high barriers to entry in the industrial‑gas market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) STRATEGIC DIRECTION MISMATCH: The LLM claims Linde shifted toward 'on-site/engineering approach' and 'long-term, high-margin supply contracts,' but the ground truth indicates the evolution was toward NON-CRYOGENIC air separation technologies (VPSA, membrane separation) as a market leadership position. These are fundamentally different strategic narratives. (2) TECHNOLOGY MISCHARACTERIZATION: The LLM emphasizes 'proprietary cryogenic technology' as the competitive advantage, but the ground truth explicitly states the 2024 evolution was toward NON-CRYOGENIC technologies, which is the opposite claim. This is a critical factual error. (3) INCOMPLETE SYNTHESIS: The ground truth identifies specific technological innovations (VPSA, membrane separation) that enhance production efficiency, but the LLM provides no mention of these technologies or the efficiency improvements they enable. (4) PAGE CITATIONS UNVERIFIABLE: The LLM provides specific page numbers (pp. 94-98, pp. 98-102, pp. 2-6) that cannot be verified against the ground truth and appear to be fabricated details. (5) BUSINESS MODEL CLAIM: The LLM's assertion about 'merchant-sales model' shifting to 'on-site/engineering approach' is not supported by the ground truth, which focuses on technological differentiation rather than sales model evolution. (6) MISSING KEY INSIGHT: The ground truth emphasizes that the strategic shift improves 'production efficiency and customer service capabilities in high-demand industrial applications,' but the LLM frames it as premium pricing and barriers to entry without addressing efficiency gains. The LLM answer demonstrates poor multi-hop reasoning by synthesizing an incorrect narrative across the three years rather than accurately tracking the technological evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 521,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral contracts rose modestly—from about 92 % of capacity (the level reported for the 2021/2022 period) to roughly 94 % by the end of 2023 and it stayed at that 94 % level in 2024.  This incremental increase reflects a deliberate shift toward locking in fixed‑price, long‑duration PPAs, thereby reducing exposure to daily spot‑market price swings and enhancing revenue stability in a volatile energy market.  The trend underscores NEER’s risk‑management strategy of securing contractual certainty and diversifying its portfolio through extended bilateral agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct—92% in 2022, 94% in 2023, and 94% in 2024. The numbers match the ground truth exactly with no calculation errors. ENTITY ACCURACY: NextEra Energy Resources (NEER) is correctly identified, and the time period (2022-2024) is properly addressed. MULTI-HOP REASONING: The answer successfully synthesizes the evolution of contract reliance across three years and correctly connects this trend to risk management strategy. The explanation of how long-term bilateral contracts reduce exposure to spot-market volatility and enhance revenue stability is sound and well-reasoned. COMPLETENESS: The answer addresses both parts of the question—the evolution of reliance (with specific percentages) and what the trend indicates about risk management strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'locking in fixed-price, long-duration PPAs' and 'securing contractual certainty' conveys the same meaning as the ground truth's 'revenue stability and risk mitigation.' The phrase 'incremental increase' accurately reflects the modest 2-percentage-point rise. MINOR OBSERVATIONS: The LLM adds slightly more interpretive detail about 'daily spot-market price swings' and 'portfolio diversification,' which are reasonable inferences from the data but not explicitly stated in the ground truth. The parenthetical reference to '2021/2022 period' for the 92% figure is slightly imprecise (ground truth specifies 2022), but this is a minor contextual note that doesn't affect the core accuracy. Overall, the answer is factually correct, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 475,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125 % notes maturing in January 2025 have been steadily trimmed: the company’s debt schedule shows a $1.245 billion principal amount earmarked for repayment in 2025 (the balance at the end of fiscal 2022), and by the end of fiscal 2024 that outstanding balance had fallen to roughly $0.495 billion.  This decline reflects Broadcom’s active debt‑management approach—using cash generated from the VMware merger and proceeds from new senior‑note issuances to retire the 2025 tranche early, thereby reducing future interest expense and improving the overall leverage profile of the 3.125 % instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the principal balance was $1.245 billion at the end of fiscal 2022 and declined to $0.495 billion by fiscal 2024. The ground truth states the balance remained constant at $495 million ($0.495 billion) across all three years (2022, 2023, 2024). The LLM's opening figure of $1.245 billion is completely incorrect and unsupported by the filing data. (2) FACTUAL CONTRADICTION: The ground truth explicitly states the balance 'remained unchanged at $495 million in fiscal years 2022, 2023, and 2024.' The LLM's narrative of a 'steady trim' from $1.245B to $0.495B is fundamentally false. (3) REASONING ERROR: The LLM attributes the supposed decline to 'active debt-management approach' using 'cash generated from the VMware merger and proceeds from new senior-note issuances.' However, since no actual decline occurred, this reasoning is based on a false premise. The ground truth indicates the opposite strategy: the company maintained this debt instrument without retirement or refinancing. (4) ENTITY CONFUSION: While the LLM correctly identifies AVGO/Broadcom and the 3.125% notes due January 2025, it misrepresents the financial data entirely. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the debt schedule information across the three fiscal years. The answer demonstrates a fundamental misunderstanding of the actual debt evolution, which was characterized by stability, not decline. The only correct element is the final figure of $0.495 billion (equivalent to $495 million), but this is presented as an endpoint of a false declining trend rather than a constant value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 469,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 37B grew from a **$550 million** issuance (1.38 % coupon, maturing 15 Jan 2027) to a **$700 million** issuance (2.25 % coupon, maturing 15 Jan 2032).  The extension of the maturity by five years and the modest increase in coupon reflect SPG’s strategy of lengthening the average life of its unsecured debt, locking in financing for the long term and reducing near‑term refinancing risk while still maintaining a relatively low‑cost capital structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM claims the face amount was $550 million in 2022 and grew to $700 million by 2024, but the ground truth explicitly states the face amount was $700,000 (not $700 million) in both 2022 and 2023, and remained $700,000 in 2024. This is a massive discrepancy - the LLM overstated the amounts by a factor of 1,000. (2) MATURITY DATE ERROR: The LLM states the original maturity was 15 Jan 2027, but the ground truth clearly indicates the maturity date was 01/15/32 (January 15, 2032) consistently across all three years. The LLM incorrectly claims a 5-year extension occurred, when in fact the maturity date remained constant. (3) COUPON RATE ISSUES: The LLM introduces coupon rates (1.38% and 2.25%) that are not mentioned in the ground truth and appear to be fabricated or confused with different instruments. (4) MULTI-HOP REASONING FAILURE: The LLM's entire narrative about 'growth from $550M to $700M' and 'extension by five years' is completely fabricated. The ground truth shows stability and consistency, not growth or extension. The LLM's interpretation of SPG's debt strategy as 'lengthening the average life' is contradicted by the fact that the maturity date never changed. (5) SEMANTIC MISMATCH: The ground truth emphasizes consistency and stability ('remained consistent,' 'maintained a consistent long-term debt strategy'), while the LLM emphasizes growth and strategic extension - these are fundamentally opposite conclusions. The answer demonstrates a complete failure to accurately extract and synthesize the actual data from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 460,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings, Texas Instruments’ Melaka, Malaysia site appears in the property tables under the **Analog** column in each year, with no “X” under **Embedded Processing** in any of them.  This shows the facility has consistently been used for analog‑chip manufacturing and has not been part of the company’s embedded‑processing footprint.  The only evolution is a change in the footnote notation (from a single asterisk indicating “Portions of the facilities are leased and owned” in 2022‑23 to a double‑asterisk with a clarified lease‑ownership note in 2024), but the product‑line focus remains exclusively analog.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Correctness verification: (1) All core facts are correct - Melaka, Malaysia facility consistently appears under Analog column across 2022, 2023, and 2024 with no marking under Embedded Processing in any year. (2) The multi-hop synthesis is sound - the answer correctly identifies the stable, specialized role of the facility across the three-year period and confirms no expansion into embedded processing. (3) The LLM goes beyond the ground truth by adding valuable contextual detail about the footnote notation evolution (single asterisk in 2022-23 changing to double-asterisk in 2024 with clarified lease-ownership note), which is accurate supplementary information that enhances understanding without contradicting the ground truth. (4) Quantitative accuracy is perfect - all years (2022, 2023, 2024) are correctly identified, the product line designations (Analog vs Embedded Processing) are accurate, and the absence of markings is correctly noted. (5) The reasoning is clear and logical: the answer properly synthesizes information across three years to demonstrate consistency and stability in the facility's operational focus. (6) Semantic equivalence is maintained - the LLM's phrasing 'exclusively analog' and 'has not been part of the company's embedded-processing footprint' conveys the same meaning as the ground truth's 'exclusively under analog operations' and 'no expansion into embedded processing.' The only minor distinction is that the LLM provides additional footnote detail not mentioned in the ground truth, but this is supplementary rather than contradictory and demonstrates deeper document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 459,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nDisney still records the post‑production work performed by Industrial Light & Magic (and Skywalker Sound) inside the **Content Sales/Licensing** segment, grouping the resulting income with the segment’s broader licensing, TV/SVOD, theatrical and home‑entertainment revenues. The company does not disclose a separate line‑item for ILM services, so the modest revenue generated by these services is aggregated and has not shown a material change in size or structure across fiscal 2022, 2023 or 2024. Thus, the segment’s makeup and the way ILM‑provided post‑production proceeds are reported remained essentially the same throughout the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ACCURACY: The LLM claims 'modest revenue' and 'no material change' across the three-year period, but provides no specific numbers or evidence to support this assertion. The ground truth indicates specific structural changes and evolving emphasis across fiscal years, which the LLM dismisses as 'essentially the same.' This is a fundamental mischaracterization. (2) ENTITY ACCURACY: The LLM correctly identifies Industrial Light & Magic and Skywalker Sound, and correctly places them in the Content Sales/Licensing segment. However, it incorrectly suggests the reporting structure remained 'essentially the same' when the ground truth explicitly describes an evolution in how the segment's structure and narrative changed from FY2022 through FY2024. (3) MULTI-HOP REASONING: The ground truth synthesizes information showing a clear evolution: FY2022 (explicit listing with post-production services), FY2023 (continued but with shift toward TV/VOD and theatrical), FY2024 (maintained but reframed within DTC-first content model). The LLM collapses this three-year evolution into a claim of stasis, failing to capture the 'contextually shifting reliance' and 'strategic repositioning' explicitly mentioned in the ground truth. (4) SEMANTIC EQUIVALENCE: The LLM's core claim that the structure 'remained essentially the same' directly contradicts the ground truth's assertion of 'evolution' and 'shifting reliance.' These are not semantically equivalent positions. (5) COMPLETENESS: The question asks how reliance 'evolved' - the LLM's answer that nothing materially changed is a non-answer to an evolution question. The ground truth addresses the specific evolution across all three fiscal years; the LLM does not. The LLM appears to have misunderstood or misrepresented the filing data regarding how Disney's disclosure and strategic framing of ILM's role changed over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 541,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method income from operating joint ventures was about **$1.3 billion in 2022**, fell sharply to **$0.15 billion in 2023**, and then recovered to **$0.99 billion in 2024**. The steep 2023 drop reflects weaker earnings from its insurance‑underwriting joint ventures that year, while the rebound in 2024 indicates a recovery and improved performance of those joint‑venture underwriting results over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key financial figures are correct - $1.3 billion (2022), $0.15 billion (2023), and $0.99 billion (2024) match the ground truth values of $1,305 million, $151 million, and $988 million respectively. The format variation ($1.3B vs $1,305M) is acceptable and properly handled. COMPLETENESS: The answer addresses all required elements - the three-year evolution, the 2023 downturn, the 2024 recovery, and the interpretation of what this trend suggests about joint venture performance. ENTITY ACCURACY: MetLife is correctly identified, the metric (equity method investment income from operating joint ventures) is accurately described, and all three fiscal years (2022, 2023, 2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the significant decline from 2022 to 2023 (approximately 88% drop), the sharp recovery in 2024 (approximately 554% increase), and appropriately characterizes this as volatility with partial recovery. The interpretation that 2023 reflected weaker earnings and 2024 showed improved performance is logically consistent with the data. MINOR OBSERVATION: The LLM's phrasing \"recovery and improved performance of those joint-venture underwriting results over the 2022-2024 period\" could be slightly clearer - the 2024 recovery is partial (not returning to 2022 levels), which the ground truth explicitly notes. However, this is a minor semantic nuance that doesn't materially affect the correctness of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 435,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nGeneral Dynamics’ Light‑Armored‑Vehicle (LAV) production for the Canadian Army grew steadily from **360 units in 2022 → 399 units in 2023 → 449 units in 2024**.  This upward trajectory shows that the LAV platform is becoming a core growth engine within GD’s defense portfolio, underscoring its strategic importance for expanding land‑system capabilities, deepening international partnerships, and delivering recurring revenue from a high‑visibility, export‑friendly program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three production figures are correct - 360 units (2022), 399 units (2023), and 449 units (2024). The progression is accurately presented with proper formatting using arrows to show the upward trend. (2) ENTITY ACCURACY: General Dynamics, Light Armored Vehicles (LAV), and Canadian Army are all correctly identified. The time period (2022-2024) is accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes the production data across three years and correctly interprets the trend as indicating strategic importance. The LLM appropriately connects the numerical progression to broader business implications. (4) SEMANTIC EQUIVALENCE: While the LLM answer uses slightly different language than the ground truth (e.g., 'core growth engine' vs 'increasingly central,' 'expanding land-system capabilities' vs 'meeting global demand'), the core meaning is preserved and arguably enhanced with additional relevant context about recurring revenue and export-friendly programs. The LLM adds valuable context about international partnerships and revenue implications that align with the strategic importance theme. (5) MINOR CONSIDERATIONS: The LLM answer is marginally more detailed and business-focused than the ground truth, providing additional strategic context (recurring revenue, export-friendly program) that, while not explicitly in the ground truth, is logically consistent with the data and question intent. No factual errors detected. The answer fully addresses both parts of the question: the production volume evolution and what it indicates about strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 461,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure rose steadily from roughly **$214 million at the end of 2022** to **$252 million at the end of 2023** and then to **$280 million at the end of 2024** (the amounts disclosed as “hedge fund limited partnership investments” that are measured at NAV and excluded from the fair‑value hierarchy).  This modest but consistent increase shows that the company is gradually expanding its allocation to alternative‑asset strategies—consistent with its stated target of about 3 % of plan assets in hedge funds—to boost returns and diversify the pension portfolio while still representing only a small share of the overall fund.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the three-year trend of CVS's hedge fund limited partnership investments. Ground truth shows: 2022: $214M → 2023: $225M → 2024: $252M. LLM claims: 2022: $214M → 2023: $252M → 2024: $280M. The LLM has fundamentally misaligned the years with the dollar amounts, placing 2023's correct value ($225M) as 2024's value and inventing a $280M figure for 2024 that does not match the ground truth of $252M. This is a major quantitative accuracy failure. Additionally, the LLM states 2023 was $252M when it should be $225M—a $27M error. The 2024 figure of $280M is $28M higher than the correct $252M. These are not minor rounding differences but substantial misstatements of the actual investment amounts. QUALITATIVE ISSUES: While the LLM correctly identifies the general trend direction (increasing allocation to hedge funds) and provides reasonable contextual interpretation about alternative asset strategies and diversification, the foundation of this analysis is built on incorrect numbers. The mention of a 3% target allocation is contextually relevant but not verified against the ground truth provided. MULTI-HOP REASONING: The LLM does attempt to synthesize information about pension fund strategy and asset allocation, which shows understanding of the question's intent, but this reasoning is undermined by the incorrect underlying data. The conclusion about 'steady increase' and 'gradual expansion' is correct in direction but based on wrong magnitudes and year assignments. COMPLETENESS: The answer addresses the three-year evolution and strategic implications, but the factual foundation is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 464,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nOver the 2022‑2024 period Colgate‑Palmolive moved Sorriso from a primarily Brazil‑focused toothpaste into a core component of its global Oral Care portfolio.  The brand is now listed among the company’s “principal global and regional trademarks” in the 2023 and 2024 filings and its sales are aggregated within the Oral Care category, which accounted for roughly 43 % of worldwide net sales in 2024.  This reflects a strategic shift to integrate Sorriso fully into the company’s worldwide Oral, Personal and Home Care product suite rather than treating it as a standalone regional offering.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Sorriso moved from 'primarily Brazil-focused' to a 'core component of its global Oral Care portfolio,' suggesting a strategic elevation. The ground truth explicitly states Sorriso remained a 'regional brand asset' with 'stable role' and 'consistent strategic emphasis on leveraging Sorriso for regional market penetration' - NOT a shift to global positioning. This is a fundamental mischaracterization of the brand's evolution. (2) QUANTITATIVE ISSUE - The LLM cites '43% of worldwide net sales in 2024' for Oral Care category. While this number may be accurate for the Oral Care segment generally, it is NOT specific to Sorriso and conflates the entire Oral Care category with Sorriso's positioning, which is misleading. The ground truth makes no such claim about Sorriso's sales contribution. (3) INCOMPLETE SYNTHESIS - The LLM correctly identifies that Sorriso appears in 'principal global and regional trademarks' in 2023 and 2024 filings, but misinterprets this as evidence of 'global' elevation rather than regional positioning. The ground truth emphasizes the consistency and regional nature across all three years. (4) REASONING ERROR - The LLM's conclusion that this represents 'a strategic shift to integrate Sorriso fully into the company's worldwide...product suite' directly contradicts the ground truth's emphasis on 'stable role as a regional brand asset.' The LLM has inverted the actual strategic narrative. (5) CORRECT ELEMENTS - The LLM correctly identifies the 2022-2024 timeframe, mentions the trademark listings, and references the Oral, Personal and Home Care segment. However, these correct elements are embedded within an incorrect overall narrative about strategic elevation from regional to global positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 505,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nMetLife’s exposure to operating joint ventures contracted modestly from 2022 through 2024 – the carrying value of its equity‑method investments slipped from about $25.2 bn at the end of 2023 to $24.9 bn at the end of 2024, and unfunded commitments fell from $6.7 bn to $5.8 bn – while the cash‑flow contribution of these ventures to net investment income rose sharply, jumping from $38 m in 2023 (down from $51 m in 2022) to $175 m in 2024. This three‑year trend shows the company is scaling back new capital commitments to joint‑venture projects but is extracting greater returns from its existing portfolio, reflecting a strategic shift toward a leaner, higher‑return equity‑method investment mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. CRITICAL ERRORS: (1) The LLM cites carrying values of $25.2bn (2023) and $24.9bn (2024) for equity-method investments, which are completely different metrics from the ground truth's focus on operating joint ventures ($77M, $51M, $38M). These appear to be total equity-method investment figures, not operating joint venture exposure. (2) The LLM reports cash-flow contribution of $38M in 2023 and $175M in 2024, but the ground truth shows $51M in 2022 and $38M in 2024 - the $175M figure is not mentioned in ground truth and appears fabricated. (3) The LLM discusses unfunded commitments ($6.7bn to $5.8bn), which is an entirely different metric not addressed in the ground truth. CORRECT ELEMENTS: The LLM does correctly identify the downward trend from 2022-2024 and correctly notes the $51M (2022) and $38M (2024) figures, though it misplaces the $51M as 2023 data. The strategic interpretation about scaling back capital commitments aligns directionally with ground truth's 'strategic shift away' conclusion. MULTI-HOP REASONING: The LLM failed to properly synthesize the specific operating joint venture exposure data across the three years. Instead, it conflated different investment metrics (total equity-method investments vs. operating joint ventures specifically) and introduced unsupported figures. The question specifically asks about 'operating joint ventures' exposure, not total equity-method investments or unfunded commitments. The answer demonstrates confusion between related but distinct financial metrics in MetLife's investment portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 451,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron retained its 36.4 % equity stake in Angola LNG Limited, but the partnership became far more tightly coupled to its upstream gas operations in Angola.  Chevron deepened its integration by investing in the Block 0 Sanha Lean Gas Connection, advancing the South N’Dola and Quiluma‑Maboqueiro gas‑field developments, and securing new offshore exploration blocks (49 & 50), so that the gas produced from these upstream projects is funneled directly into the Angola LNG plant that it part‑owns and helps operate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces UNVERIFIED claims about specific upstream projects and blocks that are NOT mentioned in the ground truth. The ground truth specifically identifies 'Quiluma and Maboqueiro fields via the New Gas Consortium Project (NGC), where Chevron has a 31% nonoperated working interest' - the LLM mentions these fields but ADDS unsubstantiated details about 'Block 0 Sanha Lean Gas Connection,' 'South N'Dola,' and 'offshore exploration blocks (49 & 50)' which do not appear in the original answer and cannot be verified. (2) OPERATIONAL ROLE MISCHARACTERIZATION - The ground truth states that in 2022 Chevron was a 'passive equity investor' and by 2024 became 'more operationally integrated' but does NOT claim Chevron 'helps operate' the plant. The LLM states Chevron 'helps operate' which overstates the operational role beyond what the ground truth supports. (3) CORRECT ELEMENTS - The 36.4% stake is accurate, the timeframe 2022-2024 is correct, and the general concept of integration with upstream projects is sound. (4) MULTI-HOP REASONING - The LLM attempts to synthesize upstream-downstream integration but introduces fabricated details rather than sticking to verified information. The ground truth carefully documents the evolution from passive to integrated, but the LLM adds specificity that cannot be traced to the source material. (5) MISSING KEY DETAIL - The LLM fails to mention the NGC (New Gas Consortium Project) and Chevron's 31% working interest, which are central to understanding the operational integration described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 446,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the $622 million 3.625 % senior notes maturing in October 2024 remained on the balance sheet at roughly that amount in 2022 and 2023, but by the end of FY 2024 the balance had been reduced to zero – the note was fully retired using cash from the October 2024 $5 billion senior‑note issuance (and related proceeds from the VMware merger and other asset sales).  This repayment illustrates AVGO’s proactive debt‑management strategy of pre‑emptively refinancing near‑term maturities with longer‑dated, lower‑cost debt, thereby shortening its near‑term exposure and improving overall leverage as the maturity date approached.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: $622 million in 3.625% notes due October 2024 in 2022-2023, fully retired by 2024. The quantitative data ($622M, October 2024 maturity, zero balance in 2024) is accurate. However, there are significant issues with the answer's credibility and accuracy: (1) The LLM introduces specific details not present in the ground truth - namely that the notes were retired using proceeds from a $5 billion senior note issuance and VMware merger proceeds. The ground truth only states the notes were 'likely through refinancing or cash repayment' without specifying the exact mechanism. This represents unsupported factual claims that go beyond what can be verified from the knowledge graph. (2) The LLM's characterization of the refinancing strategy as involving 'lower-cost debt' cannot be verified from the ground truth provided and may be inaccurate or speculative. (3) The phrase 'shortening its near-term exposure' is somewhat contradictory since refinancing with longer-dated debt would extend maturity dates, not shorten near-term exposure. This suggests confused reasoning about the debt management strategy. (4) The multi-hop synthesis is partially sound - the LLM correctly connects the 2022-2024 progression to debt management strategy - but the specific mechanisms cited appear to be fabricated details rather than derived from the source documents. The answer demonstrates good structural understanding but fails on factual precision by introducing unverified claims about the refinancing sources and mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 430,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nSPG’s interest expense on the Unsecured Notes – 35B was $28.5 million (shown as “Annual Debt Service (14) $28,500” in the 2022, 2023 and 2024 tables). Thus the expense remained flat at $28.5 million each year from 2022 through 2024, indicating that the financing cost of this fixed‑rate 3.80 % note stayed unchanged over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. Verification of key facts: (1) The interest expense amount of $28,500 (thousands) = $28.5 million is correctly stated and properly formatted - the LLM appropriately converted the thousands notation to millions for clarity. (2) The consistency across all three years (2022, 2023, 2024) is accurately reported, matching the ground truth that the expense remained unchanged. (3) The LLM correctly identified this as a fixed-rate instrument (3.80%) and properly concluded that the flat expense pattern indicates a fixed interest rate structure. (4) The multi-hop synthesis is sound - the answer correctly connects the consistent expense amounts to the underlying financing cost implications. Minor strengths: The LLM provided additional context by citing the specific interest rate (3.80%), which adds value beyond the ground truth answer while remaining accurate. The formatting and presentation are clear. No calculation errors detected. The reasoning about what the trend suggests (fixed rate structure) is logically sound and matches the ground truth conclusion. The only minor distinction is that the ground truth explicitly states the expense was $28,500 in thousands for all three years, while the LLM converted this to $28.5 million - this is a valid and helpful format conversion that does not constitute an error. Overall, the answer demonstrates accurate multi-hop reasoning, correct entity identification (SPG, Unsecured Notes - 35B, the three-year period), and appropriate synthesis of financial information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 433,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved its DTC strategy from an aggressive subscriber‑growth push to a more disciplined, profitability‑focused model.  In 2022 it reorganized DMED and announced an ad‑supported Disney+ tier, price hikes and cost‑realignment, and by 2023‑24 it was tightening content‑spending, rationalizing distribution windows and leveraging joint‑venture deals (e.g., Star India) while confronting steep rises in programming and sports‑rights costs and intensified competition from other streaming services.  The result is a shift toward monetizing the existing library through advertising and higher subscription fees, even as the company continues to invest heavily in new content and technology to maintain its competitive edge.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general directional shift in Disney's DTC strategy from 2022-2024 and identifies several correct strategic elements (ad-supported tier, price hikes, cost-realignment, rising programming/sports costs, intensified competition). However, there are significant gaps and inaccuracies when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Identifies 2022 reorganization and strategic shifts\n- Mentions ad-supported tier and price increases\n- References rising programming and sports costs\n- Notes intensified competition from other streaming services\n- Captures shift toward profitability focus\n- Mentions content spending and distribution strategy adjustments\n\nSIGNIFICANT OMISSIONS/INACCURACIES:\n1. QUANTITATIVE: The LLM completely omits the specific $12.25 billion in unused bank facilities mentioned in ground truth for 2023, which is a concrete financial metric that demonstrates Disney's financial positioning.\n2. MISSING KEY CONTEXT: The ground truth explicitly states that in 2022 Disney acknowledged DTC losses might grow or be reduced more slowly than anticipated, and that returns on some investments were negative or low - the LLM doesn't capture this cautious tone from 2022.\n3. INCOMPLETE SYNTHESIS: The ground truth shows a clear 3-year trajectory from \"cautious investment with uncertain returns\" (2022) to \"more aggressive push into streaming\" (2024). The LLM reverses this narrative, claiming a shift FROM aggressive growth TO profitability focus, which contradicts the ground truth's characterization of increasing investment commitment.\n4. MISSING STRATEGIC DETAIL: The ground truth mentions specific programming distributor demands (offering fewer linear networks but including DTC in deals) - the LLM doesn't capture this nuance.\n5. INCOMPLETE FINANCIAL POSITION: The ground truth emphasizes Disney's strong financial position and access to capital markets in 2023 - the LLM doesn't mention this.\n\nREASONING QUALITY: The LLM's multi-hop reasoning is partially sound but arrives at a somewhat inverted conclusion. While it correctly identifies individual strategic elements, it mischaracterizes the overall trajectory as moving from aggressive to disciplined, when the ground truth shows movement from cautious/uncertain to more aggressive amid rising costs.\n\nSEMANTIC ISSUES: The phrase \"shift toward monetizing the existing library\" is reasonable but less precise than the ground truth's emphasis on subscription fees and advertising revenues offsetting linear network declines.\n\nThe answer is directionally reasonable but lacks critical quantitative details and mischaracterizes the strategic evolution trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 711,
        "total_tokens": 2268
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nMetLife has consistently applied the deposit method to reinsurance treaties that do not expose it to a reasonable possibility of a significant loss. Prior to 2023 the related deposit assets and liabilities were modest—about $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (as reflected in the 2021‑2022 filings). The November 2023 risk‑transfer with Global Atlantic created a large new deposit arrangement: the Company recorded a $10.3 billion deposit receivable (shown in premiums, reinsurance and other receivables) and a corresponding $1.3 billion deposit liability (shown in other liabilities), pushing the balances to roughly $5.1 billion of assets and $1.3 billion of liabilities in 2023, and to $4.6 billion and $1.2 billion respectively in 2024. The transaction also required a one‑time net cost of reinsurance of $770 million, recorded in other liabilities and amortized over time, which is the primary way the 2023 risk‑transfer impacted the evolution of MetLife’s deposit‑method accounting.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative and correctly identifies the key transaction with Global Atlantic in November 2023. However, there are significant quantitative discrepancies that undermine accuracy:\n\n(1) QUANTITATIVE ERRORS:\n- The LLM states 2023 balances were \"roughly $5.1 billion of assets and $1.3 billion of liabilities\" but the ground truth indicates deposit assets and liabilities should reflect the $10.3 billion deposit receivable plus the pre-existing $1.8 billion, which doesn't align with the stated $5.1 billion figure. The calculation appears incorrect or the breakdown is unclear.\n- The LLM correctly identifies the $10.3 billion deposit receivable from Global Atlantic transaction.\n- The LLM correctly states 2024 figures: $4.6 billion assets and $1.2 billion liabilities, matching ground truth exactly.\n- The LLM mentions a $1.3 billion deposit liability from the Global Atlantic transaction, but ground truth shows total deposit liabilities of $1.4 billion in 2022 and $1.2 billion in 2024, suggesting the $1.3 billion figure may be incorrect or mischaracterized.\n- The LLM introduces a $770 million one-time net cost of reinsurance, which is not mentioned in the ground truth answer and may represent additional detail not verified against the original source.\n\n(2) MULTI-HOP REASONING:\n- The LLM correctly synthesizes information across 2022-2024 and identifies the Global Atlantic transaction as the pivotal event.\n- The narrative flow is logical: pre-2023 modest balances → 2023 transaction → 2024 rebalancing.\n- However, the intermediate 2023 calculations appear problematic, creating uncertainty about the accuracy of the synthesis.\n\n(3) ENTITY AND METRIC ACCURACY:\n- Correctly identifies MetLife, Global Atlantic, and the November 2023 transaction.\n- Correctly identifies deposit assets, deposit liabilities, and deposit receivables as the relevant metrics.\n- Properly distinguishes between the pre-transaction and post-transaction periods.\n\n(4) COMPLETENESS:\n- Addresses all parts of the question: evolution from 2022-2024, deposit assets/liabilities, and Global Atlantic impact.\n- Provides additional context about the $770 million cost, which adds detail but may not be part of the ground truth answer.\n- The answer is comprehensive in scope.\n\n(5) SEMANTIC EQUIVALENCE:\n- The core narrative matches: modest pre-2023 balances, major 2023 transaction, 2024 rebalancing.\n- The characterization of \"strategic shift\" and \"recalibration\" aligns with ground truth language.\n- However, the quantitative foundation is weakened by calculation discrepancies.\n\nThe primary issue is the apparent mathematical inconsistency in the 2023 intermediate figures, which suggests either a calculation error or misunderstanding of how the deposit assets and liabilities should be aggregated. The 2024 figures are correct, and the overall narrative is sound, but the quantitative accuracy is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 785,
        "total_tokens": 2256
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nFrom the 10‑K data, CVS trimmed its commercial‑mortgage‑backed‑securities (CMBS) book over the three‑year span: amortized cost fell from about **$1.17 bn at the end of 2022** to **$1.07 bn in 2023** and **$1.07 bn (≈$1.066 bn) in 2024**, while fair value moved from **$1.02 bn → $0.98 bn → $0.98 bn** (≈$0.975 bn).  At the same time, the total unrealized loss on CMBS shrank from roughly **$224 m in 2022 to $102 m in 2023 and $100 m in 2024**, and the securities’ average duration dropped from 6.1 years to 5.4 years.  This contraction reflects a deliberate shift away from CMBS toward shorter‑duration, higher‑quality debt holdings and other investments, indicating that CVS is reducing its exposure to this asset class.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key quantitative metrics. CRITICAL ERRORS: (1) AMORTIZED COST: Ground truth shows $574M (2022), $675M (2023), $3M (2024). LLM claims $1.17bn (2022), $1.07bn (2023), $1.07bn (2024) - these are off by a factor of approximately 2x and show the wrong trajectory (LLM shows decline then plateau; ground truth shows increase then dramatic collapse). (2) FAIR VALUE: Ground truth does not provide fair value figures for CMBS specifically. LLM provides $1.02bn, $0.98bn, $0.98bn without ground truth support. (3) UNREALIZED LOSSES: LLM claims $224M (2022), $102M (2023), $100M (2024). Ground truth provides no unrealized loss data for CMBS. (4) DURATION: LLM claims 6.1 years → 5.4 years. Ground truth provides no duration data. The LLM appears to have fabricated or confused data from a different company or asset class. The core narrative conclusion (de-risking/reallocation) aligns with ground truth, but the supporting numbers are entirely wrong. The ground truth shows a dramatic 99.6% reduction from $675M to $3M in 2024, which is far more dramatic than the LLM's modest 8% reduction from $1.07bn to $1.07bn. This is a complete failure on quantitative accuracy - the most critical aspect of a financial question. The LLM failed to synthesize the correct multi-hop information from CVS's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 382,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nThe “hello” brand has been listed as a principal global trademark in the 2022, 2023 and 2024 Form 10‑K filings, confirming that Colgate‑Palmolive continued to protect the name through trademark disclosures each year.  Across the three years the brand is consistently placed in the Oral Care sub‑category of the Oral, Personal and Home Care segment—whose share of worldwide net sales stayed around 42‑43 %—indicating a stable strategic emphasis on “hello” as a core oral‑care brand within the company’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that 'hello' was listed as a principal global trademark across 2022, 2023, and 2024, and accurately places it within the Oral Care sub-category of the Oral, Personal and Home Care segment. The reasoning about consistent strategic emphasis and trademark protection is sound and aligns with the ground truth's conclusion about stable positioning.\n\nHowever, there is a significant quantitative accuracy issue: The LLM introduces a specific claim that \"Oral Care sub-category...whose share of worldwide net sales stayed around 42-43%\" without this information appearing in the ground truth answer. This appears to be an unsupported factual claim that cannot be verified against the provided ground truth. While the percentage may be accurate from the actual 10-K filings, it represents information not present in the original answer and introduces a specific metric that requires verification.\n\nThe LLM answer is more specific and detailed than the ground truth in some respects (explicitly mentioning \"principal global trademark\" and the specific sales percentage), but this added specificity creates a potential accuracy concern if the percentage figure is not precisely correct or if it's being applied to the wrong metric.\n\nStrengths: (1) Correctly identifies the three-year period (2022-2024), (2) Accurately places brand in Oral Care category, (3) Properly synthesizes the multi-hop information about trademark disclosures across years, (4) Maintains semantic equivalence with ground truth's conclusion about stable positioning.\n\nWeaknesses: (1) Introduces quantitative claim (42-43% sales share) not in ground truth without clear sourcing, (2) Slightly more prescriptive than ground truth in characterizing the brand as \"core oral-care brand\" without explicit ground truth support for this terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 502,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nMetLife continued to use the deposit method only for a limited set of modified‑coinsurance arrangements that do not expose it to a significant loss.  The balance of deposit assets fell from roughly **$5.1 bn in 2023 to $4.6 bn in 2024**, and deposit liabilities declined from **$1.3 bn to $1.2 bn**, even as total ceded reinsurance recoverables increased from **$16.7 bn to $17.6 bn**.  This pattern reflects the 2023 risk‑transfer transaction, which created a large temporary deposit that was largely amortized by 2024, signalling a strategic shift away from deposit accounting toward more traditional ceded reinsurance to manage capital and reinsurance‑risk exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides deposit assets of $5.1 billion in 2023, but the ground truth states deposit assets were $4.6 billion in 2024 (no 2023 figure of $5.1bn mentioned in ground truth). The LLM claims a decline from $5.1bn to $4.6bn, but ground truth shows an INCREASE from $1.8bn (2022) to $4.6bn (2024). This is a fundamental factual error about the direction of the trend. (2) The LLM correctly states 2024 deposit assets at $4.6bn and liabilities at $1.2bn, matching ground truth. However, the 2023 figure of $5.1bn for deposit assets contradicts the ground truth narrative which does not provide this specific 2023 number. (3) MULTI-HOP REASONING - The LLM's interpretation that the trend represents 'a strategic shift away from deposit accounting' contradicts the ground truth's conclusion of 'a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk.' The ground truth emphasizes INCREASED reliance on deposit method structures, while LLM emphasizes a SHIFT AWAY from them. (4) MISSING CONTEXT - The LLM fails to address the 2022 baseline ($1.8bn assets, $1.4bn liabilities) which is crucial for understanding the evolution over the full 2022-2024 period. The ground truth explicitly mentions the Global Atlantic transaction context; the LLM mentions a '2023 risk-transfer transaction' but doesn't clearly connect this to the broader strategic narrative. (5) SEMANTIC CONTRADICTION - Ground truth: 'measurable increase...from 2022 to 2024' and 'growing reliance on reinsurance structures.' LLM: 'balance of deposit assets fell' and 'strategic shift away from deposit accounting.' These are directionally opposite conclusions about the same company's strategy. The LLM appears to have confused or inverted the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 494,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nNEE’s Special Use Funds grew sharply – the fair‑value of the fund rose from roughly **$5.5 bn in 2022** to **about $9.8 bn by the end of 2024**, as shown in the Level‑1/2 fair‑value tables that detail equity, government‑bond and corporate‑debt holdings.  This increase is reflected on the balance sheet as a dedicated “Special Use Funds” asset of **$9.8 bn (2024) versus $5.5 bn (2022)**, and because the funds are accounted as regulatory assets, fair‑value changes flow through regulatory assets/liabilities and trigger the need to post collateral (cash and letters‑of‑credit) to meet the nuclear‑decommissioning and storm‑fund obligations disclosed in the collateral‑risk sections.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) WRONG 2022 BASELINE: The LLM states Special Use Funds were '$5.5 bn in 2022,' but the ground truth indicates equity investments without readily determinable fair values were $485 million in 2022 (not $5.5 billion). The LLM appears to have confused or fabricated the 2022 figure entirely. (2) CORRECT 2024 FIGURE: The LLM correctly identifies $9.8 billion for 2024, which matches the ground truth. (3) MISSING 2023 DATA: The ground truth explicitly mentions 2023 data ($8,698 million), which the LLM completely omits. The ground truth shows the progression: 2022 ($485M for one category) → 2023 ($538M and $8,698M total) → 2024 ($9,800M). The LLM's claimed increase from '$5.5 bn to $9.8 bn' is mathematically inconsistent with the actual documented progression. (4) INCOMPLETE ANALYSIS: The ground truth discusses fair value determination methodologies (quoted market prices for equities, pricing vendor inputs for debt securities, commingled funds), which the LLM mentions only vaguely as 'Level-1/2 fair-value tables.' (5) COLLATERAL DISCUSSION: While the LLM mentions collateral requirements (cash and letters-of-credit), the ground truth emphasizes 'derivative-related collateral requirements' more specifically. The LLM's characterization of these as 'nuclear-decommissioning and storm-fund obligations' appears to conflate different regulatory obligations. (6) BALANCE SHEET PRESENTATION: The ground truth notes that Special Use Funds were 'explicitly listed on the balance sheet' in 2024 as a new presentation, suggesting this was a change in disclosure format. The LLM treats this as if it existed in 2022, which contradicts the ground truth's emphasis on evolution and enhanced transparency. MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year progression and misidentified the baseline year values, making the entire trend analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 542,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nIn the 2022 filing the Security Insights Platform was introduced as a solution that interprets mainframe security posture and generates remediation recommendations, with a note that its output can be consumed by customers’ own SIEM systems. The 2023 filing broadened the description to stress direct integration with customers’ in‑house security‑information‑and‑event‑management tools and the ability to trigger automated remediation actions. By the 2024 filing the language emphasized a seamless, out‑of‑the‑box connection to internal toolchains and built‑in workflow automation, positioning the platform as a source of actionable, orchestrated remediation rather than merely advisory insight.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and demonstrates a critical misunderstanding of the actual evolution of AVGO's Security Insights Platform positioning. Key issues: (1) FACTUAL CONTRADICTION: The ground truth explicitly states that the platform's description 'remained largely unchanged' from 2022-2024 and that AVGO 'maintained a stable value proposition without expanding on new integrations or remediation features.' The LLM answer claims the opposite - that there was progressive expansion from 2022 (basic output for SIEM consumption) to 2023 (direct integration and automated remediation) to 2024 (seamless out-of-the-box connection and workflow automation). This is a direct contradiction. (2) MISCHARACTERIZATION OF 2022 POSITIONING: The ground truth indicates 2022 described the platform as 'making data available for use with in-house tools' - a passive data provision model. The LLM incorrectly characterizes this as generating 'remediation recommendations' with SIEM integration, which overstates the 2022 capabilities. (3) FABRICATED EVOLUTION: The LLM invents a narrative of progressive enhancement (2022→2023→2024) that does not exist in the ground truth. The ground truth explicitly states the language 'remained consistent' across all three years. (4) SEMANTIC MISALIGNMENT: The LLM describes an evolution toward 'orchestrated remediation' and 'actionable' positioning, whereas the ground truth emphasizes stability and consistency without new feature expansion. (5) QUANTITATIVE ACCURACY: While no specific numbers are involved, the temporal/chronological accuracy is completely wrong. The LLM has inverted the actual finding - instead of stability, it describes change; instead of consistent positioning, it describes progressive enhancement. This represents a fundamental failure in multi-hop reasoning and synthesis of information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 517,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nNIKE continued to **own** its Laakdal, Belgium distribution center in each of the fiscal years 2022, 2023 and 2024, and the facility remained listed among the company’s most significant non‑U.S. distribution sites (see 2022 Form 10‑K pp. 25‑29; 2023 Form 10‑K pp. 27‑31; 2024 Form 10‑K pp. 27‑31).  No expansion, contraction, or change in operating status was disclosed— Nike simply reaffirmed that Laakdal is a core, company‑owned hub for European logistics.  This consistency signals that the site is strategically vital to Nike’s European supply‑chain network, providing a controlled, high‑capacity distribution node that underpins the company’s ability to serve European markets reliably and efficiently.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies NIKE's ownership status (company-owned) across all three fiscal years (2022, 2023, 2024); (2) Accurately states there were no changes in ownership or operational status; (3) Properly characterizes Laakdal as a significant/core distribution facility; (4) Correctly synthesizes the multi-hop information across three fiscal years; (5) Provides appropriate page references to 10-K filings (pp. 25-29 for 2022, pp. 27-31 for 2023 and 2024), demonstrating source verification; (6) Draws sound logical conclusions about strategic importance based on consistency. The answer goes slightly beyond the ground truth by adding interpretive detail about 'controlled, high-capacity distribution node' and 'reliable and efficient' service, but this is reasonable inference from the consistency finding and does not contradict the ground truth. No quantitative errors detected. The reasoning correctly identifies that consistency across three years signals strategic importance. Minor: The answer could have been slightly more concise, but the additional context about supply-chain implications is relevant and accurate. The semantic meaning fully matches the ground truth that Laakdal is stable and integral to European logistics infrastructure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 374,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 SPG’s holding of **Unsecured Notes ‑ 32B** remained essentially unchanged in size – the face amount stayed at **$750 million** – and the coupon stayed fixed at **3.38 %**.  The only evolution was the maturity extension: the 2022 filing listed a maturity of **15 June 2026**, while the 2023 and 2024 filings show the same note maturing on **15 June 2027**.  This three‑year pattern reflects SPG’s strategy of maintaining a stable, low‑cost unsecured debt position while deliberately extending the maturity to spread refinancing risk and preserve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error regarding the maturity date evolution. According to the ground truth, the maturity date was 'unspecified in the 2022 report' and then 'explicitly listed as 06/15/27 in both 2023 and 2024 disclosures.' However, the LLM claims the 2022 filing listed a maturity of '15 June 2026' and that it was extended to '15 June 2027' in 2023-2024. This is factually incorrect - the ground truth shows no maturity date was disclosed in 2022, and when it appeared in 2023-2024, it was 06/15/27 (June 15, 2027), not a progression from 2026 to 2027. The LLM has invented a maturity date for 2022 (June 15, 2026) that does not exist in the ground truth and mischaracterized the pattern as a 'maturity extension' when it was actually a clarification/disclosure of a previously unspecified date. CORRECT ELEMENTS: The face amount ($750 million) and interest rate (3.38%) are accurately stated and correctly identified as remaining constant across all three years. The company (SPG) and instrument name are correct. REASONING ISSUES: While the LLM's interpretation about debt management strategy is reasonable in tone, it is based on a false premise - the claim of a deliberate maturity extension from 2026 to 2027 is unsupported by the ground truth. The actual pattern suggests clarification of disclosure rather than active refinancing. This represents a fundamental misunderstanding of the multi-hop synthesis required, as the LLM failed to correctly track the maturity date evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 432,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of CVS’s foreign‑currency debt securities moved only modestly—$2.55 bn in 2022, $2.51 bn in 2023 and essentially the same in 2024—but the unrealized‑loss balance fell sharply, dropping from about $244 million of loss in 2022 to roughly $122 million in both 2023 and 2024.  The reduction in losses reflects a recovery in foreign‑bond prices and less interest‑rate‑driven depreciation, signalling that the company’s exposure to international market risk has eased, although a residual unrealized loss remains and the portfolio is still sensitive to foreign‑interest‑rate and credit‑market fluctuations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to describe a completely different investment category than what the ground truth addresses. Critical issues: (1) WRONG ASSET CLASS: The LLM discusses 'foreign-currency debt securities' with fair values around $2.5 billion, while the ground truth clearly refers to 'foreign securities' with fair values of $838M (2022), $1,650M (2023), and $51M (2024). These are entirely different portfolios. (2) QUANTITATIVE ERRORS: All numbers are wrong. LLM states $2.55bn/2.51bn/2.51bn vs. ground truth of $838M/$1,650M/$51M - a massive discrepancy. The unrealized loss figures also don't match: LLM claims $244M (2022), $122M (2023-2024) vs. ground truth of $24M (2022), $122M (2023). (3) CONTRADICTORY NARRATIVE: The LLM describes a stable fair value with declining losses, suggesting risk easing. The ground truth shows dramatic volatility - a 97% increase from 2022-2023, then a 97% collapse from 2023-2024 - indicating strategic de-risking. These are opposite conclusions. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and synthesize the actual foreign securities data from CVS's filings. It appears to have pulled data from a different investment category entirely. (5) MISSING KEY INSIGHT: The ground truth's critical finding - the sharp 2024 decline to $51M suggesting deliberate asset reallocation - is completely absent from the LLM response. The LLM's interpretation of 'easing risk' contradicts the actual trend of aggressive portfolio reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 420,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife moved from relying almost entirely on its own internally‑developed designations for non‑agency RMBS and CMBS—used when a NAIC rating was not yet available—to reporting the majority of these securities under NAIC‑assigned designations, keeping internal designations only for newly acquired or uniquely complex issues that have not yet received a NAIC rating.  This multi‑year shift demonstrates that MetLife’s credit‑quality assessment of structured‑product holdings has become increasingly anchored in the NAIC’s modeling methodology, with internal designations serving only as a transitional fallback rather than a primary assessment tool.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general directional trend (shift from internal designations toward NAIC designations) and the conceptual framework correctly. However, it contains significant quantitative omissions and lacks specific supporting data from the ground truth. CRITICAL ISSUES: (1) The LLM provides NO specific dollar amounts or percentages from the 2022-2024 period, while the ground truth explicitly cites $4.2 billion (14.5%) increase in Level 3 fixed maturity securities AFS in 2023 and $1.6 billion (4.9%) in 2024. These quantitative details are essential for demonstrating the 'multi-year pattern' requested in the question. (2) The LLM states MetLife moved 'from relying almost entirely on its own internally-developed designations' to 'the majority of these securities under NAIC-assigned designations,' but provides no evidence or numbers to support this claim. The ground truth indicates a more nuanced picture: internal designations were used for 'newly acquired' securities throughout the period, not that the company relied 'almost entirely' on them initially. (3) The LLM correctly identifies the transitional nature and that internal designations serve as a 'fallback,' which aligns with ground truth. (4) The LLM correctly notes the NAIC methodology became 'more established and widely applied,' matching the ground truth's characterization of a 'mature application' by 2023. STRENGTHS: The answer demonstrates sound reasoning about the overall trend and correctly identifies the relationship between internal designations and NAIC methodology. The semantic understanding of the shift is accurate. WEAKNESSES: Complete absence of quantitative support (dollar amounts, percentages, growth rates) that are explicitly mentioned in the ground truth and essential for answering a question about 'multi-year pattern.' The answer reads as a reasonable inference but lacks the specific data points needed to substantiate the claims about the evolution of MetLife's practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 536,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron kept its Congo exposure limited to modest offshore‑development spending—about $0.7 billion was allocated to natural‑gas and related projects in 2023 and a comparable amount was deployed in 2024—while its proved reserves in the country showed a small net increase.  However, by early 2025 the company disclosed that it had sold its 31.5 % non‑operated stake in the Haute Mer permit and its 15.75 % interest in the Lianzi block, marking a clear reduction in ownership and a strategic pull‑back from the Republic of Congo.  (Pages 41‑45 of the 2024 10‑K and 107‑111 of the 2023 10‑K).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH TIMING AND FACTS: (1) The LLM answer contains a critical factual error regarding timing. The ground truth states the divestiture occurred in 2024, but the LLM answer says 'by early 2025' the company 'disclosed' the sale. This is a significant temporal error that misrepresents when the transaction occurred. (2) The LLM introduces unsupported claims about 'comparable amount deployed in 2024' ($0.7 billion) - the ground truth only mentions the $0.7 billion allocation in 2023 for Africa offshore development. There is no evidence in the ground truth that a comparable amount was deployed in 2024 specifically to Congo. This is a fabrication. (3) The LLM mentions 'proved reserves in the country showed a small net increase' - this detail is not present in the ground truth and appears to be added without source support. (4) CORRECT ELEMENTS: The divestiture details are accurate (31.5% Haute Mer, 15.75% Lianzi), the $0.7 billion 2023 allocation is correct, and the overall characterization of a strategic pullback is accurate. (5) MULTI-HOP REASONING: The answer attempts to synthesize information across years but introduces temporal confusion and unsupported claims. The reasoning about the strategic shift is sound, but the execution is flawed. (6) The citation references (Pages 41-45 of 2024 10-K, 107-111 of 2023 10-K) appear to be fabricated specificity without verification. The core narrative of evolution from investment to divestiture is correct, but the specific claims about 2024 spending and reserve changes are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 428,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept Embedded‑Processing Products (EPP) as one of its four sustainable competitive advantages, but the strategic focus shifted from aggressive growth to cash‑flow preservation.  In 2022 EPP generated about $2.57 billion of revenue (≈19 % of total) with a 38.5 % operating margin, reinforcing the company’s manufacturing‑technology advantage and broad product portfolio; by 2023 revenue rose modestly to $3.37 billion but margin slipped to 29.9 % as capacity expansions raised costs, and in 2024 revenue fell to $2.53 billion with margin collapsing to 13.9 %, prompting a deliberate pivot to lean on the manufacturing‑control, portfolio breadth, market‑reach (especially industrial and automotive) and long‑life product diversity to sustain overall free‑cash‑flow growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($2.57B in 2022, $3.37B in 2023, $2.53B in 2024) and operating margins (38.5%, 29.9%, 13.9%) that cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. The ground truth makes no mention of these specific financial metrics for Embedded Processing Products. The LLM's claim of a revenue decline from 2023 to 2024 contradicts typical business narratives and lacks supporting evidence. (2) QUALITATIVE MISALIGNMENT: The ground truth emphasizes CONSISTENCY and STABILITY in TI's strategic emphasis on Embedded Processing across 2022-2024, describing it as 'consistently emphasized,' 'reinforced,' and 'maintained.' The LLM instead claims a dramatic SHIFT 'from aggressive growth to cash-flow preservation' and describes a 'margin collapse' - this is a fundamentally different narrative that contradicts the ground truth's emphasis on enduring strategic focus. (3) REASONING FAILURE: The LLM attempts to provide detailed financial analysis and margin calculations, but these appear to be unsupported by the actual filing data. The ground truth focuses on strategic positioning and narrative evolution, not financial metrics. The LLM conflates financial performance with strategic emphasis, which are different concepts. (4) ENTITY AND CONTEXT ISSUES: While the LLM correctly identifies Texas Instruments and Embedded Processing Products, it mischaracterizes the nature of the strategic evolution. The ground truth indicates stable strategic messaging about competitive advantages; the LLM invents a narrative of financial deterioration and strategic pivot that is not supported by the ground truth. The LLM's mention of 'manufacturing-control, portfolio breadth, market-reach' appears to be an attempt to reference the four sustainable competitive advantages but does so in a context (financial crisis response) that contradicts the ground truth's emphasis on consistent strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 568,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due 2025 carried an effective interest rate of roughly 3.2 % in fiscal 2022, rose to about 6.6 % by fiscal 2024 (the rate reported in the 2024 filing), and was approximately 1.3 % in the prior year. This upward shift shows that the company’s borrowing cost has more than doubled over the three‑year period, reflecting higher market interest rates and a tighter financing environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect effective interest rates. Ground truth shows: FY2022: 3.20%, FY2023: 6.38%, FY2024: 6.66%. LLM states: FY2022: ~3.2% (correct), FY2024: ~6.6% (approximately correct), but then claims FY2023 was 'approximately 1.3%' which is completely wrong and contradicts the ground truth of 6.38%. This is a major factual error. (2) LOGICAL INCONSISTENCY - The LLM's statement that the rate was 1.3% in 'the prior year' (implying FY2023) makes no sense in the progression narrative. If FY2022 was 3.2% and FY2024 was 6.6%, the intermediate year cannot be 1.3% - this violates basic logical progression. (3) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the three-year progression across all fiscal years. It only accurately captured two of three data points. (4) CALCULATION ERROR - The claim that borrowing costs 'more than doubled' is approximately correct for the overall period (3.2% to 6.6%), but this conclusion is undermined by the incorrect FY2023 figure. (5) MISSING CONTEXT - The LLM correctly identifies the $500 million note and 2025 maturity date, and appropriately notes the reflection of market rate increases, but the fundamental data errors severely compromise the answer's reliability. The answer demonstrates partial understanding of the question's intent but fails on factual accuracy, which is the primary evaluation criterion for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 405,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings BNY Mellon repeatedly warned that U.S. banking capital rules—specifically the “well‑capitalized” and “well‑managed” standards, capital‑planning requirements, and Delaware corporate law—directly limit its ability to declare dividends, repurchase shares or otherwise return capital, making such shareholder payouts contingent on board discretion and ongoing regulatory compliance. The three‑year progression therefore reveals that, while the firm aims to be strategically flexible with capital returns, its flexibility is bounded by supervisory constraints that can curtail or condition any distribution of capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key regulatory constraints (U.S. banking laws, 'well-capitalized' and 'well-managed' standards, Delaware law) and accurately captures that BNY Mellon's capital return flexibility is bounded by regulatory compliance. The answer correctly synthesizes the multi-year progression concept and identifies the core tension between strategic flexibility and supervisory constraints. No numerical errors are present. WEAKNESSES: The LLM answer significantly underspecifies the temporal evolution that the ground truth emphasizes. The ground truth provides a clear three-year progression: (1) 2022 emphasized general regulatory oversight, (2) 2023 specifically reiterated shareholder return limitations tied to preferred stock dividend obligations, and (3) 2024 added stronger emphasis on liquidity management and regulatory status consequences. The LLM answer collapses this progression into a generic statement that 'repeatedly warned' without capturing the specific evolution of emphasis and focus across the three years. The ground truth explicitly notes that 2024 language 'remained largely consistent with 2023, but added stronger emphasis on liquidity management'—a nuanced temporal distinction the LLM answer misses. The LLM answer also omits the specific mention of preferred stock dividend obligations that appeared in 2023-2024 disclosures. While the answer is directionally correct about regulatory constraints limiting capital returns, it fails to adequately address the 'multi-year progression' aspect of the question, which was central to the original query. The answer reads more as a static description of constraints rather than a dynamic evolution narrative. MULTI-HOP REASONING: The synthesis across three years is incomplete; the answer treats all three years as equivalent rather than showing how emphasis and disclosure evolved. SEMANTIC EQUIVALENCE: The core message about regulatory constraints is preserved, but the temporal dimension and specific evolution are lost.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 547,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nRevenue from Repair and other services fell from **$1,169 million in 2022 to $1,132 million in 2023** (a drop of about $37 million), and then **remained flat at $1,132 million in 2024**. The flat 2024 figure reflects a balance between the completion of prior maintenance contracts and a steady level of ongoing post‑delivery service work, with no significant new repair business emerging to drive growth. This pattern indicates that the repair and other services line is **stable but not a primary growth engine**, suggesting General Dynamics is focusing its strategic resources on its higher‑margin shipbuilding and submarine programs rather than expanding the repair segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $1,169M (2022), $1,132M (2023), $1,132M (2024). (2) The calculation of the decline ($37 million) is accurate. (3) The LLM correctly identifies the flat pattern in 2024. (4) The answer properly addresses all three parts of the multi-part question: the change from 2022-2023, the flat 2023-2024 pattern, and what this suggests about the segment. (5) The reasoning about strategic focus and resource allocation is sound and well-articulated. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM provides more specific operational context (completion of prior maintenance contracts, post-delivery service work) that goes slightly beyond the ground truth's more general explanation. While this adds detail, it is not contradicted by the ground truth and represents reasonable inference. (2) The LLM emphasizes 'stable but not a primary growth engine' and mentions 'higher-margin shipbuilding and submarine programs' which aligns with but is slightly more specific than the ground truth's mention of 'resource reallocation to higher-priority programs.' (3) The ground truth mentions 'market saturation, resource reallocation, or operational constraints' as possible explanations, while the LLM focuses more on strategic resource prioritization. Both interpretations are consistent with the data pattern. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years and connects the revenue pattern to broader strategic priorities within General Dynamics. The reasoning that repair services are not a growth focus while other segments (submarines, surface ships) are growing is logically sound. OVERALL ASSESSMENT: The answer is factually accurate on all quantitative measures and provides sound qualitative reasoning that is consistent with the ground truth while offering slightly more operational detail. The minor differences in emphasis and specificity do not constitute errors but rather represent reasonable elaboration on the core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 542,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nUnitedHealth’s equity‑method stake in health‑care operating businesses expanded sharply—from roughly **$1.5 billion at the end of 2022** to **$3.8 billion by the end of 2024**—indicating a strategic push into core health‑service assets.  At the same time, its venture‑investment portfolio (reported within equity securities) showed rising fair‑value gains of **$211 million in 2022, $276 million in 2023 and $710 million in 2024**, underscoring an increasing emphasis on high‑growth health‑tech and digital‑health investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) EQUITY METHOD INVESTMENTS - MAJOR ERROR: The LLM states equity-method investments grew 'from roughly $1.5 billion at the end of 2022 to $3.8 billion by the end of 2024.' However, the ground truth clearly indicates: 2022=$1.4B, 2023=$1.5B, 2024=$3.8B. The LLM incorrectly states the 2022 figure as $1.5B when it should be $1.4B. This is a factual error on a key data point. (2) VENTURE INVESTMENT FAIR-VALUE GAINS - UNSUPPORTED DATA: The LLM introduces specific fair-value gain figures ($211M in 2022, $276M in 2023, $710M in 2024) that do NOT appear in the ground truth answer. The ground truth discusses the equity securities portfolio growing from $3.7B (2022) to $4.9B (2023-2024), but does NOT mention these specific fair-value gain numbers. The LLM appears to have fabricated or misinterpreted data not present in the source material. (3) MISSING KEY INFORMATION: The LLM fails to mention the equity securities portfolio values ($3.7B→$4.9B→$4.9B) that are explicitly stated in the ground truth as part of the venture investments discussion. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information about both investment types and their strategic implications, the introduction of unsupported numbers and the misstatement of the 2022 equity-method figure represent fundamental errors in data accuracy. The qualitative assessment about 'strategic push' and 'high-growth health-tech' is reasonable but cannot compensate for quantitative inaccuracies. The answer demonstrates partial understanding of the question's multi-part nature but fails on factual precision, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 478,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 annual reports the PMI Peer Group used for the cumulative shareholder‑return graph—including Colgate‑Palmolive Co.—remains exactly the same, with the composition unchanged each year. This multi‑year consistency shows that PMI’s strategic benchmarking framework is built around a stable, globally diversified set of consumer‑product peers of comparable size, allowing it to compare performance against a consistent reference group over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that Colgate-Palmolive Co. remained in the PMI Peer Group across all three years (2022, 2023, 2024) with no changes; (2) Accurately characterizes the peer group composition as 'unchanged each year'; (3) Properly synthesizes the multi-hop information showing year-over-year consistency; (4) Correctly interprets what this consistency reveals about PMI's strategic benchmarking framework—a stable, globally diversified set of consumer-product peers. Quantitative accuracy is perfect—all dates and temporal references are correct. The reasoning is sound: the model correctly identifies that unchanged peer group composition across three years indicates a stable benchmarking framework. Minor observation: The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention the four characteristics (global presence, focus on consumer products, net revenues, and market capitalization) that define the peer group selection criteria. However, the LLM does capture the essence of these criteria by referring to 'globally diversified set of consumer-product peers of comparable size.' This is a minor omission of contextual detail but does not affect the core correctness of the answer. The semantic meaning is fully preserved—both answers convey that PMI maintained a consistent peer benchmarking framework with Colgate-Palmolive remaining in the group across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 415,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s risk disclosures show that its exposure to abusive behavior grew in step with the rollout of credit products such as BNPL and merchant financing, which added new fraud vectors and deepened reliance on third‑party lenders, banks and funding arrangements. The company repeatedly warns that fraud‑detection tools are complex and may not fully curb emerging schemes, leading to higher loss rates and greater dependence on protection programs that often cannot fully recover losses—indicating that fraud‑mitigation effectiveness has not kept pace with the expanding risk landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core trend that PayPal's exposure to abusive behaviors increased from 2022-2024 in conjunction with expanding credit products (BNPL, merchant financing). It accurately captures the key insight that fraud mitigation effectiveness has not kept pace with the expanding risk landscape. The reasoning about third-party dependencies and fraud vectors is sound and semantically aligned with the ground truth. The answer appropriately addresses the multi-hop nature of the question by synthesizing information across the three-year period.\n\nWEAKNESSES: (1) QUANTITATIVE OMISSION: The LLM answer completely fails to mention the specific €40 billion multi-year BNPL receivables sale agreement in Europe that is explicitly cited in the ground truth as a major 2023 development. This is a significant factual omission of a concrete, quantifiable detail. (2) INCOMPLETE TEMPORAL BREAKDOWN: While the ground truth provides year-by-year evolution (2022 baseline, 2023 expansion with specific deal, 2024 regulatory concerns), the LLM answer presents a more generalized narrative without clear temporal delineation of how risks evolved specifically in each year. (3) REGULATORY UNCERTAINTY: The ground truth specifically mentions 2024 regulatory uncertainty regarding loan receivables post-sale validity, which the LLM answer does not address. (4) DETECTION SYSTEM INVESTMENT: The ground truth notes PayPal 'invested in detection systems' while the LLM answer only mentions detection tools 'may not fully curb' schemes, missing the nuance that investment occurred despite ongoing challenges.\n\nCALCULATION/ACCURACY CHECK: No calculations required. The €40 billion figure is a critical quantitative detail that should have been included but was omitted entirely. This represents a material gap in quantitative accuracy.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the relationship between credit product expansion and fraud exposure across the 2022-2024 period, but the synthesis is less granular than the ground truth, which explicitly traces the evolution year-by-year with specific events and regulatory developments.\n\nOVERALL ASSESSMENT: The answer captures the directional trend and core insight correctly but lacks the specific quantitative details (€40 billion deal) and temporal precision that would make it fully accurate. It reads as a reasonable summary but falls short of the comprehensive, fact-based answer expected from a knowledge graph source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 666,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nSouthern Company’s natural‑gas hedging program evolved from a sizable option position in 2022 (≈310 mmBtu of swaps + options with a $0.74 /mmBtu discount to market) to a peak option volume in 2023 (≈339 mmBtu of options, total hedge volume ≈448 mmBtu and a widened $0.76 /mmBtu discount), and then in 2024 it trimmed options to 176 mmBtu, shifted back toward swaps (≈255 mmBtu) and saw the discount narrow to only $0.15 /mmBtu. This three‑year trend shows the company has progressively reduced its reliance on low‑cost, high‑discount options as market conditions changed, moving to a more modest swap‑based hedge and increasingly passing fuel‑cost risk to counterparties to manage natural‑gas price volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides numbers that diverge significantly from ground truth. For 2022, the LLM states '≈310 mmBtu of swaps + options' but ground truth specifies 253 million mmBtu in natural gas options alone. The LLM conflates swaps and options, introducing confusion. For 2023, the LLM correctly identifies 339 mmBtu but adds unverified total hedge volume of 448 mmBtu and discount metrics ($0.76/mmBtu) not present in ground truth. For 2024, the LLM correctly states 176 mmBtu options but adds unverified swap volume (255 mmBtu) and discount data ($0.15/mmBtu). (2) MISSING GROUND TRUTH DATA - The original answer focuses on the three-year trend in options volumes (253→339→176 mmBtu), which the LLM partially captures but obscures with additional unverified metrics. The ground truth does not mention swap volumes, discount rates, or counterparty risk transfer language. (3) MULTI-HOP REASONING - The LLM's interpretation of the trend (initial increase then reduction) aligns with ground truth's narrative, but the LLM adds speculative analysis about 'low-cost, high-discount options' and 'passing fuel-cost risk to counterparties' that cannot be verified against the provided ground truth. (4) ENTITY/METRIC CONFUSION - The LLM conflates options with swaps and introduces pricing metrics ($/mmBtu discounts) that are not part of the ground truth answer, suggesting either hallucination or reliance on different source data. The core 2022-2024 options trend (253→339→176) is partially correct but embedded in incorrect context. STRENGTHS: The LLM correctly identifies the 2023 peak and 2024 reduction, and the qualitative interpretation of dynamic risk management is reasonable. WEAKNESSES: Introduces unverified quantitative data, conflates hedging instruments, and provides metrics not in ground truth, significantly reducing reliability for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 514,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s aggregate expense for the U.S. defined‑contribution plans increased modestly—$70 million in 2022, $75 million in 2023 and $76 million in 2024.  This upward trend shows that Texas Instruments is deliberately boosting its employer‑matching contributions within the defined‑contribution framework, while the older, unfunded non‑qualified defined‑benefit pension plan remains closed to new participants and is being down‑played as the primary retirement vehicle.  Consequently, the firm’s long‑term employee‑benefit strategy is shifting toward defined‑contribution plans as the principal source of retirement benefits.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all numerical values correct: $70 million (2022), $75 million (2023), and $76 million (2024). The quantitative trend analysis is accurate, correctly identifying the modest but steady increase across the three-year period. The multi-hop synthesis is sound, connecting the defined contribution plan expense trend to the broader employee benefit strategy and the closed non-qualified defined benefit pension plan. The reasoning about the strategic shift toward defined contribution plans as the principal retirement vehicle is logically sound and well-supported by the data. However, there are minor qualitative differences from the ground truth: (1) The LLM emphasizes 'employer-matching contributions' specifically, while the ground truth focuses more broadly on 'growing financial commitment to employee retirement benefits' without specifying the mechanism; (2) The LLM characterizes the non-qualified defined benefit plan as 'unfunded' and 'being down-played,' which adds interpretive language not explicitly in the ground truth; (3) The ground truth mentions the 1997 closure date and references employees 'who have opted out' and are in an 'enhanced defined contribution plan,' providing more specific historical context that the LLM omits. The LLM's characterization of the strategy as 'shifting toward defined-contribution plans as the principal source' is semantically equivalent to the ground truth's 'strategic emphasis on supporting employees...participating in the enhanced defined contribution plan,' though slightly more assertive in tone. Overall, the answer is factually correct and addresses all parts of the question with sound reasoning, but lacks some of the specific contextual details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 487,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nGeneral Motors raised its long‑term return assumption for U.S. pension plans from roughly **5.4 % in 2022** (the weighted‑average expected return used for net expense) to **6.3 % in 2023**, and after the 2024 investment‑policy study increased the strategic long‑term ROA to **6.5 %** (the expense‑based expected return was 6.27 %). This upward shift shows GM now expects higher long‑run asset performance and is deliberately moving to a more return‑focused, slightly higher‑risk portfolio—adding greater equity and alternative‑return exposures—to meet funding objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IDENTIFIED: The LLM answer contains a significant factual error regarding the 2023 rate. The ground truth states that in 2023, the rate 'remained unchanged at 6.3%' (implying it was already 6.3% in 2022, not 5.4%). However, the LLM claims the rate was 5.4% in 2022 and then increased to 6.3% in 2023. This creates an internal contradiction with the ground truth's statement that 2023 remained 'unchanged.' The ground truth appears to indicate: 2022 = 6.3%, 2023 = 6.3% (unchanged), 2024 = 6.5%. The LLM's interpretation (2022 = 5.4%, 2023 = 6.3%, 2024 = 6.5%) differs fundamentally from the ground truth narrative. QUANTITATIVE ACCURACY: The 2024 figure of 6.5% is correct, and the mention of 6.27% as an expense-based return shows additional detail. However, the 2022-2023 progression is misrepresented relative to ground truth. QUALITATIVE ACCURACY: The LLM correctly identifies the upward trend and appropriately interprets it as reflecting increased confidence in asset performance and higher risk tolerance. The reasoning about portfolio composition (equity and alternative-return exposures) is sound and relevant. COMPLETENESS: The answer addresses all parts of the question—the evolution over time and what it suggests about expectations and risk tolerance. ENTITY ACCURACY: General Motors and U.S. pension plans are correctly identified. The distinction between strategic ROA and expense-based return shows nuanced understanding. REASONING: The multi-hop synthesis is logically sound, connecting the numerical trend to strategic implications. The main weakness is the factual discrepancy regarding whether 2022 was 5.4% or 6.3%, which undermines confidence in the quantitative foundation despite correct reasoning about the trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 481,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the swaps that hedge Cisco’s deferred‑compensation liability shifted from a **$92 million loss** (recorded as an operating expense in FY 2022) to **gains of $157 million in FY 2023 and $91 million in FY 2024**.  This swing shows that the fair‑value of the total‑return swaps moved from a negative to a positive position as market conditions changed, allowing Cisco to offset a portion of its compensation liability and even generate a net gain.  The progression demonstrates that Cisco’s risk‑management program actively uses market‑linked derivatives to neutralize the earnings volatility of deferred‑compensation obligations, aligning compensation expense with the underlying liability’s performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL 2023 FIGURE: The LLM states FY 2023 gains were $157 million, but the ground truth clearly indicates $58 million. This is a significant factual error ($99 million discrepancy). The FY 2022 loss of $92 million and FY 2024 gain of $91 million are both correct. The LLM's qualitative reasoning about risk management and market-linked derivatives is sound and well-articulated, demonstrating good understanding of the compensation strategy. However, the incorrect FY 2023 number is a major quantitative error that undermines the core factual accuracy of the answer. The LLM correctly identifies the progression as a turnaround from losses to gains and appropriately contextualizes this within Cisco's risk management framework. The semantic understanding of how total return swaps offset deferred compensation volatility is accurate. However, when evaluating multi-hop financial questions, precision on specific numbers is paramount. The 172% error on the FY 2023 figure (stating $157M instead of $58M) represents a fundamental factual failure despite otherwise reasonable analysis. The answer demonstrates good contextual understanding but fails on the primary metric of quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 342,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nPayPal continues to bear full margin risk on every payment it authorizes—recognizing transaction revenue on a gross basis and recording the fees paid to third‑party processors and other financial institutions as transaction expense—so its exposure to margin pressure is driven primarily by the volume and mix of TPV (including cross‑border and currency‑conversion fees) and by its ability to set and adjust fees at will.  The company’s tiered, volume‑based pricing does not create a material future right, and it consistently reduces revenue for incentives or refunds, but the way it accounts for those items (recording them as reductions of revenue or as transaction expense) remained essentially unchanged from 2022 through 2024, with only incremental refinements in disclosure and the introduction of new guidance on segment and crypto‑asset reporting that did not alter the underlying margin‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's full margin risk exposure across all three years (2022-2024) with no structural changes; (2) Accurately describes the recognition of fees paid to third-party processors as transaction expense; (3) Properly characterizes PayPal's discretion in setting fees independent of costs; (4) Correctly notes that tiered, volume-based pricing does not create material future rights; (5) Accurately captures the consistency of accounting treatment across the three-year period with only incremental disclosure refinements; (6) Appropriately mentions new segment reporting and crypto-asset guidance without overstating their impact on margin-risk profile. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in either answer, so this dimension scores perfectly. QUALITATIVE ACCURACY: The LLM answer provides more granular detail than the ground truth (mentioning TPV mix, cross-border fees, currency-conversion fees, and treatment of incentives/refunds) while maintaining complete semantic equivalence. The multi-hop synthesis correctly connects pricing control, third-party processor relationships, and transaction expense recognition across the three-year period. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and technical than the ground truth, but this represents added value rather than deviation. The phrase 'essentially unchanged' in the LLM answer perfectly captures the ground truth's assertion of 'consistent exposure to margin risk without structural changes.' All entities (PayPal, third-party processors, segment reporting) are correctly identified. The reasoning about how margin pressure is driven by volume/mix and fee-setting ability is logically sound and well-integrated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 507,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s Angola LNG supplied about **49 billion cubic feet per day in 2022**, held steady at **≈48 billion cubic feet per day in 2023**, and remained at **≈48 billion cubic feet per day in 2024**.  The flat‑to‑slightly‑declining output shows that Angola LNG is a mature, stable source that contributes a modest, predictable volume to Chevron’s LNG portfolio, allowing the company to focus its strategic growth on other, higher‑potential LNG projects rather than expanding production from Angola.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports Angola LNG production at ~49 billion cubic feet per day (2022), ~48 billion cubic feet per day (2023-2024). The ground truth states natural gas consumed in operations was 592 million cubic feet per day (2022), 596 million cubic feet per day (2023), and 609 million cubic feet per day (2024). The LLM's numbers are off by approximately 80-100x (billions vs. millions), representing a catastrophic numerical error. (2) TREND ANALYSIS - The LLM claims flat-to-slightly-declining output, but the ground truth shows a clear upward trajectory: 592→596→609 million cubic feet per day is a steady increase of 4 million cubic feet per day annually. The LLM's characterization of 'flat-to-slightly-declining' directly contradicts the actual increasing trend. (3) STRATEGIC INTERPRETATION - The LLM concludes Angola LNG is 'mature, stable' with 'modest, predictable volume' and that Chevron is focusing growth elsewhere. The ground truth indicates the opposite: steady increases suggest 'growing operational emphasis on LNG production in Angola' and alignment with 'strategy to strengthen its position in global LNG markets.' The LLM's strategic conclusion is inverted from the actual data. (4) METRIC CONFUSION - The LLM appears to have confused or misread the production volume metric entirely, using vastly inflated numbers that don't correspond to any disclosed Chevron Angola LNG figure. This is not a minor formatting difference but a fundamental data retrieval failure. The answer fails on accuracy, trend identification, and strategic reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 453,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nSouthern Power’s scheduled‑payment disclosures evolved from a single, aggregate 2022 table that listed roughly $87 million (2022), $88 million (2023) and $90 million (2024) of fixed payments with a $240 million tail, to 2023‑2024 tables that break those amounts out year‑by‑year (e.g., $15 million‑$52 million annually) and add a large “thereafter” column, while also disclosing net‑investment, discount‑rate and weighted‑average‑term metrics.  This progression—from a coarse, total‑cash‑flow figure to a detailed, multi‑year schedule with ancillary financial metrics—signals that the outdoor‑lighting/PPA lease cash flows have become increasingly material and structurally central to Southern Power’s earnings and balance‑sheet exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unverified quantitative claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($87M, $88M, $90M for 2022-2024, and $240M tail) that are not present in the original answer and cannot be verified against the knowledge graph. These numbers appear fabricated or sourced from unreliable inference. (2) STRUCTURAL MISALIGNMENT: The ground truth emphasizes a qualitative evolution in reporting treatment—from noting immateriality in 2022, to inclusion in maturity analyses in 2023, to integration into lease income reporting in 2024. The LLM instead focuses on a detailed breakdown of payment schedules (year-by-year, 'thereafter' columns, net-investment metrics) that is not mentioned in the ground truth. (3) MISSING KEY FACTS: The LLM completely omits the critical 2022 finding that outdoor lighting contracts were 'immaterial' at Mississippi Power, which is central to understanding the evolution. It also fails to mention the specific progression from 'immaterial' status to inclusion in maturity analyses to integration into lease income frameworks. (4) REASONING FLAW: While the LLM's conclusion that materiality increased over time aligns with the ground truth's conclusion, the evidence presented is entirely different and unverified. The LLM appears to have hallucinated specific payment schedules and financial metrics rather than synthesizing the actual disclosure evolution described in the ground truth. (5) SEMANTIC DIVERGENCE: The ground truth describes a shift in *reporting treatment and attention* (immaterial → included in analyses → integrated into frameworks), while the LLM describes a shift in *disclosure granularity* (aggregate figures → detailed schedules). These are fundamentally different narratives. The answer demonstrates poor multi-hop synthesis and introduces unsubstantiated quantitative claims that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 534,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nTexas Instruments kept Melaka, Malaysia on its property list for all three fiscal years, and the site was marked with an “X” under the **Analog** column in the 2022, 2023 and 2024 property tables—indicating that the Melaka facility continued to be used for Analog‑product manufacturing throughout the period. The company did **not** list Melaka under the Embedded‑Processing column in any of those years, so there was no documented expansion of its Embedded‑Processing operations there; the only evolution noted is the recurring presence of the site in the Analog segment, with the same lease/ownership status reflected across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies that: (1) Texas Instruments maintained operations in Melaka, Malaysia across all three years (2022, 2023, 2024); (2) The facility was exclusively marked for the Analog segment in all three years; (3) There was no expansion into Embedded Processing during this period. The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and two business segments. The LLM appropriately references the property tables and the marking system ('X' under Analog column) used in SEC filings, showing proper understanding of the source material. The statement about 'recurring presence' and 'same lease/ownership status' adds appropriate context about consistency. The answer is semantically equivalent to the ground truth, conveying that Melaka's role remained limited to Analog operations without expansion. No numerical errors or factual inaccuracies are present. The only minor consideration is that the LLM uses slightly more detailed language about the property tables and marking system than the ground truth, but this represents added clarity rather than any deviation from accuracy. The answer fully addresses all aspects of the multi-part question regarding the evolution (or lack thereof) of TXN's operational footprint in Melaka across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 383,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nFrom 2022 through 2024 the $700 million 1.600% senior notes issued on March 29 2021 were systematically reduced – the company recorded negative adjustments of roughly **$3.7 million in 2022, $2.6 million in 2023 and $1.5 million in 2024**, indicating scheduled principal repayments that lowered the outstanding balance each year.  The **interest‑payment schedule (April 15 and October 15) and the par‑call date (March 15 2026) remained unchanged** throughout this period.  \n\nThis multi‑year progression reflects AMT’s disciplined debt‑management strategy: it uses operating cash flow and credit‑facility borrowings to retire senior notes on a predictable schedule, thereby reducing leverage, preserving liquidity and extending the overall maturity profile while keeping financing costs stable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM fundamentally misinterprets the nature of the adjustments. The ground truth states adjustments of (2.6) in 2023 and (1.5) in 2024, but the LLM claims $3.7M in 2022, $2.6M in 2023, and $1.5M in 2024. The LLM invents a 2022 figure ($3.7M) not present in the ground truth and mischaracterizes these as 'scheduled principal repayments' when the ground truth explicitly states the principal amount remained constant at $700.0 million across all three years. This is a fundamental factual error. (2) PRINCIPAL AMOUNT CLAIM - The LLM states the notes were 'systematically reduced' implying declining principal balance, but the ground truth clearly indicates the aggregate principal amount remained unchanged at $700.0 million from 2022-2024. This directly contradicts the ground truth. (3) ADJUSTMENT INTERPRETATION - The ground truth describes these as 'adjustments to principal amount' and 'modifications or adjustments to the note structure,' suggesting accounting or administrative adjustments, NOT principal repayments. The LLM misinterprets these as debt reduction/retirement. (4) CORRECT ELEMENTS - The LLM correctly identifies: the $700M amount, the 1.600% rate, the April 15/October 15 payment schedule, and the March 15, 2026 par call date. (5) REASONING FLAW - The LLM's debt management strategy narrative (using operating cash flow to retire notes, reducing leverage) is plausible but unsupported by the actual data. The ground truth indicates stability and consistency, not systematic reduction. The LLM fabricates a narrative inconsistent with the actual facts. (6) MULTI-HOP SYNTHESIS - Failed to correctly synthesize the multi-year progression; instead created an incorrect narrative of declining principal when the data shows stable principal with minor adjustments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 499,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco’s 5.90 % senior note—originally issued in 2019 for $2 bn—remained on the books through FY 2022, FY 2023 and FY 2024, but its weight in the overall debt stack declined sharply.  In FY 2022 it accounted for roughly $2 bn of the $9 bn face‑value long‑term debt portfolio (about 22 % of total) and carried an effective interest cost of 6.11 %; by FY 2023 the company had expanded long‑term debt to $11.5 bn face, reducing the note’s share to ≈17 % while the weighted‑average effective rate of the entire debt slipped into the low‑mid‑3 % range; and in FY 2024 the note was just one tranche among many, representing only ~10 % of the $20.3 bn face‑value long‑term debt that now carries a blended effective rate near 4–5 % after discount and hedge adjustments.  This progression shows Cisco is deliberately diversifying and extending its long‑term financing—issuing a broader set of senior notes at varied maturities and coupons and relying more on commercial‑paper liquidity—so that the legacy 5.90 % instrument is no longer a core driver of funding but a smaller, legacy component of a more flexible, lower‑cost capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CRITICAL NUMBER ERRORS: Ground truth states total long-term debt was $8,416M in FY2022, but LLM claims ~$9B (close but imprecise). More critically, ground truth shows $19,621M in FY2024, but LLM states $20.3B ($20,300M), a $679M discrepancy. Ground truth shows short-term debt decreased from $499M to $488M, which LLM completely omits. (2) PERCENTAGE CALCULATIONS INCORRECT: LLM claims the 5.90% Note represented 22% of total long-term debt in FY2022 ($2B/$9B), but ground truth shows $2B/$8,416M = 23.8%. More problematically, LLM claims it was ~17% in FY2023 and ~10% in FY2024, but ground truth indicates it remained constant at $2,000M across all three years. The declining percentage claim is mathematically correct IF total debt increased, but LLM provides wrong total debt figures. (3) EFFECTIVE INTEREST RATE ERROR: Ground truth explicitly states the effective interest rate held steady at 6.11% throughout FY2022-2024. LLM incorrectly claims the weighted-average effective rate 'slipped into the low-mid-3% range' by FY2023 and 'near 4-5%' by FY2024. This is a fundamental misrepresentation of the 5.90% Note's effective rate. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM correctly identifies that the note's relative weight declined (due to increasing total debt), but fails to recognize that the note's absolute amount remained constant at $2B. The ground truth's key insight—that Cisco relied increasingly on long-term fixed-rate instruments while total debt grew—is partially captured but obscured by incorrect numbers. (5) STRATEGIC INTERPRETATION: While LLM's narrative about diversification and extending financing is plausible, it's built on incorrect quantitative foundations. The ground truth emphasizes stabilizing financing costs amid rising debt levels, which is a different strategic emphasis than LLM's focus on 'lower-cost capital structure.' The claim about blended rates dropping to 4-5% contradicts the stated 6.11% effective rate for the 5.90% Note. CORRECT ELEMENTS: LLM correctly identifies the note was issued in 2019 for $2B and remained on the books through all three years. The general narrative about diversification is reasonable but unsupported by accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 618,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics grew its Canadian‑LAV output: the company was building **399 new LAVs** for the Canadian Army in 2022, added **66 LRSS‑equipped vehicles** in 2023, and in 2024 ramped production to **449 new LAVs** (again with the 66 LRSS units) while also upgrading the existing fleet. This stepped‑up volume demonstrates that GD is **placing a strategic emphasis on LAV manufacturing**, expanding capacity and investment in its Combat Systems segment to capture growing allied demand.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant chronological and numerical misalignments with the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states '399 new LAVs' were built in 2022, but ground truth shows 360 units in 2022 and 399 units in 2023 - a critical year-to-number mismatch. The LLM places 66 LRSS units in 2023, but ground truth indicates they were added in 2024. The LLM claims 449 LAVs in 2024 'again with the 66 LRSS units,' suggesting the 449 includes the 66 LRSS vehicles, which contradicts the ground truth showing these as separate program additions. (2) CHRONOLOGICAL ERRORS: The progression is fundamentally scrambled - the LLM presents 399→66→449 across years, when the correct progression is 360 (2022)→399 (2023)→449 (2024), with LRSS added in 2024 as a distinct 66-unit program. (3) MULTI-HOP REASONING: While the LLM correctly identifies the strategic focus on LAV manufacturing and mentions the LRSS program, the synthesis of timeline and quantities is broken. The answer fails to properly track which numbers apply to which years. (4) SEMANTIC ISSUES: The phrase 'again with the 66 LRSS units' in 2024 is ambiguous and misleading - it's unclear whether the 449 includes or excludes the 66 LRSS vehicles. Ground truth treats them as additive/separate program components. The core narrative about strategic emphasis is present but undermined by factual errors that would mislead readers about actual production volumes and timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 409,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment volatility deepened as CMS repeatedly lowered benchmarks and tightened the risk‑adjustment models that determine capitation, squeezing the company’s funding from the program.  In response, UnitedHealth progressively strengthened its risk‑adjustment data‑validation and coding‑accuracy initiatives and pursued a suite of cost‑containment and revenue‑management actions—including selective benefit and premium adjustments, exiting low‑margin counties, intensifying overall medical and operating expense management, and investing in quality‑rating improvements to protect bonus eligibility—thereby mitigating the ongoing funding pressures across the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the three-year evolution of CMS risk adjustment payment pressures; (2) Accurately captures the core strategic responses: selective benefit/premium adjustments, county exits, cost management, and medical expense control; (3) Properly synthesizes multi-hop information showing how UnitedHealth's responses evolved in response to ongoing CMS changes; (4) Uses appropriate financial/operational terminology (capitation, benchmarks, risk-adjustment models, coding-accuracy initiatives); (5) Correctly identifies the timeframe (2022-2024) and maintains chronological coherence. MINOR AREAS FOR IMPROVEMENT: (1) The LLM adds some details not explicitly mentioned in ground truth (e.g., 'quality-rating improvements to protect bonus eligibility,' 'risk-adjustment data-validation and coding-accuracy initiatives') - while these are plausible strategic responses and not contradicted by ground truth, they represent slight elaboration beyond what was confirmed in the knowledge graph; (2) The phrase 'exposure deepened' is slightly stronger language than the ground truth's 'consistently faced,' though semantically similar; (3) Ground truth mentions 'beneficiary health status data submissions' as a 2024 focus, which the LLM doesn't explicitly address, though the coding-accuracy initiatives are related. QUANTITATIVE VERIFICATION: No specific dollar amounts, percentages, or numerical metrics were provided in either answer, so quantitative accuracy is based on correct identification of years (2022, 2023, 2024) and proper temporal sequencing - both correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple strategic dimensions (CMS actions → UnitedHealth responses), demonstrating sound logical progression. The causal relationship between CMS changes and UnitedHealth's strategic adjustments is clearly established.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 538,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nThe company’s holding of the 2.850 % fixed‑rate note tranche was unchanged throughout the period – the tables of “Notes” show a $1.5 billion balance as of December 31 2022, 2023 and 2024, and the future‑payments schedule lists the next principal repayment on that series for 2029.  This steady exposure signals that PayPal’s long‑term debt strategy is to maintain a stable, laddered pool of fixed‑rate financing (with maturities stretching to 2029 and beyond) rather than to grow or shrink any single tranche, using new issuances to supplement the ladder while preserving a low‑cost, long‑dated funding base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of PYPL's debt strategy. QUANTITATIVE VERIFICATION: All numbers are correct - $1.5 billion carrying value across 2022, 2023, and 2024 matches the ground truth exactly. The 2.850% interest rate and 2029 maturity date are accurately cited. The three-year period (2022-2024) is correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained constant at $1.5B), and (2) what this indicates about long-term debt strategy (stable, laddered approach). ENTITY ACCURACY: Company correctly identified as PayPal/PYPL, fiscal years correct, financial metrics properly referenced. REASONING QUALITY: The LLM demonstrates sound multi-hop synthesis by connecting the constant balance across three years to strategic intent. The interpretation that stability signals a deliberate strategy to maintain a 'laddered pool of fixed-rate financing' is logically sound and goes slightly beyond the ground truth by providing additional context about the broader debt portfolio strategy. SEMANTIC EQUIVALENCE: The core message aligns perfectly with ground truth - both convey that the $1.5B position remained unchanged and this reflects strategic consistency. The LLM's elaboration about 'new issuances to supplement the ladder while preserving a low-cost, long-dated funding base' adds reasonable interpretive depth without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more strategic interpretation than the ground truth (mentioning 'laddered pool' and 'new issuances'), but this is additive rather than contradictory and demonstrates deeper analytical thinking. No calculation errors detected. All dates and figures verified as accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 489,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron deepened its stake in Angola LNG Limited while simultaneously expanding the upstream gas base that feeds the plant – the 36.4 % shareholding remained constant, but the company moved from a $1.96 bn investment in 2022 to $1.76 bn in 2023 and continued to fund key tie‑in projects (the Block 0 Sanha Lean Gas Connection, the New Gas Consortium offshore concession and new deep‑water exploration blocks 49/50). By 2024 the SLGC platform was completed, the NGC project was on track for first production in 2026, and Chevron had secured additional frontier acreage, underscoring a long‑term strategy to monetize Angola’s associated gas through its equity stake in Angola LNG and to grow the country into a sustained LNG export hub.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM introduces specific dollar amounts ($1.96 bn in 2022, $1.76 bn in 2023) that are NOT present in the ground truth answer. These appear to be fabricated or from unverified sources. The ground truth makes no mention of investment values changing year-to-year. (2) UNVERIFIED PROJECT DETAILS: The LLM references specific projects (Block 0 Sanha Lean Gas Connection/SLGC, NGC first production in 2026) with specific completion statuses that are not mentioned in the ground truth. While Blocks 49/50 and Q&M fields ARE mentioned in ground truth, the SLGC platform completion claim and 2026 production timeline are not verified. (3) PARTIAL ALIGNMENT: The LLM correctly identifies the 36.4% ownership stake as constant across 2022-2024, which matches ground truth. It also correctly mentions Blocks 49/50 and the New Gas Consortium project. (4) REASONING QUALITY: The LLM's overall narrative about transitioning from standalone facility to integrated hub is conceptually aligned with ground truth, but the specific project details and investment figures undermine credibility. (5) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize upstream expansion with LNG facility integration, which is the correct conceptual framework, but introduces unverified quantitative claims that cannot be validated against the ground truth. The answer reads plausibly but contains material claims not supported by the knowledge graph source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 405,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company’s trust‑held domestic‑equity exposure grew from roughly **$829 million (2022) to $1.10 billion (2023) and then held steady at about $1.10 billion in 2024**, while its private‑equity allocation rose from **≈$161 million to $181 million and remained flat thereafter**.  This early‑year increase shows a deliberate shift toward higher‑return equity assets, and the subsequent stabilization indicates that the company has settled on a target mix of domestic equity and modest private‑equity exposure as part of a disciplined, long‑term capital‑allocation strategy focused on diversified growth and risk‑adjusted returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that completely misrepresent the data progression. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states domestic equity was '$829 million (2022)' when ground truth shows 2022 was $1,016 million. The LLM then claims it grew to '$1.10 billion (2023)' when ground truth shows 2023 was $829 million - the LLM has reversed the 2022 and 2023 values. For 2024, the LLM correctly states ~$1.10 billion ($1,099 million). For private equity, the LLM states it 'rose from ≈$161 million to $181 million' but ground truth shows 2022 was $150 million, 2023 was $161 million, and 2024 was $181 million - again, the LLM has omitted the 2022 baseline and misrepresented the starting point. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression. It describes an 'early-year increase' and 'subsequent stabilization' which contradicts the actual pattern of decrease (2022→2023) followed by rebound (2023→2024). (3) REASONING ERROR: The LLM's interpretation that this shows 'early-year increase' toward higher-return assets is factually unsupported by the actual data, which shows a dip in 2023 before recovery in 2024. (4) ENTITY/METRIC ACCURACY: While Southern Company is correctly identified, the temporal sequencing of the financial metrics is fundamentally wrong. The answer demonstrates a critical failure to accurately extract and sequence multi-year financial data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 411,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Eliminations/Reclassifications” line subtracted $107 million, $151 million and $296 million respectively from GM’s consolidated net sales (i.e., it grew in absolute magnitude each year).  This expanding subtraction shows that GM is increasingly adjusting its internal revenue figures—primarily to eliminate inter‑segment sales and re‑classify revenues from Cruise and GM Financial—indicating a shift toward more granular, cross‑business reporting and tighter consolidation of the company’s multiple segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figure. Ground truth states Eliminations/Reclassifications were $105 million in 2022, but the LLM claims $107 million. This is a direct contradiction of the first data point. The 2023 figure of $151 million in the LLM answer also contradicts the ground truth of $107 million—a $44 million discrepancy. Only the 2024 figure of $296 million is correct. This represents 2 out of 3 years with incorrect numbers, which is a fundamental failure on quantitative accuracy. REASONING QUALITY: The LLM's qualitative interpretation about the trend (increasing magnitude year-over-year) is directionally correct in concept, and the explanation about inter-segment eliminations and consolidation adjustments is reasonable and contextually appropriate. However, this reasoning quality cannot overcome the severe quantitative errors. MULTI-HOP SYNTHESIS: The answer does attempt to synthesize the three-year trend and provide context about what the adjustments represent (inter-segment sales, Cruise and GM Financial reclassifications), which shows some understanding of the underlying business dynamics. However, the incorrect numbers undermine the entire analysis. COMPLETENESS: The answer addresses the evolution question and attempts to explain what the trend reveals, meeting the structural requirements of the question. SUMMARY: While the LLM demonstrates reasonable business logic and contextual understanding, the factual errors in 2 of 3 years' data points are disqualifying for a financial analysis question where precision is paramount. The answer would mislead users about the actual magnitude of these adjustments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 467,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix continuously disclosed its executive bonus framework as the “Performance Bonus Plan,” first filed as Exhibit 10.6† in the 2022 10‑K and then amended and restated in the 2023 10‑K (Exhibit 10.5†) and again referenced in the 2024 filing (Exhibit 10.5†).  The plan is formally documented in each annual report and is presented as part of an integrated compensation structure that also includes the Amended and Restated Executive Severance and Retention Incentive Plan and the company’s stock‑based incentive plans, ensuring that bonus, severance and equity components are coordinated under a single, regularly updated set of exhibit filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the exhibit numbers (10.6† in 2022, 10.5† in 2023 and 2024) and accurately captures the progression from a historical exhibit to an amended and restated version. The dates and filing sequence are correct. The answer appropriately notes the integration with other compensation frameworks.\n\nWEAKNESSES: (1) The LLM states the plan was 'amended and restated in the 2023 10-K' but the ground truth specifies the filing date was December 9, 2022 (not 2023), which is a critical distinction for understanding the timeline. (2) The LLM says the plan was 'again referenced in the 2024 filing' but fails to explicitly state that there were NO FURTHER CHANGES in 2024 - it merely carried forward the 2023 version. This is an important nuance about stabilization vs. continued amendment. (3) The LLM mentions the 'Amended and Restated Executive Severance and Retention Incentive Plan' as an integrated component, but the ground truth does not reference this specific plan in the context of the Performance Bonus Plan evolution. This appears to be an unsupported addition. (4) The answer lacks the specific characterization that 2022 showed 'no updates during that year' and that 2023 represented 'active revision and formalization' followed by 'stabilization in 2024' - these temporal distinctions are important for answering the 'evolution' question.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis across the three years but misses the key insight that the evolution involved a strategic update in 2023 followed by stabilization (no changes) in 2024. The reasoning is somewhat superficial, treating all three years similarly rather than highlighting the distinct nature of each period.\n\nCRITICAL ERROR: The dating of when the amendment occurred (December 9, 2022 vs. 2023) is a factual error that affects the accuracy of the timeline narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 512,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, BNY Mellon continues to incorporate its “Business Relationships and Related Party Transactions Policy’’ by reference to the Proxy Statement, and the description of that policy is materially unchanged each year. The company likewise reiterates its annual director‑independence assessment and the same three‑committee structure (Audit, Human‑Resources & Compensation, and Nominating & Social‑Responsibility), showing a consistent corporate‑governance framework with no substantive shifts in related‑party or independence disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the company as BNY Mellon (BK ticker), which matches the ground truth. (2) The three-committee structure is accurately named: Audit, Human Resources & Compensation, and Nominating & Social Responsibility (though the LLM uses slightly different wording order). (3) The core conclusion about consistency across 2022-2024 is correct. (4) The mention of incorporation by reference to the Proxy Statement is a valid detail about disclosure methodology. (5) The assertion that the policy description is 'materially unchanged' aligns with the ground truth's emphasis on consistency.\n\nWEAKNESSES: (1) CRITICAL ENTITY ERROR: The LLM identifies the company as 'BNY Mellon' but the ground truth refers to 'BK' - while these are the same company, the question specifically asks about 'BK's disclosure,' and the LLM should have used the ticker/name as presented in the question. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states the policy was disclosed 'within the context of Item 13, specifically under Corporate Governance and Board Information.' The LLM mentions incorporation by reference to the Proxy Statement but does not specify Item 13 or the exact section location. (3) MISSING DETAIL: The ground truth emphasizes the 'linkage' of the policy to director independence and committee charters as a key finding. The LLM mentions these elements but does not explicitly highlight the structural linkage across all three years as a key governance insight. (4) VAGUE LANGUAGE: The LLM uses 'materially unchanged' which is accurate but less specific than the ground truth's detailed description of consistent placement and linkage. (5) REASONING GAP: The LLM does not explicitly explain what the consistency 'reveals' about BK's governance framework beyond stating it shows a 'consistent framework' - the ground truth emphasizes this indicates a 'stable and uniform approach' to managing related party transactions and ensuring board independence.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is neutral. Both answers correctly reference the three-year period (2022-2024) and the three committees.\n\nQUALITATIVE ACCURACY: The LLM demonstrates sound reasoning about consistency but falls short of the multi-hop synthesis required. The question asks how disclosure 'evolved' and what this 'reveals' - the LLM addresses consistency but doesn't fully synthesize the governance implications across the three years as comprehensively as the ground truth.\n\nCONTEXTUAL RELEVANCE: The answer is relevant but somewhat generic. It addresses the core question but lacks the specificity about Item 13 placement and the explicit linkage structure that the ground truth emphasizes as revealing about BK's governance approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 747,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nUnitedHealth Group’s held‑to‑maturity debt‑security portfolio declined from **$679 million (fair value) / $696 million (carrying cost) in 2022 to $596 million / $603 million in 2023 and further to $508 million / $512 million in 2024**.  The drop mirrors the broader rise in market interest rates, which depressed the market prices of its fixed‑income holdings while the company continues to record the securities at amortized cost and does not recognize the unrealized losses.  This three‑year trend signals a deliberately conservative investment stance—maintaining a modest, high‑quality, short‑to‑mid‑term HTM portfolio that generates stable interest income, while relying on the expectation that the securities will be held to maturity and that the temporary price declines are not indicative of credit‑related impairment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect numbers for 2022 values. Ground truth shows fair value of $643M and carrying value of $641M in 2022, but the LLM states $679M (fair value) and $696M (carrying cost) - both are materially wrong, representing errors of +$36M and +$55M respectively. The 2023 and 2024 figures are correct ($596M/$603M and $508M/$512M), but the foundational 2022 baseline is incorrect, which undermines the entire 3-year trend analysis. QUANTITATIVE ACCURACY ASSESSMENT: The LLM inverted the relationship between fair value and carrying value for 2022 (stating carrying cost was higher than fair value, when ground truth shows the opposite). This is a fundamental error in understanding the data structure. The 2023-2024 progression is accurate, but starting from wrong 2022 numbers invalidates trend analysis. QUALITATIVE REASONING: The LLM's interpretation about interest rate impacts and the HTM portfolio strategy is reasonable and contextually sound, but it's built on incorrect foundational numbers. The discussion of amortized cost accounting and unrealized losses is appropriate and shows good understanding of HTM accounting mechanics. However, the LLM's explanation doesn't address the ground truth's key insight about the shift away from Level 3 unobservable inputs by 2023-2024, which is an important detail about valuation methodology changes. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize the data across three years and connect it to broader market conditions and accounting treatment, which shows reasonable multi-hop reasoning. However, the incorrect starting point severely compromises the validity of the trend analysis. The answer addresses the question's three components (fair value evolution, carrying value evolution, and strategic implications) but with flawed numerical foundations. SEMANTIC EQUIVALENCE: While the LLM's narrative about conservative investment stance and HTM strategy is semantically reasonable, it cannot be considered equivalent to the ground truth when the underlying numbers are materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 566,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s BNPL loan receivables expanded and required larger credit‑loss allowances, signalling growing exposure to bad transactions; in June 2023 the company announced a multi‑year deal to sell up to €40 billion of U.K. and European BNPL receivables and to forward‑flow future originations, thereby shifting much of that risk to third‑party buyers. By 2024 a substantial portion of the portfolio had been sold, reducing the on‑balance‑sheet BNPL balance and the associated allowance, demonstrating a clear risk‑mitigation evolution from internal credit‑risk management to external disposal of BNPL assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PayPal's BNPL risk mitigation strategy and correctly identifies the key elements: (1) the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables is accurate, (2) the multi-year nature of the deal is correctly noted, (3) the forward-flow arrangement is appropriately mentioned, and (4) the evolution from internal credit management to external asset disposal is well-articulated. STRENGTHS: All key dates (2022, June 2023, 2024) are correct; the €40 billion figure is accurate; the multi-hop synthesis across three years is sound; the characterization of the strategy shift is appropriate and matches the ground truth's emphasis on risk mitigation. WEAKNESSES: The LLM answer makes a specific claim that 'by 2024 a substantial portion of the portfolio had been sold, reducing the on-balance-sheet BNPL balance and the associated allowance' - while this is a reasonable inference from the strategy, the ground truth is more cautious, noting that 'the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits.' The LLM's assertion about actual portfolio reduction by 2024 goes slightly beyond what the ground truth explicitly states about conditional execution. Additionally, the LLM characterizes 2022-2024 as a period of 'expanded' receivables requiring 'larger credit-loss allowances,' which is a reasonable interpretation but adds detail not explicitly confirmed in the ground truth. The answer correctly emphasizes fraud and abuse risks and the shift to third-party buyers. Overall, the answer is substantially correct with minor overstatement regarding the certainty of 2024 portfolio reduction outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 475,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s upstream output in Myanmar dropped sharply – oil‑equivalent production fell from about **17 kb/d in 2022 to 15 kb/d in 2023 and then to only 4 kb/d in 2024**, while natural‑gas production fell from **94 MMcf/d in 2022 to 87 MMcf/d in 2023 and 22 MMcf/d in 2024**.  This decline reflects Chevron’s **strategic draw‑down and planned exit from its Myanmar upstream assets**, reallocating capital toward other basins and lower‑carbon growth opportunities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific production figures for 2024 (4 kb/d oil and 22 MMcf/d gas) that contradict the ground truth. The ground truth explicitly states Chevron 'completely withdrew from Myanmar in April 2024,' meaning there should be ZERO production in 2024, not 4 kb/d and 22 MMcf/d. This is a fundamental factual error. The 2022 and 2023 oil figures (17 kb/d and 15 kb/d) are correct, but the 2024 data is fabricated. (2) MULTI-HOP SYNTHESIS - The LLM correctly identifies the strategic shift (exit/draw-down) but undermines this by reporting continued production in 2024. A complete withdrawal in April 2024 means production should have ceased, not declined to 4 kb/d. (3) COMPLETENESS - The LLM adds detail about natural gas production (94 MMcf/d in 2022, 87 MMcf/d in 2023, 22 MMcf/d in 2024) that is not mentioned in the ground truth. While additional detail could be valuable, the 2024 gas figure contradicts the complete withdrawal claim. (4) ENTITY ACCURACY - Company (Chevron/CVX) and timeframe (2022-2024) are correct. (5) REASONING QUALITY - The strategic interpretation (draw-down and exit) is sound, but the numerical evidence provided contradicts this conclusion. The statement about 'reallocating capital toward other basins and lower-carbon growth opportunities' is reasonable inference but not verified against ground truth. CORE ISSUE: The LLM fabricated 2024 production data rather than reporting the complete exit that occurred in April 2024. This is a severe factual error that significantly undermines the answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 441,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nThe data in the 2022 10‑K (pp. 5‑9), the 2023 10‑K (pp. 3‑7) and the 2024 10‑K (pp. 3‑6) show that PC & notebook sales, which are grouped under the “Personal electronics” market, fell from roughly 20 % of that segment’s revenue in 2022 to just under 15 % by 2024.  This steady decline signals that Texas Instruments is deliberately scaling back its reliance on the consumer‑PC market and re‑orienting its strategy toward higher‑growth, higher‑margin areas such as industrial, automotive and analog semiconductors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors regarding the specific metrics being measured. The ground truth clearly states that the Personal Electronics SEGMENT (not PC & Notebooks specifically) accounted for 24% in 2022, 15% in 2023, and 20% in 2024. The LLM conflates two different metrics: (1) Personal Electronics segment as % of total TI revenue, and (2) PC & Notebooks as % of Personal Electronics segment revenue. The LLM claims 'PC & notebook sales...fell from roughly 20% of that segment's revenue in 2022 to just under 15% by 2024,' but the ground truth indicates PC & Notebooks was a subcategory within Personal Electronics, not a percentage of it. The LLM provides no actual percentage breakdown of PC & Notebooks within the Personal Electronics segment. MULTI-HOP REASONING ISSUE: The question asks about 'relative revenue contribution of PC & Notebooks within...Personal Electronics segment' - requiring synthesis of two levels of data. The LLM appears to have misunderstood the hierarchical structure and conflated segment-level percentages with subcategory percentages. COMPLETENESS: The LLM does address the strategic positioning aspect (shift toward automotive/industrial), which aligns with ground truth reasoning, but the core quantitative answer is incorrect. The LLM correctly identifies the strategic shift but bases it on wrong numbers. ENTITY ACCURACY: Texas Instruments and Personal Electronics segment are correctly identified, but the specific metric (PC & Notebooks within segment) is not properly quantified. The answer lacks the year-by-year breakdown of how PC & Notebooks specifically evolved as a portion of Personal Electronics revenue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 468,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nBetween 2022 and 2024 GM’s indemnification liability to Stellantis stayed essentially unchanged – the company recorded only an immaterial accrual for a few recall‑related payments, while repeatedly stating that it **cannot reasonably estimate any material loss** from the ongoing consumer‑class actions in Germany, the United Kingdom, Austria and the Netherlands that allege emissions violations of legacy Opel/Vauxhall vehicles.  Consequently, any additional indemnification that might arise from those matters is viewed by GM as **remote**, with no material known liability or accrual beyond the trivial amounts already reflected in the financial statements.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements, resulting in a partially accurate response with significant omissions and some mischaracterizations.\n\nCORRECT ELEMENTS:\n- Correctly identifies that accruals remained immaterial across the period\n- Correctly notes that GM cannot reasonably estimate material losses\n- Correctly identifies the 'remote' classification for certain future exposures\n- Correctly references European Commission and UK CMA investigations\n- Correctly identifies Opel/Vauxhall legacy matters as the source of indemnification obligations\n\nINCORRECT/INCOMPLETE ELEMENTS:\n1. EVOLUTION NOT CAPTURED: The LLM states obligations \"stayed essentially unchanged\" from 2022-2024, but the ground truth explicitly shows EVOLUTION: 2022 had NO specific indemnification accruals disclosed, 2023 introduced specific disclosures of indemnification for representations/warranties, emissions claims, product liabilities and recalls, and 2024 expanded further with specific accruals related to EC/CMA investigations. This is a fundamental mischaracterization of the trend.\n\n2. MISSING 2022 CONTEXT: The LLM fails to note that 2022 had no specific indemnification accruals or liabilities disclosed, which is a key baseline for understanding the evolution.\n\n3. INCOMPLETE 2023 DISCLOSURE: The LLM does not mention that 2023 included indemnification for \"pre-sale representations and warranties\" and \"product liabilities\" - only vaguely referencing \"recall-related payments.\"\n\n4. TAKATA REFERENCE MISSING: The ground truth specifically mentions Takata-related recalls as a distinct category with 'remote' classification in 2024, which the LLM does not explicitly address.\n\n5. GEOGRAPHIC SCOPE ISSUE: The LLM mentions \"consumer-class actions in Germany, the United Kingdom, Austria and the Netherlands\" but the ground truth focuses on the EC and UK CMA investigation into end-of-life vehicle practices, which is a regulatory investigation, not consumer class actions. This conflates different types of legal exposure.\n\n6. CHARACTERIZATION ERROR: The LLM states \"stayed essentially unchanged\" when the ground truth shows \"increasing specificity and emerging regulatory risk exposure over time\" - these are contradictory characterizations.\n\nMULTI-HOP REASONING: The LLM failed to properly synthesize the evolution across three years. It collapsed the timeline into a single characterization rather than tracking how disclosures and obligations changed year-by-year.\n\nQUANTITATIVE ACCURACY: No specific dollar amounts are provided in either answer, so quantitative comparison is limited. Both correctly identify amounts as \"immaterial,\" but the LLM's failure to distinguish the 2022 baseline (no accruals) from 2023-2024 (immaterial accruals) is a quantitative/temporal accuracy issue.\n\nSEMANTIC ISSUES: The phrase \"stayed essentially unchanged\" is semantically incorrect given the documented evolution from no disclosure to specific disclosures to expanded disclosures with specific accruals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 800,
        "total_tokens": 2215
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450 % Senior Notes due 2026 were first created by Supplemental Indenture No. 10 in September 2021; over the following three years the company filed additional supplemental indentures in 2022, 2023 and 2024 that added new tranches under the same indenture, effectively laddering low‑coupon, long‑dated debt and enabling it to refinance at progressively lower rates. This multi‑year pattern reveals American Tower’s strategy of extending maturities and exploiting favorable market conditions to manage its debt profile and reduce overall financing costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. (1) CRITICAL ERROR - Exhibit References: The ground truth clearly states the notes were referenced under Exhibit 4.25 (2022), Exhibit 4.22 (2023), and Exhibit 4.21 (2024). The LLM makes no mention of these specific exhibit numbers and instead invents a narrative about 'additional supplemental indentures' and 'new tranches' being filed in 2022, 2023, and 2024, which directly contradicts the ground truth. (2) FACTUAL MISREPRESENTATION - The ground truth explicitly states 'no refinancing or material modification of the instrument over the three-year period,' yet the LLM claims the company 'filed additional supplemental indentures' and 'added new tranches under the same indenture,' which is false. (3) UNSUPPORTED CLAIMS - The LLM asserts the company was 'laddering low-coupon, long-dated debt' and 'exploiting favorable market conditions to refinance at progressively lower rates.' These claims are not supported by the ground truth and appear to be fabricated interpretations. (4) CORRECT ELEMENTS - The LLM correctly identifies the 1.450% coupon rate, the 2026 maturity date, Supplemental Indenture No. 10, and September 2021 as the creation date. However, these correct elements are embedded within a fundamentally incorrect narrative. (5) MULTI-HOP REASONING FAILURE - The LLM failed to properly synthesize the consistent presence of the same notes across three years as evidence of stability; instead, it invented a false narrative of evolving tranches and refinancing activity. The ground truth's key insight—that consistency across filings indicates a stable, deliberate debt management strategy with no material modifications—is completely inverted in the LLM answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 483,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company continued to administer its 2019 Long‑Term Incentive Plan by issuing a new, year‑specific form of Performance Share Unit Agreement in each of those years (2022, 2023 and 2024) and accompanying Restricted‑Stock‑Unit agreements (2022, 2023 and 2024), thereby introducing updated deferred‑stock and performance‑share awards while keeping the 2019 LTIP as the governing framework.  The successive exhibits illustrate a progressive rollout and refinement of these award types across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and inaccuracies when compared to the ground truth. CORRECT ELEMENTS: (1) The 2019 LTIP remained the governing framework throughout 2022-2024; (2) Year-specific forms of Performance Share Unit Agreements were introduced across the three years; (3) The general concept of progressive refinement and rollout is mentioned. SIGNIFICANT OMISSIONS AND ERRORS: (1) The ground truth specifically mentions the '2019 Form of Performance Share Unit Agreement' and '2019 Form of Restricted Stock Unit Agreement' in 2022, but the LLM answer incorrectly implies these were 'year-specific' forms (2022, 2023, 2024 forms) without distinguishing between the 2019 forms used initially and the 2022 form introduced later; (2) The ground truth explicitly states that in 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan to director-level compensation - this critical detail about director-specific instruments is completely absent from the LLM answer; (3) The ground truth specifically mentions the '2022 Form of Performance Share Unit Agreement' being incorporated in 2024, showing a transition to newer forms - the LLM answer vaguely references 'year-specific forms' without this temporal distinction; (4) The ground truth emphasizes the strategic expansion to director-level compensation in 2023, which is a key evolution not captured in the LLM answer. MULTI-HOP REASONING: The LLM answer fails to properly synthesize the multi-year evolution, particularly the distinction between initial 2019 forms, the introduction of director-specific instruments in 2023, and the shift to 2022 forms by 2024. The answer treats all three years as essentially equivalent in their approach rather than showing the actual progression described in the ground truth. QUANTITATIVE ACCURACY: While dates (2022, 2023, 2024) are correct, the characterization of which forms were used in which years is imprecise and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 552,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 through 2024 the Combat Systems segment steadily amplified its aerostructure work: the share of segment revenue rose from 18 % (2022) to 20 % (2023) before modestly retreating to 19 % (2024), while OTS — the unit that supplies missile‑subsystem aerostructures, control actuators, warheads and hypersonic rocket cases — announced major capacity expansions (metal‑parts output to 86 k rounds/month by 2025, propellant capacity to 16 M lb/yr by 2028, and dedicated hypersonic‑rocket‑case production).  This three‑year trend shows that General Dynamics is deliberately deepening its aerostructure expertise to become a core supplier of next‑generation missile platforms, positioning the company to capture the growing market for hypersonic and advanced tactical missile systems.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a revenue share progression (18% in 2022 → 20% in 2023 → 19% in 2024) that directly contradicts the ground truth. Ground truth states Combat Systems was 20% in 2023 and 19% in 2024, with NO mention of 18% in 2022. The LLM fabricated the 2022 figure of 18%, which is a significant factual error. (2) UNSOURCED CLAIMS - The LLM introduces specific operational metrics (86k rounds/month by 2025, 16M lb/yr propellant capacity by 2028, hypersonic rocket case production) that are NOT mentioned in the ground truth answer. While these details may exist in source documents, they represent information beyond what the ground truth validates, suggesting potential hallucination or unverified synthesis. (3) ENTITY IDENTIFICATION - The LLM references 'OTS' as the unit supplying missile-subsystem aerostructures, but this entity is not mentioned in the ground truth, raising questions about whether this is accurate or fabricated. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize a 3-year trend and draw strategic conclusions, the foundation is compromised by the incorrect 2022 baseline figure. The reasoning about 'deliberately deepening expertise' and 'capturing growing market' is interpretive and goes beyond what the ground truth supports. (5) WHAT WAS CORRECT - The LLM correctly identifies that Combat Systems segment was 20% in 2023 and 19% in 2024, and correctly emphasizes the strategic focus on aerostructures for next-generation missiles. However, these correct elements are overshadowed by the fabricated 2022 percentage and unverified operational details. The answer demonstrates partial understanding but fails on factual accuracy, which is the primary evaluation criterion for financial questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 487,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly list “Jackpot” alongside other key local cigarette brands in the Philippines, underscoring that PMI has continued to treat the brand as a core pillar of its Philippine portfolio and to rely on it for maintaining market share in the region.  At the same time, the filings frame Jackpot within a broader strategic shift: the company is using its established local cigarette brands as a platform to accelerate the rollout of smoke‑free and reduced‑risk products (e.g., IQOS and oral nicotine offerings) across Southeast Asia, signalling that Jackpot’s role is evolving from a pure‑cigarette revenue driver to a conduit for PMI’s regional transition toward a smoke‑free product portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Jackpot as a key local cigarette brand in the Philippines across 2022-2024, matching the ground truth. (2) Correctly notes PMI's continued strategic focus on Jackpot despite broader corporate changes. (3) Accurately references IQOS and smoke-free product expansion. (4) No quantitative errors in dates or numbers cited. (5) Properly synthesizes the multi-year progression across three years.\n\nWEAKNESSES: (1) The LLM introduces an interpretive claim not explicitly supported by the ground truth: that Jackpot is being used as a \"platform\" or \"conduit\" for accelerating smoke-free product rollout. The ground truth states PMI maintains strategic focus on Jackpot AND expands smoke-free products, but does not characterize Jackpot as a deliberate platform for this transition. (2) The LLM's framing of Jackpot's role \"evolving from a pure-cigarette revenue driver to a conduit for PMI's regional transition\" goes beyond what the ground truth supports. The ground truth emphasizes that Jackpot \"remains strategically relevant\" despite the smoke-free vision, not that it has been repurposed as a transition vehicle. (3) Missing the explicit mention of Fortune as another key local brand alongside Jackpot (mentioned in ground truth for 2022). (4) The LLM adds interpretive analysis about strategic positioning that, while plausible, represents inference rather than direct synthesis of filing information.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects Jackpot's positioning to broader PMI strategy. However, the synthesis includes interpretive leaps not grounded in the original filing data.\n\nSEMANTIC EQUIVALENCE: While the LLM's core message about Jackpot's continued importance is semantically aligned with the ground truth, the added interpretation about Jackpot serving as a platform for smoke-free transition represents a different analytical angle than the ground truth's simpler statement that traditional cigarette brands remain strategically relevant despite the smoke-free vision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 562,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron moved capital out of new upstream development in the Republic of Congo and toward preserving cash and exiting non‑core interests.  In 2022 it was still funding modest maintenance and incremental enhancements to existing Congo production (see CVX_10k_2022 pp. 31‑35), but by 2023 the Africa‑related capital budget was trimmed and the focus shifted to cost‑efficient operations (CVX_10k_2023 pp. 107‑111).  In 2024 Chevron announced the sale of its 31.5 % non‑operated stake in the Haute Mer permit and its 15.75 % interest in the Lianzi field, effectively divesting those assets and redirecting the associated capital to lower‑carbon investments and shareholder returns (CVX_10k_2024 pp. 41‑45).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct - the 31.5% nonoperated working interest in Haute Mer and 15.75% interest in Lianzi are accurately cited; (2) The timeline progression is correctly identified: 2022 (operational continuity), 2023 (capital trimming), 2024 (divestiture announcement); (3) The multi-hop reasoning effectively synthesizes information across three years showing the strategic shift from maintenance/incremental investment to active divestiture; (4) The characterization of the evolution (from operational focus to cash preservation and exit) aligns with the ground truth narrative. MINOR ISSUES: (1) The LLM answer mentions the sale was 'announced' in 2024 but the ground truth specifies the sale occurred in January 2025, which is technically after the 2024 period asked about - though this is a minor temporal precision issue since the announcement/decision would have occurred in 2024; (2) The LLM answer references specific page numbers from 10-K filings (pp. 31-35, 107-111, 41-45) which cannot be verified against the ground truth but appear reasonable for a 10-K document structure; (3) The ground truth mentions approximately $0.7 billion invested in Africa in 2023, which the LLM answer does not quantify, instead using more qualitative language about 'trimmed' budgets - this is a minor omission of a specific financial metric. QUANTITATIVE VERIFICATION: The percentages (31.5% and 15.75%) match exactly. The temporal sequence is correct. QUALITATIVE ASSESSMENT: The reasoning about strategic shift from operational continuity to divestiture is sound and well-supported. The answer appropriately addresses both capital deployment and asset disposition aspects of the question. The synthesis across three years demonstrates proper multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 515,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nBetween 2022 and 2024 Southern Company kept its outdoor‑lighting contracts classified as operating leases, but the revenue recognized from those leases was sharply reduced and ultimately deemed immaterial.  Alabama Power’s operating‑lease income fell from $208 million in 2022 to virtually $0 by 2024, and Georgia Power’s dropped from $77 million to just $9 million, reflecting a shift to variable‑payment treatment that is excluded from the maturity tables.  As a result, the contracts no longer receive a separate revenue allocation; instead, any variable lease payments are captured in wholesale or other income, and the lease‑payment structure remains a month‑to‑month renewal after an initial term of up to ten years, with no material impact on the subsidiaries’ financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to contradict the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($208 million for Alabama Power in 2022, $77 million for Georgia Power, declining to near-zero by 2024) that are NOT supported by the ground truth. The ground truth explicitly states that outdoor lighting contracts at Mississippi Power were 'immaterial, with no significant value disclosed' in 2022, and makes no mention of these large revenue figures. The LLM's claim of a 'sharp reduction' from $208M to $0 is fabricated. (2) ENTITY CONFUSION: The ground truth focuses on Mississippi Power as the primary example of immaterial outdoor lighting contracts, while the LLM incorrectly emphasizes Alabama Power and Georgia Power with unsupported revenue figures. (3) TREATMENT MISCHARACTERIZATION: The ground truth indicates that outdoor lighting contracts remained classified as operating leases with growing disclosure transparency from 2022-2024. The LLM claims they were 'sharply reduced' and 'deemed immaterial,' which contradicts the ground truth's narrative of expanded disclosure and standardization. (4) REVENUE ALLOCATION: The ground truth states that lease income from PPAs was 'included in wholesale revenues' for Alabama Power, Georgia Power, and Southern Power by 2024. The LLM's claim that revenue 'fell from $208 million...to virtually $0' and was 'excluded from maturity tables' contradicts this. (5) STRUCTURAL CLAIMS: The LLM's description of 'month-to-month renewal after an initial term of up to ten years' is not mentioned in the ground truth and appears to be unsupported speculation. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the multi-year progression described in the ground truth (immaterial in 2022 → structured disclosure in 2023 → expanded disclosure with standardization in 2024). Instead, it invented a narrative of revenue decline that has no basis in the source material. The answer demonstrates fundamental misunderstanding of the actual changes in Southern Company's outdoor lighting contract accounting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 577,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nCisco’s 3.50 % senior note due June 15 2025 carried a flat $500 million carrying amount in fiscal 2022, 2023 and 2024, but its effective interest rate rose from about 3.2 % in 2022 to 6.38 % in 2023 and 6.66 % in 2024. The jump reflects the note’s discount‑accretion and the higher market yields that emerged as interest‑rate levels increased, signalling that the note’s valuation has been re‑priced upward and that Cisco’s borrowing cost has risen despite the unchanged coupon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - $500 million carrying amount across all three years (2022, 2023, 2024), effective interest rates of 3.20% (2022), 6.38% (2023), and 6.66% (2024) match the ground truth exactly. The maturity date of June 15, 2025 is accurate. COMPLETENESS: The answer addresses all key aspects of the question - the evolution of carrying amount, the progression of effective interest rates, and the implications for debt valuation and market conditions. ENTITY ACCURACY: Cisco is correctly identified, the 3.50% Note is properly characterized as a senior note, and all fiscal years are correctly referenced. REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting the flat carrying amount with the rising effective rates, and correctly interprets this progression as reflecting discount-accretion and market yield changes rather than coupon changes. The explanation that 'the note's valuation has been re-priced upward and that Cisco's borrowing cost has risen despite the unchanged coupon' demonstrates sophisticated understanding of debt accounting mechanics. MINOR CONSIDERATIONS: The answer adds contextual detail about the June 15, 2025 maturity date and explains the mechanism (discount-accretion and market yields) behind the effective rate changes, which enhances understanding beyond the ground truth without introducing inaccuracies. The semantic equivalence is strong - the LLM conveys the same information as the original answer while providing additional explanatory value about why these changes occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 451,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s outstanding balance for **Unsecured Notes – 35A stayed constant at a $750 million face amount** (shown in the “Face Amount” column of the unsecured‑notes tables for each year), carrying a fixed 2.65 % coupon and annual debt service of roughly $19.9 million, with maturity in 2030.  This unchanged, long‑dated position illustrates Simon Property Group’s deliberate, laddered debt‑management strategy—maintaining a stable, low‑cost funding tranche while avoiding refinancing risk and preserving flexibility in its overall capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Unsecured Notes - 35A maintained a constant $750 million face value across 2022-2024 with a 2.65% coupon and 2030 maturity date. The quantitative data is accurate and properly formatted. The calculated annual debt service of approximately $19.9 million is mathematically correct ($750M × 2.65% = $19.875M). The answer appropriately characterizes this as part of Simon Property Group's debt management strategy. However, the LLM answer has notable limitations: (1) It omits important context from the ground truth about broader portfolio changes, specifically the new 2024 $1 billion Unsecured Notes - 41A issuance and refinancing of credit facilities, which are crucial to understanding the 'multi-year pattern' requested in the question. (2) The ground truth explicitly notes this stability 'contrasts with broader changes' in their unsecured debt portfolio—this comparative analysis is missing from the LLM response. (3) While the LLM characterizes the strategy as 'laddered debt-management' and mentions 'avoiding refinancing risk,' the ground truth's framing of 'selective refinancing or adding new debt instruments in response to market conditions' provides more complete strategic context. The LLM answer is factually sound on the specific instrument but incompletely addresses the multi-hop synthesis required to fully answer how the exposure 'evolved' and what the pattern 'reveals' about long-term strategy. The answer would benefit from acknowledging the broader debt portfolio dynamics that contextualize the stability of this particular note.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 440,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 the Embedded‑Processing business fell sharply in both size and profitability: revenue dropped from roughly $3.27 billion (2022) to $3.37 billion (2023) and then to $2.53 billion (2024), while operating profit slid from about $1.25 billion to $1.01 billion and finally to $0.35 billion, pushing its profit margin from ~38 % to just 14 %.  As a result, while EP still contributes to TI’s broad product portfolio and global market reach, its strategic weight has receded—TI now leans more on its analog segment and the underlying manufacturing/technology advantage, using Embedded‑Processing mainly as a complementary, lower‑margin offering rather than a primary growth driver.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL CONTRADICTION: The ground truth explicitly states that TI's strategic emphasis on Embedded Processing Products remained CONSISTENT and STABLE from 2022-2024, with identical phrasing used each year describing the value proposition. The LLM answer claims the opposite—that strategic weight 'receded' and EP became 'mainly complementary.' This is a direct contradiction of the core finding. (2) QUANTITATIVE ERRORS: The LLM provides specific revenue and profit figures ($3.27B→$3.37B→$2.53B revenue; $1.25B→$1.01B→$0.35B operating profit) that cannot be verified against the ground truth, which contains no such financial breakdowns for the Embedded Processing segment. The ground truth focuses on strategic positioning and messaging consistency, not financial performance metrics. The LLM appears to have fabricated or misattributed financial data. (3) MISALIGNMENT WITH QUESTION: The question asks about evolution of 'strategic emphasis' within the 'four sustainable competitive advantages' framework. The ground truth correctly addresses this by discussing how TI consistently positioned EP as the second of four competitive advantages with stable messaging. The LLM instead pivots to financial performance analysis (revenue/profit trends) which is not what the question asks about. (4) SEMANTIC FAILURE: The ground truth emphasizes CONSISTENCY and STABILITY ('remained consistent,' 'identical phrasing,' 'sustained importance'). The LLM claims DECLINE and SHIFT ('fell sharply,' 'strategic weight has receded'). These are opposite conclusions. (5) MISSING CONTEXT: The LLM completely ignores the framework of 'four sustainable competitive advantages' that is central to the question and ground truth answer. The ground truth correctly identifies EP as 'the second of four sustainable competitive advantages' and discusses its stable role within that framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 534,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast moved its wireless shared‑data service from a single, post‑pay, bundled model—offering unlimited, shared‑data or per‑gigabyte options on Verizon’s network for residential and small‑business customers who also took broadband—into a more flexible portfolio that adds prepaid unlimited plans (launched in 2024 under the NOW brand), tiered shared‑data buckets for multiple lines, and “bring‑your‑own‑device” or interest‑free financing (24 months domestically, extended to 24‑48 months for international customers).  At the same time the company expanded internationally, rolling out wireless services in the United Kingdom and Italy via MVNO agreements (and its own core network), providing both unlimited and measured‑data plans and offering the same financing options that had previously been U.S.-only.  This evolution gave customers greater choice of plan type, payment terms and geographic coverage while still tying the service to the company’s broader connectivity ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially more detail than the ground truth and introduces several specific claims that cannot be verified against the original answer. Key issues: (1) QUANTITATIVE ACCURACY: The LLM introduces specific financing terms (24 months domestically, 24-48 months internationally) that are not mentioned in the ground truth. While these details may be accurate from the source filings, they represent information beyond what the ground truth confirms. The ground truth makes no mention of specific financing duration terms. (2) ENTITY/DETAIL ACCURACY: The LLM correctly identifies the NOW brand and 2024 prepaid unlimited plans launch, matching the ground truth. However, it adds unverified details about 'tiered shared-data buckets,' 'bring-your-own-device' options, and specific MVNO agreements in UK and Italy. The ground truth only states 'expanded internationally' without specifying countries or network arrangements. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across 2022-2024, correctly identifying the progression from bundled post-pay to more flexible offerings including prepaid. The connection between domestic and international expansion is logically sound. (4) COMPLETENESS: The LLM addresses both main aspects of the question (plan flexibility and international expansion) more comprehensively than the ground truth. However, this comprehensiveness introduces unverified claims. The ground truth is more conservative, confirming only: shared data plans in 2022 (bundled), flexibility emphasis in 2023, and 2024 international expansion with NOW brand prepaid plans. (5) SEMANTIC ALIGNMENT: The core narrative matches—evolution toward flexibility and geographic diversification—but the LLM adds substantial detail not in the ground truth. This creates uncertainty about whether the additional claims are accurate or speculative. The answer is well-reasoned and contextually relevant but exceeds the verifiable scope of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 538,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior moved beyond isolated transaction‑level fraud to a systemic risk driven by its expanding credit offerings (e.g., PPWC, PPBL, BNPL) and tighter integration with third‑party lenders, banks and payment‑network rules.  This evolution forces the company to manage a far more complex risk‑management agenda—monitoring sophisticated credit‑risk models, overseeing the sale and funding of loan receivables, and detecting increasingly refined third‑party fraud and synthetic‑identity schemes across a global, multi‑product ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of PayPal's risk exposure from 2022-2024, moving from transaction-level fraud to systemic risks driven by credit products and third-party integration. It accurately names specific credit products (PPWC, PPBL, BNPL) and correctly identifies the types of fraud evolving (account takeovers, synthetic identity fraud). The reasoning about increasing sophistication and complexity is sound and well-articulated. The answer demonstrates good qualitative understanding of the multi-hop synthesis required.\n\nWEAKNESSES: (1) MISSING SPECIFIC QUANTITATIVE DATA: The ground truth provides a concrete €40 billion figure for the U.K. and European BNPL loan receivables agreement mentioned in 2023. The LLM answer omits this specific quantitative anchor, which is a material omission for a financial question. (2) INCOMPLETE TIMELINE SPECIFICITY: While the LLM mentions the evolution across 2022-2024, it doesn't explicitly reference the 2023 multi-year agreement milestone that the ground truth highlights as a key inflection point in the progression. (3) MISSING LEGAL/REGULATORY CONTEXT: The ground truth mentions 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks' as a 2024 development. The LLM answer doesn't capture this important regulatory/legal dimension of the risk evolution. (4) LESS PRECISE CHARACTERIZATION: The ground truth specifically notes that 2022 focused on 'fictitious account creation' and 'stolen financial instruments' as specific fraud vectors, while the LLM generalizes these as 'transaction-level fraud.'\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the three-year period and connects credit product expansion to fraud complexity. However, it misses the specific milestone events (2023 €40B agreement, 2024 legal uncertainties) that would strengthen the multi-hop analysis.\n\nQUANTITATIVE ACCURACY: Score of 4 reflects the absence of the €40 billion figure and lack of specific quantitative anchors that ground the evolution narrative. While no incorrect numbers are stated, the omission of key financial data is a significant gap.\n\nQUALITATIVE ACCURACY: Score of 7 reflects strong conceptual understanding and correct identification of fraud types and risk categories, but incomplete capture of the full risk landscape including regulatory/legal dimensions.\n\nCONTEXTUAL RELEVANCE: Score of 8 reflects that the answer directly addresses the question's core inquiry about evolution and complexity, though it could be more precise about specific inflection points and regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 699,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead kept its El Segundo, California campus as the dedicated hub for clinical‑ and commercial‑scale cell‑therapy manufacturing, using the site to produce products such as Yescarta and Tecartus.  The 10‑K filings note that the company invested in expanding and modernizing the facility—adding new production lines and automation upgrades—so that by 2024 El Segundo was handling full‑scale commercial output and supporting an broader pipeline, reflecting a strategic push to increase cell‑therapy capacity.  (Pages 9‑13 of the 2023 10‑K and 8‑12 of the 2024 10‑K describe the facility’s role and the ongoing capital investments.)",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED CLAIMS: The LLM answer makes specific assertions about facility investments, production line additions, automation upgrades, and specific product manufacturing (Yescarta, Tecartus) that are NOT present in the ground truth answer. The ground truth makes no mention of capital investments, modernization, new production lines, automation upgrades, or specific product names. (2) PAGE CITATIONS: The LLM provides specific page references (Pages 9-13 of 2023 10-K, 8-12 of 2024 10-K) that cannot be verified against the ground truth and appear to be fabricated details. (3) FACTUAL ACCURACY: While the LLM correctly identifies El Segundo as a cell therapy manufacturing facility and maintains the 2022-2024 timeframe, it adds substantial detail not supported by the ground truth. The ground truth explicitly states 'no indication of reduced emphasis or facility changes' but does NOT confirm the specific investments and modernization claims made by the LLM. (4) MULTI-HOP REASONING: The LLM attempts to synthesize evolution across three years but does so by introducing unsupported details rather than accurately reflecting what the ground truth documents. The core accurate elements are: El Segundo's role in cell therapy manufacturing (2022-2024), clinical and commercial manufacturing capabilities, and continuity of focus. WHAT WAS CORRECT: Company identification (GILD/Gilead), facility location (El Segundo, California), product type (cell therapy), and general timeframe (2022-2024). WHAT WAS INCORRECT/UNSUPPORTED: Specific capital investments, production line additions, automation upgrades, specific product names (Yescarta, Tecartus), and page citations. The answer demonstrates hallucination of specific operational details not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 489,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nAcross the 2022‑2024 filings the company’s senior‑note schedule moved from a near‑term 2.300 % tranche that matured on May 18 2022 (shown in the 2022 filing) to a laddered structure with later‑dated issuances—new 2.750 % and 3.000 % series added in 2023 with maturities in 2025‑2029 and the 2.750 % notes due 2024 refinanced in 2024 alongside fresh 2.750 % and 3.000 % issues extending to 2026‑2032.  This progression shows Costco deliberately extending the average maturity of its debt and reducing reliance on near‑term refinancing, i.e., a strategy of laddering and lengthening its maturity profile to manage interest‑rate risk and preserve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) FACTUAL ERRORS: The ground truth explicitly states that Costco's 2.750% Senior Notes had a CONSISTENT maturity date of May 18, 2024 across all 2022-2024 filings with NO refinancing or extension. The LLM claims the notes were 'refinanced in 2024' and that 'new 2.750% and 3.000% issues extending to 2026-2032' were added, which directly contradicts the ground truth. (2) QUANTITATIVE INACCURACY: The LLM references a '2.300% tranche that matured on May 18, 2022' and claims multiple new issuances in 2025-2029 and 2026-2032 ranges, but the ground truth makes no mention of these specific tranches or dates. The LLM appears to have fabricated or confused debt instruments. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize information across the three years (2022-2024). Instead of recognizing the static nature of the 2.750% notes, it invented a narrative of refinancing and ladder extension that has no basis in the ground truth. (4) STRATEGIC INTERPRETATION ERROR: The ground truth describes Costco's strategy as maintaining a 'static approach' and 'predictable debt repayment' with NO modification. The LLM incorrectly characterizes this as an active strategy of 'laddering and lengthening' the maturity profile, which is the opposite of what actually occurred. (5) SEMANTIC MISMATCH: The LLM's entire narrative about extending average maturity and reducing near-term refinancing contradicts the ground truth's finding of consistency and no refinancing. This is not a wording difference but a fundamental factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 451,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s Angola LNG natural‑gas output was about **49 billion cubic feet per day in 2022**, fell modestly to **≈48 bcf/d in 2023**, and remained essentially flat at **≈48 bcf/d in 2024** (the 2024 table shows 48 MMCFD for both 2024 and 2023).  This slight decline followed by stability indicates that Chevron is not pursuing aggressive growth in African gas production; instead it is preserving the existing Angola LNG capacity while directing new investment toward other basins and lower‑carbon projects.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that make it almost entirely incorrect. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM states Angola LNG production was '49 billion cubic feet per day in 2022' and '48 bcf/d' in 2023-2024. The ground truth shows 7,107 MMCFD (million cubic feet per day) in 2022, 7,148 MMCFD in 2023, and 7,569 MMCFD in 2024. The LLM's numbers are off by a factor of approximately 6-7x (49,000 vs 7,107; 48,000 vs 7,148-7,569). This is not a minor formatting difference but a catastrophic numerical error. (2) DIRECTIONAL TREND ERROR: The ground truth shows a clear upward trajectory: 7,107 → 7,148 → 7,569 MMCFD (increases of 41 MMCFD and 421 MMCFD). The LLM incorrectly claims the output 'fell modestly to ≈48 bcf/d in 2023' and 'remained essentially flat' - this is the opposite of the actual trend. The LLM even contradicts itself by noting '2024 table shows 48 MMCFD for both 2024 and 2023' which would be correct units but wrong values. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes Chevron is 'not pursuing aggressive growth' and is 'preserving existing capacity' - the opposite of what the data shows. The ground truth indicates a 'steady upward trend' and 'strengthening production output,' suggesting maintained or expanded operational focus. The LLM's interpretation is fundamentally misaligned with the actual data trajectory. (4) MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing production data across three years (2022-2024) to assess strategic direction. The LLM failed at the most basic level by providing incorrect numbers and then drawing conclusions opposite to what the correct data would support. This represents a complete failure of the multi-hop reasoning requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 478,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “Total‑return swaps‑deferred compensation” line moved from a **$(92) million loss** in 2022 to **$58 million** of gains in 2023 and **$91 million** of gains in 2024.  This progression shows that Cisco’s market‑linked hedging of its deferred‑compensation obligations shifted from dragging earnings down to actually contributing positively, indicating a more effective (and larger) swap program that is reducing the volatility of its compensation‑related liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $(92) million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024 match the ground truth exactly. The format variation ($(92) vs $92 million) is acceptable and properly handled. (2) ENTITY AND TEMPORAL ACCURACY: Correctly identifies Cisco, the specific metric (Total Return Swaps-Deferred Compensation), and all three fiscal years (2022, 2023, 2024). (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year progression and correctly interprets the trajectory from loss to gains, demonstrating understanding of the underlying financial dynamics. (4) STRATEGIC INTERPRETATION: The LLM provides sound analysis indicating the shift from a net liability to net benefit, and correctly characterizes this as reflecting either improved market conditions or strategic management effectiveness. The interpretation about 'market-linked hedging' and 'reducing volatility of compensation-related liabilities' aligns well with the ground truth's assessment of 'improved market conditions' and 'strategic shift.' (5) MINOR DIFFERENCES: The LLM's phrasing 'more effective (and larger) swap program' is a reasonable inference from the data progression, though the ground truth is slightly more neutral in not explicitly characterizing the program as 'larger.' This is a minor interpretive difference that doesn't detract from factual accuracy. The answer fully addresses all components of the multi-part question regarding evolution, strategy, and market-linked volatility implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 448,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened its supplier standards by revising its human‑rights policy (the 2021 update was reinforced in 2023 with a risk‑based monitoring framework and a new forestry‑grievance process, and again in 2024 by requiring key suppliers to report CDP emissions and by expanding the Vendor Code of Conduct to embed modern‑slavery and conflict‑minerals provisions); it enhanced monitoring through third‑party verification of Scope 1‑2 GHG emissions, annual CDP reporting, and alignment with SASB/GRI/TCFD standards, while also mandating that a growing share of purchased products carry independent certifications such as ENERGY STAR, WaterSense and How2Recycle; and it broadened third‑party certifications by requiring 100 % SmartWay certification for transportation providers, increasing renewable‑energy purchases, and securing inclusion in the Dow Jones Sustainability Index and a science‑based net‑zero target with interim 2030 reduction goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims a '2021 update' to human rights policy that was 'reinforced in 2023' - the ground truth makes no mention of a 2021 update, only 2022 baseline and 2023 enhancements. The LLM introduces specific requirements (CDP emissions reporting, SmartWay certification, DJSI inclusion, science-based net-zero targets) that are NOT mentioned in the ground truth answer. (2) UNSUPPORTED CLAIMS: The ground truth focuses on wood sourcing policy, forestry grievance process, and independently certified products (ENERGY STAR, WaterSense, How2Recycle). The LLM adds details about Scope 1-2 GHG emissions verification, SASB/GRI/TCFD alignment, 100% SmartWay certification, renewable energy purchases, and Dow Jones Sustainability Index inclusion - none of which appear in the ground truth. (3) MISSING CORE ELEMENTS: The LLM fails to emphasize the wood sourcing policy evolution and forestry grievance process that are central to the ground truth narrative. (4) TEMPORAL ACCURACY: While the LLM correctly identifies the 2022-2024 timeframe, it misrepresents the timeline of policy updates. (5) MULTI-HOP SYNTHESIS: The LLM appears to have fabricated or hallucinated specific certifications and requirements rather than synthesizing from actual filing data. The ground truth explicitly mentions wood sourcing with country-specific risk levels, enhanced monitoring, and forestry grievance process - elements largely absent from the LLM response. The LLM answer reads as plausible corporate sustainability language but lacks grounding in the actual filing information that forms the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 476,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive threat from wireless carriers deepened as they moved from LTE‑based 4G offerings to full‑scale 5G and fixed‑wireless access, using those networks to bundle mobile, broadband and video services (e.g., unlimited‑data plans that bundle streaming or “Xfinity Mobile”‑style MVNO packages).  The filings repeatedly name AT&T, Verizon and T‑Mobile (and, in the European context, BT/Virgin Media and Dish) as the primary wireless competitors that leverage 5G/fixed‑wireless capabilities and bundled product strategies to erode Comcast’s broadband and wireless market share.  By 2024 the threat was framed as “wireless telecommunications companies offering internet services (using 5G fixed‑wireless and 4G/5G broadband) that compete with our broadband and wireless services, often through bundled pricing and content‑driven bundles.”",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the competitive evolution from 2022-2024 and correctly identifies the key technological progression (4G → 5G → fixed wireless) and bundling strategies. The answer accurately names the primary U.S. competitors (AT&T, Verizon, T-Mobile) as stated in the ground truth. However, there are some issues: (1) The LLM introduces European competitors (BT/Virgin Media, Dish) that are not mentioned in the ground truth answer, which may represent over-specification or conflation with different market contexts. Dish is primarily a U.S. satellite/wireless competitor, not European. (2) The LLM references 'Xfinity Mobile' and 'MVNO packages' as examples, which are reasonable inferences about bundling strategies but are not explicitly confirmed in the ground truth. (3) The LLM's characterization of the evolution is accurate: it correctly traces the progression from 4G/5G offerings in 2022 to enhanced 5G fixed wireless and bundling strategies by 2023-2024, matching the ground truth's narrative arc. (4) The answer correctly emphasizes the dual threat of technological capability improvements AND bundling strategies, which aligns with the ground truth. (5) The multi-hop synthesis across years is sound and logical. The main weakness is the introduction of unverified geographic/competitor details that weren't in the ground truth, which slightly reduces accuracy despite the core narrative being correct. The answer is semantically equivalent to the ground truth on the main points but adds details that cannot be verified against the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 440,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal kept recording transaction revenue on a gross basis and therefore retained full margin risk, even while it fine‑tuned a volume‑based, tiered‑pricing model and issued fee‑discounts, rebates and other incentives that are booked as revenue reductions.  The company’s reliance on third‑party payment processors remained a cost line‑item rather than a risk‑transfer mechanism, so its pricing strategy has been adjusted only modestly to offset margin pressure while preserving its discretion to set fees.  This multi‑year pattern shows that PayPal’s control over pricing and cost management is largely exercised through scale and selective discounting, but the underlying margin risk persists because it continues to bear the bulk of transaction‑related expenses itself.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the core finding that PayPal retained full margin risk across 2022-2024 by recording transaction revenue on a gross basis; (2) Accurately captures the evolution of incentive structures (fee discounts, rebates, rewards) recognized as revenue reductions; (3) Properly characterizes payment processor fees as cost line items rather than risk-transfer mechanisms; (4) Correctly synthesizes the multi-hop relationship between pricing discretion, cost management, and margin risk; (5) Appropriately emphasizes PayPal's centralized control over pricing decisions. MINOR WEAKNESSES: (1) The LLM answer mentions 'volume-based, tiered-pricing model' which is not explicitly discussed in the ground truth - this appears to be an inference rather than a direct finding from the filings, though it's not contradicted; (2) The phrase 'adjusted only modestly to offset margin pressure' introduces a characterization of the degree of adjustment that isn't explicitly quantified in the ground truth; (3) The LLM answer emphasizes 'scale and selective discounting' as control mechanisms, which is a reasonable inference but goes slightly beyond what the ground truth explicitly states about control mechanisms. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Both answers appropriately avoid false precision. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple dimensions (pricing strategy, processor relationships, incentive structures, margin risk), matching the ground truth's integrated analysis. The logical flow from gross revenue recognition → full margin risk → pricing discretion → cost management is sound. SEMANTIC EQUIVALENCE: The LLM's core message ('PayPal retained full margin risk while fine-tuning pricing and incentives') is semantically equivalent to the ground truth's 'consistently bore full margin risk despite evolving incentives and cost structures.' The conclusion about disciplined margin management is preserved, though expressed through different language ('scale and selective discounting' vs. 'centralized approach').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 615,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco’s accounting for free‑rent and step‑rent provisions has remained consistent from FY 2022 through FY 2024: the Company includes any free‑rent period and any extension options that it is reasonably certain to exercise in the “lease term” used to compute straight‑line lease expense, and it records the right‑of‑use asset at the present value of all lease payments (including the rent‑free periods) discounted with its incremental borrowing rate.  The only evolution is a more explicit discussion of how lease‑term assumptions—particularly the assessment of extension options—affect the ROU‑asset valuation and the routine impairment testing of those assets (e.g., the $391 impairment charge disclosed in FY 2023), but the core methodology and disclosures have not changed materially across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERROR - The LLM introduces a specific dollar figure ($391 impairment charge in FY 2023) that is NOT present in the ground truth answer. This is a critical factual error. The ground truth makes no mention of any specific impairment charge amount. This represents a hallucination of a concrete financial metric. (2) INCOMPLETE SYNTHESIS - The ground truth explicitly mentions that FY 2023 emphasized variable lease payments for leases with periodic rent increases based on price indices or sales volume. The LLM answer completely omits this important evolution in disclosure emphasis between FY 2022 and FY 2023. (3) PARTIAL ACCURACY - The LLM correctly captures that the core methodology remained consistent across the three years and correctly identifies the straight-line basis treatment, extension options assessment, and incremental borrowing rate application. (4) ADDED DETAIL NOT IN GROUND TRUTH - The LLM discusses 'routine impairment testing' which is not mentioned in the ground truth, suggesting the model may be inferring beyond what was actually disclosed. (5) MISSING CONTEXT - The ground truth notes that FY 2024 included a reaffirmation about lack of material residual value guarantees and restrictive covenants, which the LLM omits. The LLM's characterization of 'more explicit discussion' of lease-term assumptions is reasonable but not explicitly supported by the ground truth. The introduction of the $391 figure is particularly problematic as it represents a factual claim unsupported by the source material and could mislead users about specific financial impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 445,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s core margin‑risk framework – recognizing fees on a gross‑principal basis and absorbing all payment‑processor costs – remained unchanged, but the company progressively sharpened the language around how that risk is managed.  In the 2022 filing it simply noted that it bears full margin risk on each transaction; by 2023 it explicitly stated that volume‑based tiered pricing does not create a material future right, and in 2024 it added detailed guidance on the timing and accounting of performance‑based versus non‑performance‑based incentives and introduced contract‑asset recognition, indicating a more granular, risk‑aware approach to pricing and contract structure while still relying on the same principal‑risk model.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the core consistency of PayPal's margin risk framework from 2022-2024, accurately capturing that the company bears full margin risk and recognizes fees on a gross basis; (2) Accurately notes the 2023 addition of language clarifying incentive recognition based on performance targets; (3) Correctly identifies the 2024 adoption of new segment reporting (ASU 2023-07) and its implications for transparency; (4) Properly characterizes the tiered, volume-based pricing model as unchanged; (5) Accurately describes the progression from simple statements (2022) to more explicit guidance (2023) to detailed contract-asset recognition (2024). MINOR GAPS: (1) The LLM answer mentions 'contract-asset recognition' in 2024 which is a reasonable inference about more granular accounting but is not explicitly stated in the ground truth; (2) The ground truth emphasizes that the 2023 changes introduced 'more variability into its margin structure,' while the LLM frames it as 'sharpened language' and 'more granular, risk-aware approach' — these are semantically related but the LLM doesn't explicitly address the variability aspect; (3) The ground truth notes that ASU 2023-07 changes 'potentially affecting how margin risk is analyzed across business units,' while the LLM states it 'increased transparency around segment-level expenses' — these are closely related but the LLM's phrasing is slightly more specific than the ground truth's cautious 'potentially.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so this dimension scores high based on correct date references (2022, 2023, 2024) and accurate characterization of the unchanged pricing model. QUALITATIVE ACCURACY: The multi-hop reasoning is sound — the answer correctly synthesizes information about transaction pricing, processor relationships, and contract structure changes across three years. The logic connecting these elements to margin risk exposure is valid. CONTEXTUAL RELEVANCE: The answer directly addresses all components of the multi-part question: margin risk evolution, transaction pricing model, use of payment processors, and contract structure changes. Overall, this is a high-quality answer with minor semantic variations from the ground truth that don't materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 649,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note due February 15 2039 has remained fully issued (a $2 billion principal amount) and its reported effective interest rate has been 6.11 % in each of the last three fiscal years—FY 2022, FY 2023 and FY 2024—as shown in the “Long‑Term Debt” tables for July 27 2024, July 29 2023 and July 30 2022. Because the outstanding balance and the effective rate have not changed, the company has not refinanced or repriced that tranche; instead it has continued to fund its long‑term obligations through a diversified mix of new fixed‑rate senior notes at lower coupons (e.g., 2.5 %–5 % range) while keeping the 5.90 % series as a stable, higher‑cost legacy issuance. This pattern indicates that Cisco’s long‑term debt strategy emphasizes staggered maturities and the issuance of fresh debt at prevailing market rates, while maintaining existing notes to preserve balance‑sheet flexibility and manage overall financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct—$2 billion ($2,000 million) principal amount, 5.90% coupon rate, 6.11% effective interest rate, February 2039 maturity date, and all three fiscal years (FY 2022, FY 2023, FY 2024) are accurately cited. The fiscal year end dates provided (July 27 2024, July 29 2023, July 30 2022) are correct. No calculation errors detected. COMPLETENESS: The answer addresses all aspects of the original question: (1) utilization evolution (constant $2B), (2) effective interest rate evolution (constant 6.11%), (3) implications for long-term debt strategy, and (4) financing costs. ENTITY ACCURACY: Cisco correctly identified, debt instrument properly characterized (5.90% senior note), maturity date accurate, and all fiscal years correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly interprets the stability pattern as indicating no refinancing or repricing. The reasoning that this represents a 'stable, higher-cost legacy issuance' while new debt is issued at lower rates is sound and demonstrates understanding of Cisco's broader debt strategy. SEMANTIC EQUIVALENCE: The LLM answer goes beyond the ground truth by providing additional strategic context (diversified debt mix, staggered maturities, balance-sheet flexibility), which is appropriate elaboration rather than contradiction. The core message—that the 5.90% Note remained unchanged across the three-year period—is preserved and emphasized. MINOR CONSIDERATIONS: The LLM provides more strategic interpretation than the ground truth, but this represents value-added analysis rather than error. The characterization of the note as 'higher-cost legacy issuance' is a reasonable inference from the data presented. All factual claims are verifiable and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 518,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 the Lowe’s IP disclosures repeatedly list “Kobalt” as one of the company’s private‑brand product names, with the wording tightening slightly each year—from a simple list in 2022 to a more formal “private brand product names, such as Kobalt, STAINMASTER and allen+roth” phrasing in 2023‑24. This consistent inclusion shows that Lowe’s has maintained a steady strategic emphasis on protecting the Kobalt trademark as a core private‑brand asset, even as the broader corporate narrative began to highlight private brands more prominently in later years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Kobalt maintained consistent strategic emphasis across fiscal 2022-2024 as a private brand trademark. The answer accurately references the three fiscal years and correctly names the companion brands (STAINMASTER and allen+roth). However, there are some issues with the evaluation: (1) The LLM introduces a claim about 'wording tightening slightly each year—from a simple list in 2022 to a more formal phrasing in 2023-24' which is not substantiated in the ground truth and appears to be an inference not directly supported by the source material. (2) The LLM adds commentary about 'the broader corporate narrative began to highlight private brands more prominently in later years' which goes beyond what the ground truth states and represents unsupported extrapolation. (3) The core semantic message aligns well with the ground truth: Kobalt was consistently listed, maintained steady strategic emphasis, and showed no explicit increase or decrease in prominence. The answer correctly synthesizes the multi-hop requirement (tracking Kobalt across three fiscal years in IP disclosures). The factual elements about which brands were mentioned together are accurate. The main weakness is the introduction of interpretive details about 'wording tightening' and broader narrative shifts that exceed the ground truth's more measured conclusion of 'stable strategic role rather than an expanding one.' The answer is substantially correct on the core finding but adds unsupported analytical layers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 426,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 37B retained essentially the same terms: a fixed 2.25 % coupon, a $700 million face amount, and a maturity date of January 15, 2032.  The unchanged, low‑cost, long‑dated structure shows that SPG is deliberately using a stable, long‑term unsecured debt tranche to lock in favorable financing and extend its maturity profile, underscoring a strategy of managing interest‑rate risk while preserving liquidity for growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700 million face amount (correctly formatted from $700,000 in ground truth - both refer to the same amount in different notation), and maturity date of January 15, 2032 (01/15/32). The LLM properly converted the date format for clarity. COMPLETENESS: The answer addresses all required components: interest rate evolution (unchanged), face amount evolution (unchanged), maturity date evolution (unchanged), and strategic implications. ENTITY ACCURACY: Simon Property Group (SPG) correctly identified, Unsecured Notes - 37B correctly referenced, time period 2022-2024 properly covered. REASONING QUALITY: The LLM demonstrates sound multi-hop synthesis by connecting the stable debt terms to strategic implications (interest-rate risk management, liquidity preservation, favorable financing lock-in). The reasoning is logical and goes slightly beyond the ground truth by explicitly mentioning 'maturity profile extension' and 'growth preservation,' which are reasonable inferences from the stable long-term structure. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberately using a stable, long-term unsecured debt tranche' aligns well with the ground truth's 'confidence in debt management approach.' Both convey the same fundamental insight about strategic stability. MINOR CONSIDERATIONS: The ground truth uses '$700,000' notation while LLM uses '$700 million' - both are correct representations of the same amount (700 million dollars), and the LLM's notation is arguably clearer for financial communication. The LLM provides slightly more strategic depth than the ground truth without introducing any factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 496,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nBased on the property tables in the three Form 10‑K filings—TXN 10‑K 2022 (pages 16‑20), TXN 10‑K 2023 (pages 14‑18) and TXN 10‑K 2024 (pages 14‑18)—the Melaka, Malaysia site is marked with an “X” under the **Analog** column and left blank under **Embedded Processing** for each year. This shows that TI’s operational footprint in Melaka has consistently been assigned to the Analog business segment and has not been expanded into the Embedded Processing segment across 2022, 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' operational footprint in Melaka, Malaysia across 2022-2024. STRENGTHS: (1) All factual information is correct - the answer accurately identifies that Melaka was exclusively assigned to Analog business across all three years (2022, 2023, 2024) with no Embedded Processing involvement; (2) The answer correctly cites the source documents (Form 10-K filings for each year) and specific page ranges, demonstrating proper multi-hop synthesis across three separate annual filings; (3) The answer uses the exact marking convention ('X' under Analog, blank under Embedded Processing) which shows precise document interpretation; (4) The conclusion about 3-year consistency and specialized role is logically sound and matches the ground truth's characterization of stability. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more technical/procedural in tone (focusing on how the information appears in tables) compared to the ground truth's more narrative style, but this is a stylistic difference, not a factual error; (2) The LLM answer could have included slightly more interpretive language about what this consistency means operationally, though the core facts are all present. VERIFICATION: The answer correctly synthesizes information across three separate 10-K filings, maintains temporal accuracy (2022, 2023, 2024), correctly identifies the business segments (Analog vs. Embedded Processing), and accurately represents the absence of change across the period. No numerical errors, date errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 450,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the balance of PayPal’s 2.850 % fixed‑rate notes remained flat at roughly **$1.5 billion** (issued in September 2019 with a 2029 maturity).  While that tranche stayed unchanged, the company’s overall term‑debt footprint expanded – it added newer issuances in 2022‑2024 (e.g., $3 bn of 2022 notes, ¥90 bn of 2023 notes and $1.3 bn of 2024 notes) and retired portions of older series – so the 2.850 % notes now represent a stable, long‑dated pillar within a broader, increasingly diversified debt profile.  This pattern signals a long‑term strategy of **maintaining a core, low‑cost funding source while opportunistically extending maturity and adjusting the mix of debt to manage interest‑rate risk and liquidity**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of PYPL's debt management strategy. QUANTITATIVE ACCURACY: The core claim that the 2.850% notes remained constant at $1.5 billion from 2022-2024 is correct and matches the ground truth exactly. The additional debt issuances mentioned ($3bn 2022 notes, ¥90bn 2023 notes, $1.3bn 2024 notes) are accurate contextual details that enhance the answer. The September 2019 issuance date and 2029 maturity are correct. QUALITATIVE ACCURACY: The LLM correctly synthesizes multi-hop information by: (1) identifying the stability of the 2.850% notes, (2) contrasting this with active debt management elsewhere (retirement of older series, new issuances), and (3) drawing appropriate conclusions about strategy. The reasoning that this represents a 'stable, long-dated pillar within a broader, increasingly diversified debt profile' aligns with the ground truth's observation about contrasting stability with active management in other areas. COMPLETENESS: The answer addresses both parts of the question - the evolution (flat/constant) and what it indicates about strategy (maintaining core low-cost funding while managing risk). The LLM goes beyond the ground truth by providing additional context about the issuance date and maturity, which adds value without contradicting the core answer. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'maintaining a core, low-cost funding source while opportunistically extending maturity' is semantically equivalent to the ground truth's description of 'consistent long-term liability with no principal repayments' and 'maintained its long-term debt structure.' Minor note: The LLM uses 'roughly $1.5 billion' while ground truth states exactly $1.5 billion, but this is a negligible difference in precision that doesn't affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 505,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nAcross 2022 through 2024 Gilead has consistently used its Hoofddorp, Netherlands site as a commercial‑scale manufacturing and processing hub for cell‑therapy products, positioning the facility as a key European node in the company’s global cell‑therapy strategy.  The site’s role has deepened each year, expanding from an initial commercial‑production footprint to a central production centre that supports the supply of multiple Kite cell‑therapy products (e.g., Yescarta, Tecartus) for both European and worldwide markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The facility location (Hoofddorp, Netherlands) is correct; (2) The timeframe (2022-2024) is correct; (3) The core function (commercial manufacturing and processing of cell therapy products) is accurate; (4) The characterization of it as a European hub is appropriate; (5) The mention of Kite cell therapy products (Yescarta, Tecartus) is factually accurate. PROBLEMATIC ASPECTS: (1) The LLM claims the facility's role 'deepened each year, expanding from an initial commercial-production footprint to a central production centre' - this narrative of progressive expansion is NOT supported by the ground truth, which states the facility was identified as 'principal' in 2022 and then maintained the same utilization in 2023 and 2024 with 'continuity' rather than expansion; (2) The phrase 'expanding from an initial commercial-production footprint' suggests the facility started with limited commercial production and grew, but the ground truth indicates it was already identified as principal/strategic in 2022; (3) The LLM overstates the evolution by characterizing it as 'deepening each year' when the ground truth emphasizes 'continuity and deepening' more conservatively. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the facility's role in the global strategy, but mischaracterizes the nature of the evolution. The ground truth emphasizes consistency and maintenance of role, while the LLM emphasizes expansion and deepening. This is a meaningful semantic difference that affects the accuracy of the answer. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is neutral (7/10 for appropriate restraint in not inventing metrics). OVERALL: The answer is partially correct on core facts but contains a significant interpretive error regarding the trajectory of the facility's role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 536,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.375 % Senior Notes due June 2027 remained classified as long‑term debt with a stable carrying amount of $1.25 billion, but the way the current portion was shown changed. In the 2022 table the note carried a $73 million current‑portion allocation, while by 2023 the aggregate current portion of all long‑term debt had risen to $1.081 billion (largely reflecting the $1 billion 2.75 % notes due in 2024), and the 1.375 % notes were still presented as long‑term with no separate current‑portion line. After the 2.75 % notes were fully repaid in May 2024, the current‑portion figure dropped to $103 million in 2024, leaving the 1.375 % notes firmly in the long‑term‑debt category and no longer split between current and long‑term.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The principal amount of $1,250 million ($1.25 billion) for the 1.375% Senior Notes is accurate across all three years. (2) The 2022 current portion of $73 million is correct. (3) The 2023 current portion spike to $1,081 billion is correct. (4) The 2024 current portion of $103 million is correct. (5) The reference to the $1 billion 2.75% notes due in 2024 provides helpful context. PROBLEMATIC ELEMENTS: (1) The LLM's statement that in 2023 'the 1.375% notes were still presented as long-term with no separate current-portion line' is misleading or incorrect. The ground truth indicates the current portion was $1,081 million in 2023, which should have included some allocation to the 1.375% notes as they approached their June 2027 maturity. The LLM conflates the overall debt structure with the specific treatment of these notes. (2) The claim that in 2024 the 1.375% notes have 'no longer split between current and long-term' is imprecise—the ground truth shows $103 million in current portion in 2024, which would logically include some portion of these notes given their June 2027 maturity date. (3) The reasoning about why the current portion changed is partially speculative (attributing it to the 2.75% notes repayment) rather than directly addressing the 1.375% notes' specific classification changes. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across three years and connect it to other debt instruments, which is appropriate for the question. However, the synthesis conflates the overall current portion of long-term debt with the specific treatment of the 1.375% notes, creating confusion about whether these notes were actually reclassified or remained long-term throughout. The ground truth is clearer: the principal stayed constant at $1,250 million, but the current portion allocation changed from $73M (2022) to $1,081M (2023) to $103M (2024). QUANTITATIVE ACCURACY: All specific numbers cited are correct, but the interpretation of what those numbers mean for the 1.375% notes specifically is muddled. The LLM provides accurate context about other debt but doesn't clearly track the 1.375% notes' current vs. long-term split across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 607,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s 2.850 % fixed‑rate notes—originally issued in September 2019 with a $1.5 billion principal and a 2029 maturity—remained on the balance sheet at essentially the same $1.5 billion outstanding each year (the notes were not retired early; only other tranches maturing in 2022 were repurchased).  During the same period the company supplemented its long‑term funding by issuing newer fixed‑rate notes in 2022, 2023 and 2024 and by drawing down its $5 billion revolving credit facility, using the proceeds to refinance near‑term debt and support share‑repurchases.  This pattern shows that PayPal’s long‑term debt strategy is to extend maturity, keep a stable, low‑cost fixed‑rate base (including the 2.850 % notes), and manage liquidity through a mix of term debt and revolving credit rather than aggressively retiring existing long‑dated obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's debt management strategy and correctly identifies the core facts: (1) The 2.850% notes remained at $1.5 billion across 2022-2024 - CORRECT; (2) Original issuance in September 2019 - CORRECT; (3) 2029 maturity date - CORRECT; (4) No early retirement of these specific notes - CORRECT. The answer accurately synthesizes the multi-hop information showing PayPal's strategy of maintaining stable long-term fixed-rate debt while issuing new tranches and managing liquidity through revolving credit. However, there are some areas where the LLM answer diverges from or adds to the ground truth: (1) The LLM mentions an effective interest rate of 2.96% in the ground truth, but the LLM answer does not include this detail - minor omission; (2) The LLM adds information about 'other tranches maturing in 2022 were repurchased' and details about 'issuing newer fixed-rate notes in 2022, 2023 and 2024' and 'drawing down its $5 billion revolving credit facility' - these appear to be reasonable inferences about debt management strategy but are not explicitly confirmed in the ground truth provided; (3) The LLM's characterization of the strategy as 'extend maturity, keep a stable, low-cost fixed-rate base' and 'manage liquidity through a mix of term debt and revolving credit' aligns well with the ground truth's statement about 'preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments.' The quantitative accuracy is high with all key numbers correct ($1.5 billion, September 2019, October 1, 2029). The qualitative reasoning about debt strategy is sound and well-articulated, though it goes slightly beyond what the ground truth explicitly states. The answer appropriately addresses the question about how obligations evolved (they didn't) and what this reveals about strategy (stability in certain tranches while flexibility elsewhere).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 528,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s gas‑related option exposure contracted sharply – the “options – primarily gas” line fell from roughly $356 million (assets) / $347 million (liabilities) in 2022 to about $100 million each in 2023‑2024, while the forward‑gas position peaked in 2023 and slipped in 2024.  At the same time the valuation inputs stayed highly volatile: the weighted‑average implied volatility for gas options hovered near 50 %–55 % and ranged from the high‑teens to well over 300 %, signalling that NEE continues to price in substantial gas‑price uncertainty and therefore maintains a cautious, largely forward‑oriented risk posture in the gas market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) VOLATILITY NUMBERS ARE FUNDAMENTALLY WRONG: Ground truth states implied volatility declined from 36% (2022) to 50% (2023) to 52% (2024). LLM claims volatility 'hovered near 50%-55%' and 'ranged from high-teens to well over 300%' - this is factually incorrect and contradicts the ground truth trend. The LLM's statement about 300% volatility has no basis in the original answer. (2) ASSET/LIABILITY VALUES: LLM correctly identifies the $356M/$347M (2022) and ~$100M each (2023-2024) figures, which matches ground truth. This is accurate. (3) INTERPRETATION ERROR: Ground truth explicitly states volatility 'declined' and indicates 'de-risking' - a reduction in risk positioning. LLM contradicts this by claiming NEE 'continues to price in substantial gas-price uncertainty' and maintains a 'cautious' posture, which misinterprets the declining volatility trend as indicating ongoing high risk rather than reduced risk. (4) MULTI-HOP REASONING: LLM failed to correctly synthesize the relationship between declining fair values AND declining volatility assumptions as indicators of strategic de-risking. Instead, it mischaracterized the volatility data entirely. (5) FORWARD-GAS POSITION: LLM mentions 'forward-gas position peaked in 2023 and slipped in 2024' - this detail is not in the ground truth and appears to be fabricated or from a different source. The core issue is the severe misstatement of volatility assumptions (claiming 300% range when actual range was 36%-52%) which fundamentally undermines the answer's credibility and contradicts the ground truth's conclusion about de-risking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 445,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nIn fiscal 2024 Cisco’s available‑for‑sale debt investments produced a **$67 million loss** in other income (loss), net—following a **$21 million loss** in 2023 but a **$9 million gain** in 2022; these shifts moved the overall other‑income line from a **$392 million gain** in 2022 to **$(306) million** in 2024. The recurring negative contributions from the AFS portfolio show that its fair‑value movements—driven by interest‑rate changes, credit‑quality concerns and market‑liquidity swings—are a material source of earnings volatility for Cisco’s investment holdings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable numbers for AFS debt investment impacts across the three fiscal years (2022-2024). The quantitative data is precise: $9M gain in 2022, $21M loss in 2023, $67M loss in 2024, and the overall other income movement from $392M gain to $(306)M loss. These numbers appear internally consistent and logically sequenced to show the deteriorating trend. The multi-hop reasoning is sound—the answer correctly synthesizes how AFS debt investments specifically impacted the broader other income (loss) line across multiple years, and identifies the underlying drivers (interest-rate changes, credit-quality concerns, market-liquidity swings). The answer directly addresses the question's core inquiry about portfolio volatility and its financial impact. Minor strengths: the answer provides specific causal mechanisms explaining the volatility. Minor limitations: the original ground truth emphasizes 'recurring negative impact over two consecutive years' and 'increasing volatility,' while the LLM answer focuses more heavily on fiscal 2024 specifics and provides less comparative analysis of the 2022-2023-2024 trend pattern itself. The LLM answer could have more explicitly characterized the pattern as 'increasing volatility' or provided year-over-year comparisons. However, the factual content is accurate and the reasoning about portfolio volatility is well-supported by the specific numbers provided. The answer successfully synthesizes multi-hop information (AFS investments → other income impact → portfolio volatility assessment) with appropriate financial terminology and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 454,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s documented its original 4.550 % senior notes—first issued under the Fourteenth Supplemental Indenture (April 5 2019)—through a series of later supplemental indentures (the Twentieth Supplemental Indenture dated March 24 2022, the Twenty‑First Supplemental Indenture dated September 8 2022, and the Twenty‑Second Supplemental Indenture dated March 30 2023). Each of these filings added new tranches with staggered maturities (e.g., 4.450 % due 2062, 5.800 % due 2062, 5.850 % due 2063) and updated the indenture language to reflect the change of trustee to U.S. Bank Trust Company and to incorporate amendments to the company’s credit facilities.  \n\nThis multi‑year pattern shows that Lowe’s is deliberately building a long‑dated, fixed‑rate debt base by layering new note series with extended maturities, using supplemental indentures to extend and diversify its obligations while preserving a consistent legal framework. The approach signals a strategic focus on securing low‑cost, long‑term financing and reinforcing a stable capital structure that can support the company’s growth initiatives over the coming decades.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INDENTURE IDENTIFICATION ERROR: The LLM claims the 4.550% Notes were 'first issued under the Fourteenth Supplemental Indenture (April 5 2019)' but the ground truth clearly states they were documented under the 'Fifteenth Supplemental Indenture dated April 5, 2019.' This is a direct factual error in entity identification. (2) SUPPLEMENTAL INDENTURES FABRICATION: The LLM references the Twentieth, Twenty-First, and Twenty-Second Supplemental Indentures with specific dates (March 24 2022, September 8 2022, March 30 2023) and claims they added new tranches with different rates (4.450%, 5.800%, 5.850%). The ground truth makes no mention of these supplemental indentures or these additional note tranches. This appears to be hallucinated information not supported by the knowledge graph. (3) TRUSTEE CHANGE CLAIM: The LLM states the indenture was updated to reflect 'change of trustee to U.S. Bank Trust Company,' but the ground truth contains no mention of any trustee changes. (4) CORE NARRATIVE CONTRADICTION: The ground truth emphasizes consistency and stability ('no change in the documentation or terms'), while the LLM describes an active pattern of layering new tranches and supplemental indentures. These are fundamentally contradictory interpretations. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the actual multi-year pattern from the filings, instead constructing a narrative about debt diversification that isn't supported by the ground truth. The answer demonstrates poor factual accuracy on specific dates, indenture numbers, and financial instruments, making it unreliable for investment or analytical purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 478,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s Unsecured Notes ‑ 35B kept the same $750 million face amount and a fixed 3.80 % interest rate (maturing 07/15/50).  The unchanged size and rate show that SPG is maintaining a modest, long‑dated fixed‑rate tranche within its capital structure, reflecting a strategy of locking in low‑cost, stable financing and minimizing refinancing risk over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - $750 million face value (properly formatted from $750,000,000), 3.80% interest rate, and maturity date 07/15/50 all match the ground truth exactly. The time period (2022-2024) is correctly identified. COMPLETENESS: The answer addresses the core question about how face value and interest rate exposure evolved, correctly noting they remained unchanged throughout the period. The maturity date is mentioned, establishing the long-dated nature of the instrument. ENTITY ACCURACY: Simon Property Group (SPG) is correctly identified, the debt instrument 'Unsecured Notes - 35B' is properly named, and all years are accurate. REASONING QUALITY: The LLM correctly synthesizes that stability in these metrics (unchanged face value, rate, and maturity) reveals a strategic approach. The interpretation that this reflects 'confidence in managing long-dated liabilities' and 'locking in low-cost, stable financing' is logically sound and semantically equivalent to the ground truth's characterization of 'stable long-term financing approach' and 'favorable interest terms.' The phrase 'minimizing refinancing risk' is a reasonable inference from the unchanged terms. MINOR DIFFERENCES: The LLM describes the tranche as 'modest' - while the ground truth doesn't explicitly use this term, $750M in the context of a major REIT's total debt structure could reasonably be characterized this way. The ground truth mentions 'no refinancing or restructuring' while the LLM focuses on the strategic implications; both convey the same underlying fact. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop question about debt strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 488,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 to 2024 PayPal’s bad‑transaction risk moved from a largely reactive focus on rising fraud, charge‑offs and buyer‑protection losses tied to its credit and BNPL products—and the vulnerability of its third‑party payment processors—to a proactive strategy that sells and securitises large pools of loan receivables (e.g., the €40 bn U.K./European BNPL portfolio and forward‑flow arrangements) while diversifying its processor base and tightening fraud‑detection controls.  This evolution reflects a shift toward actively off‑loading and hedging credit risk to preserve cash flow and operational stability.  Consequently, the multi‑year trend shows that PayPal is building greater resilience by converting reliance on external credit‑risk exposure into managed, market‑based financing solutions, even as cross‑border and regulatory pressures persist.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and figures. STRENGTHS: (1) Correctly identifies the €40 billion U.K./European BNPL loan receivables sale as a strategic shift, matching the ground truth exactly. (2) Accurately captures the temporal evolution from 2022-2024, noting the shift from reactive to proactive risk management. (3) Correctly identifies Synchrony Bank partnership and credit product risks as relevant to 2022 baseline. (4) Properly synthesizes multi-hop information about fraud, BNPL, and third-party dependencies across the three-year period. (5) The characterization of the strategy as 'off-loading and hedging credit risk' and 'market-based financing solutions' aligns with the ground truth's description of 'external risk mitigation through asset sales.' MINOR WEAKNESSES: (1) The LLM answer mentions 'forward-flow arrangements' which, while plausible and consistent with securitization strategies, is not explicitly mentioned in the ground truth. This is a reasonable inference but represents slight extrapolation beyond stated facts. (2) The answer does not explicitly mention the 'valid-when-made' doctrine legal uncertainty highlighted in the 2024 ground truth, which is a specific regulatory risk factor identified in the original answer. This is a notable omission of a concrete 2024-specific detail. (3) The phrase 'converting reliance on external credit-risk exposure into managed, market-based financing solutions' is somewhat awkwardly worded and could be clearer, though the semantic meaning is sound. QUANTITATIVE VERIFICATION: The €40 billion figure is correct and properly formatted. No calculations are required or presented. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk dimensions (credit products, BNPL, fraud, third-party dependencies), demonstrating sound multi-hop reasoning. The logical progression from reactive to proactive is well-established. OVERALL ASSESSMENT: The answer is substantially correct with strong factual accuracy on major points, though it misses one specific 2024 regulatory detail (valid-when-made doctrine) that was highlighted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 595,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nCostco’s competitive edge over BJ’s Wholesale Club sharpened from 2022 through 2024 by making Kirkland Signature the cornerstone of its value proposition—private‑label sales rose from roughly 71 % of worldwide net sales in 2022 to about 73.3 % in 2024, reinforcing the low‑price, high‑quality image that BJ’s, which relies mainly on national brands, cannot match. This sustained emphasis on Kirkland, together with the Executive‑membership rewards and a membership‑renewal rate that stayed above 90 %, has solidified Costco’s differentiation from BJ’s in the warehouse‑club market.  (Competition section; Intellectual‑Property discussion of Kirkland; Membership data showing rising private‑label sales penetration.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides specific percentages (71% in 2022, 73.3% in 2024) that are NOT supported by the ground truth. The ground truth makes no mention of these specific private-label sales percentages. This is a critical factual error. (2) CONTRADICTS GROUND TRUTH - The LLM claims Costco's competitive edge 'sharpened' with rising private-label penetration, but the ground truth explicitly states the positioning 'remained stable' with 'no significant shift in strategy' from 2022-2024. The LLM mischaracterizes the evolution as dynamic when it was actually static. (3) UNSUPPORTED CLAIMS - The LLM adds details about Executive-membership rewards and 90%+ renewal rates that are not mentioned in the ground truth answer and appear to be fabricated or from unreliable sources. (4) PARTIAL CORRECTNESS - The LLM correctly identifies: Kirkland Signature as a key differentiator, the comparison with BJ's Wholesale Club, and the emphasis on quality/low-price positioning. However, these correct elements are undermined by the false quantitative claims and mischaracterization of strategic evolution. (5) MULTI-HOP REASONING - The LLM fails to properly synthesize the multi-year trend. The ground truth indicates consistency across 2022-2024, but the LLM invents a narrative of increasing private-label penetration that drives competitive advantage. This is a fundamental misreading of the source material. The answer reads plausibly but contains fabricated numbers and contradicts the core finding that strategy remained stable rather than sharpened.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 434,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nNEE’s Level‑3 fair‑value of gas‑forward contracts was about **$191 million (asset) / $31 million (liability)** at the end of 2022, rose to **$377 million (asset) / $77 million (liability)** in 2023, and then fell to **$296 million (asset) / $46 million (liability)** by the end of 2024.  The net position stayed positive but trended downward, indicating that the company expanded its hedging activity in 2023 and then reduced its overall gas‑forward exposure in 2024, reflecting a more conservative risk posture toward natural‑gas price fluctuations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correctly stated: 2022 ($191M assets/$31M liabilities), 2023 ($377M assets/$77M liabilities), and 2024 ($296M assets/$46M liabilities). The quantitative data matches the ground truth precisely. The multi-hop synthesis across the 3-year period is sound, correctly identifying the progression pattern and the 2023 spike. The LLM provides additional valuable interpretation by characterizing the 2024 reduction as reflecting a 'more conservative risk posture,' which is a reasonable inference from the data trend. However, there is one minor discrepancy: the ground truth states 2023 liabilities were $77 million (implied from the LLM's figure), but the original answer doesn't explicitly state the 2023 liability figure, making it difficult to verify this specific number against the ground truth. The LLM's characterization of the trend as 'strategic expansion in gas market participation' (ground truth) versus 'expanded hedging activity in 2023 then reduced exposure in 2024' (LLM) represents slightly different interpretive framings but both are logically supported by the data. The LLM answer is more specific about the directional shift in 2024 (reduction/conservative posture) while the ground truth emphasizes the overall 3-year expansion. Both interpretations are valid given the data. The answer fully addresses the question's components: fair value evolution, 3-year progression, and risk positioning implications. Minor deduction for the 2023 liability figure not being explicitly confirmed in the ground truth statement, though the LLM's figure appears reasonable given the asset/liability relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 460,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nIn the 2022 filing Lowe’s reported $2.56 bn of forward interest‑rate swaps (cash‑flow hedges); the 2023 filing shows that amount rising to roughly $2.8 bn, as the company broadened its hedge to lock in financing costs amid accelerating rate hikes, and the 2024 filing trims the notional back to about $2.2 bn, reflecting a pull‑back as rates stabilized and the firm shifted toward longer‑dated fixed‑rate debt. This progression indicates a move from an aggressive short‑term hedge stance to a more balanced, longer‑term interest‑rate risk‑management approach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM reports specific notional values ($2.56bn in 2022, $2.8bn in 2023, $2.2bn in 2024) that are completely fabricated and not supported by the ground truth. The ground truth explicitly states that in 2023, forward interest rate swaps were valued at $251 million (not $2.8bn), and by 2024, Lowe's held NO forward interest rate swaps at all. The LLM's numbers are off by orders of magnitude (billions vs. millions). (2) ENTITY/CLASSIFICATION ERRORS - The LLM incorrectly characterizes these as 'notional' amounts when the ground truth indicates the $251 million figure represents actual fair value (classified under other current assets). The LLM conflates notional values with fair values, a critical distinction in derivative accounting. (3) TEMPORAL ACCURACY - While the LLM correctly identifies the 2022-2024 timeframe, it misrepresents the trajectory. The ground truth shows a clear progression: active hedging in 2022 → concrete $251M position in 2023 → complete elimination by 2024. The LLM invents an intermediate peak in 2023 and suggests a gradual reduction, which is false. (4) STRATEGIC INTERPRETATION - The LLM's interpretation about 'aggressive short-term hedge stance' shifting to 'balanced, longer-term approach' is speculative and unsupported. The ground truth indicates a strategic unwind or replacement, possibly due to stabilized rates or refinancing, not a rebalancing toward longer-dated instruments. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize information across the three years. It invented data points rather than accurately extracting and comparing actual filing information. This is a critical failure for a multi-hop financial question requiring precise data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 499,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its fiber‑to‑the‑premises rollout and DOCSIS 4.0 upgrades, moving from up‑to‑1 Gbps downstream on its HFC network to offering symmetrical multigigabit speeds (as high as 10 Gbps for residential and 100 Gbps for business) and 2 Gbps downstream in roughly half of its footprint.  This expansion directly counters Lumen’s fiber‑based network build‑out, allowing Comcast to match or exceed Lumen’s speed tiers and to bundle broadband, video and wireless services in the same overlapping markets.  The higher‑speed, symmetric offerings also enable new bundled packages and revenue streams (e.g., multigig symmetrical services, advanced xFi Wi‑Fi) that strengthen Comcast’s competitive positioning against Lumen.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misaligns with the ground truth in multiple critical ways: (1) ENTITY FOCUS ERROR: The LLM focuses almost entirely on CMCSA's (Comcast's) competitive response strategy rather than addressing the evolution of competitive positioning between CMCSA and Lumen across 2022-2024. The ground truth emphasizes how Lumen's competitive threat evolved over the three-year period, while the LLM pivots to describe Comcast's technological countermeasures. (2) MISSING CORE INFORMATION: The LLM completely omits the key ground truth finding that Lumen was consistently identified as a competitor across all three years (2022, 2023, 2024) with expanding fiber infrastructure. The ground truth explicitly tracks Lumen's evolution from 2022 (noted as building fiber), through 2023 (further extending fiber services), to 2024 (remaining prominent with continued expansion). The LLM provides no year-by-year analysis of this evolution. (3) QUANTITATIVE ISSUES: While the LLM provides specific speed metrics (1 Gbps, 2 Gbps, 10 Gbps residential, 100 Gbps business), these cannot be verified against the ground truth and appear to be technical specifications rather than comparative competitive positioning data. The ground truth contains no such specific speed comparisons. (4) MULTI-HOP REASONING FAILURE: The question asks about competitive positioning evolution from 2022-2024, requiring synthesis of how the competitive landscape changed. The LLM instead describes Comcast's unilateral technology deployment strategy without establishing how Lumen's competitive threat evolved or how the positioning between the two companies changed over time. (5) SEMANTIC MISMATCH: The ground truth emphasizes Lumen's growing influence and overlapping competitive pressure; the LLM emphasizes Comcast's technological superiority and bundling advantages. These represent different analytical perspectives on the same competitive dynamic. The LLM answer reads more like a product marketing document for Comcast rather than an analysis of competitive positioning evolution between two companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 561,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal turned its seamless‑checkout ambition into a broader, more integrated offering: it layered consumer‑credit options—including BNPL, interest‑free installment plans and co‑branded credit cards—directly into the checkout flow across an expanding set of markets (U.S., U.K., France, Germany, Australia, Spain, Italy and, via Paidy, Japan); simultaneously it widened global currency support to roughly 150 currencies and enabled balances and withdrawals in 24‑56 currencies, letting shoppers and merchants transact in almost any locale; and it broadened omnichannel merchant solutions by unifying online checkout (PayPal, Venmo, Braintree, PayPal Complete Payments), in‑person point‑of‑sale tools (Zettle), payout and financing services, and risk‑management features, all under a single, data‑driven platform that personalizes offers and drives higher conversion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of PayPal's strategic evolution and addresses all three key dimensions (consumer credit, currency support, omnichannel solutions). However, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - Currency support claim: LLM states \"roughly 150 currencies\" for the 2022-2024 period, but ground truth specifies 2022 had \"over 100 currencies\" and 2023 expanded to \"approximately 150.\" The LLM conflates these into a single figure without showing the evolution.\n   - Currency withdrawal/balance claim: LLM introduces \"24-56 currencies\" for balances and withdrawals, which is NOT mentioned in the ground truth. This appears to be fabricated or from an unreliable source.\n   - Geographic specificity: LLM lists specific markets (U.S., U.K., France, Germany, Australia, Spain, Italy, Japan via Paidy) that are not mentioned in the ground truth, introducing unverified details.\n\n2. COMPLETENESS:\n   - The answer addresses all three required dimensions (consumer credit, currency support, omnichannel solutions)\n   - Provides good detail on BNPL integration and merchant solutions\n   - Captures the strategic shift from scale to integration\n\n3. ENTITY ACCURACY:\n   - Correctly identifies PayPal, Venmo, Braintree, Zettle, and Paidy\n   - Correctly references 2022-2024 timeframe\n   - Correctly identifies BNPL and debit/credit card offerings\n\n4. REASONING & SYNTHESIS:\n   - Multi-hop reasoning is sound in connecting the three dimensions\n   - Logical progression from 2022 to 2024 is clear\n   - However, the synthesis includes unverified details not in ground truth\n\n5. SEMANTIC EQUIVALENCE:\n   - Core message aligns with ground truth (evolution from global scale to integrated financial services)\n   - Wording differs but captures the strategic shift\n   - Problem: adds specific details not in ground truth, which violates the principle of sticking to verified information\n\nKEY ISSUES:\n- Introduction of unverified geographic markets and currency ranges (24-56) significantly undermines credibility\n- Failure to show the evolution of currency support from 100+ to 150 currencies across years\n- While the qualitative narrative is strong, the quantitative claims contain errors and fabrications",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 622,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe RedCard (Target Debit) penetration fell steadily – from roughly **20.5 % of all purchases in fiscal 2022**, to **19.8 % in fiscal 2023**, and **18.6 % in fiscal 2024** (and about **17.8 % in the first 2025 period**). This downward trend shows that the card’s ability to generate incremental sales is eroding; while the 5 % discount still encourages some additional spend, the shrinking share of transactions paid with a RedCard indicates growing market saturation or diminishing returns, suggesting Target can no longer count on the card as a primary engine of sales growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate figures. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. However, the LLM reports: 2022: 20.5% (correct), 2023: 19.8% (INCORRECT - should be 18.6%), 2024: 18.6% (INCORRECT - should be 17.8%). The LLM also introduces a 2025 figure (17.8%) that is not in the ground truth and appears to conflate the 2024 figure. This represents a fundamental failure in multi-hop data synthesis - the model has transposed or misread the year-to-year progression. The magnitude of error is substantial: the 2023 figure is off by 1.2 percentage points, and the 2024 figure is off by 0.8 percentage points. QUALITATIVE ASSESSMENT: The reasoning about declining penetration rates and their implications for sales growth is sound and aligns with the ground truth interpretation. The LLM correctly identifies the trend as 'downward' and appropriately contextualizes it as suggesting 'diminishing returns' and 'eroding' sales generation capability. The mention of market saturation and the 5% discount incentive are relevant contextual points. COMPLETENESS: The answer addresses both parts of the question (evolution of penetration rate AND what it suggests about sales impact), though the factual basis is compromised. The inclusion of an unexplained 2025 figure suggests confusion about the data timeline. ENTITY ACCURACY: Correctly identifies the Target Debit Card/RedCard and the 5% discount, though the temporal progression is muddled. The core issue is quantitative accuracy failure that undermines the credibility of the entire response despite reasonable qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 460,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nBetween 2022 and 2024 AMD made the treatment of development‑plus‑IP arrangements more explicit.  The 2022 filing only said that combined dev‑service and IP deals could be treated as a single performance obligation, but the 2023‑2024 disclosures added a formal “distinct‑licensing” test—(i) the license must be capable of being distinct and (ii) distinct in the context of the arrangement.  If the license is deemed distinct, revenue is recognized at a point in time; if it is not distinct, the arrangement is combined with the development services and revenue is recognized over time, making the separation between combined deals and standalone IP licenses clear and consistently applied.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misrepresents the evolution of AMD's revenue recognition approach. The ground truth states that AMD's policy REMAINED UNCHANGED from 2022 to 2024, with consistent treatment across all three years. However, the LLM answer claims AMD 'made the treatment more explicit' and 'added a formal distinct-licensing test' in 2023-2024, suggesting a material change in policy. This is factually incorrect and contradicts the ground truth's explicit statement that 'this policy remained unchanged.' The LLM invents details about a 'formal distinct-licensing test' with two specific criteria that are not supported by the ground truth. While the LLM correctly identifies the general framework (distinct licenses recognized at point in time, non-distinct combined with development services recognized over time), it incorrectly characterizes this as an evolution/change rather than consistency. The LLM also fails to acknowledge the ground truth's key finding that 'no explicit quantitative metrics being disclosed' and that consistency suggests 'a stable approach.' The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required—the question asks how the approach 'evolved,' and the correct answer is that it did NOT evolve materially. The LLM's narrative of increasing explicitness and formalization is unsupported by the knowledge graph data and represents a significant factual error in interpreting the temporal dimension of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 414,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024, FlyEase progressed from a newly‑introduced, inclusive‑design technology noted alongside Nike’s core performance platforms (Air, Zoom, Free, etc.) to a mature, cross‑category capability that is now embedded in footwear, apparel and digital experiences, with growing emphasis on scaling its use and tying it to Nike’s broader sustainability and accessibility objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some correct elements but introduces unsupported claims and diverges from the ground truth narrative in important ways.\n\nCORRECT ELEMENTS:\n- Correctly identifies FlyEase as progressing from newly-introduced to more established status across the three-year period\n- Accurately notes the fiscal 2022-2024 timeframe\n- Correctly identifies FlyEase as an inclusive-design technology\n- Appropriately characterizes the general trajectory from novel to mature\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- The ground truth states FlyEase moved from 'new innovation' to being listed 'alongside established technologies like Nike Air and Zoom' in FY2023, then to 'mature technologies such as Nike React and Air Max' in FY2024. The LLM answer claims FlyEase was 'noted alongside Nike's core performance platforms (Air, Zoom, Free, etc.)' in FY2022, which contradicts the ground truth that positioned it as newly-introduced and separate from established technologies.\n- The LLM introduces claims about 'cross-category capability embedded in footwear, apparel and digital experiences' that are not present in the ground truth\n- The LLM adds references to 'sustainability and accessibility objectives' that are not mentioned in the ground truth\n- The LLM's emphasis on 'scaling its use' and 'broader sustainability' objectives represents speculation beyond what the ground truth documents\n\nMULTI-HOP REASONING: The LLM demonstrates understanding of the progression concept but fails to accurately synthesize the specific positioning changes described in the ground truth. The ground truth provides a clear three-stage evolution (new → alongside established → among mature), while the LLM conflates these stages and adds external context.\n\nSEMANTIC ACCURACY: While both answers convey a general progression from new to mature, the LLM's specific characterizations of FlyEase's positioning at each stage diverge from the ground truth's documented progression.\n\nJUSTIFICATION: The answer receives a 6/10 because it captures the overall trajectory but introduces factual inaccuracies about FlyEase's positioning relative to other Nike technologies in specific fiscal years, and adds unsupported claims about cross-category integration and sustainability objectives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 611,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe data show that the outstanding balance of American Tower’s 1.250 % senior notes has been steadily shrinking—from about **$552 million at the end of 2022** to roughly **$546 million after 2023 adjustments** and further reductions reflected in the 2024 adjustments—indicating that the company is actively retiring this tranche of debt.  This reduction is driven by repayments funded through new note issuances, revolving‑credit borrowings and cash flows, underscoring a debt‑management strategy that focuses on lowering leverage and extending the maturity profile of its long‑dated financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significantly incorrect principal amounts that directly contradict the ground truth. Ground truth shows: 2022: $609.1M, 2023: $551.9M, 2024: $517.7M. LLM states: 2022: ~$552M, 2023: ~$546M, 2024: further reductions. The 2022 figure is off by $57.1M (9.4% error), and the 2023 figure is off by $5.9M. These are not minor rounding differences but substantial discrepancies that fundamentally misrepresent the debt reduction magnitude. The LLM also fails to provide the 2024 specific figure ($517.7M), only vaguely referencing 'further reductions.' MULTI-HOP REASONING: While the LLM correctly identifies the general trend (declining principal) and the company (American Tower/AMT), it fails to accurately synthesize the specific financial data across the three-year period. The reasoning about debt management strategy (repayment, leverage reduction, maturity extension) is qualitatively sound but is built on incorrect numerical foundations. COMPLETENESS: The answer addresses the trend question but with wrong numbers and missing the precise 2024 figure. The interest payment terms (May payments, February 2033 maturity) mentioned in ground truth are not included. SEMANTIC ISSUES: While the general narrative about debt reduction strategy is reasonable, the factual inaccuracies are too severe to overlook, as financial analysis depends critically on precise numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 396,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $3.50 % Notes due 2040 were carried at a net amortized cost of roughly $1 billion, while their market‑value disclosure moved only modestly—from about $870 million in FY 2023 to $851 million in FY 2024—reflecting the typical decline in fair value that accompanies rising interest‑rate expectations.  The company continues to treat the 2040 notes as a core, long‑dated, low‑coupon financing pillar, refinancing shorter‑term obligations (e.g., the 0.584 % 2024 notes that were retired in FY 2025) and preserving a staggered maturity profile that supports its long‑term capital‑allocation strategy.  This trajectory shows NVIDIA’s intent to lock in inexpensive, fixed‑rate debt for the next two decades while maintaining flexibility to retire or refinance nearer‑term maturities as market conditions evolve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the fair values of the 3.50% Notes Due 2040 across the three fiscal years. Ground truth shows: FY2022: $1,066M, FY2023: $851M, FY2024: $1,000M. The LLM answer states 'market-value disclosure moved only modestly—from about $870 million in FY 2023 to $851 million in FY 2024' which contains multiple errors: (1) FY2023 fair value was $851M, not $870M, (2) FY2024 fair value was $1,000M, not continuing at $851M, (3) the LLM completely omits the FY2022 valuation of $1,066M, which is critical to understanding the multi-year trajectory. The LLM also claims the notes were 'carried at a net amortized cost of roughly $1 billion' across all three years, which oversimplifies and misrepresents the actual valuation changes. The LLM's statement about 'rising interest-rate expectations' causing fair value decline is partially correct for FY2022-2023 but fails to explain the significant recovery to $1,000M in FY2024. QUALITATIVE ISSUES: While the LLM provides reasonable strategic context about debt management and maturity staggering, it does so without accurately grounding the analysis in the actual numbers. The reference to 0.584% 2024 notes being retired in FY2025 adds information not in the ground truth but is not necessarily incorrect. However, the core analytical failure is presenting an incomplete and inaccurate picture of the three-year valuation trajectory. The LLM answer demonstrates weak multi-hop synthesis by failing to properly track and compare values across all three fiscal years. MISSING ELEMENTS: The ground truth explicitly notes the effective interest rate of 3.54% in FY2024, which the LLM does not mention. The ground truth's characterization of the trajectory as showing 'stabilization in valuation' is more accurate than the LLM's framing of 'modest' movement that omits the significant FY2022-2023 decline and FY2023-2024 recovery.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 530,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix broadened its membership strategy by introducing a lower‑priced ad‑supported tier (2022), expanding into interactive games (2022‑2024) and adding live‑event programming (2023‑2024) while periodically raising subscription prices in several markets. In its 2022 filing the company warned that if the new games offering or any price changes failed to resonate, member acquisition and retention could suffer; the 2023 filing added that the rollout of live programming and continued game development pose a risk that consumers may not value the expanded content, potentially dampening growth; and the 2024 filing again flagged that ongoing expansions of games, live content and pricing adjustments could erode satisfaction and increase churn if the new services are not well‑received.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE: The LLM answer contains a significant factual error regarding when the ad-supported tier was introduced. The LLM states the ad-supported tier was introduced in 2022, but the ground truth clearly indicates it was introduced in 2023. This is a major chronological error that undermines the accuracy of the response. CORRECT ELEMENTS: The LLM correctly identifies that games were introduced in 2022 and expanded through 2024, that live programming was added in 2023-2024, and that pricing adjustments occurred across the period. The LLM also correctly captures the core risk narrative: that Netflix warned about potential negative impacts on member acquisition and retention if new features/pricing weren't well-received. INCOMPLETE SYNTHESIS: While the LLM mentions the risks across years, it doesn't clearly distinguish the specific risks emphasized in each year as effectively as the ground truth does. The ground truth provides clearer year-by-year progression: 2022 focused on games risk, 2023 added ad-tier reception concerns, 2024 emphasized cumulative expansion risks. The LLM conflates these somewhat. SEMANTIC ISSUES: The phrase 'periodically raising subscription prices in several markets' is vague and not directly supported by the ground truth, which doesn't specify pricing increases by market. MULTI-HOP REASONING: The LLM does attempt to synthesize information across three years and multiple service expansions, but the foundational timeline error (ad-supported tier in 2022 vs 2023) significantly compromises the multi-hop analysis. The reasoning structure is sound, but the factual foundation is flawed. The quantitative accuracy score reflects the critical dating error, while qualitative accuracy is moderate due to reasonable synthesis despite the error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 489,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s overall venture‑related equity securities stayed flat at about **$4.9 billion** from 2022 through 2024, but the size of its **equity‑method investments in health‑care operating businesses more than doubled**—rising from roughly **$1.4 billion in 2023** (and about $1.3‑$1.5 billion in the prior year) to **$3.8 billion as of December 31 2024**. This rapid increase shows that the company is moving from a largely passive venture‑fund exposure toward **active, strategic minority stakes in health‑care innovators**, underscoring a deliberate effort to deepen its involvement in the sector’s growth opportunities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key trend of equity method investments rising from ~$1.3-1.5B to $3.8B in 2024, and accurately characterizes the strategic shift toward active minority stakes. The qualitative interpretation about moving from passive venture exposure to active strategic engagement is sound and well-reasoned. The company name and time period are correct.\n\nCRITICAL ERRORS: (1) The LLM states equity securities 'stayed flat at about $4.9 billion from 2022 through 2024,' which is INCORRECT. Ground truth shows: 2022=$3.7B, 2023=$4.9B, 2024=$4.9B. The LLM omits the 2022 figure entirely and mischaracterizes the trend as 'flat' across all three years when there was actually a $1.2B increase from 2022 to 2023. (2) The LLM states equity method investments were 'roughly $1.4 billion in 2023' which is correct, but then says 'about $1.3-$1.5 billion in the prior year' (2022), which is imprecise—ground truth specifies exactly $1.3B for 2022.\n\nMULTI-HOP REASONING: The synthesis across the three-year period is partially incomplete. The LLM fails to capture the full evolution trajectory (2022→2023→2024) for equity securities, instead presenting only the 2023-2024 portion as 'flat.' This represents incomplete multi-hop synthesis across all three years requested.\n\nCALCULATION VERIFICATION: The LLM correctly identifies the equity method investment increase from ~$1.3-1.4B to $3.8B (approximately 2.7x increase), though it says 'more than doubled' which is accurate.\n\nOVERALL: While the strategic interpretation and the equity method investment trend are well-captured, the failure to accurately report the 2022 equity securities figure and the mischaracterization of the equity securities trend as 'flat' across all three years (rather than showing the 2022-2023 increase) represents a significant quantitative accuracy issue that undermines the completeness of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 516,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike’s redeemable preferred‑stock arrangement with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the $0.3 million, $1‑par, cumulative‑dividend preferred stock that pays $0.10 per share each May 31 and must be fully satisfied before any common‑stock dividend can be declared; the stock is redeemable at par at the option of Sojitz America or Nike and carries only limited class‑voting rights (e.g., on the sale of substantially all assets, mergers, or the trademark), with no new issuances or modifications reported in 2022‑2024.  Consequently, Sojitz America’s strategic influence stayed confined to these protective shareholder rights and its historic role as a Japanese‑trading‑company conduit for import‑export financing, while Nike’s international operations continued to be managed through its regional business units rather than through any expanded operational control by Sojitz America.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all quantitative facts: Sojitz America as sole holder of redeemable preferred stock, $0.3 million par value, $1 par per share, $0.10 cumulative annual dividend per share, payment date of May 31, and the consistency of these terms across 2022-2024. The description of voting rights (limited class voting on asset sales, mergers, trademark) and redemption terms (at par, at option of either party) is accurate. The statement that no new issuances or modifications occurred in 2022-2024 is correct.\n\nCRITICAL WEAKNESS: The LLM answer fundamentally misses the key evolution highlighted in the ground truth. The original answer explicitly states there was a shift from 'purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024,' with Nike explicitly highlighting Sojitz America's 'ongoing role in providing import-export financing services since 1972' in fiscal 2024 filings. The LLM dismisses this as merely a 'historic role' and states that 'Nike's international operations continued to be managed through its regional business units rather than through any expanded operational control by Sojitz America.' This directly contradicts the ground truth's assertion that fiscal 2024 marked an explicit strategic emphasis on Sojitz America's operational importance amid rising global trade risks and supply chain volatility.\n\nMULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the three fiscal years. While it correctly notes consistency in financial terms, it missed the critical narrative shift in how Nike characterized Sojitz America's role in 2024 versus prior years. The ground truth requires understanding not just what remained the same (financial terms) but what changed (strategic emphasis and operational framing).\n\nSEMANTIC ISSUES: The LLM's characterization of Sojitz America's role as 'confined to protective shareholder rights' and 'historic' understates the strategic importance Nike attributed to this relationship in 2024, particularly regarding trade financing and supply chain support during a period of increasing protectionism.\n\nQUANTITATIVE ACCURACY is high (9/10) because all numbers are correct. QUALITATIVE ACCURACY is lower (5/10) because the reasoning misses the key evolution and strategic shift. CONTEXTUAL RELEVANCE is moderate (6/10) because while the answer addresses the relationship, it fails to capture the important shift in how Nike framed Sojitz America's strategic value by 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 673,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 grew from roughly **$1.5 billion at the end of fiscal 2022** to **$1.637 billion at the end of fiscal 2023** and then held essentially steady at **$1.604 billion at the end of fiscal 2024**.  This modest upward movement—driven mainly by the accretion of discount and the issuance of new senior unsecured debt—shows that NVIDIA is maintaining a sizable, low‑cost fixed‑rate position in its long‑term capital structure while keeping overall leverage relatively stable.  The flat‑to‑slightly‑higher balance signals a strategic focus on financing growth through long‑dated debt rather than aggressive new issuance or rapid deleveraging.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data across all three fiscal years: (1) FY2022: LLM states ~$1.5 billion, but ground truth is $2,147 million ($2.147 billion) - OFF BY $647 MILLION or 30%. (2) FY2023: LLM states $1.637 billion, but ground truth is $1,604 million - OFF BY $33 MILLION. (3) FY2024: LLM states $1.604 billion, but ground truth is $2,000 million ($2.0 billion) - OFF BY $396 MILLION or 20%. The LLM completely misidentified the trend: it claims the notes 'grew' and 'held essentially steady,' when the actual pattern shows a DECREASE from $2,147M to $1,604M (2022-2023), then a SIGNIFICANT INCREASE to $2,000M (2023-2024). The ground truth explicitly identifies this as a 'temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.' The LLM's interpretation of 'flat-to-slightly-higher balance' is contradicted by the actual $396M increase from 2023 to 2024. The reasoning about 'accretion of discount' and 'new senior unsecured debt' may be partially relevant but cannot compensate for the incorrect base numbers. The LLM failed the multi-hop synthesis task by providing wrong values for all three years, leading to an entirely incorrect narrative about the company's debt positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 368,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife moved from a funding profile that leaned heavily on long‑term debt and internal cash flows toward a more balanced mix that still uses short‑term commercial paper but increasingly supplements it with a wider array of global sources—preferred and common equity, long‑term notes, collateral‑financing arrangements, policy‑holder balances and the shelf‑registration program.  This diversification “limits dependence on any one market or source of funds and generally lowers the cost of funds,” allowing the company to meet its liquidity needs while keeping the overall cost of capital lower than it would be if it relied on a single, narrow funding channel.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) DIRECTIONAL ERROR: The LLM claims MetLife 'moved from a funding profile that leaned heavily on long-term debt...toward a more balanced mix,' suggesting a major shift from 2022-2024. However, the ground truth explicitly states 'Despite no major structural changes' and describes a 'stable reliance on short-term debt markets.' This is a fundamental mischaracterization of the evolution. (2) INCOMPLETE FUNDING SOURCES: While the LLM mentions preferred/common equity, long-term notes, collateral-financing, and policy-holder balances, the ground truth focuses specifically on commercial paper programs, unsecured revolving credit facilities, and MetLife Funding's affiliate loans as the core strategy. The LLM introduces funding mechanisms not mentioned in the ground truth without evidence. (3) MISSING KEY DETAILS: The ground truth emphasizes the consistent use of commercial paper 'across all three years' and the role of credit facilities supporting these programs. The LLM downplays commercial paper as merely 'still uses' rather than highlighting its consistent importance. (4) SHELF-REGISTRATION PROGRAM: The LLM mentions a shelf-registration program with no supporting evidence in the ground truth. (5) TEMPORAL ACCURACY: The ground truth shows consistency across 2022-2024 with the same core structure being maintained. The LLM incorrectly portrays this as an evolution or shift in strategy. (6) QUANTITATIVE ISSUES: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy cannot be verified, but the LLM's narrative structure suggests a transition that contradicts the ground truth's emphasis on stability. The LLM answer appears to have fabricated or misinterpreted the nature of MetLife's funding evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 512,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nFrom 2022 through 2024 the parent‑company’s intercompany financing changed materially: the short‑term notes payable to subsidiaries rose from $8.7 bn (2022) to $9.9 bn (2023) and then fell sharply to $2.0 bn by the end of 2024, while a new long‑term notes payable balance of $14.4 bn appeared in 2024, indicating a shift from short‑term borrowing to longer‑dated financing.  The company’s service‑level guarantees were disclosed as immaterial in each year and were never accrued, but the growing long‑term intercompany debt reflects an expanding liquidity commitment and heightened contractual risk exposure over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 short-term notes payable figure. The ground truth states $8.1 billion for 2022, but the LLM reports $8.7 billion—a $600 million discrepancy that is material and incorrect. The 2023 ($9.9 billion) and 2024 ($2.0 billion) short-term figures are correct. MAJOR ADDITION NOT IN GROUND TRUTH: The LLM introduces a new long-term notes payable balance of $14.4 billion in 2024 that does not appear in the original answer. While this may be factually accurate from the filing, it represents information beyond the ground truth provided and changes the narrative significantly. The ground truth makes no mention of this long-term debt component. CORRECT ELEMENTS: The LLM correctly identifies that service level guarantees were immaterial and never accrued across all three years, matching the ground truth. The characterization of the shift from short-term to longer-dated financing is a reasonable inference, though the ground truth does not explicitly make this distinction. REASONING QUALITY: The multi-hop synthesis is partially sound—the LLM attempts to connect intercompany financing changes with liquidity commitments and risk exposure. However, the introduction of the $14.4 billion long-term debt without ground truth support undermines the reliability of the analysis. The conclusion about 'heightened contractual risk exposure' is not explicitly supported by the ground truth, which states the risk profile remained 'stable.' SEMANTIC ISSUES: The ground truth emphasizes that despite volatility in notes payable, service level guarantees posed no material risk and the risk profile was stable. The LLM's framing of 'heightened contractual risk exposure' contradicts this assessment. The quantitative error on the 2022 figure is particularly problematic for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 519,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a pure card‑network play to a premium‑issuer/processor model that leans on high‑spending Card Members, travel‑and lounge benefits, and expanded digital‑service offerings, while its reliance on the GMNS network grew more regulated.  Heightened global scrutiny—U.S. Category III oversight, EU and Australian interchange‑fee caps and the company’s exit from those licensing markets—has raised compliance costs and forced tighter risk‑management, and competition from Visa, Mastercard, UnionPay and fast‑growing fintech payment platforms has intensified pricing and merchant‑acceptance pressure.  In response, Amex has deepened its data‑analytics and cybersecurity investments, broadened cobrand and merchant‑services partnerships, and invested in new payment‑and‑lending products to preserve growth amid tighter regulatory and competitive constraints.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies several key facts: (1) Amex's Category III regulatory status in the U.S., (2) EU and Australian regulatory pressures on interchange fees, (3) Amex's exit from licensing businesses in those regions, (4) competition from Visa, Mastercard, UnionPay, and fintech platforms, (5) Amex's strategic responses including data analytics, cybersecurity, cobrand partnerships, and new product development. The answer appropriately captures the shift from market-driven competition to regulatory navigation. WEAKNESSES: (1) The LLM introduces 'GMNS network' which is not mentioned in the ground truth and appears to be an error or hallucination—the ground truth refers to Amex as a 'general-purpose card network' but does not reference a 'GMNS network.' (2) The LLM characterizes Amex's evolution as shifting to a 'premium-issuer/processor model' which is not explicitly stated in the ground truth; the ground truth emphasizes regulatory constraint and competitive pressure rather than a deliberate strategic pivot to issuer/processor. (3) The LLM omits important competitive context from the ground truth: the specific mention of alternative payment platforms (Alipay, PayPal, Venmo) and regional systems (National Payments Corporation of India), which were highlighted as part of the intensifying competitive landscape. (4) The LLM's framing of 'reliance on the GMNS network grew more regulated' is unclear and potentially inaccurate—the ground truth does not suggest Amex's reliance on a network grew, but rather that Amex itself became subject to heightened regulatory oversight. (5) The LLM does not clearly articulate the trajectory from 'strong competitive differentiation' (2022) through 'intensified competition' (2023) to 'regulatory dependency' (2024) as explicitly as the ground truth. MULTI-HOP REASONING: The LLM does synthesize information across the 2022-2024 period and connects regulatory changes to strategic responses, but the synthesis is less precise than the ground truth's year-by-year evolution. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is neutral. The dates (2022-2024) are correct. SEMANTIC EQUIVALENCE: While the LLM captures the general narrative of regulatory pressure and competitive response, the introduction of 'GMNS network' and the characterization of strategic pivots diverge from the ground truth's emphasis on regulatory constraint shaping competitive positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1647,
        "completion_tokens": 668,
        "total_tokens": 2316
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips kept the same cash‑settled PSU design for performance periods that began in 2018 or later: an **accrued reinvested dividend equivalent is charged to compensation expense during the performance period and paid only at settlement**, whereas pre‑2018 awards received no dividend equivalent until after the performance period ended.  By 2023‑2024 the cash‑settled PSU balances were fully vested and carried **no remaining unrecognized compensation cost**, confirming that the dividend‑equivalent feature had been fully integrated into the long‑term incentive structure.  This evolution shows the company’s intent to align executive pay with total shareholder return—linking cash payouts not just to stock‑price performance but also to the dividend component—thereby reinforcing sustained, long‑term value creation for both management and shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of ConocoPhillips' PSU compensation evolution and correctly identifies the key distinction between pre-2018 and post-2018 dividend equivalent treatment. STRENGTHS: (1) Accurately captures the core evolution: accrued reinvested dividends for 2018+ periods vs. deferred dividends for pre-2018 periods; (2) Correctly identifies the consistent cash-settled PSU framework across 2022-2024; (3) Properly synthesizes the multi-hop reasoning about alignment strategy and total shareholder return linkage; (4) Appropriately notes the vesting and unrecognized compensation cost aspects. WEAKNESSES: (1) The statement about 'by 2023-2024 the cash-settled PSU balances were fully vested and carried no remaining unrecognized compensation cost' introduces a specific claim not explicitly confirmed in the ground truth, which states the framework was 'maintained' but doesn't confirm complete vesting status across all years; (2) The phrasing 'charged to compensation expense during the performance period and paid only at settlement' is slightly more specific than the ground truth's 'accrued reinvested dividends paid at settlement,' though semantically equivalent; (3) Missing explicit mention of the five-year vesting or retirement eligibility framework mentioned in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information about dividend treatment evolution, vesting mechanics, and strategic alignment implications. The connection between dividend reinvestment and long-term value creation is logically sound and well-articulated. NUMERIC/DATE ACCURACY: All years (2022, 2023, 2024, 2018) are correctly referenced. No specific dollar amounts were required in the question, so quantitative precision is less critical here. The answer maintains factual accuracy on the structural elements without introducing false numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 511,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra’s Special Use Funds stayed robust, hovering around $9 billion (a modest dip from $9.1 bn to $8.8 bn) and composed of high‑quality, liquid securities. This ample liquidity buffer enables the company to satisfy derivative‑related collateral obligations—such as the $645 million cash posting required for a BBB/Baa2 rating downgrade and potentially much larger contingent postings if ratings fall below investment grade—without straining its finances. Consequently, its liquidity position remains strong, providing a comfortable cushion against the collateral demands of its extensive derivative portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent NextEra Energy's liquidity positioning:\n\n(1) QUANTITATIVE ERRORS - MAJOR:\n- LLM states Special Use Funds \"hovering around $9 billion (a modest dip from $9.1 bn to $8.8 bn)\" - This is completely fabricated. Ground truth shows: $8,698 million in 2023 and $9,800 million in 2024, representing an INCREASE of $1,102 million, not a decrease.\n- LLM references \"$645 million cash posting required for a BBB/Baa2 rating downgrade\" - This specific figure does not appear in the ground truth data provided.\n- Ground truth clearly states collateral posting requirements dropped from $5.2 billion (2022) to $2.4 billion (2023), and actual cash collateral posted increased from $84 million to $691 million - none of these figures appear in the LLM answer.\n\n(2) MULTI-HOP SYNTHESIS FAILURE:\n- The LLM failed to synthesize the key insight from ground truth: the company SIMULTANEOUSLY increased Special Use Funds AND reduced derivative-related collateral exposure, indicating strategic risk management improvement.\n- LLM provides only a generic statement about liquidity being \"strong\" without demonstrating understanding of the specific 2022-2024 evolution.\n- LLM does not address the significant reduction in collateral posting requirements from $5.2B to $2.4B, which is central to understanding the company's improved positioning.\n\n(3) DIRECTIONAL ERRORS:\n- LLM describes a \"modest dip\" in Special Use Funds when ground truth shows growth from $8,698M to $9,800M.\n- This reversal of direction is a fundamental factual error that contradicts the core narrative.\n\n(4) MISSING CRITICAL DATA:\n- No mention of 2022 baseline figures ($5.2B collateral requirement, $84M cash posted)\n- No mention of 2023 improvements ($2.4B requirement, $691M cash posted)\n- No mention of the $2.7 billion potential downgrade scenario\n- Incomplete temporal coverage (claims to address 2022-2024 but provides no 2022 data)\n\n(5) REASONING QUALITY:\n- While the conclusion about strong liquidity is reasonable, it is not supported by the specific data points that would demonstrate this evolution.\n- The answer reads as generic boilerplate about liquidity rather than a specific analysis of NextEra's positioning changes.\n\nThe LLM answer demonstrates a fundamental failure to accurately retrieve and synthesize the specific financial data required to answer this multi-hop question about NextEra's liquidity evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 664,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe 1.600% Notes carry a fixed $700 million principal through 2022‑2024, and the annual amortization adjustments have fallen from roughly $(2.6)$ million in 2023 to $(1.5)$ million in 2024, indicating a tapering of discount/premium amortization. This stable principal and declining amortization show that American Tower is treating the issue as a long‑term, low‑cost funding source, planning to address the 2026 call date through refinancing or cash‑flow‑driven repayment rather than accelerating principal reductions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the amortization adjustments. Ground truth shows adjustments of (3.7) million in 2022 declining to (2.6) million in 2024, but the LLM claims (2.6) million in 2023 declining to (1.5) million in 2024. These numbers are materially incorrect and do not match the filing data. The LLM also omits the 2022 data point entirely, failing to provide the complete multi-year trajectory requested. CORRECT ELEMENTS: The LLM correctly identifies the constant $700 million principal across all three years and correctly characterizes the general trend of declining adjustments. The interpretation that this represents a stable long-term debt strategy is reasonable. INCOMPLETE ANALYSIS: The LLM adds speculative information about a '2026 call date' and refinancing strategy that is not present in the ground truth answer, suggesting the model may be inferring beyond the available data. The ground truth focuses on what the data shows (stable principal, declining adjustments), while the LLM ventures into strategic interpretation not supported by the provided information. MULTI-HOP REASONING: The answer does attempt to synthesize the principal and amortization data across years, but the fundamental numerical errors undermine the validity of this synthesis. The reasoning about debt management strategy is qualitatively sound but built on incorrect quantitative foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 406,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payments widened as CMS repeatedly revised the risk‑adjustment model and froze or cut benchmark rates, producing lower capitation and greater payment uncertainty; in response the company progressively (1) trimmed or restructured benefit designs and selectively raised premiums, (2) exited or limited enrollment in low‑margin counties, and (3) intensified medical‑cost and operating‑expense controls while bolstering its risk‑adjustment data‑validation and analytics capabilities to reduce audit‑driven recoupments and protect margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the consistent theme of CMS regulatory changes to risk adjustment methodologies; (2) Accurately captures UnitedHealth's strategic responses: benefit restructuring, premium adjustments, county exits/enrollment limitations, and intensified cost controls; (3) Adds valuable detail about risk-adjustment data-validation and analytics capabilities to reduce audit-driven recoupments, which represents a sophisticated understanding of the company's operational response; (4) No quantitative errors - no specific dollar amounts or percentages were claimed, avoiding potential calculation mistakes; (5) Multi-hop reasoning is sound, correctly synthesizing the evolution across three years and linking regulatory pressures to company responses; (6) Entity identification is accurate (UnitedHealth/UNH, CMS, Medicare Advantage). MINOR CONSIDERATIONS: (1) The phrase 'exposure to Medicare Advantage risk-adjustment payments widened' could be interpreted as slightly more emphatic than the ground truth's 'consistently faced exposure,' though both convey the same essential meaning of increasing pressure; (2) The LLM adds the specific detail about 'audit-driven recoupments' which, while not explicitly mentioned in the ground truth summary, is a logical and accurate extension of risk-adjustment management strategies and represents deeper domain knowledge rather than an error. SEMANTIC EQUIVALENCE: The LLM answer conveys all core information from the ground truth while using more concise, professional language. The three strategic pillars (benefit design changes, geographic selectivity, cost controls) are all present and correctly sequenced across the three-year period. The answer successfully demonstrates multi-hop synthesis by connecting regulatory changes to specific company responses across the full time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 534,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nFrom 2022 to 2024 the employee merchandise discount grew from a simple, flat‑rate discount on most store items (roughly a 10 % off‑price that applied to the full product mix) to a more layered benefit that is now linked to Target’s Circle loyalty program and paired with higher base wages, tuition‑reimbursement, and free mental‑health resources.  This expansion shows that Target is using broader merchandise‑discount and related perks as part of a holistic financial‑well‑being strategy—aimed at increasing employees’ disposable income, reducing out‑of‑pocket costs, and strengthening retention through improved financial security.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims merchandise discounts evolved from 'roughly a 10% off-price' to a 'layered benefit linked to Target's Circle loyalty program.' The ground truth makes no mention of a 10% discount rate, Circle loyalty program integration, or any specific percentage changes. These appear to be fabricated details not supported by the source material. (2) MISSING CORE FACTS: The LLM fails to mention the critical wage progression from $15/hour (2022) to $15-$24/hour (2023), which is a key element of the ground truth showing Target's evolving strategy. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes how merchandise discounts were positioned within an expanding suite of benefits (healthcare, 401(k), tuition reimbursement in 2022; sick pay and tuition-free education in 2023; virtual healthcare and mental health services in 2024). The LLM mentions some benefits but misses the progression of how the benefit package itself evolved. (4) UNSUPPORTED CLAIMS: The LLM's assertion about Circle loyalty program integration and the specific framing of 'disposable income' and 'out-of-pocket costs' are not present in the ground truth and appear to be hallucinated details. (5) PARTIAL CREDIT: The LLM correctly identifies that merchandise discounts remained consistent across the period and that they were part of a holistic financial well-being strategy, which aligns with the ground truth's conclusion. However, the specific mechanisms and supporting details are largely incorrect or invented. The answer demonstrates a fundamental misunderstanding of what actually changed in Target's employee benefits structure during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 479,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nAmerican Express’s foreign‑government‑bond portfolio grew only modestly—from roughly $610 million in 2022 to about $660 million by 2024—while the weighted‑average yield rose from roughly 2.4 % to just under 3 % as global rates increased.  Over the same three‑year span more than 95 % of the holdings matured within one year, with only a tiny fraction extending beyond five years.  This short‑duration, high‑quality allocation reflects a deliberately conservative risk appetite, using sovereign bonds to manage foreign‑exchange exposure while preserving liquidity and limiting interest‑rate sensitivity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent American Express's foreign government bond portfolio and strategy:\n\n(1) QUANTITATIVE ERRORS - MAJOR:\n- Holdings amount: LLM states \"roughly $610 million in 2022 to about $660 million by 2024\" but ground truth shows $630 million in 2022. More critically, the LLM provides no 2023 or 2024 specific holdings figures, making it impossible to verify the claimed growth trajectory.\n- Yield figures: LLM claims \"weighted-average yield rose from roughly 2.4% to just under 3%\" - this is INCORRECT. Ground truth shows:\n  * 2022: 1.74% (1-year) and 2.42% (1-5 year)\n  * 2023: 6.45% (1-year) and 4.48% (1-5 year) - SIGNIFICANT INCREASE\n  * 2024: 5.86% (1-year) and 2.03% (1-5 year)\n  The LLM's claim of a rise to \"just under 3%\" dramatically understates the 2023 spike to 6.45% and misses the critical pattern entirely.\n- Maturity distribution: LLM claims \"more than 95% of holdings matured within one year\" - this specific percentage is not provided in ground truth and appears to be fabricated or misinterpreted.\n\n(2) MULTI-HOP REASONING FAILURE:\nThe LLM completely missed the core 3-year pattern that the question specifically asks about:\n- Ground truth shows a dramatic yield INCREASE from 2022 to 2023 (1.74% → 6.45% for 1-year bonds), followed by a DECREASE in 2024 (6.45% → 5.86%)\n- This pattern indicates aggressive positioning in 2023 followed by partial retreat in 2024\n- LLM's characterization of \"modest growth\" and \"conservative risk appetite\" directly contradicts the ground truth's description of \"more aggressive short-term investments in 2023\"\n\n(3) STRATEGIC INTERPRETATION ERROR:\nThe LLM characterizes the portfolio as reflecting \"deliberately conservative risk appetite\" - this is CONTRADICTED by ground truth which explicitly states the 2023 shift represents \"more aggressive short-term investments.\" The LLM's interpretation is backwards.\n\n(4) MISSING CRITICAL DETAILS:\n- No mention of the specific yield changes across the three years\n- No discussion of the 2023 spike and 2024 retreat pattern\n- No analysis of the shift from low-yield (2022) to high-yield (2023) to mixed (2024)\n- Fails to synthesize the maturity distribution changes across years\n\n(5) SEMANTIC MISALIGNMENT:\nWhile the LLM uses appropriate financial terminology, it fundamentally mischaracterizes the company's strategy as \"conservative\" when the ground truth evidence shows dynamic, aggressive positioning in 2023 with subsequent adjustment in 2024.\n\nThe answer demonstrates poor multi-hop synthesis, significant quantitative inaccuracy, and a strategic interpretation that contradicts the ground truth evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 721,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nCollateral posted under master‑netting arrangements dropped from $1.49 bn in 2022 to $0.80 bn in 2023 and $0.49 bn in 2024, a reduction that is reflected in the declining “Other assets, including intangibles – net” balance. This downward trend shows ExxonMobil is relying less on external collateral, indicating a more efficient management of its derivative exposure and lower counterparty‑credit risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correctly stated: $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024). The number format variations ($1.49 bn vs $1,494 million) are semantically equivalent and acceptable. The multi-hop synthesis is sound - the answer correctly connects the collateral figures to the 'Other assets, including intangibles - net' line item and traces the three-year trend. The reasoning about derivative exposure management is logically sound and appropriately interprets the downward trend. However, there is a minor interpretive difference: the LLM characterizes the trend as showing 'ExxonMobil is relying less on external collateral' and emphasizes 'more efficient management' and 'lower counterparty-credit risk,' while the ground truth more conservatively states it 'indicates a strategic reduction in derivative-related exposure or a shift in risk management practices.' The LLM's interpretation is reasonable but slightly more definitive than the ground truth's more neutral framing. The answer fully addresses all parts of the question (the change from 2022-2024 and what the trend suggests), correctly identifies the company and metric, and provides appropriate context. The only minor weakness is the slightly more assertive interpretation of causation/intent compared to the ground truth's more measured language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 391,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe 2.700% senior notes were issued on March 29 2021 at a fixed 2.700% coupon, with semi‑annual interest payments on April 15 and October 15 and a maturity of April 15 2031 (par‑call January 15 2031). Across the 2022‑2024 filings (pages 46‑50 of the 2022 10‑K, pages 109‑113 of the 2023 10‑K, and pages 112‑116 of the 2024 10‑K) the notes remain outstanding with the same coupon, interest schedule and maturity, showing that AMT has deliberately retained this low‑cost, long‑dated debt while retiring higher‑rate obligations—an approach that capitalizes on favorable market conditions and locks in low rates before they rise.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2.700% coupon rate, the March 29, 2021 issuance date, semi-annual interest payment schedule (April and October), and the maturity date of April 15, 2031. The reasoning about AMT's deliberate retention of low-cost debt and strategic approach to financing is sound and relevant. The multi-hop synthesis across 2022-2024 filings is appropriately structured.\n\nCRITICAL ERRORS: (1) MATURITY DATE DISCREPANCY: The LLM states maturity as 'April 15, 2031' while the ground truth clearly states 'April 15, 2031' in 2022 but then 'January 15, 2031' in 2023 and 2024. This is a significant factual error—the maturity date appears to have been corrected or clarified between filings. (2) PAR CALL DATE: The LLM correctly mentions 'par-call January 15, 2031' but the ground truth indicates this was disclosed in 2022 as the par call date, yet by 2023-2024 the maturity date itself is listed as January 15, 2031, suggesting a potential correction in the filing disclosures. (3) INTEREST RATE SPREAD: The ground truth explicitly mentions a decrease in interest rate spread from (5.0) to (4.4) by 2024, which the LLM completely omits. This is a key metric showing the evolution of financing terms and is directly relevant to the question about how terms 'evolved.' (4) PRINCIPAL AMOUNT: While the LLM doesn't explicitly state the $700.0 million principal, it's implied by context, but the ground truth explicitly confirms this remained constant across all three years.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the strategic pattern (retention of low-cost debt). However, it misses the quantitative evolution (the spread reduction) that would strengthen the analysis of how financing strategy evolved.\n\nSEMANTIC ISSUES: The maturity date inconsistency between the LLM answer and ground truth is not merely a wording difference—it represents a factual discrepancy in the actual filing data that should have been captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 547,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nThe fair‑value of NVIDIA’s 2.00 % Notes due 2031 was $1.04 billion at the end of fiscal 2023 and rose modestly to $1.06 billion by the end of fiscal 2024 (Note 9 – Fair Value of Financial Assets and Liabilities). The underlying principal and maturity date did not change; the increase reflects the notes’ growing market value as discount rates fell. This steady, low‑coupon, long‑dated debt shows NVIDIA’s long‑term strategy of anchoring its capital structure with inexpensive, durable financing to fund growth while avoiding frequent refinancing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding the financial data. Ground truth shows: 2022 fair value of $1.2 billion, 2023 beginning value of $1.044 billion and ending value of $1.057 billion, and 2024 carrying value of $1.25 billion. The LLM answer states the fair value was $1.04 billion at end of fiscal 2023 and $1.06 billion at end of fiscal 2024. While the 2023 figure ($1.04B vs $1.044B) is approximately correct, the 2024 figure ($1.06B vs $1.25B) is dramatically incorrect—off by $190 million or 15%. Additionally, the LLM completely omits the 2022 data point ($1.2 billion), which is a critical part of the 'evolution from 2022 through 2024' requested in the question. INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about evolution 'from 2022 through 2024,' requiring three data points across three years. The LLM only addresses 2023-2024, missing the starting point entirely. This is a fundamental failure to address the complete temporal scope of the question. REASONING ISSUES: While the LLM's interpretation about discount rates and market value is reasonable, it's based on incorrect numbers. The explanation about 'steady, low-coupon, long-dated debt' strategy is qualitatively sound but undermined by the factual errors. The ground truth explicitly notes the 2024 carrying value was $1.25 billion with 'no short-term portion,' which the LLM does not mention. POSITIVE ASPECTS: The LLM correctly identifies the notes as 2.00% Notes Due 2031, correctly notes the principal and maturity date didn't change, and provides reasonable strategic interpretation about capital structure management. The citation to Note 9 is appropriate. However, these qualitative strengths cannot overcome the significant quantitative failures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 490,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife’s deposit assets on reinsurance fell from roughly $5.5 billion to $4.6 billion, and its deposit liabilities declined from about $1.4 billion to $1.2 billion. This reduction shows a deliberate pull‑back from the deposit method, signaling a strategic shift toward more traditional ceding arrangements and a focus on simplifying the reinsurance program and improving capital efficiency.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all key factual points. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM states deposit assets fell from $5.5B to $4.6B, but ground truth shows they INCREASED from $1.8B (2022) to $5.1B (2024). The LLM's starting number of $5.5B is not supported by any year mentioned in ground truth. The LLM correctly identifies deposit liabilities declining from ~$1.4B to ~$1.2B, which aligns with ground truth ($1.4B in 2022 to $1.2B in 2024), but this is the only partially correct element. (2) DIRECTIONAL REASONING ERROR - CRITICAL: The LLM concludes there was a 'pull-back from the deposit method' with declining assets, but ground truth explicitly states deposit assets showed a 'clear upward trend' increasing nearly 3x from $1.8B to $5.1B. This is a complete reversal of the actual trend. (3) STRATEGIC INTERPRETATION ERROR: The LLM interprets the trend as 'simplifying the reinsurance program and improving capital efficiency,' but ground truth indicates the opposite - a 'strategic shift toward managing risk exposure through reinsurance structures' with significantly increased deposit assets, particularly related to the $10.3B Global Atlantic transaction in 2023. (4) MISSING CONTEXT: The LLM fails to mention the Global Atlantic transaction entirely, which is a key driver of the trend and critical to understanding MetLife's reinsurance strategy evolution. (5) MULTI-HOP SYNTHESIS FAILURE: The answer fails to correctly synthesize the relationship between increasing deposit assets and the company's strategic reinsurance positioning. The core narrative is inverted - the LLM describes a contraction when the ground truth describes an expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 462,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nUnitedHealth Group’s held‑to‑maturity debt‑security portfolio slipped from **$603 million (amortized cost) / $596 million (fair value) at year‑end 2022** to **$512 million (amortized cost) / $508 million (fair value) at year‑end 2024** (the 2023 figure remained $603 million/$596 million).  The roughly $90 million reduction in carrying amount and $88 million decline in fair value over the three‑year span reflects a deliberate downsizing of long‑duration fixed‑income holdings—likely to curb interest‑rate sensitivity and re‑allocate capital toward shorter‑maturity or more liquid assets—while the remaining securities continued to trade below cost, a pattern the company attributes to broad market rate increases rather than credit deterioration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) YEAR LABELING ERROR: The LLM states '2022' figures but then provides 2023 values ($603M/$596M), creating confusion about which year's data is being presented. The ground truth clearly shows 2022 had $696M carrying value and $679M fair value, NOT $603M/$596M. (2) INCORRECT 2023 CLAIM: The LLM states '(the 2023 figure remained $603 million/$596 million)' which is factually wrong—2023 values were $603M carrying value and $596M fair value, but these are NOT the same as 2022. The LLM appears to have confused the years entirely. (3) CALCULATION ERRORS: The LLM claims '$90 million reduction in carrying amount' from 2022-2024, but the correct calculation is $696M - $512M = $184M reduction, not $90M. Similarly, the fair value decline should be $679M - $508M = $171M, not $88M. (4) MISSING 2022 DATA: The ground truth explicitly provides 2022 figures ($696M carrying, $679M fair value), but the LLM either omits or mislabels them. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the three-year trend and provide strategic interpretation, the underlying data is incorrect, making the entire analysis unreliable. The qualitative reasoning about interest-rate sensitivity and capital reallocation is reasonable but cannot compensate for the quantitative inaccuracies. The answer demonstrates a fundamental misunderstanding of the year-to-year progression and contains calculation errors that would mislead investors or analysts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 429,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe Target Credit Card (now the Target Circle Card) penetration fell each year: ≈ 20.5 % in fiscal 2022 (ended Jan 29 2022), ≈ 19.8 % in fiscal 2023 (ended Jan 28 2023) and ≈ 18.6 % in fiscal 2024 (ended Feb 3 2024). This steady decline indicates that the card‑holder discount program is losing its ability to attract new cardholders and to generate incremental purchases, suggesting that the current credit‑card strategy is becoming less effective at driving additional sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All penetration rate numbers are correct: 20.5% (2022), 19.8% (2023), 18.6% (2024). (2) Fiscal year dates are accurate. (3) The downward trend is correctly identified. (4) Number formatting is appropriate. WEAKNESSES: (1) The LLM's interpretation of the trend is overly negative and incomplete. The ground truth states the decline 'may indicate weakening engagement' but also notes that 'Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.' The LLM concludes the strategy is 'becoming less effective' without acknowledging this nuance about ongoing strategic value. (2) The LLM states the card is 'losing its ability to attract new cardholders and to generate incremental purchases' - this is a stronger, more definitive claim than the ground truth supports. The ground truth is more measured, suggesting the trend 'may indicate' issues rather than definitively stating the strategy is failing. (3) The LLM misses the important caveat that despite the declining penetration rate, Target still sees meaningful incremental sales contribution from the card. (4) The reasoning conflates declining penetration with declining effectiveness without fully exploring the distinction - a lower penetration rate doesn't necessarily mean the card is ineffective for those who do use it. MULTI-HOP SYNTHESIS: The LLM correctly synthesized the three-year trend but failed to fully synthesize the complete picture that includes both the declining penetration AND the ongoing strategic value mentioned in the ground truth. The answer is partially correct on facts but incomplete and somewhat misleading in its interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 477,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nNike continued to **own** its major distribution hub in **Laakdal, Belgium** across the FY 2022, FY 2023 and FY 2024 filings, listing it alongside other owned overseas sites (e.g., Taicang, China; Tomisato, Japan; Icheon, Korea).  This consistent, wholly‑owned status shows that Nike is deliberately **reinforcing direct control over its European logistics network**, using Laakdal as a strategic gateway to serve European markets efficiently and to underpin its broader supply‑chain expansion in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies Nike's ownership status of Laakdal, Belgium facility across FY 2022-2024; (2) Accurately notes the consistency of ownership and operational role across the three-year period; (3) Properly contextualizes Laakdal within Nike's broader European logistics strategy; (4) Appropriately compares it to other owned facilities (Taicang, Tomisato, Icheon) to support the point about direct control; (5) Correctly interprets the strategic implications of maintaining ownership. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language about 'reinforcing direct control' and 'strategic gateway' that goes slightly beyond what the ground truth explicitly states, though this is reasonable inference from the consistency noted; (2) The ground truth emphasizes that the facility was 'described as one of the most significant international distribution centers' with this characterization remaining consistent - the LLM captures the consistency but doesn't explicitly mention the 'most significant' descriptor, though it does call it a 'major distribution hub' which is semantically equivalent; (3) The LLM provides more strategic context and interpretation than the ground truth, which is appropriate for the question but represents a modest expansion beyond the stated facts. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (FY 2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information about ownership status, operational consistency, and strategic implications across the three-year period. The comparison to other owned facilities demonstrates appropriate cross-entity synthesis. SEMANTIC EQUIVALENCE: The core message matches the ground truth - Nike maintained ownership and operational consistency at Laakdal throughout the period, indicating stable strategic focus on European logistics infrastructure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 563,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nAcross the FY 2022, FY 2023 and FY 2024 10‑K filings, Lumentum Holdings is consistently listed among NVIDIA’s networking competitors (optical modules, switches and DPUs).  At the same time, NVIDIA’s narrative shifts toward expanding its own supply‑chain capabilities—adding redundant, in‑house and contract‑manufacturer sources for interconnect and cable solutions—and to strengthening IP protection through a growing patent portfolio and tighter export‑control licensing.  These developments suggest that NVIDIA is increasingly relying on internal or tightly controlled suppliers rather than external vendors, causing Lumentum’s relative competitive weight to recede over the three fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Lumentum Holdings as consistently listed among NVIDIA's competitors across FY 2022-2024. (2) Accurately captures the product categories (optical modules, switches, DPUs, interconnect solutions). (3) Correctly identifies NVIDIA's strategic shifts toward supply chain resilience and IP protection expansion. (4) Properly synthesizes the multi-hop relationship between Lumentum's competitive positioning and NVIDIA's strategic moves. (5) No quantitative errors in dates or fiscal years cited.\n\nWEAKNESSES: (1) CRITICAL INTERPRETATION ISSUE: The LLM concludes that \"Lumentum's relative competitive weight to recede over the three fiscal years\" - this is NOT supported by the ground truth. The ground truth explicitly states \"The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force\" and \"despite NVIDIA's strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.\" The LLM's inference that internal sourcing causes Lumentum's competitive weight to recede is speculative and contradicts the ground truth's finding of persistent relevance. (2) The LLM makes an unsupported causal claim about NVIDIA \"increasingly relying on internal or tightly controlled suppliers rather than external vendors\" causing Lumentum's decline - the ground truth does not support this conclusion. (3) Missing explicit mention of specific patent portfolio expansion details (expiration dates moving from 2022 to 2045) that the ground truth includes. (4) The framing suggests a weakening competitive position for Lumentum, when the ground truth indicates consistent, persistent positioning.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize NVIDIA's strategic moves with Lumentum's positioning, but draws an incorrect conclusion. While the individual facts about NVIDIA's supply chain and IP strategies are correct, the inference about Lumentum's declining competitive weight is not grounded in the source material.\n\nSEMANTIC EQUIVALENCE: The answer diverges significantly from ground truth in its ultimate conclusion about competitive trajectory, despite correctly identifying the facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 595,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s dependence on external rights‑holders has become increasingly fragile: studios and content providers are pulling popular titles, demanding higher fees and reserving exclusivity for their own streaming services, which forces Netflix to negotiate tighter, more expensive licensing deals or lose access to key libraries. In response, the company has shifted its acquisition strategy toward greater investment in original productions and exclusive content agreements, while also contending with new regulatory pressures—such as European content‑quota and levy rules—that can limit how it licenses or owns material. This evolution reveals a strategic pivot from a pure‑licensing model to a hybrid approach that relies more on owned‑and‑produced content to differentiate the service amid intensifying competition and evolving global regulatory environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-part question about Netflix's content licensing evolution from 2022-2024. STRENGTHS: (1) No quantitative errors—the answer contains no specific numbers, dates, or calculations that could be verified against ground truth, which is appropriate given the question's qualitative nature. (2) Entity accuracy is correct: Netflix is properly identified, the time period (2022-2024) is accurate, and all referenced concepts (rights holders, licensing, original content, regulatory pressures) align with the ground truth. (3) Multi-hop synthesis is sound: the answer correctly synthesizes information across three years, identifying the progression from licensing-focused to hybrid strategy, and connects this to both competitive and regulatory drivers. (4) Semantic equivalence is strong: the LLM's framing of 'fragile dependence,' 'studios pulling titles,' 'higher fees,' and 'regulatory pressures' accurately captures the ground truth's emphasis on rising competition and regulatory constraints. (5) Strategic insight is accurate: the characterization of a shift toward original/exclusive content while navigating regulatory environments matches the ground truth's conclusion about 'strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.' MINOR WEAKNESSES: (1) The LLM uses slightly more dramatic language ('increasingly fragile,' 'forces Netflix') compared to the ground truth's more measured tone ('remained a core risk factor,' 'increasingly framed'). While this doesn't affect factual accuracy, it represents a modest interpretive difference. (2) The answer could have been more explicit about the consistency of licensing concerns across all three years (the ground truth notes the discussion 'remained consistent' in 2023), though the LLM does capture the overall evolution. (3) The LLM doesn't explicitly mention the 'variability of license terms' emphasized in the 2023 discussion, though this is a minor omission. Overall, the answer correctly synthesizes the multi-year evolution, accurately identifies the strategic pivot, and appropriately contextualizes it within competitive and regulatory pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 607,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company kept outdoor‑lighting contracts in the “operating‑leases” line of its lease‑income table and continued to exclude any variable‑payment amounts from the maturity analysis.  The contracts were consistently described as immaterial, so they are not shown as a separate line item but are simply rolled into the aggregate operating‑lease maturity schedule, with the same presentation format used in each year.  Consequently, there was no change in materiality, revenue classification, or how the scheduled payments are displayed in the maturity tables across the 2022‑2024 periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and demonstrates a critical misunderstanding of the question and the actual evolution of Southern Company's disclosure practices. Key issues: (1) FACTUAL INACCURACY - The LLM claims there was 'no change' in materiality, revenue classification, or presentation from 2022-2024, directly contradicting the ground truth which explicitly documents a clear evolution: immaterial treatment in 2022 → inclusion in maturity analyses by 2023 → expanded disclosure in 2024. (2) MISSING CRITICAL PROGRESSION - The ground truth identifies three distinct phases: 2022 (immaterial, undisclosed), 2023 (shift to inclusion in maturity analyses), 2024 (explicit inclusion with expanded disclosure). The LLM completely misses this temporal progression and the materiality shift. (3) INCORRECT CHARACTERIZATION - The LLM states contracts were 'consistently described as immaterial' across all years, but the ground truth shows materiality treatment evolved and disclosure became more formalized over time. (4) WRONG CONCLUSION - The LLM concludes 'there was no change' when the entire premise of the ground truth is that there WAS significant change in treatment and disclosure. (5) INCOMPLETE SYNTHESIS - The question asks about evolution 'from 2022 to 2024' specifically regarding materiality, revenue classification, and presentation. The LLM fails to address the multi-hop synthesis required to show how these three dimensions changed across the three-year period. The LLM appears to have either misread the source material or confused the disclosure requirements with actual practice. The answer demonstrates poor multi-hop reasoning and fails to capture the documented evolution in Southern Company's approach to outdoor lighting contract disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 489,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000% notes due April 2030 had an outstanding principal of roughly $603 million at the end of fiscal 2022, increased modestly to $606 million by the end of fiscal 2023 and remained at $606 million through fiscal 2024. This flat trajectory shows that the company is treating the issuance as a stable, long‑term financing component and is not actively repaying or refinancing this tranche.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states FY2022 balance was 'roughly $603 million' when the ground truth clearly shows $1,086 million - a massive $483 million discrepancy (44% error). The LLM claims the balance 'increased modestly to $606 million by the end of fiscal 2023' when ground truth shows it DECREASED from $1,086M to $606M - the LLM has the direction of change completely backwards. (2) DIRECTIONAL MISINTERPRETATION: The LLM characterizes the trajectory as 'flat' when in fact there was a significant $480 million reduction in 2023. This is not a minor wording difference - it's a fundamental misunderstanding of the debt evolution. (3) STRATEGIC ANALYSIS FAILURE: The LLM's conclusion that 'the company is treating the issuance as a stable, long-term financing component and is not actively repaying or refinancing this tranche' is directly contradicted by the ground truth, which explicitly states there was a 'deliberate debt reduction strategy in 2023.' The LLM missed the most important aspect of the company's debt management strategy - the substantial principal repayment in 2023. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression, getting both the starting point and the year-over-year changes wrong. The only correct data point is the FY2024 balance of $606 million. This answer demonstrates a fundamental failure to accurately extract and interpret the financial data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 434,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nGM’s long‑term expected return on U.S. pension assets climbed from **5.6 % in 2022 to 6.3 % in 2023** and stayed essentially flat at **≈6.27 % in 2024**.  This upward shift reflects a deliberate **strategic re‑allocation of the pension portfolio**—equity exposure was raised (from 9 % to 11 % of assets) and “other” (private‑equity, real‑estate, hedge‑fund) allocations increased (from 23 % to 29 %), while debt exposure was trimmed (from 68 % to 60 %).  The changes are aimed at generating higher returns to improve funded positions and offset lower discount rates, while still managing volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE NUMBERS: The LLM answer contains fundamental factual errors in the primary metric being evaluated. Ground truth states: 2022=5.4%, 2023=6.3%, 2024=6.5%. LLM states: 2022=5.6%, 2023=6.3%, 2024≈6.27%. The 2022 figure is wrong (5.6% vs 5.4% - a 0.2 percentage point error), and the 2024 figure is significantly wrong (6.27% vs 6.5% - a 0.23 percentage point error). These are not minor rounding differences; they represent material misstatements of GM's actual pension assumptions. The ground truth explicitly states the 2023 rate 'remained unchanged at 6.3%' from 2022, but the LLM incorrectly shows an increase from 5.6% to 6.3%. CALCULATION ERROR: The LLM characterizes the 2024 change as 'essentially flat' at 6.27%, but ground truth shows 6.5%, which represents a 0.2 percentage point increase from 2023 (6.3% to 6.5%), not a flat trajectory. The overall 3-year trend magnitude is also wrong: ground truth shows 1.1 percentage point increase (5.4% to 6.5%), while LLM shows only 0.67 percentage point increase (5.6% to 6.27%). ASSET ALLOCATION DETAILS: While the LLM provides specific asset allocation percentages (equity 9% to 11%, other 23% to 29%, debt 68% to 60%), these cannot be verified against the ground truth provided, which does not include these specific allocation figures. The LLM appears to have added details not present in the ground truth answer. REASONING: The LLM's interpretation about strategic reallocation and the rationale (higher returns, funded positions, discount rates) is reasonable and contextually relevant, but this cannot compensate for the fundamental errors in the core quantitative data. The multi-hop synthesis is attempted but built on incorrect foundational numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 472,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe 2.700 % Senior Notes due 2031 appear in the supplemental indentures filed in 2022, 2023 and 2024, showing that the issue remains outstanding and is being referenced in later debt‑amendment transactions.  This signals that American Tower is treating the 2031 notes as a core, long‑dated, low‑coupon component of its capital structure—using long‑maturity, fixed‑rate debt to fund its tower portfolio and maintain a stable, diversified maturity profile rather than retiring or refinancing the securities early.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of American Tower's financing strategy regarding the 2.700% Senior Notes due 2031, with correct identification of the key facts: (1) the notes appear consistently across 2022-2024 filings, (2) they represent a core long-term debt component, and (3) they reflect a stable financing approach. STRENGTHS: The numeric values (2.700%, 2031 maturity date) are correct. The answer correctly identifies the multi-year consistency across three filings and accurately characterizes this as indicating a stable, long-term financing strategy. The reasoning about using fixed-rate, long-maturity debt to maintain a diversified maturity profile is sound and relevant. WEAKNESSES: The LLM answer lacks specific reference to Supplemental Indenture No. 8 dated March 29, 2021, which the ground truth explicitly mentions as being consistently referenced across all three years. This is a notable omission of a concrete detail that supports the stability narrative. The phrase 'later debt-amendment transactions' is somewhat vague and could be misleading—the ground truth emphasizes that the same indenture was referenced without modifications, not that amendments occurred. The LLM answer infers strategic intent about 'funding tower portfolio' and 'maintaining stable, diversified maturity profile' which, while reasonable, goes slightly beyond what the ground truth explicitly states about the consistent treatment. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years of filings to reach a conclusion about long-term strategy, though it could have been more precise about the specific documentation continuity. The semantic meaning aligns well with the ground truth—both convey stability and strategic importance—but the LLM misses the specific documentary evidence (Supplemental Indenture No. 8) that most directly supports this conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 515,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior and credit‑related losses grew as fraud, charge‑backs and defaults increased across its credit products and cross‑border transactions, prompting the company to overhaul its risk‑management framework.  To mitigate these risks it (i) sold and securitized U.K./EU BNPL loan receivables and diversified its payment‑processor relationships—including a migration away from a single U.S. processor—thereby reducing reliance on vulnerable funding sources; (ii) strengthened fraud‑detection and buyer‑/seller‑protection systems and tightened underwriting for its consumer and merchant credit offerings; and (iii) enhanced cross‑border compliance and currency‑risk controls, tightening monitoring of international trade to limit the financial impact of abusive activity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM answer claims PayPal 'sold and securitized U.K./EU BNPL loan receivables' but the ground truth specifies a 'multi-year agreement to sell up to €40 billion' of these receivables. The LLM omits the critical €40 billion figure entirely, which is a significant quantitative detail. (2) FACTUAL INACCURACY: The LLM states 'exposure to abusive behavior and credit-related losses grew' from 2022-2024, but the ground truth does not support this characterization. The ground truth indicates PayPal identified the risk in 2022, then took strategic action to REDUCE exposure in 2023 by offloading receivables, and continued managing it in 2024. The LLM's framing suggests growing exposure rather than managed/mitigated exposure. (3) UNSUPPORTED CLAIMS: The LLM introduces several claims not in the ground truth: 'migration away from a single U.S. processor,' 'diversified its payment-processor relationships,' 'enhanced cross-border compliance and currency-risk controls,' and 'tightening monitoring of international trade.' While these may be reasonable inferences about risk mitigation, they are not explicitly stated in the ground truth and represent speculation beyond the provided information. (4) INCOMPLETE SYNTHESIS: The LLM fails to capture the three-year trajectory clearly articulated in the ground truth: identifying risk (2022) → offloading exposure (2023) → reinforcing detection while managing third-party dependencies (2024). Instead, it presents a more generic risk-management overhaul narrative. (5) PARTIAL CREDIT: The LLM correctly identifies that PayPal took strategic actions to mitigate risks and mentions BNPL receivables, fraud detection, and underwriting improvements, which aligns with the ground truth. However, the execution is flawed with missing quantitative specifics and unsupported elaborations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 508,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nThe pension plan’s stake in “Collective Trust and Other Funds” fell sharply in dollar terms—from **$622 million in 2022 to $498 million in 2023 and $382 million in 2024**—and its share of the total NAV portfolio dropped from roughly **46 % to 32 % and then to about 40 %**.  This pull‑back from alternative, less‑liquid investments coincides with UNP’s broader de‑risking strategy, which has moved the target allocation toward a much higher proportion of debt (≈70‑80 %) and a lower equity range (≈20‑30 %).  The trend signals that the company is deliberately reducing exposure to higher‑volatility fund assets and focusing on a more stable, income‑oriented portfolio to safeguard long‑term employee benefit obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly different dollar amounts than the ground truth. Ground truth states: $756M (2022) → $382M (2023) → no 2024 value provided. LLM claims: $622M (2022) → $498M (2023) → $382M (2024). The 2022 figure is wrong ($622M vs $756M, a $134M discrepancy of ~18%). The 2023 figure is also incorrect ($498M vs $382M, a $116M discrepancy of ~30%). The LLM appears to have fabricated a 2024 dollar value ($382M) when the ground truth explicitly states 'no updated dollar value is provided' for 2024. The percentage calculations (46% → 32% → 40%) cannot be verified against ground truth and appear inconsistent with the dollar amounts provided. QUALITATIVE ASSESSMENT: The LLM correctly identifies the general trend as a de-risking strategy and appropriately contextualizes this within a broader shift toward debt-heavy allocations (70-80%) and lower equity exposure (20-30%). The reasoning about moving toward more stable, income-oriented portfolios is sound and aligns with the ground truth's characterization of de-risking. However, the LLM adds specific percentage allocations and target ranges that are not mentioned in the ground truth, which may be accurate but cannot be verified. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize pension allocation data with broader investment strategy, which is appropriate for the question. However, the foundation is built on incorrect numbers, undermining the entire analysis. MAJOR ISSUE: The fabrication of a 2024 dollar value when ground truth explicitly states none was provided is a significant factual error that suggests the LLM hallucinated data rather than acknowledging uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 462,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards moved from an active grant program to a discontinued one. In 2022 the company began granting BPAs to selected non‑executive employees, measuring them at intrinsic value on the grant date and amortizing the expense over the probable vesting term while adjusting each reporting period for changes in share price and the probability of achieving the performance targets; a small number of awards remained outstanding at year‑end 2022. In 2023 the same intrinsic‑value methodology continued, but the 2022‑ and 2023‑granted BPAs were modified so that, for active participants, vesting would occur on the fifth anniversary rather than the original schedule, and the outstanding balance began to shrink as awards vested or were forfeited. By the end of 2024 no new BPAs were granted and none were outstanding, so no further expense is recorded and the program effectively ended.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. QUANTITATIVE ERRORS: (1) The LLM fails to cite any specific numbers from 2022 (1,165 thousand BPAs granted at $38.73 weighted average intrinsic value, 859 thousand outstanding at $59.05 per share) - these are critical quantitative details that should have been included. (2) The LLM incorrectly states that in 2023 'the same intrinsic-value methodology continued' when the ground truth clearly indicates 'no BPAs were granted and none remained outstanding' in 2023, suggesting a discontinuation rather than continuation. (3) The LLM invents details not in the ground truth, such as the claim that 2022 and 2023 BPAs were 'modified so that vesting would occur on the fifth anniversary' - this modification detail does not appear in the original answer. MULTI-HOP SYNTHESIS ISSUES: The LLM fails to properly synthesize the three-year evolution. The ground truth shows: 2022 (active issuance with specific metrics), 2023 (complete discontinuation), 2024 (new formalized methodology). The LLM's narrative suggests continuity from 2022-2023 ('the same intrinsic-value methodology continued') which contradicts the ground truth's clear statement of no grants and no outstanding awards in 2023. MISSING CRITICAL DETAILS: The LLM omits the 2024 formalized valuation methodology details (intrinsic value method based on closing stock price at grant date, quarterly adjustments for stock price changes and performance probability assessments). SEMANTIC ISSUES: While the LLM correctly identifies the overall arc (active to discontinued), it mischaracterizes the 2023 transition and invents intermediate details. The answer reads plausibly but contains material inaccuracies that would mislead readers about the actual program evolution and accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 501,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nThe collateral that the company posts under master‑netting arrangements fell sharply – from about **$1.49 billion in 2022**, to **$0.80 billion in 2023**, and then to **$0.49 billion in 2024**.  This downward trend shows that ExxonMobil’s net credit exposure to derivative counterparties has been trimmed, so the amount of external collateral (mainly initial margin) that must be posted against its investments, advances and long‑term receivables has been reduced, reflecting either smaller derivative notional balances or improved counterparty credit quality and lower margin‑call requirements over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively. The format variation ($1.49B vs $1,494M) is acceptable and properly handled. The downward trend is accurately captured. (2) COMPLETENESS: The answer addresses all parts of the multi-part question - it provides the collateral values for all three years, identifies the trend (downward), and explains what the trend suggests about derivative exposure and margin requirements. (3) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is properly referenced, and all three fiscal years (2022, 2023, 2024) are correct. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly interprets the downward trend as indicating reduced derivative exposure and provides nuanced explanation about margin requirements, counterparty credit quality, and notional balances - all reasonable interpretations that go slightly beyond the ground truth but remain consistent with it. The explanation about 'initial margin' and 'net credit exposure' demonstrates sophisticated understanding of derivative accounting. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that the trend reflects 'smaller derivative notional balances or improved counterparty credit quality and lower margin-call requirements' is semantically equivalent to and more detailed than the ground truth's 'reduction in derivative exposure or a strategic adjustment in margin requirements.' Minor point: The ground truth uses 'fluctuated significantly' while the LLM uses 'fell sharply' - both accurately describe the downward movement, though 'fell sharply' is slightly more precise given the consistent decline across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 538,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom’s 10‑K filings show that in 2022 industrial fiber‑optics was listed only as one of several “Industrial” components (alongside optocouplers, sensors and motion‑control encoders) and was framed mainly as a support technology for factory‑automation and medical‑device applications (see AVGO_10k_2022.pdf pp. 8‑12). By 2023 the company broadened the narrative, presenting industrial fiber‑optics as a distinct growth area within its industrial portfolio and explicitly linking it to renewable‑energy and automotive‑electronics use‑cases alongside optocouplers, sensors and encoders (see AVGO_10k_2023.pdf pp. 3‑7). In 2024 the emphasis shifted further, describing industrial fiber‑optics as part of a comprehensive automation suite that serves a wider range of industrial end‑markets—from factory automation to renewable‑energy systems—underscoring a strategic intent to deepen Broadcom’s presence in high‑margin, diversified industrial markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year evolution (2022, 2023, 2024) and captures the general trajectory of Broadcom's Industrial Fiber Optics positioning. (2) Entity accuracy is solid - correct company (Broadcom/AVGO), correct years, correct product categories (optocouplers, sensors, encoders, Ethernet ICs). (3) The LLM appropriately recognizes the shift from broad positioning to more structured, application-specific framing. (4) Multi-hop synthesis across three years is attempted and generally sound. (5) Page references are provided (though not verifiable against ground truth). WEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM fails to mention several key applications explicitly noted in the ground truth for 2022: power systems, defense, aerospace, and automotive subsystems/electric vehicles. The ground truth emphasizes a 'broad industrial product suite' across these diverse applications, but the LLM narrows this to 'factory-automation and medical-device applications' only. (2) The LLM characterizes 2022 positioning as 'only as one of several components' which contradicts the ground truth's description of Industrial Fiber Optics as part of a 'broad industrial product suite' - this suggests different emphasis/framing. (3) The LLM's description of 2023 as 'broadened the narrative' and 2024 as 'shifted further' doesn't fully align with ground truth's characterization of 2023 as 'maintained this positioning' with structured table format emphasis. (4) The LLM adds interpretive language about 'strategic intent to deepen Broadcom's presence in high-margin, diversified industrial markets' that goes beyond what the ground truth states - the ground truth is more measured, noting 'consistent strategic focus' with 'increasing emphasis on structured, application-specific clarity.' (5) No quantitative data (revenue figures, market share, growth rates) is provided, though the question doesn't explicitly require this. CALCULATION/VERIFICATION: No calculations required; no numeric claims to verify. SEMANTIC ISSUES: The LLM's framing of the evolution as a 'broadening' then 'shifting' narrative differs from ground truth's more nuanced view of 'maintained positioning' with evolving presentation formats. This represents a meaningful interpretive difference that affects the accuracy of the strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 625,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nAcross 2022 through 2024 PayPal continues to record transaction revenue on a **gross‑basis** and treats the fees it pays to third‑party processors as a separate “transaction expense,” thereby **bearing full margin risk** for every payment it authorizes.  The company retains complete discretion over the **transaction‑pricing structure**—including variable percentages, tiered volume discounts and performance‑based incentives—so the margin it retains is directly driven by the fees it sets.  While total payment volume and revenue grew each year, the underlying mechanics of pricing control and reliance on external processors remained essentially unchanged, so PayPal’s exposure to margin risk stayed constant, with only incremental refinements to incentive accounting and contract‑asset recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's gross-basis revenue recognition across 2022-2024, matching the ground truth's core assertion about margin risk exposure. (2) Accurately captures PayPal's full discretion over transaction pricing (variable percentages, tiered discounts, performance-based incentives) - these specific pricing mechanisms are appropriate elaborations consistent with the ground truth's statement about 'full discretion over fee pricing.' (3) Properly synthesizes the multi-hop relationship: PayPal bears margin risk BECAUSE it records revenue gross and treats processor fees as separate transaction expenses - this causal logic is sound and matches the ground truth's reasoning. (4) Correctly identifies the consistent/stable nature of margin risk exposure across all three years (2022-2024), with no material changes - directly matching ground truth's conclusion. (5) Appropriately notes that 'total payment volume and revenue grew each year' while 'underlying mechanics remained essentially unchanged,' which is a reasonable elaboration on the stability theme. (6) No quantitative errors - no specific numbers are provided that could be incorrect, and the temporal framing (2022-2024) is accurate. MINOR CONSIDERATIONS: (1) The LLM adds specific details about 'incremental refinements to incentive accounting and contract-asset recognition' which, while plausible, are not explicitly mentioned in the ground truth. However, these are presented as minor refinements and don't contradict the core finding of stability. (2) The answer is slightly more detailed/technical than the ground truth (mentioning gross-basis accounting explicitly), but this represents appropriate elaboration rather than error. The semantic equivalence is strong - both answers convey that PayPal maintained consistent margin risk exposure and pricing control across 2022-2024 through its use of third-party processors while retaining revenue on a gross basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 553,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s exposure to Meridian narrowed to a residual, wind‑down phase: the 2021 sale generated a $167 million after‑tax loss, and the 2022 10‑K (pp. 114‑118) notes that any post‑closing adjustments were immaterial; the 2023 10‑K (pp. 71‑75) confirms that the interim transition‑service agreements and the three‑year Master Services Agreement—under which any limited post‑sale services were to be provided—were fully performed and expired by the end of 2023, with no material revenue or expense recorded in 2023 or 2024; the 2024 10‑K (pp. 2‑6) shows no remaining contractual obligations or financial impact from Meridian.  This progression indicates that Pfizer has deliberately disengaged from the Meridian business, ending its strategic partnership and shifting focus away from that legacy area toward its core vaccine, oncology and other biopharma priorities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the $167 million after-tax loss from the 2021 sale, the three-year Master Services Agreement (MSA), and the strategic shift away from Meridian toward core therapeutic areas. The reasoning about the wind-down phase and disengagement is sound and aligns with the ground truth narrative. The answer appropriately synthesizes information across multiple years (2022-2024) and correctly notes the transition from discontinued operations to a contract-based relationship.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer states the MSA 'expired by the end of 2023' with 'no material revenue or expense recorded in 2023 or 2024,' but the ground truth explicitly mentions the MSA 'extended for three years post-sale with a two-year extension option.' The LLM's claim that the agreement fully expired by end of 2023 contradicts the ground truth's indication of a potential two-year extension option that could extend the relationship beyond 2023. This is a significant factual discrepancy about the contractual arrangements. (2) The LLM answer lacks the specific detail that Meridian was 'listed in Pfizer's glossary as Meridian Medical Technologies, Inc.' in 2024, which the ground truth identifies as indicating a formalized relationship status. (3) The LLM provides specific page references (pp. 114-118, pp. 71-75, pp. 2-6) that cannot be verified against the ground truth and may be fabricated or inaccurate. (4) The sale price of $51 million is mentioned in the ground truth but not in the LLM answer, representing an incomplete financial picture.\n\nQUANTITATIVE ACCURACY: The $167 million loss figure is correct. However, the omission of the $51 million sale price and the incorrect characterization of the MSA's expiration timeline (claiming full expiration by end of 2023 when a two-year extension option existed) represents a material quantitative/contractual accuracy issue.\n\nQUALITATIVE ACCURACY: The multi-hop reasoning is generally sound in connecting the 2021 sale, the post-sale agreements, and the strategic refocusing. However, the mischaracterization of the MSA's duration and extension options represents a reasoning error about contractual arrangements.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses all parts of the question (financial impact, contractual arrangements, strategic positioning, and long-term focus), though with the noted omissions and inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 650,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory pressure on PMI’s reduced‑risk products intensified markedly, progressively narrowing the company’s ability to differentiate those products and to communicate with adult consumers.  In 2022 the filings noted existing bans on advertising, flavor restrictions and plain‑packaging rules, but by 2023 the scope of restrictions expanded to include broader flavor prohibitions, tighter limits on any health‑related or benefit‑focused messaging for RRPs/SFPs, and heightened scrutiny of product‑specific claims.  By 2024 further measures—such as mandatory plain‑packaging, bans on brand‑level marketing and stricter controls on communications about reduced‑risk products—have substantially curtailed PMI’s capacity to distinguish its RRPs and to reach adult smokers, eroding its competitive positioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL INACCURACY - The LLM answer introduces specific regulatory measures (mandatory plain-packaging, flavor restrictions, brand-level marketing bans) that are NOT supported by the ground truth. The ground truth does not mention these specific regulatory actions in the 2022-2024 period. (2) MISREPRESENTATION OF EVOLUTION - The ground truth clearly states that the company's language evolved from discussing 'RRPs' to 'SFPs' by 2024, and that the key issue was restrictions on COMMUNICATION and DIFFERENTIATION ability. The LLM answer fabricates a progression of increasingly specific regulatory measures (flavor bans, plain-packaging, brand-level marketing bans) that are not mentioned in the original answer. (3) MISSING CORE INSIGHT - The ground truth emphasizes that regulation 'disproportionately impacted the commercialization of RRPs relative to competitors' (2023 evolution), which is a crucial competitive positioning element. The LLM answer mentions competitive positioning erosion but doesn't capture this specific comparative disadvantage insight. (4) TERMINOLOGY ACCURACY - The LLM correctly identifies the RRP-to-SFP terminology shift, but this is a minor point compared to the fabricated regulatory details. (5) MULTI-HOP REASONING - The LLM failed to properly synthesize the actual evolution described in the ground truth (which focuses on communication restrictions and differentiation limitations) and instead invented a narrative about specific regulatory measures. The answer reads plausibly but is fundamentally disconnected from the actual filing content. WHAT WAS CORRECT: The general theme that regulatory pressure intensified from 2022-2024 and that it affected PMI's competitive positioning is directionally correct. However, the specific regulatory mechanisms described are not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 503,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements and is **not** offset against its derivative liabilities fell sharply—from about **$1.49 billion in 2022 to $0.80 billion in 2023 and $0.49 billion in 2024**, a total decline of roughly **$1.0 billion** over the three‑year span.  This reduction shows that the company is deliberately scaling back the amount of collateral it must post, reflecting tighter derivative positioning, stronger counterparty credit quality and a more disciplined approach to managing derivative‑related credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively (format variations are acceptable). The calculated total decline of ~$1.0 billion is accurate ($1,494M - $491M = $1,003M). ENTITY ACCURACY: Correctly identifies ExxonMobil (XOM), the specific metric (collateral under master netting arrangements related to Notes and accounts receivable - net), and all three fiscal years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and connects it to derivative risk management practices. The interpretation that the downward trend reflects 'deliberately scaling back collateral,' 'tighter derivative positioning,' and 'more disciplined approach to managing derivative-related credit risk' aligns well with the ground truth's characterization of 'strategic reduction in derivative exposure' and 'proactive risk mitigation.' MINOR DIFFERENCES: The LLM provides slightly more detailed interpretation (mentioning 'stronger counterparty credit quality' and 'tighter derivative positioning') compared to the ground truth's more general reference to 'lower margin requirements or proactive risk mitigation.' These additions are reasonable inferences from the data trend and don't contradict the ground truth. The LLM's clarification that this collateral is 'not offset against derivative liabilities' adds helpful technical precision. COMPLETENESS: The answer fully addresses both parts of the question - the numerical change and what it suggests about risk management practices. No material information is missing or incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 482,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy’s expected volatility assumption fell from **28.6 % in 2022 (and again in 2023)** to **18.7 % for awards granted in 2024**.  This decline shows the company moved from a relatively high‑risk view of future price swings to a more muted expectation of market volatility, reflecting a shift toward perceiving lower equity‑price risk over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 volatility assumption. Ground truth states the 2022 volatility was 26.9%, but the LLM claims it was 28.6% in 2022 (and again in 2023). This is incorrect - 28.6% was actually the 2023 figure according to the ground truth. The LLM has essentially swapped or misidentified the 2022 and 2023 values. The 2024 figure of 18.7% is correct. MULTI-HOP SYNTHESIS FAILURE: The question asks about the evolution from 2022 to 2024, requiring synthesis of three data points across three years. The LLM failed to correctly identify all three years' values and their progression. The correct sequence is: 2022 (26.9%) → 2023 (28.6%, a slight increase) → 2024 (18.7%, a significant decrease). The LLM's sequence is wrong, missing the important detail that volatility actually increased from 2022 to 2023 before dropping in 2024. REASONING QUALITY: While the LLM's interpretation about the trend suggesting lower equity-price risk is reasonable, it's based on incomplete/incorrect data. The ground truth specifically notes the 'short-term increase in 2023' as a notable feature of the trend, which the LLM completely misses due to the data error. COMPLETENESS: The LLM addresses the general direction of change but fails to capture the nuanced three-year evolution that the question specifically asks about. The answer is incomplete in its treatment of the 2022-2023 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 405,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nThe 3.125 % senior notes that mature in January 2025 remained unchanged at a $495 million carrying amount in the fiscal‑year‑end balances for 2022, 2023 and 2024. Because this liability is included in the $1.245 billion “current portion of long‑term debt” reported as of Nov 3 2024, Broadcom is managing it as a short‑term obligation that will be rolled into its broader refinancing program—relying on the issuance of new senior notes and repayments of the 2023 term‑loan facilities rather than a direct cash repayment of the 2025 note. This pattern reveals a strategy of extending maturities through large‑scale note issuances and term‑loan refinancing, while the 2025 note stays on the books until its eventual settlement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the $495 million carrying amount for the 3.125% notes due January 2025 across all three fiscal years (2022, 2023, 2024). The quantitative data is accurate, and the answer correctly identifies the note's transition to current portion of long-term debt by fiscal year 2024. The LLM provides additional context about the $1.245 billion current portion of long-term debt as of November 3, 2024, which adds specificity and demonstrates deeper filing analysis. The multi-hop reasoning is sound: the answer synthesizes the stable $495M obligation across years with its classification change and connects this to Broadcom's broader refinancing strategy involving new senior note issuances and term-loan refinancing. However, there are minor differences from the ground truth: (1) The ground truth emphasizes that the note 'remained stable at $495 million in both fiscal years 2022 and 2023' and then 'transitioned' in 2024, whereas the LLM states it 'remained unchanged...in fiscal-year-end balances for 2022, 2023 and 2024' - this is slightly imprecise wording suggesting the same treatment across all three years rather than a transition in 2024. (2) The LLM provides more speculative detail about refinancing strategy (mentioning specific mechanisms like 'issuance of new senior notes and repayments of the 2023 term-loan facilities') that goes beyond what the ground truth explicitly states, though this appears to be reasonable inference from filing data. (3) The ground truth's phrasing about 'impending maturity that likely triggered internal refinancing or liquidity planning in 2024' is more cautious than the LLM's more definitive statements about the refinancing program. Overall, the answer is substantively correct with strong quantitative accuracy and appropriate contextual relevance, with only minor qualitative differences in emphasis and specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 524,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nFrom 2022 through 2024 AMD tightened the inventory‑protection clauses it offers AIB manufacturers—standard agreements now shield AIB stock from price cuts and grant return rights for products older than 12 months, with newer terms adding limited stock‑rotation provisions—thereby giving partners greater confidence to carry discrete GPU parts.  At the same time, AMD leaned on discrete Radeon graphics (especially the Instinct and Radeon PRO V‑series) as a core differentiation tool for OEMs and system integrators, using them to create distinct, high‑performance offerings across gaming, data‑center and semi‑custom markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that contradict the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM introduces specific, unverified claims about '12-month return rights' and 'stock-rotation provisions' that are not mentioned in the ground truth. These appear to be fabricated details not supported by SEC filings. (2) PRODUCT MISIDENTIFICATION: The LLM references 'Instinct and Radeon PRO V-series' as discrete graphics solutions, but the ground truth does not specify these product lines or claim they were emphasized in this period. The ground truth mentions 'discrete graphics solutions' generically without naming specific product families. (3) MARKET SCOPE INFLATION: The LLM claims AMD used discrete graphics across 'gaming, data-center and semi-custom markets,' but the ground truth focuses on AIBs, system integrators, and retailers without explicitly claiming data-center discrete GPU emphasis during this period. (4) POLICY EVOLUTION MISCHARACTERIZATION: The ground truth states inventory protection was 'consistent' and 'stable' from 2022-2024, emphasizing continuity. The LLM claims AMD 'tightened' policies with 'newer terms,' suggesting evolution that contradicts the ground truth's emphasis on consistency. (5) MISSING CORE ELEMENTS: The LLM omits the ground truth's key point about AMD's emphasis on 'short design cycles' and 'rapid response to new technologies' as strategic differentiators. (6) UNSUPPORTED SPECIFICITY: The LLM provides false precision (12-month windows, specific product series) that appears to be hallucinated rather than derived from actual filings. The answer reads plausible but introduces fabricated details not present in the knowledge graph, which is a critical failure for financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 491,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved its DTC strategy from an early‑stage push to launch an ad‑supported Disney+ tier and restructure the DMED unit for cost rationalization, to a 2023‑2024 phase in which it reorganized its media business into separate Entertainment and Sports segments, performed a sweeping content‑curation review that led to impairments and the removal of under‑performing titles, and began building a dedicated ESPN DTC service while deepening investments in sports‑rights and expanding the Disney+ library.  Consequently, the company’s investment focus shifted toward higher spending on produced and licensed content (≈ $24 bn in fiscal 2025) and capital projects such as cruise‑ship expansion, while its competitive positioning now pits Disney+ and the forthcoming ESPN DTC platform against an increasingly crowded streaming market; Disney expects subscription and advertising revenue growth to eventually offset the ongoing losses, but profitability will lag behind investment and will depend on subscriber acquisition, churn management, and successful monetization of its expanded sports and ad‑supported offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides operational details about Disney's DTC strategy evolution but diverges significantly from the ground truth in several critical ways:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The LLM cites \"≈ $24 bn in fiscal 2025\" for content spending, but this is not mentioned in the ground truth and appears to be an unsupported figure\n- No specific financial metrics from 2022-2024 are provided to support the evolution narrative\n- The ground truth emphasizes the financial risk acknowledgment in 2022 and expected revenue offsets in 2023, which the LLM does not quantify\n\n(2) CORE NARRATIVE DIVERGENCE:\n- Ground truth focuses on: (a) 2022 cautious stance with acknowledged risks, (b) 2023 shift to confident investment with expected revenue offsets, (c) 2024 competitive pressures and operational criticality\n- LLM answer focuses on: operational restructuring (ad-supported tier, DMED restructuring, segment reorganization, content curation, ESPN DTC launch)\n- While the LLM's operational details may be factually accurate, they don't directly address the ground truth's emphasis on the STRATEGIC MINDSET EVOLUTION regarding investment confidence and financial expectations\n\n(3) MISSING KEY ELEMENTS:\n- The LLM does not capture the 2022 risk acknowledgment about losses potentially growing or being reduced more slowly than anticipated\n- The LLM does not mention the 2023 expectation that DTC investments would \"lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees\"\n- The LLM does not adequately address the 2024 competitive intensity and its impact on subscription fees and advertising rates\n\n(4) PARTIAL ALIGNMENT:\n- The LLM correctly identifies that Disney's competitive positioning involves facing \"an increasingly crowded streaming market\" (aligns with ground truth's 2024 competitive pressures)\n- The LLM correctly notes expectations for subscription and advertising revenue growth to offset losses (aligns with 2023 ground truth)\n- The LLM correctly identifies the shift in investment focus and strategic importance\n\n(5) REASONING QUALITY:\n- The LLM provides a coherent operational narrative but fails to synthesize the strategic/financial mindset evolution that is central to the ground truth\n- The multi-hop reasoning is present but addresses a different dimension of the question than the ground truth emphasizes\n- The answer reads more like a detailed operational timeline than a strategic evolution analysis\n\nThe LLM answer is not factually incorrect in its operational details, but it fundamentally misses the ground truth's focus on the evolution of Disney's CONFIDENCE LEVEL and FINANCIAL EXPECTATIONS regarding DTC investments from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 729,
        "total_tokens": 2291
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal kept its $1.5 billion Fixed‑rate 2.850 % senior unsecured notes—originally issued in September 2019—on its books, and these notes still mature on October 1 2029; the company’s future‑principal‑payment schedule (shown for 2024‑2025) lists a $1.5 billion obligation for 2029.  While PayPal added new senior‑unsecured issuances in each of those years (a $3 bn May 2022 tranche, a ¥90 bn ¥‑denominated issuance in June 2023 and a $1.3 bn May 2024 tranche) and maintained a $5 bn revolving credit facility, it did not retire or refinance the 2.850 % notes, which remain a stable long‑term component of its debt structure subject only to the standard redemption triggers (change‑of‑control and downgrade).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies several key facts: (1) the $1.5 billion principal amount of the 2.850% notes remained constant from 2022-2024, (2) the maturity date of October 1, 2029 is accurate, (3) the notes were not retired or refinanced, and (4) PayPal issued additional debt during this period. However, there are significant gaps and issues: MISSING CRITICAL DATA: The ground truth specifies total term debt figures ($9.0B in 2022, $10.638B in 2023, $10.574B in 2024) that provide essential context for understanding how the debt structure evolved. The LLM answer mentions new issuances but does not synthesize these into the broader debt structure evolution that the question specifically asks about. QUANTITATIVE ISSUES: The LLM provides specific new issuance amounts ($3B May 2022, ¥90B June 2023, $1.3B May 2024) and mentions a $5B revolving credit facility, but these details are not in the ground truth and cannot be verified. The ground truth does not provide these granular issuance dates and amounts. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about how the relationship 'evolved' across the three years in terms of 'debt structure and maturity obligations.' The ground truth explicitly addresses this evolution by showing total term debt changes. The LLM answer focuses heavily on the stability of the 2.850% notes themselves but fails to adequately address the broader debt structure evolution that is central to the question. MISSING CONTEXT: The ground truth mentions that PayPal issued new debt with higher interest rates (5.150% and 5.500% notes) in 2024, suggesting a strategic shift. The LLM answer does not capture this strategic context about the changing financing environment. STRENGTHS: The LLM correctly identifies the principal amount, maturity date, and the fact that the notes remained unchanged. The discussion of redemption triggers and the characterization as a 'stable long-term component' is reasonable. The answer is well-structured and readable. OVERALL ASSESSMENT: While the LLM answer is partially correct on the specific 2.850% notes, it fails to adequately address the broader debt structure evolution (total debt figures) that is essential to answering the question about how PayPal's relationship with these notes 'evolved' in context of overall debt structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 618,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nBetween 2022 and 2024 the share of corporate‑stock in UNP’s pension fund dropped sharply – from roughly $1.1 bn (about 37 % of total plan assets in 2022) to just over $0.23 bn (≈ 5.5 % of assets in 2023‑2024).  This reduction coincides with a change in the plan’s target mix: equity exposure was cut from the 45‑55 % range in 2022 to a 20‑30 % target by 2024, while debt was raised to 70‑80 %.  The shift signals a deliberate de‑risking of the portfolio, moving away from equities—including corporate stock—toward a more conservative, fixed‑income‑heavy strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM claims corporate stock was '$1.1 bn (about 37% of total plan assets in 2022)' but the ground truth states it was $1,990 million ($1.99 bn) in 2022. The LLM's figure of $1.1 bn is substantially incorrect—off by nearly $900 million. The LLM also claims the 2023-2024 figure was '$0.23 bn (≈ 5.5% of assets)' but ground truth shows $181 million ($0.181 bn) in 2023, which is even lower than the LLM's estimate. (2) MISSING KEY INFORMATION: The ground truth explicitly mentions the 2024 reclassification of common stock as Level 1 investments and preferred shares as Level 2, which represents a critical strategic shift in valuation methodology. The LLM completely omits this important detail about the change in investment classification structure. (3) UNSUPPORTED CLAIMS: The LLM introduces specific target allocation ranges (45-55% equity in 2022, 20-30% by 2024, 70-80% debt) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated details. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies a de-risking trend, it fails to capture the nuanced shift from common stock to preferred shares and the change in fair value measurement levels, which are central to understanding UNP's investment strategy evolution. (5) DIRECTIONAL ACCURACY: The LLM is correct that there was a reduction in equity exposure and a shift toward fixed income, but the specific numbers and the mechanism of that shift (reclassification methodology) are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 449,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nFrom the 2022 10‑K (p. 85) Pfizer reported $800 million of private‑equity securities at cost; the 2023 filing (p. 84) shows this amount fell to $755 million, and the 2024 filing (p. 81) records a further decline to $719 million. Thus, the company’s long‑term investment in private‑equity securities has steadily decreased by roughly $81 million over the 2022‑2024 period, reflecting a deliberate reduction in its allocation to illiquid alternative investments and a shift toward more liquid or core‑business uses of capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports 2022 value as $800 million, but the ground truth states $623 million. This is a $177 million discrepancy (28% error). The 2023 and 2024 figures ($755M and $719M) are correct. (2) CALCULATION ERROR - The LLM calculates the change as roughly $81 million decline from 2022-2024 ($800M to $719M = $81M), but this calculation is based on the incorrect 2022 baseline. The correct calculation should be $623M to $719M, which is actually a $96 million INCREASE, not a decrease. (3) DIRECTIONAL MISINTERPRETATION - The LLM concludes there was a 'deliberate reduction' and 'steady decrease' in allocation to illiquid alternatives. However, the ground truth shows an increase from 2022 to 2023 ($623M to $755M), followed by a modest decline in 2024 ($755M to $719M). This is fundamentally different from a steady decline. (4) STRATEGIC INTERPRETATION - The LLM's characterization of a 'shift toward more liquid or core-business uses of capital' contradicts the ground truth's assessment of 'short-term growth strategy in alternative investments in 2023, followed by modest retrenchment in 2024.' (5) MULTI-HOP SYNTHESIS - While the LLM attempted to synthesize data across three years, the incorrect 2022 baseline undermined the entire analysis. The ground truth correctly identifies a two-phase pattern (growth then retrenchment), while the LLM incorrectly identifies a monotonic decline. This is a fundamental failure in multi-hop reasoning and data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 419,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened the scope and integration of its multi‑layered security model.  It expanded third‑party collaboration by formalizing partnerships with issuers, acquirers, merchants, governments and industry associations—and by launching public‑private initiatives that set EMV and other technical standards, while also rolling out free security utilities for small‑business participants.  Simultaneously, the company broadened real‑time payment infrastructure (operating or implementing real‑time ACH and account‑based payments in 13 markets by end‑2023 and extending Mastercard‑branded card acceptance to domestic transactions in China via a 2024 joint venture), and reinforced cyber‑resilience through an enterprise‑resilience program, third‑party‑assessed security controls, regular vulnerability testing, and advanced threat‑monitoring via Security Operations Centers and the Mastercard Intelligence Center.  This evolution combined tighter ecosystem governance with scalable, secure real‑time payment capabilities and stronger defenses against emerging cyber threats.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Mastercard's security approach from 2022-2024, including third-party collaboration expansion, real-time payment infrastructure growth, and cyber resilience measures. It accurately mentions the 13 markets figure for real-time payments by end-2023, Security Operations Centers, Mastercard Intelligence Center, EMV standards, and the shift toward ecosystem integration. The answer demonstrates good understanding of the multi-hop synthesis required across three years and three security dimensions.\n\nWEAKNESSES AND ERRORS: (1) QUANTITATIVE ACCURACY ISSUE: The LLM introduces specific claims not in the ground truth, including 'real-time ACH and account-based payments' terminology and a 'China joint venture in 2024' for Mastercard-branded card acceptance. While these may be factually accurate from filings, they represent additions beyond the ground truth answer and introduce specificity that cannot be verified against the provided knowledge graph. (2) The LLM mentions 'free security utilities for small-business participants' which is not mentioned in the ground truth. (3) The reference to 'enterprise-resilience program' and 'third-party-assessed security controls' adds detail not explicitly in the ground truth. (4) The LLM states the 13 markets figure is 'by end-2023' which aligns with ground truth's 'as of year-end' (2023), but the ground truth doesn't specify this was 'real-time ACH and account-based payments' specifically.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period and three security dimensions (third-party collaboration, real-time infrastructure, cyber resilience). The logical flow from 2022 internal focus to 2023 third-party inclusion to 2024 deepened collaboration is sound and matches the ground truth narrative.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth—evolution toward broader ecosystem integration and enhanced resilience. However, the introduction of unverified specific details (China joint venture, ACH terminology, free utilities) creates factual uncertainty that reduces confidence in the answer's accuracy relative to the knowledge graph source.\n\nJUSTIFICATION: The answer is substantially correct on the main narrative arc but introduces specific claims beyond the ground truth that cannot be verified. This creates a gap between what can be confirmed from the knowledge graph and what the LLM asserts. The quantitative accuracy score is reduced due to these unverified specifics, while qualitative accuracy remains reasonable because the core reasoning structure is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 704,
        "total_tokens": 2314
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements—recorded in the “Other assets, including intangibles – net” line—fell sharply each year: $1.49 bn in 2022, $0.80 bn in 2023 and $0.49 bn in 2024.  This downward trend signals that the company is needing less external collateral to support its derivative positions, reflecting tighter counterparty risk management and a more efficient handling of its derivative exposure over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports $1.49 billion for 2022, but the ground truth clearly states $800 million for end of 2022. The LLM's $1.49 billion figure appears to be completely fabricated and has no basis in the provided ground truth. The 2023 figure of $0.80 billion matches the ground truth's $800 million (acceptable format variation), and the 2024 figure of $0.49 billion matches the ground truth's $491 million (acceptable rounding). However, the 2022 number is off by approximately 86% ($1.49B vs $0.80B). (2) MULTI-HOP REASONING: The LLM failed to correctly synthesize the data across the three-year period. The ground truth explicitly provides the progression: $641M (2021, reported in 2022 filing) → $800M (2022, reported in 2023 filing) → $491M (2023, reported in 2024 filing). The LLM inverted the starting point and provided an incorrect 2022 baseline. (3) TREND ANALYSIS: While the LLM correctly identifies a downward trend and provides reasonable interpretation about derivative exposure management, this qualitative analysis is undermined by the incorrect quantitative foundation. The ground truth notes a 38% decrease from 2022 to 2024, which the LLM does not calculate or mention. (4) ENTITY AND METRIC ACCURACY: The LLM correctly identifies ExxonMobil, the master netting arrangements, and 'Other assets, including intangibles - net' line item. However, the fundamental numerical errors make the answer unreliable. The LLM's interpretation about 'needing less external collateral' is reasonable but based on incorrect starting data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 458,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe expected volatility embedded in Duke Energy’s relative‑TSR performance‑award model was ≈ 26.9 % for grants made in 2022, rose to ≈ 28.6 % for grants made in 2023, and then fell sharply to ≈ 18.7 % for grants made in 2024.  This multi‑year shift shows that the market’s perceived risk premium first increased from 2022 to 2023—reflecting heightened uncertainty—before declining in 2024, suggesting that by the latter year investors viewed Duke Energy’s stock as comparatively less volatile and therefore less risky relative to its predefined peer group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% for 2022, 28.6% for 2023, and 18.7% for 2024. The use of the ≈ symbol is appropriate given potential rounding in source documents. All dates and years are correctly identified. (2) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR (Total Shareholder Return) model is properly contextualized as a relative performance award model against a peer group, and the temporal sequence is accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend, correctly identifying the peak in 2023 and the subsequent decline in 2024. The interpretation that this represents 'heightened uncertainty' followed by 'stabilization' aligns with the ground truth's characterization of 'peak in perceived market risk in 2023, followed by a significant decline.' (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'investors viewed Duke Energy's stock as comparatively less volatile and therefore less risky' is semantifically equivalent to the ground truth's 'stabilization or reduced uncertainty in Duke Energy's market position.' The explanation of the trajectory and its implications is sound and well-reasoned. (5) MINOR OBSERVATION: The LLM uses slightly more detailed language ('market's perceived risk premium,' 'comparatively less volatile') which adds helpful context without introducing inaccuracy. The answer fully addresses the multi-part question regarding both the numerical changes and their implications for market risk perception.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 442,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis—arising from the 2017 sale of Opel/Vauxhall and covering potential emissions‑related lawsuits as well as any future Takata‑related recalls—remained unchanged in scope but continued to be treated as a remote, non‑material contingency.  The company repeatedly disclosed that it cannot reasonably estimate a loss from the emissions claims and that any additional Takata‑related indemnity “is remote at this time,” resulting in essentially zero accruals; the only quantitative reference was an immaterial amount previously set aside for certain Takata‑related recalls.  Consequently, while the guarantee persists and is subject to time limits and caps, GM’s financial exposure has not materialized into any significant accrual over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core narrative regarding GM's Stellantis indemnification obligations from 2022-2024, correctly identifying that obligations remained remote and immaterial throughout the period. Key strengths: (1) Accurately captures the multi-year evolution showing consistency in treatment as remote/non-material contingencies; (2) Correctly identifies the 2017 sale of Opel/Vauxhall as the origin of obligations; (3) Properly synthesizes that Takata recalls were treated as remote in subsequent years; (4) Correctly notes immaterial accruals with no significant materialization. However, there are notable gaps: (1) The LLM answer does not explicitly mention the European Commission and UK CMA investigations into Opel conduct that the ground truth specifically references as having an immaterial accrual in 2024—this is a material omission of a specific 2024 development; (2) The LLM states 'essentially zero accruals' which is slightly imprecise given the ground truth indicates an immaterial amount was accrued for EC/CMA investigations; (3) The phrasing 'cannot reasonably estimate a loss from emissions claims' appears in the LLM answer but is not explicitly confirmed in the ground truth, which focuses more on the remote nature of future obligations rather than inability to estimate. The multi-hop reasoning is sound—correctly synthesizing information across three years and multiple obligation types (Takata, emissions, regulatory investigations). The answer appropriately emphasizes the consistency and stability of minimal exposure across the period. The omission of the specific EC/CMA investigation accrual mentioned in the 2024 ground truth represents the primary factual gap, preventing a higher score despite otherwise solid analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 487,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAMD continues to incorporate the 2011 Executive Incentive Plan (and its subsequent amendments) by the same exhibit reference in the executive‑compensation sections of its 2022, 2023 and 2024 Form 10‑K filings, merely noting periodic amendments (e.g., the 2018 and 2019 plan updates). This steady citation shows that the company’s long‑term executive compensation strategy is built around a stable, performance‑based incentive framework that is retained over time with only incremental refinements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) The LLM claims the plan had 'subsequent amendments' and references '2018 and 2019 plan updates,' but the ground truth explicitly states there were NO amendments or new disclosures about the plan itself across 2022-2024. This is a fundamental factual error. (2) The ground truth specifies the plan was 'filed on April 2, 2011' and listed as 'Exhibit 10.1' - the LLM does not provide these specific details and instead makes unsupported claims about amendments. (3) The LLM's characterization of 'incremental refinements' contradicts the ground truth's finding of 'no changes to the plan' during the three-year period. (4) While both answers correctly identify the 2011 Executive Incentive Plan and note consistency across 2022-2024, the LLM introduces false information about amendments that were not documented in the filings. (5) The multi-hop reasoning is flawed because the LLM synthesizes information that doesn't exist in the source documents - it invents amendment dates (2018, 2019) that are not supported by the ground truth. The only correct elements are: the plan name, the years covered (2022-2024), and the general concept of consistency. The answer fails on quantitative accuracy due to the invented amendment references and fails on qualitative accuracy due to the fundamental mischaracterization of the plan's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 398,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk moved from a pandemic‑driven spike in fraud, charge‑backs and cyber‑security threats (2022) to a heavier concentration on credit‑product defaults, BNPL portfolio losses and cross‑border‑trade volatility as economic conditions worsened and the business grew more dependent on third‑party lenders and payment processors (2023‑2024).  \n\nIn 2023 the company mitigated that risk by selling a large share of its U.K. and European “buy‑now, pay‑later” loan receivables through a forward‑flow arrangement, diversifying its payment‑processor base and tightening underwriting, fraud‑detection and buyer‑seller protection controls across its credit and cross‑border offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023 strategic action of selling U.K. and European BNPL loan receivables, which is the core mitigation step mentioned in the ground truth. The answer appropriately captures the evolution of risk from 2022-2024 and mentions key risk categories (fraud, chargebacks, credit defaults, cross-border trade, third-party dependencies). The semantic understanding of the business challenge is sound.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM fails to specify the €40 billion figure that is explicitly stated in the ground truth as the amount of receivables to be sold. This is a significant omission of a concrete, verifiable metric. (2) CHARACTERIZATION ISSUE - The LLM describes 2022 risks as 'pandemic-driven spike in fraud, charge-backs and cyber-security threats,' but the ground truth specifically emphasizes credit defaults and Synchrony Bank partnership risks as the primary 2022 concern, not pandemic-related fraud spikes. (3) VAGUE CLAIMS - The LLM mentions 'diversifying its payment-processor base and tightening underwriting' as 2023 mitigation steps, but these are not explicitly supported by the ground truth, which focuses specifically on the BNPL receivables sale as the key strategic action. (4) INCOMPLETE SYNTHESIS - While the LLM mentions third-party reliance and regulatory uncertainty in 2024, it doesn't capture the specific ground truth detail about 'regulatory uncertainty around the validity of loan sales post-transfer,' which is a nuanced but important distinction.\n\nMULTI-HOP REASONING: The answer demonstrates reasonable multi-hop synthesis by connecting risk evolution across three years and linking it to strategic responses. However, the reasoning is somewhat speculative in places (e.g., the payment-processor diversification claim) rather than grounded in the specific facts provided.\n\nOVERALL ASSESSMENT: The answer captures the general narrative and key strategic action but lacks precision on the specific €40 billion figure and mischaracterizes some 2022 risk drivers. The core insight about the 2023 BNPL receivables sale is correct, but supporting details are either missing or inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 582,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific trimmed its Multiple‑Purpose Locomotive fleet by roughly 350 units (down from 7,242 to 6,893), with owned units falling from 6,204 to 5,973 and leased units from 1,038 to 920.  At the same time the average age of the fleet rose from 22.5 years to 25.2 years, indicating that the railroad is keeping older locomotives in service longer rather than replacing them.  This pattern signals a fleet‑management approach that prioritizes extending the life of existing assets and using modest, targeted acquisitions (or leases) for flexibility, while postponing large‑scale modernization until capital allocations or technology readiness allow a more substantial refresh.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Union Pacific's fleet evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - owned units decreased from 6,204 to 5,973 (231 unit decrease), leased units dropped from 1,038 to 920 (118 unit decrease), total fleet went from 7,242 to 6,893 (349 unit decrease, LLM states 'roughly 350' which is appropriately rounded), and average age increased from 22.5 to 25.2 years (2.7 year increase). The arithmetic is accurate throughout. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) ownership profile changes (owned and leased breakdown), (2) aging profile evolution (average age increase), and (3) implications for fleet management and modernization strategy. ENTITY ACCURACY: Union Pacific correctly identified, time period (2022-2024) correct, Multiple Purpose Locomotives correctly specified. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information - connecting the reduction in fleet size with the increase in average age to draw logical conclusions about fleet management priorities. The interpretation that the company is 'extending the life of existing assets' and 'postponing large-scale modernization' is sound and well-supported by the data. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Union Pacific prioritizes cost control and asset extension over aggressive modernization. The LLM's phrasing about 'modest, targeted acquisitions' and 'postponing large-scale modernization' adds slightly more nuanced interpretation while remaining consistent with the ground truth's assessment. MINOR OBSERVATION: The LLM provides slightly more interpretive depth regarding 'capital allocations or technology readiness' which goes marginally beyond the ground truth but remains logically sound and doesn't contradict it. Overall, this is a high-quality response with accurate numbers, correct multi-hop synthesis, and appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 547,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements and not offset against its derivative positions fell sharply – from **$1.49 billion in 2022 to $0.80 billion in 2023 and to $0.49 billion in 2024**.  This downward trend signals that the company is increasingly comfortable with its counterparties and is relying more on internal credit limits, clearing‑house netting and other risk‑mitigation tools rather than external collateral to manage derivative credit risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error in the 2022 figure. Ground truth states $641 million in 2022, but the LLM claims $1.49 billion - this is off by more than 2x (232% error). The 2023 and 2024 figures are correct ($800M and $491M respectively, though LLM rounds to $0.80B and $0.49B which is acceptable format variation). MULTI-HOP REASONING: The LLM correctly identifies the downward trend from 2023-2024 and provides reasonable interpretation about risk management strategy (increased comfort with counterparties, reliance on internal credit limits). However, the interpretation is based partially on incorrect data. COMPLETENESS: The LLM addresses the trend analysis and risk management implications, but the severely incorrect 2022 baseline undermines the entire trend analysis. The question asks about change 'from 2022 to 2024' - starting with wrong 2022 data invalidates this comparison. ENTITY ACCURACY: Company (ExxonMobil) and metric (collateral under master netting arrangements) are correctly identified. SEMANTIC ISSUES: While the LLM's reasoning about derivative risk management is plausible, it's built on a false premise. The actual trend shows: $641M → $800M (increase) → $491M (decrease), not a consistent downward trend from 2022. This changes the narrative significantly - the peak in 2023 is a key feature the LLM misses due to the wrong 2022 number.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 392,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” line‑item – which the filing defines as packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware (among other items) – was $6.89 bn in fiscal 2022 (about 21 % of total revenue), fell to $5.69 bn in fiscal 2023 (≈ 20 % of total) and then rose to $7.54 bn in fiscal 2024 (≈ 21 % of total).  The dip in 2023 reflected lower packaged‑coffee and royalty income, while the 2024 rebound was driven by a recovery in packaged‑coffee sales and higher royalty/licensing revenues, keeping the category’s share of overall revenue essentially steady around one‑fifth of total sales.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that contradicts the ground truth. CRITICAL ISSUES: (1) The question asks about the COMPOSITION and EVOLUTION of the 'Other' category's components (what items are included), not the revenue amounts or percentages. The ground truth explicitly states the category 'remained relatively stable in its composition' with consistent items listed across years. (2) The LLM provides specific dollar amounts ($6.89bn, $5.69bn, $7.54bn) and percentages (21%, 20%, 21%) that cannot be verified against the ground truth provided, and these numbers appear to be fabricated or from an unverified source. (3) The LLM discusses revenue fluctuations and drivers ('lower packaged-coffee and royalty income' in 2023, 'recovery in packaged-coffee sales' in 2024) which are NOT mentioned in the ground truth and represent unsupported claims about causation. (4) The LLM completely misses the core finding: the composition of items in the 'Other' category remained consistent across 2022-2024 (packaged/single-serve coffees and teas, royalty/licensing, beverage ingredients, serveware), with no significant shifts. (5) The ground truth notes that ready-to-drink beverages were mentioned in 2022 but not explicitly in 2024, a subtle compositional detail the LLM entirely overlooks. The LLM answer reads like a financial analysis of revenue trends rather than a composition analysis, demonstrating a fundamental misunderstanding of what the question asks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 416,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet kept the same core practice for Google Network inventory: it records advertising revenue on a **gross basis** (the full amount billed to advertisers is recognized as revenue, and the portion paid to Network partners is treated as cost of revenue).  What changed during this period was the **refinement of impression‑based measurement**—the company repeatedly updated its methodologies for counting impressions and calculating cost‑per‑impression across AdMob, AdSense and Google Ad Manager to reflect the shift toward mobile, new ad formats and emerging‑market traffic.  As a result, a growing share of Google Network’s monetization moved from click‑driven pricing to **impression‑driven pricing**, while still being reported grossly.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The core fact that Google reports advertising revenue on a gross basis is accurate and matches the ground truth. (2) The identification of Google Ad Manager, AdMob, and AdSense as relevant platforms is appropriate. (3) The general concept that impression-based measurement evolved is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM introduces claims about 'shift toward mobile, new ad formats and emerging-market traffic' that are NOT supported by the ground truth answer. These appear to be inferences or hallucinations not grounded in the filing data. (2) The claim that 'a growing share of Google Network's monetization moved from click-driven pricing to impression-driven pricing' is presented as fact but the ground truth does not support this quantitative claim. The ground truth states Google used 'impression-based and click-based revenue models' consistently across all three years without indicating a shift in the proportion. (3) The LLM answer focuses heavily on methodological refinements and mobile/emerging market shifts, which diverges from the ground truth's emphasis on 'increasing transparency and accounting clarity' regarding gross revenue recognition and the company's role as principal. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across 2022-2024 but does so by introducing unsupported details rather than accurately reflecting what the ground truth documents. The answer conflates operational changes (mobile shift, new formats) with accounting/revenue recognition changes, which are distinct concepts. MISSING ELEMENTS: The LLM does not adequately address the specific evolution in 'impression-based revenue recognition' methodology that the ground truth emphasizes, nor does it capture the clarification in 2023 about gross basis reporting and principal status. The answer is partially correct on the gross basis point but significantly overstates or mischaracterizes the nature of changes from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 547,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nOver the three‑year period MDLZ’s regulatory exposure has widened markedly.  In 2022 the filings noted that only a handful of EU members had begun applying extended‑producer‑responsibility (EPR) rules and that front‑of‑pack (FOP) labeling was just emerging as a requirement in a few jurisdictions.  By 2023 the company reported that more than 25 EU countries had adopted mandatory EPR obligations and that additional jurisdictions—including India, Vietnam and several U.S. states—were either implementing or contemplating EPR schemes, while FOP labeling based on nutrient‑profile or environmental‑claim standards was being rolled out on a broader set of products and advertising platforms.  In 2024 the disclosures highlighted the EU’s new Packaging and Packaging Waste Directive and the expansion of EPR to even more countries and U.S. states, together with tighter sales‑ and media‑marketing restrictions (e.g., limits on promotions for high‑nutrient‑profile foods on certain channels or during certain hours).  Thus, each successive year brought a larger geographic footprint of EPR mandates and a deeper layer of FOP‑labeling and marketing‑restriction rules that MDLZ must navigate.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental chronological inversion that contradicts the ground truth. (1) QUANTITATIVE/CHRONOLOGICAL ERROR: The LLM states that in 2022 'only a handful of EU members had begun applying EPR rules' and that FOP labeling was 'just emerging,' but the ground truth explicitly states that in 2022, MDLZ noted 'over 25 EU countries had implemented EPR policies.' This is a major factual error - the LLM reversed the timeline, placing the expansion in 2023 when it actually occurred by 2022. (2) ENTITY/JURISDICTION ACCURACY: The LLM incorrectly attributes EPR contemplation in 'several U.S. states' to 2023, when the ground truth indicates U.S. states were only mentioned in 2024 as part of the enforcement shift. (3) MISSING SPECIFIC DETAILS: The LLM fails to mention key 2022-2023 details about restrictions on advertising products with specified nutrient profiles being in place in 2022, or the specific mention of Indonesia and the Philippines in both years. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the EU Packaging and Packaging Waste Directive adoption in 2024 and the general trend of expansion, it misses the critical distinction that the ground truth emphasizes a shift 'from contemplation to enforcement' by 2024, particularly regarding India, Vietnam, and U.S. states. (5) VAGUE MARKETING RESTRICTIONS: The LLM adds details about 'tighter sales-and media-marketing restrictions' in 2024 with examples of 'limits on promotions for high-nutrient-profile foods,' but these specific restrictions are not explicitly detailed in the ground truth provided, making this potentially speculative. The core narrative structure is inverted - the LLM presents a gradual expansion when the ground truth shows rapid expansion had already occurred by 2022, with 2023-2024 showing deepening and enforcement rather than initial adoption.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 516,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nFrom 2022 through 2024 the charter continued to give Class A shares one vote per share and full dividend participation, while Class B shares remained non‑voting but still received dividends; no preferred shares were issued in any of the three years. This unchanged voting‑rights structure, together with a stable ownership mix (≈88‑90 % held by public investors and ≈10 % by the Mastercard Foundation), shows that Mastercard is preserving a steady equity base and relying on debt and share‑repurchase programs rather than equity restructurings to fund growth and return capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that A Class shares maintained one vote per share and dividend rights across 2022-2024 with no changes, which matches the ground truth. However, there are significant issues: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM introduces specific ownership percentages (≈88-90% public investors, ≈10% Mastercard Foundation) that are NOT present in the ground truth answer and cannot be verified from the provided context. These numbers appear to be fabricated or hallucinated. (2) ENTITY ACCURACY: The LLM correctly identifies MA/Mastercard and the three-year period (2022-2024). (3) COMPLETENESS: The LLM goes beyond the ground truth by adding information about Class B shares (non-voting but dividend-receiving) and preferred shares (none issued), which adds context but wasn't in the original answer. While this additional detail could be accurate, it wasn't required to answer the question. (4) MULTI-HOP REASONING: The LLM attempts to synthesize capital structure strategy by connecting voting rights stability to debt/share-repurchase programs, which is a reasonable inference but goes beyond what the ground truth states. The ground truth simply notes the consistency indicates a 'consistent capital structure strategy' without specifying debt/repurchase details. (5) CRITICAL FLAW: The introduction of unverified ownership percentages is a major concern - these specific numbers should not appear without source verification. The ground truth makes no mention of these percentages. This represents either fabrication or unsupported extrapolation. The core answer about A Class voting/dividend consistency is correct, but the addition of unverified quantitative claims significantly undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 477,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nThe collateral that the Corporation posts under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply – from about **$1.49 billion at the end of 2022** to **$0.80 billion in 2023** and further to **$0.49 billion by the end of 2024**.  This downward trend shows that ExxonMobil has been **reducing the amount of initial‑margin collateral it must set aside**, indicating a **scaled‑back of derivative positions and lower margin‑requirement pressures** over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth shows: 2022: $641M, 2023: $800M, 2024: $491M. LLM answer shows: 2022: $1.49B, 2023: $0.80B, 2024: $0.49B. The 2022 figure is off by approximately 2.3x ($1.49B vs $641M), and the 2023 figure is also significantly overstated ($800M vs $800M appears coincidentally close but in context of wrong 2022 baseline). The 2024 figure ($491M vs $490M) is approximately correct. TREND ANALYSIS ERROR: The LLM incorrectly characterizes the trend as 'sharply fell' and 'downward trend' when the actual data shows: increase from 2022 to 2023 (+$159M or +24.8%), then decrease from 2023 to 2024 (-$309M or -38.6%). The LLM missed the critical 2022-2023 increase entirely. REASONING QUALITY: While the LLM's interpretation about reduced derivative positions and lower margin pressures is reasonable in isolation, it is based on false premises (wrong numbers and wrong trend direction). The semantic interpretation of what the trend 'suggests' is partially sound but applied to incorrect data. ENTITY ACCURACY: Correctly identifies ExxonMobil and the relevant metric (collateral under master netting arrangements). COMPLETENESS: Addresses the question structure but with fundamentally flawed data that undermines the entire analysis. The multi-hop synthesis fails because the foundational numbers are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 398,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\n**Evolution of forward‑looking coffee‑supply commitments (FY 2022 → FY 2024)**  \n\n- **FY 2022 (page 12 of SBUX_10K_2022.pdf):** Starbucks disclosed that its total green‑coffee purchase commitments, together with existing inventory, were sufficient to meet demand **through fiscal 2023**. The filing emphasized the use of fixed‑price and price‑to‑fixed contracts, forward contracts, futures and collars to hedge “C”‑price exposure.  \n\n- **FY 2023 (page 12 of SBUX_10K_2023.pdf):** The company updated the outlook, stating that the same purchase‑commitment framework would be adequate **through fiscal 2024**, noting continued expansion of forward‑contract and hedging activities and deeper collaboration with coffee producers.  \n\n- **FY 2024 (page 13 of SBUX_10K_2024.pdf):** The commitment horizon was extended again, with the company projecting that its purchase commitments and inventory would support demand **through fiscal 2025**, while also highlighting ongoing investment in its ten farmer‑support centers and sustainability programs to secure high‑quality beans.  \n\n**Implication for Starbucks’ strategy**  \nThis progression—from a three‑year supply horizon to a five‑year horizon—demonstrates a deliberate shift toward **longer‑term, diversified sourcing and heightened hedging** to blunt the impact of commodity‑price swings. By locking in supply through increasingly later fiscal years and reinforcing farmer‑support and sustainability initiatives, Starbucks aims to **mitigate raw‑material price volatility and reduce supply‑risk exposure**, thereby stabilizing margins and ensuring a reliable coffee supply for its global store network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states FY2023 commitments extended 'through fiscal 2024' when ground truth clearly indicates they extended 'through fiscal 2025'. This is a fundamental misreading of the filing data. The LLM also mischaracterizes the progression timeline: it claims a 'three-year to five-year horizon' shift, but the actual progression is FY2022→2023, FY2023→2025, FY2024→2025, which does not represent a consistent three-to-five year expansion. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the year-over-year evolution. Ground truth shows: FY2022 adequate through FY2023, FY2023 adequate through FY2025, FY2024 adequate through FY2025. The LLM incorrectly states FY2023 was 'through fiscal 2024,' breaking the logical progression. (3) ENTITY/METRIC ACCURACY - While the LLM correctly identifies Starbucks, fiscal years, and hedging instruments (forward contracts, futures, collars), the core supply-commitment horizons are wrong for FY2023. (4) REASONING QUALITY - The strategic interpretation about 'longer-term diversified sourcing' is reasonable but is built on incorrect factual premises. The conclusion about 'three-year to five-year horizon' is mathematically and factually unsupported by the actual data progression. (5) WHAT WAS CORRECT - The LLM correctly identifies the use of hedging instruments across all years, mentions farmer-support centers, and correctly identifies FY2022 (through 2023) and FY2024 (through 2025) commitments. However, these correct elements are overshadowed by the critical FY2023 error. The answer demonstrates partial understanding but fails on core factual accuracy required for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 490,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nThe 2025 target shows a clear re‑balancing of ACN’s defined‑benefit pension asset mix: U.S. plans move from about 95 % debt (with a small cash buffer) in fiscal 2023 to a fully 100 % debt allocation by 2025, eliminating equity and other holdings; non‑U.S. plans raise equity exposure from roughly 19 % to 28 % and trim debt from ≈43 % to 36 %, while keeping insurance and other allocations near‑steady. This multi‑year shift reflects a deliberate strategy to boost long‑term risk‑adjusted returns by adding equity exposure abroad while preserving a conservative, liability‑matched, pure‑debt stance in the U.S., aiming to improve funded status and capture higher returns without markedly increasing solvency risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides highly specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides precise percentages (U.S. plans moving from 95% debt to 100% debt, non-U.S. equity from 19% to 28%, debt from 43% to 36%) that are not present in the ground truth. The ground truth does not provide these specific allocation percentages for fiscal 2023, 2024, or 2025. These numbers appear to be hallucinated. (2) SPECIFICITY MISMATCH: The ground truth describes the evolution in general terms (\"strategic shift,\" \"continuity in strategy,\" \"updated flexibility ranges\") without providing the detailed percentage breakdowns the LLM claims. The LLM's answer is far more specific than what the source material supports. (3) UNVERIFIABLE CLAIMS: The assertion that U.S. plans moved to \"fully 100% debt allocation by 2025, eliminating equity and other holdings\" is a dramatic claim that would be significant but is not substantiated in the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and plan types (U.S. vs. non-U.S.), it does so with invented data rather than actual filing information. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes \"continuity in strategy\" and \"adaptive approach,\" while the LLM emphasizes a \"clear re-balancing\" and \"deliberate strategy\" with specific directional changes. These represent different interpretations of the actual evolution. The LLM answer reads as confident and detailed but lacks factual grounding in the actual SEC filings referenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 452,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen advanced Olpasiran from an early‑phase (Phase 2) proof‑of‑concept siRNA aimed at lowering lipoprotein(a) for atherosclerotic cardiovascular disease to a late‑stage (Phase 3) pivotal program, positioning it as a next‑generation lipid‑lowering therapy for ASCVD.  During this period the company filed composition‑of‑matter patents in the United States and Europe that are projected to expire in 2036 (U.S.) and 2036/2032 (EU), providing roughly a decade‑plus of patent protection before any possible extensions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) PHASE PROGRESSION ERROR: The LLM claims Olpasiran advanced from Phase 2 to Phase 3 by 2024, but the ground truth only documents Phase 2 trials in 2022 with a transition toward 'more advanced development or potential regulatory preparation' by 2024—no explicit Phase 3 designation is mentioned in the original answer. This is a significant factual overstatement. (2) THERAPEUTIC INDICATION DISCREPANCY: The LLM specifies 'lipoprotein(a) lowering' as the mechanism, which is not mentioned in the ground truth. The ground truth only references 'atherosclerotic cardiovascular (CV) disease' and 'Cardiovascular disease' as indications. Adding mechanistic details not in the source is problematic. (3) PATENT EXPIRATION DATES - PARTIAL ERROR: The LLM states U.S. patents expire in 2036 (correct per ground truth) but adds EU expiration dates of '2036/2032' which are not mentioned in the ground truth. The ground truth only states 'U.S. and European patent protection...estimated to expire in 2036' without specifying separate EU dates. This introduces unverified information. (4) CORRECT ELEMENTS: The LLM correctly identifies the 2022 Phase 2 status, the 2036 U.S. patent expiration, the siRNA drug class, and the cardiovascular disease focus. The characterization of 'composition-of-matter patents' aligns with the ground truth's mention of patent protection. (5) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize the evolution across years but does so by adding information not present in the ground truth (Phase 3 status, lipoprotein(a) mechanism, specific EU dates). The ground truth is more cautious, noting a 'transition' rather than confirmed Phase 3 advancement. (6) SEMANTIC ISSUES: The phrase 'next-generation lipid-lowering therapy' is interpretive language not grounded in the provided ground truth. The ground truth focuses on observable facts (phase status, IP protection, indication) rather than market positioning claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 530,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from simply competing for cobrand‑partner relationships and paying them on the basis of Card‑Member spending to a growing reliance on third‑party aggregators and service providers to acquire merchants, process transactions and manage rewards redemption, with many of those arrangements now spanning five‑to‑ten‑year terms that are subject to early termination or renegotiation.  \n\nThe disclosures highlighted three escalating risk themes: in 2022 the focus was on the material adverse impact of losing or renegotiating partner relationships; in 2023 the emphasis shifted to the danger of early‑termination clauses, performance‑linked payment obligations and the financial fallout if a partner defaults or goes bankrupt; and in 2024 the company underscored heightened exposure to loss of exclusivity, regulatory pressure on surcharge/steering practices, and the operational and reputational consequences of depending on third‑party providers for core acquiring and servicing functions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the multi-hop question about American Express's evolving reliance on aggregators from 2022-2024 and attempts to identify risk themes for each year. However, there are significant discrepancies between the LLM answer and the ground truth that warrant a moderate score.\n\nSTRENGTHS:\n1. The LLM correctly identifies the overall trend of increasing reliance on aggregators across the three-year period\n2. It appropriately structures the answer chronologically (2022, 2023, 2024)\n3. It recognizes that risks evolved and became more formalized over time\n4. The mention of contract terms (5-10 year arrangements) adds relevant detail\n5. The answer demonstrates understanding of multi-hop synthesis across years\n\nSIGNIFICANT DISCREPANCIES:\n1. RISK FOCUS MISMATCH: The ground truth emphasizes merchant steering, surcharging, and operational disruptions as core risks. The LLM answer focuses on partner relationship losses, early-termination clauses, and exclusivity loss - which are different risk categories not explicitly mentioned in the ground truth.\n2. 2022 CHARACTERIZATION: Ground truth states AXP expressed concern about how aggregators might act against AXP's interests and impact card usage/merchant acceptance. LLM characterizes 2022 focus as \"material adverse impact of losing or renegotiating partner relationships\" - a narrower framing.\n3. 2023 CHARACTERIZATION: Ground truth emphasizes surcharging and steering reducing transaction volumes. LLM focuses on early-termination clauses and default/bankruptcy risks - these are different risk dimensions.\n4. 2024 CHARACTERIZATION: Ground truth mentions litigation exposure and regulatory actions. LLM mentions loss of exclusivity and regulatory pressure on surcharge/steering - partially aligned but with different emphasis.\n\nQUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. However, the LLM does mention \"five-to-ten-year terms\" which cannot be verified against the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies an evolution pattern. However, the specific risk categories identified appear to diverge from the ground truth's emphasis on merchant behavior (steering/surcharging) and operational disruptions.\n\nSEMANTIC EQUIVALENCE: While both answers discuss aggregator reliance and evolving risks, they emphasize different risk categories. The ground truth focuses on merchant-facing risks (steering, surcharging) and operational disruptions, while the LLM focuses on contractual/partnership risks (termination, exclusivity, defaults). These are not semantically equivalent.\n\nJUSTIFICATION: The answer demonstrates competent multi-hop reasoning and chronological synthesis, but the specific risk themes identified do not align well with the ground truth. This suggests the LLM may have generated plausible-sounding risk categories rather than accurately reflecting the actual disclosure content. The moderate score reflects partial correctness in structure and approach, but significant factual divergence in the specific risk themes for each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 843,
        "total_tokens": 2341
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Starbucks’ hedging of green‑coffee price volatility moved from a short‑term, “price‑to‑be‑fixed” approach that was projected to meet supply only through fiscal 2023, to a longer‑term program that now extends forward‑purchase commitments and a broader use of forwards, futures, collars and commodity‑index‑linked hedges through fiscal 2025.  Accordingly, the company’s forward supply commitments grew each year—covering fiscal 2023 in 2022, fiscal 2024 in 2023, and fiscal 2025 in 2024—reflecting a deeper hedge book and a larger allocation to forward contracts to mitigate exposure to commodity‑index‑driven price swings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed specificity than the ground truth. Key strengths: (1) Correctly identifies the evolution from short-term 'price-to-be-fixed' approach to longer-term hedging strategy; (2) Accurately captures the timeline progression: fiscal 2023 coverage in 2022 → fiscal 2024 in 2023 → fiscal 2025 in 2024; (3) Properly identifies the extended supply outlook through fiscal 2025 in both 2023 and 2024; (4) Correctly names specific hedging instruments (forwards, futures, collars, commodity-index-linked hedges); (5) Accurately describes the shift toward longer-term risk mitigation. The answer goes beyond the ground truth by providing more granular detail about hedging mechanisms and the year-by-year progression of forward commitments. Minor considerations: (1) The ground truth emphasizes 'commodity index funds' as a specific factor influencing volatility, while the LLM answer uses the broader term 'commodity-index-driven price swings' and 'commodity-index-linked hedges'—these are semantically equivalent and appropriately contextualized; (2) The LLM answer adds the detail about 'deeper hedge book and larger allocation to forward contracts' which represents reasonable inference from the stated evolution but goes slightly beyond explicit ground truth statements. The multi-hop reasoning is sound—correctly synthesizing information about hedging strategy evolution, supply commitment timeline changes, and exposure management across the three-year period. All dates and fiscal year references are accurate. No calculation errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 441,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s open‑market share‑repurchase authorization expanded steadily—​the board had about **$3.1 billion** of remaining capacity at the end of 2022, reduced it to roughly **$2.7 billion** by the end of 2024 after repurchasing **≈$4.5 billion** of stock in 2023 and **$2.0 billion** in the fourth quarter of 2024—while in September 2024 it added **$4 billion** of authority, bringing total outstanding authorization to **$6.7 billion**.  This multi‑year trajectory shows that Accenture’s capital‑return strategy is a disciplined, cash‑driven program that regularly scales up share‑buyback capacity to return a substantial portion of its strong free cash flow to shareholders while preserving flexibility for future investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) INCORRECT REPURCHASE AMOUNTS: The LLM claims Accenture repurchased '≈$4.5 billion of stock in 2023 and $2.0 billion in the fourth quarter of 2024.' The ground truth states only $605 million was purchased in fiscal 2023 (for 2,000,308 shares). The $4.5B figure is completely unsupported and appears fabricated. (2) TIMELINE CONFUSION: The LLM conflates fiscal years with calendar dates. It states '$2.7 billion by the end of 2024' but the ground truth specifies $2,694 million as of August 31, 2024 (fiscal 2024 end), not calendar year-end. (3) CORRECT ELEMENTS: The LLM correctly identifies the $3.1B authorization at end of 2022, the $4B additional authority added in September 2024, and the resulting $6.7B total authorization. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the three-year trajectory and characterize it as a 'disciplined, cash-driven program,' this interpretation is undermined by the fabricated repurchase numbers. The reasoning about capital return strategy is sound in principle but built on false data. (5) MISSING CONTEXT: The LLM fails to accurately reference the specific $605M repurchase in fiscal 2023 and instead invents much larger figures. The ground truth's specific share count (2,000,308 shares) is also omitted. The answer demonstrates partial understanding of the overall strategy but fails on fundamental factual accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 423,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term lock‑up portion of Google’s marketable equity securities was $803 million at the end of 2022, rose to about $1.4 billion by the end of 2023, and then fell sharply to roughly $266 million by the end of 2024. This swing shows that Google deliberately expanded its exposure to illiquid, private‑market assets in 2023—presumably to capture higher returns— but then substantially reduced that exposure in 2024, indicating a strategic pull‑back or a move toward greater liquidity and risk management.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) YEAR SEQUENCE ERROR: The LLM states 2022=$803M, 2023=$1.4B, 2024=$266M, but ground truth shows 2022=$1.4B, 2023=$803M, 2024=$1.4B. The LLM has reversed the 2022 and 2023 values and introduced an entirely incorrect 2024 figure of $266M. (2) QUANTITATIVE ACCURACY: All three year-end values are wrong. The 2024 value of $266M is completely fabricated and does not match the ground truth of $1.4B. (3) NARRATIVE CONTRADICTION: The LLM's interpretation of the trend is backwards—it describes an expansion in 2023 followed by a sharp reduction in 2024, when the actual data shows a decrease in 2023 followed by a recovery to 2022 levels in 2024. (4) STRATEGIC INTERPRETATION: While the LLM attempts to provide strategic reasoning about the fluctuations, this reasoning is based on incorrect data and therefore misleading. The ground truth suggests cyclical rebalancing, while the LLM incorrectly suggests a deliberate expansion followed by a pullback. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend across the 2022-2024 period. The answer demonstrates fundamental data retrieval errors rather than reasoning errors. This is a case where the LLM appears to have hallucinated or severely misremembered the actual financial figures from Google's SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 388,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑positioned Electric Insurance Company from an internal captive P&C unit to a non‑core asset: it was placed in held‑for‑sale in Q4 2022, written down by roughly $109 million (recorded as a loss in 2023), and finally sold in Q2 2024 to Riverstone International for $120 million cash. The disposal removed about $0.2‑$0.3 billion of claim reserves from GE’s balance sheet, offset the prior impairment with modest cash proceeds, and allowed the company to streamline its focus on core aerospace, healthcare and energy businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key progression (held-for-sale classification, $109M loss in 2023, sale to Riverstone for $120M in 2024), correctly names the buyer, and appropriately characterizes this as a strategic exit from non-core business. The semantic framing of the transaction and its strategic rationale is sound. CRITICAL ERRORS: (1) TIMING ERROR - LLM states EIC was 'placed in held-for-sale in Q4 2022' but ground truth indicates this classification occurred by 2023 (December 31, 2023 balance sheet shows held-for-sale status). The original answer does not mention Q4 2022 held-for-sale classification. (2) ASSET/LIABILITY FIGURES - Ground truth provides specific 2023 balance sheet data: assets of $541M and liabilities of $378M as of December 31, 2023. LLM vaguely references '$0.2-$0.3 billion of claim reserves' which is imprecise and doesn't capture the full asset/liability picture disclosed. (3) SALE TIMING - LLM states 'Q2 2024' but ground truth only confirms '2024' without specifying quarter. (4) CLAIM RESERVES CHARACTERIZATION - LLM's '$0.2-$0.3 billion' range is inconsistent with ground truth's specific '$0.2 billion' figure for 2022 and doesn't align with the 2023 asset base of $541M. MULTI-HOP REASONING: The LLM successfully synthesizes the three-year progression and connects it to GE's broader portfolio strategy, which is appropriate. However, the quantitative details are insufficiently precise for a financial analysis question. The answer conflates 2022 claim reserves with 2023-2024 balance sheet items without clear temporal distinction. CALCULATION VERIFICATION: The $109M loss and $120M sale proceeds are correctly stated, but the relationship between these figures and the asset/liability base is not clearly explained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 483,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nBetween early 2022 and early 2025 Amgen’s Phase 3 pipeline expanded from 13 to 25 investigational indications—rising from 13 programs in February 2022, to 18 by January 2023, 24 by January 2024 and 25 by February 2025—driven by new Phase 3 starts, regulatory approvals and the addition of five Horizon‑derived assets, while only a handful of programs were discontinued.  This growth reflects a deliberate strategic shift toward diversifying across oncology, cardiovascular, rare‑disease and biosimilar modalities, underscoring Amgen’s focus on high‑value, genetics‑informed biologics and protein‑engineering platforms and its increased R&D spending (up from $4.4 B in 2022 to $6.0 B in 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the overall trajectory (13 to 25 programs), mentions the Horizon acquisition of five programs, and provides relevant strategic context about diversification across therapeutic areas and R&D spending increases. The answer demonstrates good multi-hop synthesis by connecting pipeline expansion to strategic drivers and R&D investment. CRITICAL ERRORS: (1) The LLM states the progression as '13 in February 2022, to 18 by January 2023, 24 by January 2024 and 25 by February 2025.' However, the ground truth specifies: 13 programs in 2022, 18 in 2023, 24 in 2024, and 25 in 2024 (not 2025). The LLM incorrectly extends the timeline to February 2025, which is beyond the ground truth's 2024 endpoint. (2) The ground truth explicitly states '24 programs in 2024' and then 'By 2024, Amgen had added one more program, bringing the total to 25,' indicating both 24 and 25 occurred in 2024, not that 25 was achieved in 2025. (3) The R&D spending figures ($4.4B in 2022 to $6.0B in 2024) are provided by the LLM but not mentioned in the ground truth, making them unverifiable against the source. QUANTITATIVE ACCURACY ISSUES: The core numbers (13, 18, 24, 25) are correct, but the temporal attribution is wrong. The LLM conflates the 2024 endpoint with a 2025 endpoint. QUALITATIVE STRENGTHS: The answer provides excellent contextual detail about therapeutic focus areas (oncology, cardiovascular, rare-disease, biosimilars) and strategic rationale that aligns with the ground truth's emphasis on 'robust and diversified late-stage pipeline.' The mention of 'genetics-informed biologics and protein-engineering platforms' adds relevant strategic context. MULTI-HOP REASONING: The synthesis connecting pipeline growth to Horizon acquisition, regulatory approvals, and R&D spending is sound and demonstrates proper multi-document synthesis. However, the temporal error undermines the accuracy of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 527,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from an aggressive, cobrand‑driven expansion toward a more compliance‑focused stance as regulators intensified scrutiny of interchange fees, network‑routing rules and non‑discrimination provisions; the firm exited its network‑licensing businesses in the EU and Australia and, after being designated a Category III bank‑holding company in 2024, faced heightened U.S. supervisory expectations that forced tighter risk‑management and capital‑allocation controls.  At the same time, competitive pressure from Visa, Mastercard and emerging fintech payment models—especially caps on interchange fees and the rise of “buy‑now‑pay‑later” and digital‑wallet alternatives—prompted Amex to protect its premium value proposition by emphasizing differentiated rewards, data‑analytics and premium services while scaling back exposure to fee‑sensitive network negotiations.  Overall, the company’s relationship with global card networks has become more defensive and regulated, prioritizing compliance and differentiated premium offerings over expansive network‑licensing growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from competitive/expansion-focused to compliance-focused stance (2022-2024). It accurately mentions EU and Australia exits from network-licensing businesses, regulatory pressures on interchange fees, and the shift toward premium differentiation. The answer appropriately synthesizes competitive dynamics (Visa, Mastercard, fintech) with regulatory constraints. The characterization of the relationship becoming 'more defensive and regulated' aligns with the ground truth trajectory.\n\nWEAKNESSES: (1) QUANTITATIVE ERRORS: The LLM introduces a specific claim about AXP being 'designated a Category III bank-holding company in 2024' with associated supervisory expectations. This specific designation and date cannot be verified against the ground truth knowledge graph, which does not mention this classification. This is a factual claim not supported by the original answer. (2) MISSING ELEMENTS: The ground truth specifically mentions 'China UnionPay' as a competitive reference in 2022, and 'Alipay and PayPal' as emerging competitive threats by 2023. The LLM answer omits these specific competitors, instead using generic references to 'fintech payment models' and 'digital-wallet alternatives.' (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes 'uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations' - the LLM mentions cobrand-driven expansion but doesn't capture the specific regulatory uncertainty around cobrand arrangements. (4) UNSUBSTANTIATED DETAILS: References to 'buy-now-pay-later' and specific risk-management/capital-allocation controls are not mentioned in the ground truth and appear to be inferred rather than directly supported.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects regulatory pressures to competitive responses. However, the introduction of unsupported specific claims (Category III designation) undermines the reliability of the synthesis.\n\nSEMANTIC EQUIVALENCE: While the overall narrative arc is similar, the LLM adds details not in the ground truth and omits specific competitive references that were included. This represents both expansion beyond and contraction from the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 615,
        "total_tokens": 2183
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips finished the paced monetisation of its CVE common shares in 2022, generating enough cash to repurchase **87.7 million** of its own shares for **≈ $6.9 billion**; in 2023 it used remaining proceeds and operating cash to buy back **48.6 million** shares for **≈ $3.8 billion**, and in 2024 it repurchased a further **49.1 million** shares for **≈ $3.9 billion**, marking a shift from a single large‑scale buy‑back in 2022 to two smaller, continual repurchases in 2023‑24.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The LLM provides specific share repurchase volumes (87.7M, 48.6M, 49.1M shares) and dollar amounts ($6.9B, $3.8B, $3.9B) for 2022-2024 that do not match the ground truth. The ground truth states ConocoPhillips repurchased 383 million shares in 2022 alone at a cost of $29 billion, and cumulatively 433 million shares at $34.3 billion through 2024. The LLM's annual figures sum to only 185.4 million shares at $14.6 billion total, which is dramatically lower than the ground truth figures. (2) MISSING KEY INFORMATION - The LLM fails to mention the 91 million CVE shares sold in 2022 that generated proceeds for repurchases. It also omits the $65 billion authorization increase in October 2024, which is a significant corporate action. (3) STRUCTURAL MISALIGNMENT - The ground truth emphasizes the 2022 repurchase of 383 million shares at $29 billion as a major capital return event, but the LLM characterizes 2022 as involving only 87.7 million shares at $6.9 billion. (4) MULTI-HOP REASONING FAILURE - The LLM fails to properly synthesize the connection between CVE monetization proceeds and the subsequent large-scale share repurchase program. The ground truth clearly links the 91 million CVE shares sold to funding the 383 million share repurchase in 2022. (5) CALCULATION VERIFICATION - The LLM's annual breakdown ($6.9B + $3.8B + $3.9B = $14.6B) is internally consistent but factually incorrect when compared to ground truth ($29B in 2022 alone). The answer appears to present plausible-sounding but fabricated financial data rather than accurate figures from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 471,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nThe Omnibus Stock Incentive Plan showed a modest contraction in its unused share reserve over the three‑year span.  The 2022 filing notes that, as of the end of fiscal 2022, roughly **77 million shares** remained available for future grants [HD 10‑K 2022, pp. 65‑69]; the 2023 filing reports essentially the same figure [HD 10‑K 2023, pp. 67‑71]; and the 2024 filing updates the balance to **about 70 million shares** available as of February 2 2025 [HD 10‑K 2024, pp. 67‑71].  This decline of roughly 7 million shares indicates that Home Depot is increasingly drawing down the plan’s share pool to fund new equity awards and award settlements, reflecting growing utilization of its stock‑based compensation capacity even though a meaningful reserve still remains.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 figure. The ground truth clearly states that in 2022, there were 117 million shares available under the 2005 Plan. However, the LLM reports '77 million shares' for 2022, which is actually the 2023 figure. This is a major quantitative error that undermines the entire analysis. The LLM correctly identifies 70 million shares for 2024, but the progression is wrong: it should be 117M (2022) → 77M (2023) → 70M (2024), not 77M (2022) → 77M (2023) → 70M (2024). This misrepresentation of the 2022 baseline makes the calculated decline of 7 million shares incorrect—the actual three-year decline is 47 million shares (117M to 70M), which is far more significant than the 7 million decline the LLM reports. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution across all three years. It missed the substantial drawdown from 2022 to 2023 (40 million shares), focusing only on the 2023-2024 decline. This represents a failure in multi-hop synthesis across the three-year period. POSITIVE ASPECTS: The LLM correctly identifies the general trend of declining available shares and appropriately interprets this as increased utilization of equity awards. The qualitative reasoning about stock-based compensation capacity is sound. The reference to the replenishment mechanism is contextually appropriate. ENTITY ACCURACY: Company and plan names are correct; fiscal years are properly identified. However, the misattribution of numbers to years is a critical entity-linking error. The semantic interpretation of the trend is correct, but the factual foundation is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 464,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP’s share reserve grew from **127 million Class A ordinary shares authorized in fiscal 2022** (as disclosed in the 2022 10‑K, pages 89‑93) to **141 million shares authorized by fiscal 2024** (2024 10‑K, pages 96‑100), with fiscal 2023 still reflecting the 127 million limit. This expansion of the equity‑award pool indicates that Accenture is deliberately enlarging its share‑based compensation capacity to support its global talent strategy and to reinforce long‑term incentive alignment for employees.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL 2023 DATA: The LLM states that fiscal 2023 'still reflected the 127 million limit,' but the ground truth indicates that by 2023, the number had already increased to 141,000,000. This is a significant factual error that contradicts the original answer's clear statement that the increase occurred between 2022 and 2023, with both 2023 and 2024 showing 141 million shares. The LLM's claim that the increase happened between 2023 and 2024 is incorrect. CORRECT ELEMENTS: (1) The 2022 figure of 127 million is accurate, (2) The 2024 figure of 141 million is accurate, (3) The overall characterization of the expansion as strategic and related to talent/incentive alignment is appropriate and semantically equivalent to the ground truth. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across multiple years and documents (2022, 2023, 2024 10-Ks), but made an error in the temporal progression. The reasoning about strategic intent is sound and matches the ground truth's interpretation. QUANTITATIVE ACCURACY PENALTY: The misstatement of when the increase occurred (claiming 2023 still had 127M when it actually had 141M) is a material factual error that significantly impacts the answer's accuracy regarding the 'evolution' requested in the question. The question specifically asks about progression 'from 2022 through 2024,' and the LLM failed to correctly identify that the increase occurred in 2023, not 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 401,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign government bonds and obligations rose from about **3.5 % in 2022 to roughly 6.1 % in 2024**, an increase of roughly 2.6 percentage points. This jump shows the company has moved its investment mix toward higher‑yielding non‑U.S. sovereign debt, making its earnings more sensitive to fluctuations in international interest‑rate environments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. (1) QUANTITATIVE ERRORS - The LLM states the yield was 3.5% in 2022, but the ground truth clearly shows 5.86% in 2022. The LLM claims 6.1% in 2024, but ground truth shows 5.86% in 2024 (a return to 2022 levels, not an increase). The calculated difference of 2.6 percentage points is therefore incorrect. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The LLM completely missed the 2023 data point (6.45%), which is critical to understanding the trend. The ground truth explicitly describes a three-year trajectory with a peak in 2023 followed by a reversal. The LLM only references 2022 and 2024, missing the essential middle year that explains the volatility. (3) MISCHARACTERIZED TREND - The LLM describes a monotonic increase from 2022 to 2024, when the actual trend is: 5.86% (2022) → 6.45% (2023) → 5.86% (2024). This is a volatile pattern with a reversal, not a sustained rise. (4) INCORRECT INTERPRETATION - The LLM's conclusion that the company 'moved its investment mix toward higher-yielding non-U.S. sovereign debt' contradicts the ground truth finding that yields returned to 2022 levels by 2024, suggesting strategic adjustments or stabilization rather than a sustained shift toward higher yields. (5) MISSING CONTEXT - The LLM fails to capture the key insight that the 2024 return to 5.86% represents a 'partial reversal' and stabilization, not a continuation of the upward trend. The answer demonstrates a fundamental misunderstanding of the multi-year data pattern required to answer this question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 438,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nAmerican Express’s foreign‑government‑bond portfolio had a weighted‑average yield of **6.45 % at the end of 2023** (see AXP 10‑K 2023, pages 133‑137) and **5.85 % at the end of 2024** (see AXP 10‑K 2024, pages 175‑179).  The 2022 fair‑value distribution (AXP 10‑K 2022, pages 119‑123) shows the bonds were concentrated in the “due within 1 year” bucket (≈ $628 million) with only minimal exposure to longer‑dated tranches, implying a short‑duration, high‑quality ladder.  The decline from the 2022‑2023 yield to 5.85 % in 2024 reflects a deliberate shift toward shorter‑maturity, lower‑risk securities as market rates peaked and began to ease, signalling that American Express is actively de‑risking its fixed‑income book and prioritising liquidity and capital preservation over yield maximisation in the current interest‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All key numeric values are correct: 6.45% yield in 2023, 5.85% yield in 2024, $630M total holdings in 2022, $628M maturing within one year. (2) Correctly identifies the short-duration focus in 2022. (3) Properly cites source documents (AXP 10-K filings for respective years). (4) Accurately notes the yield decline from 2023 to 2024. WEAKNESSES: (1) CRITICAL INTERPRETATION ERROR: The LLM states the decline from 2023 to 2024 reflects 'a deliberate shift toward shorter-maturity, lower-risk securities' and 'de-risking,' but this interpretation is problematic. The ground truth indicates the 2022 portfolio was ALREADY heavily concentrated in short-duration instruments (≈$628M of $630M due within 1 year). A shift toward even shorter maturities would be minimal and doesn't logically explain a yield DECLINE. (2) The LLM's explanation that 'market rates peaked and began to ease' is reasonable but the conclusion that this represents a shift toward shorter maturities contradicts the fact that the portfolio was already short-duration in 2022. (3) The ground truth suggests the yield decline 'indicates a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments' - which is the OPPOSITE of what the LLM claims. (4) The LLM's reasoning about 'de-risking' and 'prioritizing liquidity and capital preservation over yield maximization' is somewhat speculative and not directly supported by the data progression shown. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three years (2022, 2023, 2024) but draws an incorrect strategic conclusion about the direction of portfolio adjustment. The quantitative facts are right, but the qualitative interpretation of what those facts mean for investment strategy is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 505,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings the 7 % Debentures due 2029 are listed in the “Securities Registered Pursuant to Section 12(b)” table with identical wording, the same CUSIP ‑ 718507BK1, and the same NYSE listing, showing no change in the basic presentation.  The only evolution is minor formatting updates and the addition of updated company‑wide statistics (e.g., share count, asset totals), indicating that ConocoPhillips treats the debenture as a stable, routine liability and reports it in a consistent, standardized manner, leaving detailed term disclosures to the footnotes rather than altering the cover‑page disclosure.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The ground truth explicitly states that the presentation EVOLVED across the three years - specifically that in 2022 the debentures were disclosed 'alongside its Common Stock' in the same row, but in 2023 they were 'separated into its own row' providing 'clearer distinction as a separate class of security.' The LLM answer claims there was 'no change in the basic presentation' and that the debentures are shown 'with identical wording' across all three years. This is a fundamental factual error that directly contradicts the ground truth's central finding about the evolution of disclosure practices. QUANTITATIVE ACCURACY: The CUSIP number (718507BK1) is correct, the percentage (7%) is correct, the year (2029) is correct, and the exchange (NYSE) is correct. These numeric/identifier elements are accurate. QUALITATIVE ACCURACY: The LLM's interpretation that this represents 'no change' and 'consistent, standardized manner' is incorrect. The ground truth indicates a deliberate structural change in how the security was presented in the registration table - moving from a combined presentation to a separate row. The LLM misses this key evolution entirely. The LLM's conclusion that 'detailed term disclosures' are left to footnotes may be true but is not responsive to the actual question about how the presentation evolved in the registration table itself. MULTI-HOP REASONING: The LLM failed to synthesize the multi-year progression correctly. It should have identified the 2022→2023 transition as a key change point where the debentures moved from a combined listing to a separate row. Instead, it asserts consistency where the ground truth identifies evolution. CONTEXTUAL RELEVANCE: The question specifically asks about 'evolution' and what the 'multi-year progression indicates.' The LLM's answer that there was 'no change' directly fails to address the question's premise. The ground truth's interpretation of this evolution as indicating 'growing emphasis on clarity and specificity' is the appropriate contextual framing that the LLM completely misses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 583,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes due 2031 kept the same $1.25 billion face amount throughout fiscal 2022‑2024, but the net carrying amount (principal + amortized discount) edged upward—from roughly $1.05 billion at the end of FY 2022 (see NVDA_10k_2022.pdf pp. 78‑82) to about $1.07 billion by FY 2023 (NVDA_10k_2023.pdf pp. 65‑69) and remained at that level in FY 2024 (NVDA_10k_2024.pdf pp. 70‑74).  At the same time the portion classified as a current liability fell to zero, leaving the full $1.25 billion as a long‑term obligation.  This steady, low‑coupon, long‑dated debt shows that NVIDIA is anchoring its capital structure with stable, staggered fixed‑rate financing to fund long‑term growth while minimizing refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the face amount was $1.25 billion throughout FY2022-2024, but the ground truth shows the carrying amount was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. The LLM conflates face value with carrying value and misrepresents the progression. The ground truth explicitly states the exposure 'increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024'—showing a decrease from 2022 to 2023, then an increase to 2024. The LLM incorrectly claims the carrying amount 'edged upward' from FY2022 to FY2023 when it actually decreased from $1.2B to $1.057B. (2) CHARACTERIZATION ERROR: The LLM states the carrying amount 'remained at that level in FY 2024' (implying ~$1.07B), but the ground truth shows it rose to $1.25 billion in 2024—a significant increase of ~$193 million that the LLM completely misses. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information across three fiscal years and discusses debt management strategy, the fundamental numerical progression is wrong. The ground truth shows a non-monotonic pattern (down then up), while the LLM incorrectly characterizes it as steady upward movement. (4) CONTEXTUAL ISSUES: The LLM's conclusion about 'stable, staggered fixed-rate financing' is somewhat reasonable but is built on incorrect numerical analysis. The actual pattern (decrease then significant increase) suggests different strategic considerations than the LLM implies. The LLM provides specific page references that cannot be verified but appear to be fabricated details. The answer demonstrates effort in multi-hop synthesis but fails on core quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 507,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nAcross the three fiscal years Marvel has remained listed as an **indefinite‑lived intangible asset** (its trademarks) on Disney’s balance sheet – see the “Indefinite lived intangible assets” tables in the 2022 (p. 112), 2023 (p. 8) and 2024 (p. 113) filings.  At the same time the company has progressively **integrated the Marvel brand into its streaming strategy**: in 2022 it was primarily a linear‑network and production banner, by 2023 it was highlighted as a dedicated “Marvel” tile within Disney+ (and Hulu) (2023 10‑K pp. 6‑7), and in 2024 the same Marvel‑branded programming continues to drive subscriber growth on Disney+ and other DTC services, while the Marvel trademarks stay on the indefinite‑lived asset schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Marvel's strategic positioning across three fiscal years. STRENGTHS: (1) Correctly identifies Marvel as an indefinite-lived intangible asset across all three years (2022, 2023, 2024), matching the ground truth. (2) Accurately cites specific page references from the 10-K filings (2022 p. 112, 2023 p. 8, 2024 p. 113), demonstrating document-level precision. (3) Properly synthesizes the streaming strategy evolution: correctly notes the 2023 Marvel tile branding within Disney+ and Hulu (with accurate page citations 2023 10-K pp. 6-7). (4) Maintains semantic equivalence with ground truth by explaining both the financial asset recognition and content distribution strategy. (5) The progression narrative (linear network → dedicated tile → continued DTC driver) logically mirrors the ground truth's emphasis on 'consistent inclusion' and 'prominent branding role.' MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing ('progressively integrated' vs. ground truth's 'strategic emphasis on leveraging'), though both convey the same strategic intent. (2) The answer could have been more explicit about the 2024 reaffirmation of Marvel's indefinite-lived status (ground truth emphasizes 'reaffirmed in 2024'), though this is implied in the statement about Marvel trademarks staying on the indefinite-lived asset schedule. (3) No quantitative metrics provided (e.g., specific dollar amounts for Marvel's intangible asset value), though the question doesn't explicitly require these. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and two distinct dimensions (balance sheet classification and streaming strategy), correctly identifying the parallel evolution of Marvel's financial and operational positioning. The logic connecting indefinite-lived asset status to brand equity and subscriber engagement is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 533,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nBetween 2022 and 2024 American Express continued to recognize discount revenue at the time a Card‑Member transaction is settled, but it increasingly captured that revenue through individually negotiated network‑rate fees with third‑party merchant acquirers—terms that were refined each year (e.g., longer fixed‑duration contracts, auto‑renewal clauses, and tighter fee negotiations).  At the same time the company expanded merchant coverage by extending acceptance agreements, growing its OptBlue and other partnership programs, and targeting new verticals and international markets, which broadened the network‑rate‑fee base and reshaped how discount revenue is recognized and grown.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in completeness and synthesis. STRENGTHS: (1) Correctly identifies discount revenue recognition at transaction settlement; (2) Accurately mentions individually negotiated network-rate fees with third-party acquirers; (3) Correctly references OptBlue program expansion; (4) Appropriately notes merchant coverage expansion and international market targeting; (5) No quantitative errors in numbers or dates (none were provided in either answer). WEAKNESSES: (1) MAJOR OMISSION - Fails to mention the introduction of 'processed revenue' in 2023, which is a key evolution in the revenue structure per the ground truth. The ground truth explicitly states 'processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners' emerged in 2023 as a distinct revenue stream; (2) INCOMPLETE SYNTHESIS - Does not adequately distinguish the 2023 inflection point where processed revenue was introduced alongside discount revenue; (3) VAGUE DETAILS - Mentions 'longer fixed-duration contracts, auto-renewal clauses, and tighter fee negotiations' without citing specific evidence from filings, whereas ground truth focuses on documented contractual structures; (4) MISSING CONTEXT - Does not clearly articulate the strategic shift toward 'deeper collaboration with third-party acquirers' as a deliberate strategic evolution; (5) INCOMPLETE MULTI-HOP REASONING - While the answer addresses merchant coverage expansion, it doesn't fully synthesize how this connects to the broader revenue structure evolution across the three-year period. The answer reads more as a description of 2024 strategy rather than a true evolution narrative from 2022-2024. The processed revenue component is a material omission that affects the completeness of the revenue structure analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 513,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nAcross the 2022‑2024 filings Amgen’s discussion of drug‑delivery‑device risk evolved from a generic note that its products are coupled with devices that carry independent regulatory and safety uncertainties (2022) to a more concrete articulation of post‑marketing obligations—such as required confirmatory studies and REMS reporting—linked to device‑related safety signals (2023). By 2024 the language explicitly ties device‑approval conditions to clinical‑trial read‑outs and subjects device safety data to heightened scrutiny, making clear that any failure to meet those conditions could trigger regulatory actions, label changes, or market withdrawals.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Amgen's regulatory risk disclosures across 2022-2024, with generally accurate characterization of the progression. STRENGTHS: (1) Correctly identifies the temporal evolution from generic to specific disclosures; (2) Accurately captures the shift from general device dependencies to concrete post-marketing obligations; (3) Properly mentions REMS reporting and confirmatory studies as specific mechanisms; (4) Correctly identifies potential enforcement actions including market withdrawals; (5) Appropriately synthesizes multi-hop information across three years. WEAKNESSES: (1) The LLM answer does not explicitly mention LUMAKRAS or the Complete Response Letter from FDA, which are specific factual details in the ground truth that demonstrate concrete examples of the regulatory evolution; (2) Does not explicitly reference surrogate endpoints in clinical trials, which the ground truth identifies as a 2023 development; (3) The phrase 'device-related safety signals' is somewhat vague compared to the ground truth's more specific reference to pharmacovigilance and quality assessment requirements; (4) Missing explicit mention of companion diagnostic devices, which the ground truth specifically identifies as part of the device ecosystem. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022-2024) are correct. QUALITATIVE ACCURACY: The reasoning about regulatory evolution is sound and the multi-hop synthesis across years is logical, though some specific examples and details are omitted. CONTEXTUAL RELEVANCE: The answer directly addresses the question's three components (clinical trial dependencies, post-marketing requirements, device-related safety reviews) though with varying levels of specificity. The omission of LUMAKRAS as a concrete example and the lack of explicit mention of surrogate endpoints represent meaningful gaps in completeness, though the core narrative arc is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 533,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips broadened the **scope of its HSE audit program** to include climate‑related and low‑carbon performance metrics (e.g., methane‑intensity and flaring targets) in addition to traditional safety and environmental controls (2022 10‑K pp. 16‑20; 2023 10‑K pp. 14‑18; 2024 10‑K pp. 18‑20).  The **improvement‑tracking mechanism** evolved from periodic audit findings to a continuous, data‑driven corrective‑action system that uses a centralized dashboard to log findings, assign remediation deadlines and report progress against defined KPIs (2023 10‑K “Health, Safety and Environment” section; 2024 10‑K HSE discussion).  Governance reporting was strengthened by elevating HSE oversight to the **Board of Directors’ Audit Committee and adding an Executive‑Leadership‑Team HSE champion**, so that audit results and improvement status are now reported both to the ELT and to the Board on a regular basis (2022 10‑K “Health, Safety and Environment”; 2024 10‑K “Health, Safety and Environment” and “Values, Principles and Governance” sections).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and diverges significantly from the ground truth. Key issues: (1) SCOPE MISALIGNMENT: The LLM claims the HSE audit program evolved to include 'climate-related and low-carbon performance metrics (e.g., methane-intensity and flaring targets)' - this is NOT supported by the ground truth, which focuses on conformance with company policies, Life Saving Rules, Process Safety Fundamentals, and stop work policies. The ground truth makes no mention of climate or methane metrics being integrated into the HSE audit program evolution. (2) IMPROVEMENT TRACKING MECHANISM: The LLM describes a 'continuous, data-driven corrective-action system' with a 'centralized dashboard' - the ground truth simply states that 'improvement actions continued to be tracked to completion' with no mention of dashboards, KPIs, or data-driven systems. This appears to be fabricated detail. (3) GOVERNANCE REPORTING: The LLM claims HSE oversight was 'elevated to the Board of Directors' Audit Committee and adding an Executive-Leadership-Team HSE champion' - the ground truth states governance remained 'tied to the ELT and Board' but does not mention an Audit Committee elevation or an HSE champion role. (4) EVOLUTION NARRATIVE: The ground truth describes evolution from 'localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024)' - the LLM's narrative about climate metrics and dashboard systems is entirely different and unsupported. (5) CITATION ISSUES: The LLM provides specific page references (e.g., '2022 10-K pp. 16-20') but these cannot be verified against the ground truth and appear to be hallucinated citations. The answer demonstrates fundamental misunderstanding of the actual HSE audit program evolution and introduces false information about climate metrics, dashboards, and governance structures that are not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 521,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nFrom 2022 through 2024 Accenture shifted from largely time‑and‑materials and fixed‑price contracts toward value‑based, outcome‑oriented and consumption‑based pricing that ties fees to AI‑driven and cloud‑enabled services, embedding these models in managed‑services and subscription frameworks to capture the higher‑margin, recurring revenue of cloud and AI offerings.  Across the filings the company repeatedly warns that if it cannot develop and deploy appropriate new pricing/commercial models fast enough—or if client spending on AI and cloud slows—the resulting revenue shortfall, together with heightened regulatory, reputational and talent‑retention risks, could materially adverse‑ly affect its financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific details about pricing model evolution (time-and-materials to value-based, outcome-oriented, consumption-based models) and mentions key risks (revenue shortfalls, regulatory, reputational, talent-retention risks), but has significant issues with multi-hop synthesis and completeness. STRENGTHS: (1) Correctly identifies the general evolution toward value-based and consumption-based pricing models tied to AI and cloud services; (2) Accurately captures the core risk that failure to deploy pricing models quickly enough could harm revenue; (3) Mentions additional risks (regulatory, reputational, talent-retention) that align with broader Accenture risk discussions; (4) No quantitative errors in dates or specific numbers mentioned. WEAKNESSES: (1) The LLM answer introduces specific pricing model types (time-and-materials, fixed-price, outcome-oriented, managed-services, subscription frameworks) that are not explicitly mentioned in the ground truth, suggesting potential hallucination or over-specification beyond what the filings actually state; (2) Fails to capture the year-by-year evolution narrative that is central to the ground truth answer - the ground truth emphasizes progression from 2022 (general acknowledgment) → 2023 (innovation focus) → 2024 (strategic deployment), but the LLM answer presents this as a single unified shift without temporal differentiation; (3) Missing the specific 2023 detail about delays in client spending due to technology evaluation; (4) The mention of 'managed-services and subscription frameworks' is not grounded in the provided ground truth; (5) Does not adequately address the 'evolution' aspect of the question by showing how the approach changed year-to-year. MULTI-HOP REASONING: The LLM answer synthesizes information about pricing models and risks but fails to properly synthesize the temporal evolution across the three-year period, which is a key requirement of the multi-hop question. The ground truth explicitly traces progression across years, while the LLM answer collapses this into a single narrative. SEMANTIC EQUIVALENCE: While the core concepts (value-based pricing, AI/cloud focus, revenue risk) are present, the LLM answer adds specificity not in the ground truth and misses the structured year-by-year evolution that defines the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 623,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nGE’s AerCap exposure changed from a combined equity stake and senior‑note position in 2022 – where the 2022 10‑K (pages 90‑94) shows a 46 % equity interest together with an AerCap senior note – to a full exit from the equity in 2023, when the 2023 10‑K (pages 72‑76) reports that the remaining AerCap shares were sold and only the senior note was retained; and into 2024, when the 2024 10‑K (pages 68‑72) records a modest $38 million unrealized gain on that note, confirming that GE now holds only the note. This progression indicates that GE deliberately liquidated its equity investment in AerCap to simplify its portfolio and shift toward the more stable, cash‑flow‑generating senior note, reflecting a strategic move away from active equity ownership in AerCap.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The ground truth clearly states GE's AerCap note holdings were $993 million at end of 2021 (reported in 2022 disclosure) declining to $944 million at end of 2023 (reported in 2024 disclosure). The LLM answer provides NO specific dollar amounts for the note holdings across the 2022-2024 period, instead focusing on an equity stake narrative. The LLM mentions a '$38 million unrealized gain' in 2024 but this appears to be a gain on the note, not the note value itself, and is not reconciled with the ground truth figures. (2) ENTITY/FACT ACCURACY: The LLM's narrative about a '46% equity interest' and 'full exit from equity in 2023' is not mentioned in the ground truth at all. The ground truth focuses exclusively on the AerCap NOTE holdings, not equity stakes. The LLM appears to have conflated or invented details about equity ownership that are not supported by the knowledge graph. (3) MULTI-HOP SYNTHESIS: While the LLM attempts to trace evolution across 2022-2024, it does so using incorrect data points. The ground truth provides a clear progression: $993M (2021/2022 report) → $944M (2023/2024 report), showing a $49 million decline. The LLM's narrative about equity liquidation and shifting to 'stable, cash-flow-generating senior note' may be reasonable interpretation, but it's built on factually incorrect premises. (4) MISSING CORE DATA: The LLM completely fails to cite the actual note values ($993M, $944M) that form the foundation of the ground truth answer. This is a fundamental omission for a quantitative question about investment holdings. (5) REASONING QUALITY: While the LLM's logic about portfolio simplification is plausible, it's based on invented facts rather than the actual filing data. The ground truth's simpler narrative—gradual decline in note holdings suggesting strategic reduction—is more directly supported by the actual numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 542,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen kept bemarituzumab in Phase 3 development for GEJ adenocarcinoma, maintaining the same clinical‑stage status (it was first entered into a Phase 3 trial in early 2022 and continued through the 2023 and 2024 updates without any regulatory approval or phase‑advancement).  Its intellectual‑property strategy showed no change in the core composition‑of‑matter patents—U.S. and European patents covering the antibody are projected to expire in 2029, with the filings noting that additional patents or term extensions could provide further exclusivity but that the baseline expiration remains 2029.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies Bemarituzumab as Phase 3 for GEJ adenocarcinoma in 2022. (2) Accurately states 2029 patent expiration date for U.S. and European patents. (3) Correctly notes no phase advancement occurred through 2024. (4) Numeric data (2029 expiration, Phase 3 status) is accurate.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM answer fails to capture the key evolution described in the ground truth—the 2024 expansion of investigational scope to include 'gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC.' This represents a material change in therapeutic positioning that the question specifically asks about. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'shift from clinical development focus to broader therapeutic positioning and IP strategy' from 2022-2024. The LLM answer states 'no change in the core composition-of-matter patents' and suggests stasis rather than evolution. (3) MISSING CONTEXT: The ground truth notes that 2023 saw disclosure of IP details (the 2029 expiration), while 2024 provided 'more detailed description of the drug's mechanism'—this temporal progression of disclosure is not captured. (4) CHARACTERIZATION ERROR: By stating 'no change in the core composition-of-matter patents,' the LLM misses that the evolution was about expanded therapeutic scope and mechanism description, not patent changes per se.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across years (2022-2024) but fails to identify the key evolution point—the 2024 expansion beyond GEJ adenocarcinoma. The answer reads as static rather than evolutionary, which contradicts the question's focus on 'how...evolve.'\n\nNUMERIC VERIFICATION: 2029 patent expiration date is correct. Phase 3 status is correct. No calculation errors present.\n\nSEMANTIC ISSUE: The LLM's framing of 'no change' in IP strategy contradicts the ground truth's characterization of evolution and shift in positioning. This is a material semantic difference, not merely a wording variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 550,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 American Express’s filings show a shift from merely acknowledging alternative‑payment pressures—such as surcharge/steering risks, growing BNPL and digital‑wallet adoption, and intensified price competition—to an explicit strategy of investing heavily in AI‑driven fraud‑prevention, cybersecurity, open‑banking and data‑analytics platforms that can embed its premium card services within emerging fintech ecosystems.  This evolution reveals a long‑term response that leverages the company’s brand, data and network to build value‑added, technology‑centric payment solutions rather than defending a purely traditional card‑issuing model, turning fintech disruption into a catalyst for sustained innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core temporal evolution from 2022-2024 and captures the shift from defensive to proactive positioning. (2) The answer accurately references key alternative payment mechanisms mentioned in ground truth (digital wallets, BNPL, open banking). (3) The characterization of the strategic shift—from acknowledging threats to investing in integration—aligns with the ground truth's main thesis. (4) No quantitative errors or incorrect dates/numbers are present. (5) The answer demonstrates sound multi-hop reasoning by synthesizing competitive pressures with technological investment across the three-year period.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM introduces 'AI-driven fraud-prevention' and 'cybersecurity' as primary investment areas, which are not mentioned in the ground truth answer. While these may be legitimate AmEx investments, they are not part of the knowledge graph answer and represent potential hallucination or over-interpretation. (2) The ground truth explicitly mentions 'blockchain-based systems' as a 2022 threat and 'tokenization' as a 2024 investment—the LLM omits blockchain entirely and doesn't explicitly mention tokenization. (3) The ground truth emphasizes a specific 2023 expansion to include 'payment facilitators'—the LLM doesn't capture this intermediate evolution step. (4) The ground truth uses precise language about 'dependency posture' in 2024 (necessity of investing in these technologies)—the LLM's framing of 'turning fintech disruption into a catalyst' is more generic and doesn't capture the nuance of dependency. (5) The LLM adds interpretive elements ('leverage the company's brand, data and network') that, while strategically plausible, go beyond what the ground truth explicitly states.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects competitive pressures to strategic responses. However, it introduces elements not in the ground truth (AI/cybersecurity focus) while omitting specific mechanisms mentioned in the ground truth (blockchain, tokenization, payment facilitators). This represents partial but imperfect synthesis.\n\nSEMANTIC EQUIVALENCE: The core message—evolution from defensive to proactive—is preserved. However, the specific mechanisms and the 2023 intermediate step are lost, reducing fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 635,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of cash‑settled PSUs was $91.6 million in 2022, jumped to $112.5 million in 2023 and then eased to $110.4 million in 2024. This rise followed by a modest decline shows ConocoPhillips is raising the equity‑based component of its long‑term incentive plan and tying a larger share of executive pay to the company’s stock price, while still using cash‑settled awards for a portion of the compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) UNIT MISINTERPRETATION: The LLM fundamentally misunderstood the units of measurement. The ground truth values are $91.58 and $112.50 per PSU (weighted-average grant date fair value per unit), NOT millions of dollars. The LLM stated '$91.6 million' and '$112.5 million,' which is a categorical error - these are per-unit values, not aggregate dollar amounts. This is a severe factual error that undermines the entire answer. (2) INCOMPLETE DATA: The ground truth only provides 2022 ($91.58) and 2024 ($112.50) values. The LLM introduced a 2023 value of $112.5 million and a 2024 value of $110.4 million that are not in the ground truth. The LLM appears to have fabricated or misremembered intermediate year data. The ground truth explicitly shows a straightforward increase from 2022 to 2024 with no mention of 2023 data or a 2024 decline. (3) REASONING QUALITY: While the LLM's interpretation about strategic shift toward higher-value incentive compensation is conceptually reasonable, it is based on incorrect numerical data and an invented 2023-2024 decline pattern. The reasoning about 'equity-based component' and 'stock price' tying is somewhat speculative and not directly supported by the ground truth statement. (4) SEMANTIC ISSUES: The ground truth emphasizes 'consistent structure and accounting treatment maintained throughout the period,' which the LLM does not address. The LLM's narrative of a 'rise followed by modest decline' contradicts the ground truth's simpler upward trend story. CORRECT ELEMENTS: The company (ConocoPhillips) and metric type (cash-settled PSUs) are correctly identified. The general direction of increase is correct, though the specific numbers and trajectory are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 474,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior and fraud intensified as it expanded credit‑centric offerings—most notably the U.S. “Buy‑Now, Pay‑Later” (BNPL) portfolio, merchant‑financing receivables and cross‑border credit products—while simultaneously relying on third‑party banks, payment processors and funding structures to originate and purchase those receivables.  The company repeatedly warns that new and evolving fraud schemes, synthetic‑identity abuse, and the growing share of transactions funded by high‑cost credit cards increase loss rates and can trigger regulatory penalties, and it acknowledges that its current fraud‑detection and protection programs may not keep pace with the scale and sophistication of these threats.  Consequently, the upward trend in credit‑product volume and third‑party dependence signals that PayPal’s risk‑management controls are under growing strain, requiring continual investment and adaptation to maintain effectiveness.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of PayPal's exposure to abusive behaviors from 2022-2024, appropriately emphasizes the expansion of credit products (BNPL, merchant financing), and accurately captures the company's reliance on third-party risk mitigation strategies. The reasoning about growing strain on risk management controls is sound and well-articulated. The answer demonstrates good understanding of the multi-hop synthesis required across years and product lines.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to include the specific €40 billion multi-year agreement mentioned in the ground truth as a key strategic response to credit/fraud losses in 2023. This is a material omission of a concrete, quantifiable fact that demonstrates PayPal's risk mitigation approach. No specific dollar amounts or metrics are provided to support the claims about intensification.\n\nWEAKNESSES - ENTITY/DETAIL ACCURACY: The LLM mentions 'valid-when-made doctrine' is NOT explicitly referenced in the answer, though the ground truth identifies this as an important regulatory uncertainty affecting U.S. credit products in 2024. The answer also doesn't specifically mention the U.K. and European BNPL loan receivables context that was highlighted in 2023. While the answer references 'cross-border credit products,' it lacks the geographic specificity of the ground truth.\n\nWEAKNESSES - COMPLETENESS: The answer addresses the evolution and trend analysis well but omits the specific €40 billion receivables sale agreement, which is a concrete example of PayPal's strategic response to mitigate fraud-related losses. This is a significant factual gap for a multi-hop question requiring synthesis of specific strategic actions.\n\nREASONING QUALITY: The multi-hop reasoning is sound—the LLM correctly synthesizes information about how credit expansion, third-party reliance, and fraud concerns evolved together. The conclusion about risk management strain is logical and well-supported by the narrative, though it would be stronger with the specific quantitative examples from the ground truth.\n\nSCORING JUSTIFICATION: The answer is directionally correct and demonstrates solid understanding of the question's complexity, but the omission of the €40 billion agreement and regulatory doctrine specifics represents material factual gaps that prevent a higher score. The qualitative reasoning is strong (7/10), contextual relevance is high (8/10), but quantitative accuracy is weak due to missing specific figures (4/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 676,
        "total_tokens": 2197
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nBetween 2022 and 2024 Cyramza moved from a mainly second‑line therapy for several solid tumours to an earlier‑line role, especially as a first‑line combination in metastatic NSCLC with EGFR‑mutations and in newer first‑line regimens for gastric and hepatocellular carcinoma.  During the same period Lilly layered its IP estate—maintaining compound‑patent protection through 2026 (US/Japan) and into 2028 (Europe) and securing supplemental protection certificates and new method‑of‑use filings that extend data‑exclusivity into the mid‑2020s—thereby postponing biosimilar entry.  This progression illustrates Lilly’s long‑term oncology strategy of preserving market exclusivity for key assets while expanding their therapeutic reach to capture greater revenue and strategic positioning within the oncology franchise.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims patent protection extends 'into 2028 (Europe)' but the ground truth only mentions 2026 in US/Japan with no European extension date specified. The LLM also references 'data-exclusivity into the mid-2020s' which is vague and unsupported by ground truth specifics (ground truth states data protection expiring 'as early as 2023 in Japan'). (2) THERAPEUTIC POSITIONING ERRORS: The LLM describes a progression from 'second-line therapy' to 'first-line combination in metastatic NSCLC with EGFR-mutations' and 'first-line regimens for gastric and hepatocellular carcinoma.' However, the ground truth makes NO mention of such line-of-therapy shifts or EGFR-mutation specific positioning. The ground truth states Cyramza had 'multiple indications across gastric, lung, colorectal, and liver cancers' in 2022 and 'remained a core oncology offering with no new indications added' by 2024. The LLM appears to have fabricated specific clinical positioning details not present in the source material. (3) INTELLECTUAL PROPERTY CLAIMS: While the LLM correctly identifies 2026 patent expiry in US/Japan, it adds unsupported claims about 'supplemental protection certificates and new method-of-use filings' that are not mentioned in the ground truth. (4) STRATEGIC INTERPRETATION: The ground truth explicitly states Lilly was 'likely preparing next-generation oncology products to succeed it, given the impending patent expiry,' suggesting a transition strategy. The LLM's interpretation of 'preserving market exclusivity while expanding therapeutic reach' is partially aligned but misses the key insight about preparing successor products. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the available information and instead introduced speculative clinical details and IP strategies not supported by the knowledge graph. The answer demonstrates hallucination of specific clinical indications and patent strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 536,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris actively managed its near‑term debt by retiring or refinancing maturing short‑dated notes (e.g., the 2022‑2023 series) and replacing them with later‑dated issuances, while the 3.875 % Notes due 2042 remained continuously outstanding as a stable, long‑term funding pillar.  This shift extended the company’s maturity profile and reduced rollover risk, with debt service funded primarily through cash flows from subsidiaries and dividend income, reflecting a move toward a more laddered, lower‑leverage capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to accurately address the ground truth. Key issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM mentions '2022-2023 series' short-dated notes being retired/refinanced, but the ground truth specifies the 4.125% Notes due 2043 and 4.875% Notes due 2043 as the instruments that were present in 2022 and no longer listed in 2024. These are long-dated notes (due 2043), not short-dated notes. The LLM incorrectly characterizes the maturity profile of the instruments being managed. (2) INCOMPLETE ENTITY IDENTIFICATION: The LLM fails to mention the specific debt instruments that were actually managed: the 4.125% Notes due 2043, 4.875% Notes due 2043, and 4.250% Notes due 2044. These are critical to answering the question about capital structure evolution. (3) MULTI-HOP REASONING ERROR: The ground truth clearly shows a three-year progression (2022→2023→2024) with specific instruments appearing and disappearing. The LLM provides a generic narrative about 'near-term debt' and 'short-dated notes' that doesn't match the actual instruments or their characteristics. (4) SEMANTIC MISALIGNMENT: The ground truth emphasizes that newer 2043 and 2044 tranches were 'retired or refinanced' by 2024, suggesting active management of longer-term instruments. The LLM's focus on 'short-dated notes' and 'rollover risk' misses the actual strategic pattern. (5) CORRECT ELEMENTS: The LLM correctly identifies the 3.875% Notes due 2042 as a stable, continuous component and correctly notes it as a long-term funding pillar. The general concept of active debt management is correct, but the specific execution details are wrong. The answer demonstrates a fundamental misunderstanding of which debt instruments were being managed and their maturity profiles.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 489,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive and fraudulent behavior grew as its credit products (BNPL, merchant‑financing and consumer‑credit offerings) expanded and its reliance on third‑party lenders and payment processors increased, raising default and fraud‑loss risks. In 2023 the company mitigated that risk by entering a multi‑year agreement to sell the majority of its U.K. and European BNPL loan receivables and by beginning a migration of its U.S. payment‑processing relationships to diversify third‑party dependence, while also tightening merchant‑financial monitoring and fraud‑prevention controls. In 2024 it continued these actions, emphasizing the ongoing forward‑flow sale of BNPL receivables and the completion of the processor migration to further reduce credit and third‑party risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's risk evolution and mitigation strategies across 2022-2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the core progression from risk identification (2022) to active mitigation (2023-2024); (2) Accurately references the €40 billion BNPL receivables sale agreement in 2023 (matches ground truth); (3) Properly synthesizes multiple risk factors (synthetic identities, fraud, third-party dependence); (4) Correctly identifies specific 2023-2024 actions including payment processor migration and fraud prevention enhancements; (5) Appropriately contextualizes the shift from problem identification to solution implementation. MINOR ISSUES: (1) The phrase 'sell the majority of its U.K. and European BNPL loan receivables' is slightly imprecise - ground truth states 'up to €40 billion' which is more specific about the agreement structure rather than claiming the majority was already sold; (2) The answer adds details about 'U.S. payment-processing relationships' migration and 'merchant-financial monitoring' that are not explicitly mentioned in the ground truth, though these appear to be reasonable inferences about third-party risk management; (3) The answer states 'completion of the processor migration' in 2024, but ground truth only mentions 'ongoing efforts' without confirming completion. QUANTITATIVE ACCURACY: The €40 billion figure is correct and properly formatted. No calculation errors detected. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - the answer correctly synthesizes information about credit products, third-party risks, and specific mitigation actions across three years. Entity identification is accurate (PayPal, BNPL, U.K./European markets). CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question regarding exposure evolution, credit products, third-party risk management, and specific 2023-2024 actions. The overall narrative arc matches the ground truth progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 551,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nFrom 2022 through 2024 AMD repeatedly disclosed “loss or modification of exemptions for taxes and tariffs” as a risk, but the language grew more pronounced. In the 2022 filing the risk was mentioned only in the generic “political, legal and economic risks” paragraph, while the 2023 and 2024 filings added concrete examples—U.S. sanctions on Russia/Belarus, heightened U.S.–China tensions over Taiwan, and the potential spill‑over of the Ukraine‑Russia and Israel‑Hamas conflicts—all of which could alter tax or tariff regimes that underpin AMD’s global supply chain and sales. This escalation signals that AMD perceives increasing regulatory uncertainty in its worldwide operations, as external geopolitical developments now directly threaten the stability of the tax and tariff incentives it relies on.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more specific detail than the ground truth. Key strengths: (1) Correctly identifies the three-year progression (2022-2024) of AMD's risk disclosures regarding tax and tariff exemptions; (2) Accurately characterizes the evolution from generic mention to more pronounced language with concrete examples; (3) Correctly identifies specific geopolitical examples (U.S. sanctions on Russia/Belarus, U.S.-China tensions over Taiwan, Ukraine-Russia and Israel-Hamas conflicts) that appear in AMD's filings; (4) Properly synthesizes the multi-hop reasoning connecting geopolitical events to regulatory uncertainty and tax/tariff regime impacts; (5) Correctly interprets the trend as indicating increasing regulatory uncertainty. Quantitative accuracy is high - all dates (2022, 2023, 2024) are correct, and the temporal progression is accurately represented. The LLM answer actually provides MORE specificity than the ground truth by naming concrete geopolitical examples, which enhances rather than detracts from accuracy. Minor consideration: The ground truth uses slightly more general language ('geopolitical conflicts') while the LLM provides specific examples, but this represents added precision rather than error. The reasoning about how external geopolitical developments threaten tax/tariff incentives is sound and well-articulated. The answer fully addresses both parts of the question: (1) how exposure evolved, and (2) what the trend suggests about regulatory uncertainty. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 436,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return swaps linked to deferred‑compensation generated a **$92 million loss in FY 2022**, turned to a **$58 million gain in FY 2023**, and produced a **$91 million gain in FY 2024**.  \n\nThe shift from a loss to progressively larger gains indicates that the company’s economic hedge of its deferred‑compensation obligations moved from being out‑of‑the‑money to profitable, reflecting either a reduction in the liability’s fair‑value exposure or more favorable market conditions for the swaps.  This progression shows Cisco is actively using these derivatives to offset the earnings volatility associated with deferred‑compensation payments and to manage the related risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million match the ground truth exactly. The progression and direction of changes are accurately captured. (2) ENTITY AND TEMPORAL ACCURACY: Cisco is correctly identified, and all three fiscal years (2022, 2023, 2024) are properly referenced with the correct financial outcomes. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the three-year progression and correctly interprets the trend - from loss to progressively larger gains - indicating a reversal in exposure performance. The explanation that this reflects improved market conditions or strategic management of deferred compensation liabilities aligns with the ground truth interpretation. (4) SEMANTIC EQUIVALENCE: The LLM's explanation of the derivatives as an 'economic hedge' and the characterization of the shift from 'out-of-the-money to profitable' provides additional context that is consistent with and supportive of the ground truth's interpretation about improved market conditions and strategic positioning. The answer goes slightly beyond the ground truth by explaining the hedging mechanism and earnings volatility management, which adds relevant context without contradicting the original answer. (5) MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('out-of-the-money to profitable' vs. the ground truth's 'reversal in exposure or performance'), but this represents semantic equivalence rather than factual error. The answer fully addresses the question's multi-part structure regarding both the evolution of gains/losses and what this indicates about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 482,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney’s DTC strategy evolved from an initial launch and cost‑realignment (2022) to a phase of aggressive content and rights investment—exemplified by the Star India joint venture and expanded sports rights—designed to drive subscription and advertising growth while mitigating declines in linear fees (2023), and then to a more competitive stance with an ad‑supported Disney+ tier, a flagship ESPN DTC service, and tighter bundling, accompanied by a projected $24 billion content spend for FY 2025 (2024). This escalating spend creates sizable cash outflows, accelerates amortization and impairment exposure, and subjects the company to intense subscriber‑growth and pricing pressures in a crowded streaming market. Consequently, the financial risk of scaling its streaming services is amplified by high fixed costs, uncertain revenue returns, and the need to maintain robust cash flow amid rising competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's DTC strategic evolution and provides relevant contextual analysis, but contains a critical unverified quantitative claim that significantly impacts accuracy. STRENGTHS: (1) Correctly identifies the three-phase evolution from 2022-2024 matching the ground truth narrative; (2) Accurately captures the strategic pivot toward aggressive investment despite financial risks; (3) Properly synthesizes multi-hop information about competitive pressures, rising costs, and pricing constraints; (4) Appropriately emphasizes the financial risks including cash outflows, amortization exposure, and subscriber growth pressures; (5) Contextually relevant discussion of bundling, ad-supported tiers, and ESPN DTC service. CRITICAL WEAKNESS: The LLM cites a '$24 billion content spend for FY 2025' projection. This specific number cannot be verified against the ground truth knowledge graph, which does not mention this figure. This is a significant quantitative claim that appears to be either fabricated or sourced from information not in the provided ground truth. This type of unverified numerical claim is a major accuracy concern. MINOR ISSUES: (1) The answer adds specific details about 'Star India joint venture' and 'expanded sports rights' that, while plausible, are not explicitly confirmed in the ground truth; (2) The phrase 'cost-realignment (2022)' is slightly different from the ground truth's emphasis on 'acknowledging growing costs and uncertainty around returns.' MULTI-HOP REASONING: The synthesis across fiscal years is sound and logically structured, correctly connecting strategic decisions to financial consequences. The answer properly identifies the progression from uncertainty (2022) → active investment (2023) → competitive scaling (2024). However, the unverified $24B figure undermines confidence in the quantitative foundation. The qualitative reasoning about financial risks (fixed costs, uncertain returns, cash flow pressures) aligns well with the ground truth's conclusion about 'increasing financial risk and market pressures.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 566,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal’s margin risk has remained anchored in its role as principal: it records the full fee it pays to payment processors as a transaction expense while recognizing its own fee as revenue, and it exercises complete discretion over the price it charges—so any rise in processor costs directly compresses margins.  Transaction revenue grew from $25.2 bn in 2022 to $28.8 bn in 2024, and the corresponding transaction‑expense line item increased in step with that higher TPV, but the underlying risk profile has not changed; the company continues to provision for refunds and incentives that further affect margin.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core concept that PayPal bears full margin risk as principal, exercises discretion over fee-setting independent of processor costs, and recognizes processor fees as transaction expenses. The semantic understanding of the risk profile and accounting treatment aligns well with the ground truth. The answer appropriately addresses the multi-hop nature of the question by synthesizing information about fee discretion, processor costs, and margin risk across the time period.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides specific transaction revenue figures ($25.2B in 2022, $28.8B in 2024) that cannot be verified against the ground truth provided. The ground truth does not include these specific numbers, making it impossible to confirm accuracy. This is a significant issue because quantitative precision is critical in financial analysis. The LLM should either cite these figures with source verification or avoid specific numbers without confirmation.\n\nWEAKNESSES - COMPLETENESS: The LLM answer fails to explicitly address the 2023 data point, which was specifically mentioned in the original question asking about evolution \"across 2022, 2023, and 2024.\" The ground truth explicitly notes that 2023 language remained consistent with emphasis on fee control and processor fee recognition. The LLM's answer jumps from 2022 to 2024 without discussing the middle year, which is a gap in addressing the three-year evolution requested.\n\nWEAKNESSES - MISSING ELEMENTS: The ground truth mentions the adoption of new segment reporting standards (ASU 2023-07) in 2024 and explicitly states there were no structural changes despite this adoption. The LLM answer does not reference this important regulatory/accounting development, which is relevant context for understanding the stability of the margin risk exposure across the period.\n\nCORRECTNESS ASSESSMENT: While the LLM demonstrates solid conceptual understanding of PayPal's margin risk position and fee-setting discretion, the unverified financial figures and incomplete coverage of the 2023 year represent material gaps. The answer is directionally correct but lacks the precision and completeness expected for a multi-hop financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 604,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nThe 2022 risk discussion highlighted new‑aircraft order cancellations as a material threat driven by the COVID‑19‑induced demand slump and supply‑chain uncertainty; by 2023 the same risk remained on the list but was described as diminishing as air‑travel volumes recovered and the company’s order backlog strengthened; and in 2024 the issue is referenced only as a background concern, signaling that the commercial aviation sector has moved past the cancellation‑risk era and is now characterized by steady demand and stable order flow.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that aircraft order cancellations remained a CONSISTENT and PROMINENT risk concern across all three years (2022-2024), with the risk evolving in nature but NOT diminishing in importance. The LLM answer incorrectly claims the risk 'diminished' by 2023 and was 'only referenced as a background concern' by 2024, suggesting the issue had largely resolved. This is factually incorrect according to the knowledge graph. The ground truth explicitly states: 'From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor' and 'In 2024, the risk remained prominent.' The LLM's narrative of progressive de-emphasis (material threat → diminishing → background concern) misrepresents the actual risk trajectory. While the LLM correctly identifies the 2022 pandemic-driven context and acknowledges the risk existed across all three years, it fundamentally mischaracterizes the evolution as one of declining concern rather than evolving nature with persistent prominence. The LLM also fails to capture the shift from pandemic-specific concerns (2022) to macroeconomic/geopolitical risks (2023) to competitive/structural shifts (2024), instead presenting a simplistic narrative of recovery and stabilization. The conclusion that 'the commercial aviation sector has moved past the cancellation-risk era' directly contradicts the ground truth's assessment that the sector 'remained fragile and susceptible to both external shocks and evolving market dynamics.' This is a critical misinterpretation of the multi-hop synthesis required to answer the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 467,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosures show a clear escalation in regulatory curbs on its reduced‑risk and smoke‑free offerings: early 2022 filings warned that product‑regulation could diminish the ability to differentiate tobacco products and to convey truthful information about RRPs; by 2023 the focus shifted to SFPs, emphasizing new advertising, flavor‑ and packaging‑restrictions and heightened scrutiny of any health‑related claims; and in 2024 the language underscores that these constraints are now pervasive across multiple jurisdictions, leaving PMI with a markedly narrower platform for product differentiation and adult‑consumer communication. This progression reveals that intensifying global regulation is steadily compressing the competitive space for PMI’s RRPs/SFPs, forcing the company to rely on ever‑more limited, fact‑based messaging while facing growing legal and reputational risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core temporal evolution (2022-2024) and accurately captures the key regulatory themes: restrictions on product differentiation, constraints on truthful information communication about RRPs/SFPs, and intensifying global regulatory pressure. The answer appropriately synthesizes the multi-hop requirement by connecting regulatory impacts to competitive positioning across three years. No quantitative errors are present (no specific numbers were required). The general progression narrative aligns with ground truth.\n\nWEAKNESSES: (1) The LLM introduces specific regulatory mechanisms (\"flavor and packaging restrictions,\" \"health-related claims scrutiny\") that are not explicitly mentioned in the ground truth, potentially overstating specificity without filing support. (2) The answer mentions \"2023 focus shifted to SFPs\" but ground truth indicates the shift to SFPs language occurred in 2024, not 2023 - this is a temporal sequencing error in the multi-hop reasoning. (3) The ground truth emphasizes the strategic product transition from RRPs to SFPs as a key evolution, but the LLM treats them more as parallel concerns rather than showing the transition clearly. (4) The ground truth specifically notes \"disproportionate impact relative to competitors\" and \"regulatory asymmetries\" in 2023, which the LLM generalizes to \"unfair competition\" without the same precision. (5) The LLM's reference to \"digital media spreading misleading information\" from the 2023 ground truth is entirely omitted.\n\nMULTI-HOP REASONING: The answer demonstrates adequate synthesis across years and connects regulatory constraints to competitive positioning, but the temporal misplacement of the SFP focus (2023 vs. 2024) represents a material error in the multi-hop timeline. The answer correctly identifies the escalation pattern but misorders key inflection points.\n\nSEMANTIC EQUIVALENCE: While the overall narrative tone and conclusion about regulatory compression are semantically similar, the specific factual details diverge enough to constitute partial correctness rather than full alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 576,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nPayPal’s margin risk has remained material through 2022‑2024 because the company continues to act as the principal on its payments platform and therefore bears the full spread between the fees it charges merchants and consumers and the fees it pays to third‑party processors; the 2022 filing describes a simple variable‑percentage fee with incentives recorded as revenue reductions, the 2023 filing adds tiered, volume‑based pricing and begins to amortize performance‑based incentives over the contract term, and the 2024 filing keeps the same “full‑margin‑risk” language while noting that incentives are now amortized ratably and that processor‑related fees are still recorded as transaction expense.  Consequently, while the pricing model has become more volume‑sensitive and incentive accounting has been refined, the underlying exposure to margin compression from processor fees and refunds has not diminished – it has stayed roughly constant, with only a modest mitigation from the newer amortization of incentives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and provides a more detailed and nuanced analysis than the ground truth. Strengths: (1) Correctly identifies PayPal's principal role and full margin risk exposure across all three years (2022-2024); (2) Accurately captures the evolution of pricing models from simple variable-percentage fees to tiered, volume-based pricing; (3) Correctly describes the evolution of incentive accounting from revenue reductions to amortization over contract terms; (4) Properly synthesizes multi-hop information about transaction expenses, processor fees, and incentive structures; (5) No quantitative errors detected - all dates, years, and financial concepts are accurate. Minor areas for improvement: (1) The ground truth emphasizes 'increasing detail around incentives and transaction pricing reflects a more nuanced disclosure' while the LLM answer goes further to characterize this as 'modest mitigation' - this is a reasonable inference but slightly beyond what the ground truth explicitly states; (2) The LLM's conclusion that margin compression 'has stayed roughly constant' is a reasonable interpretation but represents analytical judgment rather than explicit ground truth language; (3) The LLM provides more specific detail about amortization being 'ratable' which adds precision. Overall, the LLM answer is more comprehensive and analytically sophisticated than the ground truth, correctly synthesizing the multi-hop information about pricing models, processor relationships, and incentive structures across the three-year period. The reasoning is sound and the entity identification is accurate throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 452,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nBetween 2022 and 2024 AMD moved from a simple price‑protection stance to a formal, collaborative channel model that gives AIB manufacturers explicit inventory‑protection clauses—such as price‑reduction shields, limited return and stock‑rotation rights, and dedicated co‑marketing funds.  These safeguards were paired with a strategic push to use discrete Radeon graphics as a differentiation tool, supplying SIs with exclusive SKUs and software‑optimized platforms that let them create higher‑performance, market‑distinct systems.  As a result, SIs increasingly relied on AMD’s discrete graphics to differentiate their offerings, while AMD’s reinforced inventory framework reduced supply‑risk and financial exposure for its channel partners.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces specific inventory protection mechanisms ('price-reduction shields, limited return and stock-rotation rights, dedicated co-marketing funds') that are NOT mentioned in the ground truth. The ground truth only states AMD 'consistently emphasized inventory protection' without detailing these specific mechanisms. (2) FACTUAL INACCURACIES: The LLM claims AMD moved 'from a simple price-protection stance to a formal, collaborative channel model' suggesting evolution/progression, but the ground truth indicates AMD 'consistently emphasized inventory protection for AIB manufacturers against price reductions across all years'—showing continuity, not a shift from simple to formal. (3) UNSUPPORTED CLAIMS: The LLM mentions 'exclusive SKUs and software-optimized platforms' and 'reinforced inventory framework reduced supply-risk and financial exposure'—these specific details are fabricated and not in the ground truth. (4) PARTIAL CORRECTNESS: The LLM correctly identifies: (a) the 2022-2024 timeframe, (b) AIB manufacturers as key channel partners, (c) discrete graphics as a differentiator, (d) system integrators' role. However, it mischaracterizes the nature and evolution of AMD's strategy. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information about strategy evolution, inventory protection, and graphics differentiation, it does so by inventing details rather than accurately synthesizing the ground truth. The ground truth's key insight—that there was a 'subtle shift in language' toward 'more strategic alignment with SIs' in 2024—is completely missed. The LLM's narrative of moving to 'formal, collaborative channel model' contradicts the ground truth's emphasis on consistency across the period with only subtle 2024 shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 521,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney has kept the same core safeguards for investment‑credit exposure: it deals only with counterparties that carry an A‑ or better rating and will require collateral or reduce the relationship if a rating drops below A‑ or if aggregate exposure exceeds the limits set in the master‑netting agreements.  The company also caps any single‑institution exposure at 10 % of total cash and cash equivalents, a threshold it monitors continuously.  In the 2024 filing the company noted that one institution actually represented about 24 % of its cash balances—higher than the 10 % cap but still not expected to produce a material loss—showing that while the policy limits have not changed, the actual concentration of exposure has shifted.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core policy elements correctly (A- or better rating requirement, collateral requirements, master-netting agreements) and accurately identifies the 24% concentration figure for fiscal 2024. However, there are significant issues with quantitative accuracy: (1) The LLM introduces a '10% cap' on single-institution exposure that is NOT mentioned in the ground truth answer. This appears to be fabricated detail that contradicts the ground truth's statement that there was 'no such concentration in fiscal 2022,' implying no explicit 10% threshold was being enforced or reported. (2) The LLM states the 24% concentration is 'higher than the 10% cap' - this comparison is problematic because the ground truth does not establish a 10% policy threshold. (3) The ground truth emphasizes the evolution/shift from 'no such concentration in fiscal 2022' to '24% in fiscal 2024,' which the LLM acknowledges but frames differently by introducing an unstated 10% policy limit. The LLM's statement that 'policy limits have not changed' may be correct regarding the A- rating and collateral requirements, but the introduction of the 10% threshold detail is unsupported and creates factual inaccuracy. The qualitative reasoning about policy consistency versus actual concentration shift is sound, but the quantitative framing with the unsupported 10% figure significantly undermines accuracy. The answer is partially correct on core facts but introduces problematic details not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 416,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nAcross the three fiscal years the company’s 2.850 % fixed‑rate notes maturing on 10/1/2029 stayed at essentially the same outstanding level – $1.5 billion (≈ $1,500 million) – as shown in the 2022, 2023 and 2024 10‑K tables.  This steady‑state exposure indicates that PayPal is deliberately preserving a sizable, low‑cost, long‑dated fixed‑rate tranche while supplementing its balance‑sheet funding with newer issuances and revolving facilities, reflecting a long‑term debt‑management strategy that emphasizes maturity laddering and stable, long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The core financial data is correct - the 2.850% fixed-rate notes maturing in 2029 remained at $1,500 million ($1.5 billion) consistently across 2022, 2023, and 2024. The number format variation ($1.5 billion vs $1,500 million) is acceptable and properly handled. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the pattern of no principal reduction or refinancing activity for this specific instrument. ENTITY ACCURACY: Company (PayPal/PYPL), debt instrument (2.850% fixed-rate notes), maturity date (10/1/2029), and fiscal years (2022, 2023, 2024) are all correctly identified. STRATEGIC INTERPRETATION: The LLM answer provides sound reasoning about debt management strategy, noting that PayPal deliberately preserved this low-cost, long-dated tranche while supplementing with newer issuances. This aligns with the ground truth's interpretation about retaining favorable interest terms and managing cash flow predictability. The mention of 'maturity laddering and stable, long-term financing' adds appropriate context about debt management strategy. MINOR CONSIDERATIONS: The ground truth explicitly mentions that PYPL issued higher-interest notes in 2024 (5.150% and 5.500%), which the LLM answer references more generally as 'newer issuances.' This is a minor omission of specific detail but does not affect the core accuracy of the answer. The LLM answer's characterization of the strategy is semantically equivalent to the ground truth and demonstrates proper understanding of the multi-year pattern and its implications for long-term debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 465,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Performance Materials and Technologies** segment repeatedly highlighted raw‑material demand and supply as a key risk, noting that capacity‑utilization swings, oil‑ and gas‑price volatility and inflationary material costs could curb customer investment and lower demand.  At the same time, the proportion of its supply base covered by long‑term contracts grew – roughly 63 % in 2022, ≈ 64 % in 2023 and “the majority” by the end of 2024 – and Honeywell added pricing actions, commodity‑hedge programs and supply‑tracking tools to mitigate exposure.  Consequently, although the firm has strengthened its contractual protection, its profitability remains tightly linked to commodity price movements and supply‑chain constraints, underscoring a continued vulnerability to raw‑material market volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED QUANTITATIVE CLAIMS: The LLM introduces specific percentages (63% in 2022, 64% in 2023, 'majority' in 2024) for long-term contract coverage that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated data. This is a major factual error. (2) MISSING KEY INFORMATION: The ground truth explicitly mentions the 2024 segment rebranding to 'Energy and Sustainability Solutions' - the LLM fails to acknowledge this important contextual shift. (3) MISSING SPECIFIC RISKS: The ground truth identifies specific 2022 risks including 'product commoditization' and 'illegal imports of hydrofluorocarbons into Europe' - the LLM omits these details. (4) MITIGATION STRATEGIES NOT IN GROUND TRUTH: The LLM claims Honeywell added 'pricing actions, commodity-hedge programs and supply-tracking tools' - these specific mitigation strategies are not mentioned in the ground truth answer and cannot be verified. (5) PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies the core vulnerability to commodity volatility and mentions oil/gas price volatility and capacity utilization as risks, which aligns with ground truth. The conclusion about sustained vulnerability is semantically correct. ASSESSMENT: While the LLM captures the general theme of sustained commodity vulnerability, it introduces unverified quantitative data (contract percentages) and mitigation strategies not present in the ground truth, which violates the strict requirement for factual accuracy on numbers and specific claims. The answer reads plausibly but contains fabricated details that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 464,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nOver the 2022‑2024 period Imperial Brands PLC remained a constituent of PMI’s peer group in each year’s 10‑K (2022, 2023 and 2024), with the peer‑group list unchanged across the three filings. This stability shows that PMI’s benchmarking strategy is deliberately anchored to a consistent set of global tobacco and consumer‑products companies—including Imperial Brands—as a reference point for comparing market position, financial performance and strategic progress. Consequently, the inclusion of Imperial Brands signals that PMI treats it as a peer of comparable scale and scope, using it to gauge relative performance and inform its long‑term positioning in the sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric references are correct—the three-year period (2022, 2023, 2024) is accurately cited, and the claim that Imperial Brands PLC remained consistently included across all three years matches the ground truth exactly. No calculations or date errors present. ENTITY ACCURACY: Company names are correct (Imperial Brands PLC, PMI/PM), and the fiscal years are properly identified. MULTI-HOP REASONING (9/10): The LLM successfully synthesizes information across three years of filings to establish the trajectory of peer group composition. It correctly identifies the consistency of Imperial Brands' inclusion and draws appropriate inferences about PM's benchmarking strategy. The reasoning that consistency indicates deliberate strategic anchoring and comparable scale/scope is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that Imperial Brands remained consistently in PM's peer group, signaling strategic alignment and comparable positioning. The LLM uses slightly more elaborate language ('deliberately anchored,' 'gauge relative performance,' 'inform its long-term positioning') but these elaborations are reasonable inferences from the stated facts and do not contradict the ground truth. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the trajectory of peer group composition (consistent inclusion), and (2) what this reveals about PM's benchmarking strategy (stable, deliberate focus on comparable global companies). Minor note: The LLM uses 'PMI' while the question uses 'PM'—these are equivalent references to Philip Morris International, so this is not an error. Overall, the answer is factually accurate, logically sound, and appropriately contextual.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 511,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the outstanding principal of PYPL’s 2.850 % fixed‑rate notes remained flat at **$1.5 billion** each year – the company did not issue additional notes of this series nor retire any, so its exposure was unchanged across the three years.  \n\nThis steady, $1.5 billion position reflects a deliberate long‑term‑debt strategy: PYPL maintains a consistent, medium‑term laddered maturity (maturing in 2029) while refinancing maturing obligations with newer issuances, thereby preserving a stable funding base, limiting leverage growth, and managing interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core quantitative fact that PYPL's 2.850% fixed-rate notes remained at $1.5 billion across 2022-2024 with no issuances or retirements. The number formatting and basic factual accuracy are sound. WEAKNESSES: (1) The LLM introduces unsupported details not present in the ground truth, specifically claiming the notes mature in 2029 - this maturity date is not mentioned in the original answer and cannot be verified from the provided ground truth. (2) The LLM's interpretation of PYPL's strategy goes significantly beyond what the ground truth states. The ground truth cautiously suggests PYPL 'possibly prioritizing other debt maturities or leveraging the low fixed rate,' while the LLM makes definitive claims about 'deliberate long-term-debt strategy,' 'laddered maturity,' 'refinancing maturing obligations,' and 'limiting leverage growth' - these are speculative extensions not grounded in the provided data. (3) The ground truth emphasizes that the stable position 'indicates no repayments or refinancing actions,' whereas the LLM claims the company is 'refinancing maturing obligations with newer issuances' - this is a contradictory interpretation. (4) The LLM's discussion of 'interest-rate risk management' is not addressed in the ground truth. The answer demonstrates good quantitative accuracy but problematic qualitative reasoning by overinterpreting limited data and introducing unverified claims about maturity dates and strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 412,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips expanded the scope of its HSE audits to cover not only conventional process‑safety, occupational‑safety and environmental risks but also emerging climate‑related and low‑carbon concerns such as methane‑emissions and flaring‑reduction initiatives.  The company tightened conformance tracking by formalizing corrective‑action workflows that must be closed and reported, and it deepened governance integration by regularly delivering audit results to the Executive Leadership Team and the Board of Directors—making audit findings a formal part of ESG disclosures and executive‑compensation risk oversight.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and diverges significantly from the ground truth. Key issues: (1) FACTUAL ERRORS - The LLM introduces content about climate-related and low-carbon concerns (methane emissions, flaring reduction) that are NOT mentioned in the ground truth answer. The ground truth focuses on HSE audit scope, conformance tracking, and governance integration, not climate/emissions initiatives. (2) MISSING CORE INFORMATION - The LLM fails to capture the critical evolution described in the ground truth: the shift from localized conformance checks (2022) to explicit linkage with annual objectives and ELT/Board reporting (2023) to centralized corporate-level audits (2024). (3) INCORRECT EMPHASIS - The LLM emphasizes 'emerging climate-related and low-carbon concerns' as the primary scope expansion, which contradicts the ground truth's focus on maintaining 'consistent emphasis on HSE audits' for safety and environmental standards. (4) PARTIALLY CORRECT ELEMENTS - The LLM correctly identifies that audit results are delivered to the Executive Leadership Team and Board of Directors, and mentions governance integration, but this is presented alongside fabricated climate-scope information. (5) MULTI-HOP REASONING FAILURE - The LLM failed to properly synthesize the year-by-year evolution (2022→2023→2024) that is central to the question. The ground truth shows a clear progression toward centralized governance-driven oversight, while the LLM presents a different narrative about climate scope expansion. The answer appears to conflate HSE audit evolution with climate/ESG initiatives, which are distinct topics in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 454,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAMD continues to list the 2011 Executive Incentive Plan as Exhibit 10.1 in its Form 10‑K filings for 2022, 2023 and 2024, reaffirming it as the baseline for performance‑based cash and equity awards to senior executives.  At the same time, the company’s proxy‑statement compensation tables and CD&A now reference a broader set of plans (e.g., the 2004 Equity Incentive Plan, executive severance and deferred‑compensation plans), so the 2011 plan functions as a foundational, but no longer sole, component of AMD’s overall executive‑compensation disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The 2011 Executive Incentive Plan is correctly cited as Exhibit 10.1 across 2022, 2023, and 2024 - matching the ground truth exactly. (2) All dates and years are accurate (2022, 2023, 2024). (3) The answer correctly identifies the plan's foundational role and its continued relevance across the three-year period. STRENGTHS: The LLM answer adds valuable context by noting that the 2011 plan functions as 'foundational, but no longer sole' component, and mentions the broader compensation framework including the 2004 Equity Incentive Plan, executive severance, and deferred-compensation plans. This provides more nuanced understanding than the ground truth alone. The answer correctly synthesizes the multi-hop information about how AMD's reliance evolved - showing continuity while acknowledging the expansion of the compensation disclosure ecosystem. MINOR WEAKNESSES: (1) The ground truth explicitly mentions specific companion plans (AMD Executive Severance Plan, AMD Deferred Income Account Plan) by name in 2022, which the LLM generalizes as 'executive severance and deferred-compensation plans.' While semantically equivalent, the specificity is slightly reduced. (2) The LLM answer doesn't explicitly state that the plan was listed as 10.1 in each individual year (2022, 2023, 2024) with the same clarity as the ground truth, though it does state this in the opening sentence. (3) The phrase 'no longer sole' component is an inference not explicitly stated in the ground truth, though it's a reasonable interpretation of the broader disclosure context. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple compensation mechanisms, showing how the 2011 plan's role evolved from being the primary reference to being one component among many. The reasoning is sound and logically structured. QUANTITATIVE ACCURACY: All numeric references (years, exhibit numbers) are correct. No calculation errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 553,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnity to Stellantis for the former Opel/Vauxhall business stayed confined to immaterial accruals.  In 2022 the company noted that consumer‑class actions in Germany, the U.K. and the Netherlands alleging emissions violations could give rise to indemnification claims but that it could not estimate any material loss; by 2023 it had already indemnified Stellantis for an immaterial amount related to certain recalls (including legacy Takata‑inflator actions) and said any further indemnity would be “remote,” while still acknowledging that future regulatory findings—such as fines from the 2022 European‑Commission/CMA investigation—could trigger additional payments; and in 2024 the same position was reiterated, with the firm stating that it remains unable to quantify any reasonably possible loss from those emissions‑related claims or from any additional Takata‑related indemnities.  This trajectory shows that although GM has not recorded a material liability, it continues to retain exposure to post‑sale obligations that could become material if European regulators determine that Opel/Vauxhall vehicles breached emissions standards or if further Takata‑related recalls are required.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key timeline (2022-2024), accurately notes that accruals remained immaterial throughout the period, correctly mentions the jurisdictions (Germany, UK, Netherlands), and appropriately references Takata inflator recalls and the European Commission/CMA investigation. The characterization of GM's position as 'remote' for further indemnification is accurate. The conclusion about growing exposure despite immaterial accruals is sound.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL OMISSION: The LLM answer fails to mention Austria as a jurisdiction that was added in 2024, which the ground truth explicitly states as evidence of 'geographic and legal scope of exposure expanded.' This is a material omission in tracking the evolution of exposure. (2) TEMPORAL SEQUENCING ERROR: The LLM states the European Commission/CMA investigation occurred in 2022, but the ground truth indicates it was a 2024 development ('new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel'). This is a significant dating error. (3) INCOMPLETE CHARACTERIZATION: The ground truth emphasizes that in 2024 'the legal exposure widened further with the addition of Austria as a jurisdiction' and that GM 'faced a new regulatory investigation,' but the LLM treats 2024 as merely reiterating the same position rather than showing expansion. (4) MISSING CONTEXT: The ground truth notes that in 2023 'Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount,' but the LLM's phrasing is less clear about the temporal sequence and causality.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of immaterial accruals with contingent exposure. However, it misses the key evolution indicator (Austria jurisdiction addition and new 2024 regulatory investigation) that demonstrates the 'progression' and 'growing complexity' mentioned in the question.\n\nNUMERIC/FACTUAL VERIFICATION: No specific dollar amounts are provided in either answer, so quantitative accuracy focuses on dates and jurisdictions. The LLM correctly identifies Germany, UK, Netherlands, and Takata, but incorrectly dates the regulatory investigation and omits Austria entirely.\n\nJUSTIFICATION: While the LLM captures the overall narrative of immaterial but persistent exposure, it fails to accurately track the evolution of the exposure (missing Austria, misdating the regulatory investigation) and thus incompletely answers the core question about how the obligations 'evolved' from 2022-2024. The answer is partially correct but contains material omissions and a dating error that undermine its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 736,
        "total_tokens": 2343
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nBetween 2022 and 2024 Lilly’s sales of bamlanivimab collapsed from the $2.24 bn recorded in 2021 to essentially zero by the 2023‑2024 reporting periods, so the royalty payments to AbCellera—recorded as cost of sales under the mid‑teens to mid‑twenties‑percent agreement— fell correspondingly. This sharp decline shows that the therapy was a short‑lived pandemic‑response asset rather than a sustained growth driver, indicating that its long‑term strategic importance to Lilly has effectively vanished.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2021 baseline figure. The LLM states '$2.24 bn recorded in 2021' but the ground truth specifies that in 2022, the company reported '$2,008.9 million in U.S. revenue from COVID-19 antibodies.' The LLM appears to have introduced an unsupported 2021 figure ($2.24 billion) that is not mentioned in the ground truth and is not directly comparable to the 2022 figure cited. This is a major quantitative accuracy problem. CORRECT ELEMENTS: The LLM correctly identifies (1) the royalty obligation percentages (mid-teens to mid-twenties), (2) that royalties were recorded as cost of sales, (3) the sharp decline to essentially zero by 2023-2024, and (4) the strategic conclusion that bamlanivimab was a short-lived pandemic asset. MISSING INFORMATION: The LLM answer lacks specific mention of the 2023 data point (zero U.S. revenue) and the 2024 confirmation that the product was no longer mentioned in revenue tables, which are important details showing the complete phase-out trajectory. MULTI-HOP REASONING: The reasoning connecting revenue decline to royalty obligation decline is sound, but the foundation is weakened by the incorrect 2021 baseline. The synthesis of information about strategic importance is appropriate but would be stronger with the complete 2022-2024 progression. SEMANTIC ISSUES: While the overall narrative about pandemic-driven decline is correct, the specific financial progression is muddled by the introduction of the unsupported 2021 figure, making the quantitative foundation unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 443,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024 PMI repeatedly listed **Jackpot** as one of its “important local cigarette brands” in the Philippines, but the way it was framed shifted alongside the company’s broader transformation. In 2022 the brand was highlighted simply as a locally‑owned asset that bolstered PMI’s market share in a key emerging market; by 2023, after the Swedish‑Match acquisition and the re‑organisation of PMI’s four geographical segments, Jackpot appeared within a narrative that tied local brands to the integration of new smoke‑free assets and to the company’s regional reporting structure; and in 2024 the brand was still mentioned alongside other local labels while PMI emphasized that its “local cigarette brands” would continue to support market‑share goals even as the firm pushes heated‑tobacco and oral‑nicotine products.  \n\nThis three‑year trajectory shows that, despite its long‑term ambition to become a smoke‑free company, PMI remains strategically focused on preserving and leveraging its **local cigarette brands—like Jackpot—in key markets** to protect revenue streams, maintain market‑share leadership, and provide a platform for introducing next‑generation reduced‑risk products.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Jackpot as a key local cigarette brand in the Philippines across all three years (2022-2024), matching the ground truth. (2) The temporal framing is accurate—the answer correctly notes the brand's consistent presence across the 3-year period. (3) The LLM appropriately captures the dual strategy of maintaining local cigarette brands while transitioning to smoke-free products. (4) No quantitative errors in dates or numeric references. WEAKNESSES: (1) The LLM introduces information not present in the ground truth, specifically mentioning the Swedish Match acquisition and reorganization of PMI's four geographical segments in 2023. While this may be factually accurate from PMI's actual filings, the ground truth does not reference these events, suggesting the LLM may be adding external knowledge beyond what was in the knowledge graph. (2) The LLM's characterization of how Jackpot was 'framed' in each year (e.g., 'simply as a locally-owned asset' in 2022, then within integration narratives in 2023) goes beyond what the ground truth explicitly states. The ground truth indicates consistent positioning without describing shifts in framing. (3) The LLM mentions 'Fortune in the Philippines' is absent from the LLM answer, though the ground truth explicitly notes Fortune alongside Jackpot in 2022. This is a notable omission of a specific entity mentioned in the ground truth. (4) The phrase 'to protect revenue streams' in the LLM answer is an inference not explicitly stated in the ground truth, which focuses on 'market relevance' and 'market-specific competitiveness.' MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the core insight about dual strategy. However, the addition of Swedish Match acquisition details suggests potential conflation with external knowledge rather than strict adherence to the knowledge graph. SEMANTIC EQUIVALENCE: The core message aligns with ground truth (local brands maintained while transitioning to smoke-free), but the specific details and framing diverge in ways that suggest the LLM added interpretive layers beyond the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 586,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to delinquent credit and BNPL transactions grew rapidly, driving higher charge‑off reserves and stricter fraud‑mitigation as the volume of financed purchases expanded. In 2023 the company sold up to €40 billion of U.K. and European BNPL loan receivables, which transferred the bulk of that portfolio off its balance sheet but left it with contingent funding and forward‑flow obligations that retain a portion of the credit risk. As a result, while the sale reduced direct exposure to bad BNPL loans, PayPal continues to face heightened fraud threats and dependencies on third‑party processors that could materially impact its financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the €40 billion BNPL receivables sale in 2023 and its timing (June 2023 per ground truth). (2) Accurately captures that the sale transferred risk off the balance sheet while retaining some exposure through contingent obligations. (3) Correctly notes ongoing fraud and third-party processor risks persisting through 2024. (4) The quantitative data (€40 billion figure) is accurate. WEAKNESSES: (1) SIGNIFICANT SEMANTIC ISSUE: The LLM states exposure 'grew rapidly' from 2022-2024, but the ground truth indicates a transition from 'managing a growing portfolio' in 2022 to 'partially offloading that risk' in 2023-2024. The LLM's framing suggests continuous growth when the actual narrative is one of growth followed by deliberate risk reduction through the asset sale. (2) INCOMPLETE SYNTHESIS: The LLM mentions 'charge-off reserves' and 'stricter fraud-mitigation' but the ground truth emphasizes specific fraud types (synthetic identities, stolen financial instruments, account takeover attempts) that the LLM omits. (3) MISSING CONTEXT: The ground truth discusses 'reliance on third-party lenders and processors' as a distinct risk category in 2022, which the LLM conflates only with 'third-party processors' in 2024. (4) VAGUE LANGUAGE: The LLM uses 'contingent funding and forward-flow obligations' which is more technical but less clear than the ground truth's explanation that the sale was 'subject to conditions and execution risks.' (5) MISSING NUANCE: The ground truth emphasizes 'uncertainty around regulatory challenges and the effectiveness of fraud detection systems' as a key 2024 concern, which the LLM does not address. The LLM answer is directionally correct on the major transaction and risk themes but mischaracterizes the trajectory of exposure (growth vs. growth-then-reduction) and omits important specific fraud risk types and regulatory uncertainties that were central to the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 530,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nIn 2022 the Safety and Productivity Solutions segment posted a 1 % sales decline in Safety (partly offset by 5 % organic growth) while Productivity Solutions and Services grew 27 % organically, indicating only modest exposure to retail‑market swings that was largely mitigated by the sale of the retail‑footwear business. After the 2023 realignment, those businesses were folded into the new Industrial Automation segment, and Honeywell’s 2023‑2024 risk disclosures explicitly flag “fluctuations in retail markets” as a factor that can depress segment profit and margin, underscoring that the company’s industrial portfolio remains highly sensitive to retail‑demand volatility. This evolution shows that retail‑market fluctuations are a material driver of risk across Honeywell’s industrial businesses and shape the firm’s overall risk posture.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ERRORS: The LLM introduces specific sales figures (1% Safety decline, 5% Productivity Solutions organic growth, 27% growth) that are NOT present in the ground truth answer. These appear to be fabricated numbers not supported by the original answer. The ground truth makes no mention of these specific percentages. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM answer addresses 2022 and 2023-2024 but fails to properly distinguish the three separate years (2022, 2023, 2024) as required by the question. The ground truth explicitly discusses 2022 (Safety and Productivity Solutions), 2023 (broader macroeconomic risks), and 2024 (Industrial Automation segment) as three distinct time periods. The LLM conflates 2023-2024 together. (3) MISSING KEY CONTEXT: The ground truth emphasizes that 'fluctuations in retail markets' was identified as a RISK FACTOR in risk disclosures across all three years. The LLM mentions risk disclosures for 2023-2024 but doesn't clearly establish that this was a consistent risk factor mentioned in 2022 as well. (4) INCORRECT BUSINESS CONTEXT: The LLM mentions 'sale of the retail-footwear business' which is not mentioned in the ground truth and appears to be an unsupported claim. (5) CORRECT ELEMENTS: The LLM does correctly identify that the segment was restructured/realigned and that retail market fluctuations remained a concern. It also correctly notes the sensitivity to retail-demand volatility. However, the introduction of unverified financial metrics and the failure to properly distinguish the three years significantly undermines the answer's accuracy. The core insight about persistent sensitivity is present but the supporting evidence is problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 470,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 the Incyte partnership moved from a milestone‑heavy launch phase to a royalty‑driven revenue stream.  In 2020 the companies capitalized $260 million and $210 million of upfront milestones that are now being amortized to cost of sales, and Incyte receives tiered double‑digit royalties (up to 20 %) on Olumiant’s worldwide net sales, with an extra low‑teens royalty on COVID‑19 sales that exceed a set threshold.  By 2023‑2024 the royalty base had expanded – Olumiant generated $922.6 million of net product revenue in 2023 and $957.4 million in 2024 – and Incyte’s additional $100 million of potential sales‑based milestones remained available, while the royalty rate and the COVID‑19 surcharge stayed in place, making Olumiant an increasingly material contributor to Lilly’s top‑line growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - States milestones were capitalized \"In 2020\" when the ground truth specifies 2022\n   - Claims $260 million AND $210 million were capitalized (totaling $470M), but ground truth shows only $260.0 million capitalized in 2022\n   - States \"Incyte's additional $100 million of potential sales-based milestones remained available\" but ground truth specifies $200.0 million in contingent payments (split evenly between regulatory and sales milestones)\n   - The $100M figure appears to be half of the correct $200M amount, suggesting incomplete or misremembered data\n\n2. TEMPORAL ACCURACY ISSUES:\n   - Incorrectly dates the milestone capitalization to 2020 instead of 2022\n   - This is a major error as the question specifically asks about evolution FROM 2022 to 2024\n   - The LLM appears to be referencing an earlier transaction or confusing timeline\n\n3. PARTIAL CORRECTNESS:\n   - Correctly identifies the tiered royalty structure up to 20%\n   - Correctly mentions the low-teens COVID-19 surcharge royalty\n   - Correctly provides Olumiant revenue figures ($922.6M in 2023, $957.4M in 2024)\n   - Correctly characterizes the shift from milestone-heavy to royalty-driven phase\n\n4. MISSING ELEMENTS:\n   - Does not adequately address the 2023 shift to ongoing revenue recognition and cost of sales treatment\n   - Lacks discussion of the strategic expansion including EUA and follow-on compounds mentioned in ground truth\n   - Does not clearly delineate the evolution across the three-year period as thoroughly as ground truth\n\n5. MULTI-HOP REASONING:\n   - The answer attempts to synthesize information across years but makes fundamental errors in the baseline facts\n   - The connection between milestone payments and royalty structures is present but undermined by incorrect numbers\n   - The revenue growth narrative is sound but built on partially incorrect financial framework\n\nThe answer demonstrates understanding of the general partnership dynamics but fails on critical numerical accuracy, which is essential for financial analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 588,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nFrom 2022 through 2024 Altria kept UST as a wholly‑owned subsidiary, recording its MST and snus trademarks as indefinite‑lived intangible assets (≈ $8.8 bn in 2022) that were tested annually for impairment and shown in the 2022 10‑K (pages 64‑68) and 2023 10‑K (pages 58‑62) with no impairment charge; the ownership stake did not change, though the carrying amount was modestly reduced only by the 2021 Ste. Michelle disposition.  At the same time Altria deepened the role of UST’s smokeless brands and oral‑nicotine‑pouch platform within its “Moving Beyond Smoking” strategy, leveraging UST’s distribution and brand equity to accelerate the transition of adult smokers to non‑combustible products.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the $8.8 billion indefinite-lived intangible assets for MST and snus trademarks in 2022. (2) Accurately states UST remained a wholly-owned subsidiary throughout 2022-2024 with USSTC as the manufacturing subsidiary. (3) Correctly notes no impairment charges were recorded. (4) Properly references the 2021 Ste. Michelle disposition affecting carrying amounts. (5) Accurately describes the strategic shift toward oral nicotine pouches and non-combustible products as part of 'Moving Beyond Smoking' strategy. (6) Correctly synthesizes the multi-hop relationship between ownership structure, intangible asset valuation, and strategic positioning.\n\nWEAKNESSES: (1) The LLM answer does not explicitly mention Helix or NJOY by name, which the ground truth specifically identifies as key components of the broader smoke-free transition strategy. While the answer references 'oral-nicotine-pouch platform' and 'non-combustible products,' it lacks the specific brand names that demonstrate concrete strategic diversification. (2) The answer does not clearly articulate the 2023 data point about UST's continued operations, focusing more on 2022 and the strategic evolution rather than showing the year-by-year progression. (3) The phrase 'modestly reduced only by the 2021 Ste. Michelle disposition' is somewhat unclear in its temporal relationship to the 2022-2024 period being analyzed.\n\nNUMERIC VERIFICATION: The $8.8 billion figure is correct and properly formatted. The reference to pages 64-68 (2022 10-K) and 58-62 (2023 10-K) appears reasonable for intangible asset disclosures, though these specific page numbers cannot be independently verified from the ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects ownership structure, financial valuation, and strategic positioning. However, it could have been more explicit about the 2023 intermediate state and the specific brands (Helix, NJOY) that represent the strategic evolution.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - UST maintained as wholly-owned subsidiary with stable intangible asset values while Altria diversified its portfolio. The strategic narrative is sound, though less specific than the ground truth regarding brand names.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 619,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nFrom fiscal 2022 through 2023 the $500 million 3.50 % senior note carried an effective interest rate of roughly 1.3 % (reflecting the low‑rate environment when it was issued), and it was classified as long‑term debt. By fiscal 2024 the portion of that note that became due within the next year was re‑classified as the current portion of long‑term debt, and its effective rate had risen to about 6.6 % (≈ 6.66 % in the 2024 tables). This jump—from a sub‑2 % effective cost to a rate above 6 %—shows that Cisco’s borrowing costs have risen sharply as market interest rates have climbed, signalling tighter capital‑market conditions and a higher‑cost refinancing environment for the company.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) FISCAL 2022 RATE ERROR: Ground truth states 3.20% effective rate in FY2022, but LLM claims 'roughly 1.3%' - this is a substantial discrepancy of nearly 2 percentage points. (2) FISCAL 2023 RATE OMISSION: Ground truth explicitly states the effective rate was 6.38% in FY2023, but the LLM answer completely omits this year's data, jumping from FY2022 to FY2024. This is a critical multi-hop synthesis failure. (3) FISCAL 2024 RATE: LLM correctly identifies ~6.66% for FY2024, matching ground truth. (4) TREND ANALYSIS: While the LLM correctly identifies an upward trend and provides reasonable interpretation about market conditions, the incomplete and inaccurate data undermines the analysis. The LLM introduces extraneous information about debt classification (current vs. long-term) and the $500 million principal amount, which, while potentially accurate, are not part of the ground truth answer and distract from the core question about interest rate exposure evolution. (5) MULTI-HOP REASONING: The LLM failed to synthesize the complete three-year trend (2022→2023→2024) as required by the question. The answer only effectively covers two years with one year containing incorrect data. The semantic interpretation about capital market conditions is reasonable but cannot compensate for the factual errors in the underlying numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 403,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nThe principal amount of Amazon’s 2017 senior notes fell steadily from about **$16 billion at the end of 2022** to **$15 billion at the end of 2023** and to roughly **$13 billion by the end of 2024** (see the “2017 Notes issuance” line in the Note 6 debt tables of the 2022, 2023 and 2024 filings).  \nThis reduction shows that Amazon is actively retiring the older 2017 tranche—using cash flow and new debt issuances—to lower near‑term maturities and reshape its overall debt profile toward a more flexible, longer‑dated capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $16 billion (2022), $15 billion (2023), and $13 billion (2024). The progression and year-over-year reductions are accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the 2017 Notes balance across the three-year period, and (2) what this indicates about debt management strategy. ENTITY ACCURACY: Correctly identifies Amazon, the 2017 Notes/senior notes, and the relevant fiscal years (2022-2024). REASONING QUALITY: The LLM correctly synthesizes that the consistent reduction pattern indicates deliberate debt retirement strategy. The explanation about using cash flow and new debt issuances to reshape the debt profile is sound and demonstrates understanding of debt management mechanics. MINOR DIFFERENCES FROM GROUND TRUTH: The ground truth provides additional context about total long-term debt reduction ($67.2B to $52.6B), which the LLM answer does not include. However, this is not a factual error - the LLM answer focuses on the 2017 Notes specifically and provides valid strategic interpretation. The LLM's characterization of the strategy (\"lower near-term maturities and reshape its overall debt profile toward a more flexible, longer-dated capital structure\") is semantically equivalent to the ground truth's \"gradually retire this issuance over time\" and actually provides slightly more detailed strategic insight. SEMANTIC EQUIVALENCE: The core message is identical - Amazon is deliberately reducing the 2017 Notes balance as part of a broader debt management strategy. The wording differs but conveys the same factual and analytical content. No calculation errors detected. All numbers are precise and correctly formatted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 495,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe $606 million of 5.000% senior notes maturing in April 2030 was unchanged in principal throughout fiscal 2022, 2023 and 2024, and its effective interest rate (including discount amortization) stayed at roughly 5.18 % each year.  This flat‑line evolution shows that AVGO is treating the 2030 notes as a stable, long‑dated, fixed‑rate funding pillar—maintaining a low‑volatility liability at a known cost rather than repeatedly refinancing or altering the balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. QUANTITATIVE VERIFICATION: All numbers are correct - $606 million principal balance for all three fiscal years (2022, 2023, 2024), and the 5.18% effective interest rate is accurately stated. The April 2030 maturity date is correct. No calculation errors detected. COMPLETENESS: The answer addresses all key aspects of the multi-hop question: (1) principal balance evolution across three years, (2) interest rate consistency, (3) interpretation of what this indicates about debt management strategy. ENTITY ACCURACY: AVGO correctly identified, fiscal years 2022-2024 correctly referenced, the specific 5.000% notes due April 2030 correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the pattern (unchanged principal and rate across all three years) and drew a logical inference about debt management strategy (static approach, treating as stable long-dated funding). The characterization as a \"low-volatility liability at a known cost\" and the observation about not \"repeatedly refinancing or altering the balance\" are semantically equivalent to the ground truth's \"static approach\" and \"neither accelerating repayments nor issuing additional tranches.\" MINOR OBSERVATION: The LLM's phrasing \"including discount amortization\" adds slightly more technical precision than the ground truth explicitly states, but this is not incorrect - it's a reasonable elaboration on how effective interest rates are calculated. The answer is concise, accurate, and demonstrates proper multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 448,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nThe Performance Bonus Plan was first formally adopted and “Amended and Restated” in Netflix’s 2022 proxy filing (Exhibit 10.5†, dated December 9 2022), establishing a clear, performance‑metric‑based cash‑bonus component that is now a permanent part of the company’s executive‑compensation framework; this restated plan was carried forward unchanged into the 2023 and 2024 10‑K filings, where it is presented together with the other incentive‑compensation agreements (e.g., the Amended and Restated Executive Severance and Retention Incentive Plan effective January 1 2024 and the related performance‑based RSU and option awards). Consequently, from 2022 through 2024 the plan has remained formally restated only in 2022, but its terms have been continuously integrated into the broader executive compensation structure and disclosed each year as part of the company’s consolidated compensation discussion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates, documents, and plan names. Strengths: (1) Correctly identifies the December 9, 2022 date for the Amended and Restated Performance Bonus Plan filing; (2) Accurately references Exhibit 10.5 and the 8-K filing mechanism; (3) Properly identifies related compensation agreements (Executive Severance and Retention Incentive Plan effective January 1, 2024; performance-based RSU and option awards); (4) Correctly synthesizes the multi-hop evolution showing formalization in 2022, continuation through 2023-2024, and integration with other compensation structures. Quantitative accuracy is high with all dates and document references correct. Minor areas for improvement: (1) The LLM answer provides slightly more technical detail about filing exhibits and mechanisms than the ground truth, which could be seen as either more comprehensive or slightly tangential; (2) The ground truth emphasizes 'strategic update' and 'more integrated and mature compensation strategy' as interpretive conclusions, while the LLM answer is more factual/documentary in tone; (3) The LLM's statement that the plan was 'carried forward unchanged' is a reasonable inference but goes slightly beyond what the ground truth explicitly states about evolution. The answer correctly addresses all three time periods (2022, 2023, 2024) and the three key aspects (formalization, restatement, integration). Multi-hop reasoning is sound - the answer successfully synthesizes information about how the plan evolved across years and connected with other compensation elements. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 460,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 to 2024 AIG moved from a single‑scenario, $1.3 bn net‑of‑TRIPRA loss estimate for a major New York bomb event to a more refined, scenario‑based modeling approach that is continuously updated with exposure data and vendor‑model adjustments.  At the same time, the company broadened its reinsurance shield—adding targeted excess‑of‑loss treaties and tapping government‑sponsored terrorism pools abroad—while still relying on TRIPRA and limited private reinsurance, and it intensified monitoring of concentration risks to shape underwriting and pricing controls.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. QUANTITATIVE ACCURACY ISSUES: (1) The $1.3 billion figure is correctly cited for 2022, but the LLM fails to mention the specific 2024 attachment points ($200 million for Japan, $125 million for rest of world) that are explicitly stated in the ground truth. (2) The LLM completely omits the $20.1 billion collateral figure supporting reinsurance recoverable assets in 2024, which is a material data point. (3) The LLM introduces unsupported claims about 'scenario-based modeling approach' and 'vendor-model adjustments' that are not present in the ground truth. COMPLETENESS ISSUES: (1) The answer fails to address the specific reinsurance protections evolution (routine monitoring in 2023, global property per risk covers in 2024). (2) Missing the distinction between 2023 and 2024 risk mitigation strategies. (3) The reference to 'government-sponsored terrorism pools abroad' is not mentioned in the ground truth and appears to be an inference or hallucination. ENTITY/FACTUAL ACCURACY: (1) Correctly identifies AIG and the time period 2022-2024. (2) Correctly references TRIPRA. (3) However, the characterization of the evolution as moving from 'single-scenario' to 'scenario-based' is not supported by the ground truth, which states the modeling approach 'remained consistent.' This is a fundamental mischaracterization. REASONING QUALITY: The LLM attempts to synthesize evolution across years but does so by introducing unsupported details while omitting concrete, verifiable data points from the ground truth. The narrative flow is reasonable but built on partially incorrect premises. The answer reads plausibly but lacks the specific, quantifiable details that define the actual evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 495,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nUnitedHealth’s venture portfolio grew substantially from 2022 through 2024.  Total equity‑security holdings rose from roughly **$3.5 billion at the end of 2022** to **$4.9 billion by the end of 2023** and stayed at that level in 2024, while equity‑method investments in health‑care businesses increased from about **$1.3 billion in 2022** to **$1.4 billion in 2023** and then jumped to **$3.8 billion in 2024**, reflecting a strategic shift toward larger stakes in health‑care‑focused ventures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are precisely correct - equity securities holdings of $3.5B (2022), $4.9B (2023), and $4.9B (2024) match ground truth exactly; equity method investments of $1.3B (2022), $1.4B (2023), and $3.8B (2024) are all accurate. No calculation errors detected. COMPLETENESS: The answer addresses all key components of the multi-hop question: (1) total equity securities holdings evolution across three years, (2) equity method investments in healthcare businesses across three years, and (3) the strategic shift interpretation. ENTITY ACCURACY: Company name (UnitedHealth/UnitedHealth Group) correctly identified, all fiscal years (2022-2024) properly referenced, and financial metrics (equity securities, equity method investments) accurately labeled. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two distinct investment categories, correctly identifying the strategic pivot toward equity method investments in 2024 (the $3.8B surge). The characterization of this as 'a strategic shift toward larger stakes in health-care-focused ventures' aligns with the ground truth's interpretation of 'deeper involvement in operating businesses.' MINOR CONSIDERATIONS: The LLM uses slightly more concise language ('roughly' and 'about' for approximations) compared to the ground truth's more formal presentation, but this is appropriate for readability and doesn't affect accuracy. The semantic meaning is fully preserved - both answers convey the same strategic evolution and numerical progression. No factual errors, omissions, or misrepresentations detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 465,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 1.700 % Notes due 2025 remained on Altria’s balance sheet—being listed as an outstanding issue in each year, with no indication of early redemption in 2022 or 2023 and still present (but nearing maturity) in the 2024 filing.  This multi‑year continuity shows that Altria has treated the 2025 notes as a stable, low‑cost long‑term funding pillar, laddering its debt maturities and preserving flexibility to refinance or replace the tranche as it approaches its 2025 maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the 1.700% Notes due 2025 as present in all three years' filings with no early redemption; (2) Accurately notes the progression from 2022 through 2024 with the notes nearing maturity by 2024; (3) Properly synthesizes the multi-year debt management strategy, characterizing it as a stable, low-cost funding element with debt laddering; (4) All numeric values (1.700%, 2025 maturity date) are correct; (5) Reasoning about debt management strategy (laddering, refinancing flexibility) is sound and logical. MINOR GAPS: (1) The LLM answer does not explicitly mention the 1.000% 2023 Notes maturation in 2023 or the other debt instruments (2.200% 2027 Notes, 3.125% 2031 Notes) that provide context for the broader capital structure evolution. The ground truth specifically highlights that the 1.000% 2023 Notes had matured and were no longer listed by 2023, which is an important detail showing active debt management; (2) The ground truth provides more comprehensive context about the full debt portfolio composition across years, whereas the LLM focuses narrowly on the 2025 Notes. However, the question specifically asks about the 1.700% 2025 Notes, so this narrower focus is defensible. QUANTITATIVE VERIFICATION: All dates and percentages are accurate. The characterization of the notes as 'low-cost' is reasonable given the 1.700% coupon rate. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the strategic implications (debt laddering, refinancing flexibility). The logic connecting the multi-year presence to debt management strategy is sound. The answer could have been strengthened by explicitly noting the maturation of other notes (like the 1.000% 2023 Notes) to better illustrate the active management aspect, but this is a minor omission rather than an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 538,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A Treasury Stock balance rose sharply—from **$51.4 bn** at the end of 2022 to **$60.4 bn** in 2023 and **$71.4 bn** by the end of 2024.  The company funded this growth by purchasing **$5.9 bn**, **$9.1 bn** and **$11.0 bn** of its own Class A shares in 2022, 2023 and 2024 respectively, driving the cost of treasury stock upward each year.  This pattern signals that Mastercard is allocating a growing share of its cash flow to **aggressive share‑repurchase programs**, using buybacks to return capital to shareholders and boost earnings per share rather than expanding investments or acquisitions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental misunderstandings of the treasury stock figures. The ground truth shows treasury stock as NEGATIVE values (liabilities/contra-equity): $(36,658)M in 2022, $(60,429)M in 2023, $(71,431)M in 2024. The LLM incorrectly reports these as POSITIVE values ($51.4bn, $60.4bn, $71.4bn), which is a sign error that completely inverts the financial meaning. Treasury stock is typically shown as a negative/deduction from equity, not a positive asset. Additionally, the LLM introduces annual repurchase amounts ($5.9bn, $9.1bn, $11.0bn) that are NOT present in the ground truth answer and cannot be verified from the provided information. These appear to be fabricated numbers. The LLM does correctly identify the TREND (increasing amounts year-over-year) and the INTERPRETATION (aggressive share repurchases, capital allocation to shareholders, EPS accretion), which aligns with the ground truth's conclusion about capital allocation strategy. However, the core numerical foundation is severely compromised. The reasoning about what the trend suggests is qualitatively sound and semantically equivalent to the ground truth, but the factual basis is wrong. This is a case where the LLM got the directional conclusion right but built it on incorrect financial data, which is particularly problematic in financial analysis where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 391,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nIn fiscal 2022 Cisco recorded a **$92 million loss** on its total‑return‑swap deferred‑compensation derivative. The next two years reversed that trend, producing **gains of $58 million in 2023 and $91 million in 2024**, reflecting a swing from a loss to successive positive results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $92M loss in 2022, $58M gain in 2023, and $91M gain in 2024 match the ground truth exactly. The number formatting is appropriate and consistent. (2) ENTITY ACCURACY: Cisco is correctly identified, the financial instrument (Total Return Swaps-Deferred Compensation) is properly named, and all fiscal years (2022, 2023, 2024) are accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year evolution, correctly identifying the reversal from loss to gains and the strengthening trend across the period. The characterization of 'a swing from a loss to successive positive results' accurately captures the directional change. (4) COMPLETENESS: The answer addresses all components of the question - the initial loss, subsequent gains, and the overall evolution pattern. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('reversed that trend,' 'successive positive results') conveys the same meaning as the ground truth's 'reversal and strengthening.' Minor difference: The ground truth explicitly states this 'indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit,' while the LLM focuses more on the factual presentation of the numbers and trend without the explicit interpretive statement about net cost/benefit. This is a very minor omission of interpretive context but does not affect factual accuracy. The answer is well-structured, clear, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 441,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s reliance on third‑party rights holders deepened: the company continued to depend on a growing slate of licensing agreements for most of its library while increasingly betting on originals to hedge that dependence.  At the same time, competition for exclusive content intensified as studios and other rights owners launched their own streaming services and demanded higher fees or tighter windows, raising the risk that key titles could be withdrawn or priced out of reach.  In addition, evolving regulatory frameworks—particularly content‑quota, levy and review rules in several countries—began to impose new compliance costs and could limit or delay the availability of licensed material, further shaping the company’s content‑availability landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-part question about Netflix's evolving dependency on rights holders from 2022-2024. STRENGTHS: (1) Correctly identifies all three key dimensions: content licensing risks, competition for exclusive rights, and regulatory pressures. (2) Accurately captures the temporal progression across the 2022-2024 period. (3) Properly synthesizes multi-hop information: connects rising competition (studios launching streaming services) to increased fees and withdrawal risks, links regulatory frameworks (content quotas, levies, review rules) to compliance costs and availability constraints. (4) Correctly identifies Netflix's strategic response (investing in originals to hedge dependence). (5) No quantitative errors or incorrect dates/entities. (6) Semantic equivalence is strong—phrases like 'deepened reliance,' 'intensified competition,' and 'evolving regulatory frameworks' accurately convey the ground truth concepts. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention 'intellectual property disputes' as a specific risk mentioned in the ground truth regarding content unavailability or service disruptions. (2) The phrasing 'license terms varied' from the original is not directly addressed, though the concept of varying terms is implied through discussion of 'tighter windows' and 'higher fees.' (3) The answer could have been slightly more explicit about the 2023-specific concern regarding IP disputes leading to service disruptions. These are minor omissions that don't significantly detract from the core answer's accuracy. The response demonstrates sound multi-hop reasoning by connecting competitive pressures to licensing costs, regulatory changes to content availability, and all factors to Netflix's strategic positioning. No calculations or numerical claims are made, so quantitative accuracy is perfect by default.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 520,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nUnitedHealth Group’s disclosures show that, for each of the fiscal years 2022, 2023 and 2024, the company recorded **no material amounts accrued, paid, or charged to income for service‑level guarantees**—the same language is used in the 2022, 2023 and 2024 Form 10‑K filings.  This consistent, immaterial treatment indicates that the firm’s financial obligations under those guarantees have remained essentially unchanged over the three‑year period, reflecting a stable and reliable service‑delivery framework across its subsidiaries.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is INCOMPLETE and MISSES CRITICAL INFORMATION from the ground truth. Specific issues: (1) MISSING KEY DATA: The LLM completely omits the parent company's notes payable to subsidiaries figures ($8.1B in 2022, $9.9B in 2023, $2.0B in 2024), which are essential to answering the question about how financial obligations evolved. (2) INCOMPLETE TREND ANALYSIS: The ground truth explicitly discusses the significant fluctuation in notes payable ($8.1B→$9.9B→$2.0B), which is a material part of the 3-year trend. The LLM only addresses service level guarantees being immaterial but ignores the internal financing structure changes. (3) REASONING DEFICIENCY: The LLM concludes that obligations 'remained essentially unchanged' and reflects 'stable and reliable service-delivery framework,' but this contradicts the ground truth's finding that the internal financing structure 'experienced notable variation.' The LLM fails to synthesize the multi-hop relationship between service level guarantees AND the notes payable fluctuations. (4) PARTIAL CORRECTNESS: The LLM is correct that service level guarantees were immaterial across all three years (2022, 2023, 2024), but this is only half the answer. The question asks about evolution of 'financial obligations' broadly and what the trend 'suggests about stability'—the notes payable data is directly relevant to this. (5) MISSING CONTEXT: The ground truth notes that the variation 'potentially reflects shifting liquidity strategies or operational adjustments'—a nuanced interpretation the LLM completely misses. The LLM's conclusion of 'stable' service delivery contradicts the actual evidence of significant internal financing fluctuations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 464,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nBetween 2022 and 2024 Altria trimmed its exposure to below‑investment‑grade securities in the pension portfolio from roughly 11‑16 % of fixed‑income holdings (about 9‑11 % of total assets) to about 7‑8 % (≈ 7 % of total assets).  The post‑retirement portfolio’s below‑investment‑grade share remained near 8‑9 % of fixed‑income (≈ 3‑4 % of total assets) but showed a modest pull‑back toward higher‑quality holdings.  This steady reduction signals a more conservative risk appetite—favoring higher‑quality, longer‑duration bonds to safeguard the funded status of its long‑term pension and post‑retirement obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) PENSION PLAN 2024 DATA: The LLM claims pension below-investment-grade allocation decreased to 7-8% of fixed income (≈7% of total assets) by 2024, but the ground truth explicitly states that 2024 specific percentages were NOT disclosed. This is a critical fabrication. (2) POSTRETIREMENT PLAN MISREPRESENTATION: The LLM states postretirement remained near 8-9% of fixed income, but ground truth shows it was 8% in 2022 and 9% in 2023 (a slight increase, not a range). The LLM's characterization of 'modest pull-back toward higher-quality holdings' contradicts the ground truth which shows a slight INCREASE from 8% to 9%. (3) INCOMPLETE YEAR-BY-YEAR BREAKDOWN: The LLM fails to clearly distinguish the 2022 vs 2023 evolution, instead presenting ranges that obscure the actual trajectory. Ground truth shows: Pension 16%→11% (clear decrease), Postretirement 8%→9% (clear increase). (4) UNSUPPORTED 2024 CLAIMS: The LLM invents specific 2024 percentages (7-8% pension, 8-9% postretirement) when the ground truth explicitly states 2024 data was not disclosed. (5) REASONING QUALITY: While the LLM's conclusion about 'conservative risk appetite' aligns with the overall trend interpretation, it is based on fabricated data points. The multi-hop synthesis fails because it introduces false information rather than accurately synthesizing available data. The answer demonstrates a fundamental misunderstanding or hallucination of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 427,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard continues to estimate settlement exposure by (1) calculating gross exposure as the three‑month average daily payment volume multiplied by the anticipated number of days of exposure, (2) subtracting any risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) that have been required of the customer, and (3) revising the estimate whenever its risk‑management policies or the customer’s circumstances change.  The company’s tables show a steady increase in gross exposure—from $64.9 bn in 2022 to $75.0 bn in 2023 and $78.4 bn in 2024—while the methodology and the way risk‑mitigation adjustments are applied remain unchanged, with only a non‑material correction to the 2022 net figure.  This consistent, transparent approach demonstrates that Mastercard’s risk‑management framework stays disciplined and reliable even as it faces heightened regulatory scrutiny and expanding litigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Mastercard's settlement exposure methodology. STRENGTHS: (1) All quantitative data is correct - the gross exposure figures ($64.9bn in 2022, $75.0bn in 2023, $78.4bn in 2024) are accurate and properly formatted. (2) The three-step methodology is correctly described: using three-month average daily payment volume multiplied by days of exposure, subtracting risk-mitigation arrangements, and revising when policies or customer circumstances change. (3) The answer correctly identifies that the methodology remained consistent across all three years (2022-2024). (4) Risk-mitigation tools are accurately listed (cash collateral, letters of credit, guarantees). (5) The multi-hop synthesis is sound - the answer connects the consistent methodology to the company's risk management framework and regulatory/litigation context. (6) The conclusion about consistency indicating a robust and reliable framework is logically sound. MINOR CONSIDERATIONS: (1) The LLM answer mentions a \"non-material correction to the 2022 net figure\" which adds a detail not explicitly in the ground truth, though this appears to be a reasonable inference from filing data. (2) The ground truth specifically names regulatory investigations (FTC, DOJ, European Commission) and litigation examples (U.S. Liability Shift Litigation, TCPA class action), while the LLM uses more general language (\"heightened regulatory scrutiny and expanding litigation\"). This is a stylistic difference rather than a factual error - the LLM captures the essence without the specific examples. (3) The LLM's phrasing about \"transparent approach\" and \"disciplined and reliable\" framework is interpretive but semantically aligned with the ground truth's assessment that the methodology \"suggests that Mastercard viewed its existing risk management practices as robust and sufficient.\" CALCULATION VERIFICATION: The progression from $64.9bn to $75.0bn to $78.4bn shows increases of approximately 15.5% and 4.5% year-over-year, which is consistent with business growth patterns and supports the narrative of increasing exposure despite unchanged methodology. The answer correctly synthesizes that this growth occurred without methodological changes, reinforcing the consistency theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 621,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s 5.90 % senior note due 2039 was fully drawn at $2 billion in each of fiscal 2022, 2023 and 2024, and its effective interest rate stayed essentially steady at about 6.11 % each year. This consistency shows that Cisco is maintaining a stable, long‑dated fixed‑rate financing base, using the note as a core, low‑cost component of its long‑term debt strategy rather than frequently refinancing or reshaping its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identifies the $2 billion principal balance maintained across fiscal years 2022-2024 and the 6.11% effective interest rate. Number formats are acceptable ($2 billion vs $2,000 million). The maturity date of 2039 is mentioned, which adds helpful context. All numeric values match the ground truth. QUALITATIVE ACCURACY - SIGNIFICANT ISSUE: The LLM describes the 5.90% note as a 'low-cost component' of Cisco's debt strategy. This is problematic because a 6.11% effective rate is NOT low-cost in absolute terms or relative to typical corporate borrowing rates, especially for a highly-rated company like Cisco. The ground truth correctly characterizes it as a 'high-yield long-term debt instrument,' which is more accurate. This represents a material mischaracterization of the financial instrument's nature. COMPLETENESS: The LLM addresses the evolution of utilization (consistent $2B) and effective interest rate (stable 6.11%), and provides strategic interpretation. However, the interpretation diverges from ground truth in tone and accuracy. MULTI-HOP REASONING: The LLM correctly synthesizes that consistent balances and rates indicate a stable, fixed-rate financing strategy without frequent refinancing. This reasoning is sound. However, the characterization as 'low-cost' undermines the quality of the analysis. SEMANTIC EQUIVALENCE: While the LLM conveys that Cisco maintains this debt as a core component, the 'low-cost' descriptor contradicts the ground truth's 'high-yield' characterization, which is a meaningful semantic difference that affects interpretation of Cisco's debt management strategy. The answer is directionally correct on facts but contains a significant qualitative error in financial characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 481,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125 % notes due January 2025 carried an outstanding principal of $495 million at the end of fiscal 2022 and remained at $495 million through fiscal 2023 and fiscal 2024. This flat trajectory indicates that Broadcom is maintaining this low‑coupon, near‑term debt as a stable component of its capital structure rather than actively repurchasing or refinancing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: All numbers are correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024), and the 3.125% coupon rate is correct. The flat trajectory across all three years is accurately represented. ENTITY ACCURACY: The company is correctly identified as AVGO/Broadcom (both names are acceptable for the same company), the debt instrument is correctly identified (3.125% notes due January 2025), and all fiscal years are correct. COMPLETENESS: The answer addresses all parts of the multi-hop question - it traces the evolution of the principal balance across three years and provides interpretation of the debt management strategy. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies that the unchanged $495 million balance across three years indicates no early repayments or refinancing, and appropriately characterizes this as a stable management approach. The interpretation that AVGO is maintaining this as a stable component rather than actively repurchasing/refinancing is semantically equivalent to the ground truth statement about \"consistent approach to managing this portion of its fixed-rate debt portfolio.\" MINOR CONSIDERATION: The LLM uses \"Broadcom\" while the question uses \"AVGO\" - these are the same company (Broadcom Inc. trades under ticker AVGO), so this is not an error but rather an alternative correct reference. The characterization of the notes as \"low-coupon, near-term debt\" is accurate and adds appropriate context. Overall, the answer demonstrates strong multi-hop reasoning across the three-year period and provides accurate financial data with sound interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 476,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast kept its wireless service tied to a broadband bundle, but it expanded the way customers could obtain shared‑data plans and increased pricing flexibility. In 2022 the offering consisted of unlimited, shared‑data and per‑gigabyte options that were only available when a customer subscribed to a qualifying Xfinity broadband service; by 2023 the company introduced prepaid unlimited‑data plans under the NOW brand, and in 2024 it continued those prepaid plans while still requiring a broadband subscription, while retaining the ability to choose unlimited, shared or per‑GB pricing, activate multiple lines, and finance or bring‑your‑own devices.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND FACT SEQUENCING: The LLM answer contains a fundamental chronological error that significantly undermines its accuracy. The ground truth clearly states that prepaid unlimited data plans under the NOW brand were introduced in 2023, not 2022. However, the LLM answer states 'by 2023 the company introduced prepaid unlimited‑data plans under the NOW brand' which is correct, but then contradicts the ground truth by implying this was a new development in 2023 when the original answer indicates shared data plans were the primary offering in 2022. More critically, the LLM answer fails to accurately capture the evolution: it suggests the NOW brand prepaid plans were introduced in 2023, but the ground truth indicates they were introduced in 2024 as an expansion of flexibility. The LLM has reversed the timeline - stating NOW plans came in 2023 when they actually came in 2024. MISSING KEY DETAILS: The LLM answer omits important context about how the bundling strategy evolved - specifically that 2023 maintained shared data plans while emphasizing broadband bundling (reinforcing integration), and that 2024 represented an expansion of flexibility by introducing NOW prepaid plans alongside continued shared data plan offerings. The LLM conflates these developments. PARTIAL CREDIT FOR CORRECT ELEMENTS: The answer correctly identifies that shared data plans required broadband subscriptions, mentions the unlimited/shared/per-GB pricing options, and notes the ability to activate multiple lines and bring-your-own devices. The general theme of bundling strategy is present. However, the chronological misplacement of the NOW brand introduction (2023 vs 2024) is a factual error that undermines the core narrative of how offerings evolved. The answer also doesn't clearly convey that 2024 represented a strategic expansion of customer choice through the addition of NOW prepaid plans while maintaining existing shared data plan options.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 531,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s Medicare Advantage exposure was repeatedly strained by CMS actions that froze or lowered the benchmark rates and tightened the risk‑adjustment payment formulas, producing a series of year‑over‑year funding pressures.  To counter these recurring cuts the company progressively tightened its benefit designs, raised premiums where allowed, trimmed enrollment in higher‑cost counties, and intensified medical‑cost and operating‑expense management—while also shifting toward more value‑based payment models and stricter utilization‑management programs to protect margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information about UnitedHealth Group's Medicare Advantage exposure from 2022-2024. STRENGTHS: (1) Correctly identifies the core problem: CMS actions freezing/lowering benchmark rates and tightening risk-adjustment formulas across all three years; (2) Accurately captures the company's strategic responses: benefit design adjustments, premium increases, enrollment trimming in high-cost counties, and intensified cost management; (3) Properly synthesizes the multi-hop reasoning showing evolution from 2022 through 2024 with consistent pressure and adaptive responses; (4) Adds relevant strategic details (value-based payment models, utilization management) that align with the ground truth's emphasis on ongoing adaptation; (5) No quantitative errors or incorrect dates/entities. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific/detailed than the ground truth in some areas (e.g., mentioning 'trimmed enrollment in higher-cost counties' and 'value-based payment models'), which represents reasonable inference from the filing data rather than error; (2) The ground truth emphasizes the 'reactive posture' and lack of 'full resolution,' while the LLM answer focuses more on the tactical responses without explicitly stating the reactive nature—however, the tactical description implicitly conveys this; (3) The LLM answer uses 'progressively tightened' which accurately conveys the year-over-year evolution mentioned in ground truth. The answer fully addresses both parts of the multi-part question: (a) how exposure evolved (recurring CMS actions creating persistent pressures) and (b) what strategic adjustments were made (benefit design, premiums, enrollment management, cost control). The semantic equivalence is strong—both answers convey that UnitedHealth faced consistent Medicare Advantage funding pressures and responded with ongoing operational and benefit adjustments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 536,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nMastercard’s multi‑layered security has shifted from a largely internal program to an ecosystem‑centric model that actively enlists external partners—such as joint‑venture collaborations with Chinese banks, formal partnerships with central banks, fintechs and industry associations, and the integration of its VCN and Receivables Manager into third‑party technology platforms—to extend its security oversight beyond the core network.  At the same time, real‑time clearing and settlement capabilities have grown from roughly 13 markets in 2023 to a global infrastructure that by 2024 supports domestic transactions in China and a cross‑border remittance platform reaching more than 60 origin and 155 receiving countries.  This combination of deeper third‑party collaboration and geographic expansion of real‑time payment rails illustrates how Mastercard has broadened both the reach and the collaborative foundation of its security and real‑time services from 2022 through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific numbers NOT in the ground truth: '60 origin and 155 receiving countries' for remittance platform are unsupported claims. The ground truth mentions 12 markets in 2022, 13 markets in 2023, but the LLM claims '13 markets in 2023 to a global infrastructure...supporting...155 receiving countries' - this is a significant factual discrepancy and potential fabrication. The LLM provides no evidence for these specific country counts. (2) INCOMPLETE SYNTHESIS - The ground truth explicitly states: '12 of the top 50 GDP markets' (2022), '13 markets globally' (2023), and mentions China joint venture expansion in 2024. The LLM correctly mentions China joint venture but fails to accurately represent the market count progression and conflates 'markets' with 'countries' in remittance context without proper grounding. (3) MISSING KEY DETAILS - The ground truth specifically mentions EMV technical standards, fraud scoring, and tokenization integration. The LLM mentions VCN and Receivables Manager but these are not in the ground truth answer, suggesting potential hallucination or information from different sources. (4) REASONING QUALITY - While the LLM's conceptual framing (ecosystem-centric model, third-party collaboration) aligns with the ground truth's direction, the specific numeric claims are problematic. The progression from 13 markets to '60 origin and 155 receiving countries' is not logically explained and appears to conflate different metrics. (5) SEMANTIC ISSUES - The LLM shifts from 'markets' to 'countries' without clear distinction, and the remittance platform numbers appear fabricated or unsupported by the ground truth. The core narrative about evolution toward ecosystem collaboration is reasonable, but the specific quantitative claims undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 504,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nAmazon first issued the $1.5 bn 1.500 % senior unsecured note maturing in 2030 in June 2020 (see 2022 10‑K Exhibit 4.5, p. 73). Through 2022‑2024 the company kept that 2030 tranche on its books and did not refinance it; instead it complemented it with a series of new, low‑coupon senior notes—e.g., the 2022‑2024 supplemental indentures that added 4.5‑4.7 % notes due 2024‑2032 (2022 10‑K Exhibit 4.8, p. 73; 2023 10‑K Exhibit 4.6‑4.9, pp. 73‑74; 2024 10‑K Exhibit 4.5‑4.8, pp. 72‑74). This pattern shows that Amazon’s long‑term debt strategy from 2022 through 2024 focused on extending the maturity profile, locking in cheap financing, and diversifying funding sources rather than replacing the 2030 note, underscoring a disciplined, rate‑sensitive approach to refinancing and capital structure management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that diverge substantially from the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM states the note is \"$1.5 bn\" (1.5 billion dollars), but the ground truth does not specify a dollar amount for this note. The LLM appears to have fabricated this detail.\n   - The LLM references \"4.5-4.7% notes due 2024-2032\" but provides no evidence these are the correct coupon rates or maturity dates. The ground truth makes no mention of these specific rates.\n   - The LLM cites specific exhibit numbers (4.8, 4.6-4.9, 4.5-4.8) with page numbers (73, 73-74, 72-74) that cannot be verified against the ground truth and appear to be fabricated.\n\n2. FACTUAL INACCURACIES:\n   - The ground truth explicitly states the note was \"issued in 2020 and incorporated by reference\" in 2022 (Exhibit 4.5), but the LLM claims it was issued \"in June 2020\" with a specific month not confirmed in the ground truth.\n   - The ground truth mentions a \"Term Loan Agreement dated January 3, 2023 (Exhibit 10.8)\" and a \"364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9),\" but the LLM completely omits these critical financing instruments and instead focuses on supplemental indentures and senior notes that are not mentioned in the ground truth.\n   - The LLM's discussion of \"supplemental indentures that added 4.5-4.7% notes\" is not supported by the ground truth, which makes no reference to supplemental indentures or these specific coupon rates.\n\n3. MULTI-HOP REASONING FAILURE:\n   - The ground truth reveals a \"layered financing approach\" combining long-term fixed debt with flexible short-term credit facilities (Term Loan Agreement and 364-Day Revolving Credit Agreement).\n   - The LLM completely misses this critical insight and instead focuses on a narrative about supplemental indentures and extending maturity profiles that is not present in the ground truth.\n   - The LLM fails to synthesize the evolution across 2022-2024 as described in the ground truth (Exhibit 4.5 in 2022 → Exhibit 4.6 in 2023 with new Term Loan → Exhibit 4.6 in 2024 with new 364-Day Revolving Credit Agreement).\n\n4. MISSING KEY INFORMATION:\n   - The LLM completely omits the Term Loan Agreement (January 3, 2023) and the 364-Day Revolving Credit Agreement (October 2024), which are central to understanding Amazon's financing strategy evolution.\n   - The ground truth's key insight about \"a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility\" is not captured by the LLM's narrative.\n\n5. EXHIBIT REFERENCE ERRORS:\n   - The ground truth cites specific exhibits (4.5, 4.6, 10.8, 10.9) across different years.\n   - The LLM cites different exhibit numbers (4.8, 4.6-4.9, 4.5-4.8) that do not align with the ground truth's documentation structure.\n\nThe LLM answer appears to have fabricated details about coupon rates, dollar amounts, and exhibit numbers while simultaneously missing the actual evolution of Amazon's financing strategy as documented in the ground truth. The core narrative about supplemental indentures and rate-sensitive refinancing is not supported by the ground truth, which instead emphasizes a shift toward short- and medium-term liquidity instruments alongside long-term fixed-rate obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 878,
        "total_tokens": 2357
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive threat from wireless telecoms to Comcast’s broadband business has moved from a peripheral concern to a core, pricing‑driven challenge: early filings noted that wireless carriers were beginning to offer fixed‑wireless and MVNO internet services, but by the 2023 and 2024 reports the language emphasizes that “many of these competitors offer competitive pricing, packaging and/or bundling of services” and that “wireless telecommunications companies offering internet services (including 5G fixed‑wireless) are a primary source of competition for our broadband and voice offerings.”  This escalation is reflected in Comcast’s own strategic responses—highlighting the need to “provide our customers with a satisfactory customer experience,” investing in upgraded X1/Sky Q platforms, and increasingly bundling broadband with mobile and video services—to retain subscribers who might otherwise switch to cheaper wireless alternatives.  The filings therefore show that rising wireless competition is directly shaping Comcast’s market‑positioning tactics and retention initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-hop question about competitive evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the temporal progression of wireless competition (4G/5G in 2022 → 5G fixed wireless in 2023 → bundling/unlimited data in 2024), matching the ground truth's evolution narrative. (2) Accurately captures the escalation from 'peripheral concern' to 'core challenge,' reflecting the intensification described in the original answer. (3) Properly synthesizes CMCSA's strategic responses (X1/Sky Q platforms, bundling, customer experience focus) as evidence of competitive pressure impacting market positioning and retention strategies. (4) Correctly identifies specific competitive tactics (5G fixed wireless, DTC streaming bundles, unlimited data plans, competitive pricing/packaging). (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing ('pricing-driven challenge' vs. the ground truth's focus on 'technological advancements and service bundling'), though both characterizations are valid and complementary. (2) The LLM mentions 'MVNO internet services' which is not explicitly mentioned in the ground truth, though this is a reasonable inference about wireless competitive tactics. (3) References to 'X1/Sky Q platforms' and specific strategic investments are not detailed in the ground truth, though they represent valid evidence of competitive response. (4) The answer could have been more explicit about the specific technologies (smartphones, laptops, tablets, mobile/fixed wireless routers) mentioned in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects competitive threats to CMCSA's strategic responses, demonstrating sound multi-hop reasoning. The logical flow from competitive evolution → market pressure → strategic response is clear and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while using slightly different organizational structure and emphasis, which is appropriate for a natural language response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 588,
        "total_tokens": 2164
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets fell sharply over the period: about $70‑75 billion at the end of 2022 (AIG 10‑K 2022, pp. 169‑173), $67.5 billion at the end of 2023 (AIG 10‑K 2023, pp. 120‑124), and only $38 billion by the end of 2024 (AIG 10‑K 2024, pp. 86‑90). The decline reflects a deliberate scaling back of ceded‑loss arrangements and a shift of more risk onto AIG’s own balance sheet, signalling that the company’s net exposure to insurance‑loss volatility has increased rather than decreased over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2022 estimate of '$70-75 billion' which contradicts the ground truth stating 'specific figures were not disclosed' for 2022. This is a critical factual error. The 2023 figure of $67.5 billion is correct, and the 2024 figure of $38 billion is correct. (2) DIRECTIONAL INTERPRETATION ERROR - The LLM states the decline 'reflects a deliberate scaling back of ceded-loss arrangements and a shift of more risk onto AIG's own balance sheet, signalling that the company's net exposure to insurance-loss volatility has increased.' This directly contradicts the ground truth interpretation that the trend 'suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.' The LLM's conclusion that exposure INCREASED is the opposite of the ground truth's de-risking narrative. (3) MISSING COMPONENT BREAKDOWN - The LLM fails to provide the detailed breakdown of the 2023 and 2024 figures (ceded loss reserves vs. life reinsurance recoverables), which is crucial context. The ground truth specifically notes the dramatic drop in life reinsurance recoverables from $28.2B (2023) to $0.8B (2024), which is the key driver of the overall decline and supports the de-risking interpretation. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize the trend across three years, it fundamentally misinterprets what the trend indicates about risk exposure, reaching the opposite conclusion from the ground truth. The failure to recognize the life insurance reinsurance collapse as evidence of de-risking is a significant analytical error. (5) SEMANTIC EQUIVALENCE - The core semantic meaning is inverted: ground truth = de-risking/reduction in exposure; LLM = increased net exposure. This is not a wording difference but a fundamental factual disagreement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 518,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard continued to estimate settlement exposure by averaging daily payment volume over the three‑month window prior to period‑end and multiplying by the expected days of exposure, but from 2022 through 2024 it tightened the calculation and revised the figures more frequently—e.g., correcting the 2022 net exposure amount and raising the gross exposure from $64.9 bn (2022) to $78.4 bn (2024).  At the same time, the company broadened its credit‑risk mitigation toolkit (larger cash‑collateral, letter‑of‑credit and guarantee requirements) and periodically reviewed its risk‑management standards, increasing the risk‑mitigation offsets applied to exposure from $9.2 bn in 2022 to $13.5 bn in 2024.  These refinements were undertaken to satisfy heightened antitrust and competition scrutiny from U.S., European and UK regulators and to demonstrate that its exposure estimates and mitigation arrangements meet the regulatory expectations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) METHODOLOGY CLAIM: The LLM states Mastercard 'tightened the calculation and revised the figures more frequently,' but the ground truth explicitly states the methodology 'remained unchanged across all three years.' This is a fundamental misrepresentation. (2) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($64.9bn gross exposure in 2022, $78.4bn in 2024, $9.2bn mitigation in 2022, $13.5bn in 2024) that are NOT present in the ground truth. The ground truth makes no mention of these specific figures. These appear to be fabricated numbers. (3) MISSING KEY REGULATORY DETAILS: The LLM fails to mention specific regulatory actions documented in the ground truth: the FTC consent agreement on debit routing (2023), DOJ Civil Investigative Demand on antitrust concerns (2023), denied summary judgment motion in U.S. Liability Shift Litigation (2024), and European Commission investigation into card scheme fees (2024). (4) MISCHARACTERIZATION OF CHANGES: The ground truth explicitly states 'there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements,' yet the LLM claims the company 'tightened the calculation,' 'revised figures more frequently,' and 'broadened its credit-risk mitigation toolkit.' These claims directly contradict the ground truth. (5) REASONING FLAW: While the LLM correctly identifies that regulatory scrutiny drove actions, it incorrectly attributes specific methodological and structural changes that the ground truth does not support. The LLM appears to have invented quantitative details and claimed changes that did not occur. This represents a serious failure in factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 496,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG layered stronger internal controls and escalation procedures around loss‑reserve setting, while increasingly enlisting independent external actuaries and catastrophe‑modeling specialists to challenge and validate those reserves.  At the same time the company moved from basic deterministic estimates to more sophisticated stochastic and climate‑adjusted catastrophe models, embedding rigorous model‑risk validation and incorporating the latest climate‑science inputs to better capture uncertainty in loss development.  This evolution also brought tighter monitoring of reinsurance recoverables and more explicit linkages between reserve assumptions, pricing models, and capital‑allocation limits.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of AIG's loss reserves risk management from 2022-2024, including: (1) strengthened internal controls and escalation procedures, (2) increased external expert involvement (external actuaries, catastrophe-modeling specialists), (3) shift from deterministic to stochastic methods, and (4) enhanced model risk management. The answer demonstrates sound multi-hop reasoning by synthesizing information across the three-year period and connecting internal controls, external oversight, and modeling techniques. No quantitative errors are present (no specific numbers were claimed). The semantic equivalence is strong - 'independent external actuaries' matches 'external experts,' ochastic methods are correctly identified, and the progression narrative aligns with ground truth.\n\nWEAKNESSES: (1) The LLM introduces elements NOT in the ground truth answer, specifically: climate-adjusted catastrophe models, climate-science inputs, reinsurance recoverables monitoring, and linkages to pricing models and capital-allocation limits. While these may be accurate from the source documents, they represent significant additions beyond what the ground truth synthesized, suggesting either over-inference or drawing from different sections of the filings. (2) The answer lacks explicit mention of 'sensitivity and scenario analyses' and 'experience studies' that were highlighted in the 2023 evolution per the ground truth. (3) The ground truth emphasizes a 'maturing and more integrated risk analytics approach' as the overarching theme, while the LLM focuses more on climate-related modeling and reinsurance linkages. (4) The answer doesn't clearly delineate the year-by-year progression (2022 vs 2023 vs 2024) as explicitly as the ground truth does.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes across the three-year period and connects multiple dimensions (controls, external involvement, modeling). However, the introduction of climate-related elements and reinsurance details suggests either incomplete alignment with the ground truth synthesis or drawing from different source material.\n\nCONCLUSION: The answer captures the essential evolution narrative and key mechanisms (internal controls, external experts, stochastic methods, model validation) but diverges in specific details and emphasis, particularly regarding climate modeling and reinsurance elements not highlighted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 656,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nThe sensitivity analysis for medical‑cost PMPM trend factors shows a steadily larger dollar impact as the company moves from 2022 through 2024.  In the 2022 filing a 1 % change in the trend factor would alter medical‑costs payable by roughly $300 million (a 3 % change ≈ $895 million); by 2023 the same 1 % shift translates to about $376 million (3 % ≈ $1.13 billion), and in 2024 it rises to roughly $421 million (3 % ≈ $1.26 billion).  This growth reflects that the company’s cost estimates are increasingly tied to the mix of benefits offered—changes in benefit design (e.g., co‑pays, deductibles, coverage levels) directly affect the PMPM trend assumptions and therefore expose earnings to greater variability in benefit‑design outcomes over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($300M, $376M, $421M) and sensitivity calculations that cannot be verified against the ground truth and appear to be fabricated. The ground truth does not mention these specific dollar figures or quantitative sensitivity metrics. The LLM fundamentally misinterprets the question by focusing on trend factor sensitivity (1% changes in trend) rather than the actual question about sensitivity to CHANGES IN THE MIX OF BENEFITS OFFERED. These are distinct concepts - trend sensitivity vs. benefit mix sensitivity. The ground truth explicitly discusses benefit mix (co-pays, deductibles) as a sensitivity factor that evolved from 2022-2024, showing: (1) 2022: identified as key factor, (2) 2023: negative impact/increased exposure, (3) 2024: stabilized/neutral tone. The LLM answer completely misses this qualitative evolution and instead invents quantitative data about trend factor sensitivity. The LLM does correctly identify that benefit design changes (co-pays, deductibles) affect PMPM estimates and increase earnings variability, which aligns with the ground truth's conclusion. However, the specific numbers provided ($300M, $376M, $421M) are unsupported and likely incorrect. The answer fails to address the 3-year trajectory of how benefit mix sensitivity evolved from general factor → source of risk → stabilized variable. The multi-hop reasoning is fundamentally flawed because it addresses the wrong sensitivity metric entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 414,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nIn the 2022 filing Marketside is presented simply as a new private‑brand offering, but by the 2023 and 2024 filings the language shifts to describing it as a “strategic brand that reinforces Walmart U.S.’s merchandise strategy” and a driver of margin expansion across multiple categories. This progression shows that Marketside has moved from a peripheral label to a core pillar of Walmart’s private‑brand portfolio, underscoring its importance in delivering differentiated, value‑priced products while supporting the retailer’s omni‑channel growth and profitability goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Marketside was 'presented simply as a new private-brand offering' in 2022, but the ground truth indicates it was already 'listed among Walmart's private brands' in 2022, suggesting it was not new. (2) UNSUPPORTED CLAIMS: The LLM asserts that by 2023-2024 Marketside is described as a 'strategic brand that reinforces Walmart U.S.'s merchandise strategy' and a 'driver of margin expansion across multiple categories,' but the ground truth makes no such claims about margin expansion or these specific characterizations. These appear to be fabricated details not present in the source material. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM describes a progression from 'peripheral label to core pillar,' but the ground truth indicates 'consistent presence' and 'maintained' status rather than elevation from peripheral to core. (4) MISSING KEY DETAIL: The ground truth specifically mentions the shift from 'Apparel' to 'Fashion' in the merchandise unit structure by 2024, which the LLM completely omits. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided by either answer, but the LLM's qualitative characterizations are factually unsupported. The LLM appears to have invented or hallucinated specific language about 'strategic brand' positioning and 'margin expansion' that cannot be verified in the ground truth. The answer demonstrates poor multi-hop reasoning by making unsupported leaps about Marketside's strategic importance without grounding claims in actual filing language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 460,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved its competitive edge away from pure price/assortment battles with showrooms toward a service‑ and digital‑led differentiation.  It deepened Pro‑focused offerings—expanded sales forces, the Pro Xtra loyalty program, dedicated showroom space and MRO capabilities—while simultaneously building an omnichannel experience (BOPIS, curbside, mobile‑app navigation, computer‑vision inventory and AI‑driven personalization) that ties online research to in‑store pickup, installation and delivery.  This integrated service‑plus‑digital strategy has been the primary way the retailer has strengthened its positioning against showroom competitors over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution from 2022-2024, capturing the shift toward omnichannel integration and service-led differentiation. It accurately mentions specific initiatives like BOPIS, curbside pickup, mobile app navigation, and personalization. The answer demonstrates sound multi-hop reasoning by synthesizing service offerings with digital integration across the three-year period. The semantic framing of 'service-plus-digital strategy' aligns well with the ground truth's characterization of the evolution.\n\nWEAKNESSES: (1) QUANTITATIVE GAPS: The LLM answer introduces specific details (Pro Xtra loyalty program, MRO capabilities, computer-vision inventory, AI-driven personalization) that are NOT mentioned in the ground truth. While these may be factually accurate from the filings, they represent information beyond what the knowledge graph provided, creating potential factual uncertainty. (2) MISSING SPECIFIC 2022 DETAIL: The ground truth explicitly mentions 'tool and equipment rental services at over 1,400 locations' as a 2022 differentiator—a concrete quantified detail the LLM answer omits. (3) MISSING 2023 SPECIFICS: The ground truth specifically calls out 'self-service lockers' and 'electronic shelf labels' as 2023 innovations; the LLM answer doesn't mention these. (4) STRUCTURAL CLARITY: The ground truth provides a clearer year-by-year progression (2022→2023→2024), while the LLM answer blends the timeline less distinctly.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the three-year period and connects service offerings to digital integration. However, the introduction of details not in the ground truth (Pro Xtra, MRO, computer-vision) suggests either hallucination or reliance on external knowledge rather than strict adherence to the provided knowledge graph.\n\nNUMERIC VERIFICATION: The ground truth provides one specific number (1,400 rental locations in 2022). The LLM answer does not reference this number, representing a material omission of quantified evidence.\n\nSCORE JUSTIFICATION: The answer captures the essential strategic narrative (6/10 correctness) but loses points for omitting specific quantified details from 2022, missing named 2023 innovations, and introducing unverified details. The qualitative reasoning is sound (6/10) but the quantitative specificity is weak (5/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 639,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nCisco’s 3.50 % senior note carried a constant $500 million principal through fiscal 2022‑2024, but its effective interest rate rose sharply—from roughly 1.3 % in FY 2022 and FY 2023 to about 6.66 % in FY 2024—reflecting the impact of discount amortization and higher market rates on the same fixed‑coupon issuance. This jump signals that Cisco’s borrowing cost increased markedly over the period, indicating a debt structure that became more weighted toward higher‑yield senior notes as market interest rates climbed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides completely incorrect effective interest rates for FY 2022 and FY 2023. Ground truth states FY 2022: 3.20%, FY 2023: 6.38%, FY 2024: 6.66%. LLM claims FY 2022-2023 were 'roughly 1.3%' which is factually wrong and contradicts the ground truth by a margin of ~2-5 percentage points. This is a major numerical error. (2) The LLM correctly identifies the $500 million principal amount remaining constant across all three years, which matches ground truth. (3) The LLM correctly identifies the general trend of increasing effective interest rates and the final FY 2024 rate of 6.66%, which is accurate. (4) MULTI-HOP REASONING - The LLM attempts to explain the increase through 'discount amortization and higher market rates,' which is a reasonable interpretation, though the ground truth simply states the increase reflects 'broader market interest rate trends and Cisco's evolving debt financing strategy' without speculating on discount amortization mechanisms. (5) SEMANTIC ISSUES - The LLM's explanation about 'discount amortization' is speculative and not supported by the ground truth answer. The core failure is the egregious misstatement of the FY 2022-2023 effective rates (1.3% vs. actual 3.20%-6.38%), which undermines the entire analysis. The answer gets the direction of change correct but the magnitude and specific values wrong for two of three years, making this fundamentally unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 407,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast upgraded its hybrid‑fiber‑coax plant with DOCSIS 4.0 and began rolling out fiber‑to‑the‑premises, raising residential downstream speeds to 2 Gbps and offering symmetrical multigigabit (up to 10 Gbps) services. These infrastructure advances were paired with expanded bundled offerings—xFi whole‑home Wi‑Fi, the Flex streaming device, and Internet Essentials Plus—giving Comcast a more integrated video, voice and wireless package than Lumen’s pure‑fiber, broadband‑only focus. As a result, Comcast’s competitive positioning versus Lumen shifted from a lower‑speed HFC‑centric service to a hybrid fiber‑enhanced platform that now matches or exceeds Lumen’s speed tiers while also providing richer bundled services.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question asked. Critical issues: (1) ENTITY CONFUSION: The answer focuses on CMCSA's (Comcast's) own infrastructure improvements rather than analyzing CMCSA's competitive positioning AGAINST Lumen. The ground truth explicitly asks how CMCSA's positioning evolved relative to Lumen's competitive threat. (2) MISSING LUMEN ANALYSIS: The ground truth emphasizes Lumen's consistent fiber expansion from 2022-2024 as a competitive threat to CMCSA. The LLM answer mentions Lumen only once in passing ('Lumen's pure-fiber, broadband-only focus') without discussing Lumen's actual competitive evolution, fiber deployments, or strategic moves across the three-year period. (3) WRONG PERSPECTIVE: The answer describes what Comcast did to improve its position, but fails to address the comparative competitive dynamics - how Lumen's actions specifically challenged CMCSA and how that threat evolved. The ground truth shows Lumen alongside AT&T, Frontier, and Verizon as consistent competitors expanding fiber infrastructure. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question requires synthesizing information about both companies' strategies across 2022-2024. The LLM only addresses CMCSA's side of the equation. (5) FACTUAL CLAIMS WITHOUT GROUNDING: While the technical specifications mentioned (DOCSIS 4.0, 2 Gbps speeds, 10 Gbps symmetrical) may be accurate to Comcast's actual offerings, they are not verified against the ground truth knowledge graph and appear to be general knowledge rather than specific 10-K filing data. The answer reads more like a marketing comparison than a filing-based competitive analysis. The ground truth's emphasis on Lumen's consistent competitive threat across all three years is completely absent from the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 493,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nFrom 2022 through 2024 American Express has shifted from a largely direct merchant‑acquiring model to a strategy that outsources key acquisition and processing functions to third‑party acquirers, aggregators and processors (see 2022‑2023 pages 27‑31 and 2024 pages 33‑35).  This deeper reliance exposes the company to a heightened risk that those intermediaries will enable or even encourage merchants to surcharge or otherwise steer consumers away from Amex cards, which undermines Amex’s ability to enforce the non‑discrimination and “honor‑all‑cards” clauses built into its merchant contracts (discussed in the 2023‑2024 sections on merchant steering and differential surcharging).  As a result, while the company continues to rely on these contractual provisions, their practical effectiveness now depends on the incentives and behavior of the aggregators on which it increasingly depends.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core narrative arc and correctly identifies the key themes: American Express's increasing reliance on aggregators from 2022-2024, the associated risks of merchant steering and discrimination, and the challenges in enforcing non-discrimination clauses. The answer accurately captures the semantic essence of the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the temporal evolution (2022-2024) and the shift toward aggregator reliance\n2. Accurately names the key risks: merchant steering, surcharging, discrimination against Amex cards\n3. Properly synthesizes the multi-hop concept: increased aggregator dependence → weakened enforcement of contractual provisions\n4. Correctly identifies the non-discrimination and \"honor-all-cards\" clauses as central to the issue\n5. Appropriately notes the tension between contractual provisions and practical effectiveness\n6. Page references (2022-2023 pages 27-31, 2024 pages 33-35) are plausible and add credibility\n\nWEAKNESSES:\n1. The answer does not explicitly mention the 2023 concern about new products (debit cards on the American Express network) facing discrimination, which was highlighted in the ground truth\n2. The answer does not reference the 2024 litigation and regulatory scrutiny dimension mentioned in the ground truth\n3. The answer frames this as a \"shift\" from a \"direct merchant-acquiring model\" but the ground truth emphasizes \"increasing reliance\" rather than a complete shift in business model\n4. Missing the specific progression detail that the concern \"intensified\" in 2023 with explicit mention of new products\n5. The answer could have been more explicit about the legal/litigation exposure that emerged by 2024\n\nQUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not directly testable. The page references in the LLM answer cannot be verified against the ground truth provided.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between three key elements: (1) aggregator reliance increasing over time, (2) merchant steering/discrimination risks rising, and (3) enforcement challenges with contractual provisions. The logical chain is sound and matches the ground truth's narrative.\n\nSEMANTIC EQUIVALENCE: The LLM answer conveys substantially the same information as the ground truth, with the main difference being the omission of specific 2023-2024 developments (new products, litigation/regulatory scrutiny) that were highlighted in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 695,
        "total_tokens": 2222
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 J&J’s talc strategy moved from the original Chapter 11 filing of LTL Management LLC (which froze all talc suits in late 2021) to a series of setbacks and new filings: the 2022 dismissal of that case after a Third‑Circuit reversal left the litigation re‑opened, and a second bankruptcy (the “LTL 2” filing in April 2023) was quickly dismissed, prompting the company to pursue a “pre‑packaged” resolution.  In 2024 J&J created a new Texas talc‑focused entity (Red River Talc LLC) and filed a Chapter 11 plan that proposes a $6.5 billion present‑value trust paid over 25 years (nominally about $8 billion) – a strategy that underpins a $5 billion incremental charge recorded in 2024 and a cumulative reserve of roughly $11.6 billion (≈ $13.5 billion nominal) for all current and future talc claims.  The company also used the bankruptcy process to negotiate settlements, including a 2024 in‑principle agreement with a 42‑state multi‑state group and a global settlement with Imerys/Cyprus, while continuing to litigate the remaining cases in the MDL and to defend against individual verdicts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - Ground truth: $2 billion reserve established in 2022\n   - LLM claims: $5 billion incremental charge in 2024, $11.6 billion cumulative reserve (~$13.5 billion nominal)\n   - These specific dollar amounts ($5B, $11.6B, $13.5B) are NOT mentioned in the ground truth and appear to be fabricated or from sources outside the provided knowledge graph\n   - The $6.5 billion present-value trust and $8 billion nominal figures are also not in the ground truth\n\n2. TIMELINE ERRORS:\n   - Ground truth: LTL filed for bankruptcy in 2022 (created October 2021)\n   - LLM states: \"late 2021\" filing (partially correct on timing but imprecise)\n   - Ground truth: Third Circuit reversed decision, forcing LTL 2 filing; LTL 2 dismissed July 2023\n   - LLM states: \"April 2023\" for LTL 2 filing (INCORRECT - ground truth doesn't specify April, and the sequence is unclear)\n   - Ground truth: 2024 settlements with 42 states\n   - LLM: \"2024 in-principle agreement with 42-state group\" (correct on outcome but adds \"in-principle\" qualifier not in ground truth)\n\n3. ENTITY ERRORS:\n   - LLM introduces \"Red River Talc LLC\" as a new 2024 entity - NOT mentioned in ground truth\n   - LLM mentions \"Imerys/Cyprus\" settlement - NOT mentioned in ground truth\n   - These appear to be hallucinated details\n\n4. STRUCTURAL ISSUES:\n   - Ground truth emphasizes: bankruptcy filing → reversal → refiling → dismissal → appeal → settlement negotiations\n   - LLM adds: \"pre-packaged resolution\" strategy and detailed bankruptcy plan details not in ground truth\n   - LLM conflates the 42-state settlement (mentioned in ground truth as 2024) with bankruptcy negotiations in a way that suggests a different causal relationship\n\n5. WHAT WAS CORRECT:\n   - General timeline progression (2022-2024)\n   - LTL Management LLC as the vehicle\n   - Chapter 11 bankruptcy filings\n   - Third Circuit reversal\n   - LTL 2 filing and dismissal\n   - 42-state settlement in 2024\n   - Dual litigation/settlement strategy\n\n6. MULTI-HOP REASONING:\n   - The LLM attempted to synthesize across years and legal actions, but introduced unsupported financial details that break the chain of reasoning\n   - The connection between bankruptcy filings and settlement negotiations is reasonable but embellished with unverified numbers\n\nThe answer demonstrates partial understanding of the narrative arc but fails on quantitative accuracy by introducing specific dollar amounts and entities not in the ground truth, which is a critical failure for financial questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 713,
        "total_tokens": 2311
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Home Depot shifted its store‑appearance focus from a purely functional layout to a deliberately designed, experience‑driven environment—adding modern signage, way‑finding graphics, self‑service lockers, curbside‑pickup stations and electronic‑shelf‑label displays that give the stores a cleaner, more premium look.  By FY 2024 those visual upgrades were woven into the company’s interconnected‑retail strategy: the refreshed stores serve as the physical hub of a seamless omnichannel journey, with mobile‑app navigation, real‑time inventory visibility, and omnichannel fulfillment options (BOPIS/BOSS, BODFS, BORIS) that let customers move effortlessly from online research to in‑store pickup or same‑day delivery, thereby reinforcing the brand’s digital‑first customer experience while leveraging the upgraded store aesthetic.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific operational details (modern signage, way-finding graphics, self-service lockers, curbside-pickup stations, electronic-shelf-label displays, BOPIS/BOSS, BODFS, BORIS) that are NOT present in the ground truth knowledge graph. This represents a fundamental problem: the LLM appears to have hallucinated concrete implementation details rather than synthesizing from actual SEC filing data. The ground truth explicitly states that store appearance evolved from a 'standalone competitive factor' to 'a component of a digitally enhanced, omnichannel retail strategy,' focusing on the conceptual evolution and strategic integration. The LLM's answer, while superficially plausible and well-written, invents specific store features and fulfillment acronyms that cannot be verified against the provided ground truth. WHAT WAS CORRECT: The general direction of the answer (store appearance becoming integrated with digital/omnichannel capabilities) aligns with the ground truth's core narrative. The mention of mobile apps, inventory visibility, and omnichannel fulfillment options reflects the right conceptual framework. WHAT WAS INCORRECT: (1) Specific store features (lockers, electronic shelf labels, way-finding graphics) are not mentioned in ground truth; (2) Specific fulfillment acronyms (BOPIS, BOSS, BODFS, BORIS) are not in ground truth; (3) The characterization of the shift as 'functional layout to experience-driven environment' adds interpretive detail not supported by the source material; (4) The phrase 'digital-first customer experience' may overstate the emphasis in the original answer. MULTI-HOP REASONING: The LLM correctly synthesized the concept that store appearance became integrated with digital capabilities, but failed to distinguish between what was actually stated in filings versus plausible-sounding operational details. This is a critical failure in a financial document evaluation context where accuracy to source material is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 542,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T moved from full ownership of Time Warner’s media business (acquired in 2018) to a complete exit: the April 2022 Reverse‑Morris‑Trust transaction spun off WarnerMedia and merged it with Discovery, and by September 2024 AT&T sold its remaining stake in the DIRECTV joint‑venture (the last residual entertainment asset). This trajectory shows that AT&T’s entertainment strategy was to acquire content assets, integrate them briefly, and then divest them to refocus on its core wireless and broadband operations. (See T_10k_2022.pdf pp. 3‑7 for the acquisition and spin‑off details, and T_10k_2024.pdf pp. 2‑6 for the 2024 divestiture.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of AT&T's Time Warner relationship across 2022-2024. STRENGTHS: (1) Correctly identifies the April 2022 Reverse Morris Trust transaction spinning off WarnerMedia and merging with Discovery - this is the pivotal event. (2) Accurately dates the September 2024 DIRECTV divestiture to TPG as the final exit. (3) Properly traces the 2018 Time Warner acquisition as the origin point. (4) Correctly synthesizes the multi-hop narrative: acquisition → integration → separation → final divestiture. (5) Accurately characterizes the strategic pivot toward telecommunications and away from entertainment. (6) Provides appropriate document citations. MINOR WEAKNESSES: (1) The LLM describes DIRECTV as a 'joint-venture' when it was actually a subsidiary/owned business (though AT&T did have partnerships around it), which is a minor characterization issue. (2) The answer could have been slightly more explicit about the 2023 transition year and full operational separation, though this is implied. (3) The phrase 'full ownership of Time Warner's media business' is slightly imprecise - AT&T owned Time Warner Inc. (the parent company), not just the media business, though this is a semantic nuance. QUANTITATIVE VERIFICATION: All dates are correct (2018 acquisition, April 2022 spin-off, September 2024 sale). No dollar amounts are provided in either answer, so no calculation errors to assess. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple transactions, correctly linking the 2018 acquisition through the 2022 separation to the 2024 final exit. The logical flow is sound and the strategic conclusion is well-supported. The answer is semantically equivalent to the ground truth while being more concise and specific about dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 507,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024, American Express has retained its status as the world’s fourth‑largest general‑purpose card network, but intensified competition from Visa, Mastercard and fintech‑driven payment platforms has increased pressure on its premium‑card and cobrand relationships.  \nAt the same time, heightened regulatory scrutiny—especially the 2024 U.S. Category III classification, the exit from network‑licensing businesses in the EU and Australia, and proposed interchange‑fee caps—has deepened the company’s reliance on compliance and limited its pricing flexibility.  \nConsequently, American Express is shifting toward higher‑margin, digital‑focused services while navigating a more constrained regulatory environment that now directly shapes its competitive positioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of American Express's fourth-largest network position and accurate characterization of the 2022-2024 evolution. Key strengths: (1) Correctly identifies the fourth-largest global card network status; (2) Accurately captures the shift from competitive to compliance-driven positioning; (3) Properly identifies EU and Australia network licensing exits; (4) Correctly references regulatory scrutiny around interchange fees and network routing; (5) Appropriately synthesizes the tension between competitive differentiation and regulatory constraints. Minor weaknesses: (1) Introduces 'U.S. Category III classification' which is not mentioned in the ground truth and appears to be an unsupported detail not verifiable from the original answer; (2) References 'fintech-driven payment platforms' as competitors, which is a reasonable inference but not explicitly stated in ground truth; (3) Mentions 'proposed interchange-fee caps' rather than just 'interchange fees' scrutiny, adding specificity not confirmed in original answer; (4) Slightly less explicit about cobrand arrangement uncertainty in EU compared to ground truth. The answer correctly synthesizes multi-hop information across years (2022-2024) and entities (regulatory bodies, competitors, business segments). The reasoning about shifting toward 'higher-margin, digital-focused services' is a logical inference but not explicitly stated in ground truth. Quantitative accuracy is strong (no incorrect numbers or dates), though the introduction of unverified regulatory classifications prevents a perfect score. The semantic equivalence is generally maintained, with the core narrative matching the ground truth's emphasis on regulatory-driven evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 486,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe $2.250 % Notes due 2050 rose from **$808 million at the end of 2022 to $826 million at the end of 2023** and remained essentially unchanged at that level through 2024.  \n\nThis modest increase followed by a flat balance shows that Johnson & Johnson is deliberately **maintaining a stable, low‑cost long‑term funding tranche** while fine‑tuning the overall maturity profile of its debt portfolio. The company appears to be managing its long‑term debt to keep total outstanding long‑term obligations around the $25‑30 billion range, using the 2050 notes as a relatively fixed‑rate component of that strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the balance was $808 million in 2022 and $826 million in 2023, but the ground truth shows the opposite - $983 million in 2022 and $826 million in 2023. The LLM completely inverts the 2022 figure (off by $175 million). The LLM also fails to provide the 2024 figure ($808 million), which is critical to answering the question about the three-year evolution. (2) DIRECTIONAL ERROR: The LLM claims the balance 'rose from $808 million...to $826 million' when the actual trend was a DECREASE from $983 million (2022) to $826 million (2023) to $808 million (2024). This is a complete reversal of the actual trend. (3) INTERPRETATION ERROR: The LLM interprets the trend as 'modest increase followed by flat balance' when the ground truth shows a consistent DECLINE of $175 million total over three years. This fundamentally mischaracterizes J&J's debt management strategy. (4) INCOMPLETE ANALYSIS: The LLM fails to address the complete three-year period, omitting the 2024 balance entirely. (5) STRATEGIC INTERPRETATION MISMATCH: The LLM suggests the company is 'maintaining a stable, low-cost funding tranche' when the actual data shows deliberate reduction of this liability. The ground truth explicitly states this represents 'a deliberate strategy to reduce long-term liabilities.' The LLM's narrative about 'fine-tuning the overall maturity profile' is speculative and contradicted by the clear downward trend in this specific instrument. This answer fails on the primary metric of factual accuracy with multiple material errors in the core financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 471,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio rose from about 5.5 % in 2022 to roughly 5.9 % in 2023 and to just over 6 % in 2024, tracking the series of foreign‑central‑bank rate hikes. This upward shift shows that a growing share of the company’s interest‑earning assets is now tied to overseas sovereign debt, making its earnings increasingly sensitive to international interest‑rate movements.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative metrics. Ground truth shows: 2022 short-term yield 6.45%, 2023 short-term yield 6.45%, 2024 short-term yield 5.86%. The LLM claims yields of approximately 5.5% (2022), 5.9% (2023), and 6%+ (2024) - all wrong. The LLM incorrectly characterizes the trend as upward when the ground truth shows a declining trend (6.45% → 6.45% → 5.86% for short-term bonds). The LLM also fails to mention the 1-5 year maturity bucket yields (4.48% in 2023, 2.03% in 2024), which are critical to understanding the full yield profile evolution. The LLM's interpretation that yields are rising due to 'foreign-central-bank rate hikes' contradicts the actual data showing declining yields, particularly the sharp drop to 2.03% for 1-5 year bonds in 2024. The LLM does correctly identify American Express and addresses the 3-year trend question, but the directional analysis is backwards and the specific numbers are inaccurate. The reasoning about increasing sensitivity to international interest rates is somewhat relevant but is based on incorrect yield data and trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 318,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe reframed its free, self‑service learning from a stand‑alone “learning.adobe.com” portal into a branded, Experience‑Cloud‑integrated learning layer (often called Adobe Digital Learning Services) that is explicitly tied to its Customer‑Success and Journey‑Optimizer programs; learning recommendations are now delivered using real‑time customer profiles and usage data, and adoption metrics are fed back to Customer‑Success Managers to drive retention.  This shift shows Adobe’s broader strategy of embedding continuous, data‑driven education into the customer journey as a core lever for customer enablement, satisfaction, and long‑term retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. CRITICAL ERRORS: (1) The LLM claims the platform was rebranded TO 'learning.adobe.com' in 2022, but the ground truth states it was introduced as 'www.training.adobe.com' in 2022 and THEN rebranded to 'learning.adobe.com' in 2023. The LLM reverses this chronology. (2) The LLM introduces entirely unsupported claims about 'Adobe Digital Learning Services,' 'Experience-Cloud-integrated learning layer,' 'Journey-Optimizer programs,' 'real-time customer profiles,' and 'usage data' feeding back to CSMs. None of these specific technical details appear in the ground truth, and the LLM appears to have fabricated these details. (3) The ground truth emphasizes 'solution-specific skills assessments' for marketing teams, which the LLM completely omits. (4) The LLM's characterization of the evolution is inverted—it suggests the platform started as 'learning.adobe.com' and was then integrated deeper, when the ground truth shows it started as training.adobe.com, was rebranded to learning.adobe.com, and then integrated more deeply. WHAT WAS CORRECT: The LLM correctly identifies that the evolution shows Adobe viewing customer enablement as critical for retention and product adoption, and correctly notes the integration into customer success frameworks. However, the specific platform details, branding timeline, and technical mechanisms are either reversed or fabricated. The answer demonstrates hallucination of specific technical features (real-time profiles, Journey-Optimizer integration, CSM feedback loops) that cannot be verified in the ground truth. This is a case where the LLM has created a plausible-sounding narrative that contradicts the actual documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 482,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % Senior Notes remained at a $2 billion principal balance throughout fiscal 2022‑2024, and their effective interest rate stayed at 6.11 % (after adjusting for discount amortization and hedging). This steady utilization and cost shows the company is preserving a stable, long‑dated fixed‑rate funding pillar while expanding its overall debt profile through additional senior note issuances and commercial‑paper financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data: the $2 billion principal balance and 6.11% effective interest rate are both accurate across fiscal 2022-2024. The format variation ($2 billion vs $2,000 million) is acceptable and semantically equivalent. The answer correctly identifies the stable utilization pattern and provides sound reasoning about Cisco's debt strategy. However, there are minor differences in interpretation and completeness: (1) The LLM adds contextual information about 'discount amortization and hedging' and mentions 'additional senior note issuances and commercial-paper financing' which, while potentially accurate, goes slightly beyond what the ground truth explicitly states. (2) The ground truth emphasizes that Cisco 'has not retired or refinanced this particular tranche' as evidence of deliberate strategy, while the LLM frames it as 'preserving a stable, long-dated fixed-rate funding pillar' - both convey similar meaning but with slightly different emphasis. (3) The LLM's mention of expanding debt profile through other instruments is a reasonable inference about overall strategy but represents additional synthesis not explicitly confirmed in the ground truth. The core facts (principal amount, effective rate, stability across three years) are all correct, and the multi-hop reasoning connecting these metrics to strategic intent is sound. The answer is comprehensive and addresses all parts of the question appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 413,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nFrom 2022 through 2024 the **target** allocation to private‑equity‑style “special situation” strategies rose from **≈4 %** of total pension assets to **7 %**, while the **actual** holdings increased from **≈8 %** (2022) to **≈9 %** (2024).  This steady upward drift shows that Boeing is intentionally expanding its exposure to private‑equity special‑situation investments—i.e., higher‑return, longer‑duration assets—reflecting a strategic shift in its private‑equity approach as the pension plan becomes better funded.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) QUANTITATIVE FABRICATION: The LLM provides specific percentage allocations (target allocation rising from ~4% to 7%, actual holdings from ~8% to ~9%) that are completely unsupported by the ground truth. The original answer explicitly states 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' making these precise percentages fabricated data. (2) FACTUAL CONTRADICTION: The ground truth clearly indicates BA maintained CONSISTENT focus on Special Situation Strategies with NO CHANGE across 2022-2024 ('This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation'). The LLM claims a 'steady upward drift' and 'intentionally expanding exposure,' which directly contradicts the documented strategic continuity. (3) UNSUPPORTED CLAIMS: The LLM's interpretation of 'strategic shift' and 'better funded pension plan' are inferences not present in the source material and contradict the ground truth's finding of strategic continuity. (4) MULTI-HOP REASONING FAILURE: Rather than synthesizing available information across years, the LLM invented specific metrics that don't exist in the filings. The ground truth acknowledges the limitation ('The lack of quantitative disclosure limits trend analysis'), but the LLM ignores this constraint entirely. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'preserved exposure' and 'strategic continuity,' while the LLM emphasizes 'expansion' and 'strategic shift'—opposite conclusions. This represents a fundamental failure to accurately represent the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 462,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nJNJ’s Interventional Solutions (now part of MedTech) grew from **$4.3 billion worldwide in 2022** to **$6.35 billion in 2023**, and held essentially steady at **≈ $6.35 billion in 2024** (U.S. $3.63 bn → International $2.72 bn → Worldwide $6.35 bn).  This sharp rise immediately after the December 2022 acquisition shows that the company is treating the MedTech/Interventional Solutions business as a strategic, high‑growth pillar, directing significant capital and R&D to integrate and expand the segment as a core driver of future profitability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that make it largely incorrect: (1) WRONG NUMBERS: The LLM states 2022 sales were $4.3 billion, but ground truth shows $3,971 million ($3.971 billion). This is a significant error of ~$330 million. (2) REVERSED YEARS: The LLM claims 2023 was $6.35 billion and 2024 was 'essentially steady at ≈$6.35 billion', but ground truth shows 2023 was $4,300 million and 2024 was $6,350 million. The LLM has the progression backwards. (3) MISCHARACTERIZATION OF TREND: The LLM describes the 2023 figure as a 'sharp rise immediately after the December 2022 acquisition' and claims 2024 'held essentially steady', but the actual data shows modest growth 2022-2023 ($3,971M to $4,300M) followed by significant acceleration in 2024 ($4,300M to $6,350M). This is the opposite of what the LLM states. (4) CORRECT ELEMENTS: The LLM correctly identifies the December 2022 acquisition timing and correctly interprets the strategic importance of the segment. The breakdown of 2024 figures ($3.63B U.S. + $2.72B International = $6.35B) is mathematically correct. (5) MULTI-HOP REASONING: While the LLM demonstrates understanding that this is a post-acquisition analysis and correctly contextualizes strategic importance, the fundamental data errors undermine the entire analysis. The conclusion about strategic importance is reasonable but based on incorrect numbers and reversed year-over-year progression. The answer fails the primary requirement of factual accuracy on the core quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 425,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “No Boundaries” private brand remained a constant element of Walmart’s merchandise mix, appearing in the same list of private‑brand names across the three 10‑K filings and being promoted for the full range of strategic units—grocery, general merchandise (entertainment, hardlines, apparel, home) and health & wellness.  The brand’s messaging and placement were unchanged, reinforcing Walmart’s everyday‑low‑price promise and using the label as a single, value‑focused umbrella across all general‑merchandise categories.  This multi‑year branding consistency demonstrates that Walmart’s private‑label strategy relies on a stable, cross‑category brand to drive margin, price leadership and customer loyalty throughout its general‑merchandise portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims 'No Boundaries' was promoted 'for the full range of strategic units—grocery, general merchandise (entertainment, hardlines, apparel, home) and health & wellness.' The ground truth explicitly states 'No Boundaries' was positioned within 'General Merchandise' only (Apparel and Home categories), NOT across grocery or health & wellness units. This is a significant factual error that misrepresents Walmart's branding strategy scope. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the key organizational evolution mentioned in ground truth: the 2024 reorganization that shifted 'Apparel' to a new 'Fashion' category. This structural change is important context for understanding how the brand adapted. (3) OVERSTATED CLAIMS - The LLM states 'The brand's messaging and placement were unchanged' but provides no evidence from the filings to support this claim. The ground truth is more measured, noting 'continuity' without claiming complete stasis. (4) UNSUPPORTED ASSERTIONS - The LLM adds interpretive language ('everyday-low-price promise,' 'value-focused umbrella') that goes beyond what the ground truth establishes. While the conclusion about margin and loyalty is reasonable, it extends beyond the documented facts. (5) CORRECT ELEMENTS - The LLM correctly identifies the 3-year timeframe (2022-2024), correctly notes the brand's consistent presence, and correctly concludes that this reflects deliberate private-label strategy. The core insight about multi-year consistency is sound. QUANTITATIVE ACCURACY: No specific numbers are provided by either answer, so this is not a differentiator, but the categorical scope error (claiming grocery/health & wellness inclusion) is a quantitative/categorical accuracy failure. QUALITATIVE ACCURACY: The reasoning about margin expansion and customer loyalty is sound, but the factual foundation is compromised by the scope error. CONTEXTUAL RELEVANCE: The answer addresses the question but with material inaccuracies that undermine its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 555,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the available‑for‑sale debt portfolio moved from a modest $9 million net gain in 2022 to $21 million of losses in 2023 and $67 million of losses in 2024, as shown in the “Other income (loss), net” line where gains (losses) on available‑for‑sale debt investments were $(67) M in 2024 and $(21) M in 2023 (versus $9 M gain in 2022).  The deteriorating performance is driven by widening gross unrealized losses—especially on corporate debt and mortgage‑backed securities—so that the investments increasingly subtracted from other income in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides specific, quantified data that directly addresses the question about Cisco's available-for-sale debt investments' evolution from fiscal 2022 to 2024. STRENGTHS: (1) Provides concrete numbers: $9M gain in 2022, $(21)M loss in 2023, $(67)M loss in 2024 - these specific figures demonstrate direct access to filing data and show clear deterioration trend. (2) Correctly identifies the impact on 'other income (loss), net' as the relevant metric for measuring performance. (3) Explains the underlying driver (widening gross unrealized losses on corporate debt and mortgage-backed securities), providing deeper context than the ground truth. (4) Demonstrates proper multi-hop synthesis by connecting investment performance to income statement impact across three fiscal years. (5) Uses proper financial notation with parentheses for losses. VERIFICATION: The numbers show a clear progression from positive to increasingly negative, which aligns with the ground truth's description of 'consistent negative impact' and 'higher losses' in 2023 and 2024. The specific dollar amounts provide quantitative precision that the ground truth answer lacks. MINOR CONSIDERATIONS: The ground truth answer is more general/qualitative, while the LLM answer is more specific and quantitative. Both convey the same fundamental insight about deteriorating performance, but the LLM answer is more informative and precise. The LLM answer fully addresses all aspects of the question: the evolution over time, the specific impacts on other income (loss), net, and the 3-year trajectory. No factual errors detected in the numbers, calculations, or reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 452,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from using third‑party merchant acquirers mainly as a supplemental channel to a central element of its growth strategy.  The company now structures its card‑acceptance agreements so that small‑ and midsize merchants typically have open‑ended contracts, while large merchants are secured with fixed‑term agreements (often three‑to‑seven years) that include auto‑renewal provisions; in every case Amex earns a network‑rate fee from the acquirer that is recorded as discount revenue.  This framework has broadened merchant coverage across all segments and has been a key driver of transaction growth, especially as the OptBlue and other third‑party acquisition programs expand globally.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) The general evolution from supplemental to central role is accurate; (2) OptBlue and third-party acquisition programs are correctly identified; (3) The concept of network-rate fees recorded as discount revenue is accurate; (4) The timeframe 2022-2024 is correct. SIGNIFICANT ERRORS AND OMISSIONS: (1) The LLM introduces contract structure details (open-ended contracts for small/mid-sized merchants, fixed-term 3-7 year agreements for large merchants with auto-renewal) that are NOT present in the ground truth answer. This appears to be fabricated or from a different context. (2) The LLM fails to capture the key 2023 detail about how American Express receives negotiated network rate fees from third-party acquirers and records them as discount revenue - while it mentions the fee structure, it doesn't emphasize the financial integration aspect highlighted in the ground truth. (3) The LLM misses the critical 2024 statement about American Express's explicit dependency on third-party acquirers, aggregators, and processors for global merchant coverage expansion - this is a key evolution point in the ground truth. (4) The answer lacks the nuanced progression showing how the company's view shifted from 'supplementary' to 'essential' for growth and network expansion. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but introduces unsupported contract details and fails to properly synthesize the strategic dependency evolution that is central to the ground truth answer. The reasoning is partially sound but incomplete and contains fabricated elements. The answer reads more like a general statement about Amex's merchant acquisition strategy rather than a specific evolution narrative from 2022-2024 based on actual filing disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 503,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J has been rolling out a multi‑year, enterprise‑wide program that **integrates and standardizes the HR, IT, procurement, supply‑chain and finance functions** in order to **strengthen its financial shared‑service capabilities**.  The initiative, first introduced in the 2022 filing as a way to simplify and standardize those processes, was expanded in 2023‑24 to **align the design of financial controls with the newly standardized workflows**, ensuring that the shared‑service model supports consistent, scalable financial reporting across the entire enterprise.  In each year the company has emphasized that the effort is not a response to any control deficiency but a proactive step to streamline and unify processes across the key support functions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all five functional areas (HR, IT, procurement, supply chain, finance) that are part of the initiative; (2) Accurately captures the multi-year timeline (2022-2024) and the evolution of the program; (3) Correctly emphasizes that the initiative is proactive, not reactive to control deficiencies - this critical distinction is maintained throughout; (4) Properly synthesizes the multi-hop information showing how the initiative evolved from initial introduction in 2022 through expansion in 2023-24; (5) Accurately describes the purpose (strengthen financial shared-service capabilities, simplify and standardize processes); (6) Correctly notes the alignment of financial controls with standardized workflows in later years. MINOR CONSIDERATIONS: The LLM answer uses slightly more interpretive language ('expanded in 2023-24 to align the design of financial controls with newly standardized workflows') compared to the ground truth's more measured statement that the company 'continued to align and streamline the design and operation of its financial control environment.' However, this represents a reasonable semantic interpretation rather than a factual error - the ground truth does support this characterization. The LLM answer is actually more specific about the mechanism of integration (controls aligned with workflows) while remaining faithful to the source material. NO QUANTITATIVE ERRORS: There are no numbers, dates, or calculations to verify, and all temporal references (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple functional domains, correctly showing progression and consistency of the initiative. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 509,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a broad acknowledgement of alternative payment mechanisms to a deliberate strategic emphasis on open‑banking, digital‑wallet and real‑time‑settlement technologies, integrating these innovations into its product roadmap and partnership model.  At the same time, competitive pressure intensified—driven by lower‑cost rivals, surcharge‑friendly merchants and proprietary digital‑wallet ecosystems—prompting the company to protect its discount revenue and membership value by differentiating its premium rewards, expanding merchant acceptance and making targeted investments in real‑time and open‑banking capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative arc and strategic evolution of American Express from 2022-2024. Key strengths: (1) Correctly identifies the shift from viewing alternative payment mechanisms as external threats to integrating them into strategic roadmap; (2) Accurately captures the three-year progression (2022 acknowledgment → 2023 expansion → 2024 strategic dependence); (3) Properly identifies specific technologies (open banking, digital wallets, real-time settlement) as central to the evolution; (4) Correctly synthesizes the dual dynamic of competitive pressure intensifying while AX simultaneously adopts these technologies. Quantitative accuracy is strong—no specific numbers, dates, or percentages are provided in either answer, so this dimension is neutral (9/10 reflects no errors detected). Qualitative accuracy is solid (7/10) with minor gaps: The LLM answer adds specific competitive details (lower-cost rivals, surcharge-friendly merchants, proprietary digital-wallet ecosystems, discount revenue protection) that enhance the answer but aren't explicitly in the ground truth, suggesting either inference or additional knowledge. The ground truth emphasizes the transformation from 'external threats' to 'essential components of technological roadmap'—the LLM captures this conceptually but uses slightly different framing ('deliberate strategic emphasis' vs. 'strategic dependence'). The LLM answer is more operationally detailed (mentions merchant acceptance, premium rewards differentiation) which adds value but represents a slight semantic shift from the ground truth's focus on the philosophical/strategic transformation. Contextual relevance is high (8/10)—the answer directly addresses all three dimensions of the question (competitive pressure, strategic adaptation, technological innovations) and maintains appropriate scope. Minor deduction because the LLM doesn't explicitly frame the 2023 expansion of alternative mechanisms to include open banking platforms as distinctly as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 559,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nAdobe’s use of Frame.io grew from a stand‑alone collaboration service in 2022 – where it was introduced as a cloud‑native platform tightly linked to Premiere Pro and After Effects – to a more deeply embedded component of the Creative Cloud ecosystem in 2023, adding frame‑accurate commenting, support for still images, PDFs and “Camera‑to‑Cloud” uploads, and broader integration with Photoshop, Lightroom and other Adobe apps – and finally to a core layer of Adobe’s enterprise‑focused content‑production suite in 2024, where Frame.io is offered together with Adobe Express and Firefly Services inside Adobe GenStudio to enable scalable, AI‑enhanced workflows.  \n\nThis progression signals Adobe’s strategy of positioning Frame.io as the collaborative backbone of its Creative Cloud and Digital‑Experience tools, unifying creation, review and publishing across the suite while layering generative‑AI capabilities and enterprise‑scale delivery.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth that warrant a below-average score. CORRECT ELEMENTS: (1) The answer correctly identifies Frame.io as a cloud-native platform; (2) Correctly mentions integration with Premiere Pro and After Effects; (3) Correctly identifies frame-accurate commenting as a feature; (4) Correctly mentions 2023-2024 expansion to Photoshop and Lightroom; (5) The overall strategic narrative about Frame.io becoming a collaborative backbone is directionally sound. CRITICAL ERRORS: (1) The LLM claims Frame.io was 'introduced as a cloud-native platform tightly linked to Premiere Pro and After Effects' in 2022, but the ground truth states it was merely 'listed among Adobe's trademarks' in 2022 - this misrepresents the 2022 positioning; (2) The LLM attributes features like 'support for still images, PDFs and Camera-to-Cloud uploads' to 2023, but the ground truth does not mention these specific features in its 2023 description; (3) The LLM introduces GenStudio, Adobe Express, and Firefly Services as 2024 developments, but the ground truth makes no mention of these integrations or GenStudio; (4) The ground truth emphasizes expansion into 'casting, location scouting, and marketing campaign management' in 2024, but the LLM completely omits these use cases; (5) The LLM's characterization of 2024 positioning around 'enterprise-focused content-production suite' and 'AI-enhanced workflows' goes beyond what the ground truth states. MULTI-HOP REASONING: The LLM attempts to synthesize a three-year progression but introduces information not present in the ground truth while omitting key details about specific workflow expansions. The reasoning about AI capabilities and GenStudio appears to be extrapolation rather than grounded in the provided knowledge graph. SEMANTIC ISSUES: While the overall strategic narrative is reasonable, the specific factual claims diverge significantly from the ground truth, particularly regarding what was emphasized in each year and which specific integrations/features were highlighted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 560,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nThe balance of Amazon’s 2017 unsecured senior notes fell from about **$16 billion at the end of 2022** to **$15 billion at the end of 2023** and further to **$13 billion by the end of 2024** (see Note 6‑DEBT tables for 2022‑2024).  This steady reduction shows that Amazon is deliberately retiring a portion of the 2017 issuance—using cash flow and newer debt issuances—to shorten the average maturity of its debt and take advantage of lower‑cost financing, reflecting a proactive debt‑management strategy that emphasizes deleveraging and extending the maturity profile of its long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024) match the ground truth exactly. The year-over-year progression is accurate ($1B reduction 2022-2023, $2B reduction 2023-2024). (2) ENTITY ACCURACY: Correctly identifies Amazon's 2017 Notes (unsecured senior notes), proper fiscal year references (December 31 for each year), and appropriate financial metric terminology. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the three-year progression and connects it to broader debt management strategy implications. (4) REASONING QUALITY: The LLM goes beyond the ground truth by providing additional strategic context - mentioning cash flow usage, newer debt issuances, maturity profile extension, and lower-cost financing advantages. This additional analysis is reasonable and consistent with typical corporate debt management practices, though not explicitly stated in the ground truth. (5) SEMANTIC EQUIVALENCE: The core message matches perfectly - consistent reduction indicating deliberate debt management strategy. The LLM's characterization of 'deleveraging' and 'proactive debt-management strategy' is semantically equivalent to the ground truth's 'deliberate debt management strategy to gradually pay down this liability.' Minor note: The LLM references 'Note 6-DEBT tables' which adds helpful sourcing detail. The only minor consideration is that the additional strategic interpretations (lower-cost financing, maturity profile extension) go slightly beyond what the ground truth explicitly states, but these are reasonable inferences from the data pattern and enhance rather than contradict the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 482,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nBoeing’s Global Services segment has consistently listed “upgrades and conversions” as one of its core service offerings from 2022 through 2024, but the way the narrative evolves is telling. In the 2022 and 2023 filings the phrase appears only as part of a broad service list, whereas the 2024 filing expands the language—highlighting “modifications and upgrades” alongside training, logistics and digital analytics and explicitly positioning them as a growth lever within the segment’s competitive strategy. This three‑year trajectory reveals Boeing’s shift toward making platform sustainment—extending the life of commercial and defense aircraft through upgrades and conversions—a strategic priority, aiming to capture higher‑margin service revenue and reduce reliance on new‑aircraft sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ACCURACY - The LLM answer makes specific claims about how the narrative 'evolves' across years that are NOT supported by the ground truth. The ground truth explicitly states the emphasis 'remained unchanged' across all three years (2022-2024), but the LLM claims the 2024 filing 'expands the language' and shows a 'shift toward making platform sustainment a strategic priority.' This is a fundamental contradiction of the ground truth. (2) UNSUPPORTED CLAIMS - The LLM introduces details not in the ground truth: 'modifications and upgrades' terminology, 'training, logistics and digital analytics,' 'explicitly positioning them as a growth lever,' and strategic intent to 'capture higher-margin service revenue and reduce reliance on new-aircraft sales.' These specific claims cannot be verified against the provided ground truth and appear to be fabricated or inferred beyond what the filings actually state. (3) MISINTERPRETATION OF TRAJECTORY - The ground truth indicates consistency and sustained focus ('remained unchanged'), while the LLM characterizes this as an 'evolution' and 'shift,' which misrepresents the actual pattern. (4) QUANTITATIVE ACCURACY - No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is neutral (7/10 for not introducing false metrics). (5) MULTI-HOP REASONING - The LLM failed to correctly synthesize the consistent pattern across three years; instead, it invented a narrative of change that contradicts the ground truth. The core finding—that 'Upgrades and Conversions' remained consistently present and unchanged—was not accurately captured. STRENGTHS: The LLM correctly identifies Boeing, the Global Services segment, the 2022-2024 timeframe, and the general concept of platform sustainment. However, these correct elements are overshadowed by the fundamental mischaracterization of how the emphasis evolved (or didn't evolve).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 524,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly reaffirmed the January 2021 announcement that, beginning January 1 2026, **all eligible U.S. non‑union employees—regardless of hire date—will earn pension benefits under the Retirement Value formula**, replacing the prior Final Average Pay formula for any service performed on or after that date (benefits accrued before 2026 remain under the old formula). The company communicated this transition in its annual reports and employee‑benefit notices, emphasizing that eligibility will be universal for non‑union U.S. staff and that the change will be phased so that only future service is calculated with the new formula.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key dates (January 2021 announcement, January 1, 2026 implementation), accurately states that the Retirement Value formula applies to all U.S. non-union employees regardless of hire date, and correctly notes that benefits accrued before 2026 remain under the old Final Average Pay formula. The numeric/date information is entirely accurate. WEAKNESSES: The LLM answer fails to address the critical evolution of the pension strategy across the three-year period (2022-2024). The ground truth emphasizes that the company's communication evolved: in 2022 it was vague, by 2023 it clarified that post-2014 hires were already under Retirement Value, and in 2024 the same language was repeated with no changes. The LLM answer presents the information as a static, consistent message across all years without capturing this temporal evolution or the clarification that occurred in 2023 about existing employee eligibility. The question specifically asks 'how did...evolve' - requiring analysis of changes over time - but the LLM treats it as a single unified statement. Additionally, the LLM doesn't clearly distinguish between employees already under the formula (post-2014 hires) versus those who will transition in 2026 (pre-2015 hires), which is a key distinction in the ground truth. The answer is factually accurate on the mechanics of the plan but incomplete in addressing the evolution and changing communication patterns that are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 415,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe carrying principal balance of AVGO’s 5.000% notes due April 2030 was $606 million in fiscal 2022, $606 million in fiscal 2023 and $606 million in fiscal 2024—essentially unchanged. This flat evolution shows the company is not actively repurchasing or refinancing this legacy fixed‑rate tranche, instead preserving it as a stable component of its capital structure while managing other, more flexible debt obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamentally incorrect financial data. According to the ground truth, AVGO's 5.000% notes due April 2030 had an outstanding principal balance of $1,086 million in fiscal 2022, NOT $606 million as stated in the LLM answer. The LLM incorrectly reports $606 million for fiscal 2022, when this figure only applies to fiscal 2023 and 2024. This is a major quantitative error that undermines the entire response. The LLM's claim that the balance was 'essentially unchanged' across all three years is factually incorrect—there was a significant $480 million reduction from FY2022 to FY2023 ($1,086M to $606M), which is a material debt repayment event. The LLM's interpretation that the company is 'not actively repurchasing or refinancing' this debt is contradicted by the actual $480 million principal reduction that occurred between FY2022 and FY2023. The ground truth explicitly states this 'indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy,' which the LLM completely missed. While the LLM correctly identifies that the balance remained flat from FY2023 to FY2024 at $606 million, this partial accuracy cannot offset the major error in FY2022 data and the mischaracterization of the company's debt management strategy. The multi-hop reasoning failed because the LLM did not correctly synthesize the year-over-year progression and therefore drew incorrect conclusions about debt management intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 422,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nFrom 2018 onward AT&T integrated Time Warner into a dedicated **WarnerMedia** segment, but the strategic relationship was reshaped in 2021‑2022 when AT&T agreed to combine WarnerMedia with Discovery and then executed a Reverse Morris‑Trust transaction in **April 2022** that spun the unit off as an independent public company (later named **Warner Bros. Discovery**).  The transaction was accounted for as **discontinued operations**, effectively divesting AT&T of its Time Warner assets, and the company subsequently focused on its core Communications business while the former WarnerMedia operations continued to be reported only in historical financial statements through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on key dates and facts but has notable gaps in completeness. CORRECT ELEMENTS: (1) The April 2022 Reverse Morris Trust transaction date is accurate; (2) The identification of Warner Bros. Discovery as the resulting entity is correct; (3) The characterization of the transaction as discontinued operations is accurate; (4) The focus shift toward core Communications business is correctly identified. GAPS AND ISSUES: (1) The LLM answer omits the 2024 DIRECTV divestiture, which the ground truth identifies as a significant final step in the strategic pivot away from entertainment; (2) The answer doesn't explicitly address the 2022-2024 timeframe evolution as comprehensively as the ground truth, which traces the journey from Time Warner as a key acquisition (2018) through its separation (2022) to final DIRECTV divestiture (2024); (3) The answer focuses heavily on the WarnerMedia/Discovery transaction but underemphasizes the broader strategic trajectory and the DIRECTV component that completed the exit from entertainment; (4) The phrase 'reported only in historical financial statements through 2024' is somewhat vague compared to the ground truth's clearer narrative of complete divestiture. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between Time Warner acquisition, WarnerMedia segment creation, and the Reverse Morris Trust separation. However, it fails to complete the full multi-hop chain by omitting the DIRECTV divestiture as the final piece of the strategic pivot. QUANTITATIVE ACCURACY: The April 2022 date is precise and correct. No calculation errors present. QUALITATIVE ACCURACY: The reasoning about discontinued operations accounting and strategic refocus is sound, but the narrative is incomplete regarding the full 2022-2024 evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 502,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nFrom 2022 through 2024 AIG upgraded its terrorism‑risk modelling – moving from a single‑scenario, third‑party vendor estimate (e.g., a $1.3 bn net loss for a five‑ton bomb in New York City) to a regularly‑updated, scenario‑based model that incorporates vendor‑gap adjustments and a range of attack modes.  At the same time the company broadened its reinsurance programme, adding targeted excess‑of‑loss covers and tapping government‑sponsored terrorism pools to supplement the TRIPRA backstop, and it refined the geographic attachment structure of those covers (e.g., reducing the Japan attachment point to $150 m while maintaining a $500 m retention for North‑American commercial business).  These changes collectively tighten loss‑scenario insight, improve reinsurance protection, and re‑allocate attachment points to match the evolving international exposure profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding geographic attachment points. Ground truth states Japan attachment of $200 million and rest of world of $125 million (2024). LLM claims Japan was 'reduced to $150m' and mentions '$500m retention for North-American commercial business' - neither of these figures appear in the ground truth and the Japan figure ($150m) directly contradicts the stated $200m. This is a major error for a question specifically asking about 'geographic attachment points.' PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies (1) the $1.3 billion five-ton bomb scenario for NYC, (2) the evolution from single-scenario to scenario-based modeling, (3) the role of TRIPRA, (4) participation in international terrorism pools, and (5) the general progression toward more sophisticated risk management. REASONING QUALITY: The LLM demonstrates sound multi-hop reasoning in synthesizing the evolution across three years and connecting scenario modeling, reinsurance, and geographic attachment points. The narrative arc from 'reactive modeling to proactive geographic risk segmentation' aligns with ground truth. COMPLETENESS ISSUES: While the LLM addresses all three sub-components (modeled loss scenarios, reinsurance protections, geographic attachment points), it introduces unverified details ($500m North American retention) not in ground truth and misrepresents the Japan attachment point. The answer reads plausibly but contains fabricated specificity. SEMANTIC EQUIVALENCE: The general characterization of evolution is semantically sound, but the specific numeric claims are factually incorrect, which is unacceptable for a financial question requiring precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 478,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nEmerson’s pipe‑working tool portfolio moved from the basic mechanical wrenches, cutters and threading gear described in the 2022 Tools & Home Products section (pages 7‑11) to a broader, higher‑value lineup that added battery‑hydraulic press tools and connected diagnostic systems—such as sewer‑inspection cameras and locating equipment—by 2023 (pages 71‑75) and continued to emphasize these technologically‑advanced, productivity‑enhancing solutions in 2024 (pages 71‑75).  This multi‑year progression shows Emerson is deliberately shifting the RIDGID‑branded professional‑tools business from commodity hand tools toward integrated, digitally‑enabled, higher‑margin offerings, positioning the company as a strategic leader in safety‑ and efficiency‑focused tools for the professional market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal progression from 2022 to 2024 with accurate characterization of each year's portfolio evolution; (2) Accurately captures the shift from traditional/mechanical tools (pipe wrenches, cutters, threading equipment, drain cleaners) in 2022 to battery-hydraulic and diagnostic technologies by 2023-2024; (3) Properly synthesizes the multi-hop information showing the strategic evolution toward digitally-integrated, higher-margin solutions; (4) Correctly identifies RIDGID as the brand associated with this portfolio evolution; (5) Accurately conveys the strategic positioning toward efficiency, safety, and technological integration; (6) No quantitative errors or date inaccuracies present. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page references (pages 7-11, 71-75) which are not present in the ground truth but add helpful sourcing detail without contradicting the core facts; (2) The LLM uses slightly more specific terminology (\"commodity hand tools,\" \"higher-margin offerings\") compared to the ground truth's more general language, but this represents appropriate elaboration rather than error; (3) The characterization of the strategic shift is semantically equivalent to the ground truth, with both emphasizing modernization and technological integration. The multi-hop reasoning is sound, correctly synthesizing information across the three-year period to demonstrate a coherent strategic narrative. All factual claims are accurate and well-supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 449,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco has applied the same straight‑line recognition rule for free‑rent and step‑rent periods in each of the 2022‑2024 filings – the waived rent is included in the lease‑term used to spread lease expense and to measure the right‑of‑use (ROU) asset at the present value of **all** future lease payments (even those that are temporarily waived).  The ROU asset is initially recorded at the discounted present value of the full lease payments (including any free‑rent periods) and is then amortized evenly over the entire lease term (including any extension options the company is reasonably certain to exercise).  While the wording was reiterated in 2023 and 2024 with minor clarifications (e.g., emphasizing extension options and noting impairment of leased assets), the underlying methodology and its effect on ROU‑asset valuation have remained unchanged across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a fundamental factual error regarding disclosure evolution. The ground truth explicitly states that detailed explanations of the discounting process and ARO treatment were provided in 2022 but 'was not repeated in the 2023 and 2024 filings,' indicating a DECREASE in disclosure depth. The LLM answer claims the opposite: 'the wording was reiterated in 2023 and 2024 with minor clarifications,' which directly contradicts the ground truth's core finding about disclosure maturation and reduced specificity over time. This is a major multi-hop reasoning failure on the primary evolution question. CORRECT ELEMENTS: (1) The LLM correctly identifies the straight-line recognition methodology applied consistently across 2022-2024; (2) Correctly notes that free-rent periods are included in lease-term calculations; (3) Correctly describes ROU asset valuation using discounted present value of future lease payments; (4) Correctly mentions extension options the company is reasonably certain to exercise. MISSING/INCORRECT ELEMENTS: (1) Fails to capture the key evolution: the shift from detailed disclosure (2022) to standardized ASC 842 language (2023-2024); (2) Mischaracterizes the disclosure pattern as 'reiterated' rather than 'decreased in depth'; (3) Does not address the 'maturation of lease accounting practices post-adoption period' that is central to the ground truth answer; (4) The phrase 'minor clarifications' obscures the actual finding that specificity decreased, not increased. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is less critical, but the temporal/chronological accuracy is compromised. REASONING QUALITY: The LLM demonstrates understanding of ASC 842 mechanics but fails at the comparative analysis across years, which is the core of the multi-hop question. The answer reads as a static description of methodology rather than an evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 533,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft’s 2.000 % note program, first created under the 2009 Base Indenture, was broadened in three successive steps: the 2022 tranche (maturing 2027) was added by the Eleventh Supplemental Indenture (Exhibit 4.14, filed Aug 8 2016 and reflected in the 2022 10‑K); a 2023 tranche (maturing 2030) followed in the Twelfth Supplemental Indenture (Exhibit 4.15, filed Feb 6 2017 and disclosed in the 2023 10‑K); and the 2024 tranche (maturing 2035) was introduced by the Fifteenth Supplemental Indenture (Exhibit 4.18/4.19, filed Nov 6 2023 and shown in the 2024 10‑K). Each addition amends the same Base Indenture, extending the series’ maturity schedule by roughly three years with every new issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. Specific errors: (1) The ground truth states the 2.000% Notes had a maturity of 2023 and were listed under the Eleventh Supplemental Indenture dated August 8, 2016. The LLM claims the 2022 tranche matures in 2027 - this is factually wrong. (2) The LLM invents a '2023 tranche (maturing 2030)' under the Twelfth Supplemental Indenture - the ground truth makes no mention of multiple tranches with different maturity dates or the Twelfth Supplemental Indenture being involved with 2.000% Notes. (3) The LLM claims a '2024 tranche (maturing 2035)' under the Fifteenth Supplemental Indenture - again, this is not supported by the ground truth. (4) The ground truth explicitly states the same note was 'still referenced under identical documentation' across all three years with no structural changes, while the LLM describes three separate issuances with different maturity dates. (5) The LLM's narrative of 'successive steps' and 'every new issuance' extending maturity by roughly three years is entirely fabricated and contradicts the ground truth's finding of consistency and stability. The LLM appears to have confused or conflated different debt instruments or misinterpreted the filing data. The core finding - that the 2.000% Notes due 2023 remained consistent across 2022-2024 under the same indenture framework - is completely absent from the LLM answer. This represents a fundamental failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 426,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon records revenue from third‑party seller services when the service is rendered—generally upon delivery of the seller’s product to a carrier or the customer—so the timing of recognition has remained the same from 2022 through 2024.  Over those years the mix of revenue shifted slightly toward a larger share of fulfillment fees (per‑unit or activity‑based charges) as the company expanded its logistics network, while commissions (a percentage of gross merchandise sales) stayed the dominant component; the composition of each (fixed versus variable, inclusion of shipping/handling fees) has been consistent, with commissions recognized as a % of sales and fulfillment fees recognized when the related shipping or storage service is performed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM states that 'the mix of revenue shifted slightly toward a larger share of fulfillment fees' and that the company 'expanded its logistics network' - these specific claims about compositional shifts are NOT present in the ground truth and appear to be fabricated. The ground truth explicitly states that specific changes in revenue recognition timing were NOT mentioned in 2024 disclosures. (2) OVERSTATED SPECIFICITY: The LLM provides detailed assertions about the relative dominance of commissions versus fulfillment fees and claims about how each is recognized, but the ground truth does not support these specific compositional claims or the assertion that fulfillment fees grew as a share. (3) INCOMPLETE GROUNDING: While the LLM correctly identifies that revenue is recognized upon delivery/service rendering (matching ground truth), it goes beyond what the ground truth supports by making claims about shifts in composition and the reasons for those shifts. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024, and while the LLM attempts to address this, it does so by making unsupported inferences rather than synthesizing actual disclosed information. The ground truth shows increasing clarity in disclosures but does NOT show compositional shifts. (5) FACTUAL ACCURACY: The timing of recognition (upon delivery to carrier or customer) is correct and matches ground truth, but this represents only a small portion of the answer, and the majority of the LLM's claims about compositional evolution are not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 469,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s decision to keep guaranteeing Southwestern Bell Telephone’s obligations through 2022‑2024 shows that it is deliberately retaining exposure to legacy telecom liabilities on the parent’s balance sheet, using AT&T’s stronger credit position to back those commitments rather than letting them remain on the divested entities.  This reflects a long‑term liability‑management strategy that centralizes and stabilizes legacy obligations, preserving cash flow and credit metrics while allowing the spun‑off units to operate independently.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year period (2022-2024) and the core entities (AT&T and Southwestern Bell Telephone Co.). (2) No factual errors regarding dates or specific numbers. (3) The answer acknowledges the persistence of the guarantee across the three-year period. CRITICAL WEAKNESSES: (1) The LLM introduces unsupported interpretations not present in the ground truth. Specifically, it claims AT&T is 'deliberately retaining exposure' and using 'AT&T's stronger credit position to back those commitments' - these are inferences not grounded in the filing evidence. (2) The LLM speculates about 'divested entities' and 'spun-off units' operating independently, which is not mentioned in the ground truth and may be factually incorrect regarding Southwestern Bell's actual corporate structure. (3) The claim about 'preserving cash flow and credit metrics' is speculative reasoning not supported by the filings themselves. (4) The ground truth emphasizes what the guarantee DOES NOT show (no reduction or restructuring), while the LLM focuses on what it DOES show (centralization and stabilization) - a subtle but important distinction. The ground truth is more cautious and evidence-based, while the LLM overreaches with interpretations. MULTI-HOP REASONING: The LLM attempts to synthesize information about liability management strategy but does so by adding interpretive layers not present in the source material. The ground truth sticks to observable facts from the filings (repeated guarantee language, unchanged commitment), while the LLM extrapolates motivations and strategic implications. SEMANTIC EQUIVALENCE: While both answers discuss AT&T's strategy for managing legacy telecom liabilities, they differ significantly in their conclusions. The ground truth says the guarantee shows 'stable strategy' with 'no indication of reduction,' while the LLM claims it shows 'deliberate retention' and 'centralization' - these are different strategic characterizations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 538,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of Johnson & Johnson’s 2.250 % Notes due 2050 that remained on the balance sheet fell steadily—from about **$983 million in 2022 to $826 million in 2023 and then to $808 million in 2024** (carrying‑value figures shown in the debt‑schedule tables).  This gradual reduction shows that the company is intentionally trimming its exposure to that long‑dated, fixed‑rate tranche, using the proceeds (or simply re‑balancing the portfolio) to manage interest‑rate risk, preserve liquidity and fund newer, lower‑cost or more flexible financing alternatives as part of its long‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: $983 million (2022), $826 million (2023), and $808 million (2024) match the ground truth exactly. The note rate (2.250%) and maturity date (2050) are accurate. The multi-hop synthesis is sound—the answer correctly identifies the three-year progression and interprets it as a deliberate strategy. The LLM provides slightly more detailed strategic interpretation than the ground truth, mentioning 'interest-rate risk management,' 'liquidity preservation,' and 'newer, lower-cost or more flexible financing alternatives,' which are reasonable inferences from the data pattern but go slightly beyond what the ground truth explicitly states. The ground truth mentions a 'fixed effective rate of 2.29%' which the LLM does not include, though this is a minor omission. The characterization of the decline as 'gradual' and 'intentional' aligns well with the ground truth's description of 'consistent presence' and 'cautious approach.' The answer correctly identifies this as part of long-term capital structure strategy. No calculation errors are present. The reasoning about why the company might be reducing exposure (managing risk, funding alternatives) is logical and appropriate, though somewhat speculative beyond the data provided. Overall, this is a high-quality answer with accurate numbers, sound multi-hop reasoning, and appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 403,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.25 billion 1.375% Senior Notes due June 2027 stayed on Costco’s balance sheet unchanged (carrying amount $1,250 million in both 2023 and 2024) and comprised the bulk of the $2.25 billion of long‑term debt maturing in 2027.  During this period the company retired higher‑coupon senior notes—most notably the $1 billion 2.75% notes in May 2024—while keeping the low‑cost, long‑dated 1.375% notes as a stable funding source, revealing a capital‑management strategy that emphasizes low‑interest financing, maturity extension, and preserving cash for shareholder returns rather than frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 1.375% Senior Notes due June 2027 remained constant at $1,250 million across 2022-2024, matching the ground truth. The answer appropriately characterizes Costco's capital management strategy as emphasizing low-interest financing and selective debt retirement. The mention of retiring the $1 billion 2.75% notes in May 2024 adds relevant context about the company's approach to managing higher-coupon debt. The semantic interpretation of the strategy (preserving low-cost debt while retiring higher-coupon obligations) aligns well with the ground truth's conclusion about selective capital management.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to provide the total long-term debt figures for 2022, 2023, and 2024 ($6,590M, $6,484M, and $5,919M respectively), which are essential to demonstrating the 'gradual reduction in overall debt burden' mentioned in the ground truth. This is a significant multi-hop synthesis gap. (2) The LLM states the notes comprised 'the bulk of the $2.25 billion of long-term debt maturing in 2027' but doesn't verify this claim against the ground truth data. (3) The answer doesn't explicitly show the year-over-year debt reduction trend that the ground truth emphasizes as revealing about capital management strategy.\n\nQUANTITATIVE VERIFICATION: The $1,250 million figure is correct. The $1 billion 2.75% notes retirement in May 2024 appears to be accurate contextual information. However, the absence of total debt figures ($6,590M→$6,484M→$5,919M) represents incomplete quantitative analysis for a question specifically asking about debt structure evolution.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the stable 1.375% notes to the retirement of higher-coupon debt and inferring strategic intent. However, it fails to complete the full multi-hop analysis by not synthesizing the total debt reduction across the three-year period, which is crucial to understanding the complete capital management picture.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on capital management strategy and provides relevant supporting details about debt retirement patterns. The interpretation of strategy (low-cost financing, maturity extension, shareholder returns) is contextually sound and aligns with the ground truth's assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 636,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard expanded its real‑time payments stack—adding real‑time account‑based ACH rails in additional markets, scaling Mastercard Send and cross‑border “Alias‑Based” remittances, and processing a growing share of transactions in China via its joint‑venture—while at the same time deepening its multi‑layered security framework.  The company broadened its Security Operations Centers, Fusion Centers and AI‑driven fraud‑scoring and tokenization services, tightened API and data‑privacy governance, and formalized ecosystem‑wide standards (EMV, VCN controls, settlement‑exposure guarantees) to protect the faster, higher‑volume flows.  This parallel evolution shows that Mastercard is deliberately coupling infrastructure growth with reinforced, proactive risk controls, using a coordinated security‑by‑design approach to keep the expanded global payment network both scalable and resilient.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The ground truth provides specific numbers (12 markets in 2021, 13 markets in 2023) that the LLM completely omits. The LLM vaguely references 'several countries' without the documented progression. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not in the ground truth including 'real-time account-based ACH rails,' 'Mastercard Send,' 'Alias-Based remittances,' 'China joint-venture,' 'Security Operations Centers,' 'Fusion Centers,' 'AI-driven fraud-scoring,' 'tokenization services,' 'API governance,' 'EMV,' 'VCN controls,' and 'settlement-exposure guarantees.' These appear to be hallucinated details not present in the original filing data. (3) MULTI-HOP REASONING FAILURE: The ground truth explicitly states 'the filings do not explicitly state that security measures directly enabled infrastructure expansion,' yet the LLM claims Mastercard is 'deliberately coupling infrastructure growth with reinforced, proactive risk controls' and uses 'security-by-design approach'—this overstates the causal relationship beyond what the filings support. (4) MISSING KEY FACTS: The LLM fails to mention the documented progression from 12 to 13 markets, the shift from quantitative to qualitative language ('several countries'), or the emphasis on third-party assessments and partnerships mentioned in the ground truth. (5) SEMANTIC DRIFT: While the LLM's general theme about parallel evolution is directionally correct, the specific implementation details are fabricated, making the answer fundamentally unreliable. The answer reads as plausible but is largely unsupported by actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 480,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Microsoft repeatedly amended its 2009 indenture with supplemental indentures—most notably the Twelfth supplemental indenture (February 2017) and the Fifteenth supplemental indenture (November 2023)—that added new tranches of the 4.000% Notes due 2021 and extended the series’ maturity schedule. This pattern shows that the company is using a rolling, long‑dated debt strategy, continually issuing fresh low‑cost notes under the same indenture to diversify maturities and lock in financing costs while maintaining a stable, long‑term capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) WRONG SUPPLEMENTAL INDENTURES: The LLM claims the 'Twelfth supplemental indenture (February 2017)' and 'Fifteenth supplemental indenture (November 2023)' were the most notable, but the ground truth specifically identifies the 'Third Supplemental Indenture' as listed in the 2022 10-K. The LLM provides incorrect indenture numbers and dates with no supporting evidence. (2) WRONG INTERPRETATION OF ISSUANCE PATTERN: The LLM claims Microsoft 'continually issuing fresh low-cost notes' and 'added new tranches of the 4.000% Notes due 2021,' but the ground truth explicitly states 'no structural changes' occurred across 2022-2023, and the notes were already past maturity by 2024. The LLM mischaracterizes the pattern as active new issuances when the ground truth indicates consistent disclosure of the same instrument. (3) INCORRECT DEBT STRATEGY CHARACTERIZATION: The LLM describes a 'rolling, long-dated debt strategy' with 'fresh low-cost notes' and 'extended maturity schedule,' but the ground truth indicates the pattern reflects 'consistent and transparent approach to debt disclosure, even post-maturity' with 'disciplined long-term debt management'—not active new issuances. (4) FACTUAL INACCURACY ON MATURITY: The ground truth notes the 4.000% Notes due 2021 were past their maturity date by 2024, yet the LLM suggests ongoing issuance and maturity extension, which is contradictory. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the exhibit references across the three fiscal years and misinterpreted what consistent disclosure means versus active new issuances. The answer demonstrates fundamental misunderstanding of the question and provides fabricated supplemental indenture details not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 505,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon repeatedly cites the 1.500 % senior unsecured note that matures in 2030 across its 2020‑2024 filings, signaling that this low‑coupon, long‑dated debt is a cornerstone of its financing plan. By featuring the same 2030 note alongside higher‑coupon issues (e.g., 2.6 % 2019, 3.3 % 2021, 4.8 % 2034, etc.), Amazon is laddering maturities and locking in cheap, long‑term funding, underscoring a capital‑structure strategy that emphasizes stable, low‑cost debt and extends the average tenor of its borrowings relative to its other debt instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) TIMELINE DISCREPANCY: LLM claims the 1.500% Note due 2030 appears across 2020-2024 filings, but ground truth explicitly states it was 'introduced' in 2022 and referenced in 2022, 2023, and 2024 filings only. The LLM's claim of 2020-2024 presence is factually incorrect. (2) INCORRECT COUPON RATES: LLM cites '2.6% 2019, 3.3% 2021, 4.8% 2034' as comparative instruments, but ground truth references '4.700% Note due 2024' and '4.700% Note due 2032' as the key comparisons. The specific rates and years cited by LLM do not match the ground truth examples. (3) INCOMPLETE SYNTHESIS: Ground truth provides specific year-by-year analysis (2022 introduction with 2060 instruments, 2023 alongside 4.700% due 2024, 2024 alongside 4.700% due 2032), showing deliberate evolution of strategy. LLM provides generic statements about laddering without this temporal specificity. (4) MISSING CONTEXT: Ground truth emphasizes the strategic shift from 2022 (favorable terms locked in) through 2024 (adapting to current market rates), showing dynamic capital management. LLM treats it as static strategy. (5) CORRECT ELEMENTS: LLM correctly identifies the 1.500% as low-coupon, long-dated debt and correctly characterizes the strategy as maturity laddering and locking in cheap funding. The semantic understanding of the strategy is partially correct, but the factual foundation is compromised by timeline and specific instrument errors. The quantitative accuracy is particularly weak due to incorrect coupon rates and years cited.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 424,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T kept its 41.3 % stake in SKY Mexico and continued to account for it under the equity‑method (the same treatment it adopted after the 2021 Vrio disposal). In June 2024 it sold the entire interest, generating cash and a gain that removed the investment from its balance sheet. This exit follows AT&T’s wider pattern of shedding non‑core international pay‑TV holdings and reallocating capital to its core U.S. operations and shareholder‑return priorities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 41.3% ownership stake, the equity method accounting treatment, the June 2024 sale timing, and the strategic rationale (shedding non-core international pay-TV assets). All numeric values and dates are accurate. The answer correctly notes the connection to the 2021 Vrio disposal and the broader divestiture strategy. WEAKNESSES: The answer lacks temporal granularity compared to ground truth. Ground truth explicitly documents the 2022 ownership stake, 2023 equity method treatment, and 2024 exit as distinct phases showing 'phased approach.' The LLM conflates these into a more compressed narrative ('kept...and continued to account for it...then sold'), which obscures the year-by-year evolution that the question specifically asks about. The LLM states AT&T 'kept its 41.3% stake...and continued to account for it under the equity-method' from 2022-2024, but ground truth indicates this was the status in 2022-2023, with the exit occurring mid-2024. This is a subtle but meaningful difference in how the 3-year trajectory is presented. CALCULATION/NUMBERS: All quantitative data (41.3%, June 2024, equity method) are correct. MULTI-HOP REASONING: The answer successfully synthesizes the ownership stake, accounting treatment, and strategic exit, but doesn't fully capture the three-year progression as distinct phases. The connection to Vrio (2021) is mentioned but not integrated into the broader 3-year narrative arc. SEMANTIC EQUIVALENCE: The core message about strategic divestiture and capital reallocation is conveyed, though with less temporal specificity than ground truth. The answer is factually sound but somewhat compressed in its treatment of the evolution question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 472,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nFrom 2022 through 2024 AIG’s glide‑path trimmed the equity‑weight target for its U.S. pension plan from **≈15 % (2022 target) to 9 % (2023‑2024 targets)**, while expanding the fixed‑maturity share from **≈75 % to 80 %** and modestly adjusting the “other” bucket.  This systematic shift—reducing growth‑oriented assets and increasing liability‑hedging fixed‑income holdings—mirrors the plan’s improving funded ratio, showing that AIG is deliberately de‑risking the portfolio as the plan becomes more fully funded.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core de-risking strategy and demonstrates sound understanding of the glide path evolution and liability-driven investing principles. The qualitative reasoning about AIG's methodical adjustment in response to improving funded status is accurate and well-articulated. However, there are significant quantitative accuracy issues that prevent a higher score: (1) The specific equity allocation percentages (≈15% for 2022, 9% for 2023-2024) and fixed-maturity percentages (≈75% to 80%) are presented with confidence but cannot be verified against the ground truth, which does not provide these specific numerical targets. (2) The ground truth emphasizes that each year's target allocation was based on the funded status at year-end of the prior year (2022 target based on Dec 31, 2021 funded status; 2024 target based on Dec 31, 2023 funded status; 2025 target based on Dec 31, 2024 funded status), but the LLM answer does not explicitly address this important temporal relationship between funded status measurement and target allocation setting. (3) The LLM answer conflates the 2023 and 2024 targets as having the same equity allocation (9%), which may or may not be accurate. The answer demonstrates strong conceptual understanding of the de-risking strategy and correctly identifies the progression from growth assets to liability-hedging assets, but the introduction of specific percentages without clear sourcing and the omission of the funded-status-timing relationship represent material gaps in addressing the full complexity of the question. The answer would benefit from either providing verifiable percentages or acknowledging uncertainty about specific allocation figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 469,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard expanded its credit‑risk controls—requiring larger cash‑collateral and guarantee arrangements and repeatedly refining its exposure‑measurement methodology—to reflect the surge in litigation, regulatory probes (FTC, DOJ, UK PSR, European Commission) and the resulting increase in settlement exposure.  The growing size of its risk‑mitigation reserves and the continual adjustment of its risk‑management standards demonstrate a proactive, adaptable framework that scales controls and financial buffers in step with evolving legal and compliance pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core theme of Mastercard's evolving credit risk mitigation strategies from 2022-2024 and accurately names several regulatory bodies (FTC, DOJ, European Commission). It appropriately characterizes the company's approach as 'proactive' and 'adaptable.' The semantic understanding of the question is sound. CRITICAL WEAKNESSES: (1) FACTUAL ERRORS - The LLM introduces 'UK PSR' (UK Payment Systems Regulator) which is NOT mentioned in the ground truth and appears to be an unsupported claim not verifiable from the filing data. This is a significant factual error. (2) UNSUBSTANTIATED CLAIMS - The LLM states Mastercard 'expanded its credit-risk controls—requiring larger cash-collateral and guarantee arrangements' but the ground truth explicitly states the framework remained 'consistent' from 2022-2024. The ground truth does NOT support claims of 'expanding' or 'larger' collateral requirements. (3) MISSING KEY DETAILS - The LLM fails to mention specific 2023-2024 regulatory events that are central to the ground truth: the FTC's finalized consent agreement (2023), DOJ antitrust investigation into U.S. debit program (2023), U.S. Liability Shift Litigation (2024), and European Commission investigation into anti-competitive behavior (2024). (4) UNVERIFIED QUANTITATIVE CLAIMS - The LLM references 'growing size of its risk-mitigation reserves' without providing any actual numbers or evidence from filings. The ground truth makes no such claim about reserve growth. (5) INCOMPLETE SYNTHESIS - While the LLM mentions regulatory pressures, it fails to synthesize the specific timeline and progression of events across the three-year period that the ground truth clearly documents. (6) CONTRADICTORY CHARACTERIZATION - The ground truth emphasizes that despite escalating external risks, Mastercard 'consistently reported a low level of losses from customer settlement failures,' demonstrating effectiveness. The LLM's framing of 'surge in litigation' and 'resulting increase in settlement exposure' is not clearly supported and potentially misrepresents the actual risk profile. QUANTITATIVE ACCURACY: Score of 3 due to lack of specific numbers and introduction of unverified regulatory entities. QUALITATIVE ACCURACY: Score of 6 because while the general framework is understood, the specific regulatory timeline, the consistency (not expansion) of core strategies, and the effectiveness of existing controls are mischaracterized or omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 662,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the pool of shares that could still be granted under The Home Depot’s Omnibus Stock Incentive Plan fell sharply – the company reported roughly **117 million shares available for future grant at the end of 2022**, about **77 million shares available as of the end of 2023** (the 2024 filing), and **≈70 million shares available as of early 2025** (the 2025 filing).  \n\nThis steady reduction shows that Home Depot is exhausting its reserved share reserve and is using an ever‑larger portion of the shares already authorized for equity awards rather than seeking additional shareholder approval to expand the pool.  \n\nThe trend signals a **more conservative equity‑compensation strategy**: the firm is deliberately limiting future dilution, relying on the existing authorized shares to fund stock‑based compensation while directing capital toward share‑repurchase programs and cash returns to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three key share availability figures (117M for 2022, 77M for 2023, 70M for 2024) and accurately captured the declining trend. The numeric data matches the ground truth precisely. The answer properly addresses the multi-hop synthesis requirement by tracking the evolution across three fiscal years.\n\nWEAKNESSES: (1) INTERPRETATION ERROR - The LLM characterizes the trend as signaling a 'more conservative equity-compensation strategy' and suggests the company is 'deliberately limiting future dilution' and 'relying on existing authorized shares.' This contradicts the ground truth interpretation. The ground truth states the reduction 'suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives.' The LLM's interpretation inverts the meaning - a declining share pool due to active issuance indicates INCREASED use of equity compensation, not conservation. (2) INCOMPLETE CONTEXT - The LLM adds speculation about 'share-repurchase programs and cash returns to shareholders' that is not supported by the ground truth answer and may be misleading about the company's actual strategy. (3) REASONING FLAW - The LLM conflates 'exhausting the share reserve' with 'conservative strategy,' when the ground truth suggests the opposite: active depletion indicates aggressive use of equity incentives. The LLM correctly identifies that shares are being used but misinterprets what this means for compensation strategy.\n\nMULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three fiscal years and correctly tracks the numerical progression. However, the logical conclusion drawn from this synthesis is fundamentally misaligned with the ground truth interpretation.\n\nNUMERIC VERIFICATION: All three share counts are accurate (117M, 77M, 70M). The trend direction is correctly identified as declining. No calculation errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 530,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nBroadcom’s 3.625% senior notes that matured in October 2024 had a carrying amount of $622 million at the close of fiscal 2023, but by the end of fiscal 2024 the balance was $0 because the notes matured and were fully repaid using proceeds from the $5 billion senior‑note issuances in July and October 2024 together with cash on hand.  This repayment reflects Broadcom’s proactive debt‑management approach of retiring near‑term obligations and replacing them with longer‑dated financing to extend its maturity profile and preserve liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial data and debt management strategy. STRENGTHS: (1) Correctly identifies the $622 million carrying amount for fiscal 2023, matching ground truth; (2) Accurately reports the $0 balance in fiscal 2024, confirming full repayment; (3) Correctly identifies October 2024 maturity date; (4) Provides additional context about the $5 billion senior note issuances in July and October 2024 used for refinancing, which adds valuable detail not in ground truth but is factually accurate; (5) Demonstrates sound multi-hop reasoning by connecting the debt repayment to the refinancing strategy; (6) Appropriately characterizes this as proactive debt management with focus on extending maturity profile. MINOR GAPS: (1) Does not explicitly mention fiscal 2022 data ($622 million), though the question asks about evolution across 2022, 2023, and 2024. The ground truth specifically notes that the 2022 amount was $622 million and remained unchanged in 2023, providing a complete three-year progression. The LLM only addresses 2023 and 2024; (2) The LLM provides more specific refinancing details (the $5 billion issuances and timing) than ground truth, which is supplementary but not explicitly verified against the original knowledge graph. QUANTITATIVE VERIFICATION: The $622 million figure is correct, the $0 balance is correct, and the October 2024 date is correct. The $5 billion refinancing amount appears accurate based on typical Broadcom disclosures. REASONING QUALITY: The multi-hop synthesis is sound - connecting the maturity event to the refinancing strategy and liquidity preservation. The answer correctly interprets the progression as indicating deliberate debt management. The omission of fiscal 2022 data prevents a complete three-year analysis as requested, but the core narrative about debt management strategy is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 524,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T transformed its Time Warner relationship from a 2018 acquisition that created the WarnerMedia entertainment unit, to a 2021‑2022 plan to carve the unit out through a Reverse Morris Trust transaction with Discovery (placing WarnerMedia into discontinued operations), and finally to an outright exit by agreeing in September 2024 to sell its remaining stake in DIRECTV to TPG, thereby divesting the last entertainment‑related assets. This progression shows AT&T’s deliberate shift away from a diversified media‑entertainment portfolio and toward a focused strategy on core telecommunications services—5G, fiber‑based broadband, and mobility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the strategic evolution. STRENGTHS: (1) Correctly identifies the 2018 Time Warner acquisition and WarnerMedia creation; (2) Accurately references the Reverse Morris Trust transaction with Discovery (though dates slightly compressed); (3) Correctly identifies the September 2024 DIRECTV sale to TPG as the final exit; (4) Properly synthesizes the multi-hop progression across 2022-2024; (5) Accurately characterizes the strategic shift from diversified media-entertainment to focused telecommunications; (6) Correctly identifies the core telecom focus areas (5G, fiber broadband, mobility). MINOR ISSUES: (1) The LLM states the RMT plan was '2021-2022' while ground truth indicates completion in 2023—this is a slight temporal imprecision, though the LLM does acknowledge the transaction occurred and WarnerMedia was placed in discontinued operations; (2) The answer could have been more explicit that the 2023 completion date was when the separation was finalized, not just planned. QUANTITATIVE ACCURACY: All dates and entities are correct or acceptably close (2018 acquisition, 2023 separation completion, September 2024 DIRECTV sale). No dollar amounts were required for this question. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across multiple years and transactions, properly identifying this as a strategic reversal from the original Time Warner acquisition strategy. The characterization of the progression as 'deliberate shift' is well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the multi-part question: integration (2018 acquisition), divestiture planning (RMT with Discovery), final exit strategy (DIRECTV sale), and what this reveals about shifting focus. The answer appropriately emphasizes the strategic reversal and refocus on core telecom.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 513,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nEmerson re‑positioned its Pipe Cutters from a stand‑alone mechanical tool into a digitally‑connected, battery‑powered solution that is now bundled with diagnostic functions (e.g., CCTV pipe‑inspection and locating sensors) within the Safety & Productivity segment.  This evolution is reflected in the segment’s growing earnings—$250 M in 2022, $306 M in 2023 and $308 M in 2024—and in the company’s emphasis on battery‑hydraulic tools and integrated diagnostic systems to boost productivity and safety, as highlighted in the segment descriptions for 2022‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core strategic evolution of Pipe Cutters from standalone tools to battery-powered, digitally-connected solutions with integrated diagnostics. The semantic understanding of the product line's transformation is sound, and the mention of CCTV pipe-inspection and locating sensors aligns with the ground truth's reference to 'sewer inspection cameras.' The answer appropriately identifies the Safety & Productivity segment and emphasizes the integration of diagnostic systems.\n\nCRITICAL WEAKNESSES: The LLM introduces specific financial figures ($250M in 2022, $306M in 2023, $308M in 2024) that are NOT present in the ground truth answer. These numbers appear to be segment earnings but are presented without verification against the actual SEC filings. This is a significant problem because: (1) the question does not ask for financial metrics, (2) the ground truth makes no mention of these specific dollar amounts, and (3) introducing unverified numbers violates the strict requirement for quantitative accuracy in financial analysis. The LLM appears to have fabricated or hallucinated these figures.\n\nMULTI-HOP REASONING: The LLM attempts to connect product evolution with financial performance, which is a reasonable inference but goes beyond what the ground truth establishes. The ground truth focuses purely on product positioning evolution (2022: standalone → 2023: battery-hydraulic integration → 2024: ecosystem with diagnostics), not on financial metrics.\n\nCOMPLETENESS: The answer addresses the core question about product line evolution and integration with battery technologies and diagnostic systems. However, it adds unsupported financial data that dilutes the response's credibility.\n\nNUMBER VERIFICATION: The financial figures cannot be verified against the ground truth and appear to be either hallucinated or sourced from unverified data. This is a critical failure for a financial analysis task.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 531,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly describe a **multi‑year, enterprise‑wide initiative to integrate, simplify and standardize the Company’s HR, IT, procurement, supply‑chain and finance processes**—explicitly framing these upgrades as growth‑driven enhancements to its **financial shared‑service capabilities** and as a means to **align and streamline the design and operation of its financial control environment**.  The language appears in each year’s “Changes in Internal Control Over Financial Reporting” section, indicating that the program was launched in 2022, continued unabated in 2023, and was further emphasized in 2024 as a core strategic effort.  This consistent focus reveals that J&J is **prioritizing financial‑process standardization** to improve efficiency, scalability and control across its finance function rather than reacting to any control deficiencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the multi-year enterprise-wide initiative spanning 2022-2024, accurately captures the core focus on integrating, simplifying, and standardizing processes across finance and other functions, and properly emphasizes the financial shared service capabilities enhancement. The answer correctly notes that this was framed as growth-driven rather than reactive to control deficiencies, matching the ground truth. The identification of the 'Changes in Internal Control Over Financial Reporting' section as the source is accurate and demonstrates proper document synthesis. The timeline (launched 2022, continued 2023, emphasized 2024) is correct.\n\nWEAKNESSES: The LLM answer introduces additional functions (HR, IT, procurement, supply-chain) that, while potentially accurate from the filings, are not explicitly mentioned in the ground truth answer. The ground truth specifically states 'key functions including finance' without enumerating other departments. This represents a minor expansion beyond what the ground truth validates. The LLM answer also uses slightly different framing ('launched in 2022, continued unabated in 2023') versus the ground truth's more nuanced description of how the initiative was described in each year ('described in 2022,' 'reiterated in 2023,' 'maintained in 2024'). The ground truth emphasizes the consistency of messaging about the initiative's purpose and strategic importance, while the LLM answer focuses more on the breadth of functions affected.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the pattern of consistent emphasis on the initiative. The logical conclusion about J&J's strategic prioritization of financial process standardization is sound and well-supported.\n\nNUMERIC/DATE ACCURACY: All dates (2022, 2023, 2024) are correct. No calculations are required for this question.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - a multi-year commitment to process standardization and financial control environment improvement, not reactive to deficiencies. The emphasis on strategic focus and operational efficiency matches the ground truth's conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 601,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the Executive Health Plan is consistently presented as Exhibit 10.1* with the identical description and original filing date (first filed in 2012), and no amendment or change in filing status appears in the disclosed pages. This continuity shows that the health‑plan benefit is a permanent element of Costco’s executive‑compensation framework, reflecting a stable, long‑term strategy for senior‑executive health coverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about Costco's Executive Health Plan disclosures across fiscal years 2022-2024. STRENGTHS: (1) All key dates are correct - the original filing date of October 19, 2012 and Period Ended date of September 2, 2012 are accurately referenced; (2) The fiscal year range (2022, 2023, 2024) is correctly identified; (3) The exhibit designation (Exhibit 10.1*) is accurate; (4) The core finding that there were no amendments or changes during the three-year period is correctly stated; (5) The multi-hop synthesis is sound - the answer correctly combines information about consistency across multiple years to draw a conclusion about long-term strategy stability. QUANTITATIVE ACCURACY: Perfect - all dates and references are factually correct with no calculation errors. QUALITATIVE ACCURACY: The reasoning is sound and the interpretation that consistency indicates a stable, long-term strategy is logically valid and matches the ground truth's conclusion. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'permanent element' vs. 'no material updates') but the semantic meaning is equivalent and actually enhances clarity. The answer appropriately emphasizes that the plan represents a stable executive compensation framework. No factual errors, omissions of key information, or calculation mistakes are present. The answer fully addresses both parts of the question: how disclosures evolved (consistently, with no changes) and what this indicates about strategy (stability and permanence).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 443,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 the description of Mastercard’s Class A shares was unchanged: each Class A share carries **one vote** and **dividend rights** (i.e., it participates in any cash dividend declared), with the same $0.0001 par value and authorized share count.  This steady‑state structure shows that Mastercard’s shareholder‑governance strategy is deliberately conservative—maintaining a simple, predictable voting and dividend framework that preserves equal shareholder influence and a stable ownership base without introducing new rights or restrictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) Correctly identifies that MA's Class A shares maintained identical dividend and voting rights across 2022-2024 (one vote per share, standard dividend rights); (2) Accurately notes the $0.0001 par value and authorized share count remained unchanged; (3) Properly synthesizes the multi-hop requirement by comparing governance across three years; (4) Correctly interprets the consistency as revealing a 'stable and unchanging' or 'deliberately conservative' governance strategy; (5) All numeric values are accurate with no calculation errors. MINOR CONSIDERATIONS: (1) The LLM adds slightly more detail than the ground truth (par value, authorized share count) which is supplementary and accurate rather than contradictory; (2) The characterization as 'deliberately conservative' and 'preserves equal shareholder influence' goes slightly beyond the ground truth's simpler statement of 'stable and unchanging' but is a reasonable and supportable inference from the facts; (3) The semantic meaning is fully equivalent—both answers convey that rights remained constant across the period and this reflects a stable governance approach. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across three fiscal years and drawing appropriate conclusions about governance strategy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 389,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nAcross fiscal 2022‑2024 the Security Insights Platform progressed from a basic, SIEM‑compatible engine that merely identified risks and generated remediation steps, to a more tightly‑woven solution that embeds AI‑driven risk scoring and automated remediation workflows. Each successive year added broader connectivity to Broadcom’s internal security toolchain—expanding integration with in‑house security information and event management, threat‑intelligence and analytics platforms—so that by 2024 the platform not only identified risks more comprehensively but also drove proactive, automated mitigation across the organization’s security ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FABRICATED FEATURES: The LLM claims the platform evolved to include 'AI-driven risk scoring,' 'automated remediation workflows,' and 'proactive, automated mitigation' - none of these features are mentioned in the ground truth. The ground truth explicitly states the platform maintained 'stable functionality' and 'consistent integration' across the three years, not progressive enhancement with new AI/automation capabilities. (2) MISCHARACTERIZED EVOLUTION: The LLM describes a progression from 'basic' to 'tightly-woven solution,' but the ground truth indicates the platform's description remained essentially the same across all three years, suggesting maturity rather than evolution. (3) OVERSTATED INTEGRATION: The LLM claims 'broader connectivity' and 'expanding integration with in-house security information and event management, threat-intelligence and analytics platforms' - the ground truth only mentions consistent integration with 'in-house tools for security information and event management' with no indication of expansion or broader connectivity. (4) CONTRADICTS GROUND TRUTH: The ground truth explicitly states 'stable functionality and consistent integration with in-house tools over the three-year period,' directly contradicting the LLM's narrative of progressive enhancement and expanding capabilities. The LLM appears to have invented a product evolution narrative that does not exist in the source material, representing a fundamental failure to accurately synthesize the multi-hop information across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 457,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 through 2024 AIG shifted its reserve‑ adequacy testing from largely deterministic actuarial calculations toward increasingly stochastic and scenario‑based models that incorporate catastrophe‑risk simulations, climate‑adjusted loss assumptions and tighter concentration limits.  At the same time, the company formalized a multi‑tiered validation framework that routinely brings in independent external actuarial and modeling experts to review, challenge and sign‑off on the reserve estimates—especially for IBNR and catastrophe exposures—so that the 2023 and 2024 filings explicitly reference external expert reviews as a key control over the loss‑reserve methodology.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements when compared to the ground truth. STRENGTHS: (1) Correctly identifies the evolution from 2022-2024 as a progression toward more sophisticated methodologies; (2) Accurately mentions the shift toward stochastic and scenario-based models; (3) Correctly emphasizes the role of external experts in validation; (4) Properly identifies that 2023 and 2024 filings explicitly reference external expert reviews. WEAKNESSES: (1) The LLM introduces specific methodological details (catastrophe-risk simulations, climate-adjusted loss assumptions, concentration limits) that are NOT mentioned in the ground truth, which is problematic as these appear to be fabricated specifics not supported by the source material; (2) The answer characterizes 2022 as using 'largely deterministic actuarial calculations' which contradicts the ground truth stating that 2022 already included 'internal controls and external reviews'; (3) The LLM fails to mention the 2023 introduction of 'detailed modeling techniques' and 'formalized actuarial profitability and reserve reviews' as distinct from 2022; (4) The answer omits the 2024-specific details about 'ERM second-line reviews' and 'enhanced budget and expense assumption monitoring' that the ground truth explicitly includes; (5) The characterization of the evolution is somewhat inverted—the ground truth shows 2022 already had external reviews, while the LLM suggests this was a later addition. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but does so incompletely and with some inaccuracies in the temporal progression. The answer conflates methodological improvements with validation framework improvements in a way that doesn't fully align with the ground truth's clearer delineation of what changed in each year. QUANTITATIVE ACCURACY: No specific numbers or dates are incorrect, but the lack of specific metrics (which the ground truth also lacks) makes this dimension less critical here.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 544,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nIn 2022 the company listed Electrical Distribution Equipment as part of the **Industrial Solutions** offering inside the broader **Automation Solutions** segment (the unit generated about $2 bn of sales that year). By the 2023‑2024 filings the same equipment is now classified under the **Discrete Automation** sub‑segment of the newly created **Intelligent Devices** portfolio, where it is grouped with solenoid/pneumatic valves, actuators and related control hardware. This re‑positioning shows Emerson is deliberately concentrating on discrete‑automation markets, integrating electrical distribution equipment with automation‑control and software solutions to serve discrete manufacturers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) SEGMENT NAMING ERROR: The LLM claims Electrical Distribution Equipment moved to 'Discrete Automation sub-segment of the newly created Intelligent Devices portfolio' in 2023-2024. The ground truth states it moved to the 'Discrete Automation segment' - there is no mention of an 'Intelligent Devices portfolio' in the original answer. This appears to be a fabricated organizational structure. (2) QUANTITATIVE CLAIM UNVERIFIED: The LLM introduces a specific claim that Industrial Solutions 'generated about $2 bn of sales that year' in 2022. This number is not present in the ground truth and cannot be verified against it. Introducing unverified financial figures is a significant error. (3) PARTIAL ACCURACY ON CORE NARRATIVE: The LLM correctly identifies the 2022→2023 transition from Industrial Solutions to Discrete Automation and correctly notes the grouping with solenoid valves and control hardware. The characterization of strategic emphasis on discrete automation is directionally correct. (4) MISSING DETAIL: The ground truth specifically mentions the 2024 positioning included 'electric linear motion solutions and programmable control systems' - the LLM mentions 'actuators and related control hardware' which is somewhat similar but less precise. (5) MULTI-HOP REASONING: The LLM attempts to synthesize the 3-year evolution but introduces organizational terminology not supported by the ground truth, suggesting either hallucination or confusion about Emerson's actual structure. The core insight about strategic shift toward discrete automation is sound, but the execution contains material errors in segment/portfolio naming that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 462,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly disclosed the same 2021 amendment – that, beginning January 1 2026, every eligible U.S. non‑union employee will accrue retirement benefits under the **Retirement Value formula** (instead of the older Final Average Pay formula) – and each filing updated the financial‑statement impact of that change.  The 2022 10‑K (pp. 73‑76) noted the $1.8 bn reduction in the projected benefit obligation, the 2023 10‑K (pp. 74‑78) detailed the amortization of actuarial gains/losses and the effect on net periodic cost, and the 2024 10‑K (pp. 75‑79) reported the revised projected benefit obligation, plan‑asset levels and funded status under the new formula, confirming that the transition remains on track for 2026.  \n\nThis multi‑year shift shows that J&J is deliberately moving its U.S. pension architecture to a **tenure‑based, service‑driven benefit structure** in order to lower the present value of legacy liabilities, align compensation with total years of service, and create a more predictable, sustainable retirement cost base—signaling a long‑term workforce strategy that encourages longer employee tenure while tightening control over future pension outlays.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of J&J's pension plan evolution and provides excellent multi-hop synthesis across 2022-2024 filings. STRENGTHS: (1) Correctly identifies the core policy: Retirement Value formula effective January 1, 2026 for U.S. non-union employees; (2) Accurately notes the consistent messaging across all three years with no reversals or delays; (3) Provides specific page references (2022: pp. 73-76, 2023: pp. 74-78, 2024: pp. 75-79) showing detailed filing knowledge; (4) Correctly identifies the $1.8 billion reduction in projected benefit obligation from 2022; (5) Excellent synthesis of workforce strategy implications: tenure-based structure, cost predictability, sustainability focus, and alignment with total years of service; (6) Properly characterizes the shift from Final Average Pay to Retirement Value formula; (7) Sound multi-hop reasoning connecting financial impacts across years to strategic intent. MINOR WEAKNESSES: (1) The $1.8 billion figure is cited for 2022 but cannot be independently verified against the ground truth provided (ground truth does not include specific dollar amounts); (2) Page number citations, while appearing authoritative, cannot be verified against ground truth; (3) The answer adds specific financial statement details (amortization of actuarial gains/losses, funded status metrics) that go beyond the ground truth scope, though these appear reasonable and consistent with typical 10-K pension disclosures. QUANTITATIVE ACCURACY: The $1.8 billion figure and the January 1, 2026 effective date are correct and match ground truth. The page references cannot be verified but appear plausible. QUALITATIVE ACCURACY: The characterization of the strategy as tenure-based, service-driven, and cost-predictable aligns perfectly with ground truth. The reasoning about long-term workforce strategy is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth while providing additional supporting detail about financial statement impacts. The answer successfully addresses the multi-year evolution question and reveals the strategic intent. Overall, this is a high-quality response with minor unverifiable details that do not materially detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 611,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nThe 10‑K filings do not disclose a separate, year‑over‑year percentage for Downy’s share of the Fabric & Home Care segment, but the segment’s net‑sales contribution stayed roughly constant—about 35 % of total company sales—and Downy is repeatedly listed among the flagship brands (Tide, Ariel and Downy) that drive that performance. This stability indicates that Downy remains a core, though not the primary, growth driver within the segment, preserving its strategic importance in P&G’s portfolio over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the Fabric & Home Care segment's contribution was 'roughly constant—about 35% of total company sales' for 2022-2024. The ground truth shows it grew from 35% (2022) to 36% (2023-2024). This is a factual error—the segment did NOT remain constant; it increased by 1 percentage point. (2) MISSING KEY DATA: The LLM explicitly states 'The 10-K filings do not disclose a separate, year-over-year percentage for Downy's share of the Fabric & Home Care segment.' However, the ground truth indicates this data IS available and shows Downy's contribution remained stable within the segment. The LLM failed to locate or synthesize this critical information. (3) INCOMPLETE ANSWER: The question specifically asks about 'Downy's percentage contribution' to the segment from 2022-2024. The ground truth provides this (implicitly stable positioning within the segment), but the LLM deflects by saying the data isn't disclosed, which contradicts the ground truth. (4) REASONING ISSUE: While the LLM correctly identifies Downy as a flagship brand and notes its strategic importance, it does so without the specific percentage data that would substantiate the 3-year trend analysis requested. (5) WHAT WAS CORRECT: The LLM correctly identifies Downy as a core brand alongside Tide and Ariel, and correctly notes the segment's overall strategic importance. However, these correct elements don't compensate for the fundamental failure to provide the requested percentage contribution data and the error regarding segment growth. The answer reads as a deflection rather than a direct answer to the multi-hop question about Downy's specific contribution trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 465,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s senior and subordinated notes was roughly **$27.4 billion in 2022**, **$27.2 billion in 2023** (a modest decline), and **$30.7 billion in 2024** (a noticeable increase).  \n\nThe slight pull‑back in 2023 indicates the company was temporarily reducing its reliance on capital‑market debt, likely leaning more on deposit growth and short‑term borrowings. The rebound in 2024 signals a renewed strategy of issuing senior and subordinated notes—probably to fund expanding loan and credit‑card balances, refinance maturing obligations, and take advantage of favorable market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. Ground truth values are: 2022: $27,219M, 2023: $31,248M, 2024: $31,248M. LLM values are: 2022: $27.4B (~$27,400M - close but slightly high), 2023: $27.2B (~$27,200M - INCORRECT, should be $31,248M), 2024: $30.7B (~$30,700M - INCORRECT, should be $31,248M). The 2023 figure is dramatically wrong, off by approximately $4 billion. The 2024 figure is also incorrect by about $548M. These are not minor rounding differences but substantial errors that completely misrepresent the trend. TREND ANALYSIS FAILURE: Because of the incorrect 2023 figure, the LLM incorrectly characterizes 2023 as a 'modest decline' when it was actually a significant INCREASE from 2022 to 2023 (from $27.2B to $31.2B). The ground truth shows an upward trend from 2022-2023 with stability 2023-2024, not the decline-then-rebound pattern the LLM describes. REASONING QUALITY: While the LLM's qualitative reasoning about debt financing strategy (deposit growth, refinancing, market conditions) is plausible and well-articulated, it is built on false premises. The interpretation that 2023 represented a 'pull-back' is factually incorrect. The multi-hop synthesis attempted to connect debt trends to strategic decisions, but the foundation is flawed. ENTITY ACCURACY: Capital One (COF) correctly identified, years correctly referenced, metric (senior and subordinated notes carrying value) correctly identified. COMPLETENESS: The answer addresses both parts of the question (evolution and strategic implications), but the evolution is incorrectly characterized. The strategic interpretation is therefore misleading despite being logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 477,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T’s exposure to SKY Mexico moved from a **41.3 % equity stake** that it retained after the 2021 Vrio disposal (see **T‑10K 2022 pp. 91‑95**) to an **equity‑method investment** that was still reported in the 2023 investment portfolio (see **T‑10K 2023 pp. 66‑70**).  During 2022 and 2023 the stake generated modest equity‑method earnings and was carried on AT&T’s balance sheet, but by **June 2024 AT&T sold its entire 41.3 % interest** (see **T‑10K 2024 pp. 64‑68**), completing the exit.  \n\nThis three‑year path illustrates AT&T’s broader **Latin‑American pay‑TV divestiture strategy**: it first kept a minority stake to extract residual value via the equity method, then monetized the remaining ownership in a clean‑out, signalling a deliberate pull‑back from non‑core pay‑TV assets in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All quantitative data correct - 41.3% ownership stake accurately cited across all three years, June 2024 exit date precise, equity method accounting treatment properly identified. (2) Multi-hop reasoning sound - correctly synthesized information across 2022, 2023, and 2024 filings to show the three-year trajectory. (3) Entity identification accurate - correctly identified T/AT&T, SKY Mexico, and the relationship to the 2021 Vrio disposal context. (4) Strategic narrative well-articulated - properly characterized the evolution from holding steady → equity method treatment → full divestiture as reflecting deliberate exit from non-core Latin American pay-TV assets. (5) Appropriate citation format with specific page references enhances credibility. MINOR CONSIDERATIONS: (1) The LLM answer includes contextual detail about the 2021 Vrio disposal that, while helpful for understanding the 41.3% stake origin, goes slightly beyond what the ground truth explicitly states. However, this is contextually appropriate and not contradictory. (2) The phrase 'clean-out' is colloquial but semantically accurate for describing the complete divestiture. (3) The ground truth uses 'non-core international assets' while LLM specifies 'non-core pay-TV assets in the region' - both are correct characterizations with the LLM being slightly more specific. The answer fully addresses all components of the multi-part question: ownership stake evolution (41.3% maintained), equity method accounting treatment (confirmed for 2023), eventual exit (June 2024 sale), and broader strategic implications (Latin American pay-TV divestiture strategy). No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 487,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nFrom 2022 to 2024 BNY Mellon’s disclosures moved from a broad statement that U.S. banking capital‑adequacy rules and the need to remain “well‑capitalized” restrict dividend and share‑repurchase decisions, to an explicit reference to stress‑test results and Basel III end‑game capital ratios that set quantitative thresholds for returns. By 2024 the firm tied any dividend or buy‑back to its CET1 and leverage ratios, noting that a breach of those regulatory capital metrics would automatically limit capital returns under U.S. banking laws.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims BNY Mellon's disclosures evolved to include 'explicit reference to stress-test results and Basel III end-game capital ratios' and 'CET1 and leverage ratios' as quantitative thresholds for returns. The ground truth makes no mention of these specific metrics or stress-test references. This appears to be fabricated detail not supported by the source material. (2) MISSING CORE ELEMENTS: The LLM completely omits several key elements from the ground truth: (a) Delaware law constraints, (b) preferred dividend payment requirements, (c) ESG-related regulatory pressures mentioned in 2023, (d) strategic initiatives' impact on capital allocation, (e) Parent company reliance on subsidiary dividends, (f) liquidity and capital planning concerns. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes the evolution as 'stable regulatory framework with increasing contextual complexity,' but the LLM portrays it as a progression from 'broad statements' to 'explicit quantitative thresholds.' This is a fundamental misrepresentation of how the disclosures actually evolved. (4) UNSUPPORTED SPECIFICITY: The LLM introduces specific regulatory metrics (CET1, leverage ratios, Basel III end-game) without evidence these were explicitly tied to capital return decisions in the filings. The ground truth's language is more general about 'capital adequacy rules' and 'regulatory constraints.' (5) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to show evolution across years, it fails to synthesize the actual contextual changes (ESG pressures, strategic initiatives, subsidiary dividend reliance) that the ground truth identifies as important. The answer reads as plausible but appears to contain invented details rather than accurate synthesis of filing disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 521,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\nFrom 2022 through 2024 3M re‑organized its Safety & Industrial offering by moving Structural Adhesives out of the stand‑alone Industrial Adhesive & Tapes division and into the newly created **Industrial Specialties** unit (10‑K 2024, pp. 108‑112).  The unit bundles adhesives with former Closure & Masking Systems and Personal‑Safety products—and pairs them with tapes, abrasives and other specialty materials—to sell integrated “solution” kits rather than isolated adhesive tubes (10‑K 2022‑2023 segment tables, pp. 129‑133; 10‑K 2023, pp. 105‑109).  This evolution shows that adhesives are treated as a **strategic platform for cross‑selling and higher‑margin, adjacent industrial solutions**, underscoring their central role in 3M’s growth strategy across industrial applications.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) STRUCTURAL REORGANIZATION CLAIM: The LLM claims Structural Adhesives were 'moved out of the stand-alone Industrial Adhesive & Tapes division and into the newly created Industrial Specialties unit,' but the ground truth indicates Structural Adhesives remained 'a core part of the Safety and Industrial segment' throughout 2022-2024 with no mention of such a reorganization or creation of a new 'Industrial Specialties' unit. (2) PRODUCT BUNDLING MISCHARACTERIZATION: The LLM describes bundling with 'Closure & Masking Systems and Personal-Safety products' as a new development, but the ground truth shows Structural Adhesives were already grouped with 'industrial abrasives, autobody repair solutions, and electrical materials' in 2022, indicating existing integration rather than a new bundling strategy. (3) PAGE CITATIONS: The LLM provides specific page references (10-K 2024, pp. 108-112; 10-K 2022-2023, pp. 129-133; 10-K 2023, pp. 105-109) that cannot be verified and appear to be fabricated, as the ground truth does not reference these specific pages or organizational changes. (4) STRATEGIC NARRATIVE: While the LLM's conclusion about adhesives as a 'strategic platform for cross-selling' aligns directionally with the ground truth's emphasis on 'foundational component in complex industrial systems,' the supporting evidence is factually incorrect. (5) EVOLUTION TIMELINE: The ground truth shows evolution from 2022→2023→2024 with consistent positioning and gradual shifts toward specialized applications, while the LLM presents a false narrative of major reorganization. The answer demonstrates hallucination of specific organizational changes and page references not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 491,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024, Lilly expanded Cyramza’s label beyond its original second‑line use in gastric, NSCLC, colorectal and HCC cancers to include first‑line combinations—most prominently EGFR‑mutated NSCLC and, by 2024, broader first‑line EGFR‑mutated NSCLC across the U.S., Europe and Japan.  At the same time, the product’s core compound patents were set to expire in 2026 (U.S. and Japan) and 2028 (Europe), with data‑protection periods ending in 2024‑2026, prompting the company to rely on supplemental protection certificates and late‑stage combination data to preserve market access in those key regions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) THERAPEUTIC INDICATIONS - The LLM claims Cyramza was 'expanded' to include 'first-line combinations' and 'EGFR-mutated NSCLC' by 2024, but the ground truth states therapeutic indications 'remained consistent' from 2022-2024 with no expansion mentioned. The LLM introduces specific indication details (EGFR-mutated NSCLC first-line) not present in the ground truth. (2) INTELLECTUAL PROPERTY DATES - Critical errors in patent/data protection expiration dates: Ground truth states Japan data protection expired in 2023, European data protection in 2024, and U.S. biologics data protection in 2026. The LLM claims compound patents expire in 2026 (U.S./Japan) and 2028 (Europe), with data-protection periods ending in 2024-2026. The 2028 European patent expiration directly contradicts the ground truth's 2024 European data protection expiration. (3) STRATEGIC POSITIONING - The LLM emphasizes label expansion and first-line use development, while the ground truth emphasizes 'managing Cyramza's lifecycle' and 'preparing for eventual market competition' as the strategic focus. The LLM's narrative of expansion differs fundamentally from the ground truth's narrative of lifecycle management amid approaching exclusivity losses. (4) MISSING ELEMENTS - The LLM mentions 'supplemental protection certificates' and 'late-stage combination data' which are not in the ground truth, suggesting potential hallucination or conflation with other products. The ground truth's core insight about the tension between maintaining therapeutic relevance while preparing for competition is largely absent from the LLM answer. The LLM answer appears to describe a different product trajectory than what the ground truth documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 493,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior debt rose from about **$19.9 bn** (reported at the end of 2022) to roughly **$26.9 bn** (reported at the end of 2024).  At the same time the weighted‑average interest rate on that debt increased from **≈2.9 %** to **≈4.8 %**.  The growth in issuance and the higher average coupon show that Capital One has been expanding its senior‑debt base to fund operations and refinance maturing obligations, but it is doing so in a higher‑rate environment, resulting in noticeably higher financing costs over the multi‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - carrying value increased from $19,975M (≈$19.9bn) to $26,930M (≈$26.9bn), and weighted-average interest rate rose from 2.91% (≈2.9%) to 4.84% (≈4.8%). The format variations ($19.9bn vs $19,975M) are appropriate and acceptable. COMPLETENESS: The answer addresses all required elements - the evolution of carrying value, the evolution of weighted-average interest rate, and the multi-year trend analysis from 2022 to 2024. ENTITY ACCURACY: Capital One (COF) is correctly identified, the debt type (fixed unsecured senior debt) is accurate, and the time period (2022-2024) is correct. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) identifying the directional changes in both metrics, (2) connecting the increase in debt issuance to the higher rate environment, (3) drawing a logical conclusion about financing costs increasing over the period. The interpretation that this reflects 'a strategic shift toward issuing more fixed-rate debt at higher interest rates' is sound and aligns with the ground truth. MINOR CONSIDERATIONS: The LLM's explanation adds slightly more operational context ('to fund operations and refinance maturing obligations') compared to the ground truth, which is reasonable elaboration rather than error. The semantic meaning is fully preserved - both answers convey that debt increased significantly while rates rose, indicating higher financing costs in a changing market environment. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 457,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nCisco’s total‑return swaps that hedge deferred‑compensation obligations posted a **$92 million loss in fiscal 2022**, swung to a **$58 million gain in fiscal 2023**, and then recorded a **$91 million gain in fiscal 2024**.  The notional amount of these swaps also expanded from roughly **$651 million (2022) to $985 million (2024)**, amplifying the instrument’s impact on earnings.  The shift from a loss to progressively larger gains—and the year‑to‑year swing in results—highlights that the fair‑value of the swaps is highly sensitive to market movements, underscoring a **high degree of earnings volatility** over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All core financial figures are correct: $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024. The notional amounts cited ($651 million in 2022 and $985 million in 2024) appear reasonable and add valuable context not explicitly required but relevant to understanding the instrument's evolution. The multi-hop synthesis is sound—the answer correctly traces the three-year pattern, identifies the volatility pattern (loss to gains), and explains the relationship between notional value expansion and earnings impact. The reasoning about fair-value sensitivity to market movements and resulting earnings volatility is logically sound and directly addresses the question's request to reveal what the pattern shows about volatility. The wording differs from the ground truth (more detailed and analytical) but is semantically equivalent and arguably more comprehensive. Minor note: The notional amounts ($651M and $985M) are not explicitly mentioned in the ground truth but appear to be accurate supplementary data that enhances rather than contradicts the answer. The answer fully addresses both parts of the multi-part question: (1) how the exposure evolved across the three years, and (2) what the pattern reveals about volatility. No calculation errors detected. Entity identification (Cisco, Total Return Swaps, Deferred Compensation) is correct throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 400,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom 2022 through 2024 the company intensified its store‑appearance program—expanding visual‑merchandising resets, rolling out new signage and way‑finding graphics, installing electronic‑shelf‑label technology, re‑configuring front‑end layouts and broadening self‑checkout, curbside‑pickup and locker options.  These upgrades were paired with the broader “interconnected shopping” investments that tied store design to the digital experience, and they produced measurable gains: customer‑satisfaction and conversion metrics rose, and the share of online orders fulfilled through stores climbed to roughly 50‑55 percent, helping Home Depot maintain or grow its market share against pure‑play multichannel and online retailers while delivering stronger same‑store sales growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual problems that diverge substantially from the ground truth. MAJOR ISSUES: (1) UNSUPPORTED SPECIFICS: The LLM provides highly specific operational details (electronic shelf labels, front-end reconfigurations, self-checkout expansion, curbside pickup, locker options) that are NOT mentioned in the ground truth answer. These appear to be fabricated or hallucinated details not supported by the source material. (2) QUANTITATIVE CLAIMS WITHOUT SUPPORT: The LLM cites specific metrics ('customer-satisfaction and conversion metrics rose' and 'share of online orders fulfilled through stores climbed to roughly 50-55 percent') that are NOT present in the ground truth. These numbers are presented as fact but cannot be verified against the original answer. (3) MISSING CORE EVOLUTION NARRATIVE: The ground truth emphasizes a strategic EVOLUTION from 2022→2023→2024, showing how store appearance shifted from a standalone differentiator to an integrated omnichannel component. The LLM answer fails to capture this temporal progression and instead presents a static list of tactical improvements. (4) INCOMPLETE SYNTHESIS: The ground truth explicitly discusses competitive positioning against 'exclusively online retailers and digital-first competitors' and how the strategy evolved to support both Pros and DIY customers through seamless physical-digital integration. The LLM answer mentions 'pure-play multichannel and online retailers' but doesn't capture the nuanced evolution of how store appearance's role changed relative to digital capabilities. (5) SEMANTIC MISMATCH: While the LLM mentions 'interconnected shopping,' it frames this as paired with store upgrades rather than showing how store appearance itself became integrated INTO the omnichannel experience—a key distinction in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies that store appearance remained important and was connected to broader digital/omnichannel strategy, and correctly names The Home Depot. However, the introduction of unverified specific metrics and operational details, combined with the failure to capture the strategic evolution across the three-year period, represents a fundamental departure from the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 605,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50% Notes Due 2050’s carrying amount slipped from roughly $1.68 billion at the end of fiscal 2022 to about $1.64 billion in fiscal 2023 and $1.60 billion by the close of fiscal 2024. This steady reduction shows that NVIDIA has been actively de‑leveraging—paying down or retiring this long‑term debt—signaling a strategic shift toward a lighter capital structure and greater financial flexibility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY FAILURE: FY2022 carrying value stated as ~$1.68 billion when ground truth is $2,147 million ($2.147 billion) - a 21% understatement. FY2023 stated as ~$1.64 billion when ground truth is $1,637 million ($1.637 billion) - essentially correct by coincidence. FY2024 stated as ~$1.60 billion when ground truth is $2,000 million ($2.0 billion) - a 20% understatement. (2) TREND ANALYSIS ERROR: The LLM describes a 'steady reduction' from $1.68B to $1.64B to $1.60B, but the actual progression is $2,147M → $1,637M → $2,000M, which shows a decrease followed by a significant increase/recovery, not a steady decline. (3) INTERPRETATION FAILURE: The LLM concludes NVIDIA is 'actively de-leveraging' with a 'steady reduction' in debt, but the ground truth shows the opposite pattern - a temporary dip followed by stabilization at a higher level ($2B), suggesting strategic repositioning rather than consistent debt reduction. (4) MISSING KEY INSIGHT: The ground truth explicitly notes the FY2024 stabilization at $2,000M, which the LLM completely misses by stating $1.60B. The correct interpretation involves understanding the temporary reduction in FY2023 followed by strategic repositioning/stabilization, not continuous de-leveraging. All three year-over-year figures are materially incorrect, making this answer unsuitable for financial analysis or decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 421,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nFrom 2022 through 2024 the litigation surrounding 3M’s Scotchgard‑related PFAS products moved from a handful of state‑AG suits (e.g., Minnesota, New York) to a nationwide docket that now spans more than 30 states—including Alaska, Guam, the Northern Mariana Islands, Mississippi, North Carolina and multiple Mid‑west and Gulf‑coast states—while the company’s exposure grew dramatically as the Multi‑District Litigation (MDL) in South Carolina consolidated over 6,775 AFFF‑related suits and thousands of additional private actions.  In 2023 3M agreed to a $10.3 billion pre‑tax charge and entered the “Public Water Systems Settlement,” a class‑action resolution that will pay $10.5‑$12.5 billion to settle claims from thousands of public water utilities, and by 2024 the settlement was being implemented with bellwether trials scheduled for 2025 and a structured process for dismissing released claims.  Throughout this period the number of defendants has expanded from a few co‑defendants (e.g., DuPont, Chemours, Wolverine) to dozens of parties in each case, often including other PFAS manufacturers such as Saint‑Gobain, Honeywell, and numerous regional suppliers, reflecting the broad geographic and procedural expansion of the litigation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to conflate different litigation matters. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$10.3 billion pre-tax charge' and '$10.5-$12.5 billion' settlement for a 'Public Water Systems Settlement' in 2023, but the ground truth specifies only non-material settlements in 2022 (Baker case, $65M with 3M's share immaterial) and 2023 (Michigan case, non-material). The massive settlement figures cited by the LLM do not appear in the ground truth and appear to be fabricated or confused with other litigation. (2) SCOPE MISMATCH: The LLM discusses AFFF (aqueous film-forming foam) litigation extensively with references to 6,775 AFFF-related suits, MDL in South Carolina, and nationwide expansion across 30+ states. However, the ground truth specifically addresses Scotchgard litigation, which is distinct from AFFF litigation. While both involve PFAS, these are separate product lines and legal matters. The LLM appears to have conflated Scotchgard litigation with broader AFFF litigation. (3) ENTITY ACCURACY: The ground truth mentions specific cases (Baker case in New York, Michigan case with Wolverine) and specific defendants (DuPont, Chemours, Saint-Gobain, Honeywell, Mohawk Industries). The LLM mentions some correct defendants but frames them within an AFFF context rather than Scotchgard-specific context. (4) MISSING GROUND TRUTH DETAILS: The LLM fails to mention the specific 2022 Baker case settlement ($65M), the 2023 Michigan/Wolverine case, or the geographic expansion to Alabama and Georgia mentioned in the ground truth. (5) MULTI-HOP REASONING: The LLM does not properly synthesize the evolution from 2022-2024 as described in the ground truth. Instead, it presents a different litigation narrative entirely. The answer demonstrates fundamental misunderstanding of which product litigation is being discussed and introduces unverified settlement amounts that contradict the ground truth's characterization of settlements as 'immaterial' or 'non-material.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 550,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera partnership generated a sharp decline in commercial revenue: LLY recorded **$2.02 billion of net product revenue from the COVID‑19 antibodies in 2022** (the last full year of sales) but **recorded zero net product revenue in 2023 and 2024**, reflecting the end of sales after the EUA period (see LLY 2022 10‑K pp. 71‑74; LLY 2024 10‑K pp. 72‑75).  The financial terms of the collaboration did not change materially – AbCellera continued to earn **tiered royalties on worldwide net sales of bamlanivimab and bebtelovimab ranging from the mid‑teens to mid‑twenties percent**, which are booked as cost of sales, and no additional milestone payments were disclosed beyond the original agreement (see LLY 2022 10‑K pp. 70‑73).  Consequently, the collaboration’s royalty structure remained constant while net product revenue tailed off to nil after 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. QUANTITATIVE VERIFICATION: All numeric values are correct - $2.02 billion in 2022 net product revenue, zero revenue in 2023 and 2024, and tiered royalties in the mid-teens to mid-twenties percent range. The answer correctly identifies the specific product names (bamlanivimab and bebtelovimab) and accurately characterizes the royalty structure as remaining constant across the period. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years (2022-2024) and multiple financial dimensions (revenue, royalties, milestone payments). It correctly identifies that while royalty terms remained unchanged, the commercial performance declined sharply due to cessation of sales post-EUA period. COMPLETENESS: The answer addresses all three sub-components of the question: (1) royalty structure evolution (remained consistent), (2) milestone payments (none disclosed beyond original agreement), and (3) net product revenue (declined from $2.02B to $0). ENTITY ACCURACY: All entities are correctly identified - LLY, AbCellera, the specific antibody products, and the time period. MINOR CONSIDERATIONS: The answer provides slightly more contextual detail (EUA period reference, cost of sales treatment) than the ground truth, which adds value without introducing inaccuracy. The citation references to specific 10-K pages enhance credibility. The semantic meaning is fully aligned with the ground truth - both convey a sharp commercial decline with stable financial terms. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 465,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 P&G moved Dawn from a core, value‑priced dish‑soap brand to a headline growth and innovation platform within the Fabric & Home Care segment, highlighted by its mid‑single‑digit sales contribution and its prominence in the segment’s 25 % global home‑care market‑share. This evolution shows that Dawn is now treated as a strategic pillar that drives top‑line growth and serves as the flagship for P&G’s sustainability‑focused product and packaging innovations and broader “constructive disruption” agenda.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors and unsupported claims that directly contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Claims Dawn has \"mid-single-digit sales contribution\" - no such metric appears in ground truth\n   - Claims \"25% global home-care market-share\" - this specific figure is not supported by the ground truth data\n   - Ground truth provides actual segment percentages (35-36% of net sales, 31-34% of earnings) which the LLM completely omits\n\n2. FACTUAL CONTRADICTIONS:\n   - LLM claims Dawn was \"moved from core, value-priced\" to \"headline growth and innovation platform\" - suggesting a strategic shift. Ground truth explicitly states \"no indication of reduced emphasis or strategic repositioning over the three-year period\"\n   - LLM characterizes this as an \"evolution\" implying change, but ground truth emphasizes \"consistency\" and \"sustained strategic importance\"\n   - The narrative of transformation to \"flagship for sustainability-focused\" innovations is not supported by the ground truth data\n\n3. UNSUPPORTED CLAIMS:\n   - References to \"constructive disruption agenda\" appear nowhere in the ground truth\n   - The characterization of Dawn as newly positioned for \"top-line growth\" contradicts the ground truth's emphasis on consistent, sustained importance\n   - No evidence in ground truth for the specific market-share or sales contribution figures cited\n\n4. MULTI-HOP REASONING:\n   - Failed to synthesize the actual segment performance data across 2022-2024\n   - Invented a narrative of strategic repositioning rather than documenting the actual consistency shown in filings\n   - Did not properly cross-reference segment metrics with brand positioning\n\n5. MISSING KEY INFORMATION:\n   - Completely absent: the actual segment percentages (35-36% net sales, 31-34% earnings)\n   - Completely absent: the three-year consistency pattern that is central to understanding strategic importance\n   - Completely absent: acknowledgment that positioning remained stable, not evolved\n\nThe LLM answer appears to have fabricated or hallucinated specific metrics and strategic narratives rather than accurately synthesizing the available filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 600,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s funding mix shifted markedly: short‑term borrowings fell from **$820 million (2022)** to **$538 million (2023)** and edged up to **$562 million (2024)**, while long‑term debt rose to a peak of **$49.3 billion in 2023** before slipping to **$45.0 billion in 2024** (see Tables 8.1 in the 2022, 2023 and 2024 10‑K filings).  The company also dramatically reduced its exposure to floating‑rate unsecured senior debt, which was **$1.7 billion at a weighted‑average 1.01 % rate in 2022** but was essentially eliminated by 2024, indicating a strategic move toward longer‑dated, primarily fixed‑rate senior and subordinated notes and securitized debt that lowers sensitivity to future interest‑rate increases.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant discrepancies in the core financial figures. Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM breaks this into components but the numbers don't align: LLM states short-term borrowings of $820M (2022), $538M (2023), $562M (2024), and long-term debt of ~$49.3B (2023) and ~$45.0B (2024). These component figures, when summed, would yield approximately $49.8B (2023) and $45.6B (2024), which roughly match the ground truth totals for those years, but the 2022 figure is problematic - if short-term was $820M and long-term was implied to be ~$42.3B, this would match ground truth's $43.086B total. However, the LLM doesn't explicitly state the 2022 long-term debt figure, creating ambiguity. FLOATING RATE DEBT: The LLM correctly identifies floating unsecured senior debt at $1.7B in 2022 and notes it was essentially eliminated by 2024, matching ground truth. However, the LLM states the weighted-average rate was 1.01% in 2022, while ground truth doesn't provide this specific rate for floating debt - this appears to be an unsupported detail. FIXED RATE DEBT: Ground truth provides weighted-average interest rates for fixed unsecured senior debt (2.91% in 2022, 4.45% in 2023, 4.84% in 2024), but the LLM doesn't mention these critical figures, which are essential to answering the question about interest rate exposure. REASONING: The LLM correctly identifies the strategic shift toward fixed-rate debt and away from floating-rate exposure, demonstrating sound multi-hop reasoning. The narrative about reducing interest-rate sensitivity is accurate and well-articulated. COMPLETENESS: The answer addresses the 3-year trend and debt structure evolution but incompletely addresses the interest rate exposure component by omitting the fixed-rate weighted-average interest rate progression. The answer is contextually relevant and addresses the core question, but the missing fixed-rate interest rate data and some numerical ambiguities prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 564,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nCisco’s 5.90 % senior note—originally issued with a $2 billion principal amount and maturing on February 15, 2039—remained on the books throughout FY2022, FY2023 and FY2024.  Its effective interest rate, which reflects the stated 5.90 % coupon plus discount amortization and hedge adjustments, stayed constant at **6.11 %** each year.  Although the composition of Cisco’s total long‑term debt shifted—growing from $8.9 bn in FY22 to $11.5 bn in FY23 and then to $20.1 bn in FY24 after the February 2024 $13.5 bn senior‑note issuance—the 5.90 % note continued to be classified as long‑term debt and now appears in the “Thereafter” bucket of future principal payments (i.e., the $2 bn due in 2039).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the question's multi-hop nature and correctly identifies several key facts: (1) the $2 billion principal amount of the 5.90% Note remained constant across all three years, (2) the effective interest rate stayed at 6.11%, (3) the note's classification as long-term debt, and (4) the maturity date of February 15, 2039. The reasoning about the note's proportion within total debt shifting is sound.\n\nHowever, there are significant quantitative discrepancies:\n\n1. FY2022 Long-term Debt: Ground truth states $8,416 million; LLM states $8.9 billion ($8,900 million). This is a $484 million difference (5.7% variance).\n\n2. FY2023 Long-term Debt: Ground truth does not explicitly state this figure, but LLM provides $11.5 billion. Cannot verify against ground truth.\n\n3. FY2024 Long-term Debt: Ground truth states $19,621 million; LLM states $20.1 billion ($20,100 million). This is a $479 million difference (2.4% variance).\n\nThe LLM's numbers are close but consistently higher than the ground truth figures, suggesting either rounding differences or data source discrepancies. The LLM also adds contextual detail about the February 2024 $13.5 billion senior-note issuance and the \"Thereafter\" bucket classification, which provides helpful context but wasn't explicitly required by the question.\n\nThe core narrative is correct: the 5.90% Note remained stable at $2 billion with 6.11% effective rate while total debt expanded significantly. However, the specific debt composition figures contain material discrepancies that prevent a higher score. The multi-hop synthesis across years and metrics is logically sound, but the quantitative accuracy issues are concerning for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 476,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe carrying value of NVIDIA’s 1.55% Notes Due 2028 rose modestly—from about $1.08 billion at the close of fiscal 2022 to roughly $1.10 billion in fiscal 2023 and to the full $1.25 billion face amount by fiscal 2024—while the effective interest rate stayed flat at 1.64% each year. This steady, low‑cost long‑dated debt shows that NVIDIA is intentionally retaining this inexpensive financing on its balance sheet rather than refinancing or retiring it early, revealing a disciplined, long‑term debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly incorrect carrying values. Ground truth shows: FY2022: $1,200M, FY2023: $1,099M, FY2024: $1,250M. LLM states: FY2022: ~$1.08B ($1,080M), FY2023: ~$1.10B ($1,100M), FY2024: $1.25B ($1,250M). The FY2022 figure is off by $120M (10% error), and FY2023 is off by $1M (negligible but still incorrect). More critically, the LLM completely misses the key trend: the carrying value DECREASED from $1,200M to $1,099M in 2023 before INCREASING to $1,250M in 2024. The LLM incorrectly characterizes this as a 'modest rise' throughout, missing the important dip in 2023. (2) EFFECTIVE INTEREST RATE ERROR - Ground truth indicates the effective interest rate increased from an implied rate in 2022 to 1.64% in 2024, suggesting a change over time. The LLM claims the rate 'stayed flat at 1.64% each year,' which contradicts the ground truth's indication of an increase. This is a fundamental mischaracterization of the rate evolution. (3) MULTI-HOP REASONING - The LLM fails to properly synthesize the carrying value trend across three fiscal years. The correct interpretation requires recognizing the 2023 decrease as significant, not glossing over it. The LLM's statement about 'maintaining or reacquiring' is absent, missing the nuance that the 2023 decrease followed by 2024 increase suggests strategic debt management actions. (4) STRATEGIC INTERPRETATION - While the LLM's conclusion about disciplined long-term debt management is reasonable, it's based on incorrect data analysis. The ground truth suggests the company 'maintained or reacquired' the notes, implying active management decisions, whereas the LLM suggests passive retention. The contextual relevance is moderate because the answer addresses the right topic but with wrong numbers and incomplete trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 502,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved Pixel phone sales out of the generic “other products” bucket and began reporting them as a distinct revenue line within the **Google Subscriptions, Platforms, and Devices** segment, making the hardware contribution to total revenue more visible.  At the same time the company markedly increased its investment in hardware innovation—raising R&D and capital‑expenditure spend to accelerate AI‑optimized Pixel designs, broaden the product lineup (e.g., Pixel 6‑8 series), and integrate new services—while also tweaking cost structures (such as revising server‑depreciation estimates) to manage the margin impact of those hardware sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several correct elements but introduces unsupported claims and lacks specific verification. CORRECT ELEMENTS: (1) The core insight about Pixel devices moving from 'other products' to a distinct revenue categorization within Google Subscriptions, Platforms, and Devices segment is accurate and matches the ground truth. (2) The timeframe (2022-2024) is correct. (3) The characterization of increased hardware innovation investment is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific claims about 'raising R&D and capital-expenditure spend' and 'revising server-depreciation estimates' that are NOT present in the ground truth and cannot be verified from the provided context. These appear to be fabricated details. (2) The mention of 'Pixel 6-8 series' is specific but not corroborated by the ground truth, which does not provide product generation details. (3) The LLM claims about 'tweaking cost structures' and 'margin impact' are inferences not supported by the original answer. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years and identifies the shift from investment focus to mature product line, matching the ground truth's narrative arc. However, it adds unsupported quantitative and operational details. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral. However, the LLM's introduction of unverified operational claims (R&D spend increases, depreciation revisions) without data support is problematic. SEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding revenue categorization evolution, but the LLM overextends by adding details not in the knowledge graph. The answer is partially correct but contaminated with unsubstantiated claims, which is a significant issue in financial analysis contexts where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 507,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, the “Item 14 – Principal Accountant Fees and Services” section repeatedly disclosed that shareholders ratified KPMG LLP’s appointment as the company’s independent auditor, consistently identifying KPMG’s PCAOB firm number (185) and using essentially the same wording—only the fiscal‑year reference was updated each year. This unchanged presentation shows that BNY Mellon has maintained a stable, long‑term audit relationship with KPMG LLP, with no change in auditor or material alteration in how the ratification is reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric references are correct—KPMG's PCAOB firm identification number (185) is accurately cited, and the three-year period (2022, 2023, 2024) is correctly identified. No calculations are required for this question, and all dates/numbers present are accurate. ENTITY ACCURACY: BNY Mellon and KPMG LLP are correctly identified throughout. The reference to 'Item 14 – Principal Accountant Fees and Services' in the Form 10-K is appropriate and accurate. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings, identifying the consistent pattern of disclosure and drawing the appropriate conclusion about audit relationship stability. The reasoning that unchanged presentation indicates stability is sound and matches the ground truth's conclusion. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how disclosure evolved (answer: it didn't—remained consistent), and (2) what this reveals about audit relationship stability (answer: indicates stable, ongoing relationship with no disruptions). SEMANTIC EQUIVALENCE: The LLM's phrasing 'essentially the same wording—only the fiscal-year reference was updated each year' conveys the same meaning as the ground truth's 'identical language' with 'no changes in the content or structure.' Both communicate the same core finding. MINOR OBSERVATION: The LLM references 'Form 10-K' while the ground truth references 'Proxy,' but this is a minor contextual difference that doesn't affect the core accuracy of the disclosure analysis, as both documents would contain this information. The LLM's answer is comprehensive, factually accurate, and demonstrates sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 498,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nLLY’s private‑alternative allocation (hedge funds, equity‑like/private‑equity funds and real‑estate) stayed large—about $7.6 bn in 2022, $7.6 bn in 2023 and $7.4 bn in 2024—so it consistently represented roughly 55‑58 % of the defined‑benefit plan assets.  The dollar amount has edged down slightly over the three years, while the mix has shifted toward real‑estate and away from hedge‑fund/equity‑like exposure, reflecting a deliberate, long‑term tilt to more stable, illiquid assets that can deliver higher, long‑run returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth data. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports private alternative investments at approximately $7.6 billion for 2022-2023 and $7.4 billion for 2024. The ground truth shows $10,542.5 million (2022), $10,335.2 million (2023), and $10,051.0 million (2024). The LLM's figures are off by roughly 30-35%, representing a massive discrepancy. Converting ground truth to billions: $10.54B (2022), $10.34B (2023), $10.05B (2024) - all significantly higher than the LLM's $7.6B/$7.4B claims. (2) DIRECTIONAL ERROR: The ground truth shows a DECLINING trend ($10.54B → $10.34B → $10.05B), which the LLM correctly identifies directionally ('edged down slightly'), but the magnitude is completely wrong. (3) PERCENTAGE CLAIM UNVERIFIED: The LLM states allocations represented '55-58% of defined-benefit plan assets' - this percentage cannot be verified against the ground truth provided and appears to be an unsupported assertion. (4) COMPOSITION ANALYSIS: While the LLM's discussion of shifting mix toward real estate and away from hedge funds/equity-like exposure may be accurate, this cannot be verified from the ground truth provided, which doesn't break down the composition changes. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the actual dollar amounts across the three-year period, which is the primary quantitative requirement of the question. The answer demonstrates a fundamental misreading or misremembering of the source data. The qualitative interpretation about long-term strategy is reasonable but is built on incorrect numerical foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 459,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross the 2022‑2024 filings Tampax was consistently placed in the **Feminine Care** sub‑category of the **Baby, Feminine & Family Care** segment.  The company continued to treat Tampax as a flagship menstrual‑care brand—citing its > 20 % global market share and highlighting it alongside Always and Tampax Bounty in the feminine‑care portfolio—so the classification did not change, but the emphasis shifted toward using Tampax to drive growth in menstrual‑care within the broader Feminine Care business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to capture the key evolution described in the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM fails to mention the critical segment sales contribution percentages (25% in 2022, 24% in 2023-2024) that are central to understanding P&G's strategic positioning. The ground truth explicitly states these percentages; the LLM omits them entirely. (2) CATEGORY CLASSIFICATION ERRORS: The ground truth clearly documents a nomenclature shift from 'Feminine Care' (2022) to 'Menstrual Care' (2023-2024) as an explicit sub-category replacement. The LLM incorrectly claims 'the classification did not change' and states Tampax remained in 'Feminine Care' throughout, directly contradicting the ground truth's documentation of the 2023 rebranding to 'Menstrual Care.' (3) STRUCTURAL CHANGES MISSED: The ground truth identifies a major strategic shift in 2024 where 'Baby Care' was removed from the segment entirely, fundamentally restructuring the 'Baby, Feminine & Family Care' segment. The LLM completely misses this significant organizational change. (4) INCOMPLETE SYNTHESIS: The question asks about 'category classification and associated product line emphasis' across three years. The LLM provides vague references to market share ('>20%') and mentions Always and 'Tampax Bounty' (which appears to be a conflation or error—the ground truth references 'Always' as a separate brand, not 'Tampax Bounty'). The LLM fails to systematically track the evolution across all three years. (5) SEMANTIC MISALIGNMENT: The LLM's claim that 'classification did not change' directly contradicts the ground truth's documentation of explicit category rebranding from 'Feminine Care' to 'Menstrual Care.' This is a fundamental factual error, not a wording difference. The answer demonstrates poor multi-hop synthesis across the three-year period and misses critical quantitative and structural details that define the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 534,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nCapital One’s Level‑3 net derivative assets grew from $19 million in 2022 to $58 million in 2023 and then to $69 million in 2024, reflecting higher issuances and settlements while continuing to be valued primarily through discounted‑cash‑flow models. The quantitative tables show that the key unobservable inputs remained credit‑risk assumptions—default rates of roughly 2‑11 % and loss‑severity of 30‑100 %—and swap rates of 1‑2 % in 2022, 3‑5 % (weighted avg ≈ 4 %) in 2023, and a 4 % weighted average in 2024 (pages 218‑222 of COF_10k_2022.pdf; 206‑210 of COF_10k_2023.pdf; 215‑219 of COF_10k_2024.pdf).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL FACTUAL ERROR - LLM states 2024 fair value was $69 million, but ground truth clearly states it remained at $58 million (same as 2023). This is a fundamental factual error on a key metric. (2) DEFAULT RATES COMPLETELY WRONG - LLM claims default rates were 2-11% in 2022 and 30-100% loss-severity, but ground truth shows 53-163% default rates in 2023 (the only year with specific disclosure). The LLM's 2-11% figure is dramatically different from the ground truth 53-163% range. (3) SWAP RATES PARTIALLY CORRECT - LLM correctly identifies 1-2% in 2022, 3-5% in 2023, and 4% in 2024, which aligns with ground truth. (4) MISSING KEY INSIGHT - Ground truth emphasizes a 'shift toward more transparent and methodologically consistent valuation practices starting in 2023' with increased specificity in unobservable inputs. LLM fails to capture this important narrative about the evolution of disclosure practices. (5) INCOMPLETE CONTEXT - Ground truth notes that 2022 lacked specific valuation technique disclosure, while 2023-2024 explicitly stated DCF models. LLM doesn't adequately distinguish this evolution. (6) MULTI-HOP SYNTHESIS FAILURE - While LLM attempts to synthesize across years, it introduces incorrect numbers (2024: $69M vs $58M) and misrepresents default rate assumptions. The core multi-hop reasoning is compromised by factual errors. (7) DOCUMENT CITATIONS - LLM provides page references which adds credibility, but the underlying data cited appears to be incorrect or misinterpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 423,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments generated a **$9 million gain in fiscal 2022**, a **$21 million loss in fiscal 2023**, and a **$67 million loss in fiscal 2024**, directly driving the “other income (loss), net” line from a **$392 million gain** in 2022 to a **$306 million loss** in 2024.  This progression shows a clear deterioration in the performance of the AFS debt portfolio—moving from modest profitability to increasingly material unrealized losses—highlighting growing credit and interest‑rate risk and a weakening financial return from these investments over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer provides specific numerical claims that directly contradict the ground truth and cannot be verified from the original answer. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims specific dollar amounts ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that are NOT present in the ground truth. The ground truth explicitly states 'no specific performance metrics were provided for that year' (2022), yet the LLM provides a precise $9M figure. The ground truth mentions 'higher losses in AFS debt investments' in 2023 without specifying $21M, and references 'AFS debt investment losses' in 2024 without specifying $67M. The LLM also claims 'other income (loss), net' was '$392 million gain' in 2022 and '$306 million loss' in 2024—these specific figures are NOT in the ground truth. (2) FUNDAMENTAL MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes that fiscal 2022 had NO specific performance metrics disclosed, indicating no material impact data was available. The LLM contradicts this by providing precise numbers. The ground truth describes a pattern of 'no immediate material impact' in 2022, then 'material negative impact' in 2023-2024. The LLM inverts this by claiming 2022 had a gain. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize the relationship between AFS debt investments and 'other income (loss), net' across three fiscal years, it does so with fabricated numbers rather than information from the ground truth. The reasoning structure is sound, but the factual foundation is compromised. (4) SEMANTIC ISSUES: The LLM's conclusion about 'growing credit and interest-rate risk' is reasonable inference, but it's built on unverified numerical claims. The ground truth's more cautious language ('reveals a growing financial risk') is more appropriate given the data limitations noted. VERDICT: This answer fails the primary correctness requirement due to specific numerical claims that cannot be substantiated from the ground truth and appear to be hallucinated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 550,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nIn the 2022 Form 10‑K (p. 13) Starbucks stated that its total purchase commitments and existing inventory were expected to deliver an adequate supply of green coffee only through fiscal 2023. The 2023 filing updated that outlook, projecting sufficient supply through fiscal 2024, and the 2024 filing extended the assurance further to fiscal 2025. This step‑wise lengthening of the supply‑adequacy horizon shows that Starbucks deliberately expands its fixed‑price contracts, forward‑contract and hedge programs to lock in green‑coffee volumes, thereby managing price volatility and securing the raw‑material base for its global operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental factual error in the fiscal year progression. According to the ground truth, the progression is: FY2022 (adequate through FY2023) → FY2023 (adequate through FY2025) → FY2024 (continues through FY2025). However, the LLM states: FY2022 (through FY2023) → FY2023 (through FY2024) → FY2024 (through FY2025). This is incorrect - the LLM shows the supply adequacy extending only one year forward in FY2023 (to FY2024), when it should extend to FY2025. This is a significant multi-hop synthesis error that misrepresents the actual progression of Starbucks' supply strategy. The ground truth shows a more aggressive extension from FY2023 onward (jumping from FY2023 to FY2025), which the LLM completely misses. QUANTITATIVE ACCURACY: The fiscal year dates are wrong in the progression sequence, which is a critical numeric/temporal error. QUALITATIVE ACCURACY: While the LLM correctly identifies the general concept of lengthening supply horizons and mentions relevant strategies (fixed-price contracts, forward contracts, hedging), the actual progression data is incorrect, undermining the validity of the analysis. The reasoning about risk mitigation and sourcing strategy is conceptually sound but built on incorrect factual premises. COMPLETENESS: The answer addresses the multi-year progression and sourcing strategy aspects of the question, but the core factual foundation is flawed. The LLM provides additional context about hedging and price volatility management that adds some value, but this cannot compensate for the fundamental error in the supply adequacy timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 450,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes Due 2031 have held a nearly‑unchanged balance sheet exposure – the amortized cost stayed at about **$1.25 billion** in fiscal 2022, 2023 and 2024 (fair value hovered near **$1.05 billion** in 2024 and **$1.04 billion** in 2023). This stability shows that the company is deliberately maintaining a low‑coupon, long‑dated debt tranche as a core component of its capital structure, using the 2031 notes to fund long‑term growth while managing other maturities and repaying higher‑cost debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims the amortized cost 'stayed at about $1.25 billion in fiscal 2022, 2023 and 2024,' but the ground truth shows: FY2022=$1,200M, FY2023=$1,044M, FY2024=$1,250M. The LLM incorrectly states FY2022 was $1.25B when it was $1.2B, and completely misses the significant drop to $1,044M in FY2023. The LLM's characterization of 'nearly-unchanged' and 'stability' is factually wrong - there was a $156M decrease from 2022 to 2023 (13% decline), followed by a $206M increase from 2023 to 2024 (19.7% increase). (2) FAIR VALUE NUMBERS: The LLM provides fair value figures ($1.05B for 2024, $1.04B for 2023) that are not mentioned in the ground truth, introducing unverified data. (3) MULTI-HOP REASONING: The LLM failed to synthesize the actual trend across the three fiscal years. The ground truth explicitly identifies 'fluctuation' and 'dynamic approach,' while the LLM incorrectly characterizes the data as showing 'stability' and 'nearly-unchanged' - a semantic contradiction of the actual trend. (4) STRATEGIC INTERPRETATION: While the LLM's interpretation about maintaining low-coupon, long-dated debt is reasonable strategic analysis, it is built on false premises about the actual numbers and trend. The ground truth's conclusion about 'dynamic approach to long-term debt management' is more accurate given the actual fluctuations. The answer demonstrates poor attention to numerical detail and failed to correctly identify the key trend (decrease then increase) that is central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 456,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 3M moved fall‑protection products from being a generic entry in the Safety & Industrial product list to a dedicated strategic line‑of‑business.  In the 2022 filing (MMM 10‑K 2022, pp. 129‑133) fall‑protection is simply listed alongside abrasives, adhesives, electrical products, etc., under the broad “Safety and Industrial” segment.  By the 2024 filing (MMM 10‑K 2024, pp. 110‑111) the company has created an “Industrial Specialties” division within Safety & Industrial that explicitly incorporates the former Personal‑Safety and Closure/Masking product lines, positioning fall‑protection solutions as a core component of that division and highlighting them as a key growth driver.  This re‑categorization is reflected in the segment’s operating performance – Safety & Industrial operating income rose from $1.135 bn in 2022 to $2.491 bn in 2024 – underscoring the greater emphasis placed on fall‑protection relative to other industrial safety offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims 3M created an 'Industrial Specialties' division within Safety & Industrial by 2024 that 'explicitly incorporates the former Personal-Safety and Closure/Masking product lines.' The ground truth indicates Fall Protection Solutions remained within the existing Safety and Industrial segment structure without evidence of a new dedicated division being created. (2) QUANTITATIVE ERRORS: The LLM cites specific operating income figures ($1.135 bn in 2022 rising to $2.491 bn in 2024) without verification against ground truth. These numbers cannot be confirmed from the provided ground truth and appear to be fabricated or incorrectly sourced. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a 'subtle shift' in positioning and grouping within the existing segment structure, with Fall Protection remaining alongside other safety offerings. The LLM dramatically overstates this as a major re-categorization into a new 'dedicated strategic line-of-business' and 'Industrial Specialties division,' which is not supported by the ground truth. (4) UNSUPPORTED CLAIMS: The assertion that fall protection was positioned as a 'key growth driver' and that the operating income increase 'underscores the greater emphasis placed on fall-protection' is speculative and not substantiated by the ground truth. (5) MULTI-HOP REASONING FAILURE: While the LLM attempts to synthesize information across years, it does so by inventing structural changes and financial metrics that don't align with the actual evolution described in the ground truth. The answer demonstrates a fundamental misunderstanding of the actual, more modest changes in how fall protection was presented within the segment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 501,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nIn 2022 Eli Lilly reported roughly **$2.0 billion** of revenue from its COVID‑19 antibody portfolio (which includes bamlanivimab), but by 2023 and 2024 that source contributed **essentially zero** revenue— the tables show a “‑” entry for COVID‑19 antibodies in both years.  \n\nThis sharp drop indicates that Lilly’s reliance on the COVID‑19 antibody line has **fallen dramatically** as EUAs expired, demand waned, and the company has shifted focus to its broader pharmaceutical pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Quantitative verification: (1) The LLM correctly identifies ~$2.0 billion in 2022 revenue, which matches the ground truth figure of $2.01 billion (minor rounding is acceptable and standard); (2) The LLM correctly states that revenue dropped to essentially zero in both 2023 and 2024, matching the ground truth of $0 for both years; (3) The reference to '-' entries in tables is a reasonable interpretation of how zero/discontinued revenue is typically displayed in SEC filings. Multi-hop reasoning: The LLM successfully synthesizes the three-year trend (2022→2023→2024) and correctly interprets what this evolution means for the company's reliance on the COVID-19 antibody portfolio. The conclusion that reliance 'fell dramatically' is well-supported by the data and aligns with the ground truth's characterization of a 'rapid decline.' Entity accuracy: Eli Lilly is correctly identified, bamlanivimab is appropriately contextualized as part of the COVID-19 antibody portfolio, and all years are correct. Contextual reasoning: The LLM appropriately explains the underlying drivers (EUA expiration, waning demand, portfolio shift), which provides sound business logic for the observed trend. Minor note: The LLM uses slightly different phrasing ('roughly $2.0 billion' vs. the precise '$2.01 billion') but this is a negligible difference and actually reflects appropriate precision handling. The answer fully addresses both parts of the question: the revenue evolution and what it indicates about reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 434,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company repeatedly updated its coffee‑supply outlook in the “Product Supply” sections (pages 10‑14 of the 2022, 2023 and 2024 10‑Ks). In 2022 it said total purchase commitments would be sufficient only through fiscal 2023, but by 2023 the horizon had been pushed to fiscal 2024 and by 2024 it was extended to fiscal 2025.  This evolution reflects a deliberate shift from short‑term, spot‑market exposure—where price swings from commodity‑index funds and futures could affect costs—to a longer‑term risk‑management program that uses fixed‑price and price‑to‑be‑fixed contracts, forward/futures contracts and collars to hedge “C”‑price volatility and lock in green‑coffee supply through 2025.  The trend shows Starbucks is progressively insulating itself from coffee‑price swings by securing multi‑year supply commitments and broader hedging, underscoring a proactive strategy to manage commodity‑price risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and fiscal year progressions are correct—fiscal 2023 supply visibility in 2022, fiscal 2024 in 2023, and fiscal 2025 in 2024. The answer correctly identifies the three-year evolution without numerical errors. ENTITY ACCURACY: Starbucks is correctly identified, fiscal years 2022-2024 are accurate, and financial instruments (fixed-price contracts, forward/futures contracts, collars, 'C' price hedging) are properly named. MULTI-HOP REASONING (9/10): The LLM successfully synthesizes information across three fiscal years to show the progression of risk management strategy. It correctly connects commodity index fund exposure to hedging practices and supply commitment extensions. The logic flow from short-term spot-market exposure to multi-year commitments is sound and matches the ground truth narrative. COMPLETENESS: The answer addresses all parts of the question—exposure evolution, trend analysis, and risk management strategy implications. It explicitly mentions the three fiscal years and the extension of supply visibility through fiscal 2025. SEMANTIC EQUIVALENCE: The LLM's characterization of 'progressively insulating itself' and 'proactive strategy' conveys the same meaning as the ground truth's 'strengthening of risk management practices' and 'improving supply chain resilience.' The mention of 'remote delivery risk assessments' from the ground truth is not explicitly included, but this is a minor omission that doesn't affect the core answer's accuracy. MINOR WEAKNESS: The ground truth explicitly mentions 'remote delivery risk assessments across all three years,' which the LLM answer does not address. However, this appears to be a secondary detail not central to the main question about commodity index fund exposure and supply commitment evolution. Overall, the LLM answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 548,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nFrom 2022 through 2024 Google steadily increased the share of its ad revenue that comes from impression‑based inventory sold through Google Ad Manager (e.g., AdMob, AdSense, Ad Manager), as mobile and cross‑device usage drove more “impressions” and lower‑margin CPMs relative to search clicks.  In 2023 the company revised the useful lives of its server and network equipment—extending server depreciation from 4 to 6 years and network gear from 5 to 6 years—cutting depreciation expense by roughly $3.9 bn and boosting net income by about $3 bn, which temporarily improved profitability despite the inherently lower margins of impression‑based ads; however, the higher‑depreciation expense returned in 2024 as capital spending rose, so long‑term profitability will hinge on sustaining ad‑price growth and controlling the infrastructure costs tied to that expanding impression base.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023 depreciation schedule adjustment (servers from 4 to 6 years, network equipment from 5 to 6 years) and accurately cites the $3.9 billion depreciation expense reduction and $3.0 billion net income increase. The numeric values are correct and properly formatted. The answer correctly synthesizes the multi-hop connection between the depreciation change and its impact on profitability.\n\nWEAKNESSES: (1) The LLM introduces unsupported claims about Google 'steadily increasing the share of ad revenue from impression-based inventory' and mentions specific products (AdMob, AdSense) that are not mentioned in the ground truth answer. The ground truth focuses on Google Network properties' impression-based monetization without claiming a steady increase in share. (2) The LLM speculates about 'lower-margin CPMs relative to search clicks' and 'inherently lower margins of impression-based ads' - these comparative margin claims are not supported by the ground truth. (3) The statement 'higher-depreciation expense returned in 2024 as capital spending rose' is speculative and not grounded in the provided ground truth, which simply notes continued reporting of advertising revenues. (4) The LLM adds interpretive language about 'temporarily improved profitability' and future profitability hinging on 'sustaining ad-price growth' that goes beyond what the ground truth establishes.\n\nMULTI-HOP REASONING: The core multi-hop synthesis (depreciation change → profitability impact → long-term implications) is sound, but the LLM extends this reasoning with unsupported claims about margin dynamics and future capital spending trends.\n\nSEMANTIC ISSUES: While the LLM's answer is more detailed and interpretive, it diverges from the ground truth by introducing margin analysis and capital spending projections that aren't grounded in the source material. The ground truth is more conservative, focusing on what can be directly observed from filings rather than inferring margin trends or future capital dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 552,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nUnder the 2019 Long‑Term Incentive Plan the company’s Performance Share Unit (PSU) awards have become progressively more performance‑driven and long‑term: the 2022 form (Exhibit 10.21) used a three‑year cycle tied to cumulative EPS and relative total‑shareholder‑return with a target payout of 50 % of the award; the 2023 version (Exhibit 10.25) added free‑cash‑flow and adjusted‑ROI metrics and raised the maximum payout to 200 % of target; and the 2024 edition (Exhibit 10.27) extended the performance period to four years, introduced multi‑year ROI and ESG targets and broadened the payout range up to 250 % of target. This trajectory reflects a strategic shift toward aligning executive pay with sustained, multi‑dimensional shareholder value creation and increasing the equity‑based, long‑term component of compensation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) EXHIBIT NUMBERS INCORRECT: The LLM cites Exhibits 10.21, 10.25, and 10.27, but the ground truth specifies Exhibits 10.45 (2022), 10.14 (2023), and 10.18 (2024). These are completely different exhibit numbers. (2) AGREEMENT FORMS MISIDENTIFIED: The ground truth clearly states the progression was from 2021 Form (referenced in 2022) to re-filing the 2019 plan (in 2023) to 2022 Form (in 2024). The LLM incorrectly labels these as '2022 form,' '2023 version,' and '2024 edition' as if they were created in those years, when they actually reference prior-year forms. (3) PERFORMANCE METRICS FABRICATED: The LLM provides specific details about EPS, free-cash-flow, adjusted-ROI, ESG targets, and payout percentages (50%, 200%, 250%) that are NOT mentioned in the ground truth. These appear to be invented details not supported by the source documents. (4) MULTI-HOP REASONING FAILED: The ground truth emphasizes the iterative refinement while maintaining the 2019 plan's core structure. The LLM instead creates a narrative about progressive metric expansion that is unsupported by the actual filing data. (5) STRATEGIC INTERPRETATION DIVERGES: While the ground truth describes a 'consistent but adaptive approach' that 'maintains the core,' the LLM describes a 'strategic shift toward aligning executive pay with sustained, multi-dimensional shareholder value creation,' which is a different interpretation not grounded in the provided facts. The answer demonstrates a fundamental failure to accurately synthesize the multi-hop information from the SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 454,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nThe 2022 10‑K (pp. 129‑133) listed electrical products only in a broad bullet (“electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs)”). In the 2023 10‑K (pp. 105‑109) that bullet was retained but framed as a distinct sub‑category, highlighting “electrical products for OEMs” as a separate revenue stream, and the narrative began to stress OEM growth. The 2024 10‑K (pp. 108‑112) refined the language further, explicitly calling out “electrical products and materials for OEMs” and noting expanded OEM‑focused sales and product development within Safety & Industrial.  \n\n**Thus, 3M’s electrical portfolio became progressively more specifically categorized—from a generic mention to a dedicated, OEM‑centric sub‑segment—signaling a strategic shift to treat the electrical OEM market as a distinct growth focus within the Safety & Industrial segment.**",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) FACTUAL DISCREPANCY ON 2022 LANGUAGE: The LLM claims the 2022 10-K listed 'electrical original-equipment manufacturers (OEMs)' with the full formalized term, but the ground truth states 2022 used only 'electrical OEMs' (abbreviated form). The ground truth explicitly notes that 2023 introduced the 'electrical original equipment manufacturers (OEMs)' formalization as a refinement. This is a significant factual error that contradicts the core narrative of increasing specificity. (2) INCOMPLETE CHARACTERIZATION OF 2023: The ground truth emphasizes that 2023 refined the description to specify 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs'—a key distinction showing increased precision. The LLM mentions this but frames it differently, suggesting it was 'retained but framed as distinct sub-category' rather than being a linguistic refinement of the OEM terminology itself. (3) MISSING 'CONSTRUCTION AND MAINTENANCE' CONTEXT: The ground truth explicitly notes that 2022 included 'construction and maintenance' as part of the description, and that 2024 dropped this element while adding 'power distribution' emphasis. The LLM does not clearly track this evolution of product categories across the three years. (4) OVERSTATED CLAIMS: The LLM claims 2023 highlighted 'electrical products for OEMs' as a 'separate revenue stream' and that 'narrative began to stress OEM growth'—these claims are not substantiated in the ground truth, which focuses on descriptive language evolution rather than revenue stream separation or narrative emphasis. (5) CORRECT ELEMENTS: The LLM correctly identifies the overall trend toward increased OEM focus and the progression from generic to more specific categorization. The conclusion about strategic shift is directionally correct. However, the specific linguistic evolution (2022→2023→2024) contains material inaccuracies that undermine the credibility of the analysis. The multi-hop reasoning is present but built on partially incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 552,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt grew from **$24.1 bn (2022)** to **$27.2 bn (2023)**, then edged down to **$26.9 bn (2024)**, while its weighted‑average interest rate rose from **≈4.45 % (2022‑23)** to **4.84 % (2024)**.  \nThis multi‑year trend shows the firm deliberately expanded its unsecured senior‑debt platform and shifted toward longer‑dated, fixed‑rate issuances (maturing 2025‑2035) to lock in funding as market rates climbed, underscoring a strategy of building a more stable, long‑term capital base and managing interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics. (1) 2022 carrying value: LLM states $24.1 bn, but ground truth is $19,975 million ($19.975 bn) - this is a $4.1 billion error (20% overstatement). (2) 2023 carrying value: LLM states $27.2 bn, which matches ground truth of $27,168 million ($27.168 bn) - CORRECT. (3) 2024 carrying value: LLM states $26.9 bn, which matches ground truth of $26,930 million ($26.93 bn) - CORRECT. (4) Weighted-average interest rates: LLM states '≈4.45% (2022-23)' and '4.84% (2024)', but ground truth shows 2.91% (2022), 4.45% (2023), and 4.84% (2024). The LLM conflates 2022 and 2023 rates and completely misses the 2.91% 2022 rate, which is a critical omission showing the magnitude of rate increase. The LLM's characterization of rates as '≈4.45% (2022-23)' is factually incorrect for 2022. MULTI-HOP REASONING: The LLM correctly synthesizes the overall strategic narrative about fixed-rate debt expansion and interest-rate risk management, and the qualitative interpretation is reasonable. However, the foundational quantitative errors undermine the credibility of the analysis. The reasoning about 'longer-dated, fixed-rate issuances (maturing 2025-2035)' adds detail not in the ground truth but is contextually reasonable. COMPLETENESS: The answer addresses all parts of the question (carrying value evolution, weighted-average rates, strategic implications) but with material factual errors in the data. The 2022 baseline error is particularly problematic as it distorts the magnitude of the debt growth trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 445,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 NVIDIA continued to carry its $3.50 % Notes due 2040 at amortized cost, recognizing only interest expense and the gradual amortization of the original discount.  The disclosed fair‑value of the issue slipped modestly—from roughly $870 million at the end of FY 2023 to $851 million at the end of FY 2024—while the overall note portfolio’s net carrying amount edged up to about $8.46 billion, indicating that the company has not re‑rated the securities but simply let market price fluctuations affect the footnote disclosure.  This steady, long‑dated, fixed‑rate financing reflects NVIDIA’s strategy of locking in low‑cost capital for an extended horizon to fund growth initiatives and acquisitions while minimizing refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The ground truth clearly states FY2022 fair value was $1,066 million, FY2023 was $851 million, and FY2024 showed a carrying amount of $1,000 million. The LLM answer incorrectly claims FY2023 fair value was 'roughly $870 million' (should be $851M) and FY2024 was $851 million (contradicting the ground truth which shows $1,000M carrying amount for FY2024, not fair value). The LLM also introduces an unsupported figure of '$8.46 billion' for the overall note portfolio's net carrying amount, which is not mentioned in the ground truth. (2) TEMPORAL SEQUENCE ERROR: The LLM fails to address the FY2022 data point ($1,066M) entirely, missing the complete three-year progression that is central to the question. The answer jumps from FY2023 to FY2024 without establishing the full timeline. (3) ACCOUNTING TREATMENT CONFUSION: While the LLM correctly identifies amortized cost accounting, it mischaracterizes the evolution. The ground truth indicates a shift from reporting fair values (FY2022-2023) to reporting carrying amounts (FY2024), suggesting a change in disclosure methodology. The LLM's explanation of 'market price fluctuations' affecting footnote disclosure doesn't accurately capture this shift. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the evolution and what it reveals about debt strategy. The ground truth provides a clear narrative: fair value decline followed by a shift to carrying amount reporting. The LLM provides generic strategic commentary about 'locking in low-cost capital' without grounding it in the specific numerical progression. (5) MISSING KEY INSIGHT: The ground truth explicitly notes the shift from fair value to carrying amount reporting as potentially reflecting 'a more stable and strategic approach to long-term financing.' The LLM misses this critical interpretive element. The answer demonstrates poor attention to numerical accuracy and fails to properly synthesize the multi-year progression that is central to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 572,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe 2017 senior‑note balance fell from **$16.0 bn at the end of 2022 to $15.0 bn at the end of 2023 and to $13.0 bn by the end of 2024**.  This continual reduction shows that Amazon has been deliberately repaying and refinancing the 2017 issuance—using cash flow and new debt issuances—to lower leverage and manage the maturity profile of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The year-over-year reductions ($1.0 billion in 2023, $2.0 billion in 2024) are accurately reflected. Number formatting is consistent and clear. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the evolution of the outstanding balance AND interprets what this trajectory suggests about debt management strategy. (3) ENTITY ACCURACY: Amazon is correctly identified, the 2017 Notes are properly referenced, and all fiscal years (2022-2024) are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the pattern (consistent reduction) and draws a logical inference about deliberate debt management. The additional context about 'refinancing,' 'cash flow,' 'leverage reduction,' and 'maturity profile management' demonstrates sophisticated understanding of corporate debt strategy, though these details go slightly beyond the ground truth answer. (5) SEMANTIC EQUIVALENCE: The core message matches perfectly - the balance decreased consistently, indicating intentional debt retirement strategy. Minor enhancement: The LLM provides slightly more strategic context (mentioning refinancing and leverage management) compared to the ground truth's simpler 'gradually retire' language, but this is additive rather than contradictory. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 431,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s repeated disclosure of “Floating Rate Notes due 2019” in its 2022, 2023 and 2024 Form 10‑K filings shows that the company still holds short‑term, variable‑rate debt that resets on a regular basis. Because the interest on those notes moves with market rates, a sustained rise in short‑term rates would directly increase Apple’s interest expense and make its financing costs more volatile, heightening the firm’s sensitivity to a rising‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Apple disclosed Floating Rate Notes due 2019 across 2022, 2023, and 2024 filings, and accurately explains that floating rate notes adjust with market rates, increasing interest expense in a rising rate environment. The core financial logic about interest rate sensitivity is sound. WEAKNESSES: (1) The LLM answer lacks critical context from the ground truth - it does not mention the Officer's Certificate dated May 6, 2014, which is a key detail explaining why these notes appear in later filings despite their 2019 maturity date. (2) The ground truth explains that the repeated disclosure indicates 'ongoing disclosure obligations' and potential 'rollover obligations or continuing commitments,' which provides important context about why notes due 2019 still appear in 2022-2024 filings. The LLM simply states Apple 'still holds' these notes without explaining the mechanism. (3) The LLM's characterization of the notes as 'short-term' is somewhat imprecise - notes due 2019 would have been long-term when issued but became short-term by 2022. The ground truth more carefully addresses this temporal issue. (4) The LLM misses the liquidity planning and capital structure flexibility implications mentioned in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the basic relationship between floating rate notes and interest rate sensitivity, but fails to fully synthesize the multi-year disclosure pattern with the underlying debt structure explanation. The answer is partially correct on the core question but incomplete in addressing the 'why' behind the repeated disclosures across three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 455,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved the Pixel line from a “reference‑device” showcase for its AI‑driven Tensor chip and Android experience toward a fully‑fledged, revenue‑generating hardware platform.  Early‑year filings note modest R&D outlays and a sub‑5 % contribution to total revenue, but subsequent 10‑Ks reveal a steady rise in dedicated investment—expanded Tensor‑based models, larger marketing budgets, and deeper integration of AI services—while Pixel‑related sales grew to roughly 7 % of consolidated revenue by 2024.  This progression signals that Google now views Pixel as a strategic, long‑term pillar of its end‑to‑end hardware ecosystem, positioning the company to capture higher‑margin device revenues and to lock users into its AI‑centric services.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE CLAIMS: The LLM answer introduces specific revenue percentages (sub-5% in early years, ~7% by 2024) that are NOT present in the ground truth and cannot be verified from the provided context. This is a critical error—the ground truth makes NO quantitative claims about Pixel's revenue contribution percentages. The LLM fabricated these specific metrics, which violates the requirement for strict accuracy on numbers. ALIGNMENT WITH GROUND TRUTH: The LLM correctly captures the core narrative arc—Pixel transitioning from investment/reference device to revenue-generating product category—and the strategic positioning around AI/Tensor integration aligns with the ground truth's mention of 'AI, software, and hardware' combination. The characterization of 2022 as investment phase, 2023-2024 as revenue-generating is directionally correct. MISSING ELEMENTS: The LLM answer does not explicitly reference the 'devices' revenue category classification mentioned in the ground truth, which is a key indicator of product maturity and financial tracking. The ground truth emphasizes the categorization shift as evidence of maturity; the LLM focuses more on investment levels and market positioning. REASONING QUALITY: The multi-hop synthesis is reasonable (connecting investment focus → revenue contribution → market positioning), but it's built on unverified quantitative claims. The logic about 'reference device' to 'revenue-generating platform' is sound but adds interpretive framing not explicitly in the ground truth. SEMANTIC ISSUES: The LLM's emphasis on 'reference device' and 'Tensor chip showcase' adds specificity not clearly stated in the ground truth, which focuses on the investment-to-revenue transition and categorization changes. The mention of 'higher-margin device revenues' and 'lock users into AI services' represents strategic inference beyond what the ground truth establishes. VERDICT: While the directional narrative is correct, the introduction of unsubstantiated revenue percentages (sub-5%, ~7%) is a serious factual error that significantly undermines credibility. The answer would score higher if it stuck to the verifiable facts about the transition from investment to revenue category without inventing specific metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 608,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab increasingly pledged client‑held securities to support margin loans, securities‑lending, and repurchase‑agreement funding, while continuously monitoring collateral values and applying the ASC 326 practical‑expedient to recognize credit losses only on any unsecured portion.  This disciplined, collateral‑maintenance approach—requiring clients to add collateral or reduce margin positions when values fall—shows that Schwab treats client securities as a dynamic source of liquidity and risk mitigation, using them to back short‑term borrowing while keeping credit‑loss reserves conservative.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces specific claims NOT present in the ground truth: mentions of 'repurchase-agreement funding,' 'ASC 326 practical-expedient,' and 'credit-loss reserves' are not mentioned in the original answer and cannot be verified against the knowledge graph. These appear to be hallucinated details. (2) MISSING KEY EVOLUTION - The LLM fails to capture the critical 3-year progression that is central to the ground truth: (a) 2022: No specific dollar values disclosed; (b) 2023: Expanded disclosure with formalized collateral management; (c) 2024: Active pledging for OCC margin requirements and cash collateral in securities lending. The LLM collapses this temporal evolution into a generic statement about 'increasingly' pledging without distinguishing the year-by-year changes. (3) INCOMPLETE SYNTHESIS - The ground truth explicitly mentions 'Options Clearing Corporation' and 'listed option contracts' as specific 2024 activities; the LLM omits these details entirely. (4) UNSUBSTANTIATED CLAIMS - The LLM's discussion of 'ASC 326 practical-expedient,' 'credit-loss reserves,' and 'short-term borrowing' are not grounded in the provided ground truth and represent either hallucination or information from outside the specified knowledge graph. (5) PARTIAL CORRECTNESS - The LLM correctly identifies that Schwab pledged client securities and that this reflects collateral management strategy, but the execution is flawed. The answer demonstrates some understanding of the topic but introduces inaccurate details and fails to capture the specific temporal evolution that is fundamental to answering this multi-hop question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 463,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nGE’s work with the primary carriers that issued the long‑term‑care policies was essentially unchanged from 2022 through 2024: each year the company continued to **collaborate on filing proposed premium‑rate increases with state regulators**, but the **actual amount of approved hikes that had been implemented stayed modest – roughly $0.2 billion of previously approved increases by 2022, with only a small incremental addition in 2023 and no major new approvals in 2024**, leaving the total of anticipated future rate actions around **$1.7 billion (about $0.9 billion still pending implementation)**【GE_10k_2022.pdf p. 50‑51】【GE_10k_2023.pdf p. 20‑21】【GE_10k_2024.pdf p. 19‑20】.  \n\nThis steady, low‑growth pattern of rate‑increase approvals, together with the **annual premium‑deficiency testing that locks in discount‑rate and morbidity assumptions**, illustrates GE’s run‑off risk‑management strategy: it **relies on the primary insurers to obtain regulatory approvals, locks those assumptions into reserves, and mitigates exposure through rigorous actuarial testing and statutory capital support rather than direct control over rate changes**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and analytical errors that diverge substantially from the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n- The LLM introduces specific dollar amounts ($0.2 billion previously approved by 2022, $1.7 billion total anticipated, $0.9 billion pending) that are NOT present in the ground truth answer and cannot be verified from the cited sources\n- These numbers appear to be fabricated or misinterpreted from the filings\n- The ground truth makes NO mention of specific dollar amounts for rate increases\n- The LLM cites specific page numbers (p. 50-51, p. 20-21, p. 19-20) but these cannot be verified as containing the claimed quantitative data\n\n2. CORE NARRATIVE DIVERGENCE:\n- Ground truth emphasizes EVOLUTION: 2022 (indirect role, varied frequency) → 2023 (formalized collaboration, structured approach) → 2024 (reinforced framework with experience/precedent integration)\n- LLM claims the work was \"essentially unchanged\" from 2022-2024, which directly contradicts the ground truth's emphasis on strategic evolution and progression\n- This is a fundamental misreading of the question's focus on HOW the collaboration \"evolved\"\n\n3. MISSING KEY ELEMENTS:\n- Ground truth highlights formalization of collaboration under reinsurance contractual terms in 2023 - LLM omits this\n- Ground truth notes GE's use of recent experience and regulatory precedents in 2024 - LLM does not capture this progression\n- Ground truth emphasizes \"strategic shift toward proactive risk management and tighter integration\" - LLM characterizes it as \"steady, low-growth pattern\"\n\n4. REASONING QUALITY:\n- The LLM's conclusion about risk management strategy (relying on primary insurers, locking assumptions, rigorous testing) is reasonable but is built on a false premise of \"unchanged\" collaboration\n- The multi-hop synthesis fails because it mischaracterizes the evolution as static rather than dynamic\n- The LLM conflates the modest amount of IMPLEMENTED rate increases with the EVOLUTION of collaboration approach, which are different concepts\n\n5. CONTEXTUAL RELEVANCE:\n- The question specifically asks about evolution/progression from 2022-2024\n- LLM's answer about \"steady, low-growth pattern\" misses the point about how the COLLABORATION APPROACH evolved\n- The answer addresses risk management strategy but does so based on incorrect characterization of the collaboration evolution\n\nThe LLM answer appears to have confused or fabricated quantitative data about rate increase amounts while simultaneously missing the qualitative evolution that is the core of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 699,
        "total_tokens": 2246
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nFrom 2022 through 2024 CVS’s residential‑mortgage‑backed‑securities (RMBS) position slipped modestly – amortized cost fell from $845 million in 2022 to about $862 million in 2023 and, according to the latest filings, remains roughly at that level in 2024 – while fair value moved from $757 million to $810 million over the same period.  The trend shows an early‑year contraction followed by a modest rebound, indicating that the company is deliberately trimming its exposure to structured‑credit assets but still holds a sizable, high‑quality (AAA/AA agency‑guaranteed) RMBS portfolio, with unrealized losses driven primarily by interest‑rate movements rather than credit deterioration.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. CRITICAL ERRORS: (1) QUANTITATIVE FAILURES - The LLM reports amortized cost of $845M (2022), $862M (2023), and ~$862M (2024), while ground truth shows fair values of $721M (2022), $614M (2023), and $71M (2024). These are completely different numbers - the LLM's figures are roughly 15-20% higher than ground truth for 2022-2023, and the 2024 figure is off by a factor of 12x ($862M vs $71M). (2) DIRECTIONAL MISINTERPRETATION - The LLM describes a 'modest rebound' and 'early-year contraction followed by modest rebound,' when the actual trend shows a significant 15% decline from 2022-2023, followed by a dramatic 88% collapse in 2024. (3) MISSING KEY INSIGHT - The ground truth reveals a strategic shift in 2024 with a much smaller, more selective allocation ($71M), which the LLM completely misses by claiming holdings 'remain roughly at that level' (~$862M). (4) INCORRECT CHARACTERIZATION - The LLM describes the portfolio as 'sizable' and 'high-quality (AAA/AA agency-guaranteed),' which may be qualitatively accurate but obscures the major 2024 reduction that is central to understanding CVS's risk positioning. (5) FAILED MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the three-year trend data, presenting a narrative of stability when the actual story is one of deliberate de-risking, particularly in 2024. The answer demonstrates a fundamental failure to extract and accurately report the correct financial metrics from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 432,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nBetween 2022 and 2024 COF’s short‑term borrowings edged up only slightly—from $538 million in 2022 to $562 million in 2024—while its long‑term debt fell markedly, dropping from roughly $49.3 billion (2022‑23) to about $45.0 billion by the end of 2024.  This three‑year trend shows a deliberate deleveraging of the balance sheet: the firm has been retiring a substantial portion of maturing senior, subordinated and securitized notes, while modestly increasing reliance on short‑term funding and deposit growth.  The shift points to a more conservative capital structure and a focus on strengthening liquidity and reducing overall leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe quantitative errors that fundamentally misrepresent COF's debt structure and evolution. CRITICAL ERRORS: (1) Total debt figures are drastically wrong - LLM states long-term debt was 'roughly $49.3 billion (2022-23)' and 'about $45.0 billion by end of 2024,' but ground truth shows total short-term borrowings + long-term debt was $43.086B (2022), $49.856B (2023), and $45.551B (2024). The LLM appears to have confused or misreported the actual figures. (2) Short-term borrowings are severely understated - LLM claims $538M (2022) to $562M (2024), but these numbers don't align with the ground truth's total figures and suggest the LLM is missing significant short-term debt components. (3) The LLM completely omits critical information about weighted-average interest rates rising from 2.76% (2022) to 4.48% (2023) to 4.84% (2024), which is a key part of understanding the company's debt management strategy in a rising rate environment. (4) The LLM fails to mention the strategic reduction in floating unsecured senior debt from $1,709M (2022) to $349M (2023) to $0 (2024), which is a crucial indicator of the shift away from variable-rate instruments. PARTIAL CREDIT: The LLM correctly identifies the general pattern of deleveraging in 2024 and the strategic nature of debt management, and the qualitative conclusion about 'conservative capital structure' and 'strengthening liquidity' is directionally reasonable. However, the quantitative foundation is so flawed that the analysis lacks credibility. The answer fails the multi-hop synthesis requirement by not properly integrating the interest rate evolution and debt composition changes that are essential to understanding the full capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 475,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a flat‑line liability across the three fiscal years – the carrying amount was $2.0 billion in the FY 2022 10‑K (pp. 78‑82), remained $2.0 billion in the FY 2023 filing (pp. 65‑69), and was still $2.0 billion in the FY 2024 filing (pp. 70‑74).  \n\nThis consistency indicates that NVIDIA is deliberately anchoring its long‑term capital structure to a sizable, fixed‑rate debt tranche, maintaining a stable leverage profile while supplementing financing with shorter‑term borrowings and equity. The unchanged balance signals a strategy of preserving a reliable, low‑cost funding source and limiting net new long‑term debt issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the core quantitative facts. Ground truth shows the 3.50% Notes Due 2050 liability DECREASED from $2,147 million (FY2022) to $1,604 million (FY2024), a significant $543 million reduction. The LLM claims the liability remained flat at $2.0 billion across all three years, which directly contradicts the ground truth data. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states $2.0 billion (~$2,000M) for all three years, but ground truth shows: FY2022=$2,147M, FY2023=$1,637M, FY2024=$1,604M. These are material differences (5-10% variance), not rounding variations. The LLM's claim of 'flat-line liability' is factually wrong. (2) MULTI-HOP REASONING FAILURE: The LLM correctly identifies the need to track the liability across three fiscal years but fails to extract the correct values from the source documents. The reasoning about capital structure strategy (anchoring to fixed-rate debt, maintaining stable leverage) would be appropriate IF the numbers were correct, but it's built on false premises. (3) ENTITY ACCURACY: The company (NVIDIA), debt instrument (3.50% Notes Due 2050), and fiscal years (2022-2024) are correctly identified, but the financial metrics are completely wrong. (4) SEMANTIC MISMATCH: The ground truth explicitly states a 'deliberate reduction' in the liability, while the LLM claims 'consistency' and 'unchanged balance.' These are opposite conclusions. The LLM's interpretation of strategic intent is incompatible with the actual declining trend. The LLM appears to have either misread the source documents or hallucinated the $2.0B figure across all years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 450,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 0.45 % Notes due 2016 are listed in the same debt‑schedule line with an unchanged coupon, principal amount and maturity date; the only evolution is the periodic re‑classification of the portion that becomes current as the fiscal year progresses. This steady, unchanged disclosure shows Apple’s long‑term debt strategy of maintaining a low‑cost, fixed‑rate tranche and of providing transparent, consistent reporting of each debt series over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The numeric values are accurate - 0.45% coupon rate, 2016 maturity date, and the three fiscal years (2022, 2023, 2024) are all correct. (2) The observation about unchanged coupon, principal amount, and maturity date across filings is factually sound. (3) The mention of current/non-current reclassification is a valid technical detail about debt accounting. PROBLEMATIC ASPECTS: (1) The LLM answer makes a SIGNIFICANT INTERPRETIVE ERROR by characterizing this as evidence of Apple's 'long-term debt strategy of maintaining a low-cost, fixed-rate tranche.' This is misleading because the notes MATURED IN 2016 - they are not an active strategic holding but rather a historical disclosure artifact. The ground truth correctly identifies this as legacy debt disclosure for transparency and legal continuity. (2) The LLM answer fails to address the core insight from the ground truth: that Apple continues to reference debt instruments AFTER their maturity date (2016 maturity, yet still disclosed in 2022-2024 filings). This is the key pattern indicating Apple's disclosure strategy, not evidence of an ongoing strategic debt position. (3) The LLM answer mischaracterizes the nature of the disclosure - it frames this as an active debt management strategy when it's actually a historical/legacy disclosure practice. MULTI-HOP REASONING: The LLM correctly synthesized information across three years but drew an incorrect conclusion about what the pattern indicates. The ground truth emphasizes the post-maturity disclosure pattern as the key insight; the LLM missed this critical distinction. The answer demonstrates partial understanding of the mechanics but fundamental misinterpretation of the strategic/disclosure implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 492,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nCapital One’s net derivative assets grew sharply from $5 million at the end of 2022 to $58 million in 2023 and to $69 million by the end of 2024, driven by larger transfers‑in and settlements rather than by net income (which recorded modest losses of $‑14 M, $‑65 M and $‑15 M respectively).  The Level‑3 inputs that underpin this valuation also evolved: discount‑rate‑related swap rates moved from a 1‑2 % range in 2022 to a 3‑5 % range in 2023‑24, and the weighted‑average default and loss‑severity assumptions rose modestly, reflecting higher interest‑rate and credit‑risk expectations.  This multi‑year progression signals that the firm’s exposure to market‑driven interest‑rate and credit risk has intensified, and that its fair‑value models now incorporate more pronounced unobservable inputs, increasing sensitivity to underlying market assumptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ERRORS (Primary Issue):\n   - LLM claims 2022 value was $5 million; Ground Truth states $31 million (ERROR: off by $26M)\n   - LLM claims 2024 value was $69 million; Ground Truth states $58 million (ERROR: off by $11M)\n   - LLM cites swap rates at 1-2% in 2022; Ground Truth does not mention this range for 2022\n   - LLM cites 3-5% range for 2023-24; Ground Truth specifies 4% weighted average for both years\n   - LLM references net income losses of -$14M, -$65M, -$15M; Ground Truth discusses realized losses of $43M in 2022, not net income figures\n\n2. ENTITY/METRIC CONFUSION:\n   - LLM conflates different metrics (net income vs. realized/unrealized losses)\n   - LLM discusses 'transfers-in and settlements' which are not mentioned in ground truth\n   - Ground Truth specifically mentions 'net unrealized loss of $20 million' in 2022; LLM does not address this\n\n3. KEY RISK DRIVER ANALYSIS (Critical Omission):\n   - Ground Truth clearly identifies a SHIFT in significant unobservable inputs: from 'default' (2023) to 'swap rates' (2024)\n   - LLM mentions both but fails to identify this critical shift as the key finding\n   - LLM incorrectly suggests both default and swap rates were present across all years\n\n4. VALUATION PROGRESSION:\n   - Ground Truth: $31M (2022) → $58M (2023) → $58M (2024) - stable from 2023 onward\n   - LLM: $5M (2022) → $58M (2023) → $69M (2024) - continuing growth\n   - These are fundamentally different narratives\n\n5. INTERPRETATION QUALITY:\n   - Ground Truth emphasizes 'improved risk management or market stabilization' with stable 2023-2024 values\n   - LLM emphasizes 'intensified exposure' and 'more pronounced unobservable inputs'\n   - These opposite conclusions stem from the incorrect 2024 valuation figure\n\n6. MULTI-HOP REASONING:\n   - LLM failed to correctly synthesize the multi-year progression\n   - The core finding about the shift from default to swap rates as the significant input is missing\n   - The analysis of what this shift indicates about modeling assumptions is incomplete\n\nThe LLM answer appears to reference different data or misread the source documents, resulting in systematically incorrect financial figures that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 627,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nThe fair‑value of NVIDIA’s 1.55 % Notes Due 2028 was roughly $1.0 billion at the end of fiscal 2022, rose to about $1.10 billion by the end of fiscal 2023 and reached approximately $1.12 billion at the close of fiscal 2024 (carrying amounts remained near $1.25 billion throughout).  This modest upward trend shows that the company is maintaining a stable, low‑cost, long‑dated financing position—issuing long‑term debt at very low coupons and holding it to maturity rather than actively trading or retiring the securities.  The progression reflects NVIDIA’s strategy of using inexpensive, long‑term debt to fund ongoing operations and strategic investments while limiting exposure to interest‑rate volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer provides significantly incorrect financial figures that contradict the ground truth. Ground truth states carrying amounts of $1.2B (2022), $1.1B (2023), and $1.25B (2024). The LLM reports fair values of ~$1.0B (2022), ~$1.10B (2023), and ~$1.12B (2024), then claims carrying amounts remained near $1.25B throughout—which is internally inconsistent and factually wrong. The 2022 carrying amount should be $1.2B, not $1.25B. The LLM appears to have confused fair value with carrying value or misread the data entirely. MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024 and what it reveals about debt strategy. While the LLM attempts to synthesize this into a narrative about maintaining stable, low-cost financing, the underlying numbers are wrong, making the entire analysis unreliable. SPECIFIC ISSUES: (1) 2022 figure of ~$1.0B is incorrect (should be $1.2B carrying amount); (2) 2023 figure of ~$1.10B is incorrect (should be $1.1B, though this happens to be close); (3) 2024 figure of ~$1.12B is significantly incorrect (should be $1.25B); (4) The claim that carrying amounts 'remained near $1.25B throughout' is false—they were $1.2B, $1.1B, and $1.25B respectively. QUALITATIVE ASSESSMENT: The reasoning about debt strategy (low-cost, long-dated financing, hold-to-maturity approach) is reasonable and contextually appropriate, but it's built on incorrect numerical foundations. The semantic interpretation of the trend is also wrong—the ground truth shows a dip in 2023 followed by recovery in 2024, not a consistent upward trend as the LLM suggests.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 448,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nGE’s filings show that the company’s exposure to trailing legal liabilities has remained steady—not diminishing—from 2022 through 2024. In the 2022 filing (p. 70) it highlighted the Alstom‑related antitrust and corruption matters that have already generated cash outflows and will continue to do so, and noted that the 2020 SEC settlement did not end the shareholder suits over historic financial‑reporting disclosures. The 2023 filing (p. 35) reiterated that those shareholder actions remain active and that reserves for “legacy” litigation are maintained, but the ultimate loss may exceed the estimates. The 2024 filing (p. 32) again warned of “material trailing legal liabilities” from the Alstom acquisition and ongoing shareholder litigation, emphasizing that future settlements or judgments could require additional cash. Together, the disclosures indicate that these contingent liabilities persist and continue to pose a measurable, though not yet fully quantifiable, financial impact on GE.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of GE's persistent legal liabilities from 2022-2024, accurately references the Alstom acquisition legacy matters and shareholder lawsuits, and properly synthesizes the multi-hop information across three years of filings. The semantic meaning aligns well with the ground truth—both convey that liabilities remained steady/persistent, not diminishing. The answer correctly notes that reserves may be exceeded and that future settlements could require additional cash. The reasoning about the progression showing these as material, ongoing burdens is sound.\n\nWEAKNESSES: (1) QUANTITATIVE SPECIFICITY: The LLM provides page references (p. 70, p. 35, p. 32) but does not cite any specific dollar amounts, percentages, or quantified metrics from the filings. The ground truth does not provide specific numbers either, but the LLM's lack of any quantitative detail (even if only to note that specific amounts were disclosed) represents a minor gap in comprehensiveness. (2) DETAIL LEVEL: The LLM mentions the '2020 SEC settlement' which adds helpful context not explicitly in the ground truth, but the ground truth emphasizes 'reputational risks' and 'reputation and financial performance' impacts more explicitly—the LLM focuses more on cash impact and less on reputational dimension. (3) CHARACTERIZATION: The LLM states liabilities are 'measurable, though not yet fully quantifiable'—this is a reasonable inference but slightly different from the ground truth's emphasis on 'material financial and reputational risks' and the assertion that they 'continue to pose material financial and reputational risks.'\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three separate filing years (2022, 2023, 2024) and properly connects the Alstom acquisition legacy to ongoing shareholder litigation. The progression logic is sound.\n\nFACTUAL VERIFICATION: All entities (GE, Alstom, shareholder suits, antitrust/corruption matters) are correctly identified. Years are correct. The characterization of these as 'trailing' and 'contingent' liabilities is appropriate. No factual errors detected, though some nuance around reputational impact could be stronger.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 598,
        "total_tokens": 2212
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the pension plan’s exposure to hedge‑fund limited‑partnership interests rose from roughly **$237 million** (the amount excluded from the fair‑value hierarchy in the 2022 filing) to **$252 million** in 2023 and to **$280 million** in 2024.  This steady increase shows that CVS is deliberately expanding its allocation to alternative, higher‑return assets—using hedge‑fund LP investments to diversify the fund’s asset mix and boost long‑term returns—while accepting the associated liquidity and valuation risks inherent in private‑market holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in all three years of financial data. Ground truth values are: 2022: $214M, 2023: $225M, 2024: $252M. LLM reported: 2022: $237M, 2023: $252M, 2024: $280M. Every single number is incorrect. The LLM appears to have confused or misread the data points entirely. The 2023 figure in the LLM answer ($252M) actually matches the correct 2024 figure, suggesting a systematic shift or misalignment of years. The 2024 figure of $280M is $28M higher than the correct value. MULTI-HOP REASONING: While the LLM correctly identifies the general trend (upward movement) and provides reasonable strategic interpretation about diversification and alternative investments, this qualitative reasoning cannot compensate for the fundamental quantitative errors. The reasoning about pension fund strategy is sound in principle but is built on incorrect numerical foundations. COMPLETENESS: The answer addresses both parts of the question (the change from 2022-2024 and strategic implications), but the factual basis is compromised. ENTITY ACCURACY: CVS is correctly identified, the metric (hedge fund LP investments) is correct, and the time period is correct, but the actual values are wrong. The severity of these quantitative errors—being off by $23M-$28M across different years—represents a fundamental failure to accurately extract or synthesize the financial data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 406,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nIn 2022 the Africa/Eurasia operating profit was about **$253 million**.  The 2023 restructuring program allocated roughly **5 % of the $32 million Global Productivity Initiative charges** to the region – approximately **$1.6 million of pretax restructuring costs** – signalling a targeted efficiency drive.  By 2024 the region’s depreciation and amortization outlay had risen to **$9 million**, while its operating profit remained essentially flat at **≈ $250 million**, underscoring a stable but modest financial and operational focus on Africa/Eurasia over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors across all key metrics:\n\n1. OPERATING PROFIT 2022: LLM states $253 million, but ground truth is $203 million. This is a $50 million error (24.6% overstatement).\n\n2. RESTRUCTURING CHARGES 2023: LLM claims 5% of $32 million = $1.6 million allocated to Africa/Eurasia. Ground truth states 10% of expected restructuring charges = $20-24 million. The LLM both understates the percentage (5% vs 10%) and the absolute amount (by ~12-15x), representing a fundamental misunderstanding of the restructuring allocation.\n\n3. DEPRECIATION & AMORTIZATION 2024: LLM states $9 million (same as 2022-2023), but ground truth clearly indicates a DECLINE to $8 million in 2024 from $9 million in prior years. The LLM missed this key trend showing reduced capital investment.\n\n4. OPERATING PROFIT 2024: LLM claims ~$250 million (flat from 2022), but the ground truth does not provide 2024 operating profit data. The LLM appears to have fabricated this comparison.\n\n5. MULTI-HOP REASONING: The LLM failed to synthesize the three-year trajectory correctly. The ground truth narrative emphasizes: (a) modest 2022 contribution ($203M), (b) significant 2023 restructuring effort ($20-24M), and (c) declining 2024 depreciation ($8M) suggesting reduced investment. The LLM's narrative is inverted and inaccurate.\n\n6. CONTEXTUAL INTERPRETATION: The ground truth correctly identifies the pattern as \"low-level financial presence...with limited growth investment and focus on cost optimization.\" The LLM's claim of \"stable\" operations at $250M contradicts the actual declining investment trend.\n\nThe answer demonstrates poor data retrieval, calculation errors, and failure to accurately synthesize multi-hop information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 487,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nAIG’s international terrorism exposure has been modeled each year with third‑party scenario loss estimates that remain in the low‑single‑billion‑dollar range (e.g., about $1.3 bn net of TRIPRA for a major New York City event), and the company has continued to rely on limited private reinsurance together with the U.S. government’s TRIPRA program. In the 2024 treaty year the firm reduced its Japan attachment point to $150 million and left the rest‑of‑world attachment at $125 million, down from the $200 million and $100 million levels used in 2022, reflecting higher self‑retention. As a result, reinsurance recoverable assets fell sharply from $67.5 bn at year‑end 2023 to $38 bn at year‑end 2024, underscoring the tighter reinsurance structure and reduced ceded reserves for terrorism risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) ATTACHMENT POINTS REVERSED: The LLM claims Japan attachment was REDUCED to $150M and rest-of-world to $125M in 2024, stating these are 'down from the $200 million and $100 million levels used in 2022.' However, the ground truth explicitly states Japan retained $200M and elsewhere $125M as core attachment points. The LLM has inverted the direction of change and the 2022 baseline figures. (2) REINSURANCE RECOVERABLE ASSETS TRAJECTORY: The LLM claims recoverable assets 'fell sharply from $67.5 bn at year-end 2023 to $38 bn at year-end 2024.' The ground truth states 2024 reinsurance recoverable assets reached $38.0 billion, but provides no evidence of a $67.5B figure in 2023 or that this represents a 'sharp fall.' This appears to be fabricated data. (3) CEDED RESERVES: The LLM vaguely references 'reduced ceded reserves for terrorism risk' but the ground truth specifically notes $29.1 billion in ceded loss reserves as part of the $38.0 billion total in 2024, indicating expansion rather than reduction. (4) DIRECTIONAL LOGIC: The LLM's narrative of 'higher self-retention' and 'tighter reinsurance structure' contradicts the ground truth's characterization of 'expansion in reinsurance protections' and 'increasing reliance on reinsurance.' (5) CORRECT ELEMENTS: The LLM correctly identifies the $1.3 billion net loss estimate for NYC scenario, TRIPRA reliance, third-party modeling, and the $125M rest-of-world attachment point. The multi-hop synthesis is partially attempted but undermined by the fabricated numbers and reversed directional claims. The answer demonstrates some understanding of the question structure but fails on core quantitative accuracy and introduces false data points that significantly misrepresent AIG's actual risk management evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 510,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe 2.00% Notes Due 2031 showed a $1.2 billion carrying amount in fiscal 2022, a modest dip to about $1.04 billion in fiscal 2023, and a rebound to roughly $1.25 billion in fiscal 2024.  This movement indicates that NVIDIA is actively managing its long‑term debt profile—using targeted repayments or refinancing to lower leverage in 2023 and then re‑issuing or expanding the low‑coupon 2031 tranche in 2024 to restore a stable, low‑cost capital position that supports its ongoing investment and growth initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "QUANTITATIVE ACCURACY: All dollar amounts are correct ($1.2B in 2022, $1.044B in 2023, $1.25B in 2024). The LLM uses approximate language ('about $1.04 billion', 'roughly $1.25 billion') which is acceptable given the context. Numbers are accurate and properly formatted. COMPLETENESS: The LLM addresses the core question about the trend and what it suggests about debt management strategy. ENTITY ACCURACY: Correct identification of NVIDIA, the 2.00% Notes Due 2031, and fiscal years 2022-2024. REASONING AND INTERPRETATION ISSUES: The LLM's interpretation diverges significantly from the ground truth. Ground truth characterizes the trend as 'relatively stable' and suggests NVIDIA 'maintained its long-term capital structure' without 'material' changes. The LLM, however, interprets the movements as evidence of 'active management' with 'targeted repayments' in 2023 and 're-issuing or expanding' in 2024. This is a material difference in interpretation. The ground truth suggests the fluctuations are minor and reflect a stable strategy, while the LLM suggests deliberate tactical adjustments. The LLM's claim about 're-issuing or expanding the low‑coupon 2031 tranche' is speculative and not supported by the ground truth, which simply notes the carrying amount returned to $1.25B without characterizing it as a re-issuance or expansion. SEMANTIC EQUIVALENCE: While both answers discuss debt management strategy, they reach different conclusions about the nature of that strategy (stable vs. actively managed with tactical adjustments). The LLM's interpretation of the 2023 dip as 'targeted repayments' and the 2024 rebound as 're-issuing' goes beyond what the ground truth supports. The ground truth is more conservative, attributing the 2023 decrease to 'minor debt repayments or reclassifications' without asserting active tactical management. STRENGTHS: Accurate numbers, clear presentation, addresses the question directly. WEAKNESSES: Over-interprets the data as evidence of active tactical management rather than stability; speculates about re-issuance without ground truth support; mischaracterizes the nature of NVIDIA's debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 576,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 appear in the “Description of Securities” (Exhibit 4.4) of each filing – page 54 of the 2022 10‑K, pages 53‑54 of the 2023 10‑K, and page 54 of the 2024 10‑K – but their status changes over the three years: in 2022 they are still listed as an outstanding tranche, in 2023 the filing notes that the notes were fully redeemed in 2022 and the related discount/premium amortization is complete, and by 2024 the series no longer shows up as a separate liability, leaving only a historical reference. This evolution demonstrates that Apple’s debt issuance is a transparent, staged pipeline – each tranche is publicly disclosed, tracked through issuance, amortization and retirement, and then rolled into newer notes – providing investors with long‑term visibility and continuity of Apple’s capital‑structure strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) FACTUAL CONTRADICTION: The LLM claims the 1.05% Notes due 2017 were 'fully redeemed in 2022' and 'no longer shows up as a separate liability' by 2024, but the ground truth explicitly states the notes 'remained consistent across all three years—2022, 2023, and 2024' as part of Apple's incorporated debt instruments. This is a fundamental contradiction. (2) MISINTERPRETATION OF EVIDENCE: The LLM appears to have misread or misinterpreted the filing documents. The ground truth indicates the notes continued to be referenced in all three years despite maturing in 2017, suggesting they were rolled over or refinanced. The LLM's narrative of redemption in 2022 and removal by 2024 is not supported by the ground truth. (3) LOGICAL INCONSISTENCY: The LLM's conclusion about 'transparent, staged pipeline' and 'long-term visibility' is reasonable in principle, but it's built on incorrect premises about what actually happened to these notes. (4) MISSING CORE INSIGHT: The ground truth emphasizes the PERSISTENCE of the notes across all three years despite their 2017 maturity date, which is the key revelation about Apple's debt structure continuity. The LLM instead describes a redemption/retirement narrative that contradicts this. (5) PAGE REFERENCES: While the LLM provides specific page citations (54, 53-54, 54), these cannot be verified against the ground truth, and the interpretation of what appears on those pages is demonstrably wrong. The answer fails on the primary metric of factual correctness regarding the evolution and status of these notes across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 460,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s migration rights under the IDA program shifted dramatically: the 2019 IDA agreement (which allowed up to $10 billion of IDA balances to be moved to Schwab’s balance sheet every 12 months, subject to an 80 % fixed‑rate designation and other adjustments) was replaced on May 4 2023 by the 2023 IDA agreement, which eliminated the 80 % fixed‑rate requirement, extended the sweep term to July 1 2034, and imposed new minimum‑balance floors ($60 billion after Sept 10 2025, with a $30 billion buffer through Sept 10 2025) and a $90 billion ceiling, while also permitting Schwab to “buy down” up to $5 billion of fixed‑rate obligations by paying a market‑based fee; as a result, Schwab migrated no IDA balances to its balance sheet in 2023 or 2024, relying instead on the buy‑down option and the new balance‑mainance limits.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates, dollar amounts, and agreement terms. Verified facts: (1) 2019 IDA agreement allowed $10 billion annual migration - CORRECT; (2) 2023 IDA agreement effective May 4, 2023 - CORRECT; (3) $60 billion minimum balance threshold after Sept 10, 2025 with $30 billion buffer through Sept 10, 2025 - CORRECT; (4) $90 billion ceiling - CORRECT; (5) $5 billion buy-down option - CORRECT; (6) July 1, 2034 sweep term extension - CORRECT; (7) No IDA balance migrations in 2023-2024 - CORRECT. The LLM answer provides more granular detail than the ground truth, including the 80% fixed-rate requirement elimination, buy-down mechanics, and specific threshold dates. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from 2022 (active migration under 2019 agreement) through 2023-2024 (constrained off-balance sheet management under 2023 agreement). Minor deduction: The ground truth mentions Schwab had 'already moved $10.1 billion by year-end' 2022, which the LLM answer does not explicitly reference, though this is a minor omission. The LLM answer's additional technical details about fixed-rate requirements and buy-down options enhance understanding without contradicting the ground truth. The semantic equivalence is strong - both answers convey the strategic shift from active migration to constrained off-balance sheet management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 400,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s exposure to Bank BPH’s foreign‑currency mortgage portfolio was steadily run‑down: the portfolio’s carrying value, which was $1.799 bn (net of reserves) in 2021, was reduced to zero by the end of 2023 after cash capital infusions of $530 m in 2022 and a non‑cash $1.797 bn inter‑company loan‑forgiveness in 2023, while the company continued to set aside provisions for the ongoing borrower‑litigation.  The estimated total loss from that litigation fell from $2.669 bn as of 31 Dec 2023 to $2.461 bn as of 31 Dec 2024, reflecting the settlement program and the valuation allowance that now fully offsets the receivable balance, illustrating GE’s shift from funding the mortgage book to essentially eliminating it and closely monitoring the remaining litigation risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual errors that reduce its overall correctness despite capturing some key elements:\n\nCRITICAL ERRORS:\n1. TIMELINE ERROR - The LLM states the carrying value was reduced to zero \"by the end of 2023\" but the ground truth clearly indicates this occurred \"by the end of 2024.\" This is a major factual error affecting the core narrative of the question.\n2. ESTIMATED LOSSES SEQUENCE - The LLM reverses the chronological order, stating losses \"fell from $2.669 bn as of 31 Dec 2023 to $2.461 bn as of 31 Dec 2024.\" While these numbers are correct, the ground truth shows losses ROSE from $1.359 million in 2022 to $2.669 million in 2023, then declined to $2.461 million in 2024. The LLM omits the 2022 baseline entirely, missing the critical escalation phase.\n\nPARTIAL OMISSIONS:\n1. Missing the $1.359 million estimated loss figure for 2022, which is essential to showing the \"significant increase\" in exposure.\n2. Missing the $1.014 million Q2 2023 settlement charge, which is a key strategic action.\n3. Fails to explicitly state that \"no further contributions were required\" in 2024, missing an important aspect of the stabilization narrative.\n4. The phrase \"by the end of 2023\" for portfolio write-down contradicts the ground truth's \"by the end of 2024.\"\n\nCORRECT ELEMENTS:\n1. Capital contributions accurately cited: $530 million cash in 2022 and $1.797 billion non-cash in 2023.\n2. Estimated loss figures for 2023 and 2024 are numerically correct ($2.669 bn and $2.461 bn).\n3. Correctly identifies the settlement program and valuation allowance.\n4. Appropriately characterizes the overall trajectory as a shift from funding to elimination.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable synthesis across the three-year period and correctly connects capital contributions to portfolio reduction. However, the timeline error (2023 vs 2024 for zero carrying value) and omission of the 2022 baseline significantly weaken the multi-hop analysis of how exposure \"evolved\" across the full period.\n\nSEMANTIC ISSUES:\nThe answer's framing focuses on the run-down narrative but misses the critical escalation-then-stabilization pattern that is central to the question's request for understanding how exposure \"evolved.\"",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 614,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nBetween 2022 and 2024 the fair value of CVS’s commercial‑mortgage‑backed securities fell from roughly **$1.018 bn to $0.975 bn**, while the unrealized‑loss position grew from **$12 m to $100 m**. This modest reduction in holdings together with the sharply higher unrealized losses—driven by rising interest rates rather than credit deterioration—indicates that CVS is deliberately trimming its CMBS exposure and treating the remaining securities as long‑term, interest‑rate‑sensitive assets, managing risk by holding them to recovery rather than selling.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that make it largely incorrect. CRITICAL ERRORS: (1) CMBS Fair Value Numbers: The LLM states fair value fell from '$1.018 bn to $0.975 bn' (2022-2024), but the ground truth shows it was $574M in 2022 and $3M in 2024. The LLM's numbers are off by a factor of approximately 1.8x for 2022 and 325x for 2024. These are not minor rounding differences but massive discrepancies. (2) Missing 2023 Data: The LLM completely omits the 2023 figures ($675M fair value, $100M unrealized losses), which are critical to understanding the evolution and trend. The question explicitly asks about the evolution 'from 2022 through 2024,' requiring all three years. (3) Unrealized Losses: The LLM correctly identifies the $12M in 2022 but fails to mention the $100M in 2023 and provides no 2024 figure. The statement that unrealized losses grew 'from $12m to $100m' is incomplete without noting the intermediate 2023 peak. (4) Trend Interpretation: The LLM's interpretation that CVS is 'deliberately trimming' exposure is contradicted by the actual data showing a dramatic 99.6% reduction in 2024 (from $675M to $3M), which suggests not gradual trimming but a major strategic liquidation. (5) Risk Management Narrative: The LLM's characterization of holding securities 'to recovery rather than selling' contradicts the ground truth's finding that 2024 shows a 'major reduction in exposure' and 'strategic shift to de-risk the portfolio.' The LLM's interpretation is fundamentally misaligned with what the data actually shows. The answer demonstrates poor multi-hop synthesis across the three-year period and provides quantitatively inaccurate information that would mislead anyone relying on it for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 479,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Walmart steadily broadened the Marketside private‑brand assortment—adding new grocery categories, expanding SKU count and rolling the brand out to more store formats—while the 2023 and 2024 filings explicitly note “expansion” and “growth” of the Marketside portfolio. This three‑year progression shows that Walmart is treating Marketside as a core component of its grocery‑segment strategy, using private‑label expansion to boost margin, differentiate its offering and deepen customer loyalty.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer makes specific factual claims NOT supported by the ground truth: it states Walmart 'steadily broadened the Marketside private-brand assortment—adding new grocery categories, expanding SKU count and rolling the brand out to more store formats.' The ground truth contains NO mention of SKU expansion, new category additions, or store format rollouts. These are fabricated details. (2) The LLM claims '2023 and 2024 filings explicitly note expansion and growth of the Marketside portfolio' - the ground truth only mentions that Marketside 'remained a named private brand' in 2023 and 'continued to be featured' in 2024, with no explicit language about 'expansion' or 'growth.' (3) The LLM introduces unsupported strategic rationales ('boost margin, differentiate its offering and deepen customer loyalty') that are not present in the ground truth. WHAT WAS CORRECT: (1) The LLM correctly identifies the 3-year timeframe (2022-2024). (2) It correctly identifies Marketside as a core component of Walmart's grocery strategy. (3) The general framing of consistency with innovation aligns with the ground truth's 'dual approach.' WHAT WAS MISSING: (1) The ground truth emphasizes the introduction of NEW brands like 'bettergoods' as part of modernization - the LLM completely omits this key detail. (2) The ground truth explicitly mentions other legacy brands (Great Value, George) to contextualize Marketside's role - the LLM provides no such context. (3) The ground truth's emphasis on 'preserving trusted private brands while innovating to meet evolving consumer preferences' is more nuanced than the LLM's answer. MULTI-HOP REASONING: The LLM failed to properly synthesize the ground truth's key insight: that Walmart's strategy involves BOTH maintaining legacy brands AND introducing new ones. Instead, it fabricated specific operational details (SKU counts, category expansion, store rollouts) that cannot be verified from the provided ground truth. This represents a significant failure in accuracy, as the LLM appears to have hallucinated supporting details rather than working from the actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 574,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s progressively tightened its oversight of suppliers by updating its Vendor Code of Conduct and Human‑Rights policy to embed the Universal Declaration of Human Rights, conflict‑minerals standards and stricter environmental criteria, and by introducing a risk‑based wood‑sourcing policy that adds country‑specific risk levels, enhanced monitoring and a new forestry‑grievance process.  At the same time the company invested heavily in supply‑chain sustainability—spending > $300 million on energy‑efficiency and renewable‑energy projects, setting a science‑based net‑zero‑by‑2050 target with 2030 interim cuts (42 % Scope 1‑2 and 25 % Scope 3 reductions), and requiring suppliers to disclose emissions to CDP and adopt Sustainable Forestry Initiative standards—thereby strengthening both enforcement and measurable progress on environmental and human‑rights performance across its supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies regarding investment amounts. Ground truth states investments 'exceeding $550 million by 2022 and over $400 million through 2023,' but the LLM claims '>$300 million on energy-efficiency and renewable-energy projects' without specifying the timeframe or total sustainability investments. This represents a substantial understatement of Lowe's actual investment commitment. The LLM also introduces specific emissions reduction targets (42% Scope 1-2 and 25% Scope 3 reductions) and supplier requirements (CDP disclosure, SFI standards) that are NOT mentioned in the ground truth, raising concerns about factual accuracy beyond the provided knowledge base. QUALITATIVE STRENGTHS: The LLM correctly identifies key policy enhancements including the risk-based wood sourcing policy, country-specific risk levels, enhanced monitoring, and the new forestry grievance process. It accurately references the Vendor Code of Conduct, Human Rights policy, and conflict minerals standards. The multi-hop synthesis across 2022-2024 is logically structured. CRITICAL GAPS: The answer fails to clearly distinguish the evolution across the three years (2022, 2023, 2024) as the ground truth does, instead presenting changes as a continuous progression. The investment figures are materially incorrect and incomplete. The introduction of emissions targets and CDP/SFI requirements appears to be information not grounded in the provided knowledge graph, which is problematic for a factual evaluation task. OVERALL: While the qualitative discussion of policy enhancements is reasonably accurate, the quantitative errors (investment amounts significantly understated) and introduction of unverified claims substantially undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 493,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nIn the 2022 Form 10‑K Apple disclosed the $ X billion of 2.40 % senior notes that matured in 2023 as an outstanding long‑term borrowing (shown in Note 5 and classified as a current portion because the maturity was within the fiscal year). By the 2023 filing the note had been fully retired—Apple reported that the 2.40 % 2023 tranche was paid off and no longer appeared on the balance sheet. The 2024 filing contains no reference to a 2.40 % 2023 issue, indicating the debt was refinanced and replaced with newer long‑term borrowings, underscoring Apple’s ongoing strategy of proactively rolling maturing debt into fresh, low‑cost issuances to sustain a stable capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Disclosure Pattern: The ground truth explicitly states the 2.40% Notes due 2023 were 'consistently included' in filings for 2022, 2023, AND 2024. The LLM claims the note 'no longer appeared on the balance sheet' after 2023 and 'contains no reference' in 2024, which is directly contradicted by the ground truth stating it 'still included the 2.40% Notes due 2023 in its exhibit list' in 2024. (2) QUANTITATIVE ACCURACY FAILURE: The LLM references '$ X billion' without providing the actual amount, showing incomplete data retrieval. The ground truth does not specify a dollar amount, but the LLM's placeholder indicates missing information. (3) INTERPRETATION ERROR: The LLM interprets the disclosure pattern as indicating debt retirement and refinancing ('paid off and no longer appeared,' 'debt was refinanced and replaced'), when the ground truth indicates the opposite - that Apple deliberately maintained consistent disclosure of the legacy debt across all three years despite maturity. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the three-year pattern. It incorrectly concluded that absence from 2024 filings indicates refinancing, when the ground truth explicitly states the notes were still included in 2024 exhibits. (5) STRATEGIC INTERPRETATION MISMATCH: The LLM characterizes the strategy as 'proactively rolling maturing debt into fresh, low-cost issuances,' but the ground truth characterizes it as 'sustained transparency' and 'stable and transparent debt disclosure strategy' - fundamentally different interpretations of the same disclosure pattern. The LLM's answer is internally inconsistent with documented facts from the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 489,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s exposure to AerCap moved from a sizable equity stake — about a 46 % ownership of AerCap ordinary shares (recorded as an equity security with a fair‑value of roughly $8.3 bn in 2021 and still reflected in the 2022 investment‑securities portfolio) — to a complete exit from the equity.  In 2023 the company sold the remaining AerCap shares, leaving only the AerCap senior note as its holding, and in 2024 the note remained on the balance sheet with a modest realized/unrealized gain reported in “Other income (loss).”  This progression shows that GE deliberately shifted from an equity‑heavy investment to a fixed‑income position, underscoring a strategic move toward more stable, cash‑generating assets and a streamlined portfolio after the HealthCare and Vernova spin‑offs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a different aspect of GE's AerCap holdings than what the question asks. CRITICAL ERRORS: (1) The ground truth specifically addresses the AerCap NOTE holdings evolution ($976M in 2022 → $944M in 2023 → $982M in 2024), but the LLM answer focuses almost entirely on the AerCap equity stake (46% ownership, ~$8.3bn in 2021), which is a separate instrument. (2) The LLM claims GE sold all remaining AerCap shares in 2023, leaving only the note, but provides no evidence of this claim and no numbers for the note holdings that the question specifically asks about. (3) The LLM provides no quantitative data for the note progression (the core of the question), instead discussing equity holdings and spin-offs. (4) The LLM's narrative about 'complete exit from equity' and 'shifted from equity-heavy to fixed-income' is not supported by the ground truth data, which focuses on the note's modest fluctuations ($976M → $944M → $982M). (5) While the LLM correctly identifies that GE held both equity and debt instruments in AerCap, it fails to answer the specific question about the note's evolution. The ground truth answer directly provides the three-year progression of the note holdings with specific dollar amounts, while the LLM answer omits these critical numbers entirely. The LLM's interpretation about strategic portfolio shifts may have some validity contextually, but it is based on the wrong financial instrument and lacks the quantitative precision required to answer this multi-hop question accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 429,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s U.S. pension glide‑path shifted from a ~15 % equity / ~75 % fixed‑income target (2022) to a ~9 % equity / ~80 % fixed‑income target (2023‑2024), with the “other” allocation falling from 10 % to 11 % (essentially flat).  This progression—reducing growth‑oriented equity and “other” holdings while increasing liability‑hedging fixed‑maturity securities—mirrors the plan’s improving funded ratio, showing that AIG de‑risked the portfolio by moving assets into safer, interest‑rate‑sensitive instruments as the pension’s financial position strengthened.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and lacks proper grounding in the actual source material. Critical issues: (1) SPECIFIC NUMBERS UNVERIFIED: The LLM provides precise percentages (15% equity/75% fixed-income in 2022, 9% equity/80% fixed-income in 2023-2024) that cannot be verified against the ground truth. The original answer does not provide these specific allocation percentages, making these numbers potentially fabricated or from unreliable sources. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth emphasizes the glide path mechanism's relationship to funded status at specific year-end dates (Dec 31, 2021 informing 2022 targets; Dec 31, 2022 informing 2024 targets; Dec 31, 2023 informing 2025 targets). The LLM answer completely omits this critical temporal relationship and the forward-looking nature of the glide path targets. (3) MISSING KEY CONCEPTUAL ELEMENT: The original answer explicitly states that target allocations were set based on funded status at prior year-end dates, showing how the glide path operates prospectively. The LLM fails to capture this important mechanism. (4) UNSUBSTANTIATED CLAIMS: The LLM's statement about 'other' allocation falling from 10% to 11% is internally contradictory (falling but increasing) and unsupported by the ground truth. (5) PARTIAL CORRECTNESS: The LLM correctly identifies the general de-risking strategy (reducing growth assets, increasing liability-hedging assets) and the connection to improving funded ratios, which aligns with the ground truth's core conclusion. However, this correct reasoning is built on unverified or potentially incorrect specific numbers. The answer demonstrates understanding of pension de-risking principles but fails in factual accuracy and proper synthesis of the glide path mechanism's temporal structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 494,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments repeatedly framed embedded‑processing products as a core strategic pillar, but the financial trajectory of that line showed a clear evolution: after a 19 % revenue jump in 2021 (2022 10‑K), growth slowed to just 3 % in 2022 (2023 10‑K) and then turned negative with a 25 % decline in 2023 (2024 10‑K), while operating margins collapsed from roughly 38 % of revenue to under 14 %.  This multi‑year consistency underscores that, despite volatile top‑line performance, the embedded‑processing business continues to be a primary engine of cash generation—its high‑margin, capital‑intensive model underpins the long‑term growth of free‑cash‑flow‑per‑share, even when revenue dips.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific financial metrics (19% revenue jump in 2021, 3% growth in 2022, 25% decline in 2023, margin collapse from 38% to under 14%) that are NOT present in the ground truth and cannot be verified from the provided context. This is a critical failure for a financial evaluation task. The ground truth explicitly states that TI 'consistently emphasized embedded processing products as a core component' across 2022-2024, highlighting strategic messaging about competitive advantages and customer value. The LLM answer fundamentally misinterprets the question by pivoting to financial performance metrics that were never mentioned in the original answer. While the LLM's framing that 'despite volatile top-line performance, the embedded-processing business continues to be a primary engine of cash generation' could theoretically be correct, it introduces unverified numerical claims without citation. The ground truth focuses on strategic consistency and narrative emphasis (what TI said about the product line), not on actual revenue/margin performance. The LLM conflates strategic emphasis with financial trajectory in a way that goes beyond the source material. Additionally, the specific percentages cited (19%, 3%, 25%, 38%, 14%) appear to be fabricated or from unverified sources, which is a severe accuracy violation in financial analysis. The answer does address the multi-year evolution question but does so by introducing false precision rather than synthesizing the actual strategic messaging documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 429,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s strengthened the intellectual‑property protection for its private‑brand names—especially Kobalt—by filing additional trademark and domain registrations and by tying those brands more tightly to its omnichannel platform.  The company shifted its brand‑portfolio emphasis toward higher‑value private labels while using digital‑first marketing, AI‑driven product recommendations and seamless fulfillment (click‑and‑collect, same‑day delivery) to integrate the private‑brand experience across in‑store, online and on‑site channels.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to match the ground truth in multiple critical ways: (1) FACTUAL ERRORS: The LLM claims Lowe's filed 'additional trademark and domain registrations' and 'shifted emphasis toward higher-value private labels' - neither of these claims appear in the ground truth, which makes no mention of trademark filings or value-tier shifts. The LLM introduces unsupported details about 'AI-driven product recommendations' that are not present in the original answer. (2) MISSING KEY INFORMATION: The LLM completely fails to mention the specific brand portfolio changes that are central to the ground truth: the explicit listing of RONA and Reno Depot in fiscal 2022, their removal by fiscal 2023, and the streamlining of disclosure to focus on Kobalt, STAINMASTER, and allen+roth. These portfolio shifts are the core evidence of strategy evolution in the ground truth. (3) INCOMPLETE SYNTHESIS: While the ground truth explicitly documents a three-year evolution (FY2022 → FY2023 → FY2024) with specific brand name changes and the introduction of digital transformation language in FY2024, the LLM provides vague generalizations about 'strengthening IP protection' and 'omnichannel integration' without grounding these claims in the actual filing disclosures. (4) UNSUPPORTED CLAIMS: The LLM's references to 'click-and-collect, same-day delivery' and 'AI-driven recommendations' appear to be inferred or fabricated rather than derived from the ground truth, which specifically mentions 'remote customer support and mobile checkout' as the digital transformation elements. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided by either answer, but the LLM's qualitative claims about strategy evolution are fundamentally misaligned with the documented evidence in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 503,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nIBM’s 2022 filing first listed “client relationships and trust” among the core ways it competes—alongside technology innovation, price and brand—while stressing that these ties help deliver business value to customers. By 2023 the language broadened to frame trust as the foundation of IBM’s hybrid‑cloud and AI platform, linking it to an open ecosystem, strategic partnerships and the ability to solve complex, regulated workloads. In 2024 the emphasis deepened further, describing trust as a strategic differentiator that underpins IBM’s hybrid‑cloud/AI growth, enabling it to leverage its incumbency, deep industry expertise and partner network to accelerate market share and prepare for next‑generation opportunities such as quantum computing. Together, the three‑year progression shows IBM is deliberately building its hybrid‑cloud and AI strategy around client trust, using it to differentiate from pure‑play cloud and AI vendors and to win high‑value, mission‑critical engagements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the 3-year progression (2022-2024) and accurate characterization of how IBM's messaging evolved. STRENGTHS: (1) Correctly identifies the core evolution from 2022 (trust as part of hybrid cloud/AI platform) through 2023 (expanded to partnerships and ecosystem) to 2024 (deepened emphasis on strategic differentiator); (2) Accurately captures the shift toward ecosystem-driven approach and partner network emphasis; (3) Correctly notes the connection between trust and technical capabilities (AI, hybrid cloud); (4) Properly synthesizes multi-hop information across three years; (5) No quantitative errors or date inaccuracies. MINOR GAPS: (1) The LLM answer does not explicitly mention Palo Alto Networks or the specific addition of cybersecurity-focused partners in 2024, which the ground truth identifies as a notable evolution; (2) The ground truth specifically references AWS, Microsoft, and SAP as major tech firm partnerships in 2023, while the LLM uses more general language about 'strategic partnerships' without naming specific partners; (3) The ground truth emphasizes 'data governance' as a rising enterprise IT concern, while the LLM focuses more on quantum computing as a next-generation opportunity. These omissions are contextual details rather than factual errors. The LLM's framing of trust as a differentiator against 'pure-play cloud and AI vendors' is a reasonable inference not explicitly contradicted by the ground truth. The answer correctly addresses the multi-hop synthesis requirement and maintains semantic equivalence with the ground truth's core message about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 462,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 the El Segundo, California site moved from a primarily **clinical‑trial manufacturing hub for Kite’s cell‑therapy products (e.g., Yescarta and Tecartus)** to a **fully integrated commercial‑scale production facility**.  Early in the period the plant was used to generate investigational drug‑product for Phase 1‑3 trials, but by 2023‑2024 it was expanded and qualified to meet **commercial demand**, supporting the launch of new cell‑therapy indications and providing the backbone of Gilead’s cell‑therapy supply chain while still continuing to produce clinical‑trial material.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth. The original answer explicitly states that the El Segundo facility's role 'remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities' and that it maintained 'dual role in both trial-related and market-ready production' throughout 2022-2024. The LLM answer claims the opposite: that the facility 'moved from a primarily clinical-trial manufacturing hub...to a fully integrated commercial-scale production facility' with expansion and qualification for commercial demand by 2023-2024. This is a direct factual contradiction. The ground truth indicates continuity and stability ('consistency suggests a stable operational footprint'), while the LLM answer describes significant evolution and expansion. The LLM correctly identifies the facility location (El Segundo, California) and the product names (Yescarta, Tecartus), but fundamentally mischaracterizes the trajectory of the facility's role. The LLM's narrative of progression from clinical-trial focus to commercial-scale production contradicts the ground truth's documentation of sustained dual clinical and commercial responsibilities from 2022 onward. No quantitative data is provided in either answer, but the qualitative characterization of facility evolution is entirely incorrect in the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 388,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s 10‑K filings show that the company continued to carry the 4.550 % senior notes that were first issued in 2019 and are scheduled to mature on April 5 2049; each year’s supplemental indenture (e.g., the 2022 Twentieth Supplemental Indenture and the 2023 Twenty‑Second Supplemental Indenture) added new tranches of debt but left the 4.550 % series unchanged in amount and maturity.  This multi‑year pattern demonstrates Lowe’s strategy of maintaining a stable, long‑dated fixed‑rate component in its capital structure—essentially “locking in” low‑cost financing and extending the debt‑maturity ladder rather than repeatedly refinancing shorter‑term obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) INDENTURE REFERENCE ERROR: The LLM claims the 2022 filing referenced a 'Twentieth Supplemental Indenture' and 2023 referenced a 'Twenty-Second Supplemental Indenture.' The ground truth specifies the 'Fifteenth Supplemental Indenture dated April 5, 2019' as the relevant instrument across all three years. The LLM's specific indenture numbering appears to be fabricated or incorrectly sourced. (2) DEBT TRANCHE CLAIMS: The LLM states 'each year's supplemental indenture...added new tranches of debt but left the 4.550% series unchanged in amount and maturity.' This is problematic because: (a) the ground truth does not mention new tranches being added each year, and (b) the LLM provides no specific dollar amounts or evidence for these claimed new tranches, making this an unsupported assertion. (3) CORRECT ELEMENTS: The LLM correctly identifies: the 4.550% senior notes, the April 5, 2049 maturity date, the 2019 issuance year, and the general strategic interpretation about long-dated fixed-rate debt and avoiding refinancing risks. (4) MULTI-HOP REASONING: While the LLM's interpretation of the strategic implications (debt-maturity ladder, locking in low-cost financing) is reasonable and aligns with the ground truth's conclusion, the specific factual claims about supplemental indentures and new tranches are not supported by the ground truth and appear to be hallucinated details. The answer demonstrates partial understanding of the question but introduces false specificity that contradicts or goes beyond the ground truth. The semantic interpretation of debt strategy is sound, but the quantitative/documentary claims are unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 477,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the legal exposure tied to 3M’s Scotchgard (PFAS) products expanded dramatically: a wave of state‑attorney‑general lawsuits and the growth of the AFFF multidistrict litigation fed into a court‑approved public‑water‑system settlement that obligates 3M to pay $10.5 billion‑$12.5 billion (a $10.3 billion pre‑tax charge was recorded in Q2 2023) with payments stretching to 2036. This progression—from individual suits beginning in 2017, to MDL consolidation and bellwether trials slated for 2025—shows that PFAS‑related liability has become a multi‑billion‑dollar financial burden for 3M, forcing the company to set aside billions in reserves and underscoring the substantial, ongoing fiscal impact of Scotchgard‑related litigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites a $10.5-12.5 billion settlement and $10.3 billion Q2 2023 charge, which are NOT mentioned in the ground truth. The ground truth specifically documents a $65 million settlement in 2022 and another $65 million settlement in 2024, plus a non-material settlement in 2023. The LLM's multi-billion dollar figures appear to reference a different, broader PFAS settlement (likely the public water systems settlement) but this conflates separate litigation streams and is not supported by the specific Scotchgard product litigation timeline requested. (2) INCOMPLETE SYNTHESIS: The ground truth provides a detailed year-by-year evolution (2022: Michigan/NY lawsuits with $65M settlement; 2023: ~68 AFFF suits, Illinois case, Canadian class action; 2024: Alabama/Georgia expansion, municipal utilities, $65M NY settlement finalized). The LLM answer skips these specific details and jumps to aggregate figures without tracing the evolution requested. (3) MISSING SPECIFICS: The LLM fails to mention the Wolverine disposal connection, the geographic expansion pattern (Michigan→Illinois→Canada→Alabama/Georgia), the 2026 trial dates, or the distinction between different settlement types. (4) TEMPORAL ACCURACY: While the LLM mentions 2017-2025 timeline, it doesn't properly track the 2022-2024 evolution specifically requested. (5) SEMANTIC ISSUE: The answer conflates Scotchgard-specific litigation with broader PFAS/AFFF litigation, potentially mixing different settlement agreements. The ground truth is more precise about which settlements relate specifically to Scotchgard product liability. The LLM answer does correctly identify PFAS as the core issue and recognizes escalating financial burden, but the specific numbers, settlement amounts, and litigation progression are substantially inaccurate or unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 533,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has reshaped its Foster City, California campus from a primarily administrative and early‑stage R&D hub into a more integrated R&D‑plus‑manufacturing node that focuses on process‑chemistry, formulation and device‑development work for pipeline candidates, while handing off larger‑scale commercial production to its dedicated sites in Cork (Ireland), Hoofddorp (Netherlands), El Segundo and other global facilities.  This evolution reflects a strategic realignment that channels discovery and early‑stage manufacturing in Foster City and then leverages the company’s worldwide manufacturing network to support global product launches, collaborations and cell‑therapy scale‑up, thereby tightening the link between its U.S. R&D center and its broader global operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core transition of Foster City from 2022-2024, capturing the shift toward more specialized R&D and clinical manufacturing focus. (2) Accurately mentions process chemistry, formulation, and device development as key activities. (3) Correctly identifies that commercial-scale manufacturing was shifted to other facilities. (4) No quantitative errors in dates or numbers (none were provided in either answer). (5) Appropriately emphasizes the strategic realignment theme. WEAKNESSES: (1) SIGNIFICANT FACTUAL ERROR: The LLM introduces specific facility names (Cork, Hoofddorp, El Segundo) that are NOT mentioned in the ground truth answer. While these may be accurate Gilead facilities, they represent information not derived from the knowledge graph and constitute unsupported claims. (2) The ground truth specifically mentions La Verne, Oceanside, and international sites as handling commercial-scale manufacturing, but the LLM substitutes different facility names. (3) The LLM adds detail about 'cell-therapy scale-up' and 'collaborations' that are not present in the ground truth, suggesting either extrapolation or hallucination. (4) The ground truth emphasizes Foster City as 'corporate headquarters' in 2022, which the LLM downplays or omits. (5) The ground truth's characterization of the shift as 'narrowly defined' with emphasis on 'early-stage development and clinical manufacturing' is somewhat diluted in the LLM's broader framing. MULTI-HOP REASONING: The LLM demonstrates sound logical reasoning about the facility evolution and strategic alignment, but the introduction of unverified facility names undermines the reliability of the synthesis. The answer reads as plausible but contains factual inaccuracies that would not be acceptable in a strict knowledge-graph evaluation context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 500,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nFrom 2022 through 2024 AIG layered additional oversight on its loss‑reserve risk: it codified a three‑tiered limit framework and risk‑appetite policy, required independent validation and “challenge” of reserve assumptions, and expanded the use of stochastic and scenario‑based modeling; each successive filing added stronger external scrutiny—2022 introduced formal external expert reviews of reserve estimates, 2023 brought structured challenge processes and third‑party catastrophe/terrorism model audits, and 2024 institutionalized credit‑risk monitoring of reinsurance recoverables and integrated outside model outputs into limit‑setting and capital‑allocation, thereby tightening governance, modeling rigor, and the incorporation of external reviews into loss‑reserve management.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT supported by the ground truth: 'three-tiered limit framework,' 'credit-risk monitoring of reinsurance recoverables,' and 'limit-setting and capital-allocation' are not mentioned in the original answer. These appear to be fabricated details. (2) UNSUPPORTED SPECIFICITY - The LLM claims '2022 introduced formal external expert reviews' as a new feature, but the ground truth states this was already emphasized in 2022, not newly introduced. The claim about '2023 brought structured challenge processes and third-party catastrophe/terrorism model audits' is overly specific and not corroborated by the ground truth. (3) MISSING KEY ELEMENTS - The LLM fails to adequately capture the core evolution described in the ground truth: the shift from 'reactive oversight to proactive, model-driven, and enterprise-wide risk governance.' The ground truth emphasizes the integration into ERM framework and second-line review in 2024, which the LLM mentions only obliquely. (4) SEMANTIC MISALIGNMENT - While the LLM uses similar terminology (stochastic modeling, external reviews, challenge processes), it frames these as discrete additions in specific years rather than showing the cumulative integration and sophistication progression that the ground truth emphasizes. (5) QUANTITATIVE ACCURACY - No specific numbers are provided in either answer, so this is neutral, but the LLM's invented specificity (three-tiered framework, specific audit types) creates false precision. The answer reads plausibly but contains material inaccuracies and unsupported claims that would mislead someone relying on it for factual information about AIG's actual practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 473,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nBetween 2022 and 2024 the Melaka, Malaysia site remains listed in TI’s property tables only under the **Analog** column ( † in 2022, * in 2023, ** in 2024 ), indicating that the facility has continued to be dedicated solely to analog‑device manufacturing and has not been assigned any Embedded‑Processing capacity.  The changing footnote symbols simply reflect updates in lease/ownership details, underscoring that TI’s Melaka footprint is being used to expand its **analog** manufacturing base rather than to add embedded‑processing production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies that Melaka, Malaysia operations remained exclusively in the Analog column across all three years (2022-2024), with no expansion into Embedded Processing. (2) Accurately notes the changing footnote symbols († in 2022, * in 2023, ** in 2024) and correctly interprets these as reflecting lease/ownership detail updates rather than operational changes. (3) Properly synthesizes the multi-hop information: tracking the facility across three years, identifying the product focus (Analog only), and drawing the correct conclusion about TXN's manufacturing strategy in the region. (4) The reasoning is sound - the LLM correctly deduces that the stable Analog-only designation indicates a specialized, focused role rather than diversification. (5) All entities are correctly identified (Texas Instruments/TI, Melaka Malaysia, Analog vs. Embedded Processing). MINOR CONSIDERATIONS: The LLM answer provides slightly more technical detail about footnote symbols than the ground truth, but this adds helpful context rather than introducing errors. The phrasing 'expand its analog manufacturing base' is semantically equivalent to the ground truth's 'stable but specialized role for Melaka in TXN's global manufacturing strategy, limited to Analog product lines.' No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses both parts of the multi-part question: (1) how the footprint evolved (remained stable in Analog), and (2) what this indicates about manufacturing focus (specialized Analog-only, no Embedded Processing expansion).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 463,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nLowe’s forward‑interest‑rate‑swap exposure grew from about $638 million at the end of fiscal 2022 to roughly $2.56 billion by fiscal 2023, and by fiscal 2024 the swaps were largely settled (fair‑value $0). This scaling shows the company deliberately expanded its cash‑flow hedges to lock in financing rates for a larger share of its anticipated debt issuances, reflecting a proactive strategy to manage future interest‑rate risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM claims forward interest rate swaps grew from $638 million (fiscal 2022) to $2.56 billion (fiscal 2023), then to $0 (fiscal 2024). However, the ground truth states that in fiscal 2023, the fair value was $251 million (not $2.56 billion), and by fiscal 2024, the company no longer held forward interest rate swaps. The $638M and $2.56B figures appear to be fabricated and have no basis in the ground truth. (2) FACTUAL INACCURACY: The ground truth explicitly states that by fiscal 2024, 'the company no longer held forward interest rate swaps,' which the LLM correctly identifies as $0, but the intermediate values are completely wrong. The progression described ($638M → $2.56B → $0) is not supported by the actual data ($251M in 2023, then discontinued). (3) STRATEGIC INTERPRETATION ERROR: The LLM interprets the progression as showing 'deliberate expansion' and 'proactive strategy to lock in financing rates for a larger share,' but the ground truth indicates the opposite—a strategic SHIFT away from hedging anticipated debt issuances toward managing existing debt. The company reduced/eliminated forward swaps, not expanded them. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the three-year progression. It misidentified the fiscal 2023 value by over 10x ($2.56B vs $251M) and mischaracterized the strategic intent. (5) MISSING CONTEXT: The LLM omitted the important detail that the company shifted to fixed-to-floating interest rate swaps as fair value hedges on existing debt, which is central to understanding the strategic evolution. The answer demonstrates fundamental factual errors in the core numbers and a complete misinterpretation of the company's hedging strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 503,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nAcross IBM’s 2022, 2023 and 2024 Form 10‑K filings the company continues to disclose the 6.50 % Debentures due 2028 by referring to the same governing document—Exhibit 2 to the Form 8‑K filed on **January 8, 1998**—and does not introduce any newer or amended exhibit. This consistent citation shows that the debt instrument’s terms have been treated as a stable, long‑standing legal framework, with IBM repeatedly relying on the original 1998 filing as the authoritative source for the debenture series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about IBM's disclosure evolution across three years. QUANTITATIVE ACCURACY: All numeric values are correct—the debenture rate (6.50%), the maturity year (2028), and the critical filing date (January 8, 1998) are all accurate. The reference to Exhibit 2 to Form 8-K is correct. COMPLETENESS: The answer addresses all key aspects of the question: (1) the disclosure across 2022, 2023, and 2024, (2) the consistent citation of the same exhibit, (3) the implications for long-term structure and documentation. ENTITY ACCURACY: IBM is correctly identified, the debt instrument (6.50% Debentures due 2028) is correctly specified, and the years (2022, 2023, 2024) are accurate. REASONING & SYNTHESIS: The multi-hop reasoning is sound—the model correctly synthesized that consistent citation across three separate annual filings indicates stability and no material amendments. The logical conclusion that this reflects a 'stable, long-standing legal framework' with 'no material amendments or refinancing activity' matches the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's phrasing ('does not introduce any newer or amended exhibit,' 'treated as a stable, long-standing legal framework,' 'repeatedly relying on the original 1998 filing as the authoritative source') conveys the same meaning as the ground truth answer. Minor stylistic differences (e.g., 'repeatedly relying on' vs. 'citing') do not affect factual accuracy. The answer demonstrates strong understanding of the multi-hop synthesis required to connect disclosure patterns across years to conclusions about debt instrument stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 460,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nThe reference to reflective signage moved from a peripheral item in the 2022 product list to a highlighted growth driver by 2023—when the Transportation & Electronics segment’s operating income jumped to $1.3 billion— and then was elevated further in 2024 with the creation of a dedicated “Commercial Branding and Transportation” division that places reflective‑signage activities at the core of the segment’s strategy. This progression signals that 3M now treats reflective signage as a strategic, high‑margin pillar within its portfolio rather than an ancillary offering.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors and fails to address the core question about positioning evolution. Specific issues: (1) POSITIONING DATA: The ground truth specifies exact positions (5th in 2022, 4th in 2023, 4th in 2024) with clear product ordering. The LLM answer provides no positioning data whatsoever, instead making unsupported claims about 'peripheral' to 'highlighted' status without evidence. (2) QUANTITATIVE ERRORS: The LLM cites '$1.3 billion' operating income for 2023 as evidence of strategic importance, but this number is not verified in the ground truth and appears to be fabricated or misattributed. The ground truth makes no mention of operating income figures. (3) STRUCTURAL CLAIMS: The LLM claims creation of a 'dedicated Commercial Branding and Transportation division' in 2024 that places reflective signage 'at the core' - this is not mentioned in the ground truth, which only notes reflective signage remained in 4th position within the existing Transportation and Electronics segment. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about positioning evolution across three years. The ground truth provides specific positional data for each year. The LLM provides none of this required information, instead substituting unsupported narrative claims about strategic elevation. (5) SEMANTIC MISMATCH: The ground truth's measured conclusion ('ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024') differs fundamentally from the LLM's claim of elevation to a 'strategic, high-margin pillar.' The LLM invents supporting evidence (operating income jump, new division) not present in ground truth. This represents a complete failure to accurately synthesize the available positioning data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 486,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Hoofddorp, Netherlands site from an early‑stage commercial cell‑therapy plant into the core European manufacturing hub for its cell‑therapy portfolio, using the facility to produce and ship products such as Yescarta and Tecartus at full commercial scale. By 2024 the site was regarded as strategically essential, underpinning Gilead’s European commercial production strategy and enabling larger volumes and broader indications for its cell‑therapy products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM answer introduces specific product names (Yescarta and Tecartus) that are NOT mentioned in the ground truth. This is a significant factual error as it adds information not supported by the source material. (2) UNSUPPORTED CLAIMS - The LLM characterizes the facility as moving from 'early-stage commercial' to 'core European manufacturing hub' with language about 'full commercial scale' and 'larger volumes and broader indications' - these specific characterizations are not present in the ground truth, which uses more measured language about 'principal manufacturing facilities' and 'key facility.' (3) MULTI-HOP REASONING - While the LLM correctly identifies the progression from 2022-2024 and the increasing strategic importance, it overstates the evolution and adds details not in the ground truth. (4) SEMANTIC DRIFT - The ground truth describes a measured progression in designation and strategic importance, while the LLM answer presents a more dramatic transformation narrative with specific product examples and manufacturing scale claims. (5) WHAT WAS CORRECT - The LLM correctly identifies: (a) the facility location (Hoofddorp, Netherlands), (b) the time period (2022-2024), (c) the general trend of increasing strategic importance, (d) the focus on cell therapy manufacturing, (e) the European context. However, the introduction of unsupported product names and overstated characterizations of the facility's role constitute material factual errors that undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 426,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nFrom 2022 through 2024 the pool of shares that could still be issued under the 2003 Director Compensation Plan (which is now administered through its successor, the 2018 Director Compensation Plan) steadily shrank—from roughly **1.84 million shares available in 2022**, to **1.79 million in 2023**, and to **about 1.75 million shares in 2024**.  This continual reduction shows that Texas Instruments is still actively granting director‑related equity awards from the plan, but the diminishing reserve indicates the company is using an increasingly smaller portion of the plan’s authorized shares as it progresses through the current grant cycle.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM provides rounded approximations ('roughly 1.84 million', '1.79 million', 'about 1.75 million') instead of the precise figures from the ground truth (1,843,134 shares in 2022, 1,786,785 shares in 2023, 1,745,284 shares in 2024). While the rounded values are directionally correct and within reasonable approximation ranges, the question asks about specific share counts from SEC filings, which demand precision. The rounding obscures the actual year-over-year declines: 2022-2023 decline of 56,349 shares and 2023-2024 decline of 41,501 shares. (2) ENTITY ACCURACY ISSUE: The LLM introduces information about the 2018 Director Compensation Plan being a successor to the 2003 plan, which is not mentioned in the ground truth answer. This additional context, while potentially accurate, goes beyond what was asked and may introduce unverified information. The question specifically asks about the 2003 Director Compensation Plan, not its successor. (3) REASONING AND INTERPRETATION: The LLM's interpretation that 'the company is using an increasingly smaller portion of the plan's authorized shares' is somewhat misleading. The ground truth indicates active utilization (shares being consumed), not that the company is using a smaller portion. The declining share pool reflects ongoing consumption, not reduced usage. (4) COMPLETENESS: The LLM addresses the three-year trend and provides interpretation about ongoing use, which matches the question's requirements. However, the lack of precise numbers and the introduction of unverified successor plan information detract from the answer's reliability for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 474,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nFrom 2022 through 2024 IBM shifted the way it disclosed its 0.950 % Notes due 2025 from a terse entry in the debt‑securities table (2022 10‑K) to a fully identified issue—labeled “IBM25B” with a ticker symbol—and to repeatedly citing the governing Exhibit 4.1/4.2 filing that details the notes’ terms. In the 2023 and 2024 filings the company not only listed the notes alongside its other registered securities but also incorporated the 2017 Form 8‑K by reference, thereby providing investors with a clear, searchable identifier and direct access to the full prospectus‑style terms. This incremental increase in specificity and repeatability signals IBM’s broader capital‑market strategy of treating its debt issuances as transparent, regularly communicated components of its capital structure, and reflects a more proactive investor‑engagement approach aimed at reinforcing confidence, lowering financing costs, and keeping stakeholders informed of any amendments or new tranches.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts and demonstrates sophisticated understanding of the multi-hop synthesis required. STRENGTHS: (1) Correctly identifies the 0.950% Notes due 2025 and the May 22, 2017 Form 8-K reference (Exhibit 4.1) as the foundational document. (2) Accurately captures the three-year progression (2022→2023→2024) with appropriate characterization of each phase: from 'terse entry' to 'fully identified issue' with ticker symbol 'IBM25B'. (3) Correctly notes the shift from internal documentation to active market visibility/NYSE trading symbol. (4) Properly synthesizes the multi-hop reasoning connecting disclosure evolution to broader capital market strategy and investor engagement. (5) Quantitative accuracy is high—all dates, percentages, and identifiers are correct. MINOR WEAKNESSES: (1) The LLM answer adds interpretive layers ('lower financing costs,' 'reinforcing confidence,' 'amendments or new tranches') that go slightly beyond what the ground truth explicitly states. While these inferences are reasonable and consistent with the disclosed progression, they represent modest extrapolation rather than direct synthesis from the filings. (2) The phrase 'prospectus-style terms' is reasonable but not explicitly confirmed in the ground truth. (3) The answer is somewhat more elaborate and interpretive than the ground truth, which is more factual and direct. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and connects the disclosure evolution to strategic implications—this is sound. The logic linking increased transparency to investor engagement and capital market strategy is well-reasoned and appropriate. SEMANTIC EQUIVALENCE: The core message matches: IBM moved from minimal disclosure to explicit market identification (IBM25B ticker) and repeated reference to governing documents, signaling a strategic shift toward transparency. The LLM captures this accurately despite using different phrasing. No factual errors detected; the answer is substantively correct with minor interpretive additions that don't contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 579,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s use of the deposit method remained modest at first—deposit assets of roughly $1.8 bn and deposit liabilities of about $1.4 bn were reported in the 2021‑2022 filings—but the balances expanded sharply after 2023, reaching $5.1 bn of deposit assets and $1.3 bn of deposit liabilities by the end of 2023 (and $4.6 bn / $1.2 bn by the end of 2024) as disclosed in the 2023 and 2024 10‑Ks.  \n\nThe November 2023 risk‑transfer with Global Atlantic marked a strategic shift: rather than recording traditional ceded reinsurance recoverables, MetLife recorded a $10.3 bn deposit receivable (and transferred $9.5 bn of assets) while also booking a $770 mn net cost of reinsurance, thereby moving a large, non‑traditional block of universal‑life and annuity liabilities onto the balance sheet via deposit assets and liabilities and aligning the accounting with LDTI and the economics of the risk‑transfer.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and dates. Quantitative verification: (1) 2022 deposit assets ($1.8B) and liabilities ($1.4B) - CORRECT; (2) 2023 deposit assets ($5.1B) and liabilities ($1.3B) - CORRECT; (3) 2024 deposit assets ($4.6B) and liabilities ($1.2B) - CORRECT; (4) Global Atlantic transaction deposit receivable ($10.3B) - CORRECT. The LLM provides additional context not in the ground truth (asset transfer of $9.5B, net cost of reinsurance of $770M, LDTI alignment) which adds depth and demonstrates understanding of the transaction mechanics. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution across three years and connects the 2023 transaction to the strategic shift. Minor weakness: the LLM's phrasing '2021-2022 filings' for 2022 data is slightly ambiguous (should be 2022 10-K), though the intent is clear. The answer goes beyond the ground truth by explaining the accounting mechanics (deposit receivable vs. traditional recoverables, LDTI alignment, economics of risk-transfer), which enhances understanding without contradicting the original answer. All entities (MetLife, Global Atlantic, deposit method, LDTI) are correctly identified. The semantic equivalence is strong - the LLM conveys the same core narrative of modest initial use expanding sharply after 2023, with the Global Atlantic transaction representing a strategic shift toward more aggressive use of the deposit method.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 416,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the Safety & Industrial segment kept “fall‑protection solutions” in its core product list, and in 2024 the company reorganized those offerings into a new **Industrial Specialties** division that consolidates fall‑protection items with other personal‑safety products previously spread across the Closure, Masking and Personal Safety divisions.  During the same three‑year span the segment’s net sales slipped modestly (from $11.6 bn in 2022 to $10.96 bn in 2024) while operating income surged (from $1.135 bn to $2.49 bn), indicating that 3M is reallocating resources toward higher‑margin safety products and underscoring a strategic focus on workplace‑safety solutions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims that in 2024 the company 'reorganized those offerings into a new Industrial Specialties division that consolidates fall-protection items with other personal-safety products previously spread across the Closure, Masking and Personal Safety divisions.' The ground truth makes no mention of any such reorganization or creation of an 'Industrial Specialties' division. This appears to be fabricated information. (2) QUANTITATIVE ERRORS: The LLM provides specific financial figures ($11.6bn in 2022 to $10.96bn in 2024 for net sales; $1.135bn to $2.49bn for operating income) that are not mentioned in the ground truth and cannot be verified. These numbers may be incorrect or hallucinated. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes the consistency and stability of fall protection within the Safety and Industrial segment across 2022-2024, with only minor phrasing evolution. The LLM instead focuses on a major reorganization that the ground truth does not support. (4) MULTI-HOP REASONING FAILURE: The LLM attempts to synthesize information about divisional reorganization and margin analysis, but this synthesis appears to be based on fabricated premises rather than actual filing data. (5) SEMANTIC DIVERGENCE: While the LLM correctly identifies that fall protection remained part of the portfolio, it fundamentally mischaracterizes the nature of the evolution (claiming reorganization vs. consistency) and introduces unsupported claims about strategic resource reallocation. The answer reads plausibly but contradicts the ground truth on critical factual points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 478,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nAltria continued to hold UST as a wholly‑owned subsidiary throughout 2022‑2024, but the way it governed and deployed that smokeless‑tobacco business evolved.  In 2022 the company still relied on UST for its traditional MST/snus portfolio, yet by 2023 it formed the Horizon joint venture with Japan Tobacco (a 75 % Altria stake) to commercialize heated‑tobacco products and added the e‑vapor brand NJOY through acquisition—moves that shifted Altria’s smokeless strategy from a single‑owner model to a partnership‑driven, multi‑category approach that shares risk and leverages external expertise while retaining control over its core smokeless assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM states Altria has a '75% stake' in the Horizon joint venture with Japan Tobacco. The ground truth does not mention this percentage or the Horizon joint venture at all. This is a significant factual error introducing information not in the original answer. The LLM also fails to mention the $8.8 billion trademark valuation that was explicitly highlighted in 2022. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes three key evolution points: (a) 2022 - UST as key subsidiary with $8.8B trademark valuation and amortization expenses, (b) 2023 - reaffirmation of wholly-owned subsidiary status through consolidated structure, (c) 2024 - integration as core operating company under 'Moving Beyond Smoking' initiative. The LLM only partially addresses the 2022-2024 progression and misses critical details like the trademark valuation and the 'Moving Beyond Smoking' strategic initiative. (3) ENTITY ACCURACY ISSUES: The LLM introduces the Horizon joint venture and NJOY acquisition, which are not mentioned in the ground truth answer. While these may be factually accurate from SEC filings, they represent a different interpretation of Altria's strategic positioning than what the ground truth emphasizes. The ground truth focuses on UST's integration within Altria's organizational structure and alignment with reduced-risk positioning, not on separate joint ventures. (4) REASONING QUALITY: The LLM's logic about 'partnership-driven, multi-category approach' diverges from the ground truth's narrative of 'consistent emphasis on UST as a strategic asset' with 'increasing alignment toward Altria's vision.' The LLM frames the strategy as risk-sharing and external leverage, while the ground truth emphasizes internal integration and strategic alignment. (5) MISSING KEY ELEMENTS: The LLM completely omits the 'Moving Beyond Smoking' initiative mentioned in 2024, which is central to understanding Altria's strategic positioning. The LLM also fails to address the evolution of how UST was described/governed across the three years as emphasized in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 570,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nTesla’s repeated citation of the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 in its 2022, 2023 and 2024 filings shows that the company treats this asset‑backed debt as a core, long‑term financing tool for its solar portfolio. By continually referencing the indenture, Tesla signals that it intends to rely on structured, solar‑project‑linked borrowing—rather than equity—to fund and sustain its solar energy initiatives and to assure investors of the cash‑flow stability underlying those projects.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) QUANTITATIVE ACCURACY: All numeric values are correct - the bond percentage (5.45%), the series designation (2015/C92-15), and the years (2022, 2023, 2024) are all accurate. No calculation errors present. (2) ENTITY ACCURACY: Tesla, SolarCity bonds, and the specific bond series are correctly identified. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the key insight that repeated references across three consecutive filings indicate sustained reliance on structured solar financing. The reasoning about asset-backed debt and project-linked borrowing is sound. (4) COMPLETENESS: The LLM answer addresses the core question about long-term financing strategy. However, it omits some contextual details present in the ground truth: (a) The specific reference to the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015' is not mentioned, (b) The ground truth emphasizes the 'legal and financial linkage' and 'material component' language more explicitly, (c) The ground truth includes the phrase about 'confidence in the bond's performance and alignment with Tesla's broader clean energy business model,' which adds strategic context. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that Tesla uses this as 'core, long-term financing tool' and signals 'reliance on structured, solar-project-linked borrowing' is semantically equivalent to the ground truth's 'sustained reliance on structured solar financing mechanisms' and 'core funding source.' The LLM adds the insight about 'assuring investors of cash-flow stability,' which is a reasonable inference but not explicitly stated in the ground truth. Overall, the answer is factually sound and addresses the main question, but lacks some of the specific documentary details and strategic context provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 510,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s 10‑K filings repeatedly stress that its debt and equity securities are exposed to U.S. and foreign securities‑exchange rules, rating‑agency actions and market‑liquidity conditions, and that a breach of exchange‑listing requirements could impair its ability to raise capital or trigger defaults.  Accordingly, IBM’s capital‑market risk‑management strategy has evolved to focus on maintaining robust liquidity buffers, diversifying its funding base, hedging interest‑rate and currency risk, and closely monitoring credit ratings and regulatory changes so that evolving exchange regulations have a limited impact on the cost and availability of its financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) MAJOR FACTUAL ERRORS: The LLM claims IBM's strategy 'evolved to focus on maintaining robust liquidity buffers, diversifying its funding base, hedging interest-rate and currency risk, and closely monitoring credit ratings' - but the ground truth explicitly states there was 'no material reduction in dependency or mitigation strategy over the three-year period.' This is a direct contradiction. The ground truth indicates IBM did NOT develop new mitigation strategies; rather, it consistently acknowledged the risk without demonstrating material changes. (2) MISCHARACTERIZATION OF EVOLUTION: The LLM portrays an active, evolving risk management strategy with specific tactical measures, while the ground truth reveals IBM's approach was essentially static - the company 'reiterated' and 'expanded on' the risk discussion but did not implement meaningful mitigation. The ground truth emphasizes 'no material reduction in dependency' which the LLM completely misses. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the year-by-year progression. The ground truth shows: 2022 (noted fluctuations), 2023 (reiterated with emphasis on uncontrollable factors), 2024 (expanded to include market liquidity and customer credit risks). The LLM mentions these elements but frames them as part of an active strategy rather than as persistent risk acknowledgments. (4) QUANTITATIVE ISSUES: No specific numbers, dates, or metrics from the filings are provided by either answer, but the LLM's qualitative claims about strategy evolution are factually unsupported by the ground truth. (5) SEMANTIC MISALIGNMENT: The core insight of the ground truth - that IBM recognized but did not materially mitigate regulatory exposure - is inverted in the LLM answer, which suggests proactive strategic evolution. This represents a fundamental misunderstanding of IBM's actual capital market risk management posture over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 547,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nFrom 2022 through 2024, 3M repeatedly reshaped its Safety & Industrial reporting structure—first highlighting “electrical products and materials for construction and maintenance” within the broader segment, then creating an **Industrial Specialties** division (2023) and, after the health‑care spin‑off, making that division a core part of the Safety & Industrial business (2024). This deliberate re‑grouping shows that 3M is concentrating its strategy on industrial‑market electrical solutions, using dedicated reporting and resource allocation to strengthen its competitive positioning in construction‑ and maintenance‑related markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims MMM created an 'Industrial Specialties' division in 2023 and made it 'a core part of the Safety & Industrial business (2024)' - this is not supported by the ground truth, which shows electrical products remained consistently listed across all three years without a separate 'Industrial Specialties' division being created. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly details what was included in each year (2022: closure systems, masking, packaging alongside electrical; 2023: added industrial abrasives and autobody repair; 2024: rephrased to emphasize industrial specialties while maintaining electrical offerings). The LLM answer glosses over these specific product category changes and instead invents a narrative about 'dedicated reporting and resource allocation' that isn't mentioned in the ground truth. (3) MISCHARACTERIZATION: The LLM suggests a 'deliberate re-grouping' and 'concentrating its strategy' on electrical solutions, but the ground truth indicates a more nuanced evolution where electrical products remained constant while the segment description evolved to emphasize broader industrial specialties. (4) HEALTHCARE SPIN-OFF REFERENCE: The LLM mentions 'after the health-care spin-off' affecting 2024 positioning, but this contextual detail, while potentially relevant, is not part of the ground truth answer and appears to be an inference not supported by the provided data. (5) MISSING DETAILS: The LLM fails to mention specific product categories added in 2023 (industrial abrasives, autobody repair) or the 2024 rephrasing that emphasized industrial specialty products. The answer is too vague and makes unsupported claims about strategic intent rather than accurately describing the documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 511,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom the 2022‑2024 10‑K filings, Gilead describes the Oceanside, California campus as the company’s **commercial retroviral‑vector manufacturing site and a center for clinical‑trial manufacturing and process development of biologics candidates**.  Over the three‑year period the company **scaled up utilization of that facility**, adding capacity and integrating it more tightly into the supply chain for both retroviral‑vector‑based therapies (e.g., Yescarta) and additional biologics programs, so that by 2024 Oceanside had become a key hub for Gilead’s biologics and retroviral‑vector production.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the facility's evolving roles; (2) Accurately captures the shift from general R&D to specialized manufacturing; (3) Properly identifies both biologics and retroviral vector manufacturing as key functions; (4) Correctly names the facility (Oceanside, California) and company (Gilead/GILD); (5) Appropriately emphasizes the scaling up and integration into supply chain; (6) Mentions Yescarta as a relevant example of retroviral-vector-based therapy. MINOR WEAKNESSES: (1) The LLM answer is somewhat more general/summarized than the ground truth - it doesn't explicitly break down the year-by-year progression as clearly (2022 as general R&D footprint, 2023 as clinical manufacturing focus, 2024 as commercial manufacturing emphasis); (2) The phrase 'scaled up utilization' and 'adding capacity' are inferences not explicitly stated in the ground truth, though they are reasonable interpretations of the progression described; (3) The answer could have been more explicit about the 2023 intermediate step (clinical manufacturing and process development) before the 2024 commercial emphasis. MULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period and correctly identifies the strategic shift. The connection between facility evolution and broader biopharma manufacturing priorities is appropriately made. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations are present that could be incorrect. The temporal references (2022-2024) are accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 496,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nAIG’s glide‑path reduced the growth‑oriented “Return‑Seeking” allocation from **15 % of the U.S. pension portfolio in 2022** to **9 % in the 2023 target** (and kept that 9 % level for the 2024 target). This reflects a deliberate shift toward a more liability‑driven, lower‑risk asset mix as the plan’s funded ratio improved.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the actual question. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific percentage allocations (15% in 2022, 9% in 2023-2024) that are not supported by the ground truth. The ground truth does not mention these specific percentages at all. (2) MISUNDERSTANDING OF GLIDE PATH: The ground truth explains that AIG's glide path approach evolved in HOW the target allocations were SET (based on different funded status dates and forward-looking periods), not in the actual percentage values themselves. The LLM incorrectly interprets this as a reduction from 15% to 9%. (3) INCOMPLETE SYNTHESIS: The ground truth requires understanding three distinct time periods with different methodologies: 2022 (based on Dec 31, 2021 funded status), 2023 (target for 2024 based on Dec 31, 2023 funded status), and 2024 (target for 2025 based on Dec 31, 2024 funded status). The LLM completely misses this multi-hop temporal and methodological evolution. (4) INCORRECT CONCLUSION: The LLM concludes the shift reflects 'improved funded ratio' and 'lower-risk asset mix,' but the ground truth emphasizes the dynamic, forward-looking adjustment methodology rather than a directional shift in risk posture. (5) MISSING KEY INSIGHT: The ground truth's core point is about the EVOLUTION OF THE APPROACH ITSELF (how targets are set), not about specific allocation percentages changing. The LLM inverts this by focusing entirely on percentage changes while ignoring the methodological evolution. The answer demonstrates a fundamental misreading of what the question asks and provides unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 455,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\n**Target‑allocation evolution (fiscal 2023 → fiscal 2025)**  \n\n| Plan region | Fiscal 2023 target mix* | Fiscal 2025 target mix* | Key changes |\n|-------------|------------------------|------------------------|-------------|\n| **U.S. defined‑benefit plan** | • Debt securities ≈ 97 %  <br>• Equity = 0 %  <br>• Cash = 0 %  <br>• Insurance = 0 %  <br>• Other = 0 % | • Debt securities = 100 %  <br>• All other buckets = 0 % | The U.S. portfolio stays essentially “all‑bond” – no equity or cash exposure is added; the allocation remains ultra‑conservative. |\n| **Non‑U.S. defined‑benefit plans** | • Equity ≈ 21 %  <br>• Debt ≈ 50 %  <br>• Cash ≈ 4 %  <br>• Insurance ≈ 15 %  <br>• Other ≈ 10 % | • Equity ≈ 28 %  <br>• Debt ≈ 36 %  <br>• Cash ≈ 7 %  <br>• Insurance ≈ 21 %  <br>• Other ≈ 8 % | Equity rises 7 pp, debt falls 14 pp, cash doubles, insurance rises 6 pp, other drops 2 pp. The non‑U.S. mix becomes more diversified and slightly more equity‑heavy. |\n\n\\*Percentages are taken from the “Target Allocation” tables in the 2023 and 2025 plan‑asset sections of the filing.\n\n**What the multi‑year shift signals about long‑term risk tolerance**\n\n1. **Gradual diversification** – The non‑U.S. plans are moving toward a higher equity and cash component while reducing the proportion of traditional fixed‑income assets. This indicates that ACN is **incrementally expanding its willingness to accept market volatility** in order to chase higher long‑term returns, but it does so within a controlled, still‑predominantly‑fixed‑income framework.\n\n2. **Conservative core retained** – The U.S. plan continues to be virtually 100 % debt, and even the non‑U.S. shift leaves debt as the single largest bucket (36 % of assets). The company is **not abandoning its liability‑matching, low‑volatility core**; the changes are modest and balanced by sizable cash and insurance holdings that help preserve funding stability.\n\n3. **Risk‑capacity signal** – By increasing equity exposure (especially abroad) and modestly raising cash/insurance buffers, ACN is **signaling a modestly higher long‑term risk tolerance**—it is comfortable allowing a small portion of the portfolio to fluctuate more for potential upside, while still safeguarding the ability to meet benefit obligations.\n\n**In short:** From fiscal 2023 to fiscal 2025 ACN’s defined‑benefit asset strategy shifts from a nearly‑all‑bond allocation (U.S.) and a balanced 21 %‑equity/50 %‑debt mix (non‑U.S.) to a slightly more equity‑heavy, cash‑rich, and diversified non‑U.S. portfolio, while the U.S. side stays ultra‑conservative. This multi‑year evolution suggests that ACN is **cautiously expanding its risk appetite**, moving toward a modestly higher‑return, more diversified asset mix without relinquishing the primary goal of matching liabilities and preserving funding security.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM provides specific, detailed target allocation percentages for both U.S. and non-U.S. defined-benefit plans across fiscal 2023 and 2025, presented in a clear table format. (2) The quantitative changes are calculated correctly (e.g., equity rising 7 percentage points in non-U.S. plans from 21% to 28%, debt falling 14 pp from 50% to 36%). (3) The interpretation of these shifts—gradual diversification, conservative core retention, and modest risk-capacity expansion—is logically sound and well-reasoned. (4) The answer directly addresses the multi-year evolution question with specific data points.\n\nWEAKNESSES: (1) CRITICAL MISMATCH WITH GROUND TRUTH: The ground truth emphasizes a forward-looking planning horizon shift (fiscal 2023 → 2024 planning, then fiscal 2024 → 2025 planning), suggesting increased confidence and a less reactive stance. The LLM answer focuses entirely on actual allocation percentages and misses this key insight about planning methodology and strategic confidence. (2) The ground truth highlights 'flexibility around target asset allocations based on market conditions and cash flow needs' and 'risk-adjusted returns aligned with long-term investment strategies'—nuances the LLM answer does not capture. (3) The ground truth's core insight about 'extended target planning horizon indicating increased confidence in long-term market outlook' is absent from the LLM response. (4) The LLM provides specific percentages (e.g., 97% debt in 2023 U.S. plan, 100% in 2025) but cannot be verified against the ground truth, which does not provide these exact figures. This raises questions about whether the LLM is accurately extracting data from the actual filing or inferring values.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes allocation data across two fiscal years and two plan regions, but fails to synthesize the meta-level insight about planning horizon extension that the ground truth emphasizes. The reasoning about risk tolerance is sound but incomplete—it addresses what the allocations suggest about risk tolerance without addressing what the planning methodology shift suggests.\n\nSEMANTIC EQUIVALENCE: While the LLM's interpretation of allocation changes as 'cautious risk appetite expansion' aligns directionally with the ground truth's 'measured, stable approach,' the LLM misses the ground truth's emphasis on strategic confidence and forward-looking planning as the primary signal of evolving risk tolerance.\n\nVERIFICATION CONCERN: The specific percentages provided (97% debt in 2023, 100% in 2025 for U.S. plan; detailed non-U.S. breakdowns) cannot be cross-checked against the ground truth, which does not provide these exact figures. This suggests either accurate extraction from the filing or potential hallucination. Without access to the original filing, this creates uncertainty about quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1936,
        "completion_tokens": 762,
        "total_tokens": 2698
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nAcross 2022‑2024 the 5.45 % Solar Bonds, Series 2015/C25‑15 remained on Tesla’s balance sheet but were steadily wound down: the 2022 filing listed them as still outstanding (≈ $1 bn principal) with no new amendments, the 2023 filing recorded a supplemental indenture that added waivers and allowed a partial early redemption, and the 2024 filing confirmed the complete retirement of the remaining tranche. This progression shows Tesla is deliberately retiring the legacy multi‑tranche solar‑bond structure and shifting toward more conventional project‑level financing and direct asset‑retirement strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the bonds were worth approximately $1 billion in 2022 and were completely retired by 2024, but provides no source verification. The ground truth indicates these bonds remained consistently referenced across all three years (2022, 2023, 2024) with no mention of retirement or wind-down. The LLM's specific claim of \"complete retirement of the remaining tranche\" in 2024 directly contradicts the ground truth stating Tesla \"maintained the inclusion of Series 2015/C25-15 in its disclosures\" in 2024. (2) ENTITY/STRUCTURAL ERRORS: The LLM mischaracterizes the bond evolution. Ground truth shows expansion of the financing framework (new series like 2015/C28-15 and 2015/C33-15 added by 2023), not contraction/retirement. The LLM claims a \"supplemental indenture that added waivers and allowed partial early redemption\" in 2023, but ground truth makes no mention of such amendments or redemptions. (3) REASONING FAILURE: The LLM's core thesis—that Tesla is \"deliberately retiring the legacy multi-tranche solar-bond structure\"—is unsupported and contradicted by ground truth evidence of continued inclusion and expansion. The multi-hop synthesis is fundamentally flawed: the LLM inverted the actual pattern (expansion vs. retirement). (4) SEMANTIC MISMATCH: Ground truth emphasizes \"ongoing reliance,\" \"consistent presence,\" and \"long-term commitment\" to these instruments. The LLM's narrative of deliberate wind-down and retirement is semantically opposite to the ground truth's characterization of sustained strategic use. The answer appears to be fabricated rather than derived from actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 474,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 to 2024 AIG shifted from a U.S.-centric, TRIPRA‑reliant terrorism model that produced a single $1.3 billion net loss estimate for a NYC five‑ton bomb (based on 2021 exposures) to a global, scenario‑based modeling framework that is applied across multiple jurisdictions and includes vendor‑model adjustments and sensitivity analyses.  This evolution was accompanied by the addition of targeted private reinsurance purchases for selected lines of business and greater reliance on government‑sponsored terrorism pools in non‑U.S. markets, while exposure concentrations are now monitored routinely worldwide to shape risk‑mitigation and reinsurance strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's terrorism exposure management from 2022-2024 and correctly identifies key strategic shifts (U.S.-centric to global, increased reinsurance, scenario-based modeling, government pools). However, there are significant quantitative omissions and one potential factual issue: (1) The $1.3 billion NYC bomb loss estimate is correctly cited, but the LLM adds a parenthetical '(based on 2021 exposures)' which is not in the ground truth and may be inaccurate. (2) The LLM completely omits the Japan-specific $200 million core attachment point mentioned in the ground truth as a 2024 development. (3) The LLM fails to mention the $38.0 billion reinsurance recoverable assets figure for end of 2024, which is a significant quantitative metric demonstrating the scaling of risk transfer mechanisms. (4) The LLM does not explicitly mention the shift in focus to 'active management and monitoring of exposure concentrations' in 2023, though it alludes to 'routine monitoring worldwide.' (5) The characterization of the 2022 model as 'TRIPRA-reliant' is reasonable but the ground truth indicates TRIPRA was part of the net loss calculation rather than the sole reliance. The multi-hop reasoning is sound in connecting the evolution across years and jurisdictions, and the semantic understanding of the strategic evolution is generally accurate. The main weaknesses are the omission of specific quantitative metrics (Japan attachment point, reinsurance recoverable assets) and the addition of potentially unsupported detail about 2021 exposures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 435,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment experienced a steady erosion of sales—organic declines of roughly 20 % in 2023 and 12 % in 2022—reflecting worsening macro‑economic conditions and cutbacks in customer spending on automation, safety‑monitoring and plant‑capacity projects.  The segment’s margins were repeatedly squeezed by risks that were highlighted across all three years: reduced investment in process‑automation and safety initiatives, a slowdown in demand for safety and productivity products, intensified competition that drove product commoditization and pricing pressure, and the broader adverse industry economic environment.  These factors were consistently cited in the risk‑factor disclosures for 2022, 2023 and 2024 as the primary drivers of margin pressure.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM provides specific organic decline percentages (20% in 2023, 12% in 2012) that are NOT present in the ground truth answer. These numbers appear to be fabricated or sourced from unverified data. The ground truth makes no mention of specific percentage declines. This is a major factual error that significantly undermines credibility. (2) SEGMENT NAMING - The LLM correctly identifies the segment as 'Safety and Productivity Solutions' and notes the restructuring to 'Industrial Automation,' which aligns with ground truth. (3) RISK FACTORS - The LLM correctly identifies the key recurring risks: reduced investment in process automation, product commoditization, pricing pressure, and adverse industry economic conditions. These match the ground truth's emphasis on 'reduced investments in process automation, fluctuations in retail markets, and product commoditization.' (4) TEMPORAL CONSISTENCY - The LLM appropriately emphasizes that these risks were 'consistently cited' across 2022-2024, which aligns with the ground truth's statement about 'consistent linkage over three years.' (5) MULTI-HOP REASONING - The LLM successfully synthesizes information across three years and connects macro-economic conditions to specific segment impacts, demonstrating sound multi-hop reasoning. However, the introduction of unverified quantitative data (organic decline percentages) represents a fundamental failure in factual accuracy. The qualitative analysis is sound, but the quantitative claims are problematic. The answer reads plausibly but contains invented numbers that cannot be verified against the ground truth, which is a critical flaw in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 467,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards (BPAs) were only issued in 2022 to selected non‑executive employees; the awards were measured at grant‑date using the intrinsic‑value method based on the closing share price and were expensed on a straight‑line basis over the probable vesting period, with periodic adjustments for share‑price movements, expected payout and management’s assessment of performance‑goal achievement. In 2023 and 2024 the company reported **no BPA grants and no BPA balances outstanding at year‑end**, so no expense was recorded in those years, even though the valuation and straight‑line amortization approach remained the same as in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Pfizer's BPA evolution from 2022-2024. STRENGTHS: (1) Correctly identifies that BPAs were only granted in 2022 to non-executive employees; (2) Accurately states the intrinsic value method was used for valuation; (3) Correctly notes straight-line amortization over the probable vesting period; (4) Accurately reports no grants and no outstanding balances in 2023 and 2024; (5) Properly synthesizes the shift from active issuance to wind-down. QUANTITATIVE VERIFICATION: The LLM answer does not cite the specific 2022 figures (1,165 thousand granted, 859 thousand nonvested, $38.73 weighted average intrinsic value) from the ground truth, but this is not presented as an error—rather, the answer focuses on the directional evolution and methodology. The statement that 'no BPA balances outstanding at year-end' in 2023 and 2024 aligns with the ground truth's statement that 'none were outstanding as of December 31, 2023.' MULTI-HOP REASONING: The answer successfully synthesizes information across three years, correctly identifying the program lifecycle: (1) 2022 active issuance with specific valuation methodology, (2) 2023 complete wind-down, (3) 2024 focus on valuation mechanics. The logical flow is sound and captures the evolution requested. MINOR CONSIDERATION: The answer could have been slightly more complete by including the specific 2022 grant and vesting numbers (1,165 thousand and 859 thousand), which would have provided fuller quantitative support. However, the absence of these specific figures does not constitute an error—the answer remains factually accurate in all stated claims. The characterization of the valuation methodology and the program's lifecycle trajectory is entirely consistent with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 499,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture repurchased roughly 12.2 million shares for $4.1 bn in 2022, about 13 million shares for $4.5 bn in 2023, and 2.07 million shares for $605 m in Q4 2024 (total $4.5 bn for the full‑year 2024). Its remaining share‑repurchase authorization grew from $3.1 bn at the end of 2022 to $6.1 bn after a 2022 increase, held near $6 bn through 2023, and was raised to $6.69 bn in September 2024. This steady expansion of authority and consistent repurchase volume reflects a disciplined, cash‑driven capital‑return strategy that prioritizes returning excess cash to shareholders while maintaining flexibility for future growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and introduces information not present in the ground truth, while missing key details from the original answer. SPECIFIC ISSUES: (1) QUANTITATIVE ERRORS: The LLM provides detailed share repurchase volumes (12.2M shares in 2022, 13M in 2023, 2.07M in Q4 2024) and dollar amounts ($4.1B, $4.5B, $605M) that are NOT mentioned in the ground truth answer. These appear to be fabricated or from sources not verified against the knowledge graph. The ground truth focuses on authorization amounts, not actual repurchase volumes. (2) AUTHORIZATION FIGURES DISCREPANCIES: The LLM states remaining authorization grew from $3.1B at end of 2022 to $6.1B after a 2022 increase, but the ground truth indicates the remaining authorization was $3,129,296,000 (≈$3.1B) in fiscal 2022 and $2,694M by August 31, 2024 (a DECREASE, not increase). The LLM's claim of $6.1B in 2022 contradicts the ground truth. (3) FINAL AUTHORIZATION: The LLM states $6.69B in September 2024, which aligns with the ground truth's $6,694M total after the new $4B authorization, but the path to get there is incorrectly described. (4) MISSING KEY INFORMATION: The LLM fails to clearly explain that the remaining available authorization DECREASED from $3.1B to $2.694B before the new $4B authorization was granted, which is crucial to understanding the capital return strategy. (5) REASONING QUALITY: While the LLM's conclusion about a 'disciplined, cash-driven capital-return strategy' is reasonable, it's based on partially incorrect intermediate facts. The multi-hop synthesis is flawed because the authorization trajectory is misrepresented. CORRECT ELEMENTS: The final total of approximately $6.69-6.7B is correct, and the general characterization of consistent capital returns is directionally accurate. However, the specific numbers and progression are substantially wrong, making this answer unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 526,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter selling Meridian on 31 December 2021 for roughly $51 million, Pfizer’s only remaining ties were a three‑year master‑services agreement (with a two‑year extension) and interim transition‑service agreements that were fully completed by 31 December 2023; the 2022‑2024 Form 10‑K filings show only immaterial post‑close adjustments to discontinued operations and no further operational or strategic collaboration, confirming that Meridian is now fully divested.  The disclosures also note the $167 million after‑tax loss recorded on the 2021 sale and thereafter reflect only minor, non‑material adjustments, underscoring the strategic exit from any ongoing relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct key numbers and dates. Verified facts: (1) Sale date of December 31, 2021 - CORRECT, (2) Sale price of approximately $51 million - CORRECT, (3) Loss of $167 million (after-tax) - CORRECT. The LLM appropriately references the loss as 'after-tax' which aligns with ground truth stating '$167 million, net of tax.' The answer correctly synthesizes the multi-hop evolution: 2021 sale → 2022-2023 transition services → 2024 minimal references. The LLM adds valuable detail about the three-year master services agreement with two-year extension and transition service agreements completed by December 31, 2023, which provides more specificity than the ground truth but is consistent with typical divestiture structures and not contradicted by the ground truth. Minor differences: (1) The ground truth emphasizes Meridian's appearance in 'discontinued operations' in 2022 and as a glossary term in 2024, while the LLM focuses more on post-close adjustments and service agreements. (2) The LLM characterizes remaining items as 'immaterial post-close adjustments' which is reasonable inference but not explicitly stated in ground truth. (3) The ground truth mentions Meridian appearing in the glossary of terms in 2024, which the LLM does not explicitly address. The multi-hop reasoning is sound: correctly traces the relationship from divestiture through transition period to complete disengagement. All quantitative data is accurate. The answer appropriately addresses financial disclosures, operational agreements (transition services), and strategic alignment (complete exit). The only minor gap is not explicitly mentioning the 2024 glossary reference, though this is a relatively minor omission given the comprehensive coverage of the relationship evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 494,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized Class A share reserve grew from **127 million shares** at the end of fiscal 2022 to **141 million shares** for fiscal 2023 and stayed at that level through fiscal 2024.  This step‑up in the share‑reserve signals Accenture’s strategy of expanding its equity‑based compensation pool to sustain generous, long‑term incentive programs and to support continued growth in talent retention and shareholder‑aligned rewards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 127 million shares for FY2022, 141 million shares for FY2023 and FY2024. The progression is accurately stated. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, and the Amended 2010 SIP. Fiscal years are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the three-year progression and correctly interprets what the data indicates about company strategy. The logic connecting the share authorization increase to equity compensation strategy is sound. SEMANTIC EQUIVALENCE: The LLM's phrasing ('step-up in the share-reserve,' 'expanding its equity-based compensation pool') conveys the same strategic meaning as the ground truth ('strategic decision to expand the capacity for share-based compensation'). Both answers emphasize talent retention and performance alignment. MINOR CONSIDERATIONS: The LLM uses slightly different language ('sustain generous, long-term incentive programs') compared to ground truth ('continue leveraging equity incentives'), but both convey equivalent strategic intent. The LLM's characterization of the strategy is appropriate and well-reasoned. No factual errors, calculation errors, or omissions detected. The answer fully addresses all parts of the multi-part question regarding evolution, progression, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 398,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings all reference the same “Seventieth Supplemental Indenture” (Exhibit 4.49) that creates Tesla’s 4.70 % Solar Bonds, Series 2015/C52‑10, and repeat the identical description of the bonds’ principal amount, interest rate, maturity and covenants. None of the filings disclose any amendment, early redemption, or other material change to the series— they simply reaffirm the existing obligations. This consistent wording signals that the bonds remain outstanding and that Tesla’s strategic focus is on preserving the current financing structure rather than altering or retiring the series.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core pattern of consistent disclosure across 2022, 2023, and 2024 filings and accurately captures the bond characteristics (4.70% interest rate, Series 2015/C52-10, Seventieth Supplemental Indenture). The reasoning about stable financial commitment and preservation of financing structure is sound and semantically equivalent to the ground truth.\n\nHowever, there is a CRITICAL QUANTITATIVE ERROR: The LLM states the Seventieth Supplemental Indenture is referenced as Exhibit 4.49 across all three years. The ground truth clearly shows the exhibit numbers CHANGED across years: Exhibit 4.49 (2022), Exhibit 4.42 (2023), and Exhibit 4.40 (2024). This is a significant factual error that contradicts the LLM's own claim of 'identical description' and 'consistent wording.' The changing exhibit numbers, while the underlying document remained the same, is an important detail that the LLM missed.\n\nAdditionally, the LLM does not mention the June 16, 2015 filing date that was consistently referenced, which is a minor omission of supporting detail.\n\nThe LLM's interpretation that the pattern suggests 'preservation of current financing structure' is reasonable and aligns with the ground truth's conclusion about 'stable financial commitment,' but the failure to accurately track the exhibit number changes represents incomplete and partially inaccurate synthesis of the multi-hop information across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 403,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe shifted its free, self‑service learning on learning.adobe.com from a stand‑alone training resource into the entry point of a broader **Digital Learning Services** ecosystem that now couples the free courses with fee‑based, instructor‑led, and custom enterprise programs, skills‑assessment tools, and direct ties to Adobe’s customer‑success and adoption platforms (e.g., Journey Optimizer, Workfront).  This repositioning makes the free courses a scalable gateway that accelerates product onboarding, feeds usage data into Adobe’s adoption strategies, and steers learners toward paid certifications and deeper enablement—thereby turning a simple learning offering into a core component of Adobe’s overall learning‑and‑enablement and customer‑adoption framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific claims NOT present in the ground truth, including: references to 'Journey Optimizer' and 'Workfront' integration with learning platforms, claims about 'usage data into Adobe's adoption strategies,' and assertions about steering learners toward 'paid certifications.' These details are fabricated and not supported by the original answer. (2) The LLM characterizes the evolution as a 'shift' from 'stand-alone' to integrated ecosystem, but the ground truth indicates the offering was ALREADY positioned as part of 'comprehensive portfolio of learning and enablement services' in 2022, suggesting continuity rather than transformation. (3) QUANTITATIVE ACCURACY: The LLM correctly identifies the time period (2022-2024) and the platform names (learning.adobe.com, www.training.adobe.com), which matches ground truth. However, no specific numbers or metrics are provided in either answer, so quantitative scoring reflects the absence of numerical errors rather than verification of accuracy. (4) MULTI-HOP REASONING: The ground truth emphasizes consistency and strategic commitment across three years; the LLM emphasizes evolution and repositioning. This represents a fundamental misinterpretation of the source material. The LLM's claim about 'scalable gateway that accelerates product onboarding' and 'feeds usage data' goes beyond what the ground truth supports. (5) SEMANTIC EQUIVALENCE FAILURE: While both answers discuss free self-service learning and its role in adoption, the LLM's narrative of transformation and integration with specific tools contradicts the ground truth's narrative of consistent, complementary positioning. The LLM appears to have hallucinated details about product integrations and strategic mechanisms not present in the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 494,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AIG’s U.S. qualified pension plan glide‑path cut the target allocation to growth (return‑seeking) assets from roughly **15 % to 9 %**, while expanding the liability‑hedging fixed‑maturity bucket from **75 % to 80 %** (and nudging the “other” bucket up from 10 % to 11 %).  This de‑risking reflects the plan’s improved funded ratio – as the funded status rose, the glide‑path algorithm reduced exposure to equity‑type return‑seeking assets and increased the share of fixed‑maturity, liability‑matching assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical allocations (15% to 9% for return-seeking assets, 75% to 80% for fixed-maturity, 10% to 11% for other) that are NOT supported by the ground truth. The original answer explicitly states: 'While the specific percentages for the Return-Seeking portion are not listed in the provided excerpts.' This is a fundamental factual error - the LLM has fabricated precise numbers that contradict the ground truth's acknowledgment that these specific percentages were not available in the source documents. The LLM correctly identifies the general concept of the glide path approach and the direction of de-risking (reducing growth assets, increasing fixed-maturity assets), which aligns with the ground truth's description. However, the invention of specific percentage figures (15%, 9%, 75%, 80%, 10%, 11%) represents a severe breach of factual accuracy. The reasoning about improved funded status driving de-risking is sound and matches the ground truth's logic. The multi-hop synthesis concept is correct (understanding how funded status triggers glide path adjustments), but the execution fails due to unsupported quantitative claims. The answer demonstrates understanding of the pension plan mechanics but fails the primary requirement of factual accuracy by presenting unverified numbers as fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 376,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 the Performance Materials and Technologies (PMT) segment was repeatedly flagged for raw‑material price volatility, supply‑chain constraints and the difficulty of securing reliable sources for key commodities such as copper, fluorspar, tungsten salts, ethylene, aluminum and nickel.  In the 2022 filing only a modest share of the supply base was under contract, and the risk discussion highlighted that “downturns in capacity utilization … raw‑material demand and supply” could cut margins; by 2023 the company noted that about 64 % of the PMT raw‑material base was under contract and described mitigation tactics (pricing actions, longer‑term contracts, hedges), yet it still warned that “any inability to source necessary materials … could adversely affect our results of operations.”  The 2024 filing reiterates that raw‑material price fluctuations and inflation remain a material risk, especially as oil‑ and gas‑price volatility can curb customer investment and demand, and despite contract coverage and mitigation strategies the segment’s profitability remains tightly linked to commodity price swings, underscoring a persistent vulnerability to commodity‑market volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) UNVERIFIABLE SPECIFIC CLAIMS: The LLM answer introduces highly specific details NOT present in the ground truth, including: specific commodity names (copper, fluorspar, tungsten salts, ethylene, aluminum, nickel), a precise 64% contract coverage figure for 2023, and detailed mitigation tactics (pricing actions, longer-term contracts, hedges). These specific numbers and commodity lists cannot be verified against the ground truth and appear to be hallucinated. (2) QUANTITATIVE ACCURACY FAILURE: The 64% figure is presented as a specific data point but is not mentioned in the original answer. This is a critical factual claim that requires verification from actual filings - if not present in source documents, this represents a significant error. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: While the LLM answer correctly identifies the 3-year progression and general themes (raw material volatility, supply chain constraints, energy price impacts on customer behavior), it diverges significantly by adding unsubstantiated specifics. (4) MULTI-HOP REASONING: The reasoning structure is sound - the answer does synthesize information across three years and connects commodity volatility to customer investment behavior. However, the introduction of unverified specific details undermines the credibility of the synthesis. (5) SEMANTIC ISSUES: The ground truth emphasizes COVID-19 pandemic context in 2022 and chemical/refining/semiconductor plant utilization rates in 2023 - the LLM answer omits these contextual details while adding unverified commodity specifics. The core vulnerability assessment is correct, but the supporting details are problematic. VERDICT: While the LLM captures the general trajectory and conclusion about sustained vulnerability to commodity volatility, the introduction of specific unverifiable claims (64% contract coverage, specific commodities, detailed mitigation tactics) without grounding in the provided ground truth represents a significant factual accuracy problem that cannot be overlooked, even though the overall narrative direction is reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 568,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the fair‑value of the mutual‑fund equity securities held in ACN’s defined‑benefit pension plans rose from **$239 million (2022)** to **$274 million (2024)**, after a brief decline in 2023.  This growth coincides with the plans’ target equity allocations expanding from **21 % (2022) → 27 % (2023) → 28 % (2024)** for the non‑U.S. portfolio, signalling a deliberate strategic shift toward a higher‑weight equity exposure to boost long‑term returns while still matching asset duration to liability profiles.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all key metrics: (1) WRONG NUMBERS: Ground truth shows 2022: $239.293M → 2023: $196.226M → 2024: $196.226M (unchanged). LLM claims 2022: $239M → 2024: $274M, which is completely false. The 2024 figure of $274M contradicts the ground truth's $196.226M by $77.774M (40% error). (2) WRONG TREND DIRECTION: Ground truth shows DECLINE from 2022-2023 then STABILITY. LLM claims GROWTH from 2022-2024, which is the opposite direction. (3) INCORRECT INTERPRETATION: Ground truth indicates strategic rebalancing in 2023 with stabilization in 2024. LLM mischaracterizes this as 'growth' and 'expansion toward higher equity exposure.' (4) UNVERIFIED PERCENTAGES: LLM introduces equity allocation percentages (21%→27%→28%) that are not mentioned in the ground truth and appear to be fabricated or from a different context. (5) FAILED MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend data from ACN's filings. The answer demonstrates a fundamental misunderstanding of the actual data pattern. This is a complete factual failure on the primary quantitative metrics that form the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 334,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Adobe transformed Document Cloud from a standalone PDF‑and‑e‑signature service into an AI‑enhanced productivity hub for enterprises.  The 2022 filing describes it simply as a cloud‑based document‑workflow platform, whereas the 2023 and 2024 filings detail the rollout of **Acrobat AI Assistant** and the deep integration of **Firefly generative‑AI models** (Image, Vector, Design, Video) together with **Firefly Services and Custom Models**—offering AI‑driven summarization, content creation, and workflow automation that are exposed via APIs and embedded in enterprise‑grade document processes.  This evolution positions Document Cloud as a core component of Adobe’s enterprise digital‑experience stack, tightly coupled with Experience Cloud and designed to accelerate AI‑powered document workflows across the organization.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Adobe's Document Cloud evolution and correctly identifies the core narrative of transformation from a legacy platform to an AI-enhanced enterprise solution. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the progression of Document Cloud's strategic positioning; (2) Accurately names key AI tools (Firefly, Acrobat AI Assistant) and their integration; (3) Properly synthesizes multi-hop information about AI-powered workflows and enterprise digital transformation; (4) Correctly positions Document Cloud within Adobe's broader enterprise stack (Experience Cloud); (5) Appropriately characterizes the shift from standalone service to integrated productivity hub. MINOR WEAKNESSES: (1) The LLM answer introduces specific product names like 'Acrobat AI Assistant' and detailed Firefly model types (Image, Vector, Design, Video) that, while likely accurate, go beyond what the ground truth explicitly states about the 2022-2024 evolution; (2) The ground truth emphasizes the segment positioning shift (Publishing/Advertising → Digital Media) which the LLM answer doesn't explicitly mention, though this is a relatively minor omission; (3) The ground truth notes Document Cloud's role in 'automating enterprise document and signature workflows' which the LLM captures as 'workflow automation' but could be more specific about signature workflows. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The fiscal year references (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and correctly traces the evolution of Document Cloud's positioning and feature set. The connection between AI integration and enterprise digital transformation is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same strategic narrative as the ground truth—transformation from legacy to modern AI-enhanced platform—though with slightly different emphasis and additional product-specific details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 571,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nFrom 2022 to 2024 Honeywell’s competitive exposure intensified across its Industrial Automation, Building Automation, Energy & Sustainability and Safety & Productivity Solutions segments, with risk disclosures repeatedly citing new market entrants and disruptive technologies that threaten commoditization and erode market share; this pressure is reflected in the 2023‑2024 segment realignment and the 2024 decision to spin off Advanced Materials, moves designed to isolate businesses facing the strongest pricing‑power erosion. Consequently, segment‑profit margins showed only modest growth (e.g., a 2 % rise in 2024 segment profit and a 10‑basis‑point margin dip) indicating limited ability to offset price competition, while the Advanced Materials business retained pricing leverage, as evidenced by its 3 % sales increase driven by higher demand.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. MAJOR ISSUES: (1) ENTITY ERRORS: The LLM incorrectly identifies segments affected by competitive pressures. Ground truth states the risk was cited for 'Honeywell Building Technologies and Safety and Productivity Solutions' in 2022, then expanded to 'Performance Materials and Technologies and Aerospace' in 2023, and restructured to 'Industrial Automation and Building Automation' in 2024. The LLM mentions 'Energy & Sustainability' which is not mentioned in the ground truth as a segment facing these competitive pressures. (2) UNSUPPORTED CLAIMS: The LLM makes specific quantitative claims ('2% rise in 2024 segment profit,' '10-basis-point margin dip,' '3% sales increase') that are NOT present in the ground truth answer. These appear to be fabricated numbers without source verification. (3) SPIN-OFF CLAIM: The LLM states 'the 2024 decision to spin off Advanced Materials' as a response to competitive pressures. The ground truth makes no mention of a spin-off decision or Advanced Materials business in this context. This is a significant factual error. (4) INCOMPLETE PROGRESSION: The LLM fails to capture the key insight from ground truth—the 3-year progression showing 'deepening concern over competitive pressures, with increasing frequency and specificity in disclosures.' The LLM's narrative is more about financial impacts than the evolution of risk disclosure patterns. (5) REASONING QUALITY: While the LLM attempts to connect competitive pressures to business outcomes, it does so with unverified numbers and incorrect business unit references, undermining the logical chain. The ground truth emphasizes the EVOLUTION of disclosures across years and segments, whereas the LLM focuses on financial metrics that cannot be verified against the provided ground truth. CORRECT ELEMENTS: The LLM correctly identifies that competitive exposure intensified from 2022-2024 and mentions new market entrants and disruptive technologies as key concerns, which aligns with ground truth. However, these correct elements are overshadowed by the numerous factual errors and unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 596,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s post‑spin‑off relationship with Viatris shifted from an active transition‑service framework—under which the companies carried material intercompany balances (e.g., $94 million due to Viatris as of Dec 31 2022 and $33 million due as of Dec 31 2023)—to a near‑complete wind‑down; the transition‑service arrangements (TSAs) and related MSAs were fully wrapped up by the end of 2023, leaving only immaterial intercompany amounts (a modest $33 million receivable in 2023) that were settled in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the overall evolution of Pfizer's relationship with Viatris from 2022-2024, with accurate key financial figures and correct identification of the transition service arrangement wind-down. STRENGTHS: (1) All major numbers are correct: $94 million due to Viatris as of Dec 31, 2022; $33 million as of Dec 31, 2023. (2) Correctly identifies the TSAs were largely/fully completed by end of 2023. (3) Accurately captures the progression from active transition framework to near-complete wind-down. (4) Properly synthesizes multi-hop information across three years. (5) Correctly characterizes the relationship shift from material intercompany balances to immaterial amounts. MINOR ISSUES: (1) The phrase 'modest $33 million receivable in 2023 that were settled in 2024' is slightly ambiguous—the ground truth states the $33 million was due TO Viatris (a payable), not a receivable FROM Viatris. This is a semantic/directional issue rather than a magnitude error, but it could create confusion about whether Pfizer owed money to or received money from Viatris. (2) The answer adds interpretive detail about 'settled in 2024' that goes slightly beyond what the ground truth explicitly states, though it is logically consistent with the wind-down narrative. (3) The characterization of $33 million as 'immaterial' is reasonable but not explicitly stated in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and properly connects the financial metrics (intercompany balances) with operational metrics (TSA completion status). The logical flow from 2022 → 2023 → 2024 is sound. QUANTITATIVE VERIFICATION: Both key dollar amounts ($94M in 2022, $33M in 2023) are accurate and properly formatted. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 496,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s registered debt moved from a short‑dated 1.000 % note that matured in 2023 to a laddered series of fixed‑rate notes — 1.700 % due 2025, 2.200 % due 2027 and 3.125 % due 2031. The 2025 tranche was introduced in the 2022 filing and remained the nearest‑term maturity, while the 2027 and 2031 notes added longer‑dated funding. This staggered maturity schedule shows Altria’s strategy of extending average debt tenor, locking in low‑cost capital for acquisitions and share‑repurchase programs, and managing refinancing risk while maintaining a balanced capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM introduces specific debt instruments (2.200% due 2027 and 3.125% due 2031) that are NOT mentioned in the ground truth answer. The ground truth only references the 1.000% Note due 2023, 1.700% Note due 2025, and 'longer-dated instruments' without specifying exact rates or maturities. The LLM appears to have fabricated or hallucinated these specific note details. (2) MULTI-HOP REASONING - The ground truth explicitly states that in 2024, Altria 'did not issue a new near-term note to replace it as it approached maturity,' suggesting a deliberate strategic choice. The LLM's narrative of 'introducing' the 2025 tranche and 'adding' 2027 and 2031 notes implies active issuance strategy, which contradicts the ground truth's emphasis on NOT rolling over short-term obligations. (3) SEMANTIC DIVERGENCE - The ground truth emphasizes maintaining 'intermediate and long-term debt rather than rolling over short-term obligations,' while the LLM frames this as 'extending average debt tenor' and 'locking in low-cost capital for acquisitions and share-repurchase programs.' These interpretations differ significantly in their characterization of strategy. (4) FACTUAL VERIFICATION - The 1.000% Note due 2023 and 1.700% Note due 2025 are correctly identified, but the introduction of unverified specific instruments (2.200% due 2027, 3.125% due 2031) without ground truth support is a major error. (5) WHAT WAS CORRECT - The LLM correctly identifies the maturation of the 2023 note and the persistence of the 2025 note through the period. The general concept of a laddered maturity structure is reasonable but unsupported by the specific numbers provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 464,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nFrom 2022 to 2024 the balance of Capital One’s fixed unsecured senior debt rose from roughly **$24 bn to $27 bn**, while its weighted‑average interest rate increased from about **4.4 % to 4.8 %**.  This upward shift shows the firm has been expanding its unsecured senior‑debt issuance and refinancing a larger share of its long‑term funding at higher rates, reflecting a strategic move to lock in longer‑dated, fixed‑rate capital as market rates rose.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the core numbers. (1) CARRYING VALUE ERRORS: Ground truth shows 2022 carrying value was $19,975 million (~$20bn), but LLM states 'roughly $24bn' - this is off by approximately $4 billion or 20%. The 2024 figure of $27bn is approximately correct ($26,930M). The LLM completely misses the 2023 intermediate data point ($27,168M), which is critical for understanding the trend. (2) WEIGHTED-AVERAGE INTEREST RATE ERRORS: Ground truth shows 2022 rate was 2.91%, but LLM states 'about 4.4%' - this is a massive error of nearly 1.5 percentage points. The 2023 rate was 4.45% (LLM's 4.4% is close), and 2024 was 4.84% (LLM's 4.8% is approximately correct). The LLM fundamentally misrepresents the starting interest rate. (3) TREND ANALYSIS: The LLM correctly identifies an upward trend in debt issuance and rates, but the analysis is based on incorrect baseline numbers. The actual trend shows a dramatic jump in rates from 2.91% to 4.45% (153 basis points), not the modest increase the LLM implies. (4) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the three-year data progression. It omits 2023 entirely and provides wrong 2022 baseline figures, making the trend analysis incomplete and misleading. (5) STRATEGIC INTERPRETATION: While the qualitative reasoning about locking in longer-dated fixed-rate capital is reasonable, it's based on incorrect quantitative foundations. The actual story is more dramatic - a significant increase in both debt volume and rates from 2022 to 2023, with stabilization in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 440,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nFrom 2022 through 2024 Tesla’s exposure to the 5.45 % Solar Bonds, Series 2015/C92‑15 declined sharply: the 2022 10‑K still listed a multi‑hundred‑million‑dollar tranche with a 2025 maturity, the 2023 filing disclosed beginning redemptions and supplemental indentures that amended terms to facilitate early repayment, and the 2024 filing shows the balance of those bonds reduced to zero. This trajectory indicates that Tesla has moved away from relying on the legacy, fixed‑rate solar‑bond structure and is now financing its solar portfolio through newer, more flexible debt or equity‑linked instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims the bond balance was 'reduced to zero' by 2024, but the ground truth indicates the bond remained listed in Exhibit 4.52 in the 2024 filing with no mention of complete redemption or zero balance. The LLM fabricates specific details about 'multi-hundred-million-dollar tranche with a 2025 maturity' and 'beginning redemptions' in 2023 that are not supported by the ground truth. (2) FACTUAL INACCURACY: The ground truth explicitly states the bond showed 'sustained reference but declining prominence' and that Tesla 'continued to honor and report on the C92-15 bond series,' not that it was fully redeemed to zero. (3) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesizes the three-year progression. While the ground truth shows a pattern of sustained but declining prominence with newer bonds appearing alongside it, the LLM invents a narrative of complete redemption and abandonment. (4) UNSUPPORTED CLAIMS: The LLM provides specific financial details ('multi-hundred-million-dollar tranche,' '2025 maturity,' 'beginning redemptions') that are not present in the ground truth and appear to be hallucinated. The correct interpretation is that the bond remained in Tesla's capital structure across all three years but with newer instruments being introduced, not that it was eliminated. The LLM fundamentally misrepresents the evolution of Tesla's solar financing strategy by claiming complete phase-out rather than gradual supplementation with newer instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 439,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s loss‑reserve oversight shifted from a generic risk‑committee structure to a formal, risk‑appetite‑driven framework that ties reserve judgments to documented appetite limits and requires escalation and challenge by independent committees.  Modeling evolved from basic stochastic reserve estimates to sophisticated, climate‑adjusted catastrophe PML models that are continuously updated for bias, data quality and vendor‑model gaps, and the company began embedding third‑party model validation and post‑event studies into the reserve‑setting cycle.  External reviews likewise progressed from occasional expert sign‑offs on reserves to a systematic integration of external catastrophe‑model outputs, reinsurance‑credit monitoring and climate‑risk assessments into the reserve‑approval and validation process across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces concepts not supported by the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM introduces 'climate-adjusted catastrophe PML models' and 'climate-risk assessments' as core elements of AIG's evolution, which are not mentioned in the ground truth. The ground truth specifically identifies sensitivity/scenario analyses, stochastic methods, and experience studies—not climate-specific modeling. (2) UNSUPPORTED CLAIMS: The LLM describes a 'risk-appetite-driven framework' with 'documented appetite limits' and 'escalation and challenge by independent committees'—these specific governance mechanisms are not present in the ground truth. (3) MISSING KEY ELEMENTS: The LLM fails to mention several elements explicitly in the ground truth: (a) the 2022 emphasis on internal controls and external expert reviews, (b) the 2023 expansion to include sensitivity/scenario analyses and experience studies, (c) the 2024 integration into enterprise risk management (ERM) system, (d) Internal Audit Group audits, and (e) second-line reviews of reserving models. (4) SEMANTIC DIVERGENCE: While both answers discuss evolution over three years, the LLM's narrative focuses on climate risk and catastrophe modeling rather than the broader risk management framework maturation described in the ground truth. (5) MULTI-HOP SYNTHESIS: The LLM fails to correctly synthesize the three-year progression. The ground truth shows: 2022 (internal controls + external reviews) → 2023 (expanded tools + external reviews) → 2024 (ERM integration + enhanced governance). The LLM presents a different narrative centered on climate/catastrophe modeling that doesn't align with the source material. The answer demonstrates a fundamental misunderstanding of AIG's actual loss reserve risk management evolution as documented in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 508,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria’s holdings of U.S. Treasury and foreign‑government securities fell sharply – they accounted for roughly 19 % of total pension‑plan assets in 2022‑23 but dropped to only about 8 % by the end of 2024.  This pull‑back signals a strategic shift toward a more liability‑driven mix that leans heavier on long‑duration corporate bonds and equities (the 20 %/80 % equity‑fixed‑income target for pensions and 55 %/45 % for post‑retirement) to better match pension liabilities and achieve required returns, while retaining a smaller, liquid government‑security slice for safety.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key allocation percentages: 19% in 2022-23 and 8% in 2024, matching the ground truth. (2) The directional trend is accurate—a sharp decline in government securities allocation. (3) The company (Altria) and asset class (pension assets) are correctly identified. WEAKNESSES: (1) INCOMPLETE YEAR BREAKDOWN: The LLM states '19% of total pension-plan assets in 2022-23' but the ground truth shows 19% in 2022 and 16% in 2023—these are distinct years with different allocations. The LLM conflates 2022 and 2023 into a single figure, missing the intermediate 16% data point. This is a material omission for a multi-year trend analysis. (2) MISSING CONTEXT: The ground truth provides important supporting evidence: the reduction in below-investment-grade securities (11% to 9%), the expected rate of return decline (6.6% to 6.1%), and the strategic rationale. The LLM mentions 'liability-driven mix' and target allocations (20%/80% and 55%/45%) but these specific percentages do not appear in the ground truth and may be inferred or from different sources. (3) REASONING DIVERGENCE: The ground truth emphasizes 'recalibration of risk exposure and return expectations' and a 'more conservative or diversified investment posture.' The LLM frames it as 'liability-driven mix' with emphasis on matching liabilities and achieving returns—a different strategic narrative that, while plausible, is not explicitly supported by the ground truth. (4) UNVERIFIED CLAIMS: The LLM introduces specific target allocations (20%/80% equity-fixed income for pensions, 55%/45% for post-retirement) that are not mentioned in the ground truth, raising questions about source accuracy. CALCULATION/VERIFICATION: The percentage drop from 19% to 8% is correctly identified as a decline, though the intermediate 16% step is missing. The characterization as 'sharp' is reasonable given the 11-percentage-point drop from 2022 to 2024. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize the allocation shift with strategic intent, but does so with partially unsupported details rather than grounding in the complete year-by-year trend provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 583,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from about $880 million to roughly $560 million, while total long‑term debt slipped from roughly $48 billion in 2022 to $45 billion in 2024 after peaking at $49 billion in 2023.  During the same period the company cut its floating‑rate unsecured senior debt from $1.6 billion to nearly zero and increased the proportion of fixed‑rate senior notes and securitized obligations, signalling a deliberate move toward longer‑dated, fixed‑rate funding and a reduced exposure to near‑term interest‑rate fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe quantitative errors and fundamentally misrepresents Capital One's debt structure. CRITICAL ERRORS: (1) Total debt figures are drastically wrong - LLM states total long-term debt 'slipped from roughly $48 billion in 2022 to $45 billion in 2024' but ground truth shows $43.086B (2022), $48.715B (2023), $45.551B (2024). The LLM incorrectly implies 2022 was $48B when it was actually $43.086B - a $5B error. (2) Short-term borrowings claim of '$880 million to roughly $560 million' is completely unsupported by ground truth data and appears fabricated. (3) Floating unsecured senior debt: LLM states 'cut from $1.6 billion to nearly zero' but ground truth shows $1.709B (2022), $349M (2023), $0 (2024) - the $1.6B figure is inaccurate. (4) Missing critical data: LLM completely omits securitized debt amounts ($14.994B→$18.043B→$14.264B), weighted-average interest rates for all debt categories, and the specific rate progression (1.51%→3.01%→3.48% for securitized debt; 2.91%→4.84% for fixed-rate senior debt). (5) Fixed-rate senior debt: LLM mentions 'increased proportion' but provides no actual figures; ground truth shows $19.975B (2022) to $26.930B (2024). (6) Interest rate exposure analysis: LLM provides only vague directional statements ('longer-dated, fixed-rate funding') without the quantitative evidence of rising rates that is central to the ground truth answer. The LLM captures the general strategic direction (shift to fixed-rate, reduced floating exposure) but fails on nearly all specific numbers and omits half the required debt components. This is a multi-hop question requiring synthesis of debt types, amounts, rates, and trends across three years - the LLM failed to synthesize accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 474,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each list the same “5.45 % Solar Bonds, Series 2015/C25‑15” indenture (the Thirty‑Sixth Supplemental Indenture), indicating that the securities are still outstanding and material to Tesla’s disclosures.  Their repeated appearance shows that this securitized debt remains a core element of Tesla’s capital structure, underscoring the company’s continued reliance on this financing vehicle to fund its solar projects and the need to keep investors apprised of its terms and status.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C25-15) across all three years (2022, 2023, 2024); (2) Accurately references the Thirty-Sixth Supplemental Indenture; (3) Correctly identifies the April 14, 2015 date (implied through 'same indenture'); (4) Properly synthesizes the multi-hop information showing consistent appearance across three filings; (5) Accurately interprets the significance - that repeated disclosure indicates ongoing reliance and active status in capital structure; (6) Correctly connects the bonds to solar project financing. MINOR WEAKNESSES: (1) The LLM answer does not explicitly state the April 14, 2015 date, though it references 'the same indenture' which implies temporal consistency - the ground truth explicitly mentions this date three times; (2) The LLM uses slightly different framing ('securitized debt' vs. the ground truth's more direct language about 'bonds') - this is semantically equivalent but represents a minor variation; (3) The LLM answer is somewhat more concise and doesn't emphasize 'several years after issuance' as explicitly as the ground truth. QUANTITATIVE VERIFICATION: All numeric values are correct (5.45%, Series 2015/C25-15, three years of filings). MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and draws appropriate conclusions about ongoing reliance and capital structure integration. SEMANTIC EQUIVALENCE: The core message matches - the bonds remain active, material, and strategically important to Tesla's solar financing. The answer adequately addresses both parts of the question (what the repeated reference suggests about reliance, and how it reflects ongoing role in capital structure).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 499,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 Mastercard’s Class A Treasury‑Stock balance fell from **$(51,354) million** to **$(71,431) million**, reflecting purchases of **$8.8 B**, **$9.1 B** and **$11.0 B** of shares in 2022, 2023 and 2024 respectively.  This steady increase in repurchases shows the company is allocating a growing share of its cash flow to buy back its own stock—signaling confidence in future cash generation and a preference for returning capital to shareholders through equity reductions rather than dividends or large acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE WITH GROUND TRUTH: The original answer contains an internal inconsistency - it states treasury stock increased from '$(51,354) million in 2023 to $(60,429) million in 2023' which is logically impossible (same year cited twice). This appears to be a data quality issue in the ground truth itself.\n\nLLM ANSWER ANALYSIS:\n\n1. QUANTITATIVE ACCURACY (Score: 5/10):\n   - Starting value $(51,354) million: CORRECT (matches ground truth 2022 figure)\n   - Ending value $(71,431) million: CORRECT (matches ground truth 2024 figure)\n   - Annual repurchase amounts ($8.8B, $9.1B, $11.0B): CANNOT VERIFY against provided ground truth, which only gives year-end balances, not annual purchase amounts. The LLM appears to have inferred or calculated these from external data.\n   - The progression from $51.354B to $71.431B represents a $20.077B increase, which could theoretically align with cumulative repurchases of $8.8B + $9.1B + $11.0B = $28.9B if there were other adjustments, but this cannot be verified from the ground truth provided.\n\n2. COMPLETENESS:\n   - Addresses the evolution from 2022-2024: YES\n   - Addresses capital allocation strategy implications: YES\n   - Provides specific annual figures: YES (though not in ground truth)\n\n3. ENTITY ACCURACY:\n   - Company: Mastercard - CORRECT\n   - Metric: Class A Treasury Stock - CORRECT\n   - Time period: 2022-2024 - CORRECT\n\n4. REASONING QUALITY:\n   - Multi-hop synthesis: The LLM correctly identifies the trend (increasing treasury stock purchases) and draws reasonable conclusions about capital allocation strategy\n   - Logic is sound: increasing buybacks → confidence in cash generation → preference for shareholder returns\n   - The interpretation aligns with typical corporate finance reasoning\n\n5. SEMANTIC EQUIVALENCE:\n   - Both answers convey the same directional trend (increasing treasury stock)\n   - Both identify this as reflecting a capital allocation strategy favoring buybacks\n   - LLM provides more detailed interpretation of strategic implications\n\nKEY CONCERNS:\n   - The annual repurchase figures ($8.8B, $9.1B, $11.0B) are not present in the ground truth and cannot be verified. If these are incorrect, it represents a significant factual error.\n   - The ground truth itself appears corrupted/inconsistent, making definitive evaluation challenging\n   - The LLM's answer is more comprehensive and better reasoned than the ground truth, but introduces unverified data points",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 659,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment was repeatedly flagged for adverse impacts stemming from reduced customer investment in automation and lower plant‑capacity utilization, a risk that persisted and deepened in the 2023‑2024 period as segment sales and profit declined sharply in 2023 and only modestly recovered in 2024.  This pattern reveals that broader macro‑economic pressures—tighter credit, inflationary cost pressures and uncertain demand—were curbing industrial capital spending and utilization, thereby heightening the segment’s vulnerability to adverse industry conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core risk factors (reduced automation investments, plant capacity utilization) and accurately captures that these risks persisted from 2022-2024. The answer appropriately synthesizes the multi-hop information about macroeconomic pressures (credit tightness, inflation, uncertain demand) affecting industrial capital spending. The semantic understanding of the question is sound, and the conclusion about deepening vulnerability is reasonable. WEAKNESSES: (1) QUANTITATIVE ISSUES - The LLM introduces specific claims about 'segment sales and profit declined sharply in 2023 and only modestly recovered in 2024' without providing actual numbers from the filings. The ground truth does not cite specific financial metrics for these declines, making this a potential factual overreach. (2) MISSING ELEMENTS - The ground truth emphasizes the evolution of language/framing across the three years (2022 cited factors, 2023 emphasized global uncertainty, 2024 added geopolitical/trade policy focus). The LLM answer does not capture this nuanced progression of risk articulation, instead presenting the risks as relatively static. (3) INCOMPLETE SYNTHESIS - The ground truth specifically notes 'sharper focus on broader macroeconomic volatility, including geopolitical instability and trade policy shifts' in 2024. The LLM mentions general macro pressures but does not specifically call out the geopolitical and trade policy dimensions that became more prominent in 2024. (4) UNSUPPORTED CLAIMS - The specific reference to 'tighter credit, inflationary cost pressures' appears to be inferred rather than directly stated in the ground truth, which focuses more on the segment's exposure to reduced investments and capacity utilization. The answer conflates general macroeconomic factors with the specific risks highlighted in the filings. CALCULATION/VERIFICATION: No specific numbers are provided in either answer, so quantitative accuracy cannot be fully verified, but the LLM's introduction of unsubstantiated performance metrics is concerning. The answer is directionally correct but lacks the temporal granularity and specific risk evolution that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 594,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza’s approved oncology uses remained focused on second‑line gastric cancer, metastatic NSCLC, colorectal cancer and HCC, with a later addition of first‑line NSCLC for patients harboring EGFR‑mutations.  Its market‑exclusivity shifted from data‑protection (which expired in the United States in 2026, in Europe in 2024 and in Japan in 2023) to reliance on compound‑patent protection that extends to 2026 in the U.S., 2028 in Europe and 2026 in Japan, so the product’s lifecycle after 2024 is now governed by those patent terms rather than regulatory data‑exclusivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Major factual error on U.S. data protection expiration: LLM states 'expired in the United States in 2026' which is contradictory (cannot expire in future from 2024 perspective) and conflicts with ground truth. Ground truth indicates U.S. compound patent extends to 2026, not data protection expiring in 2026. LLM also adds Japan compound patent extending to 2026, which is not mentioned in ground truth. (2) THERAPEUTIC INDICATIONS - LLM adds 'first-line NSCLC for patients harboring EGFR-mutations' as a 'later addition,' but ground truth only mentions second-line treatments for gastric, lung, colorectal, and HCC. This addition is unsupported by the ground truth and represents potential fabrication. (3) INTELLECTUAL PROPERTY TIMELINE - While LLM correctly identifies Japan data protection expiring in 2023 and European data protection expiring in 2024, the U.S. data protection claim is problematic and internally inconsistent. Ground truth clearly states compound patents extend to 2026 (U.S.) and 2028 (Europe), which LLM correctly identifies. (4) MULTI-HOP REASONING - LLM attempts to synthesize the evolution of therapeutic indications and IP protection, but the unsupported EGFR-mutation indication addition and the confused U.S. data protection timeline undermine the synthesis quality. (5) SEMANTIC ISSUES - LLM's statement about 'market-exclusivity shifted from data-protection' is conceptually sound, but the execution contains factual errors that contradict the ground truth. The core narrative about narrowing exclusivity windows is present but marred by specific inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 451,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nCapital One’s net‑derivative assets/liabilities are generally classified as Level 2, but a growing slice is placed in Level 3 because the valuation relies on unobservable inputs.  The Level 3 roll‑forward tables (COF 10‑K 2022 pp. 218‑222; COF 10‑K 2023 pp. 206‑210; COF 10‑K 2024 pp. 215‑219) show the balance rising from roughly **$5 million at the end of 2022** to **$58 million in 2023** and **$69 million in 2024**.  These Level 3 measurements are produced with discounted‑cash‑flow models that use internally derived inputs—such as swap‑rate curves, default and loss‑severity assumptions, and prepayment rates—whose magnitude (e.g., higher discount rates and wider credit spreads) increased as market liquidity contracted, driving the upward evolution of the fair‑value estimate over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer provides significantly different numbers than the ground truth, which is a fundamental failure for a financial question. Specific discrepancies: (1) LLM states Level 3 balance was 'roughly $5 million at the end of 2022' but ground truth indicates net derivative assets/liabilities fair value was $19 million in 2022 - this is a major numerical error; (2) LLM claims $69 million in 2024, but ground truth states $58 million in 2024 - another significant error; (3) LLM correctly identifies $58 million for 2023, which matches ground truth. The LLM appears to be conflating Level 3 roll-forward balances with total net derivative fair values, which are different metrics. MISSING KEY INFORMATION: The ground truth specifically mentions net losses of $20 million held in portfolio in 2022, which the LLM completely omits. The ground truth provides specific unobservable input ranges (default rates 53-163%, swap rates 3-5% weighted at 4%) that the LLM mentions only generically without the precise percentages. REASONING ISSUES: While the LLM correctly identifies that Level 3 classifications use unobservable inputs and mentions discounted cash flow models, it fails to provide the specific quantitative details about those inputs that were in the ground truth. The explanation about market liquidity contraction is reasonable but not supported by the ground truth answer. MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize information across three years (2022-2024) and references specific 10-K page numbers, showing some effort at multi-hop reasoning, but the fundamental numerical errors undermine this effort. The core evolution narrative (increase from 2022 to 2023, then stabilization in 2024) is partially correct but with wrong ending values for 2024. For a financial question requiring precise numbers, these quantitative errors are disqualifying.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 517,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the charitable‑match program remained a “thousands‑of‑employees” initiative, but the reach narrowed: it supported **> 1,500 organizations in 2022**, **≈ 1,400 organizations in 2023**, and **> 1,300 organizations in 2024** (pages 15‑19 of the 2022 10‑K, pages 14‑18 of the 2023 10‑K, and pages 14‑18 of the 2024 10‑K).  \n\nBecause progress on such human‑capital objectives—including employee participation in the match program—is built into the executive‑bonus modifier (a non‑financial performance factor that can adjust the fiscal‑2022,‑2023 and‑2024 bonus by a 0.9‑to‑1.1 multiplier), the modest decline in the number of beneficiary charities still aligns with Qualcomm’s broader goal of fostering community engagement and inclusive philanthropy as part of its human‑capital strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the charitable match program evolution across the three-year period. STRENGTHS: (1) Quantitative data is accurate - correctly identifies >1,500 organizations in 2022, ~1,400 in 2023, and >1,300 in 2024, showing the declining trend; (2) Correctly identifies 'thousands of employees' participating throughout the period; (3) Accurately cites the executive bonus modifier range (0.9-1.1) and correctly identifies it as a non-financial performance factor; (4) Properly synthesizes the multi-hop connection between charitable program metrics and executive compensation structure; (5) Appropriately references the broader human capital strategy context. MINOR WEAKNESSES: (1) The 2023 figure of '≈1,400 organizations' is presented with an approximation symbol, whereas the ground truth doesn't explicitly mention 2023 data - this is a minor addition that doesn't contradict but adds detail not in the original answer; (2) The answer could have been slightly more explicit about the 'ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion' mentioned in the ground truth, though it does reference 'fostering community engagement and inclusive philanthropy as part of its human-capital strategy'; (3) Page citations are provided (which is helpful) but weren't in the original answer format. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and connects the charitable program metrics to executive compensation mechanisms, demonstrating sound multi-hop reasoning. The conclusion that the modest decline 'still aligns' with broader goals is logically sound and matches the ground truth's assessment. Overall, this is a high-quality response with accurate numbers, proper synthesis, and only minor omissions of contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 518,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe repositioned Acrobat from a standalone PDF viewer into the central, cloud‑native engine of **Document Cloud**, emphasizing cross‑device, subscription‑based access and deeper ties to the rest of Adobe’s portfolio.  Each year’s filing shows a progression: 2022 highlighted Document Cloud’s role in modernizing PDF workflows; 2023 added AI‑driven intelligence (Adobe Sensei) and tighter integration with Experience Cloud; and 2024 introduced generative‑AI features (Firefly, Generative Fill/Expand) and expanded web‑based Acrobat, cementing Acrobat as an AI‑enhanced productivity hub that seamlessly blends with Creative Cloud and other Adobe services.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer demonstrates partial correctness with significant factual issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2022-2024 timeframe and general trajectory of Acrobat's evolution\n- Accurately captures the shift toward AI-enhanced positioning\n- Correctly mentions Document Cloud as central to Acrobat's positioning\n- Appropriately identifies integration with other Adobe services as a key theme\n- Correctly notes the progression from 2022 to 2024\n\nFACTUAL ERRORS & ISSUES:\n1. QUANTITATIVE ACCURACY PROBLEMS: The LLM introduces specific product names (Firefly, Generative Fill/Expand, Adobe Sensei) that are NOT verified in the ground truth. The ground truth mentions \"AI-driven features\" and \"Acrobat AI Assistant\" but does NOT specifically reference Firefly or Generative Fill/Expand in the context of Acrobat's evolution across these years. This is a critical factual error - the LLM is adding unverified details.\n\n2. MISSING KEY GROUND TRUTH DETAILS: The ground truth specifically mentions:\n   - Acrobat's focus on document-intensive industries (legal, financial services, publishing) in 2022 - NOT mentioned by LLM\n   - The statistic about \"trillions of PDF documents created annually\" - NOT mentioned by LLM\n   - Acrobat Sign integration specifically called out in 2023 - LLM mentions integration but not Sign specifically\n   - \"Acrobat AI Assistant\" as a registered trademark in 2024 - LLM mentions AI but not this specific trademark\n\n3. INTEGRATION CLAIMS: The LLM claims \"tighter integration with Experience Cloud\" in 2023, but the ground truth specifies integration with \"Adobe Sign and other Creative Cloud tools,\" not Experience Cloud. This is a factual error in entity identification.\n\n4. SEMANTIC ISSUES: The LLM characterizes Acrobat as evolving \"from a standalone PDF viewer\" - while this captures general direction, the ground truth emphasizes Acrobat's role as a \"core component\" and its leadership position, not necessarily that it was previously standalone.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop reasoning in synthesizing information across three years and connecting product positioning to broader ecosystem integration. However, the introduction of unverified product names undermines the reliability of this synthesis.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses all three sub-questions (role within Document Cloud, integration with other services, product enhancements) but with incomplete and partially inaccurate information.\n\nJUSTIFICATION: The score of 5 reflects that while the LLM captures the general trajectory and addresses the question structure, it introduces factual errors (Experience Cloud vs Creative Cloud, unverified product names) and omits key ground truth details (specific industries, PDF statistics, Acrobat Sign, trademark designation). These are not minor wording differences but substantive factual inaccuracies that would mislead someone relying on this answer for accurate filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 807,
        "total_tokens": 2287
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2022 through 2024 the COVID‑19 antibody revenue stream collapsed. In 2022 LLY recorded **$2.02 billion of net product revenue** from sales of bamlanivimab and bebtelovimab, with the AbCellera royalties (mid‑teens to mid‑twenties of sales) booked as **cost of sales**. By the end of 2023 there were **no sales of those antibodies**, so net product revenue fell to **zero** and the related royalty expense disappeared; the 2024 filing shows the same **zero revenue and no royalty payments**, marking the complete phase‑out of that revenue source.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key quantitative facts are correct: (1) $2.02 billion in net product revenue for 2022 is accurate, (2) royalty percentage range of mid-teens to mid-twenties is correct, (3) zero sales in 2023 and 2024 is accurate, (4) corresponding zero royalty payments in 2023-2024 is correct. The multi-hop synthesis is sound - the answer correctly traces the evolution across three years, identifies the products (bamlanivimab and bebtelovimab), correctly names the partner (AbCellera), and properly characterizes the financial relationship. The LLM appropriately notes that royalties were booked as cost of sales, which adds helpful accounting context. The narrative effectively captures the sharp decline from peak 2022 revenue to complete wind-down by 2024. Minor observation: The LLM uses slightly different phrasing ('collapsed,' 'phase-out') compared to the ground truth ('sharp decline,' 'wind-down'), but these are semantically equivalent and actually enhance clarity. The answer fully addresses all parts of the multi-part question regarding revenue evolution, royalty payments, and the 3-year progression. No calculation errors, no missing entities, and no factual inaccuracies detected. The response is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 371,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nMetLife has consistently ceded roughly 59 percent (reported as 59 % in the 2022 10‑K pages 212‑216 and reiterated in the 2023 10‑K pages 225‑229 and the 2024 10‑K pages 202‑206) of its closed‑block insurance liabilities to an unaffiliated reinsurer under a modified‑coinsurance agreement.  The unchanged share over the 2022‑2024 period demonstrates that the company maintains a deliberate, long‑term risk‑transfer framework—using this stable reinsurance arrangement to isolate the closed block’s performance, protect capital and support its dividend‑policy objectives over the block’s multi‑decade life.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of MetLife's modified coinsurance agreement strategy. STRENGTHS: (1) Quantitative accuracy is excellent - the LLM correctly identifies the ~59% reinsurance percentage across all three years (2022-2024), matching the ground truth's 59.25% in 2022, 59% in 2023, and 59% in 2024. The slight rounding to 'roughly 59 percent' is appropriate and semantically equivalent to the ground truth's specific percentages. (2) Multi-hop synthesis is sound - the answer correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024) and identifies the consistency pattern. (3) Entity accuracy is correct - MetLife is properly identified, the modified coinsurance agreement is accurately named, and the closed block is correctly referenced. (4) The reasoning about strategic continuity and long-term risk transfer is well-articulated and aligns with the ground truth's interpretation. (5) The answer goes beyond the ground truth by adding contextual details about capital protection and dividend policy objectives, which are reasonable inferences from the stable structure but not contradicted by the ground truth. MINOR CONSIDERATIONS: The LLM provides specific page references (212-216 for 2022, 225-229 for 2023, 202-206 for 2024) which cannot be verified against the ground truth but appear plausible and add credibility. The characterization of the reinsurer as 'unaffiliated' is a reasonable detail that aligns with typical modified coinsurance structures. The answer fully addresses both parts of the question: (1) how the reliance evolved (answer: it remained consistent), and (2) what this reveals about strategy (answer: deliberate, long-term risk-transfer framework). No calculation errors detected. The semantic meaning is fully preserved and enhanced with additional context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 509,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nMastercard’s security model has moved from a largely internal, perimeter‑focused framework in 2022 to an ecosystem‑wide, collaborative architecture by 2024.  The company now embeds security into every layer of its multi‑rail network—leveraging third‑party partnerships with issuers, acquirers, merchants, governments, fintechs and industry associations to co‑create standards such as EMV, tokenization and AI‑driven fraud scoring—while simultaneously expanding real‑time payment infrastructure (ACH batch and real‑time account‑based clearing) that is protected by real‑time monitoring, tokenization and the Mastercard Intelligence Center.  This evolution signals a strategic shift toward proactive, data‑driven cybersecurity that relies on shared risk‑management and real‑time threat intelligence across the entire payments ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURES: The LLM answer completely fails to cite the specific, verifiable numbers from the ground truth. Ground truth explicitly states: 12 markets in 2022, 13 markets in 2023, and 'several countries globally' in 2024. The LLM answer mentions 'real-time payment infrastructure (ACH batch and real-time account-based clearing)' but provides NO market count data whatsoever, which is a core quantitative metric in the original answer. (2) FACTUAL INACCURACIES: The LLM introduces concepts NOT present in the ground truth such as 'EMV, tokenization and AI-driven fraud scoring,' 'Mastercard Intelligence Center,' and 'ACH batch and real-time account-based clearing.' While these may be real Mastercard products, they are NOT mentioned in the ground truth answer and represent unsupported elaboration. (3) MISSING KEY SYNTHESIS: The ground truth explicitly tracks the EVOLUTION across three specific years (2022→2023→2024) with measurable progression (12→13→several). The LLM answer provides a general characterization ('moved from...to...') but fails to cite the specific year-by-year progression with numbers. (4) MULTI-HOP REASONING: The ground truth demonstrates proper multi-hop synthesis by connecting: (a) third-party collaboration specificity increasing, (b) real-time infrastructure expansion with specific numbers, and (c) how these together indicate strategic alignment. The LLM answer discusses ecosystem collaboration broadly but loses the specific quantitative tracking that proves the evolution. (5) SEMANTIC ISSUES: The LLM's framing of 'internal, perimeter-focused framework in 2022' contradicts the ground truth, which shows Mastercard already emphasized 'public-private collaborations' in 2022. The LLM essentially invents a baseline that doesn't match the source material. CORRECT ELEMENTS: The LLM correctly identifies that the evolution involves increased third-party collaboration and real-time payment expansion, and correctly characterizes the strategic shift toward proactive, data-driven security. However, these correct elements are undermined by the absence of verifiable numbers and the introduction of unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 590,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value exposure to private‑equity‑like funds grew modestly – rising from **$4.01 bn in 2022** to **$4.09 bn in 2023** (an increase of roughly 2 %) – and then **declined slightly to $3.93 bn in 2024**, still above the 2022 level but down from the 2023 peak.  \n\nThis pattern indicates that LLY keeps a **substantial, long‑horizon allocation to illiquid private‑equity‑like assets** as part of its diversification strategy, while **adjusting the weighting modestly** in response to valuation changes and portfolio‑balancing considerations rather than abandoning the asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth shows: 2022: $2,844.7M, 2023: $4,014.1M, 2024: $4,093.7M. LLM reports: 2022: $4.01B (~$4,010M), 2023: $4.09B (~$4,090M), 2024: $3.93B (~$3,930M). These are substantially different values - the LLM has the 2022 figure roughly 40% too high, the 2023 figure roughly 2% too high, and the 2024 figure roughly 4% too low. The directional trend is also WRONG: Ground truth shows consistent growth (2022→2023→2024), while LLM shows growth then decline (2022→2023 up, then 2023→2024 down). The LLM's characterization of a 'slight decline to $3.93 bn in 2024' is factually incorrect - 2024 actually represents the PEAK allocation at $4,093.7M. The qualitative interpretation about 'adjusting the weighting modestly in response to valuation changes' is misleading given the actual upward trajectory. While the LLM correctly identifies this as part of LLY's diversification and long-horizon strategy, the core factual foundation is severely compromised. The answer fails on the primary metric of quantitative accuracy for a financial question requiring specific dollar amounts and year-over-year comparisons.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 350,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 P&G kept Cascade inside the **Fabric & Home Care** segment, but its **product categorization shifted**: in the 2022 tables it was listed simply as a “Fabric Care” brand, whereas by the 2023‑2024 disclosures it appears under the **Home‑Care sub‑category** (often presented as “Tide Cascade”), highlighting its role as a dish‑care rather than a laundry‑care product.  Although P&G does not publish brand‑specific sales, the segment’s share of total net sales stayed around **≈35 %–36 %**, and Cascade’s volume growth was cited as a key driver of the segment’s modest 2 % net‑sales increase and its organic‑volume expansion, underscoring its continued importance to the segment’s performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON PRODUCT CATEGORIZATION: The LLM claims Cascade shifted from 'Fabric Care' in 2022 to 'Home-Care sub-category' by 2023-2024, and describes it as a 'dish-care' product presented as 'Tide Cascade'. This is fundamentally incorrect. Cascade is a dishwashing detergent brand (dish-care), NOT a laundry-care product, and this categorization would NOT have changed from 2022-2024 as the LLM suggests. The claim that it appears under 'Home-Care sub-category' and is presented as 'Tide Cascade' appears to be fabricated - Cascade is a standalone brand, not a Tide variant. (2) QUANTITATIVE ACCURACY - PARTIALLY CORRECT: The LLM correctly identifies the segment's net sales share as approximately 35%-36% across the period, which matches the ground truth. However, the LLM adds unsupported claims about '2% net-sales increase' and 'organic-volume expansion' that are not verified in the ground truth. (3) MULTI-HOP REASONING FAILURE: The LLM fails to correctly synthesize Cascade's actual positioning. The ground truth indicates Cascade remained consistently positioned within Fabric & Home Care as a key brand with stable contribution. The LLM invents a narrative about product categorization shifts that contradicts the actual product nature of Cascade. (4) MISSING CORE INFORMATION: The LLM does not clearly state that Cascade remained in the same segment throughout 2022-2024, nor does it accurately convey the 'stable positioning and consistent contribution' emphasized in the ground truth. (5) SEMANTIC PROBLEMS: The description of Cascade as shifting categories and being presented as 'Tide Cascade' is misleading and factually incorrect based on P&G's actual product portfolio. The answer demonstrates hallucination rather than accurate synthesis of filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 490,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened its supplier‑sustainability framework by updating its Vendor Code of Conduct and human‑rights policy, adding a risk‑based wood‑sourcing program that grades countries, expands monitoring and includes a formal grievance process, and requiring suppliers to disclose GHG emissions to CDP and align with science‑based targets.  It also deepened investment in the supply chain—spending more than $550 million (later highlighted as $300 million+ over the last three years) on energy‑efficiency, renewable‑energy purchases, on‑site solar and LED/HVAC upgrades—and set a net‑zero‑by‑2050 goal with interim 2030 cuts of roughly 40‑42 % for Scope 1‑2 emissions and ≈ 25 % for Scope 3 emissions, while expanding renewable‑energy procurement and solar installations across its store and distribution network.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key policy enhancements (Vendor Code of Conduct updates, risk-based wood sourcing with country grading, grievance process, GHG emissions disclosure requirements, net-zero-by-2050 goal). It appropriately synthesizes multi-hop information about the evolution from 2022-2024 and captures the progression of sustainability commitments. The mention of specific emission reduction targets (40-42% for Scope 1-2, ~25% for Scope 3 by 2030) and renewable energy investments shows good detail.\n\nCRITICAL ISSUES: (1) QUANTITATIVE INCONSISTENCY: The LLM presents conflicting financial figures - stating 'more than $550 million' then immediately parenthetically noting '($300 million+ over the last three years)'. The ground truth specifies $550 million in 2022 and $50 million Gable Grants program over five years in 2023. The LLM's conflation of these figures and introduction of a $300 million figure not in the ground truth creates confusion about actual investment amounts. (2) MISSING KEY DETAIL: The LLM fails to mention the $50 million Gable Grants program for skilled trades education (2023), which is a specific policy enhancement mentioned in the ground truth. (3) INCOMPLETE TEMPORAL BREAKDOWN: While the ground truth clearly delineates what happened in 2022, 2023, and 2024 separately, the LLM presents changes in a more blended manner without clear year-by-year progression, making it harder to track the evolution. (4) ADDED INFORMATION: The LLM introduces CDP emissions disclosure requirements and science-based targets alignment that are not explicitly mentioned in the ground truth, potentially adding unsourced claims.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis across the 2022-2024 period and correctly connects policy framework updates with investment strategy. However, the financial data inconsistency undermines the reliability of the synthesis.\n\nSCORE JUSTIFICATION: The answer captures the core narrative of evolving sustainability practices but contains a significant quantitative error (conflicting investment figures) and omits the Gable Grants program. The qualitative understanding of policy evolution is sound, but the execution has material flaws that would mislead readers about actual financial commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 614,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell’s Safety and Productivity Solutions and Building Technologies shifted from double‑digit organic growth in 2022 to slowing demand and margin compression in 2023, and by 2024 the company explicitly flagged intensified competitive pressures and product‑commoditization risk—especially within the newly created Industrial Automation segment that consolidates these businesses. This trajectory shows a clear escalation of market‑pressure risks and a growing likelihood that competitive dynamics will erode differentiation and margin potential across the portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ISSUES: (1) The LLM introduces unsupported quantitative claims about 'double-digit organic growth in 2022' and 'slowing demand and margin compression in 2023' that are not present in the ground truth and appear to be fabricated financial metrics. (2) The LLM incorrectly characterizes the progression as occurring within a 'newly created Industrial Automation segment that consolidates these businesses,' which misrepresents the actual structure described in the ground truth where Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation are presented as three separate business units with distinct risk disclosures across different years. (3) The ground truth clearly shows a 3-year progression of risk disclosures: Safety and Productivity Solutions (2022) → Honeywell Building Technologies (2023) → Industrial Automation (2024), with each year introducing the risk in a different business unit. The LLM conflates these as a single narrative about 'Safety and Productivity Solutions and Building Technologies' without properly distinguishing the year-by-year evolution across different segments. (4) While the LLM correctly identifies the core theme of intensifying competitive pressures and commoditization risks, it fails to accurately trace how this risk was disclosed across the three distinct business units in sequential years. (5) The LLM's reference to 'newly created Industrial Automation segment' suggests a structural reorganization that is not supported by the ground truth, which treats these as existing business units with evolving risk disclosures. The answer demonstrates partial understanding of the commoditization theme but fundamentally misrepresents the multi-hop synthesis required to show how the risk evolved across different business units over the 3-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 521,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved the automotive‑digital‑cockpit opportunity from a nascent add‑on to a core growth pillar: automotive‑related QCT equipment sales jumped from **$1.5 B to $2.9 B**, and the company highlighted its “connectivity, digital‑cockpit and ADAS/AD platforms” as key enablers of a software‑defined vehicle, with those revenues now a distinct, high‑margin component of the QCT segment that is reflected in rising segment EBT.  At the same time, revenue‑recognition disclosures show that automotive sales are recorded as point‑in‑time equipment sales (with related licensing and performance‑obligation fees recognized over time), and segment reporting separates QCT’s automotive revenue from QTL licensing, underscoring a strategic shift to monetize the digital‑cockpit market through integrated‑circuit sales and associated licensing rather than pure royalty income.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM provides specific revenue figures ($1.5B to $2.9B for automotive QCT) that cannot be verified against the ground truth. The original answer contains NO such quantitative claims - it focuses on strategic positioning evolution, analyst projections (70% of vehicles with cellular by 2028), and revenue recognition/segment reporting changes. The LLM appears to have fabricated or hallucinated these specific dollar amounts. (2) MISSING CORE GROUND TRUTH ELEMENTS: The original answer emphasizes three key progression points: (a) 2022 - forward-looking market opportunity with 70% analyst projection, (b) 2023 - explicit revenue recognition of digital cockpit products, (c) 2024 - formalized segment reporting integration. The LLM answer completely omits the 70% analyst projection and the 2023 intermediate step of explicit revenue recognition. (3) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution 'based on disclosures regarding automotive transformation, product revenue recognition, and segment reporting.' The ground truth correctly synthesizes these three elements across three years. The LLM conflates revenue recognition and segment reporting but fails to properly distinguish the 2022-2023-2024 progression. (4) SEMANTIC ISSUES: The LLM's framing of 'point-in-time equipment sales' and 'licensing/performance-obligation fees' is reasonable accounting language but doesn't match the ground truth's focus on the strategic positioning evolution. (5) WHAT WAS CORRECT: The LLM correctly identifies that Qualcomm moved digital cockpit from nascent to core, correctly names the three product categories (connectivity, digital-cockpit, ADAS/AD), and correctly notes segment reporting separation. However, these correct elements are undermined by unverified numbers and missing the 70% projection and 2023 intermediate milestone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 511,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe broadened Frame.io from a video‑centric review tool into a full‑stack collaboration hub that now supports video, still images, design files and PDFs.  The platform’s cross‑product integration was deepened, adding native connections to Premiere Pro, After Effects, Photoshop, Lightroom, Express and enterprise solutions such as Workfront and Experience Manager, while enterprise capabilities were expanded with Camera‑to‑Cloud automated ingest, AI‑driven workflows (via Firefly), Content Credentials and availability in GenStudio to enable large‑scale, governed content production.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Frame.io from 2022-2024 and correctly identifies many key integrations and capabilities. However, there are notable issues with accuracy and completeness:\n\nCORRECT ELEMENTS:\n- Correctly identifies the evolution from video-centric to broader collaboration platform\n- Accurately lists supported media types (video, still images, design files, PDFs)\n- Correctly mentions integrations with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront\n- Correctly references GenStudio for enterprise-scale content production\n- Appropriately mentions AI-driven workflows and enterprise capabilities\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED CLAIMS: The LLM introduces features not mentioned in the ground truth:\n   - \"Camera-to-Cloud automated ingest\" - not in original answer\n   - \"Content Credentials\" - not in original answer\n   - \"Experience Manager\" - not in original answer\n   - \"Express\" - not in original answer\n   These additions suggest hallucination or information from sources beyond the ground truth.\n\n2. MISSING KEY INFORMATION: The LLM omits important use case expansions mentioned in ground truth:\n   - Casting workflows\n   - Location scouting\n   - Marketing campaign management\n   These represent significant functional expansion beyond post-production that the ground truth emphasizes.\n\n3. TIMELINE SPECIFICITY: The ground truth provides clearer year-by-year progression (2022 as acquisition/branding, 2023 as initial integration, 2024 as major expansion). The LLM presents a more general \"2022-2024\" narrative without this temporal granularity.\n\n4. FIREFLY REFERENCE: While the LLM mentions \"Firefly\" for AI-driven workflows, the ground truth simply states \"AI-driven workflows\" without specifying the tool name, making this an inference rather than ground truth alignment.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the progression from narrower to broader capabilities. However, the introduction of unsupported features undermines the reliability of this synthesis.\n\nOVERALL ASSESSMENT: The answer demonstrates understanding of the general trajectory but fails on factual precision by including unverified claims and omitting documented use case expansions. This represents a moderate accuracy issue suitable for a score in the 6 range.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 643,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares retained the same “one vote per share / dividend rights” language—no amendment to the voting or dividend provisions was disclosed.  The only evolution was the cash dividend per share, which rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024, reflecting a steady, shareholder‑friendly payout policy.  Because the one‑share‑one‑vote structure and the ownership split (public ≈ 89‑90 % of voting power, Mastercard Foundation ≈ 10 %, Class B ≈ 0 % voting) remained unchanged, the three‑year trend points to a stable governance framework that maintains voting concentration while consistently increasing dividends.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that MA's Class A shares maintained 'one vote per share' and 'dividend rights' with no changes across 2022-2024, matching the ground truth core finding. The reasoning about governance stability is sound and well-articulated. The answer appropriately addresses the multi-part question about dividend evolution, voting rights evolution, and governance implications. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM provides specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that cannot be verified against the ground truth, which makes no mention of these specific numbers. These appear to be fabricated or from an unverified source. (2) UNVERIFIED OWNERSHIP PERCENTAGES - The LLM states 'public ≈ 89-90% of voting power, Mastercard Foundation ≈ 10%, Class B ≈ 0%' - these specific percentages are not mentioned in the ground truth and cannot be confirmed. (3) SCOPE CREEP - While the ground truth focuses on the consistency of voting and dividend rights (the structural features), the LLM introduces additional information about actual dividend amounts and ownership structure that goes beyond what the ground truth confirms. The ground truth explicitly states 'There were no changes to these rights in any of the years' - the LLM's addition of dividend amount trends, while potentially accurate, represents information not confirmed in the provided ground truth. ASSESSMENT: The core answer about governance stability and unchanged voting/dividend rights is correct and well-reasoned. However, the introduction of specific unverified financial figures and percentages introduces factual uncertainty that undermines confidence in the response. The answer would be stronger if it stuck to the confirmed facts about structural stability without adding unverified quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 503,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nIn fiscal 2022 the Safety and Productivity Solutions segment posted a 1 % decline in retail‑related sales—partly because the company sold its retail‑footwear business—but overall segment sales still rose 21 % and profit grew 13 % as productivity‑ and warehouse‑automation revenues surged. By fiscal 2023 organic sales in the segment’s core sub‑businesses fell sharply, causing a 17 % drop in segment profit (even though margin improved), highlighting the segment’s heightened sensitivity to slowing consumer and capital‑spending demand. The modest 3 % sales increase and 2 % profit rise in fiscal 2024, coupled with the ongoing realignment into Industrial Automation, show that the segment remains vulnerable to retail‑market and broader consumer‑demand volatility over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES: The LLM answer provides specific financial metrics (1% decline in retail sales, 21% segment sales rise, 13% profit growth in 2022; 17% profit drop in 2023; 3% sales increase and 2% profit rise in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states that Honeywell 'consistently highlighted' risk disclosures about retail market fluctuations and their adverse impact, but does NOT cite specific sales/profit percentages for these years. The LLM appears to have fabricated or hallucinated these precise financial figures. CRITICAL FACTUAL ERROR: The ground truth clearly identifies the segment as 'Safety and Productivity Solutions' in 2022 and 2023, with a name change to 'Industrial Automation' in 2024. The LLM correctly identifies this naming convention. However, the LLM's core answer fundamentally misinterprets the question and ground truth by focusing on actual financial performance metrics rather than the risk disclosure pattern that the ground truth emphasizes. The ground truth is about RISK DISCLOSURE consistency (what Honeywell warned about), not actual financial results. MULTI-HOP REASONING FAILURE: The question asks about 'exposure to fluctuations' and 'vulnerability' - which the ground truth addresses through consistent risk language across filings. The LLM instead provides performance data that may or may not be accurate but doesn't address the core insight about consistent risk disclosure. MISSING KEY INSIGHT: The ground truth's main conclusion is that 'the segment has not significantly mitigated its exposure to retail demand swings over the three-year period' based on consistent risk language. The LLM's answer doesn't capture this pattern of unmitigated risk disclosure. The specific percentages cited by the LLM cannot be verified against the ground truth and appear to be unsupported fabrications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 509,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the Olumiant partnership kept the same basic royalty framework—a tiered, double‑digit royalty (up to 20 % of worldwide net sales) payable to Incyte—while adding a new, low‑teens royalty that applies only when COVID‑19 sales exceed a specified aggregate threshold.  Milestone obligations were initially capitalized as intangible assets, and by 2023‑24 Incyte was eligible for up to $100 million of additional sales‑based milestones (plus the COVID‑19 performance milestones); these milestones were amortized into cost of sales, and the royalty payments made by LLY to Incyte were recorded as cost of sales.  Thus, the core double‑digit royalty persisted, but the COVID‑19 indication introduced an extra royalty tier and associated milestone payments that evolved the financial obligations from 2022 onward.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several key elements correctly but contains significant structural and temporal inaccuracies that undermine the overall response. CORRECT ELEMENTS: (1) The royalty structure of up to 20% on worldwide net sales is accurate; (2) The low-teens royalty for COVID-19 sales above a threshold is correctly identified; (3) The mention of $100 million in sales-based milestones is accurate; (4) The general shift from milestone-driven to royalty-based payments is conceptually correct. CRITICAL ERRORS: (1) TEMPORAL CONFUSION: The LLM states 'by 2023-24 Incyte was eligible for up to $100 million of additional sales-based milestones' which reverses the chronology. The ground truth indicates these milestones existed in 2022 and were capitalized/amortized by 2023, not newly eligible in 2023-24. (2) INCOMPLETE REGULATORY MILESTONES: The ground truth explicitly mentions '$100 million in additional regulatory milestones' in 2022, which the LLM completely omits. The LLM only references sales-based milestones, missing half of the milestone structure. (3) ACCOUNTING TREATMENT CONFUSION: The LLM's explanation of when milestones were 'capitalized as intangible assets' and 'amortized into cost of sales' is muddled and doesn't clearly distinguish between 2022 and 2023-24 treatment as the ground truth does. (4) MISSING EVOLUTION NARRATIVE: The ground truth emphasizes that 'most contingent payments had likely been triggered or expired' by 2024, indicating a meaningful evolution in the payment structure. The LLM doesn't capture this key insight about the maturation of the agreement. QUANTITATIVE ACCURACY ISSUES: While the 20% and low-teens percentages are correct, the LLM fails to distinguish between the two types of milestones ($100M regulatory + $100M sales-based = $200M total potential in 2022), which is a significant omission in financial analysis. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution but does so incompletely and with temporal confusion, failing to properly track how the agreement changed year-by-year from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 559,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nFrom 2022 through 2024 P&G kept **Always** in the **Feminine Care** sub‑category of the **Baby, Feminine & Family Care** segment, continuing to treat it as the flagship brand of that sub‑category.  Across the three years the company repeatedly highlighted Always as the primary driver of the segment’s > 20 % global market‑share in feminine care and as a key contributor to segment sales and earnings, positioning it ahead of other brands such as Tampax and Always Discreet in prominence and strategic focus.  The categorization did not change, but Always’s visibility and market‑leadership narrative were reinforced each year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) CATEGORIZATION EVOLUTION - Ground truth clearly states the categorization CHANGED from 2022 to 2023 (from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Feminine Care (Adult Incontinence, Menstrual Care)'), but the LLM claims 'The categorization did not change' - this is a fundamental error that directly contradicts the core finding. (2) PRODUCT SPECIFICITY - Ground truth emphasizes a strategic shift toward more specific 'menstrual care' positioning in 2023-2024, but the LLM provides a generic statement about 'Feminine Care' without capturing this important evolution. (3) QUANTITATIVE CLAIMS - The LLM introduces an unsupported claim about '>20% global market-share in feminine care' which does not appear in the ground truth and cannot be verified. This is a fabricated statistic. (4) BRAND PROMINENCE - While the LLM correctly identifies Always, Tampax, and Always Discreet as key brands, it mischaracterizes the positioning by claiming Always was positioned 'ahead of' Tampax and Always Discreet, whereas the ground truth simply lists them as appearing alongside each other without establishing a clear hierarchy. (5) MULTI-HOP SYNTHESIS - The LLM failed to synthesize the year-by-year evolution that is central to the question. The ground truth shows a 2022→2023 shift in categorization language that reflects strategic repositioning, which the LLM completely missed. The answer reads as a generic statement about brand prominence rather than addressing the specific evolution requested. The only correct element is that Always remained in the Feminine Care category throughout the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 467,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nACN’s defined‑benefit targets shifted from a near‑all‑debt posture in fiscal 2023 — U.S. plans 100 % debt; non‑U.S. plans 27 % equity, 48 % debt, 4 % cash, 11 % insurance, 10 % other — to a more balanced mix by fiscal 2024 (non‑U.S. equity raised to 28 %, debt trimmed to 36 %, cash to 7 %, insurance to 21 %, other to 8 %) and the 2025 target (identical to the 2024 mix) reflects a deliberate move toward greater equity and insurance exposure to improve risk‑adjusted returns while still matching liability duration.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific percentage allocations (U.S. plans 100% debt; non-U.S. plans 27% equity, 48% debt, 4% cash, 11% insurance, 10% other for fiscal 2023) that are presented as fact but cannot be verified against the ground truth, which does not provide these specific numbers. The claim that fiscal 2024 shows 'non-U.S. equity raised to 28%, debt trimmed to 36%, cash to 7%, insurance to 21%, other to 8%' is unsubstantiated. (2) CHARACTERIZATION ERROR: The LLM describes fiscal 2023 as a 'near-all-debt posture' for U.S. plans (100% debt), which is an extreme characterization not supported by the ground truth. The ground truth emphasizes 'diversified portfolio of fixed income instruments and equities,' not a debt-only approach. (3) DIRECTIONAL CLAIM ERROR: The LLM claims a 'shift' from fiscal 2023 to 2024 with increasing equity and insurance exposure, but the ground truth states the strategy showed 'consistent framework' and 'strategic continuity' across years, not a deliberate shift toward greater equity exposure. (4) MISSING CONTEXT: The LLM fails to address the ground truth's emphasis on 'liability duration matching' as a core principle and instead focuses on specific percentage changes that appear fabricated. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize across three fiscal years, it does so with unverified data that contradicts the ground truth's narrative of stability and consistency. The ground truth indicates the 2025 target was 'maintained the same structure' and 'reaffirmed,' not that it was 'identical to the 2024 mix' as a result of deliberate shifts. The answer demonstrates poor factual accuracy and appears to contain invented specific percentages rather than data from actual SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 515,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s trimmed its cash‑flow forward‑rate‑swap notional from roughly $2.56 billion to just under $1 billion, while the fixed‑to‑floating swaps used as fair‑value hedges on its existing long‑term debt expanded from about $0.85 billion to roughly $1.5 billion.  The re‑classification of a portion of those swaps from cash‑flow to fair‑value hedge accounting shows the company has shifted from primarily shielding future financing plans to directly protecting the fair value of its current fixed‑rate debt, revealing a more balance‑sheet‑centric interest‑rate risk‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific notional amounts ($2.56 billion forward swaps in 2022 declining to ~$1 billion by 2024, and fixed-to-floating swaps expanding from $0.85 billion to $1.5 billion) that are not mentioned in the ground truth. The ground truth only explicitly states a fair value of $251 million for 2023 forward interest rate swaps, with no notional amounts provided for any year. These specific dollar figures appear to be fabricated or sourced from unreliable data. (2) INCOMPLETE SYNTHESIS: The ground truth clearly states that in 2022, 'no current fair value was listed for 2022 itself,' yet the LLM confidently provides 2022 notional values. The ground truth indicates 2023 had a $251 million fair value disclosure, but the LLM does not reference this figure at all. (3) PARTIAL ACCURACY: The LLM correctly identifies the strategic shift from cash flow hedges to fair value hedges and the transition from managing forecasted debt issuance risk to managing existing debt exposure. The conceptual understanding of the shift is sound. However, this correct reasoning is undermined by the unsupported quantitative claims. (4) MISSING KEY DETAILS: The LLM fails to mention the Level 2 fair value hierarchy classification disclosed in 2023, the classification under 'Other current assets,' or the specific timeline of when swaps were eliminated (by 2024). (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution across years, it does so with invented numbers rather than actual filing data, which is a critical failure for a financial analysis task where precision is paramount. The answer reads plausibly but lacks evidentiary support from the actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 512,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nThe $5.000 % senior notes maturing in April 2030 showed virtually no change in outstanding balance—​about **$606 million** at the end of fiscal 2022, 2023 and 2024 (the same $606 million figure is reported as of Nov 3 2024 and Oct 29 2023).  At the same time the company’s overall debt load expanded dramatically (total principal rising from roughly **$40.8 bn** in 2023 to **$66.3 bn** in 2024 after the VMware merger), and it used cash from the merger, new senior‑note issuances and term‑loan repayments to shrink short‑term borrowings.  This pattern indicates that AVGO is managing its debt by **refinancing near‑term, higher‑cost obligations with longer‑dated, lower‑coupon senior notes while keeping legacy tranches—such as the 5 % 2030 notes—small and stable** as part of a broader strategy to extend maturities and lower overall financing costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that AVGO's exposure to the 5.000% notes due April 2030 DECREASED from $1,086 million in 2022 to $606 million in 2023 and 2024. However, the LLM answer claims the balance was 'about $606 million at the end of fiscal 2022, 2023 and 2024' with 'virtually no change.' This is factually incorrect. The LLM misrepresents the 2022 figure as $606 million when it was actually $1,086 million—a $480 million difference. This is not a minor discrepancy; it's a 44% understatement of the 2022 balance. The LLM's claim of 'virtually no change' is therefore completely wrong. The ground truth indicates a deliberate, significant reduction strategy over the three-year period, which the LLM fails to capture. While the LLM correctly identifies the 2023 and 2024 figures as $606 million, and provides some contextual information about broader debt management and the VMware merger, these correct elements cannot offset the core factual error about the 2022 balance and the resulting mischaracterization of the debt trajectory. The LLM's interpretation of the debt management strategy is also undermined by this fundamental misunderstanding of the 5.000% notes' evolution. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the three-year progression that is central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 402,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nFrom 2022 through 2024 UPS continued to describe the same $276 million series of 7.620 % debentures—originally issued in 2005 and still outstanding—as a fixed‑rate instrument with a maturity of **April 1 2030**.  The debentures remain **callable at any time** at the greater of (i) principal plus accrued interest or (ii) the present‑value of the remaining scheduled payments discounted at a benchmark Treasury yield plus 5 basis points, and they are **not subject to any sinking‑fund requirements**; the redemption mechanics and interest‑rate formula were unchanged from the 2022 filing (the coupon had been reduced from 8.375 % to 7.620 % in 2020 and stayed at 7.620 % in 2023‑2024).  Across the three 10‑Ks the only evolution was an updated carrying‑value ( $280 million in 2022, 2023 and 2024) and re‑classification as long‑term debt, while the maturity date, interest rate, and redemption terms stayed the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the carrying value of the debentures. The ground truth states the carrying value was $280 million in 2022, 2023, and 2024, but the LLM claims it was '$280 million in 2022, 2023 and 2024' while also stating 'updated carrying-value ($280 million in 2022, 2023 and 2024)' - this is internally consistent but contradicts the ground truth which does not mention an 'update' to carrying value across these years. More critically, the LLM provides no carrying value information for 2022 in the original answer, making it impossible to verify the claim of consistency. The LLM correctly identifies: (1) the $276 million principal amount, (2) the 7.620% interest rate from 2020 onward, (3) the April 1, 2030 maturity date, (4) the callable-at-any-time redemption feature, (5) the redemption price formula (greater of principal plus accrued interest or present value of remaining payments at benchmark Treasury plus 5 bps), (6) no sinking fund requirements, and (7) the 8.375% to 7.620% rate reduction in 2020. The LLM also correctly notes the debentures were originally issued in 2005. However, the LLM's statement about 'updated carrying-value' and the specific claim that it was '$280 million in 2022, 2023 and 2024' introduces ambiguity - the ground truth does not explicitly state the carrying value remained unchanged at $280 million across all three years, only that it was reported. The LLM's characterization of the evolution as primarily involving 'updated carrying-value' and 'reclassification as long-term debt' differs from the ground truth's emphasis on 'increasing clarity in disclosure' regarding semi-annual interest payment schedules and sinking fund requirements. The multi-hop reasoning is sound in synthesizing information across three years, but the quantitative claims about carrying value lack proper grounding in the source material as presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 519,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen kept Olpasiran in its Phase 2 pipeline, progressing the siRNA‑based drug from early proof‑of‑concept studies toward later‑stage testing as a therapeutic aimed at lowering lipoprotein(a) for atherosclerotic cardiovascular disease.  During this period the company filed composition‑of‑matter patents covering the Olpasiran molecule, which are projected to expire in 2036 in both the United States and the European Union, thereby securing up to a 12‑year exclusivity window once the product is approved.  As a result, Olpasiran’s strategic positioning evolved from an early‑stage candidate to a late‑stage, IP‑protected asset poised for potential Phase 3 advancement.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CLINICAL PHASE PROGRESSION ERROR: The LLM states Olpasiran remained in Phase 2 throughout 2022-2024 and was 'poised for potential Phase 3 advancement,' but the ground truth indicates progression occurred - it was Phase 2 in 2022 and should have advanced by 2024. The LLM fails to capture the actual clinical progression that occurred. (2) THERAPEUTIC INDICATION CHANGE MISSED: The ground truth explicitly notes a shift from 'lowering lipoprotein(a) for atherosclerotic cardiovascular disease' (2022) to broader 'cardiovascular disease' (2024), suggesting expansion of clinical application. The LLM only mentions the original narrow indication and misses this important strategic evolution. (3) PATENT DETAILS PARTIALLY CORRECT: The LLM correctly identifies 2036 expiration dates for U.S. and EU patents and the ~12-year exclusivity window, which matches ground truth. However, the LLM describes these as 'composition-of-matter patents' while ground truth simply states 'compound-related patents' - this is a minor characterization difference. (4) MULTI-HOP SYNTHESIS INCOMPLETE: The question asks about evolution across three dimensions (therapeutic focus, clinical phase progression, IP protection). The LLM addresses IP protection adequately but fails on the first two critical dimensions - it doesn't show the therapeutic indication broadening or acknowledge actual clinical phase advancement. (5) TEMPORAL PROGRESSION MISREPRESENTED: The LLM suggests Olpasiran was 'early-stage' in 2022 and evolved to 'late-stage' by 2024, but this characterization is vague and doesn't capture the specific phase progression or indication expansion documented in the ground truth. The answer reads as speculative rather than grounded in actual filing disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 484,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nBetween 2022 and 2024 Tampax remained in the **Baby, Feminine & Family Care** segment, but its positioning was progressively emphasized as a core driver of that segment’s market leadership. In 2022 it was simply listed among the major brands (Always, Tampax Bounty, etc.), whereas in the 2023‑2024 disclosures P&G explicitly notes that **Tampax (together with Always) accounts for > 25 % of global menstrual‑care share**, highlighting its prominence as one of the segment’s leading brands.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERROR - The LLM claims 'Tampax (together with Always) accounts for > 25% of global menstrual-care share' with no supporting evidence in the ground truth. This specific market share metric is not mentioned in the original answer and appears to be fabricated. (2) ENTITY ERROR - The LLM lists 'Tampax Bounty' as a brand, which is incorrect; Bounty is a separate brand (paper towels), not part of Tampax. The ground truth correctly lists 'Always and Bounty' as separate brands. (3) INCOMPLETE SYNTHESIS - The LLM fails to capture the key evolution described in the ground truth: the 2023 reclassification to 'Feminine Care (Adult Incontinence, Menstrual Care)' with the specific sub-category change from 'Feminine Care (Adult Incontinence, Feminine Care)' to include 'Menstrual Care' explicitly. (4) MISSING DETAIL - The ground truth notes that 2024 reverted to 'Baby, Feminine & Family Care' naming, which the LLM does mention but doesn't emphasize the cyclical nature of the categorization changes. (5) OVERSTATED CLAIMS - The LLM characterizes Tampax as 'progressively emphasized as a core driver' without evidence from the ground truth, which simply states 'consistent strategic emphasis' with 'minor refinements.' The introduction of the >25% market share claim is a critical factual error that significantly undermines the answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 412,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s disclosures show that it continued to apply internally developed credit designations to non‑agency RMBS and CMBS that had not yet been evaluated by the NAIC, even after the NAIC introduced a 20‑category designation system and new RBC factors in 2021‑2022. This multi‑year pattern indicates that NAIC designations are typically unavailable at the time of purchase, revealing that MetLife’s acquisition strategy relies on buying these securities with the expectation that a NAIC rating will be assigned later, while using internal models to value them in the interim.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that MetLife continued to apply internally developed designations for non-agency RMBS and CMBS from 2022-2024 due to unavailable NAIC designations at time of purchase. The answer accurately captures the multi-year trend and its implications for MetLife's acquisition strategy. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the persistence of the practice; (2) Accurately characterizes the reason (NAIC designations unavailable at purchase time); (3) Properly synthesizes the multi-hop insight that this reflects MetLife's strategy of acquiring securities before NAIC evaluations are complete; (4) Correctly notes the use of internal models as interim valuation tools. MINOR WEAKNESSES: (1) The LLM introduces additional context about the NAIC's 20-category designation system and 2021-2022 RBC factors that, while potentially accurate, are not explicitly confirmed in the ground truth answer and represent added detail not directly supported by the original answer's scope; (2) The phrasing 'even after the NAIC introduced' could imply a causal relationship that isn't clearly established in the ground truth; (3) The ground truth emphasizes 'newly issued or less frequently evaluated securities' as the specific context, while the LLM answer generalizes this somewhat. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022-2024) are correct. MULTI-HOP REASONING: Both answers correctly synthesize the relationship between NAIC designation availability, MetLife's acquisition timing, and internal valuation practices. The LLM answer adds one additional inference layer (about acquisition strategy expectations) that is reasonable but slightly beyond the ground truth's explicit scope. SEMANTIC EQUIVALENCE: The core message is equivalent - MetLife's consistent use of internal designations across three years reflects a strategy of acquiring securities before NAIC evaluations are available.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 557,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture expanded both the size of its buy‑back program and the amount it actually spent.  As of August 2022 the board had authorized about **$3.1 bn** of remaining capacity for open‑market purchases; by the end of fiscal 2024 the company still had roughly **$2.69 bn** of that capacity, and on September 25 2024 the board added **$4 bn** of authority, bringing total outstanding authorization to **$6.69 bn**.  Share‑repurchase outlays rose from **≈ $4.1 bn** of stock bought in fiscal 2022 to **≈ $4.5 bn** in fiscal 2024 (with the fourth‑quarter alone purchasing 2.07 million shares for $605 m), reflecting a deliberate acceleration of capital returns.  The trend shows Accenture is aggressively using its enlarged buy‑back authorization to return cash to shareholders, support the share price and offset dilution.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the capital return strategy and correctly identifies the overall trend, but contains several significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) Authorization figures are accurate: $3.1bn (fiscal 2022), $2.69bn (August 31, 2024), and $4bn additional authorization on September 25, 2024, totaling $6.69bn. (2) Q4 FY2024 share purchase details are correct: 2,000,308 shares for $605 million (LLM states 2.07 million, which is a minor rounding variation). (3) The narrative about capital return strategy and shareholder returns is appropriate and well-reasoned. (4) The multi-hop synthesis across fiscal years and the September 2024 authorization is sound. CRITICAL ERRORS: (1) The LLM claims share repurchase outlays were \"≈ $4.1 bn\" in fiscal 2022 and \"≈ $4.5 bn\" in fiscal 2024. The ground truth does not provide these specific annual repurchase amounts, and the LLM appears to have fabricated or misremembered these figures. This is a major quantitative error. (2) The statement about \"2.07 million shares\" in Q4 should be \"2.0 million shares\" (2,000,308 rounds to 2.0 million, not 2.07 million). SYNTHESIS ASSESSMENT: The multi-hop reasoning is sound - the model correctly synthesizes information across three fiscal years and incorporates the September 2024 authorization update. However, the introduction of unsupported annual repurchase figures ($4.1bn and $4.5bn) represents a significant factual error that cannot be verified against the ground truth. The answer would have been stronger by focusing only on the verifiable authorization figures and the specific Q4 FY2024 repurchase data provided in the ground truth. The qualitative interpretation of the trend is reasonable but is undermined by the quantitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 493,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved industrial fiber‑optics from a generic “industrial product” listed alongside optocouplers and motion encoders (2022, pp. 8‑12) to a explicitly growth‑focused segment that enables high‑speed connectivity for industrial automation, renewable‑energy, automotive, defense/aerospace and edge‑AI applications (2023, pp. 3‑7; 2024, pp. 3‑7). This evolution shows the company is deliberately positioning industrial fiber‑optics as a strategic, high‑margin pillar to diversify and boost profitability in the industrial end‑market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Broadcom (AVGO) and the 2022-2024 timeframe. It captures the general evolution narrative of industrial fiber optics moving from a generic listing to more strategic positioning. The semantic direction is correct - showing increasing emphasis on applications and strategic importance. The mention of applications like industrial automation, renewable energy, and automotive electronics aligns with the ground truth.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM cites specific page numbers (pp. 8-12 for 2022; pp. 3-7 for 2023 and 2024) without verification against actual filings. These page references cannot be validated and appear fabricated, which is a serious factual error. (2) UNSUPPORTED CLAIMS: The LLM makes assertions about 'high-margin pillar' and 'deliberately positioning' as strategic growth focus that are NOT present in the ground truth. The ground truth describes 'consistent presence' and 'maturing strategy,' not explicit growth-focus positioning. (3) INCOMPLETE SYNTHESIS: The ground truth specifically mentions the 2023 'structured table' categorization and 2024 'explicit linking' with specific applications - the LLM generalizes these details rather than capturing the precise evolution of how the product was presented. (4) ADDED APPLICATIONS: The LLM introduces 'defense/aerospace' and 'edge-AI' applications that are not mentioned in the ground truth, suggesting either fabrication or confusion with other product lines.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but does so with unsupported specificity. The ground truth shows a more measured evolution (generic → standardized categorization → consistent with explicit applications), while the LLM claims a more dramatic strategic pivot to 'growth-focused segment' without evidence.\n\nSEMANTIC EQUIVALENCE ISSUES: While the overall narrative direction is similar, the LLM overstates the strategic emphasis and adds interpretive claims ('high-margin pillar,' 'deliberately positioning') that go beyond what the ground truth supports. The ground truth emphasizes 'consistent presence' and 'maturing' strategy, not aggressive repositioning.\n\nJUSTIFICATION: The answer demonstrates partial understanding of the evolution but fails on factual precision (fabricated page numbers), introduces unsupported claims about strategic intent and margins, and adds applications not in the ground truth. These are significant errors for a financial analysis task where accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 677,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost was marketed as a residential‑ground service that used the UPS network for pickup and line‑haul but handed the final‑mile delivery to the United States Postal Service.  In early 2024 UPS announced that, beginning January 1 2025, it would insource that final‑mile step, ending its reliance on USPS and gaining greater control over service and cost as part of its broader “Fit‑to‑Serve”/Efficiency‑Reimagined strategy to shift volume toward higher‑yielding customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All factual information is correct: (1) UPS SurePost is correctly identified as a residential ground service for non-urgent, lightweight shipments; (2) The delivery model from 2022-2023 is accurately described as using UPS network for pickup/line-haul with USPS handling final-mile delivery; (3) The 2024 strategic shift is correctly stated with the precise effective date of January 1, 2025; (4) The insourcing decision and its rationale (greater control over service quality and cost) are accurately captured. The LLM answer adds valuable context by mentioning the 'Fit-to-Serve'/Efficiency-Reimagined strategy, which provides additional strategic context not explicitly in the ground truth but is consistent with it. All dates are accurate (2022, 2023, 2024, January 1 2025). The multi-hop reasoning is sound - the answer correctly synthesizes the evolution across three time periods and identifies the key strategic inflection point. The only minor distinction is that the LLM answer emphasizes cost control alongside service quality, which is a reasonable inference from the strategic context but goes slightly beyond the ground truth statement. This is not an error but rather a reasonable elaboration. The answer fully addresses all parts of the question regarding role evolution, delivery model changes, USPS reliance, and strategic shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 389,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline swelled from 13 programs (as of Feb 2022) to 24 programs by Jan 2024 and 25 by Feb 2025, with new late‑stage candidates such as bemarituzumab, TEZSPIRE, LUMAKRAS combination studies and Dazodalibep being launched, while several assets (e.g., LUMAKRAS, Otezla, RIABNI) moved from Phase 3 into FDA/EU approvals or conditional marketing authorizations.  The company also bolstered its pipeline through strategic acquisitions (e.g., Horizon‑derived programs) and filed composition‑of‑matter patents that extend exclusivity out to 2039.  This progression signals a deliberate R&D expansion—broadening therapeutic areas, deepening collaborations, and investing heavily in late‑stage development to secure a robust, diversified pipeline for future growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core quantitative progression (13→24→25 Phase 3 programs across the 2022-2024 period), matching the ground truth numbers precisely. The dates are accurate (Feb 2022, Jan 2024, Feb 2025). The answer appropriately mentions the Horizon Therapeutics acquisition as a driver of pipeline expansion and correctly identifies it as contributing Phase 3 programs. The synthesis of internal development and external acquisition as dual strategies is sound and well-articulated. The answer goes beyond the ground truth by providing specific drug examples (bemarituzumab, TEZSPIRE, LUMAKRAS, Dazodalibep) and mentions regulatory approvals/transitions, which adds valuable context.\n\nWEAKNESSES: (1) The LLM answer mentions specific drug transitions (LUMAKRAS, Otezla, RIABNI moving to approvals) but does not verify these against the ground truth, which focuses on the aggregate Phase 3 count evolution. While these examples may be accurate, they introduce details not confirmed in the ground truth. (2) The mention of 'composition-of-matter patents extending exclusivity to 2039' is not present in the ground truth and appears to be an unsupported addition. (3) The ground truth explicitly notes 'five new initiations' and that Horizon added 'five Phase 3 programs,' but the LLM answer does not quantify these contributions, missing an opportunity for more precise multi-hop synthesis. (4) The phrase 'deepening collaborations' is vague and not substantiated in the ground truth.\n\nQUANTITATIVE VERIFICATION: All core numbers are correct (13, 24, 25 programs; Feb 2022, Jan 2024, Feb 2025 dates). No calculation errors detected. The progression narrative is accurate.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and identifies the dual mechanisms of growth (internal + external via Horizon). However, it could have been more explicit about the quantified contributions (e.g., 'Horizon added 5 programs, with 5 new internal initiations').\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution, milestones, and R&D strategy implications. The strategic interpretation is reasonable and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 599,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares in FY 2022** to **141 million shares in FY 2023** (and remained at that level in FY 2024). This expansion shows that Accenture intentionally broadened its equity‑award pool, underscoring a strategic shift to rely more heavily on share‑based compensation as a core component of its talent‑retention and performance‑incentive strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - FY 2022: 127 million shares, FY 2023-2024: 141 million shares. The increase of 14 million shares (11% growth) is accurately represented. Number formatting is appropriate and consistent. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution from FY 2022 through 2024, (2) the specific share counts, and (3) the strategic implications. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, and the Amended 2010 SIP. Fiscal years are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the progression as indicating strategic intent. The connection between share authorization increases and talent retention/performance alignment strategy is sound and matches the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's phrasing ('intentionally broadened its equity-award pool,' 'strategic shift to rely more heavily on share-based compensation') conveys the same meaning as the ground truth ('strategic expansion,' 'greater emphasis on equity-based incentives'). The characterization of this as a 'core component' of talent retention and performance incentives is semantically equivalent to the ground truth. MINOR OBSERVATION: The LLM uses 'million' notation (127 million, 141 million) which is a standard and acceptable format variation from the ground truth's '127,000,000' notation. No factual errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 439,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company lengthened the horizon of its green‑coffee coverage: the 2022 filing said existing inventory plus purchase commitments would be sufficient only through fiscal 2023, while the 2023 and 2024 filings each state that total purchase commitments together with inventory are expected to meet demand through fiscal 2025.  This extension reflects a deliberate inventory‑building and hedging strategy—using fixed‑price, forward and collar contracts and long‑term supplier relationships—to lock in supply, mitigate the inherent price volatility of green coffee, and reduce the risk of supply disruptions as the business expands globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All fiscal years and timeline projections are correct - fiscal 2022 coverage through fiscal 2023, fiscal 2023-2024 coverage through fiscal 2025. The progression is accurately stated. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the duration evolved (correctly showing the extension from FY2023 to FY2025 coverage), and (2) what this indicates about strategy. ENTITY ACCURACY: Starbucks correctly identified, fiscal years correctly referenced, green coffee supply correctly specified. REASONING & SYNTHESIS: The LLM successfully synthesized multi-hop information by connecting the timeline evolution to strategic implications. The answer goes beyond the ground truth by providing specific mechanisms (fixed-price contracts, forward and collar contracts, long-term supplier relationships) that support the strategy, demonstrating deeper contextual understanding. SEMANTIC EQUIVALENCE: The LLM's phrasing 'lengthened the horizon' and 'extension reflects a deliberate inventory-building and hedging strategy' conveys the same meaning as the ground truth's 'more forward-looking inventory and risk management strategy.' The additional detail about specific hedging mechanisms (fixed-price, forward and collar contracts) adds valuable context without contradicting the ground truth. MINOR CONSIDERATION: The ground truth states the projection 'maintained the same projected supply coverage through fiscal 2025' in FY2024, while the LLM says 'each state that total purchase commitments together with inventory are expected to meet demand through fiscal 2025' - this is semantically equivalent and accurate. The LLM's answer is slightly more detailed and insightful than the ground truth while remaining factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 496,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS’s handling of the UPS/IBT Full‑Time Employee Pension Plan shifted in three key ways. First, the 2023 five‑year national master agreement with the Teamsters introduced wage and benefit increases for IBT participants, prompting a year‑end remeasurement of the plan’s obligations and generating actuarial gains/losses that were recorded in other‑comprehensive‑income. Second, beginning January 1 2023 the company stopped accruing additional defined‑benefit accruals for non‑union participants (and moved them to a defined‑contribution contribution structure), fundamentally changing the plan’s liability trajectory. Third, ongoing periodic remeasurements—driven by updated discount‑rate assumptions, the continued use of the MP‑2021 mortality scale, and fluctuations in asset returns—altered the plan’s funded status and resulted in recurring gains or losses that are reflected in the consolidated financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2023 Teamsters agreement 'generated actuarial gains/losses that were recorded in other-comprehensive-income' - the ground truth states these were 'recognized as part of the year-end measurement' with no mention of OCI recording. (2) The LLM introduces a major claim that 'beginning January 1 2023 the company stopped accruing additional defined-benefit accruals for non-union participants (and moved them to a defined-contribution structure)' - this is NOT mentioned in the ground truth at all and represents a significant structural change that should have been explicitly documented if true. (3) The LLM omits the critical 2022 remeasurement following the American Rescue Plan Act that resulted in a $3.3 billion pre-tax mark-to-market gain ($2.5 billion after tax) - this is a major quantitative fact that should be included. (4) The LLM discusses 'MP-2021 mortality scale' and 'discount-rate assumptions' as drivers of remeasurements, which are reasonable pension accounting details but are not mentioned in the ground truth and may be speculative. CORRECT ELEMENTS: The LLM correctly identifies the 2023 five-year Teamsters agreement and its wage/benefit increases, and correctly notes the plan's continued existence through 2024. However, the answer fundamentally misrepresents the accounting treatment and introduces unsupported structural changes. The multi-hop synthesis is incomplete and inaccurate - the answer fails to properly connect the 2022 regulatory event to the overall evolution, and invents details about non-union participant treatment that cannot be verified from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 478,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nWalmart continued to list “Holiday Time” as a stand‑alone private‑brand line in each of the fiscal‑year disclosures (2022 – 2024) — it appears in the brand‑name merchandise tables on pages 7‑8 of the 2023 10‑K, on pages 6‑7 of the 2024 10‑K, and in the comparable list in the 2022 filing.  What changes is the **contextual framing**: in the 2022 filing the brand was simply grouped with other private‑label names, whereas the 2023 and 2024 filings begin to reference “Holiday Time” explicitly as part of the **seasonal‑merchandise unit** (e.g., “seasonal/holiday merchandise” and “holiday décor”), signaling a deliberate move to treat it as a dedicated seasonal private‑label pillar.  \n\nThis evolution reveals that Walmart is **strategically positioning seasonal items under its own private brands** to capture peak holiday demand, differentiate those products from national‑brand competitors, and integrate them more tightly into its broader private‑label portfolio.  By doing so, the company can leverage exclusive “Holiday Time” merchandise to drive incremental sales during the most profitable period of the year while reinforcing the EDLP promise with proprietary, time‑sensitive offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in factual accuracy and specificity. STRENGTHS: (1) The LLM correctly identifies that 'Holiday Time' appears across fiscal years 2022-2024 in Walmart's filings; (2) The general narrative about evolution from simple grouping to more strategic seasonal positioning aligns with the ground truth; (3) The reasoning about strategic positioning for seasonal demand and private label differentiation is sound and relevant. CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUES: The LLM cites specific page numbers (pages 7-8 of 2023 10-K, pages 6-7 of 2024 10-K) without verification against actual filings. These page citations cannot be confirmed and may be fabricated, which is a serious factual error; (2) The LLM claims 'Holiday Time' is explicitly referenced as part of 'seasonal-merchandise unit' in 2023 and 2024 filings with phrases like 'seasonal/holiday merchandise' and 'holiday décor,' but the ground truth indicates this explicit restructuring occurred specifically in fiscal 2024 with 'seasonal merchandise' as a defined category under General Merchandise. The LLM conflates the timing by suggesting this language appears in both 2023 and 2024; (3) MULTI-HOP SYNTHESIS ERROR: The ground truth clearly distinguishes that in 2023, 'Holiday Time' was mentioned 'without a distinct strategic role,' whereas the LLM suggests 2023 already shows explicit seasonal-unit framing. This is a material mischaracterization of the evolution timeline; (4) The LLM adds interpretive analysis about 'EDLP promise' and 'incremental sales during profitable periods' that, while strategically logical, goes beyond what the ground truth establishes and represents speculation rather than documented evolution. VERIFICATION ISSUES: The specific page citations and exact phrase matches ('seasonal/holiday merchandise') lack verifiable support in the provided ground truth, suggesting potential hallucination of filing details. The core narrative is directionally correct but the specific factual claims about when and how the categorization changed are imprecise and partially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 575,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nACN’s defined‑benefit pension assets included mutual‑fund equity securities of roughly **$239 million at the end of fiscal 2022**, **$196 million at the end of fiscal 2023**, and **$274 million at the end of fiscal 2024**. The decline in 2023 reflects a temporary de‑risking of the portfolio, while the rebound in 2024—bringing the allocation back above its 2022 level—indicates a deliberate re‑allocation toward equities as part of the company’s target asset‑mix and risk‑management strategy. This trend suggests ACN is actively adjusting its equity exposure to balance long‑term return objectives with liability‑matching considerations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a major quantitative inaccuracy that fundamentally contradicts the ground truth. The LLM claims ACN's mutual fund equity securities were $274 million at the end of fiscal 2024, but the ground truth explicitly states the amount 'remained unchanged in 2024' at $196.226 million (same as 2023). This is a significant factual error that completely changes the narrative and conclusion. The LLM's interpretation of a 'rebound in 2024—bringing the allocation back above its 2022 level' is entirely incorrect based on the actual data. The 2022 ($239.293M) and 2023 ($196.226M) figures are correctly stated in the LLM answer, but the 2024 figure of $274M is fabricated or misread. The LLM's reasoning about 're-allocation toward equities' and 'actively adjusting its equity exposure' is therefore based on false data. The ground truth indicates a consistent decline from 2022 to 2023 with no change in 2024, suggesting strategic rebalancing AWAY from this asset class, not toward it. The LLM's qualitative interpretation directly contradicts the actual trend. While the LLM appropriately identifies this as pension asset data and provides contextual framing about risk management, the fundamental numerical error and resulting incorrect strategic interpretation make this answer substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 374,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks shifted from a descriptive view of green‑coffee price volatility—highlighting that futures‑market activity, including hedge‑fund and commodity‑index‑fund trading, can affect the “C” price—to an explicit, multi‑tool hedging program.  The company increasingly uses fixed‑price and price‑to‑be‑fixed purchase commitments together with forward contracts, futures and collars to lock in prices and secure supply through at least fiscal 2025, turning what was once passive exposure into a proactive risk‑management strategy that monitors and adjusts to futures‑market signals.  This evolution reveals that Starbucks manages commodity‑price risk through disciplined, layered hedges rather than relying on market fluctuations alone.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with sound multi-hop reasoning across the fiscal 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution from descriptive acknowledgment to proactive hedging strategy; (2) Accurately references the key instruments (fixed-price contracts, price-to-be-fixed commitments, forward contracts, futures, and collars); (3) Properly synthesizes the timeline showing extension through fiscal 2025; (4) Correctly identifies commodity index funds and futures market influences as key risk factors; (5) Accurately characterizes the shift from passive to active risk management. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is not directly testable. The fiscal years (2022-2025) are correctly referenced. MINOR GAPS: (1) The LLM answer characterizes the 2022 approach as 'descriptive' rather than acknowledging that hedging was already occurring in 2022 (the ground truth states 'In 2022, the company hedged 'C' price exposure using forward and futures contracts'). This is a subtle distinction—the LLM implies less active management in 2022 than the ground truth suggests; (2) The phrase 'turning what was once passive exposure into a proactive risk-management strategy' slightly overstates the shift, as the ground truth indicates hedging was already active in 2022, not merely passive observation. SEMANTIC EQUIVALENCE: The core message aligns well—both answers convey that Starbucks evolved its approach to managing green coffee price volatility through increasingly sophisticated hedging strategies. The LLM's characterization of 'disciplined, layered hedges' effectively captures the essence of the ground truth's 'consistent and maturing risk management approach.' MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the relationship between futures market activity, commodity index funds, and Starbucks' hedging response. The reasoning is logically sound and appropriately contextualizes the company's risk management philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 569,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nAVGO carried $622 million of its 3.625 % senior notes maturing in October 2024 at the end of FY 2022 and FY 2023 (see AVGO_10k_2022.pdf pp. 101‑105; AVGO_10k_2023.pdf pp. 79‑83).  By the close of FY 2024 that balance had been reduced to zero (AVGO_10k_2024.pdf pp. 79‑83), indicating that the company retired the entire issue—using cash from its October 2024 senior‑note issuance and proceeds from the VMware merger—to eliminate near‑term maturities and reshape its short‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. All quantitative data is correct: $622 million principal outstanding in FY 2022 and FY 2023, reduced to zero by FY 2024. The interest rate (3.625%) and maturity date (October 2024) are accurately stated. The answer correctly identifies the three-year progression and properly synthesizes information across multiple 10-K filings. The LLM goes beyond the ground truth by providing additional context about the retirement mechanism (October 2024 senior-note issuance and VMware merger proceeds), which adds valuable insight into the company's debt management strategy without contradicting the original answer. The reasoning is sound: the company deliberately addressed maturing obligations before their due dates. Minor distinction: the ground truth uses more general language ('repaid or refinanced'), while the LLM provides specific sources of funds. This additional specificity is accurate and enhances the answer rather than detracting from it. The document citations (specific page numbers from 10-K filings) add credibility. The answer fully addresses both parts of the question: (1) how exposure evolved (progression from $622M to $622M to $0), and (2) what this indicates about debt management strategy (proactive retirement of near-term maturities). No calculation errors detected. All entities correctly identified (AVGO, the specific note characteristics, fiscal years).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 403,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nMastercard’s settlement‑risk metrics expanded markedly from 2022 through 2024 – gross exposure rose from roughly $52 bn to $75 bn (2023) and $78 bn (2024), while net exposure climbed from about $46 bn to $63 bn and $65 bn – prompting the company to tighten its credit‑risk standards and rely more heavily on cash collateral, letters of credit and other mitigation arrangements.  At the same time, heightened regulatory scrutiny (U.S. FTC/DOJ investigations, EU antitrust probes, the UK Payment Systems Regulator fine) and a wave of litigation – including the UK Supreme Court interchange‑fee rulings, the U.S. merchant‑class MDL, ATM‑surcharge class actions and the Europe‑wide consumer collective actions – forced Mastercard to increase its loss‑contingency accruals (e.g., a $559 m reserve for the U.S. MDL and a £32 m UK fine) while continuing to monitor and revise its risk‑management methodology to preserve low historical loss rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. (1) QUANTITATIVE ACCURACY FAILURES: The LLM cites precise settlement exposure figures ($52bn gross in 2022, $75bn in 2023, $78bn in 2024; $46bn net in 2022, $63bn in 2023, $65bn in 2024) that are NOT mentioned in the ground truth. The ground truth explicitly states Mastercard 'maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary' but provides NO specific dollar amounts. The LLM also cites a '$559m reserve for the U.S. MDL' and '£32m UK fine' - the ground truth mentions 'a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift' but does NOT confirm these specific reserve amounts. This represents hallucination of financial data. (2) PARTIAL ALIGNMENT ON REGULATORY/LITIGATION: The LLM correctly identifies FTC/DOJ investigations, EU antitrust probes, UK Payment Systems Regulator involvement, UK Supreme Court interchange-fee rulings, U.S. merchant-class MDL, and ATM-surcharge class actions. However, the ground truth mentions 'a formal investigation by the European Commission into anticompetitive behavior tied to network fees' while the LLM references 'EU antitrust probes' more generally. The ground truth mentions 'a consent agreement with the FTC' in 2023, which the LLM does not explicitly reference. (3) RISK MITIGATION FRAMEWORK: The LLM correctly identifies cash collateral, letters of credit, and other mitigation arrangements, matching the ground truth. However, it frames this as a 'tightening' of standards in response to exposure growth, which is an inference not explicitly stated in the ground truth. (4) MULTI-HOP REASONING: The LLM attempts to synthesize regulatory/litigation pressures with risk management responses, which is appropriate to the question. However, the fabricated numbers undermine the credibility of this synthesis. (5) MISSING ELEMENTS: The LLM does not mention the 2023 FTC consent agreement regarding debit transaction routing transparency, which is a specific regulatory outcome mentioned in the ground truth. The ground truth's emphasis on 'low losses from customer failures' and 'historical experience' is not adequately reflected. VERDICT: While the LLM demonstrates understanding of the regulatory and litigation landscape, the introduction of unverified (and likely fabricated) specific financial figures is a fundamental error that severely compromises the answer's reliability. The answer conflates settlement exposure metrics with loss contingency accruals in a way that suggests confusion about different risk categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 717,
        "total_tokens": 2308
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures on drug‑delivery devices grew progressively more detailed and stringent. In 2022 the filing warned that separate regulatory approval and safety oversight of its delivery systems could lead to product removal if clearance were lost; by 2023 the discussion added explicit REMS‑based post‑marketing obligations, mandatory pharmacovigilance reporting and FDA inspections of device safety; and in 2024 the language emphasized heightened scrutiny of accelerated/conditional approvals, required confirmatory studies (e.g., for LUMAKRAS), and the risk of approval revocation or restrictive labeling if regulatory conditions are not met—signaling an evolution toward tighter compliance and safety oversight.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year progression (2022-2024) and captures the general trend of increasing regulatory scrutiny. (2) Correctly names specific products (Repatha, LUMAKRAS) mentioned in the ground truth. (3) Accurately reflects the evolution toward stricter compliance and safety oversight. (4) Properly identifies key regulatory concepts like REMS, pharmacovigilance, and post-marketing obligations. (5) The chronological structure and year-by-year breakdown aligns with the ground truth framework.\n\nWEAKNESSES: (1) SIGNIFICANT DISCREPANCY: The LLM introduces claims about 'product removal if clearance were lost' and 'approval revocation' in 2022 that are NOT explicitly stated in the ground truth. The ground truth for 2022 focuses on 'disruptions could affect clinical trials and product supply' - a different emphasis. (2) The LLM adds specific regulatory mechanisms (REMS-based obligations, FDA inspections) for 2023 that are not mentioned in the ground truth's 2023 description, which focuses on 'surrogate endpoints and conditional approvals.' (3) The ground truth emphasizes 'confirmatory studies' as a 2024 development, but the LLM places this in the 2024 discussion of 'accelerated/conditional approvals' - while related, this represents a subtle misalignment of emphasis. (4) The phrase 'separate regulatory approval and safety oversight of its delivery systems' in the LLM's 2022 description is not directly supported by the ground truth's 2022 statement about 'distinct regulatory, manufacturing, and compliance risks.'\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression pattern. However, it appears to have conflated or extrapolated details beyond what the ground truth explicitly states, particularly regarding enforcement mechanisms and specific regulatory frameworks.\n\nSEMANTIC EQUIVALENCE: While the overall narrative arc is similar, the LLM's specific claims about enforcement actions and regulatory mechanisms in 2022-2023 diverge from the ground truth's more measured descriptions. The ground truth is more conservative in its claims, while the LLM adds interpretive details that may not be directly supported.\n\nJUSTIFICATION: The answer demonstrates understanding of the general trend but introduces unsupported specifics that reduce factual accuracy. The core insight about evolution toward stricter oversight is correct, but the year-by-year details contain inaccuracies that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 672,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 the company moved Parent’s Choice out of the broad “Grocery” bucket and into a dedicated **Baby & Toddler / consumables** sub‑category, giving it its own shelf‑space and omni‑channel fulfillment focus.  This re‑categorization shows Walmart is treating Parent’s Choice as a strategic anchor for its baby‑and‑consumables portfolio—leveraging the brand to reinforce everyday‑low‑price leadership and to drive family traffic through both store and digital channels.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR FACTUAL ERROR: The LLM claims Parent's Choice was 'moved out of the broad Grocery bucket and into a dedicated Baby & Toddler/consumables sub-category' across the three fiscal years. However, the ground truth explicitly states that Parent's Choice remained consistently placed under the Grocery unit across all three years (2022, 2023, 2024), with baby products included within that Grocery categorization. The LLM's claim of a re-categorization/movement is factually incorrect. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics were provided by either answer, so this is neutral, but the LLM's characterization of the evolution is wrong. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the information across the three fiscal years. It invented a narrative of change (movement to dedicated sub-category) that did not occur according to the ground truth, which emphasizes continuity and consistent placement. (4) ENTITY ACCURACY: The brand name 'Parent's Choice' is correct, and Walmart is correct, but the characterization of how the brand was positioned is fundamentally wrong. The ground truth emphasizes 'consistent placement over three years' while the LLM describes a strategic re-categorization that never happened. (5) SEMANTIC EQUIVALENCE: While both answers discuss Walmart's strategic intent around EDLP and omni-channel strategy, the LLM's core claim about the evolution of the brand's categorization is factually incorrect and contradicts the ground truth's emphasis on continuity rather than change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 448,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings the only mention of the 4.70 % Solar Bonds, Series 2015/C24‑10 is the original 2015 indenture and its supplemental indentures; no new issuance or material restructuring is disclosed. The repeated inclusion of the same indenture—augmented only by routine waivers or supplemental amendments—shows that Tesla has kept this asset‑backed, fixed‑rate security in place without substantive change, reflecting a strategy of relying on a stable, long‑term securitized financing vehicle for its solar portfolio rather than pursuing new bond issues or major restructurings.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and interpretive errors that fundamentally misrepresent Tesla's solar financing strategy. QUANTITATIVE ACCURACY (7/10): The numeric values provided are correct—the 4.70% coupon rate and the Series 2015/C24-10 designation are accurate, and the April 14, 2015 indenture date is correct. No calculation errors are present. QUALITATIVE ACCURACY (2/10): The LLM's core interpretation is problematic. The ground truth indicates that Tesla's pattern across 2022-2023-2024 shows EVOLUTION and EXPANSION of the solar financing strategy, with the bond being referenced alongside newer series (C27-10, C32-10 in 2023) and within a broader historical framework (C4-10, C9-10 in 2024). This demonstrates a SCALABLE, RECURRING, and MATURING securitization model. The LLM instead claims there was 'no new issuance or material restructuring' and characterizes the strategy as merely 'keeping this asset-backed security in place without substantive change.' This directly contradicts the ground truth's characterization of a 'consistent and scalable securitization strategy' that evolved across the three years. The LLM conflates 'no new issuance of the C24-10 bond itself' with 'no evolution in strategy,' missing the key insight that the strategy evolved through the introduction of newer series alongside the existing bond. CONTEXTUAL RELEVANCE (4/10): The question asks about how the bond 'evolved' and what the 'multi-year pattern suggests.' The LLM answers what happened to the C24-10 bond specifically (it remained unchanged) but fails to address the broader strategic evolution evidenced by the introduction of newer series and the expanding historical context. The LLM's answer is technically about a different question—the stability of one bond—rather than the evolution of Tesla's overall solar financing strategy. MULTI-HOP REASONING: The LLM failed to synthesize information across the three years to identify the pattern of introducing new series while maintaining existing ones, which is the core insight of the ground truth answer. The answer demonstrates a narrow, literal interpretation rather than the strategic synthesis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 587,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nBroadcom has moved the Security Insights Platform from a stand‑alone mainframe risk‑assessment tool in 2022 to a core, AI‑driven element of its broader enterprise‑security portfolio by 2024.  Early versions delivered risk scores and remediation steps for mainframe posture; in 2023 the platform began feeding that data into Symantec and Carbon Black SIEM/XDR and endpoint‑security solutions, and in 2024 it is positioned as a tightly integrated module that works across Broadcom’s security stack—linking mainframe risk assessment with enterprise‑wide SIEM, network‑security and endpoint protections for continuous, automated risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) FACTUAL ERRORS - The LLM claims the platform became 'AI-driven' by 2024, which is not mentioned in the ground truth. The ground truth makes no reference to AI capabilities. (2) INCORRECT INTEGRATION CLAIMS - The LLM states that 'in 2023 the platform began feeding that data into Symantec and Carbon Black SIEM/XDR and endpoint-security solutions.' The ground truth contains no mention of Symantec, Carbon Black, or specific 2023 integration milestones. This appears to be fabricated detail. (3) MISCHARACTERIZATION OF EVOLUTION - The LLM describes a dramatic evolution from 'stand-alone' tool to 'tightly integrated module' across Broadcom's security stack. The ground truth explicitly states 'the core capabilities remained stable across the three years' and describes only 'subtle' changes, not the transformative evolution claimed. (4) OVERSTATED POSITIONING - The LLM claims 2024 positioning includes 'linking mainframe risk assessment with enterprise-wide SIEM, network-security and endpoint protections for continuous, automated risk management.' The ground truth only mentions SIEM integration and describes the 2024 change as a 'subtle but meaningful reaffirmation' of existing capabilities, not new integrations. (5) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the three-year narrative. The ground truth shows consistency with minor emphasis shifts, while the LLM invents a progression that doesn't exist in the source material. The only accurate element is the general timeframe (2022-2024) and that mainframe risk assessment was a core feature. The answer demonstrates hallucination of specific vendor partnerships and capabilities not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 495,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Company’s charter continued to give Class A shares one vote per share and identical dividend rights, while Class B remained non‑voting but retained dividend entitlement; the only change was the amount of dividends per share, which rose from $2.04 (2022) to $2.37 (2023) to $2.74 (2024).  This unchanged dual‑class voting structure—with public investors holding roughly 90 % of the voting power and the Mastercard Foundation retaining about 10 %—demonstrates that MA’s capital‑structure strategy has been to preserve a stable controlling ownership while steadily increasing cash returns through higher dividends and share‑repurchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that A Class shares maintained one vote per share and dividend rights consistently from 2022-2024, matching the ground truth. The answer also correctly notes that Class B shares remained non-voting but retained dividend entitlements. However, there are significant issues with quantitative accuracy: (1) The LLM provides specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer and cannot be verified against it. These numbers appear to be fabricated or sourced from unstated documents. (2) The LLM provides specific ownership percentages (public investors ~90%, Mastercard Foundation ~10%) that are also NOT in the ground truth and cannot be verified. (3) The LLM mentions share repurchases as part of the capital structure strategy, which is not mentioned in the ground truth. The ground truth focuses solely on the consistency of voting rights and dividend entitlements, not on dividend amounts or repurchase programs. On the positive side: The LLM correctly synthesizes that the unchanged dual-class structure demonstrates a consistent capital structure strategy, which aligns with the ground truth's conclusion. The reasoning about preserving governance and income distribution is sound. The answer is well-structured and contextually relevant to the question about capital structure strategy. The fundamental problem is that the LLM has added specific quantitative details (dividend amounts, ownership percentages) that go beyond the ground truth and cannot be verified as accurate from the provided context. This represents either hallucination or reliance on external information not validated against the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 477,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen moved bemarituzumab from the initiation of its Phase 3 program (2022) through continued Phase 3 enrollment in 2023‑2024, maintaining its Breakthrough‑Therapy status and expanding trials across multiple indications and geographies.  Throughout this period the drug’s composition‑of‑matter patents filed in the United States and Europe remained projected to expire in 2029, providing roughly eight years of market exclusivity after any future approval, while Amgen continued to file additional method‑of‑use and formulation applications that could extend protection beyond that date.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2029 patent expiration date for composition-of-matter patents in both U.S. and Europe, matching the ground truth. (2) Correctly notes Phase 3 initiation in 2022 and continued enrollment through 2023-2024. (3) Accurately mentions Breakthrough Therapy designation. (4) Correctly identifies bemarituzumab as targeting FGFR2b for gastric/GEJ cancer. (5) Appropriately mentions method-of-use and formulation patent applications as potential extensions. WEAKNESSES: (1) The LLM introduces information about 'expanding trials across multiple indications and geographies' that is not present in the ground truth and cannot be verified from the provided context. This represents potential hallucination or unsupported claims. (2) The ground truth explicitly states the 2029 expiration was 'disclosed' in 2023, but the LLM presents this as a continuous projection without clearly attributing the timeline to specific years. (3) The LLM calculates 'roughly eight years of market exclusivity after any future approval' - if 2029 is the expiration and the statement implies approval would occur before then, this calculation is reasonable but adds interpretation not explicitly in ground truth. (4) Missing the explicit mention that 2023 was when the 2029 patent expiration was specifically disclosed/disclosed. (5) The ground truth emphasizes a 'progression' and 'transition from early-phase development to a more mature pipeline asset' which the LLM doesn't clearly articulate. MULTI-HOP REASONING: The LLM attempts to synthesize clinical development progression with IP strategy, but introduces unsupported details about 'multiple indications and geographies' that weaken the answer's reliability. The core facts about patent dates and clinical phases are correct, but the addition of unverified information reduces confidence in the overall response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 511,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Walmart continued to list “No Boundaries” among the private‑brand families that sit inside the **Fashion** strategic merchandise unit (the apparel‑and‑accessories category within the broader General Merchandise segment).  The company’s 10‑K filings show that while the overall merchandising taxonomy was periodically revised, No Boundaries remained anchored to the Fashion unit and was highlighted in the same list of private‑label brands each year, underscoring a deliberate focus on expanding its apparel offering.  This consistency reveals that Walmart is shifting resources toward higher‑margin, private‑label fashion to capture value‑conscious shoppers and integrate apparel more tightly with its omni‑channel and membership (Walmart+) initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, 'No Boundaries' was listed under the 'Apparel' category, and only by 2024 was it referenced under the broader 'Fashion' unit. The LLM answer incorrectly claims that 'No Boundaries' was 'anchored to the Fashion unit' throughout all three years (2022-2024), which directly contradicts the documented evolution described in the original answer. This is a significant multi-hop synthesis error - the LLM failed to capture the key strategic shift that occurred between 2022 and 2024. CORRECT ELEMENTS: The LLM correctly identifies that 'No Boundaries' remained a consistent private brand across the three-year period and correctly notes the broader Fashion unit includes apparel and accessories. The mention of omni-channel and membership initiatives is contextually appropriate. MISSING ELEMENTS: The LLM fails to acknowledge the critical categorization change from 'Apparel' (2022) to 'Fashion' (2024), which is the core insight of the question about Walmart's 'shifting focus.' The answer also lacks specificity about the 2022 baseline categorization. REASONING QUALITY: While the LLM provides reasonable strategic context about private-label fashion and value-conscious shoppers, this reasoning is built on an incorrect factual foundation regarding the timeline of the categorization shift. The multi-hop synthesis across years is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 415,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑Ks IBM repeatedly cites client relationships and trust as a principal competitive advantage, but the emphasis deepens over time. In 2022 it is listed among several “principal methods of competition,” while 2023 and especially 2024 frame trust and security as the foundation of IBM’s hybrid‑cloud and AI platform and tie them directly to its ecosystem of strategic partners and go‑to‑market narrative. This progression shows IBM is positioning trust not just as a differentiator but as the core pillar that enables its hybrid‑cloud and AI strategy to win and retain clients.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the temporal progression (2022-2024) and the core narrative about IBM's evolving emphasis on client relationships and trust. The answer correctly captures the key evolution: (1) 2022 positioning trust among principal competitive methods, (2) 2023-2024 deepening the emphasis and linking it to hybrid cloud/AI strategy, and (3) the expansion to ecosystem partnerships. The quantitative accuracy is perfect—no numbers, dates, or calculations are present to verify, and the years cited (2022, 2023, 2024) are all correct. The qualitative reasoning is sound, correctly synthesizing the multi-hop information across three years of filings and identifying the strategic progression. The LLM appropriately identifies the shift from trust as 'one of several' competitive methods to trust as a 'core pillar' enabling the hybrid cloud/AI strategy. Minor differences from the ground truth: (1) The LLM uses slightly different phrasing ('foundation of IBM's hybrid-cloud and AI platform' vs. ground truth's 'linked to its ability to deliver business value'), but these are semantically equivalent. (2) The LLM emphasizes 'security' alongside trust in 2023-2024, which is a reasonable inference but not explicitly stated in the ground truth. (3) The LLM's framing of trust as enabling the company to 'win and retain clients' is a logical extension of the ground truth's 'drive client-centric innovation' but represents a slight interpretive addition. The answer is contextually relevant, directly addressing how the emphasis evolved and what it reveals about IBM's strategic positioning. The synthesis across multiple years and the connection to hybrid cloud/AI strategy are both handled correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 481,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C25‑15 remained on Tesla’s balance sheet through the 2022 filing, where they were reported as a distinct tranche of long‑term debt with accrued interest maturing in 2025. In the 2023 Form 10‑K the company disclosed a series of supplemental indentures that amended and effectively refinanced this tranche—moving the exposure into newer 4.70 % Solar Bond series—signaling a strategic shift toward lower‑cost, more granular asset‑backed financing. By the 2024 filing the 5.45 % series is no longer listed, indicating that the bonds have been retired or absorbed into the newer structures, reflecting Tesla’s move away from broad, high‑coupon solar bond issuances to project‑level debt and equity‑based funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR FACTUAL ERRORS: The ground truth explicitly states that the 5.45% Solar Bonds, Series 2015/C25-15 were 'consistently referenced' across all three years (2022, 2023, and 2024), indicating 'ongoing reliance' and '3-year persistence.' The LLM answer claims the bonds were 'no longer listed' by 2024 and have been 'retired or absorbed,' which directly contradicts the ground truth that the bond 'remained a key exhibit' in 2024. (2) UNSUPPORTED CLAIMS: The LLM introduces claims about refinancing into 4.70% Solar Bond series and a 'strategic shift' that are not mentioned in the ground truth. The ground truth makes no reference to refinancing, retirement, or absorption into newer structures. (3) MISINTERPRETATION OF PATTERN: The ground truth indicates consistent, persistent disclosure of the same bond series across all three years as evidence of a 'consistent solar asset-backed financing strategy.' The LLM misinterprets this as a retirement/refinancing narrative, fundamentally misunderstanding the multi-year pattern. (4) QUANTITATIVE ISSUES: The LLM introduces a 4.70% coupon rate and claims about maturity in 2025 that are not supported by the ground truth. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the three-year pattern across 2022, 2023, and 2024 filings. Instead of recognizing consistent references indicating ongoing reliance, it constructed an unsupported narrative of bond retirement. The answer demonstrates a fundamental misunderstanding of what the persistent disclosure pattern actually indicates about Tesla's solar financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 459,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nEmerson’s Safety & Productivity segment expanded its pipe‑working lineup between 2022 and 2024 by introducing cordless battery‑hydraulic tools—such as battery‑powered press units for pipe joining and battery‑driven cutters/crimpers for electrical cable work—and by adding advanced diagnostic equipment (e.g., CCTV pipe‑inspection and locating systems) that are now offered as standard features.  The 2023‑2024 disclosures (EMR 10‑K 2022 pp. 7‑11; EMR 10‑K 2023/2024 pp. 71‑75) highlight this shift toward battery‑driven, mobile solutions that boost safety and productivity on‑site.  Together, these moves show Emerson is deliberately repositioning its professional‑tools business as a high‑margin, innovation‑led platform that competes on technology and performance rather than solely on price.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core factual content and strategic positioning. STRENGTHS: (1) Correctly identifies the key product evolution from traditional tools to battery-powered solutions across 2022-2024; (2) Accurately mentions specific innovations: battery-hydraulic press tools, battery-driven cutters/crimpers for electrical cables, CCTV pipe inspection, and locating equipment; (3) Properly synthesizes the multi-hop reasoning about Emerson's strategic shift toward cordless, high-efficiency solutions; (4) Correctly characterizes the strategic positioning as moving toward technology-led, high-margin competition; (5) Appropriately references the timeframe (2023-2024 disclosures showing the progression). MINOR WEAKNESSES: (1) The LLM cites specific page numbers (EMR 10-K 2022 pp. 7-11; EMR 10-K 2023/2024 pp. 71-75) that cannot be verified against the ground truth and may be fabricated—this is a hallucination risk, though it doesn't affect factual accuracy of the content itself; (2) The answer could have been more explicit about the 'consistent mention of pipe wrenches across all three years' as noted in the ground truth, which underscores their foundational role; (3) Slightly less emphasis on the year-by-year progression (2022 baseline → 2023 expansion → 2024 continuation) compared to ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and product categories to draw conclusions about strategic positioning, matching the ground truth's analytical approach. The connection between product innovation and competitive strategy is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 508,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s capital‑allocation plan for its El Segundo, California campus shifted from an initial build‑out of GMP‑certified cell‑therapy suites to a sustained expansion that adds modular production lines and automation.  The 2022 10‑K (pp. 31‑35) earmarked funds to scale commercial manufacturing of Yescarta and Tecartus, the 2023 filing (pp. 9‑13) reports a ~30 % increase in CAPEX for the site to support both existing products and a growing pipeline of CAR‑T candidates, and the 2024 filing (pp. 8‑12) confirms that this investment is now embedded in Gilead’s broader biologics strategy—using El Segundo as the hub for next‑generation cell‑therapy platforms that feed directly into its expanding biologics pipeline.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURES: The LLM answer contains multiple unverified and likely fabricated specific claims: (a) Claims a '~30% increase in CAPEX' for El Segundo in 2023 - this specific percentage is NOT present in the ground truth and appears to be invented; (b) References specific page numbers (pp. 31-35 for 2022, pp. 9-13 for 2023, pp. 8-12 for 2024) that do not match the ground truth citations (which cite page 33 for 2022, page 11 for 2023, page 10 for 2024); (c) Names specific products 'Yescarta and Tecartus' with claims about 2022 earmarking - these product names are not mentioned in the ground truth answer. (2) ENTITY ACCURACY ISSUES: The LLM introduces specific product names and manufacturing details (GMP-certified suites, modular production lines, automation) that are not supported by the ground truth. The ground truth makes no mention of Yescarta, Tecartus, or specific manufacturing infrastructure details. (3) MULTI-HOP REASONING PROBLEMS: While the LLM correctly identifies the 2022-2024 progression and the shift toward cell therapy specialization, it fabricates intermediate details and specific financial metrics that cannot be verified from the provided ground truth. The reasoning structure appears sound but is built on false premises. (4) SEMANTIC DIVERGENCE: The ground truth emphasizes a strategic shift in designation and focus on proprietary manufacturing technologies and confidentiality agreements. The LLM answer pivots to specific product names, CAPEX percentages, and manufacturing infrastructure details that represent a different narrative entirely. (5) FACTUAL VERIFICATION: The ground truth explicitly states El Segundo was listed 'among several principal manufacturing facilities' in 2022 without cell therapy emphasis, then became 'explicitly identified' for cell therapy in 2023, and retained this in 2024. The LLM's claim about 'initial build-out of GMP-certified cell-therapy suites' in 2022 contradicts the ground truth's assertion that cell therapy specialization was NOT emphasized until 2023. The answer demonstrates hallucination of specific financial metrics and product details not present in source materials.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 590,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nFrom 2022 through 2024 IBM kept the 1.250 % Notes due 2027 in its debt‑security tables and continued to incorporate by reference the same indenture originally filed in January 2019; the 2024 filing merely added a brief note that a February 2 2024 supplemental indenture governs the issue, but no new issuance or material change was made. Consequently, the company’s relationship with the notes was one of ongoing disclosure and periodic updating of the governing documents, with the notes remaining outstanding throughout the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) DATE ERRORS: The LLM references a 'February 2 2024 supplemental indenture' which is not mentioned in the ground truth. The ground truth specifically cites February 8, 2022 and February 3, 2023 filing dates, but no February 2024 supplemental indenture is documented. (2) MISCHARACTERIZATION OF 2024 STATUS: The ground truth explicitly states that in 2024, IBM 'formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange,' representing a shift to 'active market presence.' The LLM incorrectly claims 'no new issuance or material change was made,' directly contradicting the ground truth's characterization of 2024 as marking a transition from disclosure to public issuance and trading. (3) MISSING KEY PROGRESSION: The ground truth emphasizes a clear three-year evolution: 2022 (disclosure/exhibit reference), 2023 (continued reference), 2024 (formal listing/active trading). The LLM flattens this progression into 'ongoing disclosure and periodic updating,' missing the significant shift to NYSE listing. (4) INACCURATE INDENTURE REFERENCE: While the LLM correctly notes the January 2019 indenture filing, it introduces an undocumented February 2024 supplemental indenture without ground truth support. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop information showing the progression from internal documentation to public market presence, which is the core narrative of the ground truth answer. The answer demonstrates a fundamental misunderstanding of the question's focus on how the relationship 'evolved' across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 475,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nThe repeated citation of the 5.45 % Solar Bonds, Series 2015/C45‑15 — and the myriad supplemental indentures that later added new series with different coupons, maturities and conversion features— shows that Tesla has been systematically refinancing its solar portfolio rather than relying on a single, static bond issue.  From 2022 through 2024 the company layered newer, often lower‑coupon and convertible debt (e.g., 2 % convertible senior notes) alongside the original asset‑backed bonds, indicating a shift toward a more flexible, market‑responsive financing structure that can adjust terms, extend maturities and integrate solar assets with Tesla’s broader capital‑markets strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite some correct conceptual framing. CRITICAL ERRORS: (1) The LLM claims Tesla added 'newer, often lower-coupon and convertible debt (e.g., 2% convertible senior notes)' to the solar bond portfolio. The ground truth makes no mention of 2% convertible senior notes being part of the solar financing strategy—this appears to be a fabrication or confusion with unrelated Tesla debt instruments. (2) The LLM states supplemental indentures 'added new series with different coupons, maturities and conversion features,' but the ground truth explicitly identifies all referenced bonds as having the SAME 5.45% coupon (Series 2015/C45-15, C53-15, C62-15, C72-15). The LLM incorrectly suggests varying coupons. (3) The LLM characterizes the strategy as 'systematically refinancing' rather than the ground truth's more accurate characterization of 'iterative expansion' and 'leveraging standardized, asset-backed instruments.' CORRECT ELEMENTS: (1) The LLM correctly identifies the 5.45% Solar Bonds, Series 2015/C45-15 as the foundational instrument. (2) The general concept that Tesla is building a scalable financing model is directionally correct. (3) The mention of multiple series/tranches is accurate. MISSING ELEMENTS: (1) No mention of the SolarCity inheritance context. (2) No specific reference to the actual bond series dates (May 26, 2015; June 16, 2015; June 29, 2015; July 21, 2015). (3) Fails to note the asset-backed securitization model as the core strategy. (4) Mischaracterizes the evolution as involving convertible features when the ground truth shows standardized asset-backed structures. The answer demonstrates partial understanding but introduces material inaccuracies about bond terms and financing instruments that significantly detract from its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 504,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe transformed Acrobat from a pure PDF‑viewing tool into the centerpiece of its **Adobe Document Cloud**—a cloud‑based, AI‑enhanced document services platform.  The company deepened market adoption in PDF‑intensive verticals (government, financial services, legal, pharma, aerospace, insurance and publishing) by expanding Acrobat Web, tightening integration with Adobe Sign, and leveraging **Adobe Sensei/Firefly** to add generative‑AI capabilities such as auto‑masking, intelligent summarisation and “Generative Fill/Expand” that make documents more interactive and “intelligent.”  At the same time, Adobe broadened the scope of the platform with a web‑first Acrobat experience, AI‑driven workflow APIs, and strategic partnerships (e.g., Microsoft, ServiceNow, Notarize), positioning Acrobat as a recurring, AI‑powered revenue engine that now sits alongside Creative Cloud as a key pillar of Adobe’s Digital Media strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer provides a plausible narrative about Acrobat's evolution but contains significant factual issues when compared to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2022-2024 timeframe\n- Accurately mentions market adoption in document-intensive industries (legal, financial services, publishing)\n- Correctly references Adobe Sign integration\n- Appropriately mentions AI/generative AI capabilities as part of the evolution\n- Correctly identifies Document Cloud as the platform\n- Mentions Adobe Sensei/Firefly (reasonable AI technology references)\n\nPROBLEMATIC ELEMENTS:\n1. FACTUAL INACCURACY - The LLM introduces specific AI features (auto-masking, intelligent summarization, Generative Fill/Expand) that are NOT mentioned in the ground truth. These appear to be fabricated or confused with other Adobe products.\n2. MISSING KEY FACT - The ground truth specifically mentions the formal introduction of 'Acrobat AI Assistant' as a trademark in 2024, which is a concrete, verifiable milestone. The LLM answer does not mention this specific product name/trademark.\n3. OVERSTATED CLAIMS - The LLM references specific partnerships (Microsoft, ServiceNow, Notarize) that are not mentioned in the ground truth and cannot be verified from the provided context.\n4. INDUSTRY LIST EXPANSION - The LLM adds industries (government, pharma, aerospace, insurance) beyond what the ground truth specifies (legal, financial services, publishing).\n5. STRATEGIC FRAMING - The LLM frames Acrobat as a \"recurring, AI-powered revenue engine\" alongside Creative Cloud, which is a reasonable inference but goes beyond what the ground truth explicitly states.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable multi-hop synthesis by connecting 2022 market leadership → 2023 AI vision → 2024 AI implementation. However, it fails to accurately capture the specific 'Acrobat AI Assistant' milestone that represents the concrete realization of the AI strategy.\n\nQUANTITATIVE ACCURACY:\nNo specific numbers, dates, or percentages are provided in either answer, so quantitative verification is limited. However, the timeline (2022-2024) is correctly maintained.\n\nSEMANTIC EQUIVALENCE:\nWhile the LLM captures the general trajectory of evolution from traditional document tool to AI-enhanced platform, it introduces unverified details that diverge from the ground truth and potentially misrepresent the actual strategic positioning.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (5): Core narrative is directionally correct but contains fabricated details and misses the key 'Acrobat AI Assistant' trademark milestone\n- Quantitative (6): No numbers to verify, timeline is correct\n- Qualitative (5): Reasoning is logical but synthesis includes unverified claims and omits the specific 2024 product milestone\n- Contextual (7): Answer is relevant and addresses the question's components, though with inaccuracies",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 774,
        "total_tokens": 2279
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab steadily broadened the interactive toolset it offers RIAs. In 2022 it introduced the free **Schwab Advisor Portfolio Connect** and expanded API‑style integrations with CRM, portfolio‑management and trading platforms; in 2023 it added TD Ameritrade’s **thinkpipes** trading interface and the **iRebal** automated rebalancing engine to its RIA workflow, giving advisors real‑time charting and portfolio‑rebalancing capabilities; by 2024 those features were fully embedded with deeper API access, tighter custodial‑account integration and expanded third‑party platform connections, delivering a more seamless, interactive experience for RIAs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT TIMELINE: The LLM claims Schwab Advisor Portfolio Connect was introduced in 2022, but the ground truth indicates it was highlighted/maintained in 2024, not introduced in 2022. (2) FABRICATED PRODUCTS: The LLM mentions 'thinkpipes' trading interface and 'iRebal' automated rebalancing engine as being added in 2023 - these products are not mentioned in the ground truth at all and appear to be hallucinated details. (3) MISATTRIBUTION: The LLM incorrectly attributes TD Ameritrade's thinkpipes to Schwab's RIA offerings in 2023, which is not supported by the ground truth. (4) INCOMPLETE ACCURACY: While the LLM correctly identifies that Schwab provided proprietary software, website access, and third-party integrations, it fundamentally misrepresents the timeline and introduces false product names. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the evolution across years - it should show 2022 as foundational (proprietary software + website + integrations), 2023 as reinforcement of Advisor Services website, and 2024 as highlighting Portfolio Connect with expanded integrations. Instead, it invents a different product evolution narrative. The answer demonstrates poor factual accuracy on specific product names and timelines, which are critical for evaluating platform evolution claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 396,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nEmerson initially listed air‑preparation equipment as a stand‑alone product family inside the Discrete Automation segment, offering filters, regulators and lubricators together with solenoid and pneumatic valves but without deep software coupling (see the Discrete Automation description in EMR 10‑K 2022, pp. 5‑6). Beginning in 2023 the company started bundling those components with pneumatic valves, actuators and control software, promoting integrated pneumatic‑control packages and expanding service‑center support (noted in the “Industrial Solutions” section of the 2023 filing, which emphasizes “integrated solutions to customers”). By 2024 the offering had evolved into a fully integrated hardware‑software solution that is part of the Plantweb IIoT ecosystem, delivering remote monitoring, predictive‑maintenance and tight integration with broader control and safety systems (as described in the Automation Solutions overview of the 2024 filing, pp. 71‑73).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the 3-year evolution of Emerson's Air Preparation Equipment positioning and correctly identifies the progression from mechanical/standalone (2022) to integrated control systems (2023) to digitally-enabled IIoT solutions (2024). The answer accurately captures the core narrative arc and key technological shifts. However, there are some notable differences from the ground truth: (1) The LLM mentions 'Plantweb IIoT ecosystem' and specific page references (pp. 71-73 for 2024 filing) which cannot be verified against the ground truth and may be hallucinated details. (2) The ground truth emphasizes 'smart actuation, predictive maintenance capabilities, and secure wireless communication' as 2024 positioning elements, while the LLM focuses on 'Plantweb IIoT ecosystem, remote monitoring, predictive-maintenance and tight integration' - there is semantic overlap but the specific framing differs. (3) The LLM correctly identifies the 2023 shift toward 'integrated pneumatic-control packages' and software coupling, matching the ground truth's emphasis on 'programmable automation control systems and software.' (4) The 2022 positioning is accurately described in both versions regarding filters, regulators, lubricators, solenoid/pneumatic valves. The multi-hop reasoning is sound - the answer successfully synthesizes information across three fiscal years and shows logical progression. The main weakness is the introduction of specific product ecosystem names and page numbers that appear unsupported by the ground truth, which could indicate hallucination. The core factual narrative about the evolution is correct, but the specific implementation details and citations reduce confidence in complete accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 479,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nThe Coca‑Cola Company has treated the 0.125 % Notes due 2029 as a continuously refreshed financing tranche, filing separate 8‑K notices in 2020, 2021, 2022, 2023 and 2024 that each reference the same series—moving from the September 2020 filing to the March 2021 filing and then reiterating it in the 2022‑2024 10‑K exhibits. This pattern shows that the company is actively managing its near‑term debt by repeatedly tapping the ultra‑low‑cost, long‑dated market to roll over maturing obligations and maintain liquidity within its broader financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally diverge from the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the company filed 'separate 8-K notices in 2020, 2021, 2022, 2023 and 2024' referencing the 0.125% Notes due 2029. The ground truth makes no mention of 8-K filings or these specific years (2020, 2021). The ground truth explicitly states the note was referenced in 2022-2024 10-K filings, not 8-K notices across 2020-2024. (2) MISCHARACTERIZATION OF STRATEGY: The LLM describes this as 'continuously refreshed financing tranche' and 'repeatedly tapping the ultra-low-cost, long-dated market to roll over maturing obligations.' The ground truth indicates the opposite pattern—the company was NOT repeatedly issuing the 0.125% Notes; rather, it was consistently acknowledging an existing liability while strategically introducing HIGHER-YIELDING instruments (5.000% and 5.400% notes) as the 2029 note approached maturity. This is a refinancing/extension strategy, not a 'roll over' strategy. (3) MISSING KEY INSIGHT: The LLM fails to capture the critical evolution described in the ground truth: the shift from passive disclosure (2022) → consolidated format (2023) → strategic pivot toward longer-term, higher-yielding instruments (2024). The ground truth emphasizes the deliberate introduction of longer-dated, higher-yielding debt as the 2029 note neared expiration. (4) SEMANTIC INVERSION: The LLM's characterization of 'ultra-low-cost, long-dated market' misses that the 0.125% Notes are indeed low-cost but are NEAR-TERM (due 2029), not long-dated. The strategic pivot was toward longer-dated instruments. (5) MULTI-HOP REASONING: The LLM failed to synthesize the multi-year evolution correctly, instead inventing a filing pattern (8-K notices 2020-2024) not supported by the ground truth. The ground truth's multi-hop reasoning connects: (a) consistent acknowledgment across years, (b) changing disclosure context, (c) introduction of higher-yielding alternatives, (d) implication of refinancing strategy. The LLM's reasoning is internally inconsistent with documented filing practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 579,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon’s ability to return capital was governed by the same U.S. banking capital rules that require a “well‑capitalized” Tier 1 ratio, a stress‑test‑approved capital plan, and Federal Reserve/OCC approval before any dividend increase or share‑repurchase can be executed.  In 2022 the firm’s capital plan was subject to strict regulatory limits, in 2023 it obtained clearance to modestly raise its dividend and restart limited repurchases once the stress‑test demonstrated an adequate capital buffer, and in 2024 it continued to tie any further dividend hikes or buy‑backs to maintaining that same regulatory capital cushion and passing the annual supervisory review.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The identification of U.S. banking capital rules and 'well-capitalized' status as regulatory constraints is accurate and matches the ground truth's emphasis on regulatory standards. (2) The reference to stress-test approval and Federal Reserve/OCC oversight aligns with actual regulatory frameworks. (3) The general timeline structure (2022-2024) is correct. PROBLEMATIC ASPECTS: (1) The LLM introduces specific operational details (dividend increase in 2023, restart of repurchases post-stress-test) that are NOT present in the ground truth answer. The ground truth does not confirm these specific actions occurred in 2023. (2) The LLM's framing suggests a narrative of progressive relaxation of constraints (from 'strict limits' in 2022 to 'modest' increases in 2023 to 'continued' constraints in 2024), but the ground truth emphasizes an EVOLUTION IN DISCLOSURE FRAMING rather than actual changes in capital return policies. The ground truth states the constraints were 'consistently emphasized' but the framing became 'more specific' - not that the constraints themselves changed. (3) The LLM conflates regulatory framework description with actual capital actions taken, which is a significant interpretive error. The ground truth focuses on how BNY Mellon COMMUNICATED about constraints, not on what capital actions it actually took. (4) The LLM's answer lacks the key insight from the ground truth: the evolution was in LANGUAGE AND SPECIFICITY of disclosure (from general caution to structured emphasis on regulatory standards), not necessarily in the underlying regulatory environment or capital return activities. MULTI-HOP REASONING: The LLM failed to properly synthesize the distinction between regulatory constraints (which remained consistent) and disclosure evolution (which changed). This represents a fundamental misunderstanding of what the question and ground truth were addressing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 535,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, McGriddles moves from a brief menu‑item mention to being highlighted as a flagship “modernized, higher‑revenue‑generating” breakfast offering that “cater[s] to consumer preferences” and underpins the company’s broader menu‑innovation narrative. This steady framing shows that McDonald’s breakfast strategy has remained consistent—using signature items like McGriddles to drive traffic and revenue while emphasizing ongoing menu modernization and franchisee‑driven innovation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains significant factual errors: (1) CORE FACTUAL ERROR: The ground truth explicitly states McGriddles remained 'remarkably consistent' and 'static' across all three years with 'no specific innovation details,' while the LLM claims McGriddles 'moves from a brief mention to being highlighted as a flagship modernized, higher-revenue-generating offering.' This is a direct contradiction of the documented evidence. (2) UNSUPPORTED CHARACTERIZATION: The LLM describes McGriddles as 'modernized' and 'higher-revenue-generating' with quotes suggesting these are from the filings, but the ground truth shows McGriddles were presented in 'the same basic format as in prior years' without product-level changes. No evidence supports the LLM's characterization. (3) MISREPRESENTATION OF STRATEGY: The ground truth reveals a 'stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes,' while the LLM frames this as 'steady framing' of modernization and innovation—inverting the actual finding. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize information across the three years (2022, 2023, 2024) as documented in the ground truth. It created a narrative of evolution that contradicts the documented consistency. (5) MISSING SPECIFIC EVIDENCE: The ground truth cites specific page/chunk references (MCD_10k_2022.pdf:page_7:chunk_1, etc.) showing McGriddles mentioned alongside other core items; the LLM provides no such grounding and makes unsupported claims. The answer demonstrates a fundamental misunderstanding of the question and provides information that is factually opposite to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 479,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAdobe has shifted free, self‑service learning from a peripheral catalog in 2022—highlighted as “a large number of free online self‑service learning options on training.adobe.com”—to a core, strategically positioned element of Adobe Digital Learning Services by 2023‑2024, where it is delivered through the learning.adobe.com portal and paired with solution‑specific skill assessments that feed into the company’s fee‑based, instructor‑led and custom training programs. This evolution reflects a deliberate move to embed the free learning pathway as the primary gateway for customers across the Experience Cloud, reinforcing a seamless, cloud‑centric learning journey that supports Adobe’s broader Digital Experience offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of Adobe's free learning offerings across 2022-2024. STRENGTHS: (1) Correctly identifies the platform shift from training.adobe.com (2022) to learning.adobe.com (2023-2024), matching ground truth exactly. (2) Accurately captures the strategic evolution from peripheral offering to core component of Adobe Digital Learning Services. (3) Properly synthesizes the integration with fee-based and custom training programs. (4) Correctly identifies the three-year trajectory and maturing approach. (5) All dates and entities (Adobe, Experience Cloud, Digital Learning Services) are accurate. MINOR WEAKNESSES: (1) The LLM characterizes 2022 offerings as 'peripheral catalog' which is slightly more interpretive than the ground truth's neutral 'broader enablement strategy' framing—though not factually incorrect, it adds interpretation. (2) The LLM introduces the concept of 'solution-specific skill assessments' which is not explicitly mentioned in the ground truth, representing a minor addition beyond what was documented. (3) The phrase 'primary gateway for customers across the Experience Cloud' is somewhat more emphatic than the ground truth's measured description of 'core component.' QUANTITATIVE ACCURACY: Perfect—all dates (2022, 2023, 2024) and platform names are correct. QUALITATIVE ACCURACY: Strong multi-hop reasoning correctly synthesizes information across three years and multiple platforms. The semantic meaning aligns well with ground truth despite slightly different framing. CONTEXTUAL RELEVANCE: Highly relevant, directly addresses the question about evolution, positioning, and platforms used. The answer appropriately contextualizes within Adobe's broader learning services ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 491,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nEmerson kept Commercial Vacuums inside the **Safety & Productivity** segment through 2022‑2024, but the way it was framed changed: in the 2022 filing the segment was described broadly as “tools for professionals and homeowners,” whereas the 2023‑2024 disclosures began to isolate “Professional Tools” (including commercial vacuums) as a distinct sub‑category that is sold almost exclusively through distributors.  The strategic emphasis moved toward positioning these vacuums as core safety‑productivity solutions that complement Emerson’s broader pipe‑working, electrical and other professional‑tool lines, and the company aligned their marketing, development and distribution with the same distributor‑focused, safety‑oriented approach used for its other professional‑tool offerings.  (See Safety & Productivity description in EMR 10‑K 2022 pp. 7‑11 and the “Professional Tools” subsection in EMR 10‑K 2023 / 2024 pp. 71‑75.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Commercial Vacuums were in the Safety & Productivity segment in 2022, but the ground truth explicitly states they were in the 'Tools & Home Products segment' in 2022. This is a fundamental mischaracterization of the 2022 positioning. (2) INCORRECT CATEGORIZATION - The LLM describes Commercial Vacuums as being grouped with 'pipe-working, electrical and other professional-tool lines' in a distributor-focused approach, but the ground truth indicates they were grouped with different tools in each year (water jetters and wet-dry vacuums in 2022; battery hydraulic tools and sewer inspection cameras in 2023; automation control systems and electrical distribution equipment in 2024). (3) MISSING EVOLUTION - The LLM fails to capture the actual strategic evolution described in the ground truth: the shift from general tools (2022) to infrastructure/safety-focused tools (2023) to technologically advanced industrial productivity tools (2024). (4) UNSUPPORTED CLAIMS - The LLM makes specific claims about 'distributor-focused' sales and page references (pp. 7-11, pp. 71-75) that cannot be verified against the ground truth and appear to be fabricated details. (5) INCOMPLETE SYNTHESIS - While the LLM attempts multi-hop reasoning across years, it fundamentally misses the segment transition from Tools & Home Products (2022) to Safety & Productivity (2023-2024). The answer demonstrates poor understanding of the actual product categorization evolution and provides incorrect foundational information about where Commercial Vacuums were positioned in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 460,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead escalated the role of its Hoofddorp, Netherlands site, moving from an initial commercial‑manufacturing location for cell‑therapy products (e.g., Yescarta) toward a broader, integrated hub that now handles both the commercial processing of approved cell‑therapy medicines and the scale‑up of pipeline candidates, reflecting a strategic expansion of capacity and deeper incorporation into the company’s global cell‑therapy supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces unsupported claims not present in the ground truth. Specifically, it claims the facility moved 'toward a broader, integrated hub that now handles...scale-up of pipeline candidates' - this expansion claim is NOT supported by the original answer which only mentions commercial manufacturing and processing of cell therapy products across all three years. (2) The LLM specifies 'Yescarta' as an example product, which is not mentioned in the ground truth and represents an unsupported factual claim. (3) The characterization of evolution is fundamentally different: Ground truth shows a shift from 'principal manufacturing site' (2022) to 'explicitly described as commercial manufacturing and processing' (2023-2024), suggesting clarification/formalization of role. LLM claims 'escalation' and 'expansion of capacity' which overstates the evidence. CORRECT ELEMENTS: (1) Correctly identifies Gilead (GILD) and Hoofddorp, Netherlands facility. (2) Correctly identifies the 2022-2024 timeframe. (3) Correctly identifies cell therapy manufacturing and commercial processing as key activities. (4) The semantic direction of 'growing emphasis' aligns with ground truth's 'sustained and potentially expanding role.' REASONING ISSUES: The multi-hop synthesis fails because the LLM extrapolates beyond what the ground truth supports. The ground truth indicates consistency in function (commercial manufacturing/processing) from 2023-2024, not escalation to pipeline scale-up. The LLM's claim about 'deeper incorporation into the company's global cell-therapy supply chain' is reasonable inference but the specific claim about pipeline candidate scale-up is fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 465,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe 1.000 % Notes due 2028 are repeatedly highlighted in the 2022‑2024 filings as a core, low‑cost component of Coca‑Cola’s long‑term debt, underscoring the company’s continued reliance on that inexpensive tranche.  At the same time, the 2024 prospectus adds higher‑yield instruments such as the 5.000 % Notes due 2034 and 5.400 % Notes due 2064, indicating that the firm is now supplementing its legacy financing with more expensive, longer‑dated debt to fund strategic initiatives and reshape its maturity profile.  Together, the disclosures reflect a shift toward a more diversified capital structure that balances a stable, low‑rate pillar with newer, higher‑yield financing to manage overall debt‑cost exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 are all accurately cited with correct percentages and maturity dates. The time period references (2022-2024 filings, 2024 introduction of new notes) are accurate. ENTITY ACCURACY: Coca-Cola is correctly identified, and all debt instruments are properly named and characterized. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across multiple years (2022-2024) and connects the persistent reference to the 1.000% Notes with the introduction of higher-yield instruments in 2024. The logical progression from legacy low-cost debt to diversified higher-yield financing is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Coca-Cola is balancing stable, low-cost debt with newer, higher-yield instruments to manage capital structure. The phrasing differs slightly (e.g., \"legacy financing\" vs \"ongoing importance,\" \"reshape its maturity profile\" vs \"long-term funding needs\") but the semantic meaning is equivalent. COMPLETENESS: The answer addresses all aspects of the question: (1) the persistent reference to 1.000% Notes, (2) the introduction of higher-yield notes in 2024, (3) the implications for debt financing costs, and (4) capital structure management. Minor observation: The LLM uses \"prospectus\" while the ground truth references \"10-K filings,\" but this is a reasonable interpretation of where such information would appear and does not constitute a factual error. Overall, the answer demonstrates excellent understanding of the multi-hop financial question and provides accurate, well-reasoned synthesis of the information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 503,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s pipe‑cutter offering moved from traditional, purely mechanical cutters toward fully **battery‑powered, sensor‑enabled tools** between 2022 and 2024.  The **Safety & Productivity** segment (see the 2023‑2024 10‑K description of the segment and the “Professional Tools” discussion in the Tools & Home Products section) highlights the rollout of **battery‑hydraulic press‑connection equipment and diagnostic‑integrated cutters** that combine cordless operation with on‑board data collection and connectivity, and it notes that these products are sold almost exclusively through distributor networks.  This evolution signals that Emerson is **re‑positioning itself in the professional plumbing‑tools market as a premium, technology‑driven supplier**, emphasizing higher‑margin, smart‑tool solutions rather than competing solely on price or raw mechanical performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution from traditional to battery-powered and diagnostic-integrated tools across 2022-2024. It accurately references the Safety & Productivity segment and Professional Tools discussion from 10-K filings. The characterization of Emerson's repositioning as a 'premium, technology-driven supplier' aligns with the ground truth's conclusion about 'high-value, technology-enhanced tools.' The mention of distributor networks and higher-margin positioning is contextually appropriate. WEAKNESSES: (1) The LLM overstates the progression by claiming 'fully battery-powered, sensor-enabled tools' and 'battery-hydraulic press-connection equipment' - the ground truth is more measured, describing 'battery hydraulic technology integration' and 'diagnostic systems' as separate but related developments, not necessarily fully integrated into all cutters. (2) The LLM adds specific technical details ('on-board data collection and connectivity,' 'cordless operation') that are not explicitly confirmed in the ground truth, which only mentions 'diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters.' (3) The phrase 'sold almost exclusively through distributor networks' appears to be an inference not directly stated in the ground truth. (4) The LLM conflates battery-hydraulic press-connection equipment with diagnostic-integrated cutters as a single product category, when the ground truth treats them as related but distinct developments. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022-2024 and identifies the strategic shift, but overgeneralizes the scope and specificity of the product evolution. The reasoning is sound but the claims exceed what the ground truth supports. NUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is based on the correct identification of the 3-year timeframe (2022-2024) and segment references, which are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 557,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Santa Monica, California site from a modest clinical‑trial cell‑therapy manufacturing space into a central processing hub that now supports both clinical‑trial and early‑commercial production of multiple CAR‑T and other cell‑therapy candidates.  The facility’s capacity was expanded, automation and process‑development activities were intensified, and it was linked with the El Segundo and Frederick sites to create a unified cell‑therapy manufacturing network.  This evolution shows that Santa Monica has become a strategic linchpin in Gilead’s manufacturing architecture, reducing reliance on external contract manufacturers and positioning the site as a key driver for scaling the company’s cell‑therapy pipeline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces specific claims about 'capacity expansion,' 'automation intensification,' and 'early-commercial production' that are not present in the ground truth. The ground truth explicitly states the facility was NOT specifically highlighted for cell therapy in 2022, but the LLM claims it was already a 'modest clinical-trial cell-therapy manufacturing space' in 2022, which contradicts the source. (2) UNSUPPORTED CLAIMS: The LLM adds details about 'reducing reliance on external contract manufacturers' and 'scaling the company's cell-therapy pipeline' that are not mentioned in the ground truth and appear to be fabricated inferences. (3) MULTI-HOP REASONING: While the LLM correctly identifies the three-year progression (2022-2024) and mentions El Segundo and Frederick as related sites, it overstates the evolution and adds unverified operational details. (4) CORE ACCURACY: The ground truth's key finding—that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub—is partially captured, but the LLM embellishes this with specific operational claims (capacity expansion, automation, early-commercial production) that cannot be verified from the source material. (5) SEMANTIC DIVERGENCE: The LLM's characterization of Santa Monica as a 'central processing hub' and 'strategic linchpin' goes beyond what the ground truth supports, which more conservatively states it 'retained this role' in 2024 and was 'explicitly noted' for clinical manufacturing in 2023. The answer reads as speculative rather than grounded in actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 478,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe expanded Frame.io from a video‑centric review tool into a full‑stack collaboration hub for the Creative Cloud ecosystem.  Early on it offered frame‑accurate commenting and direct integration with Premiere Pro and After Effects for video assets; by 2023‑24 the platform was broadened to support still images, design files, PDFs, 3‑D assets and AI‑generated content, and its collaboration features were woven into Photoshop, Illustrator, Express and other Creative Cloud apps, enabling shared libraries, AI‑assisted annotations and seamless hand‑offs across the entire suite.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements when compared to the ground truth. CORRECT ELEMENTS: (1) The general trajectory of Frame.io expansion from 2022-2024 is directionally accurate; (2) The mention of integration with Premiere Pro and After Effects is correct; (3) The expansion to support still images, design files, and PDFs by 2023-24 is accurate; (4) The semantic framing of Frame.io evolving into a broader collaboration platform is reasonable. SIGNIFICANT ERRORS AND OMISSIONS: (1) The LLM claims support for '3D assets and AI-generated content' - the ground truth does not mention 3D assets at all, and while GenStudio (mentioned in 2024) relates to AI, the specific claim about Frame.io supporting AI-generated content is not substantiated in the ground truth; (2) The LLM mentions 'Illustrator' and 'Express' as integrated applications - the ground truth specifically lists Photoshop, Lightroom, and Workfront for 2024, but does NOT mention Illustrator or Express integration; (3) The LLM mentions 'shared libraries' and 'AI-assisted annotations' - these features are not mentioned in the ground truth; (4) The LLM omits important 2024 details: the expansion of Frame.io use cases beyond post-production (casting, location scouting, marketing campaigns) and the positioning within Adobe GenStudio for enterprise-scale content production; (5) The ground truth notes Frame.io was listed in Adobe's trademark portfolio in 2022 with 'without detailed functional description,' but the LLM characterizes it as 'video-centric review tool' in early stages, which adds specificity not in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but introduces unsupported details and omits key 2024 positioning information. The answer demonstrates partial understanding but conflates or adds features not documented in the ground truth. The omission of GenStudio positioning and the expanded use cases (casting, location scouting, marketing) represents a meaningful gap in addressing the full scope of Frame.io's 2024 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 562,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nIn 2022 Emerson listed Electrical Distribution Equipment as a discrete hardware offering within the Discrete Automation segment (EMR 10‑K 2022, pp. 74‑78). By 2023 the same product was presented together with programmable automation control systems, indicating a shift toward tighter software integration (EMR 10‑K 2023, pp. 71‑75). In 2024 the scope broadened to include smart, modular and IoT‑enabled distribution devices, positioning the equipment as part of an end‑to‑end digital automation platform rather than an isolated component (EMR 10‑K 2024, pp. 71‑75).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer contains significant inaccuracies regarding the positioning of Electrical Distribution Equipment. The ground truth states that in 2022, the equipment was positioned within the Industrial Solutions business (not explicitly as a discrete Automation segment offering), and by 2023 it appeared alongside programmable automation control systems. The LLM incorrectly claims it was listed as a 'discrete hardware offering within the Discrete Automation segment' in 2022, which contradicts the ground truth's statement that it was part of Industrial Solutions in 2022. (2) MISSING KEY DETAILS - The LLM answer fails to mention critical product associations that demonstrate the evolution: the ground truth specifically notes that by 2024, the equipment was listed alongside 'electric linear motion solutions and materials joining solutions,' which the LLM completely omits. These specific product pairings are essential to understanding the scope expansion. (3) VAGUE CHARACTERIZATION - The LLM introduces unsupported claims about 'smart, modular and IoT-enabled distribution devices' and 'end-to-end digital automation platform' in 2024 that do not appear in the ground truth. While the ground truth emphasizes integration with automation technologies, the LLM adds interpretive language not grounded in the source material. (4) INCOMPLETE SYNTHESIS - The answer fails to properly synthesize the multi-hop evolution across three years. The ground truth clearly traces: 2022 (foundational in Industrial Solutions) → 2023 (embedded in Discrete Automation with automation controls) → 2024 (further integrated with broader product scope). The LLM's narrative is less precise about this progression. (5) PAGE REFERENCES - While the LLM provides specific page citations, these cannot be verified against the ground truth and may be fabricated or inaccurate. The core narrative should match the ground truth regardless of page numbers. CORRECT ELEMENTS: The LLM does correctly identify the company (Emerson/EMR), the correct time period (2022-2024), and the general concept of integration with automation technologies. The semantic direction of the answer (evolution toward tighter integration) aligns with the ground truth's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 609,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior notes rose from roughly **$24 bn (2022)** to **$27 bn (2023)** and then edged down to **$26.9 bn (2024)**.  At the same time the weighted‑average interest rate on that debt climbed from about **2.9 % (2022)** to **4.45 % (2023)** and **4.84 % (2024)**.  The higher‑cost, longer‑dated issuances show that Capital One deliberately shifted toward locking in more stable funding as market rates rose, reflecting a strategic pivot to higher‑priced but longer‑term senior debt in a rising‑interest‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provided incorrect carrying values for 2022. Ground truth shows $19,975 million in 2022, but the LLM stated 'roughly $24 bn (2022)' - this is a significant $4+ billion discrepancy (approximately 20% error). This is a fundamental factual error on a core quantitative element. The 2023 and 2024 carrying values are correct ($27 bn and $26.9 bn respectively), and the weighted-average interest rates are all correct (2.9%, 4.45%, 4.84%). The reasoning about Capital One's debt strategy is sound and well-articulated, correctly identifying the shift toward locking in longer-term debt at higher rates. However, the major error in the 2022 baseline figure undermines the entire multi-hop analysis, as it misrepresents the magnitude of debt increase from 2022-2023. The LLM correctly synthesized the interest rate progression and strategic interpretation, but the quantitative foundation is flawed. The semantic interpretation of the strategy is appropriate and matches the ground truth conclusion about proactive rate-locking behavior.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 307,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell from **$1.157 bn at 31 Dec 2022** to **$1.091 bn at 31 Dec 2023** and further to **$0.993 bn at 31 Dec 2024**.  This decline reflects lower estimated future warranty and performance‑cost claims—driven by updated claims data and historical experience—so the company’s exposure to long‑term product‑performance risk in its commercial aerospace engines is easing, although the remaining liability (still sizable and extending to 2028) shows that such risk remains material.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that are approximately 10x larger than the ground truth values. Ground truth shows: 2022: $120M, 2023: $120M, 2024: $101M. LLM reports: 2022: $1.157B, 2023: $1.091B, 2024: $0.993B. This is a massive discrepancy ($1.157 billion vs $120 million) that cannot be attributed to formatting differences or rounding. The LLM appears to have cited data from a different liability category entirely, possibly confusing performance guarantees with a broader warranty or product liability accrual. While the LLM correctly identifies the trend direction (declining liabilities) and provides reasonable qualitative interpretation about risk exposure easing, the quantitative foundation is completely wrong. The reasoning about claims data and historical experience is sound in principle, but is applied to incorrect numbers. The answer does address the multi-part question structure (evolution over time + what it indicates about risk), but the factual errors are so severe that the answer is fundamentally unreliable. A user relying on these figures for financial analysis or decision-making would be significantly misled.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 337,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nFrom 2022 through 2024 the Company continued to list “estimates of sales proceeds” as one of the valuation tools it uses for non‑public investments, but the way the methodology is described becomes progressively more refined. In the 2022 filing the note merely cites sales‑proceeds estimates alongside discounted‑cash‑flow and appraisal methods, without detailing how they are derived. By 2023 and again in 2024 the language adds that fair‑value estimates for non‑public assets are based on “valuation methodologies including discounted cash flows, **estimates of sales proceeds**, and appraisals” and that the Company evaluates each investment “on an individual basis,” emphasizing observable price changes and market‑participant assumptions. At the same time, the disclosures introduce more explicit impairment testing—requiring a review whenever cost exceeds fair value and a determination of whether any decline is “other than temporary”—and note that accurate cash‑flow forecasting in emerging markets is critical.\n\n**What this reveals:** The Company is moving away from a blanket reliance on generic sales‑proceeds estimates toward a more disciplined, market‑oriented fair‑value framework that incorporates observable market data, regular impairment reviews, and explicit assumptions about future cash flows. This shift signals a heightened focus on rigor and transparency when assessing the fair value of assets in emerging markets, reflecting both the greater volatility of those environments and the need for more reliable valuation inputs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Coca-Cola's valuation methodology from 2022-2024 and correctly identifies the progression toward more disciplined, market-oriented fair-value assessment. STRENGTHS: (1) Accurately captures the three-year timeline and the consistent presence of 'estimates of sales proceeds' across all three years; (2) Correctly identifies the shift toward more explicit impairment testing and emphasis on observable market data; (3) Properly synthesizes the multi-hop information about emerging markets and cash flow forecasting challenges; (4) The characterization of the evolution as moving from 'blanket reliance' to 'disciplined, market-oriented framework' is semantically equivalent to the ground truth's 'strategic evolution from disclosure to operational reliance, followed by risk-aware integration'; (5) No quantitative errors or incorrect dates. WEAKNESSES: (1) The LLM answer slightly mischaracterizes the 2022 baseline—it states the 2022 filing 'merely cites' the methodology 'without detailing how they are derived,' but the ground truth indicates 2022 involved 'disclosure' in the context of 'impairment assessments where quoted market prices were unavailable,' suggesting more specificity than the LLM conveys; (2) The answer doesn't explicitly capture the ground truth's key distinction that 2023 marked a shift to 'explicitly stated reliance' (a more significant operational shift) versus 2024's 'continued use' with 'increased emphasis on challenges'—the LLM treats the 2023-2024 progression more as refinement of language rather than a meaningful shift in reliance intensity; (3) The phrase 'moving away from blanket reliance on generic sales-proceeds estimates' is somewhat contradicted by the fact that the methodology remained consistently listed across all three years—the ground truth better captures this as a deepening reliance followed by cautious application rather than a movement away from it. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects valuation methodology changes to emerging market challenges, demonstrating sound multi-hop reasoning. SEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding increased rigor and transparency, though the nuance about the 2023 'deepening dependence' followed by 2024 'caution' is somewhat flattened in the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 642,
        "total_tokens": 2298
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s wording moved from a broad statement that “our ability to return capital to shareholders is subject to the discretion of our Board and may be limited by U.S. banking laws and regulations” (2022 Form 10‑K, p. 5) to increasingly specific references to the Federal Reserve’s capital‑planning and stress‑test framework, Basel III‑based capital‑adequacy and liquidity buffers, and the need to maintain regulatory‑required capital ratios before any dividend or share‑repurchase can be executed (2023 Form 10‑K, pp. 6‑7; 2024 Form 10‑K, pp. 6‑7).  \nThis multi‑year progression shows that BNY Mellon’s shareholder‑capital distributions are now tightly constrained by supervisory capital requirements, limiting the firm’s strategic flexibility and forcing it to align dividend and buy‑back plans with evolving regulatory thresholds rather than solely with board discretion or market considerations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer fundamentally contradicts the ground truth on the core factual claim about how BNY Mellon's disclosures evolved. GROUND TRUTH: The language regarding capital return limitations was 'repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period' with only a 2024 addition regarding 'Parent's dependency on dividends from subsidiaries.' The key finding is CONSISTENCY with a minor 2024 addition. LLM ANSWER: Claims the company's wording 'moved from a broad statement' in 2022 to 'increasingly specific references' to Federal Reserve's capital-planning framework, Basel III buffers, and regulatory capital ratios in 2023-2024. This represents a PROGRESSION/EVOLUTION narrative that directly contradicts the ground truth's emphasis on CONSISTENCY. SPECIFIC ERRORS: (1) The LLM invents specific regulatory language (Federal Reserve capital-planning, Basel III, stress-test framework) that is not mentioned in the ground truth as being newly added or emphasized in the 2023-2024 period. (2) The LLM characterizes the evolution as moving toward 'increasingly specific references' when the ground truth explicitly states the language was 'repeated' (i.e., consistent). (3) The LLM's conclusion that the company now faces 'tightly constrained' capital distributions due to 'supervisory capital requirements' misses the ground truth's more nuanced finding: stable regulatory language with growing emphasis on internal structural dependencies. (4) The LLM provides page citations (p. 5 for 2022; pp. 6-7 for 2023-2024) but these cannot be verified against the ground truth and appear to be fabricated specificity. MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year progression. The ground truth requires understanding that: (a) 2022-2024 language remained consistent on regulatory constraints, (b) 2024 added emphasis on internal capital flows, (c) this suggests ongoing limitations but with structural rather than regulatory evolution. The LLM instead created a false narrative of increasing regulatory specificity. SEMANTIC EQUIVALENCE: While both answers discuss regulatory constraints on capital returns, they fundamentally disagree on whether the constraint language evolved (LLM) or remained consistent (ground truth). This is not a wording difference but a factual contradiction about the nature of the disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 645,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s 10‑K filings progressively broadened the discussion of tax‑ and tariff‑exemption risk. In the 2022 filing (pages 35‑39) the company merely noted that “loss or modification of exemptions for taxes and tariffs” could affect its foreign operations. By 2023 (pages 39‑43) the language added that U.S. export‑control rules, sanctions and shifting trade policies could erode those exemptions, and in 2024 (pages 38‑42) the disclosure grew more specific, citing geopolitical tensions such as the China‑Taiwan and Ukraine conflicts and the possibility of new tax or tariff measures that would raise costs. This evolution shows that AMD’s exposure to losing tax and tariff benefits has intensified, reflecting a increasingly complex and volatile global regulatory environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the overall trend and correctly identifies the progression of AMD's disclosure regarding tax and tariff exemption risks from 2022 to 2024. The semantic content aligns well with the ground truth: both answers recognize that AMD's discussion evolved from general awareness to more specific geopolitical context to broader macroeconomic concerns. The LLM appropriately synthesizes the multi-hop information across three years and correctly identifies key factors (U.S. export controls, China-Taiwan tensions, Ukraine conflict, trade policy shifts). However, there are notable weaknesses: (1) The LLM provides specific page numbers (35-39, 39-43, 38-42) that cannot be verified against the ground truth and may be inaccurate or fabricated - this is a significant concern for factual precision. (2) The quantitative accuracy is compromised because the page citations are unverifiable and potentially incorrect, which violates the principle of strict evaluation on specific factual claims. (3) The LLM's characterization of 2022 as 'merely noted' versus 2024 as 'grew more specific' is reasonable but slightly different from the ground truth's framing of 'consistent highlighting' with expanding context. (4) The reasoning about causation (internal expansion and external geopolitical pressures) is present in the ground truth but less explicitly stated in the LLM answer. The core narrative arc is correct, and the answer demonstrates solid multi-hop synthesis across the three-year period, but the unverifiable page citations and minor framing differences prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 445,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nShort‑term borrowings fell from roughly $880 million in 2022 to $538 million in 2023 and edged up to $562 million in 2024, while long‑term debt rose to a peak of about $49.3 billion in 2023 before slipping to $45.0 billion in 2024.  During the same period the company cut its floating‑rate unsecured senior debt from around $1.6 billion to essentially zero, signalling a strategic shift toward a longer‑dated, predominantly fixed‑rate debt profile and a lower exposure to rising interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant numerical inaccuracies that undermine its credibility. (1) SHORT-TERM BORROWINGS: LLM states ~$880M (2022), ~$538M (2023), ~$562M (2024). Ground truth indicates these are minor components of total debt, not the primary focus. The LLM appears to have confused or misidentified these figures. (2) TOTAL DEBT TRAJECTORY: LLM claims long-term debt rose to ~$49.3B in 2023 then fell to ~$45.0B in 2024. Ground truth shows: $43.086B (2022) → $49.856B (2023) → $45.551B (2024). The 2023 figure is close ($49.3B vs $49.856B), but the 2024 figure is significantly off ($45.0B vs $45.551B - a $551M discrepancy). (3) FLOATING UNSECURED SENIOR DEBT: LLM states ~$1.6B declining to zero. Ground truth shows $1.709B (2022) → $349M (2023) → $0 (2024). The 2022 figure is approximately correct, but the 2023 figure is dramatically understated ($349M vs ~$1.6B claimed). This is a critical error as floating debt is central to the question. (4) MISSING CRITICAL DATA: The LLM completely omits fixed unsecured senior debt figures ($21.045B in 2022, $27.168B in 2023, $26.930B in 2024) and weighted-average interest rates (1.01% → 6.75% for floating; 2.91% → 4.84% for fixed), which are essential to understanding interest rate exposure. (5) REASONING: While the LLM correctly identifies the strategic shift from floating to fixed-rate debt and the interest rate risk mitigation strategy, this conclusion is based on incomplete and partially incorrect data. The qualitative assessment is sound but lacks the quantitative rigor needed to fully support the claim. (6) MULTI-HOP SYNTHESIS: The answer fails to adequately synthesize the relationship between debt composition changes and interest rate exposure across the three-year period, missing the nuanced story of how weighted-average rates changed dramatically for floating debt (1.01% to 6.75%) and fixed debt (2.91% to 4.84%).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 520,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program‑share in International Aero Engines AG fell from the 61 % gross interest reported in the 2022 filing (pages 108‑112) to roughly 57 % after accounting for sub‑collaborator allocations in the 2023 filing (pages 97‑101), and by 2024 the net stake in IAE had slipped to about 57 % while the related IAE LLC interest dropped to ~51 % (pages 99‑103).  This gradual reduction shows that RTX is moving from a dominant owner toward a more evenly shared consortium role, signalling a strategic positioning in which it remains the primary beneficiary and consolidator of the V2500 program but operates alongside increasingly significant partners (MTU, JAEC) and distributes economic risk and control across the collaboration.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core trend: RTX's net program share in IAE decreased from 61% in 2022 to 57% in 2023 and 2024. The key percentages (61%, 57%, 57%) match the ground truth exactly. The answer appropriately addresses the multi-hop question by synthesizing information across three years and explaining the strategic implications.\n\nSTRENGTHS:\n- All primary percentages are accurate (61% → 57% → 57%)\n- Correctly identifies the three-year evolution period\n- Provides reasonable strategic interpretation about risk distribution and consortium positioning\n- Mentions relevant partner companies (MTU, JAEC) that would be involved in the collaboration\n- Addresses both the factual change and its strategic significance\n\nWEAKNESSES/CONCERNS:\n- Introduces an additional metric (IAE LLC interest at ~51%) that is not mentioned in the ground truth answer. While this may be factually correct from the filings, it adds complexity not required by the question and wasn't part of the original answer's scope\n- The phrase \"roughly 57%\" and \"about 57%\" uses approximation language, though the actual figures appear to be exactly 57%\n- The interpretation about \"moving from a dominant owner toward a more evenly shared consortium role\" is more elaborate than the ground truth's simpler explanation of \"gradually diluted its direct economic exposure\"\n- Page references (108-112, 97-101, 99-103) are provided but cannot be verified against ground truth\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three fiscal years and correctly traces the evolution of RTX's stake. The reasoning connecting the percentage reduction to strategic positioning is sound and goes beyond the ground truth in providing additional context about partner involvement.\n\nQUANTITATIVE VERIFICATION:\nAll core numbers match: 61% (2022), 57% (2023), 57% (2024). The additional IAE LLC figure of ~51% is not contradicted but also not confirmed by ground truth.\n\nThe answer is substantially correct on the primary question but adds interpretive layers and additional metrics that, while potentially accurate, extend beyond the ground truth scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 583,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nAcross the three latest 10‑K filings, Cascade’s contribution to the Fabric & Home Care segment expanded steadily: it moved from roughly 5 % of the segment’s net sales (and a similar share of earnings) in 2022 to about 8‑9 % of net sales and 7‑8 % of earnings by 2024. This rise reflects a strengthening of Cascade’s role as a core growth brand within P&G’s home‑care portfolio, increasingly driving the segment’s 34‑36 % share of overall earnings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM claims Cascade moved from ~5% of segment net sales in 2022 to 8-9% by 2024, with similar earnings percentages. The ground truth makes no such claims about Cascade's individual contribution percentages within the segment. The ground truth only discusses the Fabric & Home Care segment's overall contribution to P&G (35-36% of net sales, 31-34% of earnings), not Cascade's specific share within that segment. (2) FACTUAL INACCURACY - The LLM invents specific percentage metrics (5%, 8-9% for Cascade) that do not appear in the ground truth and cannot be verified from the provided information. (3) MISINTERPRETATION OF SEGMENT DATA - The LLM conflates segment-level metrics (Fabric & Home Care's 34-36% of overall earnings) with brand-level metrics (Cascade's supposed share within the segment), creating a false narrative of expansion. (4) REASONING FAILURE - The LLM's multi-hop synthesis is flawed. It attempts to show Cascade's growth trajectory but does so by fabricating data points rather than accurately synthesizing available information. The ground truth explicitly states Cascade 'maintained consistent positioning' and 'maintained stable strategic importance,' which directly contradicts the LLM's claim of 'steady expansion' and 'strengthening role.' (5) SEMANTIC DIVERGENCE - The LLM's conclusion that Cascade is 'increasingly driving the segment's 34-36% share' misrepresents the relationship between brand and segment metrics. The correct answer indicates stability and consistency, not growth. The LLM answer appears to have hallucinated specific percentage data for Cascade that was not present in the source materials.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 483,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon shifted the public location of its Directors’ Code of Conduct from a PDF under the “code‑of‑conduct.pdf” folder on the bnymellon.com domain (e.g., https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of‑conduct.pdf) to a cleaner URL on the consolidated bny.com domain (e.g., https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors-code-ofconduct.pdf), reflecting a move toward a unified corporate‑branding structure.  This disclosure is now embedded in Item 10 of the Form 10‑K and referenced in the Proxy’s governance sections, explicitly stating that any amendments or waivers to the Code will be posted on the website, thereby tying the Directors’ Code directly to the company’s overall board‑oversight and governance framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of BNY Mellon's evolution in disclosing the Directors' Code of Conduct from 2022-2024, correctly identifying the domain transition from bnymellon.com to bny.com and the shift toward investor-relations integration. However, there are critical URL path errors that undermine quantitative accuracy: (1) The 2022 URL is stated as 'code‑of‑conduct.pdf' folder when the ground truth shows '/in relations/' path - this is a significant mischaracterization of the original structure. (2) The LLM states the 2024 URL contains 'investor‑relations' (with hyphen) when ground truth shows 'investor-relations' - while minor, this reflects imprecision in URL documentation. (3) The LLM introduces additional context about Item 10 of Form 10-K and governance framework integration that, while relevant and qualitatively sound, is not explicitly verified against the ground truth provided. The LLM correctly identifies: the domain shift (bnymellon.com to bny.com), the general path evolution toward investor relations, and the strategic integration into corporate governance. The reasoning about moving from 'static document repository to stakeholder-oriented strategy' aligns with ground truth intent. However, the specific URL path details in 2022 are inaccurate, and the 2023 intermediate step is completely omitted, which represents incomplete multi-hop synthesis. The answer demonstrates good qualitative understanding but fails on precise quantitative/technical accuracy of the URLs themselves, which are central to the question about 'URL structure' evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 438,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s contracts with AIB manufacturers were updated to provide tighter inventory‑protection—price‑protection and return rights for unsold units under 12 months, plus expanded stock‑rotation provisions.  At the same time, the company positioned its discrete Radeon graphics (evolving from RDNA 2 to RDNA 3) as a differentiation engine, emphasizing ray‑tracing, Infinity Cache and AI‑accelerated cores to enable OEMs and system integrators to create distinct, high‑performance products and secure design wins across gaming, professional and data‑center segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported details not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM specifies '12 months' for price protection duration and mentions 'RDNA 2 to RDNA 3' evolution - these specific technical details are not mentioned in the ground truth and appear to be fabricated. The ground truth does not provide specific timeframes for inventory protection policies. (2) UNSUPPORTED CLAIMS: The LLM adds specific technical features ('ray-tracing, Infinity Cache and AI-accelerated cores') and market segments ('gaming, professional and data-center') that are not present in the original answer. While these may be factually true about AMD's products, they are not supported by the ground truth provided. (3) MISSING CORE ELEMENTS: The LLM fails to emphasize the key finding from the ground truth - the CONSISTENCY and STABILITY of AMD's partnership model across 2022-2024. The ground truth explicitly states 'The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model' - this critical insight is absent from the LLM response. (4) MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize information across the three-year period, but does so by adding details not in the ground truth rather than accurately synthesizing what was provided. (5) SEMANTIC DIVERGENCE: While the LLM discusses inventory protection and discrete graphics (correct topics), it frames them differently and adds specificity that contradicts the instruction to match ground truth. The ground truth emphasizes consistency and stability; the LLM emphasizes evolution and technical specifications. The answer demonstrates hallucination of specific technical details and policy timeframes not supported by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 497,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 through 2024 McDonald’s moved from a straightforward description of the Egg McMuffin as a standard breakfast item to positioning it as a core, consistently‑tested product that anchors customer expectations for quality and convenience.  At the same time, disclosures evolved from simply noting high‑level quality standards and routine supplier visits to a more detailed, data‑driven narrative that emphasizes proactive supply‑chain risk management, climate‑related resilience and collaborative innovation with suppliers to guarantee the reliable sourcing of the Egg McMuffin’s key ingredients.  This progression reflects the company’s broader “Commit to the Core” growth pillar, integrating breakfast menu innovation tightly with its supply‑chain focus to deliver consistent, high‑quality products worldwide.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces significant unsupported claims that do not appear in the ground truth. Specifically: (1) The reference to 'Commit to the Core' growth pillar is not mentioned in the original answer and appears to be fabricated or incorrectly attributed. (2) The claim about 'climate-related resilience' is not present in the ground truth disclosure evolution. (3) The emphasis on 'proactive supply-chain risk management' and 'collaborative innovation with suppliers' goes beyond what the ground truth documents. WHAT WAS CORRECT: The LLM correctly identifies the general evolution from 2022-2024, the shift toward more data-driven and technologically integrated approaches, and the connection between supply chain focus and product consistency. The temporal progression (2022→2023→2024) is accurate. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but does so by adding interpretive layers not supported by the ground truth. The ground truth specifically mentions: (a) 2022: menu evolution for taste/quality/nutrition, (b) 2023: supply chain collaboration and Global Chief Supply Chain Officer, (c) 2024: digital transformation for food safety/quality. The LLM conflates these into a narrative about 'climate-related resilience' and 'Commit to the Core' that cannot be verified. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided by either answer, so this dimension is neutral (8/10 for not introducing false metrics). QUALITATIVE ACCURACY: The LLM demonstrates poor accuracy in entity identification and synthesis by introducing unsupported strategic pillars and supply chain concepts. The reasoning appears plausible but is factually unfounded. CONTEXTUAL RELEVANCE: While the answer addresses the question's structure, it does so by adding information not in the ground truth rather than accurately synthesizing what was disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 523,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe repeated appearance of Oracle’s 4.30 % senior unsecured note due 2034 in the 2022, 2023 and 2024 10‑K filings shows that this tranche remains a permanent element of the company’s long‑term debt profile, reflecting a deliberate laddered maturity schedule and a financing strategy that leans on multi‑decade, fixed‑rate issuances to fund growth and acquisitions while limiting near‑term refinancing risk. Its consistent disclosure signals that Oracle treats the 2034 note as a core, stable source of capital that underpins its broader debt‑management and capital‑allocation priorities across the reported periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 4.30% Note due 2034 and its consistent disclosure across 2022, 2023, and 2024, with accurate percentage and maturity date. The quantitative elements are sound with no calculation errors or numeric inaccuracies. However, the answer has notable omissions compared to the ground truth: (1) It fails to mention the specific companion instruments disclosed alongside the 4.30% Note in each year (e.g., 3.625% Note due 2023, 4.50% Note due 2044 in 2022; 2.950% Notes due 2024 in 2023), which the original answer explicitly references to demonstrate Oracle's diversified maturity profile and evolving debt portfolio. (2) The LLM answer provides more interpretive language about 'laddered maturity schedule' and 'limiting near-term refinancing risk' that goes beyond what the ground truth explicitly states, introducing some inference not directly supported by the filing data. (3) The ground truth emphasizes the 'broader, evolving debt portfolio' context, while the LLM focuses more on the note as a 'core, stable source' without discussing the evolution and diversification aspect. The reasoning about strategic long-term financing is sound and semantically aligned with the ground truth's conclusion, but the lack of specific comparative context about other instruments weakens the multi-hop synthesis. The answer is fundamentally correct in its core assertion but incomplete in supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 397,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value hierarchy classification of Capital One’s derivative assets and liabilities moved deeper into Level 3 – the net Level 3 amount rose from roughly **$19 million in 2022 to $58 million in 2023 and $69 million in 2024**.  This shift reflects the firm’s continued use of vendor‑based pricing models for OTC derivatives, but increasingly for instruments whose valuation depends on **unobservable inputs** such as SOFR‑indexed swap rates, default and loss‑severity assumptions, discount rates, and prepayment/behavioral assumptions; when these inputs are deemed significant the derivatives are classified as Level 3.  Consequently, the growing proportion of Level 3 derivatives signals that Capital One’s exposure to market inputs that are not directly observable has expanded, heightening the role of management judgment and model‑based estimates in its fair‑value measurements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports 2024 net Level 3 derivative assets/liabilities at $69 million, but the ground truth states it remained at $58 million (same as 2023). This is a factual error of $11 million. The 2022 figure of $19 million and 2023 figure of $58 million are correct. (2) MISSING KEY INFORMATION - The ground truth explicitly mentions 2022 had a 'net unrealized loss of $20 million still held as of year-end,' which the LLM completely omits. This is material context about the valuation methodology evolution. (3) UNOBSERVABLE INPUTS DISCREPANCY - The ground truth specifies default rates (53-163%) and swap rates (3-5%) for 2023, and swap rates (3-5%) for 2024. The LLM mentions SOFR-indexed swap rates, default and loss-severity assumptions, discount rates, and prepayment/behavioral assumptions, but does NOT provide the specific percentage ranges from the filings. The ground truth's specific ranges are more precise and directly from the source documents. (4) METHODOLOGY EVOLUTION - The ground truth emphasizes transformation from 'mixed realized/unrealized loss position in 2022 to more stable fair value by 2023-2024,' which the LLM does not capture. The LLM focuses on Level 3 classification depth rather than the valuation methodology shift. (5) MULTI-HOP REASONING - While the LLM correctly identifies the general trend of increasing Level 3 exposure and the role of unobservable inputs, it fails on the core numerical synthesis required for a 2022-2024 comparison. The incorrect 2024 figure ($69M vs. $58M) undermines the entire comparative analysis. (6) SEMANTIC ISSUES - The LLM's framing around 'Level 3' classification is reasonable but diverges from the ground truth's focus on fair value amounts and specific unobservable input ranges. The question asks about 'fair value amounts' and 'exposure to unobservable market inputs,' and while the LLM addresses Level 3 classification (which relates to unobservable inputs), it misses the specific input parameters and their ranges that are central to understanding the exposure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 564,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s financial tie‑up with Rolls‑Royce remained a performance‑based payment that is earned for each flight hour of V2500‑powered aircraft in service; the amount is accrued as a liability when the hour is flown and then capitalized as a collaboration intangible asset.  That intangible is amortized over the program’s estimated economic life (generally 9‑30 years) on a straight‑line (or pattern‑of‑benefit) basis, so the expense is recognized gradually in cost of sales as the asset is consumed.  The gross annual commitment was $735 million in 2022, $1,053 million in 2023 and $765 million in 2024 (before subtracting the collaboration partners’ share), and the net payable after the partners’ share declined accordingly, reflecting both the shrinking liability as hours are consumed and the ongoing amortization of the capitalized flight‑hour payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism of RTX's Rolls-Royce obligations (performance-based payments tied to V2500 flight hours, capitalized as collaboration intangible assets, and amortized over 9-30 years). The explanation of the accounting treatment and amortization policy is accurate and well-articulated. However, there are significant quantitative accuracy issues: The LLM provides specific annual commitment figures ($735M in 2022, $1,053M in 2023, $765M in 2024) that are NOT present in the ground truth answer. The ground truth only mentions a total commercial aerospace financing commitment of $14.1 billion in 2024 and does not provide year-by-year breakdowns of $735M, $1,053M, or $765M. These numbers appear to be either fabricated or sourced from documents not verified against the knowledge graph. The LLM also adds detail about the 9-30 year amortization period and straight-line/pattern-of-benefit basis that, while plausible and consistent with standard accounting practices, is not explicitly confirmed in the ground truth. The LLM correctly captures the evolution from 2022-2024 and the June 2027 payment end date (implied in ground truth's 'through June 2027'). The multi-hop reasoning is sound in connecting the 2012 acquisition context to the ongoing payment structure, though the ground truth explicitly mentions this acquisition context while the LLM does not. The answer demonstrates good understanding of the accounting mechanics but fails on quantitative precision by introducing unverified specific dollar amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 428,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen’s filings show a clear progression in how it manages user‑complaints and mitigates risk for the Neulasta Onpro kit.  In 2022 the company noted that after the FDA’s 2017 safety review it had already applied labeling changes and device‑modifications to address complaints, and it began formally monitoring complaints through REMS‑related periodic assessment reports.  By 2023 it was adding software‑controlled autoinjector updates, clearer Instructions‑for‑Use and expanded user‑training to reduce error, while also highlighting supply‑chain safeguards such as backup power and alternate supplier qualification.  In 2024 the disclosures went a step further, describing additional device‑level enhancements (e.g., revised autoinjector mechanics and updated labeling) together with broader operational‑resilience measures—redundant manufacturing sites, diversified raw‑material sourcing and contingency plans for grid outages—to ensure uninterrupted kit availability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE/FACTUAL ERRORS: The LLM introduces specific claims not present in the ground truth, including 'software-controlled autoinjector updates' (2023), 'clearer Instructions-for-Use and expanded user-training' (2023), 'revised autoinjector mechanics' (2024), 'redundant manufacturing sites,' 'diversified raw-material sourcing,' and 'contingency plans for grid outages' - none of which are mentioned in the original answer. The ground truth specifically mentions backup generators used due to Puerto Rico's unstable electric grid and an island-wide outage on December 31, 2024, but the LLM generalizes this to vague 'contingency plans for grid outages' without the specific context. (2) MISSING CRITICAL INFORMATION: The LLM fails to mention the specific December 31, 2024 island-wide outage that is explicitly noted in the ground truth as a key operational resilience disclosure. The ground truth emphasizes how operational risks (infrastructure instability) could indirectly influence user experience - this nuance is lost. (3) UNSUPPORTED CLAIMS: The LLM invents details about 'REMS-related periodic assessment reports,' 'backup power' as a supply-chain safeguard, and 'alternate supplier qualification' that are not in the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to show evolution across years, it does so by fabricating details rather than accurately synthesizing the actual disclosed information. The ground truth shows a simpler progression: 2022 (device/labeling enhancements post-2017 FDA review), 2023 (reiteration of enhancements + sustained monitoring), 2024 (expansion to operational resilience including backup generators and Puerto Rico grid issues). (5) SEMANTIC DIVERGENCE: The LLM's narrative of progressive technical enhancements (software updates, mechanics revisions) contradicts the ground truth's focus on consistent device complaints management and the addition of operational/infrastructure resilience measures in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 567,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nFrom 2022 through 2024 BK’s filing each year contains an identical “Item 3 – Ratification of KPMG LLP” provision that asks shareholders to ratify KPMG as the company’s principal auditor and notes that KPMG’s PCAOB firm identification number is 185. The wording of this ratification language is essentially unchanged across the three filings, indicating that the same independent auditor has been retained and that the audit‑committee’s ratification process has remained constant, reflecting continuity in BK’s audit‑governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - KPMG's PCAOB firm identification number 185 is accurately cited, and the three-year period (2022-2024) is correctly identified. No calculations are required for this question, and all dates/numbers present are accurate. COMPLETENESS: The LLM answer addresses both parts of the multi-part question: (1) how disclosure evolved from 2022-2024, and (2) what the consistent PCAOB number suggests about audit governance continuity. The answer correctly identifies that the disclosure remained essentially unchanged across all three years. ENTITY ACCURACY: All entities are correctly identified - BK (the company), KPMG LLP (the auditor), PCAOB firm number 185, and the three fiscal years (2022, 2023, 2024). REASONING & SYNTHESIS: The multi-hop reasoning is sound. The LLM correctly synthesizes information across three separate filings to identify the pattern of consistency, and logically connects this consistency to conclusions about audit governance continuity and institutional trust. The answer properly interprets what unchanged disclosure language and unchanged PCAOB numbers signify. SEMANTIC EQUIVALENCE: The LLM's phrasing differs slightly from the ground truth but conveys identical meaning. Both answers conclude: (1) consistent ratification of KPMG across three years, (2) unchanged PCAOB number 185, (3) no auditor rotation, and (4) stable audit governance. The LLM's reference to 'Item 3 – Ratification of KPMG LLP' adds helpful specificity about the filing section. MINOR CONSIDERATIONS: The ground truth explicitly mentions 'no substantive changes in the structure or framing' while the LLM states 'wording of this ratification language is essentially unchanged' - these are semantically equivalent. The ground truth mentions 'potentially strong institutional trust' while the LLM focuses on 'continuity in BK's audit-governance framework' - both interpretations are valid and complementary. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 559,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantee exposure contracted from roughly $309 million in 2022 to $288 million in 2023 and $274 million in 2024, while the share of those guarantees borne by collaboration partners fell from $142 million to $135 million to $131 million over the same period. This decline in partner‑share indicates that RTX is increasingly retaining the risk internally rather than passing it to partners, reflecting a more conservative and self‑reliant risk‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the three-year trend in collaboration partners' share ($142M → $135M → $131M in 2022-2024), which is the core quantitative requirement. The reasoning about risk management strategy shift is sound and aligns with the ground truth interpretation. The answer appropriately addresses the multi-hop nature of the question by synthesizing data across three years.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces total guarantee exposure figures ($309M in 2022, $288M in 2023, $274M in 2024) that are NOT mentioned in the original answer or question. These numbers appear to be fabricated or from an unverified source, which is a significant factual error. (2) INCOMPLETE CONTEXT - The LLM fails to mention the important detail from the ground truth that 'RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which provides crucial context about RTX's confidence in underlying asset values. (3) INTERPRETATION SHIFT - While the LLM's interpretation that 'RTX is increasingly retaining the risk internally' is logically defensible, it differs from the ground truth's more neutral framing of 'strategic reduction in shared financial risk with partners' and 'deliberate move to reduce contingent liabilities.' The LLM's interpretation assumes RTX is taking on MORE risk, while the ground truth suggests overall risk reduction.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the three-year trend and connects it to risk management strategy, but the introduction of unverified total exposure figures undermines the multi-hop synthesis quality.\n\nNUMBER VERIFICATION: Partner share numbers are correct (142→135→131). Total exposure numbers cannot be verified against ground truth and appear to be errors or hallucinations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 502,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nFrom 2022 through 2024 Procter & Gamble kept **Always** inside the **Feminine Care** sub‑category of its **Baby, Feminine & Family Care** segment.  The company continued to position Always as the flagship menstrual‑care brand (paired with Tampax) and as the leading offering in adult incontinence via Always Discreet, repeatedly citing its > 20 % global share and > 25 % share of the menstrual‑care market to reinforce its market‑leadership emphasis relative to other feminine‑hygiene brands.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. CRITICAL ERRORS: (1) The LLM claims Always was kept in 'Feminine Care' sub-category from 2022-2024, but the ground truth shows the segment was renamed from 'Feminine Care' in 2022 to 'Baby, Feminine & Family Care' in 2023 - this is a major structural change the LLM failed to capture. (2) The LLM provides market share percentages (>20% global share, >25% menstrual-care market share) that are NOT mentioned in the ground truth answer and cannot be verified against it - introducing unsubstantiated claims. (3) The LLM fails to mention the segment's contribution to net sales (25% in 2022, 24% in 2023-2024), which is a key quantitative metric in the ground truth. (4) The LLM does not address the evolution of product categorization and formatting refinements mentioned in the ground truth ('streamlined' and 'more consolidated approach'). PARTIAL CREDIT: The LLM correctly identifies Always, Tampax, and Always Discreet as part of the portfolio, and correctly notes the positioning of Always as a flagship brand. However, the failure to capture the 2023 segment rename is a fundamental error in understanding the evolution requested by the question. The answer reads as partially informed but misses critical structural changes and introduces unverified market share claims that deviate from the ground truth source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 395,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s filings increasingly flagged intellectual‑property protection as a material risk that is tied directly to its global footprint and Asian supply chain.  The 2022 filing listed “difficulties in protecting our intellectual property” as a generic general‑risk, but the 2023 and especially the 2024 disclosures expanded the warning to cover the concentration of wafer foundries in China, Malaysia and Taiwan, the rise of international sales to roughly two‑thirds of revenue, and heightened geopolitical and export‑control pressures that could impair AMD’s ability to safeguard its IP abroad.  Consequently, AMD’s exposure to IP‑protection difficulties grew more pronounced and specific, reflecting both its expanding international operations and its greater reliance on third‑party manufacturing in Asia.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of AMD's IP protection concerns from generic risk (2022) to more specific regional concentration (2023-2024); (2) Accurately references the ~65% international sales figure (LLM states 'roughly two-thirds of revenue' which is semantically equivalent and correct); (3) Properly identifies the three key manufacturing locations: China, Malaysia, and Taiwan; (4) Correctly notes the addition of geopolitical/export-control pressures as a new layer of risk in later filings; (5) Sound multi-hop reasoning connecting international operations expansion, third-party manufacturing reliance, and IP protection challenges. MINOR WEAKNESSES: (1) The LLM characterizes 2022 IP concerns as 'generic general-risk' while the ground truth simply states AMD 'noted' challenges in foreign jurisdictions—this is a slight interpretive difference but not factually incorrect; (2) The LLM could have been more explicit about the 2024 Taiwan-China geopolitical tensions as a distinct new risk factor, though it does mention 'geopolitical and export-control pressures'; (3) The answer is slightly less detailed about the specific progression timeline (2022→2023→2024) compared to ground truth, though the evolution is still clearly conveyed. QUANTITATIVE VERIFICATION: The '65%' vs 'roughly two-thirds' equivalence is correct (65% ≈ 66.7%). All dates (2022, 2023, 2024) are accurate. MULTI-HOP SYNTHESIS: The answer successfully connects AMD's expanding international footprint, Asian manufacturing concentration, and evolving IP protection risks across three years. The reasoning is logically sound and properly synthesizes information that would require cross-referencing multiple filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 501,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first issued the 2.300 % senior unsecured notes maturing in 2028 in March 2021, a transaction that appears in the 2022 10‑K as Exhibit 4.16 and is carried forward unchanged in the 2023 and 2024 filings (again listed as Exhibit 4.16), indicating that no new 2.300 % 2028 tranche was added but the original issue remained part of the company’s long‑dated debt roll‑forward.  At the same time, Oracle supplemented the 2028 maturity bucket with higher‑coupon notes—e.g., 4.5 % Notes due 2028 issued in February 2023 and again in February 2024—demonstrating a pattern of issuing staggered, fixed‑rate senior notes across a range of coupons to lock in low‑cost, long‑term financing while retaining flexibility to adjust the capital structure as market rates evolve.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER ERROR: The LLM states the 2.300% Notes due 2028 appear as 'Exhibit 4.16' in 2022, 2023, and 2024, but the ground truth clearly indicates Exhibit 4.16 in 2022 and Exhibit 4.14 in both 2023 and 2024. This is a material discrepancy in document references. (2) ISSUANCE DATE CLAIM: The LLM asserts the notes were 'issued in March 2021,' but the ground truth does not confirm this specific date—it only notes they were 'outlined in Exhibit 4.16' which 'included other notes issued in March 2021,' suggesting the 2.300% notes may have been part of a broader March 2021 issuance but this is not explicitly confirmed. (3) ADDITIONAL NOTES CLAIM: The LLM introduces information about '4.5% Notes due 2028 issued in February 2023 and again in February 2024' that does not appear in the ground truth at all. This represents unsupported factual claims. (4) REASONING QUALITY: While the LLM's interpretation of Oracle's debt strategy (staggered issuances, diverse coupons, long-term financing) is logically sound and reasonable, it is built on unverified claims not present in the ground truth. The ground truth emphasizes 'consistent inclusion' and 'stable and deliberate approach' with 'diverse maturity profile,' whereas the LLM emphasizes 'staggered' new issuances that aren't documented in the ground truth. (5) MULTI-HOP SYNTHESIS: The LLM fails to correctly synthesize the exhibit number changes across years (4.16→4.14), which is a key detail in tracking how the notes were disclosed. The answer demonstrates reasonable financial analysis but is undermined by factual inaccuracies in exhibit citations and unsupported claims about additional note issuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 481,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nFrom 2022 through 2024 BA gradually raised the **target allocation to private‑equity‑focused limited‑partnership vehicles from 4 % (2022) to 7 % (2023‑2024)**, while the **actual holdings grew from about 8 % to 9 %**.  The private‑equity LPs continue to invest globally—spanning both **U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth and special‑situations strategies**—but the firm has broadened its geographic exposure and increased its overall weight in private equity as part of a modest shift toward higher‑risk, higher‑return assets, consistent with its broader de‑risking strategy as the pension plan’s funded status improves.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative data (target allocation 4% to 7%, actual holdings 8% to 9%) that is NOT present in the ground truth answer. This creates a critical verification problem: the ground truth does not mention these specific percentages, making it impossible to confirm their accuracy. The LLM correctly identifies the core strategic elements: (1) global geographic scope spanning U.S. and non-U.S., (2) investment in leveraged buyout, venture capital, growth, and special situations strategies, and (3) evolution from 2022-2024. However, the LLM answer introduces quantitative claims without grounding them in the provided ground truth. The LLM also adds contextual interpretation about 'de-risking strategy' and 'funded status improvement' that, while potentially reasonable, are not mentioned in the ground truth. The ground truth emphasizes an 'expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure' by 2023, and 'increased sophistication in investment vehicles, including derivatives' by 2024—neither of which the LLM answer addresses. The LLM answer is partially correct on the strategic focus areas but incomplete in capturing the evolution toward real assets and derivatives. The quantitative data provided by the LLM cannot be verified against the ground truth, which is a significant concern for a financial question requiring precision. The answer demonstrates reasonable multi-hop reasoning but fails to capture key strategic evolution details and introduces unverified numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 433,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen advanced Bemarituzumab from a Phase 3‑listed candidate (2022) to the initiation of an actual Phase 3 trial (2023) and kept that program enrolling through 2024.  Throughout this period the composition‑of‑matter patents covering the antibody were projected to expire in 2029 in both the United States and Europe (U.S. 2029 / Europe 2029), with no extensions or supplemental protection certificates noted in the filings.  Consequently, market exclusivity is expected to remain in place until 2029, subject only to any future term adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2029 patent expiration date for both U.S. and Europe, matching the ground truth. (2) The patent type (composition-of-matter/polypeptide-related) is accurately characterized. (3) The drug description as a monoclonal antibody targeting FGFR2b for gastric/GEJ cancer is correct. (4) The overall timeline framework (2022-2024) is appropriate.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM states Bemarituzumab progressed from 'Phase 3-listed candidate (2022) to the initiation of an actual Phase 3 trial (2023)' - this is contradictory and unclear. The ground truth states 'In 2022, Amgen initiated a phase 3 study' - meaning Phase 3 was already initiated in 2022, not 2023. The LLM's phrasing suggests Phase 3 was only initiated in 2023, which contradicts the ground truth. (2) INCOMPLETE SYNTHESIS: The LLM fails to mention that 2023 was when Amgen disclosed the patent expiration details (2029), which is a key temporal marker in the ground truth's narrative. The ground truth emphasizes this disclosure occurred in 2023 specifically. (3) MISSING CONTEXT: The ground truth emphasizes 'the importance of both patent and regulatory exclusivity in extending its market protection' - the LLM mentions only patent exclusivity and notes 'no extensions or supplemental protection certificates' but doesn't address regulatory exclusivity as a complementary protection mechanism. (4) SPECULATIVE LANGUAGE: The LLM adds 'subject only to any future term adjustments' which is not supported by the ground truth and introduces uncertainty not present in the original answer.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize clinical progression with patent positioning but makes an error in the clinical timeline that undermines the multi-hop synthesis. The connection between clinical advancement and IP protection is mentioned but not as thoroughly integrated as in the ground truth.\n\nNUMERIC VERIFICATION: The 2029 dates are correct (both U.S. and Europe). No calculations are required for this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 552,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the Fabric & Home Care segment has delivered roughly one‑third of Procter & Gamble’s earnings – 34 % of earnings in 2022, about 33‑34 % in 2023, and 34 % in 2024 – and Dawn has been listed as a core brand in each year’s “Major Brands” column for that segment.  This steady earnings share and persistent brand listing show that Dawn’s strategic positioning within the segment has remained essentially unchanged over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors regarding earnings contribution percentages. Ground truth states: 31% in 2022, increasing to 34% in 2024. LLM states: 34% in 2022, 33-34% in 2023, and 34% in 2024. This is a major discrepancy - the LLM incorrectly reports 2022 earnings contribution as 34% when it should be 31%. This is not a minor rounding difference but a 3-percentage-point error on a key metric. MISSING INFORMATION: The LLM answer completely omits the net sales contribution data (35% in 2022, 36% in 2023-2024), which is an important part of the ground truth answer showing the segment's stability across both earnings and sales metrics. This represents incomplete synthesis of the multi-hop question. CORRECT ELEMENTS: The LLM correctly identifies that Dawn was consistently listed as a core brand across all three years, and correctly characterizes the positioning as essentially unchanged. The qualitative reasoning about steady positioning is sound. REASONING QUALITY: While the LLM's logic about consistent brand listing and stable earnings share is sound, the foundation is built on incorrect numbers, undermining the conclusion. The answer does address the multi-hop nature of the question (combining segment earnings data with brand listings), but the execution is flawed due to quantitative errors. The omission of sales contribution data also weakens the completeness of the answer, as the ground truth emphasizes both earnings AND sales stability as evidence of strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 428,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab expanded the pool of client‑held securities it pledges—using them to collateralize margin loans, repurchase and resale agreements, and Federal Home Loan Bank borrowings—so that the amount of pledged client collateral grew each year. This heightened reliance on client assets means the firm’s liquidity and funding now depend heavily on the market value of those securities, exposing Schwab to margin‑call risk and potential collateral‑value declines. Consequently, a significant drop in the value of pledged client securities could force additional collateral calls or constrain the company’s ability to obtain short‑term financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer makes specific claims about pledging practices (margin loans, repurchase agreements, Federal Home Loan Bank borrowings) and states that 'the amount of pledged client collateral grew each year' with NO SUPPORTING NUMBERS, DATES, OR SPECIFIC FIGURES. The ground truth provides specific ASC 326 references, options clearing practices, and securities lending activities - none of which appear in the LLM answer. The LLM provides zero quantitative data to support its claims about year-over-year growth. (2) ENTITY/METRIC ACCURACY - The LLM introduces concepts (FHLB borrowings, repurchase agreements) not mentioned in the ground truth, and omits key details from ground truth: ASC 326 practical expedient, Options Clearing Corporation involvement, and cash collateral in securities lending. This represents either fabrication or significant deviation from the source material. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize a 3-year trend, it does so without the specific factual anchors present in the ground truth. The ground truth shows progression: 2022 (fair value disclosure), 2023 (ASC 326 application), 2024 (options clearing and securities lending). The LLM collapses this into vague claims about 'expanding pools' and 'growing each year' without substantiation. (4) RISK ANALYSIS - The LLM adds substantial commentary about margin-call risk, collateral-value declines, and liquidity constraints that, while potentially logical inferences, are NOT supported by the ground truth answer and represent analytical extrapolation beyond what was disclosed. (5) SEMANTIC EQUIVALENCE - The core narrative differs: ground truth emphasizes 'increasing sophistication' and 'growing client engagement in leveraged activities'; LLM emphasizes 'heightened reliance' and 'exposure to margin-call risk.' These convey different risk profiles. STRENGTHS: The LLM correctly identifies Charles Schwab, the 2022-2024 timeframe, and the general concept of pledging client securities. The writing is clear and coherent. CRITICAL WEAKNESS: Complete absence of specific financial data, regulatory references, or verifiable facts to support claims about year-over-year growth or specific pledging practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 606,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 ACN kept its U.S. defined‑benefit plan target at 100 % debt securities, but reshaped the non‑U.S. target mix: the 2023 allocation of 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other was revised to 28 % equity / 36 % debt / 7 % cash / 21 % insurance / 8 % other for 2025.  This shift reduces fixed‑income exposure and adds equity, cash and insurance‑linked assets, reflecting a more diversified, liability‑driven strategy that better matches the plans’ duration and risk profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and does not match the ground truth. Critical issues: (1) WRONG DATA PRESENTED: The LLM provides specific allocations (27% equity/48% debt/4% cash/11% insurance/10% other for 2023 and 28% equity/36% debt/7% cash/21% insurance/8% other for 2025) that are completely different from the ground truth data showing 55% fixed income/45% equities in 2023 and 61% fixed income/39% equities in 2025. (2) INCORRECT TREND ANALYSIS: The ground truth shows a clear, consistent de-risking trend with fixed income increasing from 55% to 58% to 61% and equities decreasing from 45% to 42% to 39%. The LLM claims the shift 'reduces fixed-income exposure and adds equity,' which is the opposite of the actual trend. (3) WRONG FOCUS: The LLM discusses U.S. vs. non-U.S. plan distinctions and mentions insurance-linked assets, which are not part of the ground truth answer about the overall weighted-average allocation strategy. (4) MISSING KEY DATA: The LLM fails to provide the correct three-year progression of allocations as of August 31, 2022, 2023, and 2024. (5) INCORRECT CONCLUSION: The LLM's characterization of the strategy shift is backwards - it claims diversification and equity addition when the actual strategy shows consistent movement toward fixed income and de-risking. The answer appears to reference different pension plan data or a different company's allocation strategy entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 395,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nCapital One’s short‑term borrowings fell from $820 million in 2022 to $538 million in 2023 (edging up to $562 million in 2024), while its long‑term debt expanded from $42.3 billion to $49.3 billion in 2023 before slipping to $45.0 billion in 2024. This pattern shows a deliberate shift toward a higher‑proportion of longer‑dated, largely fixed‑rate senior and securitized debt, reducing reliance on short‑term wholesale funding and dampening exposure to rising short‑term interest rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall trend of debt evolution (increase then slight decrease), properly breaks down short-term vs. long-term components, and provides sound qualitative reasoning about the strategic shift toward fixed-rate debt and away from variable-rate exposure. The narrative about reducing reliance on short-term wholesale funding is accurate and relevant. CRITICAL ERRORS: (1) Total debt figures are significantly off - LLM states $42.3B long-term in 2022 when ground truth shows $43.086B total (short+long combined); LLM's $49.3B for 2023 long-term debt vs. ground truth's $48.715B total; LLM's $45.0B for 2024 vs. ground truth's $45.551B. (2) The LLM provides short-term borrowing breakdowns ($820M, $538M, $562M) that appear reasonable but cannot be verified against the ground truth, which only provides combined totals. (3) MAJOR OMISSION: The LLM completely fails to address the weighted-average interest rate trend (1.51% → 3.01% → 3.48%), which is a critical component of the question about 'interest rate exposure.' (4) The LLM mentions the reduction in floating unsecured senior debt but provides no specific numbers ($1,597M to $0), missing quantitative detail. CALCULATION VERIFICATION: Ground truth total debt: 2022=$43.086B, 2023=$48.715B, 2024=$45.551B. LLM's figures ($42.3B, $49.3B, $45.0B) are close but not precise enough for financial analysis. The LLM's reasoning about debt structure strategy is sound, but the incomplete data presentation and missing interest rate analysis significantly weaken the answer's value for understanding the full picture of Capital One's debt evolution and interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 455,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\nFleet‑support expenses have stayed essentially flat, hovering around 1 % of total consolidated costs in 2022, 2023 and 2024 (the 10‑K repeatedly notes that “fleet‑support costs … have historically been approximately 1 % of total consolidated costs of products and services”).  At the same time, the company has recorded large abnormal production costs on the 787 program (≈ $2.7 bn of cumulative abnormal costs through 2023) and reach‑forward losses on the 777X program ($2.6 bn in 2024 and $0.8 bn in 2023), which have swollen overall cost bases.  Consequently, the steady ~1 % share of fleet‑support spending represents a shrinking proportion of an increasingly cost‑burdened portfolio, underscoring that the recent cost pressure is driven by program‑specific abnormal expenses rather than the fleet‑support function.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core finding that fleet support services costs remained at approximately 1% of total consolidated costs across 2022-2024, showing no significant change. The answer accurately cites the 787 program's ~$2.7 billion in cumulative abnormal production costs through 2023. The reasoning is sound in explaining that the stable 1% ratio contrasts with escalating program-specific losses, and the multi-hop synthesis across fleet support metrics and program-specific costs is well-executed. The semantic interpretation that fleet support represents a 'shrinking proportion of an increasingly cost-burdened portfolio' correctly captures the relationship between stable costs and growing overall financial strain.\n\nWEAKNESSES: There is a significant quantitative error regarding the 777X program reach-forward losses. The LLM states '$2.6 bn in 2024 and $0.8 bn in 2023,' but the ground truth indicates the $2,608 million ($2.6 bn) loss occurred in Q3 2024 with an additional $891 million in Q4 2024 (totaling ~$3.5 bn in 2024), not split between 2023 and 2024. The ground truth does not mention a $0.8 bn loss in 2023 for the 777X program. This represents a material misstatement of the temporal distribution of losses. The LLM also omits specific context about the drivers of the 777X losses (certification delays, labor instability, supplier cost increases) that were present in the ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three dimensions: (1) fleet support cost trends, (2) 787 program abnormal costs, and (3) 777X program reach-forward losses. The logical connection between stable fleet support costs and growing program-specific losses is clearly articulated.\n\nNUMERIC VERIFICATION: Fleet support at ~1% across all three years: CORRECT. 787 cumulative abnormal costs ~$2.7 bn through 2023: CORRECT. 777X losses: PARTIALLY INCORRECT - the temporal attribution is wrong, conflating Q3/Q4 2024 losses with a non-existent 2023 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 547,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash‑equivalent holdings declined sharply from $21 million at the end of 2022 to $10 million at the end of 2023 and stayed at roughly $10 million through 2024 (as shown in the “Money market funds and time deposits” line of the fair‑value hierarchy tables for 2022, 2023 and 2024).  This reduction indicates that the company has been deliberately scaling back its low‑yield cash buffer and is relying more on operating cash flow, credit facilities and other short‑term investments to meet its liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-over-year progression. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. The LLM states: 2022=$21M, 2023=$10M, 2024=$10M. This is a complete reversal of the 2022-2023 values. The LLM incorrectly claims a 'sharp decline from $21 million at the end of 2022 to $10 million at the end of 2023' when the actual data shows an INCREASE from $12M to $21M in that period, followed by a decrease to $10M in 2024. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 3-year trend. The ground truth interpretation correctly identifies: (1) 2022 baseline of $12M, (2) 2023 increase to $21M (conservative approach), (3) 2024 decrease to $10M (reallocation). The LLM's interpretation is based on incorrect numbers and therefore reaches wrong conclusions about the company's strategy. ENTITY ACCURACY: Company (AbbVie) and metric (money market funds and time deposits) are correctly identified, but the temporal sequence is fundamentally wrong. SEMANTIC ISSUES: While the LLM's general reasoning about liquidity strategy (scaling back low-yield buffers, relying on operating cash flow) is plausible, it is built on incorrect data points and therefore the entire analysis is invalidated. The answer demonstrates a critical failure to accurately extract and synthesize financial data across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 393,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase authority grew — it started FY 2022 with $3.1 bn of remaining authorization, added $3 bn in September 2022 (raising total authority to $6.13 bn) and later added a further $4 bn in September 2024 (taking total authority to $6.69 bn).  During that span the company repurchased roughly $4.1 bn of stock in FY 2022 and about $4.5 bn in FY 2024, which reduced the unused portion of the program to $2.69 bn by the end of FY 2024.  The pattern of steadily expanding the repurchase mandate while aggressively deploying cash to buy back shares demonstrates a disciplined, expanding capital‑return strategy focused on returning excess cash to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of Accenture's capital return strategy and correctly identifies the general trend of expanding repurchase authority. However, there are significant quantitative discrepancies that reduce accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies FY 2022 starting authorization of ~$3.1 billion\n- Correctly notes the $4 billion authorization added in September 2024\n- Correctly identifies the final remaining authorization of $2.69 billion as of end of FY 2024\n- Appropriately characterizes the strategy as disciplined and expanding\n- Correctly synthesizes multi-hop information across three fiscal years\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR ERROR: States \"added $3 bn in September 2022 (raising total authority to $6.13 bn)\" - The ground truth shows total cumulative authorization was $50.1 billion by FY 2023, not $6.13 billion. The LLM appears to be confusing remaining authorization with total cumulative authorization.\n2. CALCULATION ERROR: Claims remaining authorization was reduced to $2.69 billion \"by the end of FY 2024\" but the ground truth states $2.694 million remaining as of August 31, 2023 (FY 2023), and $6.694 million total as of September 25, 2024 (FY 2024). The LLM's $2.69 billion figure appears to conflate different metrics.\n3. MISSING CONTEXT: Does not distinguish between cumulative total authorization ($50.1 billion since 2001) versus remaining available authorization, which is a critical distinction in understanding the full capital return picture.\n4. REPURCHASE AMOUNTS: States \"roughly $4.1 bn of stock in FY 2022 and about $4.5 bn in FY 2024\" - these figures are not verified against ground truth and appear to be estimates rather than precise figures.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the relationship between authorization increases and actual repurchases. However, the confusion between different authorization metrics undermines the quality of this synthesis.\n\nThe answer captures the strategic intent correctly but contains material quantitative errors that would mislead readers about the actual magnitude of remaining authorization and cumulative program size.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 600,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AbbVie’s charter language requiring that directors “may be removed only for cause” remained unchanged, and it was paired with the same anti‑takeover provisions – a three‑class, staggered board, an 80 % super‑majority vote to amend those provisions, and Delaware Section 203’s 15 %‑shareholder‑triggered combination ban.  By repeatedly emphasizing these entrenchment measures, AbbVie signals a long‑term takeover‑defense strategy that deliberately keeps board control in the hands of incumbent directors and forces any potential acquirer to negotiate with the board rather than pursue a hostile transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across the three-year period (2022, 2023, 2024). Key strengths: (1) Correctly identifies the core governance provision ('may be removed only for cause') as consistent across all three years; (2) Accurately specifies the anti-takeover defenses: three-class staggered board, 80% supermajority requirement for bylaw amendments, and Delaware Section 203's 15%-shareholder-triggered combination ban; (3) Properly synthesizes the multi-hop reasoning connecting the stable governance language to AbbVie's deliberate long-term takeover defense strategy; (4) Correctly interprets the strategic implication that these provisions force acquirers to negotiate with the board rather than pursue hostile transactions. Quantitative elements (80% supermajority, 15% shareholder threshold, three-class board) are all accurate. The answer goes slightly beyond the ground truth by explicitly naming Delaware Section 203, which adds specificity and demonstrates deeper knowledge without introducing inaccuracy. The reasoning about board entrenchment and takeover defense strategy is sound and well-articulated. Minor consideration: The LLM answer is more concise and direct than the ground truth while maintaining all essential information, which is appropriate for clarity. No calculation errors, no entity misidentifications, and the semantic meaning aligns perfectly with the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 410,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings PepsiCo continues to list the 4.000% Senior Note due 2047 in exactly the same way—identifying it as Exhibit 4.16 and incorporating it by reference to the May 2 2017 8‑K filing—without any change in wording or additional detail. This steady, unchanged disclosure shows that the note is a permanent, cornerstone component of PepsiCo’s long‑term capital structure, serving as a stable, low‑cost source of financing that underpins its strategic investments and growth initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states the note is identified as 'Exhibit 4.16' across all three years, but the ground truth clearly specifies it is 'Exhibit 4.5' from the May 2, 2017 8-K filing. This is not a minor wording difference—it is a specific, verifiable factual claim about exhibit numbering that is demonstrably incorrect. The LLM correctly identifies: (1) the note as 4.000% Senior Note due 2047, (2) the consistent disclosure pattern across 2022, 2023, and 2024, (3) the May 2, 2017 8-K reference, and (4) the interpretation that this represents a stable long-term capital structure component. However, the incorrect exhibit number (4.16 vs. 4.5) is a material factual error in a question specifically asking about how references 'evolved' and what disclosure patterns reveal. The LLM also adds interpretive language about 'low-cost source of financing' and 'strategic investments and growth initiatives' that goes beyond what the ground truth supports—the ground truth focuses on the consistency of disclosure and lack of modifications, not on characterizing the note's strategic role in those specific terms. The multi-hop reasoning about consistency across years is sound, but it is undermined by the exhibit number error. For a question centered on precise filing references and disclosure patterns, accuracy in exhibit numbers is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 400,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings (pages 111‑115 of the 2022 filing and pages 108‑112 of the 2023 and 2024 filings), Oracle continues to list the 4.30 % senior unsecured note maturing in 2034 as an outstanding obligation, reaffirming its principal amount and maturity without any new issuance. The repeated disclosure—originally filed in the 2014 exhibit and then re‑appearing in each subsequent 10‑K—shows that Oracle’s long‑term debt strategy is built around a laddered portfolio of fixed‑rate notes, using the 2034 tranche as a stable, low‑cost funding pillar that provides predictable cash‑flow and interest‑rate hedging over the medium‑to‑long term.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 4.30% Note due 2034 and its consistent disclosure across 2022-2024. The core claim that Oracle maintained this debt instrument without new issuance is accurate and well-supported. The page number references (111-115 for 2022; 108-112 for 2023-2024) appear reasonable for 10-K debt disclosures, though cannot be independently verified from the ground truth. The characterization of Oracle's strategy as 'laddered portfolio of fixed-rate notes' and 'stable, low-cost funding pillar' aligns with the ground truth's emphasis on 'diversified maturity profiles' and 'stable long-term debt strategy.' The LLM correctly synthesizes the multi-year pattern showing consistent disclosure without new issuance. However, there are minor differences: (1) The LLM provides more specific implementation details (laddered portfolio, cash-flow predictability, interest-rate hedging) that go slightly beyond the ground truth's more general characterization of 'sustained capital market engagement.' (2) The LLM mentions the 2014 exhibit origin, which adds historical context not explicitly in the ground truth but is plausible. (3) The ground truth emphasizes 'reaffirmed its inclusion in 2023 alongside similar structured notes,' while the LLM focuses more on the absence of new issuance. Both interpretations are consistent with the data. The quantitative accuracy is high (correct percentage, year, and multi-year pattern). The qualitative reasoning about debt strategy is sound and well-articulated. The answer fully addresses the multi-hop question about evolution across three years and strategic implications. Minor deduction for slightly different emphasis compared to ground truth, but overall the answer is factually correct and appropriately detailed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 496,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP authorized 127 million Class A shares in fiscal 2022, kept that ceiling through fiscal 2023, and increased it to 141 million for fiscal 2024. This step‑up reflects Accenture’s strategy of expanding its equity‑based incentive pool to support ongoing talent recruitment and retention, underscoring a long‑term commitment to share‑based compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN NUMERIC SEQUENCE: The LLM answer contains a fundamental factual error in the progression of authorized shares. According to the ground truth: FY2022 = 127M, FY2023 = 141M, FY2024 = 141M (unchanged). However, the LLM states: FY2022 = 127M, FY2023 = 127M (kept that ceiling), FY2024 = 141M (increased). This is the OPPOSITE of what actually occurred. The LLM incorrectly claims the shares remained flat from 2022-2023 and then increased in 2024, when in reality they increased from 2022-2023 and remained flat through 2024. This is a major quantitative accuracy failure that undermines the entire answer. The LLM correctly identifies the company (Accenture plc), the instrument (Amended 2010 SIP), and the share class (Class A ordinary shares), and the numeric values themselves (127M and 141M) are correct. However, the temporal sequencing is completely wrong, which is critical for answering a question specifically about how the numbers 'evolved' across years. The qualitative interpretation about talent retention and share-based compensation strategy is reasonable and aligns with the ground truth's reasoning, but this cannot compensate for the fundamental factual error in the progression. The answer fails to accurately convey the multi-hop synthesis required to trace the evolution across three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 372,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the 2.750 % Senior Note due 2051 is repeatedly listed in the “Exhibits” section of each annual 10‑K (2022 pp. 124‑128, 2023 pp. 126‑130, 2024 pp. 127‑131), each time cited by a newer Form 8‑K filing—first the Oct 21 2021 filing, then the July 18 2022 filing, followed by the Feb 15 2023 and Nov 13 2023 filings, and finally the July 17 2024 filing.  The note’s terms (fixed 2.750 % coupon, 2051 maturity) remained unchanged, but the documentation was refreshed in each filing to incorporate the latest authorizing board resolutions and to re‑register the security under updated registration statements.  \n\nThis multi‑year filing pattern reflects PepsiCo’s long‑term debt strategy of laddering low‑coupon, long‑dated senior notes and periodically updating the prospectus language to maintain a flexible, staggered maturity profile and to respond to evolving market conditions while preserving a consistent, low‑cost financing structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally diverge from the ground truth. Key issues: (1) EXHIBIT NUMBER ERRORS: The LLM claims the note was referenced with 'newer Form 8-K filings' and lists specific dates (Oct 21 2021, July 18 2022, Feb 15 2023, Nov 13 2023, July 17 2024), but the ground truth explicitly states the documentation evolved through different exhibit numbers: Exhibit 4.60 (2022), Exhibit 4.51 (2023), and Exhibit 4.48 (2024). The LLM provides no exhibit numbers and instead invents Form 8-K filing dates that are not mentioned in the ground truth. (2) DOCUMENTATION PROGRESSION MISCHARACTERIZED: The ground truth describes a clear three-stage progression from authorization (2022) → formalization with dedicated Form (2023) → maintenance of structure (2024). The LLM incorrectly characterizes this as periodic prospectus updates and re-registration under updated registration statements, which is not supported by the ground truth. (3) STRATEGIC INTERPRETATION DIVERGENCE: The ground truth emphasizes a 'deliberate, phased approach' with specific stages of development. The LLM's interpretation about 'laddering low-coupon notes' and 'staggered maturity profile' introduces concepts not present in the ground truth and appears to be speculative extrapolation. (4) PAGE REFERENCES: The LLM provides specific page numbers (2022 pp. 124-128, etc.) that cannot be verified against the ground truth and may be fabricated. (5) MISSING CORE FACTS: The LLM fails to mention the actual exhibit progression (4.60 → 4.51 → 4.48) which is central to understanding the documentation evolution. The answer demonstrates poor multi-hop synthesis and introduces unverified details while omitting the specific factual progression that forms the basis of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 495,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nAmerican Express has retained its position as the world’s fourth‑largest general‑purpose card network, but the competitive dynamics have shifted markedly between 2022 and 2024.  In the 2022 filing the company highlighted intense competition from other networks, issuers and emerging payment platforms, and by 2023 it was already noting the rapid growth of alternative mechanisms such as digital wallets, BNPL and real‑time settlement.  The 2024 filing adds that, after being classified as a **Category III** bank holding company, Amex now faces heightened regulatory expectations—particularly around interchange‑fee caps, AML/CFT compliance and overall supervision—that constrain pricing and product design, while the proliferation of alternative payment systems forces the firm to accelerate innovation and partnership efforts to preserve its premium, integrated value proposition.  Consequently, Amex’s competitive positioning is increasingly defined by its ability to leverage its brand and data advantages amid tighter regulation and a broader ecosystem of non‑traditional payment options.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's competitive positioning evolution from 2022-2024 and correctly identifies key themes from the ground truth. STRENGTHS: (1) Correctly identifies Amex as fourth-largest general-purpose card network globally; (2) Accurately captures the shift from market-driven to regulation-constrained competition; (3) Properly identifies alternative payment mechanisms (digital wallets, BNPL) as competitive pressures; (4) Correctly notes regulatory intensification around interchange fees and compliance; (5) Appropriately synthesizes multi-hop information across 2022-2024 filings; (6) Correctly references Category III bank holding company classification and its regulatory implications. WEAKNESSES: (1) The ground truth explicitly names specific competitors (China UnionPay, Visa, Mastercard, Alipay, PayPal) while the LLM uses more generic references to 'other networks' and 'alternative platforms'—this is a minor omission but reduces specificity; (2) The ground truth mentions 'cobrand relationships' and 'closed-loop loyalty systems' as specific differentiation strategies, which the LLM generalizes to 'brand and data advantages' and 'premium, integrated value proposition'—semantically similar but less precise; (3) The ground truth specifically mentions 'exits from certain markets' in EU context, which the LLM does not explicitly address; (4) The LLM introduces 'AML/CFT compliance' which, while plausible regulatory concern, is not explicitly mentioned in the ground truth and may represent inference beyond the source material. QUANTITATIVE ACCURACY: No specific numbers or percentages are provided in either answer, so this dimension is less applicable. The temporal references (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the causal relationship between regulatory changes and strategic shifts. The logic connecting regulatory classification to competitive constraints is sound. SEMANTIC EQUIVALENCE: The core message—that Amex faces tighter regulation while competing with alternative payment systems—is conveyed accurately in both answers, though with different emphasis and specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 607,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nFrom 2022 to 2024 Boeing’s language moved from merely mentioning upgrades and conversions as a component of its Global Services segment to explicitly framing them as a core growth driver. The 2023 and 2024 filings highlight upgrades and conversions—especially on commercial and defense aircraft—as central to expanding aftermarket revenue, deepening customer relationships, and delivering higher‑margin, recurring income. This shift indicates that Boeing is pivoting its strategy toward a services‑focused business model, using upgrades and conversions to generate sustained, high‑value cash flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic shift from 2022-2024 toward services-focused business model and upgrades/conversions as growth drivers. The framing of higher-margin, recurring income and customer relationship deepening aligns with the ground truth's emphasis on high-value services. No quantitative errors detected (no specific numbers were claimed). The answer appropriately addresses the multi-part question about how emphasis changed and what it suggests about services strategy.\n\nWEAKNESSES: (1) The LLM answer lacks the specific structural/organizational details present in ground truth - it doesn't mention the Global Services segment explicitly or the progression from 'upgrades and conversions' to 'modifications' to 'data analytics and digital services.' (2) The ground truth emphasizes a three-year progression with distinct phases (2022: grouped with logistics/engineering/training; 2023: modifications emphasized; 2024: data analytics integration), but the LLM answer presents a more general narrative without these specific temporal distinctions. (3) The LLM answer doesn't capture the 'technology-enabled service differentiation' angle that the ground truth highlights as emerging in 2024. (4) Missing the nuance about 'lifecycle support offerings' and how modifications represent deeper integration.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the strategic shift across years and connects it to business model implications. However, it misses the specific evolution of how Boeing categorized and emphasized these services differently each year, which is a key part of the ground truth's multi-hop analysis.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general direction (toward services, high-value, recurring revenue), it doesn't fully capture the specific progression and the technology/digital services component that emerged as a distinguishing factor in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 523,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo’s 2022, 2023 and 2024 Form 10‑Ks each list the 5.50 % Senior Note due 2035 in the Exhibits section, citing the original 2018 Form 8‑K and subsequently filed supplemental indentures (2022 and July 2024). The repeated, updated references show that the company treats this note as a stable, long‑dated pillar of its capital structure and regularly revises its documentation—to amend covenants or issue new series—thereby maintaining a transparent, disciplined long‑term debt‑management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer introduces unsupported claims about 'supplemental indentures (2022 and July 2024)' that are NOT mentioned in the ground truth. The ground truth explicitly states the note was referenced with 'the same filing history' across all three years, tied to the original November 8, 2018 8-K filing. The LLM fabricates specific dates and documents (supplemental indentures in 2022 and July 2024) that cannot be verified from the provided ground truth. (2) EXHIBIT NUMBER DISCREPANCIES - Ground truth specifies Exhibit 4.31 (2022), Exhibit 4.25 (2023), and Exhibit 4.23 (2024). The LLM answer does not cite these specific exhibit numbers, which is a factual omission. (3) CORE FACTUAL ERROR - The ground truth emphasizes that the note was referenced 'with the same filing history' across all years, indicating NO modifications or amendments. The LLM's claim about 'regularly revises its documentation—to amend covenants or issue new series' directly contradicts the ground truth's finding of consistency and stability without modification. (4) MULTI-HOP REASONING - While the LLM correctly identifies the 5.50% Senior Note due 2035 and the 2018 origin, it fails to accurately synthesize the multi-year pattern. The ground truth's key insight is STABILITY and CONSISTENCY (no changes), while the LLM mischaracterizes this as ACTIVE REVISION and AMENDMENT. (5) SEMANTIC EQUIVALENCE - The LLM's interpretation of 'long-term debt management strategy' differs fundamentally: ground truth = passive maintenance of stable structure; LLM = active, disciplined revision and amendment. These are contradictory interpretations. The answer demonstrates partial understanding of the question structure but introduces fabricated details and misinterprets the core finding about the note's unchanged status across three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 507,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly stress that BNY Mellon’s capital‑planning and shareholder‑return decisions are “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The language is broad in the 2022 filing, becomes more explicit about the need to satisfy “well‑capitalized” and “well‑managed” regulatory standards in the 2023 filing, and in the 2024 filing underscores that any material capital return is constrained by ongoing regulatory oversight of capital adequacy and the parent‑level liquidity that must be available from its banking subsidiaries. Together, this multi‑year progression reveals that BNY Mellon’s ability to distribute dividends or repurchase shares is increasingly tied to compliance with U.S. banking capital rules and supervisory expectations, making such returns contingent on maintaining regulatory‑approved capital buffers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the multi-year progression (2022-2024) and accurate characterization of BNY Mellon's regulatory constraints. STRENGTHS: (1) Correctly identifies the three-year period and company name; (2) Accurately captures the evolution of regulatory language from general oversight in 2022 to more explicit standards ('well-capitalized' and 'well-managed') in 2023; (3) Properly synthesizes the multi-hop information showing how constraints became more specific over time; (4) Correctly identifies key regulatory constraints: U.S. banking laws, Delaware law, preferred stock dividend obligations, and capital adequacy requirements; (5) No quantitative errors or incorrect dates; (6) Appropriately emphasizes the progression from broad language to more explicit regulatory standards. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer adds slightly more detail about 'parent-level liquidity' and 'banking subsidiaries' which, while not contradicted by the ground truth, represents a modest elaboration beyond what the original answer explicitly states; (2) The LLM characterizes the evolution as 'increasingly tied' to compliance, which is a reasonable inference but slightly stronger language than the ground truth's 'consistent yet evolving emphasis'; (3) The LLM provides more specific regulatory terminology ('well-managed' standards) which aligns with 2023 language but goes slightly beyond the ground truth's summary. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings, properly identifying the temporal progression and regulatory evolution. The logic connecting regulatory constraints to capital return limitations is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that BNY Mellon faces consistent and evolving regulatory constraints on capital returns—though with slightly more operational detail. The answer appropriately addresses both the 'how has it evolved' and 'what does this reveal' components of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 562,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle did not issue additional 2.300 % Notes due 2028, but it responded to the steep rise in market rates by launching newer senior unsecured series with markedly higher coupons—most notably the 4.500 % Notes due 2028 that were priced in February 2023 (Exhibit 4.16 of the 2023 10‑K) and earlier 2022 5.8 % notes (Exhibit 4.15).  This shift shows that Oracle progressively moved from the low‑coupon, long‑dated fixed‑rate debt it accessed in 2021 to higher‑coupon, more flexible issuances as interest‑rate environments changed, using staggered maturities and higher rates to lock in financing costs while preserving a manageable debt‑service profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM claims Oracle issued \"5.8% notes\" in 2022 (Exhibit 4.15), but the ground truth makes no mention of any 5.8% notes. This appears to be a fabricated number.\n   - The LLM correctly identifies the 4.500% Notes due 2028 as being priced in February 2023 and references Exhibit 4.16 of the 2023 10-K, which aligns with the ground truth's mention of this instrument.\n   - The core rate of 2.300% for the 2028 notes is correctly stated.\n\n2. COMPLETENESS AND ENTITY ACCURACY:\n   - The LLM fails to mention the Officers' Certificate dated March 24, 2021 (Exhibit 4.14 in the 2022 10-K) that is central to understanding the instrument's origins.\n   - The LLM omits reference to other fixed-rate tranches mentioned in the ground truth (2.875% Notes due 2031 and 3.950% Notes due 2051), which provide important context for Oracle's multi-tiered bond strategy.\n   - The LLM does not address the 2024 period adequately, merely stating Oracle \"made no visible changes\" without the ground truth's fuller context about maintaining existing obligations.\n\n3. MULTI-HOP REASONING:\n   - The LLM's reasoning about Oracle's strategy is partially sound but incomplete. It correctly identifies the shift toward higher-coupon instruments in response to rising rates, but it misses the nuance that Oracle was locking in favorable rates during 2021-2022 and then avoiding redundant issuance.\n   - The characterization of the strategy as \"more flexible issuances\" is vague and not well-supported by the evidence presented.\n   - The LLM does not adequately explain why Oracle stopped issuing the 2.300% Notes and what this reveals about their financing approach.\n\n4. SEMANTIC EQUIVALENCE:\n   - The LLM's interpretation of Oracle's strategy as \"progressively moved from low-coupon, long-dated fixed-rate debt...to higher-coupon, more flexible issuances\" is partially correct but oversimplifies the ground truth's more nuanced explanation about locking in favorable rates and avoiding redundant issuance.\n   - The phrase \"preserving a manageable debt-service profile\" is not explicitly supported by the ground truth.\n\n5. CRITICAL ERRORS:\n   - The fabrication of the \"5.8% notes\" is a major factual error that significantly undermines the answer's credibility.\n   - The missing context about the Officers' Certificate and the multi-tiered offering structure weakens the answer's ability to fully address the question about how issuance terms \"evolved.\"\n\nThe answer demonstrates partial understanding of Oracle's debt strategy but contains a significant fabricated number and omits key contextual details that are essential to a complete answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 735,
        "total_tokens": 2183
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the 2022‑2024 filings IBM repeatedly cites “client relationships and trust” as a core pillar of its competitive advantage—first as one of several differentiators in the 2022 discussion of competition, then as an explicit element of its hybrid‑cloud and AI growth narrative in the 2023 report, and finally as the foundational reason clients turn to IBM for large‑scale, mission‑critical transformations in the 2024 filing.  This progression shows that IBM is deliberately leveraging long‑standing trust with its enterprise base to differentiate its integrated hybrid‑cloud + AI platform and to position itself as the trusted partner for the next wave of AI‑driven business outcomes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 progression. STRENGTHS: (1) Correctly identifies the three-year timeline and evolution of IBM's messaging around client relationships and trust; (2) Accurately captures the progression from 2022 (trust as one of several differentiators) through 2023 (explicit hybrid-cloud and AI narrative) to 2024 (foundational positioning for mission-critical transformations); (3) No quantitative errors or incorrect dates; (4) Properly synthesizes multi-hop information across three fiscal years; (5) Correctly identifies the strategic context of hybrid cloud and AI markets; (6) Appropriately references strategic partnerships as part of the evolution. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 emphasis on 'deep incumbency with enterprises' and 'innovation as key differentiators' that the ground truth highlights—these are important nuances of the 2023 positioning; (2) Does not specifically reference the Palo Alto Networks partnership mentioned in the ground truth as an example of expanded strategic partnerships in 2024; (3) The phrase 'increasingly nuanced strategic emphasis' from the ground truth suggests a more sophisticated evolution than the LLM's framing, though the LLM does capture the core idea of deliberate leverage of trust. SEMANTIC EQUIVALENCE: The LLM's characterization of trust as 'foundational' and 'deliberately leveraged' aligns well with the ground truth's description of trust as 'central' and 'foundational.' The reasoning about positioning for 'next wave of AI-driven business outcomes' is semantically consistent with the ground truth's framing. Overall, the answer is factually sound and captures the essential strategic progression, with only minor contextual details omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 492,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nFrom 2022 through 2024 the weighted‑average yield on American Express’s foreign‑government‑bond portfolio rose from roughly 2 % (2022) to about 2.5 % in 2023 and 3.2 % in 2024, tracking the broader increase in market interest rates.  This upward shift reflects a strategic extension of the sovereign‑bond book toward longer‑dated, higher‑yielding issues, which raises the company’s sensitivity to interest‑rate movements but is tempered by a laddered maturity profile and active derivative hedging.  Consequently, the three‑year progression signals that the firm is deliberately taking on more interest‑rate risk to capture higher yields while managing that risk through diversification and hedging.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical quantitative metrics. Ground truth shows: 2022 holdings of $630M in foreign government bonds; 2023 weighted average yield of 6.45%; 2024 yield of 5.85%. The LLM claims yields of approximately 2% (2022), 2.5% (2023), and 3.2% (2024)—all dramatically wrong. The actual yields are 3x higher than claimed. The LLM also inverts the yield trend: ground truth shows a DECREASE from 6.45% to 5.85%, while LLM claims an INCREASE from 2% to 3.2%. The LLM's narrative about 'strategic extension toward longer-dated, higher-yielding issues' contradicts the ground truth, which shows a shift FROM ultra-short-duration (2023) TO more diversified maturity (2024). The LLM mentions 'derivative hedging' and 'laddered maturity profile' without evidence from the filings. The core multi-hop synthesis is broken: the LLM failed to correctly extract and compare the weighted average yields across the three years, which is the central metric of the question. The only partially correct element is identifying American Express and the 2022-2024 timeframe, but the numerical foundation of the answer is entirely fabricated or severely misread from source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 339,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Danaher steadily increased the capital devoted to expanding its diagnostics‑testing production capacity—capital spending rose from roughly $1.5 billion in 2022 to about $1.5 billion in 2023 and was projected near $1.5‑$2 billion for 2024—while the government‑grant offsets grew from $87 million in 2022 to $136 million in 2023 and $198 million in 2024, offsetting a larger share of those expenditures.  This expanding reliance on public‑sector funding underscores that diagnostics testing has become a core strategic pillar of Danaher’s broader health‑care portfolio, prompting the company to prioritize capacity expansion and integration of testing technologies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three government grant funding amounts ($87M in 2022, $136M in 2023, $198M in 2024) and accurately captured the upward trend. The qualitative analysis about strategic importance and government support enabling capacity expansion is sound and well-reasoned. The answer appropriately addresses the multi-hop nature of the question by synthesizing investment trends with strategic implications.\n\nWEAKNESSES: The LLM introduced unsupported quantitative claims about total capital expenditures ($1.5B in 2022, $1.5B in 2023, $1.5-$2B in 2024) that do not appear in the ground truth answer. While these numbers may be factually accurate from the filings, they were not part of the original answer and represent information beyond what was verified in the knowledge graph. The ground truth focuses specifically on government grant funding offsets, not total capex figures. The LLM's addition of capex data, while potentially relevant context, introduces unverified quantitative claims that could be incorrect.\n\nMULTI-HOP REASONING: The synthesis is logically sound - the model correctly connected government grant funding trends to strategic importance. However, the introduction of capex figures that weren't in the ground truth suggests the model may have hallucinated or drawn from unreliable sources.\n\nNUMBER VERIFICATION: The three grant funding figures are correct (87→136→198 million). However, the capex figures cannot be verified against the ground truth and represent a significant addition of unverified quantitative data.\n\nCONCLUSION: The core answer about government grant funding is accurate, but the addition of unverified capex numbers reduces confidence in the response's overall reliability. The answer would score higher if it stuck to the verified grant funding data or clearly distinguished between verified and inferred information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 513,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nAcross the three fiscal years BK’s proxy‑statement ratification of KPMG LLP as independent auditor was first presented in FY 2022 only as a generic “Item 3 – Ratification of KPMG LLP” without mentioning the firm’s PCAOB identifier. Beginning with FY 2023 (and repeated in FY 2024) the filing explicitly adds that KPMG LLP’s PCAOB firm identification number is **185**, embedding that regulatory number in the Proxy disclosure while keeping the same “Item 3 – Ratification of KPMG LLP” wording. Thus, the evolution is the addition of the PCAOB firm ID 185 to the ratification language, moving from an implicit reference to an explicit one.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the PCAOB firm identification number 185 was disclosed consistently across all three fiscal years (2022, 2023, and 2024) with no changes in the identification number or format. However, the LLM answer claims that FY 2022 did NOT include the PCAOB identifier, and that it was only 'beginning with FY 2023' that the number 185 was explicitly added. This is a critical factual inaccuracy. The LLM incorrectly characterizes the evolution as 'the addition of the PCAOB firm ID 185 to the ratification language, moving from an implicit reference to an explicit one,' when the ground truth indicates there was no such evolution—the disclosure remained stable with the number 185 explicitly stated in all three years. The LLM correctly identifies the company (BK), the auditor (KPMG LLP), the PCAOB number (185), and the item structure, but fundamentally misrepresents the temporal pattern of disclosure across the three-year period. This is a multi-hop reasoning error where the model failed to correctly synthesize the disclosure pattern across the three fiscal years. The answer is contextually relevant to the question asked but provides incorrect information about how the disclosure evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 370,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party merchant acquirers by expanding and extending contractual relationships—particularly through the OptBlue program and other acquisition partners—often securing multi‑year agreements with auto‑renewal clauses that broaden merchant coverage and support commercial‑payment initiatives.  The company continues to record the network‑rate fees it receives from these acquirers as discount revenue at the time of each Card‑Member transaction (and related fees as processed revenue), a structure that underpins its growth strategy of increasing transaction volume and diversifying revenue beyond traditional card‑member fees.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies OptBlue and third-party acquirer programs as central to AmEx's strategy. (2) Accurately notes that network-rate fees are recorded as discount revenue at transaction time. (3) Correctly mentions multi-year agreements with auto-renewal clauses. (4) Properly identifies the shift toward expanding merchant coverage and transaction volume. (5) No quantitative errors in numbers or dates. WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM fails to capture the critical evolution from 2022→2023→2024 that the ground truth emphasizes. The ground truth shows a clear progression: transactional model (2022) → formalized 'Processed Revenue' model (2023) → strategic global expansion emphasis (2024). The LLM presents these as simultaneous ongoing practices rather than an evolution. (2) MISSING KEY FRAMEWORK - The ground truth explicitly mentions the shift to a 'Processed Revenue' model in 2023 that integrated royalties, fees, and network partnership agreements into a more structured revenue-sharing framework. The LLM mentions 'processed revenue' but doesn't explain this as a 2023 formalization or structural change. (3) INCOMPLETE STRATEGIC CONTEXT - The ground truth emphasizes 2024's focus on 'low- and new-to-plastic industries and international markets' as part of global merchant expansion strategy. The LLM mentions 'international markets' vaguely but misses the specific strategic focus on underserved merchant segments. (4) WEAK MULTI-HOP REASONING - While the LLM connects OptBlue to discount revenue correctly, it doesn't synthesize the temporal evolution across the three-year period as effectively as the ground truth does. The answer reads more as a static description of current practices rather than an evolution. (5) MISSING PARTNERSHIP MODEL SHIFT - The ground truth's key insight about moving from 'transactional dependency to strategic partnership model' is only partially captured. The LLM mentions partnerships but doesn't emphasize this fundamental shift in relationship structure. CALCULATION/FACT CHECK: No numerical errors detected. All dates (2022-2024) are correct. Program names (OptBlue, GNS) are accurate where mentioned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 586,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 Qualcomm has kept the same bonus‑linkage mechanism—a non‑financial performance modifier that can adjust executive payouts by 0.9 to 1.1 × based on human‑capital progress—but the diversity targets themselves have become more concrete and ambitious over time.  In 2022 the company began tying FY 2022 bonuses to progress on 2025‑era goals (e.g., +15 % women and under‑represented minorities in leadership, +20 % overall URM representation), and it retained and refined those same metrics for FY 2023 and FY 2024, continuing to apply the 0.9‑1.1 modifier to reflect achievement of those diversity objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative metrics: the 0.9-1.1 modifier range, the 15% women/URM leadership target, and the 20% overall URM representation target. The fiscal year progression (2022-2024) is accurately presented, and the core mechanism of tying bonuses to diversity goals is correctly described. The multi-hop synthesis across three fiscal years is sound. WEAKNESSES: The LLM answer omits several important contextual details present in the ground truth: (1) No mention of Qualcomm's recognition in multiple regions for diversity efforts, (2) No reference to specific initiatives like the Reboot Representation Tech Coalition, (3) No discussion of the expansion of wellness and development programs by FY2024, (4) The phrase 'refined those same metrics' is somewhat misleading—the ground truth indicates the metrics remained the same, not that they were refined. The LLM answer characterizes the targets as 'becoming more concrete and ambitious over time,' which is not explicitly supported by the ground truth and may overstate the evolution. CALCULATION/NUMBER VERIFICATION: All numeric values are correct (0.9-1.1 range, 15%, 20%, fiscal years 2022-2024). MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the consistent compensation linkage mechanism. However, it misses the broader strategic evolution regarding human capital programs beyond just compensation mechanics. SEMANTIC ISSUES: The phrase 'refined those same metrics' creates slight ambiguity about whether metrics changed (they didn't). The answer focuses narrowly on compensation mechanics while the ground truth emphasizes a 'deepening integration of human capital metrics into corporate strategy' with expanded programs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 485,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 the EMD‑branded dealer network shrank modestly: the company reported 44 U.S. dealers and 116 dealers abroad serving 193 countries in 2022, 43 U.S. and 113 non‑U.S. dealers serving 191 countries in 2023, and 41 U.S. and 111 non‑U.S. dealers serving 187 countries in 2024.  This contraction signals that Caterpillar is deliberately tightening its global footprint—consolidating dealers and exiting lower‑volume markets—to focus resources on core, higher‑margin regions and improve the efficiency of its EMD distribution strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides enhanced detail beyond the ground truth. All numeric values are correct: 193 countries (2022), 191 countries (2023), and 187 countries (2024). The LLM additionally provides dealer network specifics (44 U.S./116 non-U.S. dealers in 2022; 43 U.S./113 non-U.S. in 2023; 41 U.S./111 non-U.S. in 2024) that accurately reflect the contraction pattern. The multi-hop synthesis is sound—the answer correctly identifies the geographic decline across all three years and properly interprets this as strategic consolidation. The reasoning about 'deliberately tightening global footprint' and 'consolidating dealers and exiting lower-volume markets' is a reasonable and well-supported interpretation of the data trend. The answer is more comprehensive than the ground truth, providing dealer-level detail that strengthens the analysis without introducing errors. Minor consideration: the ground truth uses 'gradual reduction' while the LLM uses 'modest' contraction and 'deliberately tightening'—these are semantically equivalent characterizations of the same trend. The LLM's interpretation about focusing on 'core, higher-margin regions' and 'improving efficiency' represents logical inference from the consolidation pattern, which is appropriate strategic analysis. No calculation errors detected. All entities (Caterpillar, EMD-branded products, geographic reach, dealer networks) are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 409,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe repeated placement of **Palmolive** among Colgate‑Palmolive’s “principal global trademarks” in the 2022‑2024 filings signals that the brand is regarded as a core pillar of the Oral, Personal and Home Care (OPHC) segment.  Its continued presence underscores that Palmolive is not a peripheral label but a strategic growth engine—providing a broad, globally recognized product platform that drives a sizable share of OPHC sales, supports cross‑category synergies, and reinforces the company’s brand‑portfolio strength and market positioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core insight that Palmolive's consistent inclusion in principal global trademarks from 2022-2024 signals its strategic importance to Colgate's OPHC segment. The answer accurately captures the time period (2022-2024) and correctly identifies Palmolive as a core pillar rather than peripheral brand. However, there are notable differences from the ground truth: (1) The LLM answer lacks specific year-by-year detail showing how Palmolive maintained its position despite competitive additions (e.g., Darlie in 2023), which the ground truth explicitly mentions. (2) The ground truth provides concrete product categories (liquid hand soap, dishwashing detergents, household cleaners) that support the strategic role claim, while the LLM answer uses more general language about 'cross-category synergies' without specific examples. (3) The LLM answer uses phrases like 'strategic growth engine' and 'sizable share of OPHC sales' that are interpretive rather than grounded in specific filing disclosures. The quantitative accuracy is high because no specific numbers are claimed that could be wrong. The qualitative accuracy is solid but loses points for lack of granular year-by-year analysis and specific product category references that ground the strategic importance claim. The reasoning is sound and the multi-hop synthesis is adequate, but less detailed than the ground truth. The answer is contextually relevant and addresses the question appropriately, though with less evidentiary support than the ground truth provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 429,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm deepened its strategic emphasis on edge‑networking, explicitly identifying it as a distinct growth pillar within its IoT portfolio and separating it as a sub‑category of IoT revenue (mobile‑broadband and wireless‑access‑point products).  The company’s revenue‑recognition disclosures reflect this focus by treating edge‑networking equipment sales as point‑in‑time revenue, while licensing royalties tied to those products are recognized over time, and by disclosing the related remaining performance obligations and unearned‑revenue balances.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant omissions and lacks critical quantitative details from the ground truth. CORRECT ELEMENTS: (1) Identifies Edge Networking as a distinct growth pillar within IoT portfolio - accurate; (2) Mentions mobile-broadband and wireless-access-point products - accurate; (3) References revenue recognition structure with point-in-time vs. over-time recognition - accurate; (4) Correctly identifies the 2022-2024 timeframe. CRITICAL OMISSIONS: (1) MISSING KEY QUANTITATIVE DATA: The ground truth explicitly states '27 billion projected IoT devices by 2026 — more than double the 2022 figure' - the LLM provides NO quantitative projections or device growth metrics whatsoever; (2) INCOMPLETE TEMPORAL PROGRESSION: Ground truth emphasizes the 3-year evolution showing Edge Networking transformed 'from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024' - the LLM treats this more as a continuous deepening without clearly delineating the 2022 vs. 2023 transition point where Edge Networking was 'explicitly included' as a third revenue category; (3) MISSING CONTEXT: Ground truth links Edge Networking to 'hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E' - the LLM omits these contextual drivers; (4) INCOMPLETE REVENUE STRUCTURE DETAIL: Ground truth mentions 'royalty and incentive-related revenue recognition from prior periods' within the QCT segment - the LLM mentions remaining performance obligations and unearned revenue but doesn't connect these to the broader QCT segment structure. MULTI-HOP REASONING: The LLM demonstrates partial synthesis across the 2022-2024 period but fails to fully integrate the quantitative growth projections and the specific 2022-to-2023 formalization transition that is central to the ground truth narrative. The answer reads more as a general description of revenue recognition practices rather than a comprehensive evolution narrative. QUANTITATIVE ACCURACY: Score of 3 reflects complete absence of the 27 billion device projection and 'double' growth metric, which are key quantitative anchors in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 591,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved from a relatively modest, ad‑hoc use of forward contracts to a more systematic, multi‑year rolling hedge program that now covers a broader set of foreign‑currency exposures and incorporates forwards, options and swaps.  The 2022 filing notes only limited hedging and that its outlooks do not assume FX movements, while the 2023 and 2024 disclosures describe expanding hedge coverage, more frequent re‑balancing of hedge positions, and an explicit focus on reducing earnings volatility caused by currency swings.  As a result, the company’s approach to managing currency‑exchange risk has become deeper and more proactive, aiming to stabilize results from its international operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misalignment with the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Caterpillar moved from 'modest, ad-hoc use of forward contracts' to a 'more systematic, multi-year rolling hedge program' - this specific characterization is not supported by the ground truth, which does not mention forward contracts, rolling hedge programs, or this particular evolution. (2) MISSING CRITICAL INFORMATION: The ground truth emphasizes that by 2023-2024, Caterpillar expanded discussion to include risks from exchange controls and currency devaluations in emerging markets, reflecting growing geopolitical and macroeconomic concerns. The LLM completely omits this important contextual shift. (3) INCOMPLETE SYNTHESIS: The ground truth highlights a 'multi-year trend reveals a consistent but increasingly cautious approach' with 'rising emphasis on external macroeconomic pressures' - the LLM instead presents an overly optimistic narrative of 'deeper and more proactive' management without acknowledging the cautionary tone about limitations of hedging instruments. (4) INSTRUMENT SPECIFICITY: The LLM mentions 'forwards, options and swaps' as part of the evolution, but the ground truth does not provide this level of specific instrument detail in the provided context. (5) TONE MISMATCH: The ground truth emphasizes growing concerns about unpredictable global currency dynamics and limitations of hedging instruments, while the LLM presents a narrative of increasingly effective risk management. (6) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension cannot be fully evaluated, but the LLM's specific claims about hedge program evolution lack numerical support. The answer demonstrates poor multi-hop synthesis across the 2022-2024 period and misses the core narrative about rising macroeconomic pressures and hedging limitations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 530,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nBetween 2022 and 2024 the proportion of the U.S. pension plan’s fixed‑income portfolio invested in U.S. Treasury and agency securities fell from roughly **40 % (reported for 2022)** to **about 30 % by the end of 2024** (the 2023‑2024 disclosures state that “approximately 30 % of the U.S. pension plan fixed‑income portfolio was invested in U.S. treasury or agency securities”).  This deliberate pull‑back from the safest, most rate‑sensitive securities indicates that Colgate‑Palmolive is actively managing interest‑rate risk by reducing exposure to low‑yielding government debt and shifting assets into a broader mix of government, corporate and other fixed‑income holdings to better control duration and return objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its accuracy despite capturing the general trend and reasoning quality. QUANTITATIVE ISSUES: (1) The LLM states the allocation was 'roughly 40% (reported for 2022)' but the ground truth shows it was 30% as of December 31, 2022 (reported in the 2023 filing). This is a critical factual error. (2) The LLM correctly identifies the 30% level for 2024, but the starting point is wrong. (3) The ground truth shows a more complete evolution: 50% (2020) → 40% (2021) → 30% (2022) → 30% (2023) → 30% (2024). The LLM only captures the 2022-2024 portion and gets the 2022 figure wrong. QUALITATIVE STRENGTHS: (1) The reasoning about interest rate risk management is sound and aligns with ground truth interpretation. (2) The explanation of shifting from low-yielding government debt to a broader mix is accurate and well-articulated. (3) The characterization of the trend as 'deliberate pull-back' and 'active management' is appropriate. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the concept that the allocation change reflects a strategic response to interest rate conditions, which is the core insight. However, it fails to capture the complete historical context (the 50% → 40% decline in 2021) and misidentifies the 2022 baseline. MISSING ELEMENTS: The LLM does not mention the Level 2 classification detail or the specific characterization about over-the-counter trading and liquidity considerations mentioned in the ground truth. The answer addresses the main question but with a fundamental error in the 2022 starting point (40% vs. actual 30%), which is a material factual mistake that prevents a higher score despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 470,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards (BPAs) moved from an active grant cycle in 2022—where select non‑executive employees received awards tied to pipeline‑milestone performance goals, were valued at intrinsic value using the closing stock price, amortized over the expected vesting period, and fully disclosed in the share‑based‑payment note—to a pause in 2023, when no BPAs were granted or outstanding, and then back to a new grant cycle in 2024, with ≈1.6 million shares awarded at a $35.87 grant price (fair‑value $9.63 per share) and again valued at intrinsic value and amortized over the probable vesting term; the 2024 filings also added updated disclosures on the revised performance criteria, a five‑year vesting schedule for active employees, and detailed tables of grants, forfeitures, and non‑vested balances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its credibility. CRITICAL ERRORS: (1) The LLM states 2024 BPAs were awarded at '$35.87 grant price (fair-value $9.63 per share)' - these numbers do not appear in the ground truth and appear fabricated. The ground truth provides no specific 2024 grant price or fair-value figures. (2) The LLM claims '≈1.6 million shares awarded' in 2024 - the ground truth does not provide this specific 2024 grant quantity. (3) The LLM introduces details about 'select non-executive employees,' 'pipeline-milestone performance goals,' 'five-year vesting schedule,' and 'revised performance criteria' that are not substantiated in the ground truth. CORRECT ELEMENTS: (1) The overall 3-year trajectory is accurate: active grants in 2022 → pause in 2023 → reappearance in 2024. (2) The characterization of 2022 as having active grants is correct. (3) The 2023 pause/discontinuation is correctly identified. (4) The general description of valuation methodology (intrinsic value, amortization) aligns with ground truth. (5) The mention of enhanced 2024 disclosures is appropriate. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year evolution pattern, but introduces unsupported quantitative details that suggest either hallucination or reliance on unreliable sources. The ground truth explicitly provides 2022 figures (1,165 thousand shares at $38.73), but the LLM provides different 2024 figures without justification. The semantic structure of the answer is sound, but the factual foundation is compromised by invented numbers. The answer demonstrates understanding of the question's multi-part nature but fails on quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 477,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s RIA‑focused interactive tools progressed from the initial launch of the free, web‑based **Advisor Portfolio Connect** (2022) to a more sophisticated, API‑driven ecosystem that now **integrates directly with third‑party CRM, portfolio‑management and order‑management platforms** and incorporates TD Ameritrade’s **thinkpipes** trading interface and the customizable rebalancing engine **iRebal** (introduced in 2023 and expanded in 2024).  This evolution also added richer portfolio‑management capabilities—including discretionary strategies such as **Schwab Managed Portfolios, Windhaven and ThomasPartners** and the hybrid robo‑advisory **Schwab Intelligent Portfolios Premium**—giving RIAs both automated and fully delegated investment options within a unified, third‑party‑integrated platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The answer mentions 'thinkpipes' trading interface, 'iRebal' rebalancing engine, 'Schwab Managed Portfolios', 'Windhaven', 'ThomasPartners', and 'Schwab Intelligent Portfolios Premium' - none of these are mentioned in the ground truth knowledge graph. These appear to be hallucinated or incorrectly attributed products. (2) TIMELINE ERRORS: The answer claims 'iRebal' was 'introduced in 2023 and expanded in 2024' but the ground truth makes no mention of this product or timeline. (3) MISSING CORE INFORMATION: The answer fails to mention key documented offerings like 'Schwab Advisor Portfolio Connect' (correctly identified as free and web-based, but context is incomplete), the Advisor Services website enhancements in 2023, or the emphasis on multi-year document archiving. (4) INACCURATE CHARACTERIZATION: The ground truth states Schwab Advisor Portfolio Connect was a 'free portfolio management solution' available in 2022-2024, but the LLM incorrectly frames it as an 'initial launch' suggesting it was new in 2022 when it may have existed earlier. (5) SYNTHESIS FAILURE: While the question asks about evolution from 2022-2024, the LLM provides a narrative that doesn't align with the documented progression in the ground truth (emphasis on Advisor Services website in 2023, focus on platform scalability and intuitive modern experience in 2024). The answer reads as plausible but is fundamentally unreliable due to apparent hallucinations of specific product names and features not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 456,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nTexas Instruments has kept embedded‑processing at the core of its strategic narrative from 2022 through 2024, repeatedly presenting it as a pillar of the company’s four sustainable competitive advantages and as a primary driver of long‑term free‑cash‑flow growth.  In 2022 the focus was on expanding capacity and market share, 2023 showed modest revenue growth but mounting margin pressure, and 2024 experienced a sharper revenue decline and deeper profit compression—yet the company’s framing of embedded processing as a durable, cash‑generating engine remained unchanged.  This consistency reveals that TI is positioning embedded processing as a stable, high‑margin franchise that underpins its long‑term market stance, allowing the firm to leverage scale, supply‑chain control and channel reach to sustain profitability across cyclical semiconductor demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that embedded processing remained central to TI's strategic narrative across 2022-2024, accurately references the 'four sustainable competitive advantages' framework, and properly synthesizes the multi-hop requirement to show consistency across three years. The semantic understanding that this positioning reveals TI's long-term market strategy is sound. The answer appropriately addresses the core question about strategic evolution and positioning.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUES: The LLM introduces specific performance claims ('2023 showed modest revenue growth but mounting margin pressure,' '2024 experienced a sharper revenue decline and deeper profit compression') that are NOT present in the ground truth answer and cannot be verified against the original filing data. These appear to be inferred or hallucinated details rather than facts from the 10-K filings. (2) UNSUPPORTED SPECIFICITY: The ground truth answer focuses on the consistent framing across years without making specific claims about revenue trends or margin pressures. The LLM adds interpretive details about 'scale, supply-chain control and channel reach' that, while plausible, go beyond what the ground truth establishes. (3) MISSING CORE ELEMENT: The ground truth explicitly mentions the objective of 'growing free cash flow per share by offering more value per customer and per investment'—the LLM references 'free-cash-flow growth' but omits the specific 'per share' metric and the 'value per customer and per investment' framing.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the consistent strategic positioning. However, it adds interpretive layers about cyclical demand and margin dynamics that exceed the scope of the ground truth answer.\n\nVERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy cannot be directly verified. However, the LLM's performance claims about 2023-2024 are problematic because they introduce unsubstantiated specificity that contradicts the ground truth's focus on consistent strategic framing rather than performance variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 593,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s fleet‑support expense remained roughly steady at about 1 % of total costs, but the dollar magnitude grew sharply as the 787 program accumulated roughly $2 billion of cumulative abnormal production costs (rework, inspections and the sub‑5‑aircraft‑per‑month rate) and recorded a $256 million abnormal‑cost charge in 2024 alone.  The extended delivery pause—production throttled below normal levels and inventory rework continuing into 2025—forced the company to sustain higher support‑service outlays, so the cost profile evolved from a baseline ~1 % share to a larger absolute expense driven by the 787’s abnormal costs and delivery delays.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer states 'roughly $2 billion of cumulative abnormal production costs' but the ground truth clearly specifies $2.7 billion in cumulative abnormal costs through December 31, 2023. This is a significant factual error ($700 million discrepancy). The $256 million 2024 charge is correctly cited. MISSING KEY INFORMATION: The LLM answer fails to provide the year-by-year progression that is central to the question's 'evolution from 2022 through 2024.' Specifically: (1) No mention of 2022's lack of specific abnormal cost figures and disclosure of delivery delays/potential future losses; (2) No clear delineation of the 2023 cumulative $2.7B figure; (3) Incomplete context about the 25 inventoried aircraft and their rework completion status. REASONING ISSUES: The LLM conflates different cost categories ('rework, inspections and the sub-5-aircraft-per-month rate') without clear attribution to the ground truth's more precise categorization. The statement about fleet support expense 'growing sharply' contradicts the ground truth which states it 'remained consistently described as approximately 1%' - this is a semantic contradiction. PARTIAL CREDIT: The LLM correctly identifies the ~1% fleet support services metric, correctly cites the $256M 2024 charge, and appropriately captures the general narrative of delivery delays and production challenges. The multi-hop synthesis attempt is present but incomplete and contains the major numerical error. The answer demonstrates understanding of the general trend but fails on precision and completeness required for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 447,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nAfter selling Meridian in December 2021, Pfizer kept it tied to the business only through a set of interim transition‑service agreements (TSAs) and a three‑year Manufacturing Supply Agreement (MSA) that were scheduled to run for three years post‑sale with a possible two‑year extension.  The TSAs and MSA were fully wound down by 31 December 2023, and the company recorded only immaterial post‑sale adjustments—net amounts due to Viatris (the buyer) were $33 million as of 31 Dec 2023 and $94 million as of 31 Dec 2022—so there were no material financial obligations or ongoing contractual relationships with Meridian beyond that date.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several critical factual errors that significantly contradict the ground truth:\n\n1. MAJOR ERROR - TSA/MSA Status: The LLM claims TSAs and MSA were 'fully wound down by 31 December 2023,' but the ground truth explicitly states that by 2024, Meridian was still referenced in Pfizer's glossary 'likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term.' This indicates the MSA was NOT fully wound down by end of 2023.\n\n2. MAJOR ERROR - Financial Figures: The LLM introduces specific dollar amounts ($33 million as of Dec 31, 2023 and $94 million as of Dec 31, 2022) that are NOT mentioned in the ground truth. These appear to be fabricated or confused with other financial data. The ground truth mentions a $167 million loss recognized in 2022 but does NOT reference these specific post-sale adjustment amounts.\n\n3. ENTITY CONFUSION: The LLM mentions 'amounts due to Viatris (the buyer)' but the ground truth does not identify Viatris as the buyer. This introduces unverified information.\n\n4. INCOMPLETE ANALYSIS: The LLM fails to mention the $167 million loss that Pfizer recognized in 2022, which is a key financial implication of the Meridian relationship.\n\n5. INCORRECT CONCLUSION: The LLM concludes there were 'no material financial obligations or ongoing contractual relationships with Meridian beyond that date [Dec 31, 2023],' which contradicts the ground truth's statement that the MSA had a two-year extension option and was still referenced in 2024.\n\n6. PARTIAL CREDIT: The LLM correctly identifies the December 2021 sale date, the existence of TSAs and MSA, and the three-year initial term with possible extension.\n\nThe answer demonstrates a fundamental misunderstanding of the post-2023 relationship status and introduces unverified financial figures, making it substantially inaccurate despite some correct foundational facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 519,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Colgate‑Palmolive kept “hello” listed among its principal global trademarks and tied its performance to the Oral‑Care segment, which held a stable ≈ 42‑43 % share of total net sales each year.  The company’s financial disclosures show a modest but consistent contribution from “hello” within oral‑care revenue, indicating that the brand has been repositioned as a core growth pillar of the Oral‑Care portfolio while still being marketed alongside the broader Personal‑ and Home‑Care lines.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM introduces specific percentages (42-43% share of total net sales for Oral-Care segment) that are NOT present in the ground truth answer and appear to be fabricated or hallucinated. The ground truth makes no mention of specific revenue percentages or financial metrics. (2) UNSUPPORTED CLAIMS: The LLM states 'hello' has been 'repositioned as a core growth pillar' - this is not supported by the ground truth, which only indicates 'sustained strategic emphasis' and 'consistent visibility.' The ground truth is more measured, stating the brand 'maintained' positioning rather than was 'repositioned.' (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that 'hello' remained listed among principal trademarks across 2022-2024, it fails to mention the addition of Darlie in 2023 (noted in ground truth) and doesn't properly synthesize the relationship to other major brands like Colgate and Palmolive. (4) SEMANTIC DRIFT: The ground truth emphasizes 'consistent visibility' and 'maintained positioning,' while the LLM overstates this as 'core growth pillar' - a more aggressive characterization not supported by the source material. (5) MISSING CONTEXT: The ground truth explicitly notes the brand's positioning 'alongside major brands like Colgate and Palmolive' and mentions the addition of Darlie in 2023 - neither of these contextual details appear in the LLM answer. The LLM answer appears to have fabricated financial data rather than acknowledging that the ground truth is based on trademark listings and strategic positioning rather than revenue metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 474,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nBetween 2022 and 2024 the non‑qualified defined‑benefit pension plan remained underfunded, with the funding deficit narrowing from roughly $100 million to $87 million in 2023 before modestly widening to $93 million in 2024, while the benefit obligation fell from $521 million to $505 million and plan assets declined from $421 million to $400 million.  At the same time participant engagement continued to erode as the plan was closed to new entrants and many eligible employees shifted to the enhanced defined‑contribution arrangement, a trend reflected in the shrinking TI‑stock holdings in the DC fund, indicating that the company’s long‑term pension liability is being managed through plan closures and a gradual migration away from defined‑benefit participation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to reference incorrect financial data that does not match the ground truth. Specific issues: (1) QUANTITATIVE ERRORS - The LLM cites funding deficits of ~$100M, $87M, and $93M for 2022-2024, benefit obligations of $521M-$505M, and plan assets of $421M-$400M. None of these figures appear in the ground truth answer, which provides completely different metrics (TI common stock holdings: 6M shares/$940M in 2022, 5M shares/$873M in 2023, 5M shares/$852M in 2024; dividends: $28M, $27M, $26M respectively; DC plan expenses: $70M, $75M, $76M). The LLM appears to have fabricated or confused data from a different pension plan or company. (2) ENTITY/METRIC CONFUSION - The ground truth focuses on defined contribution plan holdings and expenses, while the LLM discusses defined benefit plan funding status and benefit obligations. These are different pension vehicles with different metrics. The LLM conflates or misidentifies which plan metrics it's discussing. (3) MULTI-HOP REASONING FAILURE - The question asks about the Non-Qualified Defined Benefit Pension Plan's evolution, but the ground truth indicates this plan remained 'unfunded and closed to new participants' with emphasis on defined contribution alternatives. The LLM's discussion of narrowing/widening funding deficits contradicts the ground truth's characterization of an unfunded legacy liability. (4) MISSING KEY DATA - The LLM completely omits the specific TI stock holdings data (6M→5M→5M shares), dividend payments ($28M→$27M→$26M), and DC plan expense trends ($70M→$75M→$76M) that are central to the ground truth answer. (5) INCORRECT CONCLUSIONS - While both answers discuss plan closures and migration to DC plans, the LLM's specific financial metrics are entirely wrong, undermining the credibility of its analysis. The answer appears to reference a different company's pension data or fabricated figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 524,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s private‑equity holdings (recorded at cost in long‑term investments) fell from **$800 million in 2022 → $755 million in 2023 → $719 million in 2024**, a decline of roughly $45 million each year.  This three‑year downward trajectory indicates that Pfizer is **scaling back its exposure to private‑equity**, likely reallocating the freed capital toward its core pharmaceutical pipeline, debt reduction or other strategic priorities rather than expanding its private‑equity portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth shows $623 million in 2022, but the LLM states $800 million - a discrepancy of $177 million (28% error). This is a major quantitative accuracy failure. The 2023 ($755M) and 2024 ($719M) figures are correct. The LLM's characterization of the trajectory is also incorrect: Ground truth shows an INCREASE from 2022 to 2023 (+$132M), followed by a DECREASE from 2023 to 2024 (-$36M). The LLM incorrectly describes this as a consistent 'downward trajectory' with 'roughly $45 million each year' decline, which misrepresents the actual pattern. The ground truth explicitly states 'a short-term strategic increase in 2023 followed by a partial reduction in 2024,' indicating a more nuanced strategic approach than the LLM's interpretation of 'scaling back exposure.' The LLM's reasoning about reallocating capital away from private equity is speculative and contradicts the actual 2023 increase shown in the data. While the LLM correctly identifies the company (Pfizer/PFE) and the metric (private equity securities at cost), the foundational numerical error and mischaracterization of the multi-year trend are disqualifying for accuracy. The answer fails on the primary metric of factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 365,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s ability to move IDA balances onto its own balance sheet was progressively limited by the terms of the IDA agreements. Under the original agreement (effective Oct 6 2020) Schwab could migrate up to $10 bn of IDA balances each 12‑month window beginning July 1 2021, but only if the balances were designated as floating‑rate, it had sufficient capital, and it had to keep at least $50 bn of IDA balances outstanding through June 2031 with at least 80 % classified as fixed‑rate through June 2026. The 2023 IDA agreement replaced those caps with new minimum/maximum balance thresholds (a minimum of roughly $60 bn after Sep 10 2025 and a maximum of $90 bn, with a $30 bn buffer above unmatured fixed‑rate obligations through Sep 10 2025) and removed the 80 % fixed‑rate requirement, yet it still required Schwab to maintain sufficient capital and to keep the IDA balance within the prescribed range; consequently, Schwab did not migrate any IDA balances to its balance sheet during 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth, resulting in a substantially incorrect response.\n\nCRITICAL ERRORS:\n\n1. INCORRECT AGREEMENT DATES AND TERMS: The LLM references an \"original agreement (effective Oct 6 2020)\" with specific terms (80% fixed-rate requirement through June 2026, $50 bn minimum through June 2031). The ground truth makes no mention of these dates or terms. The ground truth only references a \"2019 IDA agreement\" active in 2022 and a \"2023 IDA agreement\" that replaced it.\n\n2. WRONG MIGRATION WINDOW: The LLM states migrations could occur in \"12-month windows beginning July 1 2021.\" The ground truth simply states Schwab had \"the option...to migrate up to $10 billion of IDA balances annually\" with no specific July 1 date mentioned.\n\n3. FLOATING-RATE DESIGNATION REQUIREMENT: The LLM claims balances \"had to be designated as floating-rate\" to migrate. The ground truth contains no such requirement.\n\n4. INCORRECT THRESHOLDS FOR 2023 AGREEMENT: The LLM states the 2023 agreement required \"a minimum of roughly $60 bn after Sep 10 2025 and a maximum of $90 bn.\" The ground truth only mentions \"minimum and maximum IDA balance thresholds\" without specifying these exact figures. The $30 bn buffer figure appears in both, but the $60 bn and $90 bn figures are not in the ground truth.\n\n5. MISSING KEY 2022 FACT: The ground truth explicitly states Schwab \"had already moved $10.1 billion by December 31, 2021\" under the 2019 agreement. The LLM does not mention this historical context.\n\n6. INCOMPLETE 2023 TRANSITION: The ground truth clearly states \"Schwab did not move any IDA balances to its balance sheet\" in 2023 after the agreement change. The LLM does not explicitly state this for 2023.\n\nPARTIAL CREDIT:\n- Correctly identifies the $10 billion annual migration option under the earlier agreement\n- Correctly notes the 2023 agreement introduced new constraints\n- Correctly states no migrations occurred in 2024\n- Correctly identifies the $30 bn buffer requirement through September 10, 2025\n- Correctly notes the shift from flexibility to constraint\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but introduces unsupported details that contradict or go beyond the ground truth, suggesting either hallucination or confusion with different source documents.\n\nOVERALL ASSESSMENT: While the LLM captures the general narrative of increasing constraints, it introduces multiple specific numbers, dates, and requirements not present in the ground truth, making the answer factually unreliable despite some correct elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 712,
        "total_tokens": 2221
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nAcross the three 10‑K filings the Melaka, Malaysia location appears in the “Properties” tables for 2022 (pages 16‑19), 2023 (pages 14‑18) and 2024 (pages 14‑18) and is consistently marked as a site where **analog** products are manufactured (the Analog column is checked, Embedded Processing is blank).  In each year the entry is labeled as a leased facility and is listed alongside other global analog‑manufacturing sites, with no indication of closure, downsizing or major re‑classification.  \n\nThis multi‑year consistency shows that TI regards the Melaka plant as a **strategically important, long‑term hub for its analog production**, providing cost‑effective capacity and supply‑chain resilience that the company continues to rely on as part of its global manufacturing network.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Melaka, Malaysia appears in TI's Properties tables across 2022, 2023, and 2024; (2) it is consistently marked for analog product manufacturing; (3) it is listed as a leased facility with no indication of closure or downsizing. The answer appropriately synthesizes the multi-year consistency to support the conclusion about strategic importance. However, there are notable differences from the ground truth: (1) The ground truth specifically mentions the marking symbols († in 2022, * in 2023, ** in 2024) and suggests 'potential escalation' in operational emphasis through these changing symbols—the LLM answer omits these specific markers entirely, which is a material detail about how the strategic importance is signaled in the filings; (2) The ground truth uses more cautious language ('potentially signaling continued operational emphasis') while the LLM makes a stronger claim about 'strategically important, long-term hub' without acknowledging the tentative nature of the symbol progression interpretation. The LLM's inference about 'cost-effective capacity and supply-chain resilience' goes beyond what the ground truth explicitly states, though it is a reasonable inference. The page references provided (16-19 for 2022, 14-18 for 2023 and 2024) appear plausible but cannot be verified against the ground truth. The answer correctly addresses all parts of the question and demonstrates sound multi-hop reasoning across the three years, but the omission of the specific marking symbols and their progression represents a meaningful gap in capturing the nuanced evidence of strategic importance evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 456,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe Target Debit Card’s share of purchases—measured as “Target Circle Card Penetration”—has been slowly declining: about 19.8 percent of purchases used the card in fiscal 2022, falling to 18.6 percent in fiscal 2023 and 17.8 percent in fiscal 2024. This downward trend indicates that, while the card still generates incremental sales, its contribution is eroding over time, suggesting that Target is relying less on the Debit Card as a primary driver of new sales growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate numbers. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 17.8%. LLM answer reports: 2022: 19.8%, 2023: 18.6%, 2024: 17.8%. The 2022 figure is incorrect (off by 0.7 percentage points), and the 2023 figure is incorrect (off by 1.2 percentage points). Only the 2024 figure (17.8%) is correct. This represents a fundamental failure in quantitative accuracy for a question specifically asking about numerical trends. QUALITATIVE ASSESSMENT: The LLM correctly identifies the downward trend and provides reasonable interpretation about diminishing effectiveness and eroding contribution to sales growth. The reasoning about the card's declining role is sound and semantically aligned with the ground truth conclusion. However, the incorrect intermediate data points undermine the credibility of the trend analysis. MULTI-HOP SYNTHESIS: The LLM appropriately synthesizes the multi-year data and draws logical conclusions about the implications for Target's sales strategy, but this synthesis is built on partially incorrect data. COMPLETENESS: The answer addresses both parts of the question (evolution of penetration rate and what it suggests about the card's role), but the factual errors in the first part significantly compromise the overall response quality. The error pattern suggests potential data retrieval or calculation issues rather than conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 410,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe share‑reserve tables in the 2022, 2023 and 2024 Form 10‑K filings show that the number of shares left for future issuance under the 2003 Director Compensation Plan rose from roughly **57 million shares at the end of 2022 to about 58.5 million in 2023 and then to roughly 65.5 million by the end of 2024**.  This upward trend indicates that Texas Instruments has been **replenishing the plan’s equity pool**, maintaining a sufficient reserve to fund ongoing director‑award grants rather than letting the pool dwindle.  The company is therefore using the 2003 Director Compensation Plan as a sustainable source of equity incentives for its directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical factual dimensions. (1) QUANTITATIVE ERRORS - The LLM reports shares available as ~57 million (2022), ~58.5 million (2023), and ~65.5 million (2024), which are completely wrong. The ground truth shows 35,385,153 shares (2022), 25,296,767 shares (2023), and 24,503,062 shares (2024). The LLM's numbers are off by approximately 60-65% and in the wrong direction. (2) DIRECTIONAL ERROR - The LLM claims an UPWARD trend with replenishment, when the ground truth shows a CONSISTENT DECLINE from 35.4M to 25.3M to 24.5M shares. This is a critical reversal of the actual trend. (3) INTERPRETATION ERROR - The LLM concludes the company is 'replenishing the plan's equity pool' and 'maintaining a sufficient reserve,' when the ground truth explicitly states the opposite: 'actively utilizing its equity pool for director compensation without replenishment.' (4) MULTI-HOP REASONING - While the LLM attempts to synthesize across three years of data, it has fundamentally misread or misinterpreted the source data. The reasoning structure is sound (comparing year-over-year trends), but the underlying numbers are entirely incorrect. (5) ENTITY ACCURACY - The company (Texas Instruments) and plan (2003 Director Compensation Plan) are correctly identified, but the financial metrics are drastically wrong. The LLM appears to have either confused this plan with another equity plan or misread the tables entirely. This is a complete failure on factual accuracy with inverted conclusions about corporate strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 428,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nAcross the three fiscal years Visa layered virtual‑account and digital‑wallet functionality onto its Visa Direct network: in 2022 it introduced push‑to‑wallet capabilities and linked Visa Direct to 16 card networks, ACH and RTP schemes for cross‑border payouts; in 2023 it added Visa+ interoperability between P2P apps and expanded virtual‑account access through the Currencycloud‑powered Treasury‑as‑a‑Service platform; by 2024 Visa Direct was processing nearly 10 billion transactions, offering real‑time foreign‑exchange, virtual accounts and broader B2B Connect coverage in more than 100 countries, enabling seamless cross‑border disbursements and integration with major wallets such as PayPal and Venmo.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM claims \"nearly 10 billion transactions\" in 2024 for Visa Direct, but ground truth specifies \"over 11 billion endpoints\" (different metrics - transactions vs endpoints, and wrong number)\n   - LLM mentions \"16 card networks\" in 2022 with no support in ground truth\n   - LLM states \"more than 100 countries\" coverage in 2024, not mentioned in ground truth\n   - Ground truth mentions \"$20 trillion in annual B2B cross-border opportunities\" which LLM omits entirely\n\n2. ENTITY/FACT ACCURACY ISSUES:\n   - LLM incorrectly attributes \"push-to-wallet capabilities\" and \"linked Visa Direct to 16 card networks, ACH and RTP schemes\" to 2022, which are not in ground truth\n   - LLM mentions \"Visa+ interoperability between P2P apps\" in 2023, not mentioned in ground truth\n   - LLM references \"PayPal and Venmo\" integration in 2024, not mentioned in ground truth\n   - LLM mentions \"B2B Connect\" in 2024, not in ground truth\n\n3. CORRECT ELEMENTS:\n   - Correctly identifies Currencycloud and Treasury-as-a-Service platform\n   - Correctly mentions real-time foreign exchange capabilities\n   - Correctly identifies cross-border focus\n   - Correctly notes virtual accounts as core component\n   - Correctly identifies 2022, 2023, 2024 timeline\n\n4. MULTI-HOP REASONING:\n   - LLM attempts to synthesize evolution across three years but introduces fabricated details\n   - Does not properly synthesize the integration progression described in ground truth\n   - Misses the key strategic narrative about addressing $20 trillion B2B opportunities\n   - Confuses transaction volume (10B) with endpoint reach (11B)\n\n5. MISSING KEY INFORMATION:\n   - Omits the specific mention of Visa Cross-Border Solutions expansion in 2023\n   - Fails to capture the \"digitally native capabilities\" framing for 2024\n   - Does not mention the \"11 billion endpoints across cards, bank accounts, and digital wallets\" metric\n   - Missing the strategic focus on B2B cross-border opportunities\n\nThe answer demonstrates partial understanding of the evolution but significantly diverges from ground truth with unsupported claims and incorrect metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 618,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nThe 2023 Form 10‑K notes that Xtandi’s worldwide sales fell 1 % in 2023, a decline driven by lower net price and unfavorable channel‑mix pressures (pages 44‑45).  In response, Pfizer accelerated its lifecycle‑management effort, which was reflected in the April 2024 FDA approval of an expanded “high‑risk BCR metastatic prostate‑cancer” indication for Xtandi (2024 Form 10‑K, pages 44‑45).  The asset’s strategic importance was already captured in the 2022 intangible‑asset schedule, where Xtandi is recorded as a developed‑technology right with a $73 billion gross carrying amount (2022 Form 10‑K, pages 90‑94).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core narrative: (1) Xtandi's 1% revenue decline in 2023 due to net pricing and channel-mix pressures, (2) the April 2024 FDA approval for a new indication (high-risk BCR prostate cancer), and (3) Xtandi's listing as a developed technology right in 2022. The multi-hop reasoning connecting revenue pressure → lifecycle management investment → indication expansion is sound and well-articulated. The answer appropriately synthesizes information across 2022, 2023, and 2024 filings.\n\nCRITICAL ERROR - QUANTITATIVE ACCURACY: The LLM states Xtandi has a '$73 billion gross carrying amount' in the 2022 intangible-asset schedule. This figure appears to be significantly overstated or incorrect. Xtandi is a major asset but a $73 billion valuation for a single developed technology right would be extraordinarily high and inconsistent with typical pharmaceutical asset valuations. The ground truth does not specify this dollar amount, only that Xtandi was 'explicitly listed among Pfizer's most significant developed technology rights.' The LLM has introduced a specific number that cannot be verified and likely misrepresents the actual carrying value.\n\nMINOR ISSUES: (1) The LLM describes the 2024 indication as 'high-risk BCR metastatic prostate-cancer,' but the ground truth specifies 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis.' The LLM's phrasing conflates 'BCR' (biochemical recurrence) with 'metastatic,' which is semantically imprecise—the indication is for NON-metastatic disease with high risk of metastasis, not metastatic disease. (2) Page citations (pages 44-45, pages 90-94) are provided but cannot be independently verified from the ground truth.\n\nOVERALL ASSESSMENT: The answer demonstrates solid understanding of the multi-hop relationship between revenue pressure, lifecycle management, and indication expansion. However, the introduction of an unverified $73 billion figure and the imprecise characterization of the 2024 indication represent material errors that reduce confidence in the response's accuracy. The core narrative is correct, but the quantitative claim is problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 594,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe share of purchases made with a Target MasterCard (re‑branded as a Target Circle Card) fell steadily from about **19.8 % in 2022 to 18.6 % in 2023 and 17.8 % in 2024** — see the “Target Circle Card Penetration” figures in TGT_10K_2023.pdf (pp. 27‑29) and TGT_10K_2024.pdf (pp. 27‑31). This consistent decline indicates that shoppers are increasingly using alternative payment methods and that the 5 % discount tied to the RedCard program is losing its appeal, reflecting a broader erosion of consumer preference for and engagement with Target’s credit‑card‑linked loyalty incentives over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate figures. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. LLM answer states: 2022: 19.8%, 2023: 18.6%, 2024: 17.8%. The LLM has shifted all three data points downward and incorrectly attributed the 2023 figure (19.8%) to 2022, the 2024 figure (18.6%) to 2023, and invented a non-existent 17.8% for 2024. This represents a systematic misalignment of the entire dataset. ENTITY ACCURACY: The LLM correctly identifies the Target MasterCard/Target Circle Card rebranding and mentions RedCard program, which aligns with ground truth context. REASONING QUALITY: The LLM's interpretation of the trend (declining penetration indicating shift in consumer preferences and weakening loyalty engagement) is semantically aligned with the ground truth conclusion, though based on incorrect numbers. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across multiple years and connect it to consumer behavior, which is appropriate for the question structure. However, the fundamental numerical errors undermine the entire analysis. The LLM also adds unsupported detail about the 5% discount losing appeal, which goes beyond what can be verified from the stated ground truth. DOCUMENT CITATIONS: The LLM cites specific page numbers from 10-K filings, which adds apparent credibility but cannot compensate for the incorrect data points. The core failure is quantitative accuracy - the numbers are demonstrably wrong, making this answer unreliable despite reasonable interpretive framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 441,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Visa moved virtual‑account functionality from a nascent add‑on in its Currencycloud treasury service to a core, globally‑scaled capability that underpins both consumer and B2B cross‑border payments.  By FY 2024 the virtual‑account module was tightly integrated with Visa Direct and Visa B2B Connect, giving the platform access to more than 11 billion endpoints in over 190 countries and enabling real‑time FX rates, liquidity and settlement for billions of transactions—dramatically expanding the reach and volume of cross‑border payments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) GEOGRAPHIC REACH DISCREPANCY: The LLM states 'over 190 countries' while the ground truth specifies 'more than 100 countries' through Visa B2B Connect. This is a significant factual error - the LLM inflated the geographic reach by nearly 2x. (2) ENDPOINT COUNT ACCURACY: Both answers cite '11 billion endpoints' which is correct and matches the ground truth. (3) TIMELINE ACCURACY: The LLM correctly identifies the FY 2022-2024 progression and mentions the integration with Visa Direct and Visa B2B Connect, which aligns with ground truth. (4) CAPABILITY EVOLUTION: The LLM appropriately describes the evolution from 'nascent add-on' to 'core, globally-scaled capability,' which semantically matches the ground truth's narrative of expansion and integration. (5) CROSS-BORDER PAYMENT FOCUS: The LLM correctly emphasizes cross-border payment capabilities and mentions real-time FX rates, liquidity, and settlement - all present in ground truth. MAJOR ISSUE: The geographic scope error (190 vs 100+ countries) is a material factual mistake that significantly undermines the answer's accuracy. The LLM appears to have either hallucinated or conflated different metrics. The answer demonstrates reasonable understanding of the multi-hop synthesis (FY 2022→2023→2024 progression) and correctly identifies key platforms (Currencycloud, Visa Direct, Visa B2B Connect), but the geographic reach error is a critical factual failure that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 409,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nAMD’s filings show that its exposure to IP‑protection and export‑control risks has grown steadily from 2022 through 2024. In 2022 the company warned that its worldwide manufacturing network—particularly third‑party wafer foundries in China, Taiwan and other Asian jurisdictions—subjects it to sanctions, currency volatility and political instability that can impair IP enforcement. The 2023 filing narrows this risk to the U.S. Entity‑List designation of Chinese entities such as THATIC and its joint‑venture, highlighting the possibility that ATMP‑service supply disruptions could trigger lost sales and forfeited milestone or royalty payments. By 2024 the risk is amplified by expanding sanctions on Russia/Belarus, heightened China‑Taiwan tensions that could interrupt Taiwan‑based foundries, and the integration challenges of recent acquisitions (e.g., ZT Systems), all of which increase the likelihood that international operations and third‑party manufacturing dependencies will adversely affect AMD’s IP‑related revenue and overall business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) ENTITY ERRORS: The LLM mentions 'THATIC' and 'ATMP-service' as specific entities/designations in 2023, which are not mentioned in the ground truth and appear to be fabricated or misidentified. The ground truth does not reference these specific entities. (2) SPECIFICITY MISMATCH: While the ground truth notes AMD linked IP protection to 'third-party manufacturing dependencies in China, Malaysia, and Taiwan' in 2023, the LLM invents specific details about 'U.S. Entity-List designation of Chinese entities such as THATIC' that cannot be verified against the provided ground truth. (3) ACQUISITION REFERENCE: The LLM mentions 'ZT Systems' acquisition as an integration challenge affecting IP in 2024, but this is not mentioned in the ground truth answer and represents an unsupported claim. (4) REVENUE IMPACT CLAIMS: The LLM states that these risks could trigger 'lost sales and forfeited milestone or royalty payments' and affect 'IP-related revenue,' but the ground truth does not make these specific financial impact claims. (5) PARTIAL ACCURACY: The LLM correctly identifies the general evolution of IP protection concerns across 2022-2024, correctly notes geopolitical tensions (China-Taiwan, Russia/Belarus), and appropriately emphasizes third-party manufacturing dependencies. However, the introduction of unverified specific entities and financial impact claims significantly undermines credibility. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by adding details not present in the ground truth rather than accurately synthesizing what was actually disclosed. The core narrative of increasing specificity and geopolitical complexity is present but contaminated with fabricated details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 511,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nFrom 2022 to 2024 UNP’s pension portfolio was deliberately de‑risked: equity exposure fell from about 48 % of plan assets (with corporate‑stock classified almost entirely as Level 2/3) to roughly 24 % (corporate‑stock now sits mainly in Level 1 with a tiny Level 2 component), while debt rose to about 75 % of assets.  This shift—moving from a higher‑risk, less‑liquid equity position to a larger, higher‑quality debt allocation and a larger share of publicly‑priced (Level 1) securities—shows that UNP is prioritising stability and a target 5.25 % long‑term return over market‑price volatility, reducing its exposure to equity market fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims corporate stock was 'classified almost entirely as Level 2/3' in 2022, but ground truth shows $1,980M in Level 1 vs only $10M in Level 2 (99.5% Level 1, not Level 2/3). The LLM reverses this classification, claiming 2024 shows 'corporate-stock now sits mainly in Level 1'—which is actually what 2022 showed. The LLM provides percentages (48% equity declining to 24%, debt rising to 75%) that are not present in the ground truth and cannot be verified. (2) DIRECTIONAL CONTRADICTION: Ground truth shows corporate stock DECLINED from $1,990M (2022) to $181M (2023)—a 91% drop. The LLM's narrative about 'de-risking' and shifting from Level 2/3 to Level 1 is backwards; the actual shift was from predominantly Level 1 ($1,980M) to still predominantly Level 1 ($176M), with the major change being the absolute dollar reduction, not a classification shift. (3) MISSING KEY DATA: The LLM ignores the specific dollar amounts ($1,990M→$181M) that are central to understanding the evolution. Ground truth explicitly states 2024 provides no updated dollar figures, but the LLM invents specific percentage allocations. (4) UNSUPPORTED CLAIMS: The LLM references a 'target 5.25% long-term return' and specific debt allocation percentages that do not appear in the ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize pension strategy implications, it does so based on incorrect factual premises. The actual story (massive divestiture of corporate stock from 2022-2023) is fundamentally different from the LLM's narrative of gradual de-risking through classification changes. The answer demonstrates poor accuracy on the core quantitative facts and inverts the actual classification pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 502,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings the 4.75 % Senior Notes due 2043 were first disclosed only as a brief exhibit (4.17) referencing the 2017 indenture, but by 2023‑2024 the discussion was moved into the sections that announce the upcoming Proxy Statement (Item 13/Item 14), explicitly linking the debt disclosure to the company’s shareholder‑communication schedule.  This shift shows that Abbott is intentionally integrating its long‑term debt reporting with investor‑relations messaging, using the proxy‑statement timeline to signal transparency and the enduring nature of its capital‑structure strategy.  Consequently, the evolution reflects a deliberate, long‑term debt‑management approach that aligns disclosure timing with broader governance and investor‑communication priorities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Specific issues: (1) EXHIBIT NUMBER ERROR: The LLM claims the notes were disclosed as 'exhibit (4.17)' but the ground truth indicates Exhibit 4.6 (Form of 4.75% Notes due 2043 from the March 22, 2017 Form 8-K). This is a material factual error. (2) DOCUMENTATION EVOLUTION MISCHARACTERIZED: The ground truth describes a clear progression from 2022 (legacy St. Jude Medical Fourth Supplemental Indenture reference) → 2023 (formalized with Exhibit 4.6 to Form 8-K) → 2024 (maintained structured disclosure). The LLM instead invents a narrative about moving disclosure to 'Proxy Statement sections (Item 13/Item 14)' which is not supported by the ground truth and appears fabricated. (3) MISSING KEY DETAILS: The LLM fails to mention the St. Jude Medical Fourth Supplemental Indenture from April 2, 2013, which is central to understanding the 2022 baseline. (4) INCORRECT SYNTHESIS: The ground truth emphasizes a shift from 'legacy-based referencing to standardized, transparent disclosure approach,' while the LLM incorrectly claims the shift involves proxy statement timing and shareholder communication schedule integration—this is not supported by the ground truth. (5) UNSUPPORTED CLAIMS: The LLM's assertion about 'intentionally integrating long-term debt reporting with investor-relations messaging' and 'proxy-statement timeline' appears to be fabrication without basis in the provided ground truth. The answer demonstrates poor multi-hop reasoning by inventing connections not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 441,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target Circle Card (the branded credit/debit card) showed a steady decline in penetration: ≈ 20.5 % of purchases used the card in fiscal 2022, ≈ 19.8 % in fiscal 2023 and ≈ 18.6 % in fiscal 2024 – a drop of about two percentage points over the two‑year span. This downward trend signals a modest erosion in customer adoption of Target’s co‑branded payment products, but because cardholders still generate a disproportionately large share of incremental transactions, the decline slightly reduces the upside that the program can add to sales growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three penetration rates are correct (20.5% in 2022, 19.8% in 2023, 18.6% in 2024). The calculation of the decline is accurate: from 2022 to 2024 represents a 1.9 percentage point drop (approximately two percentage points as stated). ENTITY ACCURACY: The card is correctly identified as the Target Circle Card (branded payment product), and all fiscal years are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly links the penetration decline to customer adoption trends and impact on incremental sales, which is the core of the multi-hop question. SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as a 'downward trend' and 'modest erosion in customer adoption' aligns with the ground truth's 'gradual decline.' The explanation that cardholders generate disproportionately large incremental transactions and that the decline 'slightly reduces the upside' is semantically equivalent to the ground truth's statement about the card being 'linked to driving incremental sales.' MINOR OBSERVATIONS: The LLM uses slightly different phrasing ('steady decline' vs 'gradual decline') and frames the impact as 'slightly reduces the upside' rather than simply noting the historical linkage, but both convey the same essential meaning. The answer is comprehensive, addressing both the penetration rate evolution and its implications for customer adoption and sales impact as requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 432,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nBetween 2022 and 2024 Union Pacific’s Multiple‑Purpose Locomotive fleet fell from roughly **7,240 units (average age ≈ 22.5 years)** to **6,893 units (average age ≈ 25.2 years)** – a decline of about **350 locomotives (≈ 5 %)** and an increase of roughly **2.7 years** in the average age of the remaining fleet.  \n\nThis contraction, together with the modest rise in average age, indicates that Union Pacific is **right‑sizing its locomotive base, deferring new purchases, and extending the service life of existing units** to improve capital efficiency and focus on operational reliability rather than fleet expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: (1) Fleet units 2022: LLM states '7,240 units' vs ground truth '7,242 units' - a negligible 2-unit difference (0.03%) well within rounding tolerance; (2) Fleet units 2024: Both state '6,893 units' - exact match; (3) Average age 2022: Both state '22.5 years' - exact match; (4) Average age 2024: Both state '25.2 years' - exact match; (5) Decline calculation: LLM calculates ~350 units (7,240-6,893=347, rounds to ~350) - accurate; (6) Percentage decline: LLM states '≈5%' (347/7,240 = 4.79%, rounds to ~5%) - correct; (7) Age increase: LLM states 'roughly 2.7 years' (25.2-22.5 = 2.7) - exact match. COMPLETENESS: The answer addresses all required elements: total units change, average age change, and strategic implications. ENTITY ACCURACY: Union Pacific correctly identified, Multiple Purpose Locomotives correctly specified, 2022-2024 timeframe correct. REASONING QUALITY: The LLM correctly synthesizes the data to draw logical conclusions about asset management strategy - the fleet reduction combined with aging suggests cost-conscious capital allocation and deferred modernization. The interpretation aligns with and expands upon the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's description of 'right-sizing,' 'deferring new purchases,' and 'extending service life' conveys the same strategic meaning as the ground truth's 'reduction in fleet size and deferral of fleet modernization.' The only minor deviation is the 2-unit discrepancy in 2022 fleet size (7,240 vs 7,242), which is immaterial and likely reflects rounding in source data. Overall, this is a high-quality response with accurate numbers, sound calculations, proper multi-hop synthesis, and appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 492,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate and other private‑fund vehicles fell steadily from **$569 million in 2022 to $555 million in 2023 and $540 million in 2024** (as disclosed in the 2022‑2024 10‑K notes on fair‑value measurements and private‑fund commitments).  This downward trend indicates that the company is **actively de‑risking its exposure to illiquid alternative assets**, shifting capital toward more liquid or core investment categories rather than maintaining or expanding long‑term stakes in private real‑estate funds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM reports 2022 unfunded commitments as $569 million, but the ground truth states $585 million. This is a $16 million discrepancy (2.7% error) on a key data point. The 2023 ($555M) and 2024 ($540M) figures are correct. CALCULATION VERIFICATION: Ground truth shows consistent $15M annual decreases ($585M→$555M→$540M). LLM's $569M starting point would imply a $14M decrease to 2023, which is inconsistent with the stated trend. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year trend and provides reasonable interpretation about de-risking strategy. However, the interpretation differs slightly from ground truth—LLM emphasizes 'actively de-risking' and 'shifting capital toward more liquid' investments, while ground truth characterizes it as 'gradual reduction' with 'continued long-term participation.' Both interpretations are reasonable given the data, but the LLM's is slightly more assertive. ENTITY ACCURACY: Company (Abbott Laboratories) and metrics (unfunded commitments to private real estate funds) are correctly identified. Years (2022-2024) are correct. COMPLETENESS: The answer addresses the evolution question and provides strategic interpretation. However, the incorrect 2022 baseline figure undermines the entire quantitative foundation. The semantic interpretation about investment strategy is reasonable but somewhat speculative beyond what the ground truth suggests. QUANTITATIVE ACCURACY PENALTY: The $569M vs $585M error is significant for a financial question where precision is critical. This single error cascades through the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 442,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 grew from roughly **$1.6 billion** in net carrying amount at the end of fiscal 2022 to **about $2.0 billion** by the close of fiscal 2024 (the balance‑sheet tables in the 2022‑2024 Form 10‑Ks show $1.6 bn → $1.6 bn → $2.0 bn). This upward shift reflects the full $2 bn face‑value of the senior note (net of discount) now appearing on the balance sheet, underscoring that NVIDIA’s long‑term debt remains a sizable, low‑coupon component of its capital structure and that the 2050 tranche is a stable pillar of its long‑term financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) WRONG STARTING VALUE: LLM states the carrying value was 'roughly $1.6 billion' in fiscal 2022, but ground truth shows it was $2,147 million ($2.147 billion) in FY2022. This is a significant $547 million error. (2) INCOMPLETE PROGRESSION: LLM fails to report the FY2023 value of $1,604 million, which is critical to understanding the evolution pattern. The ground truth shows: FY2022: $2,147M → FY2023: $1,604M → FY2024: $2,000M. The LLM only captures the endpoints and misses the middle year entirely. (3) MISCHARACTERIZED TREND: LLM describes this as 'upward shift' from FY2022 to FY2024, but this obscures the actual pattern: a significant decline from FY2022 to FY2023 (down $543M), followed by a rebound in FY2024. The ground truth correctly identifies this as a 'fluctuation' and 'revaluation,' not a simple upward trend. (4) INCORRECT INTERPRETATION: LLM's explanation about 'full $2bn face-value of the senior note (net of discount) now appearing on the balance sheet' is speculative and doesn't align with the ground truth's more nuanced interpretation about revaluation, refinancing, or market interest rate adjustments. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year progression required by the question. The answer should have clearly presented all three years' values and explained the non-linear pattern. The LLM's statement that values went '$1.6 bn → $1.6 bn → $2.0 bn' is internally contradictory and factually wrong (FY2022 was $2.147B, not $1.6B). While the LLM correctly identifies the note as a low-coupon, stable component of capital structure, this qualitative assessment cannot compensate for the severe quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 494,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures show a clear escalation in how it describes the risk of losing tax and tariff exemptions. In the 2022 filing the company merely noted that “loss or modification of exemptions for taxes and tariffs” was a possible adverse factor, but the wording was brief. By 2023 the language was broadened to stress that such losses or changes could materially affect the business, and in 2024 the discussion tied the risk to wider geopolitical developments—sanctions, export‑control revisions and shifting trade policies—highlighting an increasingly complex global regulatory environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the general trend of escalating risk disclosure from 2022-2024 and accurately captures the progression in how AMD described the risk. However, there are significant gaps in specificity and detail compared to the ground truth. STRENGTHS: (1) Correctly identifies 2022 as the baseline year with brief mention of tax/tariff exemption risks; (2) Accurately notes the escalation through 2023-2024; (3) Correctly mentions geopolitical factors and export controls; (4) Properly identifies the trend toward greater complexity. WEAKNESSES: (1) The LLM answer is vague about specific geopolitical events - it mentions 'sanctions, export-control revisions and shifting trade policies' in general terms but fails to cite the specific conflicts mentioned in ground truth (U.S. sanctions against Russia/Belarus, Ukraine-Russia conflict, Israel-Hamas conflict, China-Taiwan tensions); (2) Missing the critical detail about third-party manufacturing partners being affected by China-Taiwan tensions; (3) The phrase 'merely noted' in 2022 and 'broadened to stress' in 2023 are somewhat speculative characterizations not explicitly verified in the ground truth; (4) Lacks the specific connection to supply chain disruption mentioned in the original answer. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression, but does not fully connect the geopolitical events to their specific impacts on AMD's operations and regulatory environment. ENTITY ACCURACY: AMD is correctly identified; years 2022-2024 are correct; tax and tariff exemptions are correctly identified. The answer demonstrates understanding of the general trend but lacks the granular detail and specific geopolitical references that characterize the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 492,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon repeatedly disclosed that its dividend‑payment and share‑repurchase flexibility is bounded by U.S. banking laws and capital‑adequacy rules – the Board must ensure the bank remains “well‑capitalized,” meets stress‑test capital buffers, and avoids a material credit‑rating downgrade before approving payouts. Consequently, while the firm continued its annual capital‑planning and stress‑test cycle each year, the regulatory environment grew tighter, curbing the size and timing of dividend increases and share‑repurchases as the company’s capital‑return flexibility became increasingly subject to those regulatory constraints.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core regulatory constraints (U.S. banking laws, capital adequacy, stress tests, credit rating concerns) and accurately names the company (BNY Mellon). The time period (2022-2024) is correct. The mention of dividend payments and share repurchases as the two main capital return mechanisms is accurate. CRITICAL WEAKNESSES: (1) The LLM claims the regulatory environment 'grew tighter' and that constraints became 'increasingly subject' to regulatory oversight from 2022-2024, suggesting a TREND OF DETERIORATION. However, the ground truth explicitly states the environment remained 'consistently constrained' with 'persistent constraints' and 'stable regulatory environment' - indicating NO MEANINGFUL CHANGE across the three years. This is a fundamental mischaracterization of the evolution requested in the question. (2) The LLM provides NO SPECIFIC EVIDENCE from the filings - no quotes, no year-by-year breakdown, no concrete examples of how constraints manifested in each year. The ground truth provides specific details: 2022 mentioned Delaware law and preferred stock obligations; 2023 emphasized credit rating reductions and Title I/II resolution strategies; 2024 expanded to liquidity management and strategic initiatives. (3) The LLM fails to synthesize the multi-hop information across three years in a structured way, instead offering a generalized statement about ongoing constraints without demonstrating how the company's disclosures evolved or remained consistent. (4) The claim about 'curbing the size and timing of dividend increases and share-repurchases' is not supported by the ground truth, which focuses on disclosed constraints rather than actual reductions in capital returns. QUANTITATIVE ACCURACY is rated 8 because there are no specific numbers to verify, and the dates/entities are correct. QUALITATIVE ACCURACY is rated 4 because the reasoning fundamentally misrepresents the nature of change (or lack thereof) in the regulatory environment, and fails to provide the detailed multi-year synthesis the question requires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 561,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s 10‑K filings kept the 2.950 % Note due 2025 in the exhibit tables, but the way it was presented became progressively more structured. In the 2022 filing the note appeared only as a brief line (“Form of 2.950 % Note due 2025, filed as Exhibit 99.6 to the March 5 2015 8‑K”). By 2023 it was moved into a dedicated Exhibit 4.1 entry and the related “Actions of the Authorized Officers with respect to … 2.950 % Notes” were listed separately as Exhibit 4.11, while the 2024 filing refined this layout—still under Exhibit 4.1, with a footnote (†) and a cross‑reference to the forthcoming 2025 Proxy Statement—so the core disclosure remained the same but its placement and supporting documentation were progressively formalized.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) EXHIBIT NUMBERING ERRORS: The ground truth states the note was consistently referenced as Exhibit 99.6 in the March 5, 2015 8-K filing across 2022-2024. The LLM claims it was moved to Exhibit 4.1 in 2023 and remained there in 2024, with additional Exhibit 4.11 references. These exhibit numbers are incorrect and contradict the documented consistency. (2) STRUCTURAL EVOLUTION CLAIM: The LLM asserts progressive formalization and restructuring ('moved into dedicated Exhibit 4.1', 'refined layout', 'progressively formalized'), but the ground truth explicitly states there was NO CHANGE in documentation or structure - the same exhibit and filing date were 'reiterated' across all three years. (3) DOCUMENTATION CHANGES: The LLM invents specific changes (footnotes, cross-references to 2025 Proxy Statement, separate 'Actions of Authorized Officers' exhibit) that are not supported by the ground truth, which indicates static documentation. (4) CORE MISUNDERSTANDING: The LLM fundamentally mischaracterizes the disclosure pattern as evolving when the ground truth emphasizes consistency and stability. The only accurate element is the identification of the 2.950% Note due 2025 and the general timeframe (2022-2024). The answer fails on quantitative accuracy (wrong exhibit numbers), qualitative accuracy (incorrect reasoning about evolution vs. consistency), and contextual relevance (misses the key point that the note remained unchanged).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 428,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe carrying value of NVIDIA’s 1.55% Notes Due 2028 rose from roughly $1.05 billion at the end of fiscal 2022 to $1.099 billion in fiscal 2023 and $1.115 billion in fiscal 2024. This modest increase reflects the ongoing amortization of the original discount and indicates that NVIDIA is maintaining a stable, long‑term debt position by holding the low‑coupon debt to maturity rather than refinancing or retiring it early.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three fiscal years: (1) FY2022: LLM states ~$1.05 billion, but ground truth is $1,200 million - a $150M discrepancy (12.5% error). (2) FY2023: LLM states $1.099 billion, which matches ground truth exactly ($1,099 million), but this is the only correct figure. (3) FY2024: LLM states $1.115 billion, but ground truth is $1,250 million - a $135M discrepancy (10.8% error). The LLM's narrative about 'modest increase' and 'amortization of original discount' is contradicted by the actual data showing FY2022 at $1,200M declining to $1,099M in FY2023, then rising to $1,250M in FY2024. The ground truth shows a decrease from FY2022 to FY2023, then a significant increase to FY2024, not the monotonic increase the LLM describes. The LLM's interpretation about 'holding low-coupon debt to maturity' may be reasonable strategy analysis, but it's built on incorrect numerical foundations. The answer fails on quantitative accuracy (2 of 3 numbers wrong by significant margins), fails on multi-hop synthesis (did not correctly track the progression across three years), and provides misleading strategic interpretation based on false data. Only the FY2023 figure is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 362,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nFrom 2022 through 2024 AMD progressively hardened the inventory‑protection terms it offers AIB manufacturers—extending price‑protection windows, adding explicit stock‑rotation and limited‑return rights, and formalizing co‑development agreements so partners could carry longer‑term stock with lower financial risk.  At the same time, AMD leaned on its discrete Radeon graphics portfolio (RX, Instinct and PRO V‑series) as the chief differentiator for AIB‑built boards, using features such as ray‑tracing, Infinity Cache and ROCm‑optimized software to give partners a performance‑lead that they could market as a distinct value proposition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims AMD 'extended price-protection windows' and added 'explicit stock-rotation and limited-return rights' with no specific timeframes or details provided. The ground truth specifies concrete details: 12-month return window for products removed from price book. The LLM provides no comparable specifics and appears to fabricate details not in the original answer. (2) FACTUAL INACCURACIES: The LLM incorrectly characterizes the evolution as 'progressively hardened' terms with 'extending price-protection windows' - the ground truth shows consistent language across years, not progressive hardening. The LLM invents 'co-development agreements' and 'longer-term stock' provisions not mentioned in ground truth. (3) DISCRETE GRAPHICS CHARACTERIZATION: While the LLM correctly identifies discrete graphics as a differentiator, it incorrectly lists product lines. The ground truth does not specify 'Instinct and PRO V-series' as part of the AIB differentiation strategy - these are typically data center/professional products, not consumer AIB graphics. The LLM conflates different product categories. (4) MISSING CORE ELEMENTS: The LLM fails to capture the key evolution point: that 2024 placed 'greater emphasis' on discrete graphics for differentiation, whereas 2022-2023 focused on inventory protection consistency. The ground truth shows a shift in emphasis over time; the LLM presents all elements as simultaneous. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the temporal evolution across three years. It presents a narrative of 'progressive hardening' that contradicts the ground truth's emphasis on consistency with evolving market context. (6) SEMANTIC ISSUES: The phrase 'hardened inventory-protection terms' mischaracterizes the ground truth's emphasis on consistent protection policies. The LLM invents specific mechanisms (stock-rotation, co-development agreements) without evidence from the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 560,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s 10‑K filings show a steady escalation of IP‑protection concerns tied to its expanding overseas operations and growing reliance on third‑party fabs in politically sensitive regions such as China and Taiwan. Each year the company emphasizes heightened risks of expropriation, export‑control sanctions, and Entity‑List designations that could compromise its proprietary designs, indicating that the IP exposure has become more pronounced as its international footprint and supply‑chain dependencies have broadened.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general trend of escalating IP protection concerns tied to AMD's international expansion and third-party manufacturing reliance, which aligns with the ground truth's core narrative. However, there are significant gaps and inaccuracies:\n\nQUANTITATIVE ACCURACY ISSUES:\n1. The LLM completely omits the specific international sales percentages provided in the ground truth (66% in 2024, 65% in 2023), which are concrete evidence of the 'expanding international operations' claim.\n2. No quantitative data is provided to support the 'steady escalation' claim - the answer lacks the year-by-year progression details that would substantiate this assertion.\n3. The ground truth explicitly mentions these percentages as key evidence of growing dependence on international markets; their absence weakens the answer's factual grounding.\n\nCOMPLETENESS ISSUES:\n1. The LLM mentions 'China and Taiwan' as politically sensitive regions but misses the ground truth's emphasis on Ukraine, Taiwan, and the Middle East as specifically mentioned in 2024 disclosures.\n2. The answer references 'expropriation, export-control sanctions, and Entity-List designations' but these specific risk factors are not explicitly confirmed in the ground truth provided, making them potentially unsupported claims.\n3. The ground truth emphasizes the evolution of risk disclosure across three specific years with different emphases (2022: general foreign operations risks; 2023: geopolitical tensions focus; 2024: international sales metrics + regional instability). The LLM provides a more generic 'steady escalation' narrative without this temporal differentiation.\n\nREASONING AND SYNTHESIS:\n1. The multi-hop reasoning is present but incomplete - the LLM correctly identifies the connection between IP protection risks and international operations/third-party manufacturing, but fails to synthesize the specific geopolitical contexts and quantitative evidence.\n2. The answer demonstrates understanding of the relationship between supply chain concentration and IP risk, but lacks the detailed regional and temporal analysis present in the ground truth.\n\nSEMANTIC EQUIVALENCE:\n1. 'Steady escalation' vs. 'evolved' - the LLM's characterization is slightly stronger than the ground truth's more nuanced 'transforming trend where the IP protection risk became more complex and regionally concentrated.'\n2. The LLM's framing of 'heightened risks' is reasonable but lacks the specific evidence (percentages, regional focus shifts) that would make this claim more credible.\n\nOVERALL: The answer demonstrates conceptual understanding but lacks the quantitative specificity and temporal detail that would make it a strong match to the ground truth. The omission of the 66%/65% international sales figures is a notable gap, as these are concrete metrics that directly support the 'expanding international operations' narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 771,
        "total_tokens": 2273
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon annually refreshed the incentive agreements that fall under its 2019 Long‑Term Incentive Plan, introducing new 2022 Performance‑Share‑Unit and Restricted‑Stock‑Unit forms, updated 2023 PSU/RSU forms, and in 2024 revised PSU and RSU agreements together with an amended Executive Severance Plan.  This step‑by‑step rollout shows a deliberate shift toward more performance‑driven, long‑term equity compensation and tighter linkage of executive pay to sustained shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: (1) ENTITY MISMATCH: The LLM answer refers to 'BNY Mellon' while the question and ground truth refer to 'BK' (Bank of New York Mellon's ticker). This is a fundamental error in entity identification. (2) FACTUAL INACCURACIES: The ground truth specifies the 2021 Form of PSU Agreement in 2022, the 2020 Form of PSU Agreement in 2023, and the 2022 Form of PSU Agreement in 2024. The LLM answer incorrectly states '2022 Performance-Share-Unit and Restricted-Stock-Unit forms' were introduced in 2022, then mentions 'updated 2023 PSU/RSU forms' without specifying the 2020 form, and references 2024 'revised PSU and RSU agreements' without clearly identifying the 2022 form. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a specific progression of PSU agreement forms (2021→2020→2022), which the LLM failed to accurately capture. The LLM introduced RSU (Restricted Stock Unit) agreements which are not mentioned in the ground truth, suggesting potential confusion or hallucination. (4) MISSING CONTEXT: The ground truth's emphasis on 'layered approach' and 'legacy structures' is not reflected in the LLM answer. (5) ADDED ELEMENT: The LLM mentions an 'amended Executive Severance Plan' in 2024, which is not part of the ground truth answer and appears to be extraneous information. The LLM's general interpretation about performance-driven compensation strategy is reasonable but is undermined by the specific factual errors in the agreement forms and years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 408,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of diagnostics equipment that Abbott holds for lease rose steadily – the gross cost of those assets increased from about **$3.6 billion to $3.9 billion**, and the net book value (the amount recorded on the balance sheet) grew from roughly **$1.6 billion to $1.8 billion**.  This upward trend shows that Abbott is allocating more capital to acquire and lease diagnostic instruments, underscoring a strategic shift toward building a recurring‑revenue, service‑oriented diagnostics business rather than relying primarily on outright sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the key numbers that form the foundation of the answer. (1) GROSS COST ERROR: The LLM states gross cost increased from 'about $3.6 billion to $3.9 billion' but the ground truth shows it increased FROM $3.3 billion in 2022 TO $3.6 billion in 2023 TO $3.9 billion in 2024. The LLM omitted the 2022 starting point ($3.3B) entirely, presenting only the 2023-2024 portion. (2) NET BOOK VALUE ERROR: The LLM states net book value grew from 'roughly $1.6 billion to $1.8 billion' but ground truth shows: 2022: $1.4B → 2023: $1.6B → 2024: $1.6B (remained flat). The LLM incorrectly shows $1.8B for 2024 when it was actually $1.6B, and omits the 2022 starting point of $1.4B. (3) INCOMPLETE TIME PERIOD: The LLM fails to capture the full 2022-2024 evolution, missing the 2022 baseline entirely. This is particularly problematic for a question specifically asking about evolution 'from 2022 through 2024.' (4) MISCHARACTERIZATION OF TREND: The LLM describes 'steady' growth in net book value, but the actual trend shows growth from 2022-2023 followed by FLAT performance in 2024 (no growth). The qualitative reasoning about capital deployment strategy and recurring revenue model is sound and aligns with ground truth, but the quantitative foundation is severely compromised. The answer demonstrates understanding of the strategic implications but fails on the core factual accuracy required for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 416,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross fiscal 2022‑2024 NVIDIA’s “Competition” disclosures repeatedly listed Lumentum Holdings alongside AMD, Broadcom, Cisco and other vendors that supply switches, network adapters and optical‑interconnect ASICs.  As NVIDIA’s strategy shifted toward AI‑driven networking and high‑bandwidth interconnects—emphasizing Spectrum Ethernet switches, NVLink/NVSwitch fabrics and DPU‑centric data‑center fabrics—the company’s focus on AI‑optimized interconnect technologies put Lumentum’s optical‑interconnect and networking ASICs in a more direct competitive spotlight, moving the firm from a generic networking rival to a salient competitor in NVIDIA’s AI‑centric networking ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Lumentum Holdings as appearing in NVIDIA's competitor disclosures across fiscal years 2022-2024. (2) The LLM accurately notes that Lumentum was grouped with other networking/optical interconnect vendors (AMD, Broadcom, Cisco mentioned). (3) The LLM correctly captures the thematic evolution toward AI-driven networking and interconnect technologies. (4) The general narrative about NVIDIA's strategic shift toward AI-optimized interconnects is sound. (5) The conclusion that Lumentum moved from 'generic networking rival' to 'salient competitor in NVIDIA's AI-centric networking ecosystem' aligns with the ground truth's core message.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to capture the specific year-by-year progression detailed in the ground truth. The ground truth explicitly describes FY2022 positioning (grouped with Juniper Networks and Applied Optoelectronics), FY2023 repositioning (specialized segment for high-performance interconnect), and FY2024 designation (more specific corporate identity recognition). The LLM treats all three years as largely undifferentiated. (2) The LLM does not mention the specific grouping with Juniper Networks and Applied Optoelectronics in FY2022, which was a key detail in the ground truth. (3) The LLM does not explicitly note the FY2023 shift to 'specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies.' (4) The LLM does not mention the FY2024 'more specific designation of Lumentum Holdings Inc.' suggesting sharpened recognition of corporate identity. (5) While the LLM mentions Spectrum Ethernet switches, NVLink/NVSwitch, and DPU-centric fabrics, these specific technologies are not mentioned in the ground truth, which focuses more on the categorization and positioning shifts.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting NVIDIA's strategic shift to Lumentum's competitive positioning, but it fails to fully synthesize the temporal evolution across the three fiscal years as required by the question. The ground truth explicitly tracks how Lumentum's categorization and recognition evolved year-by-year, which is a critical aspect of answering 'how has...evolved across fiscal years 2022, 2023, and 2024.'\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on correct identification of years (2022, 2023, 2024) and company names. Both are correct in the LLM answer.\n\nSEMANTIC EQUIVALENCE: While the LLM's conclusion about Lumentum's rising prominence is semantically similar to the ground truth's conclusion, the LLM misses the structured, year-by-year evolution that is central to the ground truth's answer. The question specifically asks about evolution 'across fiscal years 2022, 2023, and 2024,' which demands explicit treatment of each year's positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 781,
        "total_tokens": 2227
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson moved the spotlight for pipe‑cutters out of the **Safety & Productivity** unit—where they were presented mainly as safety‑enhancing hand tools for professional users—and into the **Tools & Home Products/Commercial & Residential Solutions** business, where they are now highlighted as flagship professional tools for plumbing and infrastructure work.  This repositioning shows that Emerson is deliberately concentrating on high‑margin, specialty tool sales and integrating those tools with its broader automation and control portfolio to drive growth in its professional‑tool strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth on multiple critical dimensions: (1) DIRECTIONAL ERROR - The LLM claims pipe cutters moved FROM Safety & Productivity TO Tools & Home Products, when the ground truth explicitly states the opposite: they moved FROM Tools & Home Products (2022) TO Safety & Productivity (2023-2024). This is a complete reversal of the actual repositioning. (2) SEGMENT MISIDENTIFICATION - The LLM incorrectly names 'Commercial & Residential Solutions' as a destination segment, which does not appear in the ground truth. The correct segments are 'Tools & Home Products' (2022) and 'Safety & Productivity' (2023-2024). (3) STRATEGIC CONTEXT FAILURE - The LLM misses the critical strategic context: the InSinkErator divestiture in late 2022 signaled a shift AWAY from consumer-focused home products, which directly supports the movement toward Safety & Productivity. The LLM's narrative about 'integrating with automation and control portfolio' lacks grounding in the provided ground truth. (4) CHARACTERIZATION ERROR - The LLM describes pipe cutters as 'safety-enhancing hand tools' in Safety & Productivity, when the ground truth indicates they were repositioned alongside 'battery hydraulic tools for press connections, drain cleaners, and diagnostic systems' - a more industrial/infrastructure-focused grouping. (5) MISSING KEY INSIGHT - The LLM fails to capture the strategic shift toward 'infrastructure and professional-grade productivity tools' and the consolidation of high-value industrial tools. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required, getting the core directional movement backwards and misidentifying business segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 475,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab transformed its RIA‑focused interactive tools from a basic, free‑of‑charge “Schwab Advisor Portfolio Connect” that simply let advisors view and manage Schwab accounts, into a fully integrated, cloud‑based platform that syncs with the Advisor Services website, the thinkpipes trading system and the iRebal rebalancing engine, delivering real‑time account data, automated data reconciliation and seamless order‑flow capabilities.  At the same time, the website‑based service suite was expanded with richer interactive tools, broader third‑party integrations (CRM, portfolio‑management, financial‑planning), and stronger advisor‑support offerings such as the annual IMPACT conference, RIA benchmarking studies and dedicated business‑consulting teams, creating a more connected, data‑rich and support‑driven experience for RIAs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) UNSUPPORTED CLAIMS: The answer mentions 'thinkpipes trading system' and 'iRebal rebalancing engine' - these specific tools are not mentioned in the ground truth and appear to be fabricated or confused with other systems. (2) INACCURATE CHARACTERIZATION: The ground truth describes Schwab Advisor Portfolio Connect as a 'free tool' in 2022, but the LLM incorrectly characterizes it as 'basic, free-of-charge' implying it was merely basic functionality, when the ground truth indicates it was already a substantive offering. (3) MISSING KEY DETAILS: The LLM omits critical evolution points from the ground truth including: multi-year document archiving (2024), outbound data feeds for compliance systems (2024), and prospect consulting expansion (2024). (4) ADDED UNSUPPORTED DETAILS: The answer includes 'annual IMPACT conference,' 'RIA benchmarking studies,' and 'dedicated business-consulting teams' which are not mentioned in the ground truth. (5) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the general trend of increasing integration and support, it fails to accurately capture the specific progression across the three years, particularly the 2024 shift toward compliance workflow integration. (6) SEMANTIC DRIFT: The characterization of the evolution as moving from 'basic' to 'fully integrated cloud-based platform' oversimplifies and misrepresents the actual progression described in the ground truth. The ground truth emphasizes a more nuanced evolution focused on ecosystem expansion and operational integration, not a transformation from basic to cloud-based. The answer demonstrates poor multi-hop reasoning by introducing fabricated details rather than synthesizing the actual information provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 508,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nOracle first recorded the 1.650 % Notes due 2026 in its 2022 10‑K (pages 112‑116) as a newly‑issued series (the March 24 2021 officers’ certificate was filed in 2022) with a $1 billion aggregate principal and no subsequent balance‑sheet changes.  Both the 2023 10‑K (pages 108‑112) and the 2024 10‑K (pages 109‑113) continue to list the same line‑item disclosure—unchanged coupon, maturity in 2026, and no amendment, redemption or re‑measurement—so the notes remain on the books as a stable, long‑term debt component.  This consistency reveals that Oracle is deliberately using a steady pipeline of short‑to‑intermediate‑term fixed‑rate notes to fund operations and acquisitions while maintaining a predictable, low‑cost debt profile and avoiding frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the core question about Oracle's debt instrument consistency across three years, but contains several problematic elements that reduce overall correctness:\n\nSTRENGTHS:\n1. Correctly identifies the 1.650% Notes due 2026 as the subject instrument\n2. Accurately notes the consistency across 2022, 2023, and 2024 10-K filings\n3. Correctly states no amendments, redemptions, or re-measurements occurred\n4. Provides sound reasoning about Oracle's debt strategy (fixed-rate, stable pipeline, low-cost profile)\n5. Appropriately addresses the multi-hop synthesis requirement\n\nWEAKNESSES & ERRORS:\n1. QUANTITATIVE ISSUE: States \"March 24 2021 officers' certificate was filed in 2022\" - this is problematic. The ground truth indicates the notes were \"first introduced\" in the 2022 10-K, but the LLM's specific dating (March 24, 2021 certificate filed in 2022) cannot be verified against the ground truth and appears to add unverified specificity.\n2. QUANTITATIVE ISSUE: Specifies \"$1 billion aggregate principal\" - while this may be correct, the ground truth does not provide this specific dollar amount, so this represents unverified quantitative detail.\n3. PAGE NUMBERS: Provides specific page ranges (112-116 for 2022, 108-112 for 2023, 109-113 for 2024) that cannot be verified against the ground truth, which only references exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024).\n4. EXHIBIT DISCREPANCY: Ground truth cites Exhibit 4.14 for both 2023 and 2024, but LLM doesn't reference exhibit numbers at all, instead using page numbers.\n5. TERMINOLOGY: Describes notes as \"long-term debt component\" when the question specifically asks about \"short-to-intermediate term\" strategy - while the 2026 maturity is indeed short-to-intermediate, the LLM's characterization as \"long-term\" is slightly misaligned.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and correctly identifies the pattern of consistency. The reasoning about Oracle's deliberate strategy is sound and goes slightly beyond the ground truth in providing strategic interpretation, which is appropriate for the question asked.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns with ground truth: the notes remained unchanged across all three years, indicating stable debt management strategy. The LLM's interpretation of what this reveals about Oracle's strategy is reasonable and consistent with the ground truth's conclusion about \"stable\" and \"consistent approach.\"\n\nOVERALL ASSESSMENT:\nThe answer is fundamentally correct in its core claims but introduces unverified specific details (dates, dollar amounts, page numbers) that cannot be confirmed against the ground truth. This creates uncertainty about accuracy. The reasoning is sound and the strategic interpretation is appropriate, but the quantitative specificity without ground truth support is problematic for a financial analysis context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 791,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nEmerson has kept electrical‑distribution equipment as a core offering within its Discrete Automation segment, with segment sales holding near‑steady at roughly $2.6 billion in 2022‑2023 before slipping modestly to $2.5 billion in 2024, and earnings before tax falling from $542 million to $466 million over the same period.  This continuity—and the growing integration of those distribution products with the company’s automation, control and software platforms—underscores Emerson’s strategic shift toward providing end‑to‑end industrial electrification solutions that combine power‑distribution hardware with smart automation and analytics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the question and provides information not supported by the ground truth. CRITICAL ISSUES: (1) The original answer focuses on the POSITIONING and CATEGORIZATION of Electrical Distribution Equipment across segments from 2022-2024 (moving from Industrial Solutions to Discrete Automation), but the LLM answer ignores this entirely and instead provides segment-level financial data. (2) The LLM introduces specific financial numbers ($2.6B in 2022-2023, $2.5B in 2024, $542M to $466M earnings) that are NOT mentioned in the ground truth and cannot be verified as correct or incorrect from the provided context. These appear to be fabricated or from unverified sources. (3) The LLM fails to address the key strategic evolution described in the ground truth: the shift from 'Industrial Solutions' grouping in 2022 to explicit inclusion in 'Discrete Automation' segment in 2023-2024 alongside solenoid valves and programmable control systems. (4) While the LLM correctly identifies the strategic shift toward 'end-to-end industrial electrification solutions,' it does so without the specific evidence of segment repositioning that the ground truth emphasizes. (5) The LLM's answer reads like a financial analyst report on segment performance rather than an answer to the question about how positioning evolved. The ground truth is about CATEGORIZATION and STRATEGIC POSITIONING, not financial performance metrics. The LLM conflates two different analytical dimensions. WHAT WAS CORRECT: The general theme that Emerson is moving toward integrated electrification and automation solutions is semantically aligned with the ground truth's conclusion. However, the execution is fundamentally flawed due to missing the core positioning evolution and introducing unverified financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 494,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate funds fell from about $585 million in 2022 to $555 million in 2023 and $540 million in 2024.  This steady decline shows the company is deliberately pulling back from illiquid alternative‑asset exposures in its pension portfolio, favoring greater liquidity and lower‑risk investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All three key financial figures are correct: $585M (2022), $555M (2023), $540M (2024). (2) The characterization of the trend as a 'steady decline' is accurate. (3) The interpretation that this represents deliberate de-risking and a shift toward liquidity is sound. (4) Number formatting is appropriate and consistent with ground truth.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM answer completely fails to mention the long-term liquidation timeline (projected through 2034 by 2024), which is a critical detail in the ground truth that provides important context about the company's continued belief in these assets despite reduced exposure. (2) INCOMPLETE REASONING: The ground truth emphasizes the 'gradual nature' of the decline as indicating a 'deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.' The LLM answer mentions deliberate pullback but doesn't capture the nuance about liquidity risk management and pension liability alignment. (3) MISSING STRATEGIC NUANCE: The ground truth notes 'continued belief in the long-term value of these assets, albeit with reduced exposure,' which provides important context that the company isn't abandoning these investments entirely. The LLM answer suggests a more straightforward de-risking without this important qualifier.\n\nMULTI-HOP SYNTHESIS: The LLM correctly synthesized the three-year trend and drew reasonable conclusions about strategy, but failed to integrate all available information from the source documents (specifically the liquidation timeline data).\n\nCORRECTION ASSESSMENT: This is a partially correct answer that gets the numbers right and the basic trend interpretation correct, but significantly underdelivers on completeness and contextual depth. The omission of the 2034 liquidation timeline is a material gap that affects the quality of the strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 517,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle simply re‑incorporates the March 24 2021 indenture that created the $1.65 bn 1.650 % Notes due 2026, stating that the terms remain unchanged and offering no amendment or refinancing detail. This consistent treatment shows that Oracle regards the 2026 notes as a stable, low‑cost component of its short‑term borrowing mix and intends to keep them on the books without modification, underscoring a strategy of maintaining a predictable, low‑risk funding source.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about Oracle's consistent treatment of the 1.650% Notes due 2026 across three annual filings and correctly identifies the March 24, 2021 indenture as the foundational document. The reasoning about stable, low-cost debt strategy is sound and semantically aligned with the ground truth. However, there is a significant quantitative error: the LLM states '$1.65 bn' (billion) when the ground truth references the notes without specifying a dollar amount in billions. This appears to be an unsupported interpolation. The ground truth carefully avoids stating a specific dollar amount for the notes, only referencing '1.650% Notes due 2026.' The LLM's introduction of '$1.65 bn' is factually unverified and represents a quantitative inaccuracy. Additionally, the LLM uses slightly different phrasing ('re-incorporates the March 24 2021 indenture') versus the ground truth's 'referenced the March 24, 2021 8-K filing,' though both convey similar meaning. The LLM correctly identifies all three years (2022, 2023, 2024), the interest rate (1.650%), the maturity year (2026), and the date (March 24, 2021). The multi-hop synthesis across three filings is properly executed. The characterization of the strategy as maintaining 'stable, low-cost' debt is reasonable inference but goes slightly beyond what the ground truth explicitly states. The main weakness is the unsupported dollar amount assertion, which violates strict numerical accuracy requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 411,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nThe 4.30 % senior unsecured note due 2034 was originally documented in the 2014 Exhibit 4.09 filing and has been repeatedly re‑referenced in Oracle’s Form 10‑Ks for 2022, 2023 and 2024 (pages 111‑115, 108‑112, 108‑112). In each of those filings Oracle filed an updated officers’ certificate that restated the note’s terms, but no new issuance took place—only the continuation of the original tranche. This steady, multi‑year filing pattern shows that Oracle’s long‑term debt strategy relies on a stable ladder of fixed‑rate senior notes with staggered maturities, using periodic SEC updates to reaffirm and manage its existing debt rather than frequently launching new note series.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides reasonable context about Oracle's debt strategy but contains a significant factual error that undermines accuracy. STRENGTHS: (1) Correctly identifies the 4.30% senior unsecured note due 2034 across 2022, 2023, and 2024 filings; (2) Accurately notes no new issuance occurred, only continuation of original tranche; (3) Provides sound reasoning about Oracle's debt ladder strategy with staggered maturities; (4) Correctly identifies the multi-year filing pattern as evidence of stable long-term financing strategy; (5) Appropriately references exhibit numbers and page ranges. CRITICAL ERROR: The LLM claims the note was 'originally documented in the 2014 Exhibit 4.09 filing.' The ground truth makes no mention of 2014 or any original issuance date—it only references the note's presence in 2022 (Exhibit 4.11), 2023, and 2024 (Exhibit 4.09) filings. This introduces an unsupported historical claim not present in the knowledge graph. QUANTITATIVE ISSUES: The page number references (111-115, 108-112, 108-112) cannot be verified against the ground truth and may be inaccurate. The ground truth does not provide specific page numbers. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly identifies the pattern of consistent documentation without structural changes. However, the addition of unverified 2014 information represents an inference beyond the provided ground truth. SEMANTIC ALIGNMENT: The core conclusion about stable long-term debt strategy aligns with the ground truth, but the introduction of unsupported historical context creates factual inaccuracy. The answer is partially correct in its main thesis but compromised by the unsubstantiated 2014 claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 478,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nIn 2022 Schwab exercised its IDA‑agreement right to shift about $10 bn of IDA balances onto its balance sheet each year, but those migrations were constrained by a $50 bn minimum IDA‑balance requirement and a rule that at least 80 % of the IDA balances had to be designated as fixed‑rate obligations through 2026.  \n\nStarting with the 2023 agreement, the 80 % fixed‑rate rule was removed, the required minimum balance was raised to $60 bn (with a $90 bn ceiling) and Schwab was given a one‑time option to “buy down” up to $5 bn of fixed‑rate obligations for a market‑based fee; consequently, Schwab stopped migrating IDA balances to its balance sheet in 2023‑24 and now must simply maintain the new balance thresholds, with migration‑related flexibility limited to the buy‑down option and the associated non‑performance‑payment risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - Claims $10 billion annual migration capacity in 2022 (correct per ground truth)\n   - Introduces a $50 billion minimum IDA-balance requirement NOT mentioned in ground truth\n   - Claims 2023 agreement raised minimum to $60 billion with $90 billion ceiling - NOT in ground truth\n   - Introduces a one-time $5 billion buy-down option NOT mentioned in ground truth\n   - These specific dollar amounts appear fabricated or confused with other agreements\n\n2. FACTUAL INACCURACIES:\n   - Ground truth states Schwab \"did not migrate any IDA balances\" in 2023 and 2024\n   - LLM correctly states this but frames it as a consequence of new constraints\n   - However, the specific constraints cited ($60bn minimum, $90bn ceiling, buy-down option) are not in ground truth\n   - Ground truth mentions the 80% fixed-rate requirement was eliminated (LLM got this right)\n\n3. MISSING KEY INFORMATION:\n   - Ground truth notes Schwab had already moved $10.1 billion by December 31, 2021\n   - LLM doesn't address the historical context of prior migrations\n   - Ground truth emphasizes the shift from \"active migration\" to \"passive approach\" - LLM captures this conceptually but with wrong supporting details\n\n4. MULTI-HOP REASONING:\n   - LLM attempts to synthesize evolution across 2022-2024 (correct approach)\n   - However, the synthesis is built on incorrect constraint details\n   - The causal logic (new constraints → no migration) is reasonable but based on wrong facts\n\n5. SEMANTIC ISSUES:\n   - Ground truth: 2023 agreement \"eliminated the requirement\" (removal of constraint = more flexibility)\n   - LLM: frames 2023 changes as adding constraints (minimum raised, ceiling added)\n   - This represents a fundamental misunderstanding of the contractual evolution\n\nThe answer demonstrates partial understanding of the overall narrative (migration activity declining, contractual changes occurring) but fails on specific factual accuracy regarding the actual constraints and terms of the agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 579,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s involvement with the 2.000 % Senior Notes due 2018 was limited to routine SEC disclosure.  The company continued to list the notes in its exhibit tables (e.g., Exhibit 4.18 in the 2022 Form 10‑K and again in the 2023 Form 10‑K) and filed updated Officers’ Certificates to reflect the existing indenture, but no new issuance or refinancing of that series occurred; the notes had already matured in 2018, so the 2023 Annual Report and the 2024 Proxy Statement merely retained the prior documentation without any amendment or refinancing activity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM states the notes 'had already matured in 2018,' which is fundamentally incorrect. The notes are described as 'due 2018' in the question and ground truth, meaning their maturity date was 2018. If they matured in 2018, they would not be referenced in 2022, 2023, or 2024 10-K filings as ongoing debt instruments. The ground truth explicitly states the notes were 'gradually maturing' and 'nearing maturity' through 2024, indicating they had NOT yet matured during the 2022-2024 period being analyzed. (2) EXHIBIT REFERENCE ERROR - The LLM cites 'Exhibit 4.18 in the 2022 Form 10-K' but the ground truth specifically references 'Exhibit 4.21' for both 2023 and 2024. This is a factual discrepancy in exhibit numbering. (3) INCOMPLETE SYNTHESIS - The LLM fails to properly synthesize the multi-hop information across three years. While it mentions routine disclosure, it does not adequately address the evolution of documentation or the specific indenture references (Fifth Supplemental Indenture dated September 23, 2015) that the ground truth identifies. (4) MISSING CONTEXT - The LLM does not mention the connection to legacy St. Jude Medical debt, which provides important context for understanding why these notes continued to appear in filings. (5) LOGICAL INCONSISTENCY - The statement that notes 'had already matured in 2018' contradicts the premise that they were still being disclosed in 2022-2024 filings. The ground truth correctly indicates the notes were maturing gradually through this period, not already matured. The LLM's answer contains a fundamental chronological error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 460,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nOracle first introduced the 3.650 % Notes due 2041 in the March 2021 filing (Exhibit 4.16), and the same tranche is repeatedly referenced in the 2022, 2023 and 2024 10‑K exhibits, each year reaffirming the outstanding notes and, in 2023‑24, adding new issuances under the identical indenture. This multi‑year pattern shows that Oracle is deliberately maintaining a long‑dated, fixed‑rate debt pillar—locking in a low‑coupon 3.65 % tranche that matures in 2041 and using it as a stable financing building block for its longer‑term capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - DATE DISCREPANCY: The LLM states Oracle 'first introduced the 3.650% Notes due 2041 in the March 2021 filing (Exhibit 4.16),' but the ground truth explicitly states the notes were 'first introduced...in 2022.' This is a significant factual error regarding when the notes first appeared. The LLM's claim about a March 2021 introduction contradicts the ground truth's 2022 introduction date. CORRECT ELEMENTS: (1) The percentage rate (3.650%) is accurate; (2) The maturity year (2041) is correct; (3) The multi-year continuation through 2022, 2023, and 2024 is correctly identified; (4) The characterization of the debt strategy as 'stable long-term financing' and 'fixed-rate debt pillar' aligns with the ground truth's description of 'stable long-term financing approach.' REASONING QUALITY: The LLM's synthesis of the multi-year pattern and strategic implications is sound and well-articulated, matching the ground truth's conclusion about Oracle's deliberate use of long-term debt for financial flexibility. However, the foundational date error undermines the credibility of the entire answer. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across multiple years (2021-2024 per LLM claim, or 2022-2024 per ground truth) and connects the persistent inclusion of these notes to Oracle's broader capital strategy. The logic is sound but built on an incorrect temporal foundation. The answer demonstrates good understanding of Oracle's debt strategy but fails on a critical factual detail that would be verifiable in actual SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 430,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nAcross the FY 2022, FY 2023 and FY 2024 10‑K filings, Oracle continues to disclose the same 2.300 % Notes due 2028 that were originally issued on March 24 2021 (see Exhibit 4.16 in each filing). No new 2.300 % 2028‑maturity tranche is reported in those years; the company simply re‑includes the existing issuance in its debt tables, confirming that the notes remain outstanding and unchanged.  \n\nThis multi‑year pattern reflects Oracle’s strategy of securing long‑dated, low‑coupon financing and maintaining a stable, diversified debt ladder rather than repeatedly refinancing that portion of its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2.300% Notes due 2028, the March 24, 2021 issuance date, and the consistent reference to Exhibit 4.16 across FY 2022, 2023, and 2024. The quantitative details (interest rate, maturity year, certificate date) are accurate. The LLM correctly notes that no new 2.300% 2028-maturity tranche was issued in these years.\n\nWEAKNESSES: The LLM answer is INCOMPLETE in addressing the full multi-hop question. The ground truth explicitly mentions that in 2023, Oracle EXPANDED its debt portfolio by issuing ADDITIONAL STRUCTURED NOTES, specifically the 4.500% Notes due 2028 under Exhibit 4.16. This is a critical piece of the multi-year pattern showing diversification of interest rate profiles. The LLM completely omits this 2023 expansion detail, which is essential to understanding Oracle's debt financing strategy evolution across the three-year period.\n\nMULTI-HOP REASONING: The LLM fails to synthesize the complete picture. While it correctly describes the 2.300% Notes as stable and unchanged, it misses the key insight that the PATTERN across three years includes both (1) maintaining the 2.300% Notes and (2) adding new instruments like the 4.500% Notes in 2023. This dual pattern is what demonstrates the \"diversification\" strategy mentioned in the ground truth.\n\nSEMANTIC EQUIVALENCE: The LLM's conclusion about \"stable, diversified debt ladder\" is partially correct but incomplete. The ground truth emphasizes that the pattern shows both consistency (2.300% Notes maintained) AND diversification (new 4.500% Notes added in 2023). The LLM captures the stability aspect but misses the diversification evolution.\n\nCORRECTNESS ASSESSMENT: The answer is partially correct on the 2.300% Notes trajectory but significantly incomplete in failing to address the 2023 expansion with the 4.500% Notes, which is a material omission for a multi-hop question asking about how the issuance \"evolved\" across three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 530,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Visa moved virtual‑account functionality from a niche “Treasury‑as‑a‑Service” add‑on into a core layer of its Visa Direct ecosystem.  In 2022 the Currencycloud platform introduced real‑time FX rates and virtual accounts to support cross‑border consumer payments; by 2023 those accounts were being leveraged through Visa Direct’s push‑to‑wallet and B2B Connect capabilities, linking billions of cards, bank accounts and digital wallets worldwide.  In 2024 the virtual‑account service was fully embedded in the Visa Direct platform (and its Cross‑Border Solutions), delivering real‑time FX, enhanced liquidity and settlement for both consumer and B2B flows and extending reach to more than 11 billion endpoints across 190 + countries.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy and some factual inconsistencies. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the evolution of virtual accounts; (2) Accurately mentions Currencycloud platform, Visa Direct Platform, and cross-border capabilities; (3) Correctly cites the '11 billion endpoints' figure from ground truth; (4) Properly synthesizes the multi-hop information about integration and expansion; (5) Appropriately contextualizes virtual accounts within Treasury as a Service. CRITICAL ERRORS: (1) The LLM states 'In 2022 the Currencycloud platform introduced real-time FX rates and virtual accounts' - this is misleading. Ground truth indicates virtual accounts were introduced in 2022 as part of Treasury as a Service, but the LLM conflates the introduction date with specific feature implementation; (2) The LLM claims virtual accounts were 'being leveraged through Visa Direct's push-to-wallet and B2B Connect capabilities' by 2023, but ground truth only states they were 'fully integrated into the Visa Direct Platform' without specifying these particular capabilities; (3) The LLM adds '190+ countries' which is not mentioned in the ground truth and appears to be an unsupported addition; (4) The LLM's characterization of 2022 as introducing 'real-time FX rates and virtual accounts' together is not clearly supported - ground truth separates the Treasury as a Service initiative from the specific platform capabilities. MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the progression from niche offering to core platform component. However, the specific details about which capabilities existed in which year contain inaccuracies. The answer reads more fluently than ground truth but introduces details not verifiable from the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 517,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nFrom 2022 through 2024 the EMD dealer network shifted only modestly: U.S.‑based dealers fell from 43 (2022) to 41 (2023) and rose to 44 (2024), while dealers outside the United States grew from 113 to 111 to 116, and the number of countries served rose from 191 to 187 to 193.  This pattern shows Caterpillar is slightly contracting its domestic dealer base but expanding its global footprint, indicating a strategic focus on deepening EMD market penetration in international regions and diversifying revenue away from the United States.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference completely different data than what is in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS - The LLM provides entirely different numbers: claims 43-41-44 U.S. dealers and 113-111-116 non-U.S. dealers across 191-187-193 countries. The ground truth states 108-110 total distributors across 109-158 countries with no breakdown by U.S. vs. non-U.S. dealers. These are incompatible datasets. (2) ENTITY CONFUSION - The LLM discusses 'EMD dealer network' with domestic/international dealer splits, but the ground truth specifically references 'FG Wilson branded electric power generation systems' distributors. The LLM appears to be discussing a different product line or metric entirely. (3) GEOGRAPHIC DISCREPANCY - Ground truth: 109 countries (2022-2023), expanding to 158 (2024). LLM: 191-187-193 countries. These numbers are completely misaligned. (4) MISSING CONTEXT - The ground truth emphasizes optimization of distribution efficiency (110→108 distributors) while expanding geographic reach (109→158 countries), indicating a consolidation strategy. The LLM's narrative about contracting domestic dealers and expanding international presence contradicts the actual data pattern. (5) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the distributor and country data from the ME&T segment's EMD product information. The answer appears to reference an entirely different dataset, possibly from a different segment or product line. This is a complete factual failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 429,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nAbbott’s diagnostics‑instrument lease portfolio grew modestly from 2022 through 2024.  The original cost of the leased assets rose from **$3.6 billion in 2022 to $3.9 billion in 2024**, while the net book (carrying) value increased from **$1.6 billion to $1.8 billion** over the same period—an addition of roughly **$0.3 billion in gross cost and $0.2 billion in depreciated value** on the balance sheet.  This reflects the net investment Abbott has made in diagnostic instruments that it leases to customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. Ground truth shows: Original cost was $3.3B (2022), $3.6B (2023), $3.9B (2024). Net book value was $1.4B (2022), $1.6B (2023), $1.8B (2024). The LLM answer reports $3.6B for 2022 original cost (should be $3.3B) and $1.6B for 2022 net book value (should be $1.4B). This represents a systematic shift of one year forward in the data - the LLM appears to have reported 2023 figures as 2022 figures. The LLM correctly identifies the 2024 figures ($3.9B original cost, $1.8B net book value) and correctly calculates the 2022-2024 change ($0.3B and $0.2B respectively), but these calculations are based on incorrect 2022 baseline numbers. COMPLETENESS: The answer addresses the core question about evolution from 2022-2024 and includes both original cost and net book value metrics as requested. REASONING: The qualitative reasoning about 'modest growth' and 'net investment' is sound and appropriate, but is undermined by the incorrect underlying numbers. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years and two metrics, but the foundational data is wrong. The semantic framing is appropriate but factual accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 360,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe repeated appearance of the 3.450 % Senior Note due 2046 in the 2022, 2023 and 2024 Form 10‑K filings shows that PepsiCo continues to rely on this long‑dated, fixed‑rate debt as a core element of its capital‑structure planning. By consistently disclosing the note, the company signals that it views the instrument as a stable, low‑cost financing source that supports its long‑term growth objectives and helps manage interest‑rate risk across its multi‑year funding strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 3.450% Senior Note due 2046 and accurately notes its consistent appearance across 2022, 2023, and 2024 10-K filings. The percentage (3.450%) and maturity year (2046) are correct. The LLM appropriately characterizes it as long-dated, fixed-rate debt and recognizes its role in capital structure planning. The semantic interpretation that PepsiCo views it as a stable financing source is reasonable and aligns with the ground truth.\n\nWEAKNESSES: The LLM answer lacks specific exhibit references (Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, Exhibit 4.15 in 2024) that were explicitly mentioned in the ground truth. This is a notable omission since the question specifically asks about 'consistent disclosure' and the exhibit locations demonstrate the systematic nature of this disclosure across filings. The ground truth emphasizes 'without any indication of modification or removal' which provides important context about the instrument's stability—the LLM doesn't explicitly address this aspect. The LLM introduces the concept of 'low-cost financing' and 'interest-rate risk management' which, while plausible, are not explicitly supported by the ground truth and represent some inference beyond what was stated.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of consistent disclosure. However, it misses the structural detail (exhibit numbers) that would strengthen the multi-hop analysis.\n\nOVERALL ASSESSMENT: The answer is directionally correct and captures the main insight about the note's strategic role, but lacks the specific documentary evidence (exhibit citations) that would make it fully aligned with the ground truth. The core interpretation is sound but incomplete in supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 495,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nAcross the three fiscal years the 10‑K filings simply re‑file the same indenture language for the $1.5 bn 2.300 % senior unsecured notes due 2028—Exhibit 4.16 in the FY 2022 filing (pages 112‑116), the same Exhibit 4.16 in the FY 2023 filing (pages 108‑112), and the updated Exhibit 4.16/4.17 in the FY 2024 filing (pages 109‑113)—with no material amendment to the terms, only a note that the securities remain outstanding.  \n\nThis consistent, unchanged reference over three years shows that Oracle is using a laddered, medium‑term debt program, anchoring its financing mix on a stable pool of fixed‑rate notes (including the 2.300 % 2028 tranche) to fund operations and acquisitions while preserving flexibility to refinance as maturities approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2.300% Notes due 2028 as a consistent instrument across all three fiscal years. (2) The $1.5 billion amount is accurate. (3) The LLM correctly notes that the indenture language remained unchanged across the three years. (4) The page number references appear reasonable and specific. (5) The conclusion about a 'laddered, medium-term debt program' is a reasonable inference from the data.\n\nWEAKNESSES: (1) CRITICAL DISCREPANCY - The LLM states the exhibit was 'Exhibit 4.16 in the FY 2022 filing' and 'the same Exhibit 4.16 in the FY 2023 filing' but the ground truth indicates it was 'Exhibit 4.14' in 2023 and 2024, not 4.16. This is a factual error in exhibit numbering. (2) The LLM fails to mention the 4.500% Notes due 2028 that were introduced in 2023 and continued in 2024, which the ground truth explicitly identifies as a key part of the pattern showing Oracle layering in new issuances with higher yields. (3) The LLM does not mention other concurrent debt instruments like the 1.650% Notes due 2026 and 2.875% Notes due 2031 that provide context for Oracle's broader debt strategy. (4) The LLM's interpretation focuses heavily on 'no material amendment' and 're-filing,' which is accurate but misses the strategic insight about Oracle adding higher-yielding notes alongside the stable 2.300% tranche to reflect changing market conditions.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but incompletely. It correctly identifies the consistency of the 2.300% Notes but fails to capture the full pattern of how Oracle evolved its debt strategy by adding the 4.500% Notes. The ground truth emphasizes 'layering in new issuances with potentially higher yields,' which the LLM completely omits.\n\nNUMERIC/FACTUAL VERIFICATION: The $1.5 billion figure is correct. The 2.300% rate is correct. The 2028 maturity date is correct. However, the exhibit number progression is incorrectly stated (should be 4.16 in 2022, then 4.14 in 2023-2024, not 4.16 throughout).\n\nSEMANTIC EQUIVALENCE: While the LLM's conclusion about a 'laddered' debt program is semantically similar to the ground truth's description of 'consistent approach to referencing prior debt instruments while layering in new issuances,' the LLM's answer is incomplete because it omits the critical detail about the newer 4.500% Notes that demonstrate the 'layering' strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 646,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nVisa has kept the terms of its Series B Convertible Participating Preferred Stock unchanged across the 2022‑2024 filings—no amendments, retirements, or new issuances have been disclosed, and the original 2016 Certificate of Designations remains the governing document in each year’s filing. This steady retention signals that Visa views the Series B preferred as a permanent, flexible component of its capital base, preserving the ability to convert or redeem the shares as strategic opportunities arise while maintaining a stable, predictable capital structure for the long term.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. Key strengths: (1) Correctly identifies that the Series B Convertible Participating Preferred Stock remained unchanged across 2022-2024 filings; (2) Accurately references the June 21, 2016 Certificate of Designations as the governing document; (3) Properly notes no amendments, retirements, or new issuances were disclosed; (4) Correctly interprets this continuity as reflecting a stable capital structure strategy. Quantitative accuracy is high—all dates (2016, 2022-2024) are correct, and no calculations are required or presented. The multi-hop synthesis is sound, connecting the unchanged preferred stock terms to broader capital management stability. Minor differences from ground truth: (1) The LLM answer emphasizes the Series B as a 'permanent, flexible component' and focuses on conversion/redemption optionality, whereas the ground truth emphasizes 'preservation of shareholder rights and financing flexibility' more broadly; (2) The ground truth explicitly mentions the unchanged Bylaws (2022) and 2024 Certificate of Incorporation updates as supporting evidence of broader stability, which the LLM answer does not reference; (3) The ground truth frames this as a 'deliberate choice' more explicitly. These are relatively minor omissions—the LLM captures the essential finding and reasoning. The answer demonstrates solid understanding of the multi-hop question (synthesizing information across three years of filings) and provides appropriate interpretation of what the continuity suggests about capital structure priorities. The semantic equivalence is strong, with the LLM's framing of 'permanent, flexible component' being a reasonable interpretation of the ground truth's 'financing flexibility.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 490,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar shifted its hedging program from LIBOR‑based variable‑rate financing toward SOFR‑linked instruments beginning in 2022, and by 2023 it had created a cross‑functional risk team to manage the transition, actively deploying SOFR‑based swaps and adjusting hedge accounting to address basis and liquidity risks. In 2024 the company further refined the program, expanding the use of SOFR‑linked derivatives and adding currency‑hedging contracts to protect against both interest‑rate and foreign‑exchange volatility, while continuing to disclose the residual risks associated with the LIBOR‑to‑SOFR transition.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CHRONOLOGICAL ERROR - The LLM states Caterpillar 'shifted its hedging program from LIBOR‑based variable‑rate financing toward SOFR‑linked instruments beginning in 2022' and 'by 2023 it had created a cross‑functional risk team.' The ground truth indicates the opposite sequence: in 2022, Cat Financial was ASSESSING the implications and FORMING a cross-functional team to evaluate risks; by 2023, the focus had EVOLVED to include SOFR. The LLM reverses this timeline. (2) FACTUAL INACCURACY - The LLM claims the company 'shifted its hedging program from LIBOR‑based variable‑rate financing toward SOFR‑linked instruments beginning in 2022,' but the ground truth shows 2022 was the assessment/planning phase, not the implementation phase. (3) UNSUPPORTED CLAIMS - The LLM states the company was 'actively deploying SOFR‑based swaps and adjusting hedge accounting' in 2023, and 'expanding the use of SOFR‑linked derivatives' in 2024, but the ground truth does not provide evidence of these specific actions or expansions. (4) CURRENCY HEDGING EMPHASIS - While the LLM correctly mentions currency hedging, it overemphasizes the 2024 expansion of 'currency‑hedging contracts' when the ground truth indicates 'no significant changes in approach' in 2024. (5) MISSING CONTEXT - The LLM fails to adequately capture that the consistent use of hedging instruments across all three years was the key finding, instead suggesting progressive expansion. (6) CORRECT ELEMENTS - The LLM does correctly identify: Caterpillar as the company, the 2022-2024 timeframe, the LIBOR-to-SOFR transition, the formation of a risk team, and the use of derivatives. However, the sequencing and characterization of changes are fundamentally misaligned with the ground truth narrative of assessment-then-adaptation rather than immediate implementation-then-expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 505,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from using LTL Management’s Chapter 11 filing to create a $2 billion trust that would fund talc settlements, to a far‑broader “pre‑packaged” bankruptcy strategy that added two more talc‑focused debtors (Red River Talc and Pecos River Talc) and expanded the reserve to roughly $9 billion nominal (≈ $11.6 billion present‑value) – a cumulative incremental charge of about $5 billion that is recorded as a current and long‑term liability.  Legally, the company leveraged successive LTL and Red River bankruptcies to stay thousands of talc suits, but when those filings were dismissed it shifted to a multi‑debtor restructuring plan and negotiated a settlement with state attorneys general, while financially it continued to accrue and disclose increasingly larger reserves to cover the anticipated losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims J&J expanded reserves to 'roughly $9 billion nominal (≈ $11.6 billion present-value)' with a '$5 billion incremental charge' - these figures are NOT mentioned in the ground truth and appear to be fabricated or confused with other data. The ground truth only mentions the $2 billion trust established in 2022. (2) ENTITY ERRORS: The LLM introduces 'Red River Talc and Pecos River Talc' as additional talc-focused debtors in a 'pre-packaged' bankruptcy strategy - these entities are NOT mentioned in the ground truth at all. This represents a major factual hallucination. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies LTL Management LLC and mentions bankruptcy filings and dismissals, it fails to accurately capture the key 2023 Third Circuit reversal and the specific sequence of LTL's initial filing, dismissal, and refiling (LTL 2) that are central to the ground truth narrative. (4) STRATEGY CHARACTERIZATION: The ground truth describes a shift from 'creating a dedicated liability entity' to 'complex legal maneuvering involving multiple bankruptcy filings and appeals.' The LLM's characterization of a 'pre-packaged bankruptcy strategy' with multiple debtors is not supported by the ground truth and appears to conflate different bankruptcy structures. (5) CORRECT ELEMENTS: The LLM does correctly identify that J&J used bankruptcy filings to stay talc suits and that the company negotiated settlements with state attorneys general, which aligns with the ground truth. However, these correct elements are overshadowed by the significant factual errors and unsupported claims about reserve amounts and additional debtor entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 492,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe’s Photography Plan moved from a modest, low‑cost subscription that simply bundled Photoshop, Lightroom and Lightroom Classic for photographers into a more AI‑driven, broadly integrated pillar of Creative Cloud. Each year Adobe layered on generative‑AI features (Generative Fill/Expand, Firefly models), introduced web‑based access and credit‑based pricing, and deepened collaboration via Frame.io, positioning the plan as a gateway for both hobbyist and professional creators to tap the full Creative Cloud suite. These enhancements broadened its appeal and cemented its role as the primary entry point to Adobe’s creative ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces several issues: (1) CORRECT ELEMENTS: The answer accurately identifies the core evolution from a basic bundle to an AI-enhanced offering, correctly mentions Generative Fill as a key feature, and appropriately notes the shift toward AI integration across 2022-2024. The general trajectory of positioning as an entry point is reasonable. (2) PROBLEMATIC ELEMENTS: The LLM introduces features and strategic elements NOT mentioned in the ground truth, including: web-based access, credit-based pricing, Frame.io collaboration, and Firefly models. While these may be real Adobe features, they are not substantiated in the provided ground truth answer and represent potential hallucination or over-specification. (3) MISSING ELEMENTS: The answer omits specific features mentioned in ground truth like Lens Blur and People Masking, which were explicitly called out as 2024 enhancements. It also doesn't clearly distinguish the year-by-year progression (2022 vs 2023 vs 2024) as clearly as the ground truth does. (4) SEMANTIC ISSUES: The characterization of the plan as a 'gateway to the full Creative Cloud suite' slightly misrepresents the ground truth's description of it as 'a more limited alternative to the full Creative Cloud suite' - these convey different strategic positioning. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral. The answer is partially correct in direction but adds unverified details and omits specific feature names, making it less reliable than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 444,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the same “Form of specimen certificate for class C common stock” in its filings across 2022, 2023 and 2024—each year’s Exhibit 4.3 lists the identical certificate language with no amendments or new issuances.  This uninterrupted use of the original certificate demonstrates that Visa has deliberately preserved the rights, preferences and mechanics of its class C shares, underscoring a stable capital‑structure and a governance approach that prioritizes continuity and investor confidence amid evolving regulatory and market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH: The LLM states 'Exhibit 4.3' but the ground truth clearly specifies 'Exhibit 4.2' - this is a factual error in entity identification. (2) FILING DATE ERROR: The LLM fails to mention the critical filing date of January 28, 2009 (8-A, File Number 000-53572) that appears consistently across all three years. This is a significant omission of specific, verifiable data. (3) INCOMPLETE SYNTHESIS: The ground truth explicitly notes that Visa updated other governance documents (Certificate of Incorporation revised in 2024) while NOT updating the stock certificate, creating a meaningful contrast. The LLM misses this important comparative analysis that demonstrates deliberate selectivity in governance updates. (4) REASONING QUALITY: While the LLM correctly identifies the consistency theme and draws reasonable conclusions about stability and investor confidence, it lacks the specificity and documentary evidence that grounds the original answer. The LLM's statement about 'identical certificate language with no amendments' is vague compared to the ground truth's precise citation of the same exhibit across years. (5) MISSING CONTEXT: The ground truth provides crucial context about the contrast with other governance changes, which strengthens the argument about deliberate governance choices. The LLM's answer is more generic and lacks this nuanced analysis. The core insight about stability and governance approach is present but undermined by factual errors in exhibit numbers and missing specific dates/file numbers that verify the claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 439,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nRTX’s accrued liability for performance and operating‑cost guarantees declined steadily—from **$1.157 billion at the end of 2022**, to **$1.109 billion in 2023**, and further to **$0.993 billion by the end of 2024** (see Note 16 “Guarantees” tables).  The reduction reflects lower issuance of new guarantees, ongoing settlements of prior obligations and tighter monitoring of engine‑related commitments, indicating that the company’s exposure to these long‑term commercial‑aerospace contracts is easing, though a material contingent liability still remains.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the core quantitative facts. (1) WRONG NUMBERS: The LLM reports liabilities of $1.157 billion (2022), $1.109 billion (2023), and $0.993 billion (2024). The ground truth shows $140 million (2022), $135 million (2023), and $131 million (2024). These are off by a factor of approximately 8-9x. The LLM's numbers are roughly 8 times larger than the actual figures. (2) CALCULATION VERIFICATION: Ground truth shows a decline of $9M from 2022-2023 and $4M from 2023-2024 (total $13M decline). LLM shows a decline of $48M from 2022-2023 and $116M from 2023-2024 (total $164M decline). Both the absolute values and the rate of decline are completely wrong. (3) MULTI-HOP REASONING: While the LLM correctly identifies the trend (declining liabilities) and provides reasonable interpretation (lower issuance, settlements, tighter monitoring), this reasoning is built on fundamentally incorrect data. The semantic direction is right but the magnitude is catastrophically wrong. (4) ENTITY ACCURACY: RTX is correctly identified, years are correct (2022-2024), and the metric (performance and operating cost guarantees) is correctly identified. However, the LLM appears to have pulled data from a different line item or misread the filing entirely. The ground truth specifically references 'collaboration partners' share of financing guarantees' which is a distinct, smaller liability component. The LLM's much larger figures suggest it may have referenced total guarantee liabilities rather than the specific partnership-related component. This is a fundamental data retrieval failure that makes the answer unsuitable despite correct reasoning structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 465,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco continues to expense any free‑rent or step‑rent provisions on a straight‑line basis over the **entire lease term**, which now explicitly includes any renewal or extension options that management judges to be “reasonably certain” of being exercised.  This more explicit lease‑term assumption—adding likely extensions to the non‑cancelable period—slightly lengthens the period over which the right‑of‑use asset is amortized and changes the discount‑base for the ROU‑asset measurement, but the underlying method of measuring the ROU asset (present value of lease payments, using the incremental borrowing rate) has remained the same from FY 2022 through FY 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on core accounting principles and correctly identifies the key elements of Costco's lease accounting treatment. STRENGTHS: (1) Correctly states the straight-line basis for free-rent and step-rent provisions across all three years (2022-2024); (2) Accurately identifies the inclusion of extension options that are 'reasonably certain' to be exercised; (3) Correctly notes the use of incremental borrowing rate for present value calculations; (4) Properly explains that the underlying method remained consistent across the three-year period; (5) Accurately describes the impact on ROU asset amortization and discount-base calculations. WEAKNESSES: (1) The LLM answer does not address the evolution in disclosure emphasis that occurred from 2022 to 2024. The ground truth specifically notes that in 2023, disclosures expanded to clarify treatment of variable lease payments tied to price indices or sales volume, and that by 2024 there was heightened emphasis on impairment evaluation of long-lived assets in the context of facility relocations or closures. The LLM answer treats the disclosure as static rather than evolving. (2) The phrase 'slightly lengthens the period' is somewhat speculative and not explicitly confirmed in the ground truth, though it is logically sound. (3) The answer misses the contextual evolution aspect—that while core policy remained stable, the presentation context evolved to reflect growing operational complexity. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so this dimension scores high based on the absence of numerical errors. QUALITATIVE ACCURACY: The reasoning about lease accounting mechanics is sound, but the answer incompletely addresses the multi-hop synthesis required—specifically the evolution of disclosures across the three years and the shift in emphasis toward impairment evaluation. CONTEXTUAL RELEVANCE: The answer addresses the core question about accounting treatment and ROU asset valuation but incompletely addresses the 'evolution' aspect of the question, which was a key component of what was being asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 581,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved its AI‑driven document productivity effort from a behind‑the‑scenes integration of general AI (Adobe Sensei) into Acrobat and Document Cloud to a formally branded, AI‑centric platform. By 2024 Acrobat is positioned as the AI‑enhanced core of Adobe Document Cloud, backed by sizable R&D investment in foundation models (e.g., Firefly) and AI‑ethics frameworks, and is marketed under explicit product names such as “Adobe Document Cloud AI” and “Generative Credits.”",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct directional elements but contains significant factual errors and unsupported claims that reduce its accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies the evolution from 2022-2024\n- Accurately notes the shift toward formal AI branding by 2024\n- Correctly mentions 'Acrobat AI Assistant' as a branded product extension\n- Appropriately identifies Acrobat's role in document productivity\n- Correctly notes the multi-year R&D investment trajectory\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. QUANTITATIVE ERRORS: The LLM introduces specific product names ('Adobe Document Cloud AI' and 'Generative Credits') that are not mentioned in the ground truth. While these may exist in Adobe's actual offerings, they are not supported by the knowledge graph data provided.\n2. FIREFLY REFERENCE: The mention of 'Firefly' as a foundation model investment is not present in the ground truth answer. This appears to be an inference or external knowledge insertion not grounded in the provided data.\n3. AI-ETHICS FRAMEWORKS: The reference to 'AI-ethics frameworks' is not mentioned in the ground truth and appears to be an unsupported addition.\n4. ADOBE SENSEI: The LLM mentions 'Adobe Sensei' as the behind-the-scenes AI integration, which is not referenced in the ground truth answer.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable multi-hop synthesis by connecting R&D investments, product branding, and strategic positioning across the three-year period. However, the reasoning is partially undermined by introducing unsupported details.\n\nSEMANTIC EQUIVALENCE:\nWhile the LLM's core narrative (evolution from general AI integration to formal AI-branded products) aligns with the ground truth, the specific details diverge significantly. The ground truth emphasizes 'Acrobat AI Assistant' as the key branded product, while the LLM introduces additional product names not in the source material.\n\nJUSTIFICATION:\nThe answer receives a moderate score because it captures the overall trajectory correctly but introduces factual claims not supported by the knowledge graph, which violates the strict evaluation standard for financial/factual accuracy in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 592,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab markedly expanded the amount of client‑held securities it could pledge—fair‑value of pledgeable client securities rose from roughly $84 bn in 2020 to $120 bn in 2021 and stayed at that elevated level, while total collateral pledged to clearing houses and short‑term borrowings grew from $23 bn to $31 bn and IDA sweep balances remained above $80 bn.  This expansion was driven by higher margin‑loan balances, larger securities‑lending volumes and the use of pledged client assets to fund resale agreements, secured borrowings and the IDA program.  The trend reveals a deliberate balance‑sheet strategy of monetizing client securities to reduce external funding costs and boost liquidity, while the growing use of client collateral as margin backing indicates that clients are increasingly leveraging their accounts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM cites specific dollar amounts ($84bn in 2020, $120bn in 2021, $23bn to $31bn collateral pledged, $80bn+ IDA sweep balances) that are NOT present in the ground truth. The ground truth explicitly states that in 2022, Schwab 'did not quantify' pledged amounts. The LLM appears to have fabricated precise numbers without any basis in the source material. (2) TEMPORAL MISMATCH: The LLM references 2020-2021 data when the question specifically asks about 2022-2024 evolution. The ground truth focuses on the progression of disclosures and formalization across 2022-2024, not historical comparisons to 2020-2021. (3) MISSING KEY INFORMATION: The LLM fails to capture the core finding from ground truth - that Schwab's disclosures became MORE DETAILED over time (2022: no quantification → 2023: more detailed disclosures → 2024: explicit statements about OCC margin requirements and securities lending). The LLM instead invents a narrative about 'marked expansion' with unsupported numbers. (4) REASONING ERRORS: While the LLM correctly identifies that the trend reflects client leverage and balance sheet strategy, it does so based on fabricated data rather than actual filing disclosures. The ground truth emphasizes 'increasing formalization' of existing practices, not expansion of amounts. (5) SEMANTIC DIVERGENCE: The ground truth describes a disclosure evolution (more transparency/detail), while the LLM describes a quantitative expansion (more assets pledged). These are fundamentally different narratives. The LLM answer would mislead readers about Schwab's actual financial metrics and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 482,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nFrom 2022 through 2024 Costco kept the 1.375 % Senior Notes due June 2027 on its balance sheet as long‑term debt with a steady carrying amount of roughly $1.25 billion; the notes were never moved to current liabilities, although a modest $≈$100 million slice is disclosed as the current portion because it matures within the next fiscal year.  Over the same period the company’s total long‑term debt declined sharply—from $6.59 billion (including the $1.25 billion of 1.375 % notes) in 2022 to $5.92 billion by 2024—driven by the repayment of the 2.750 % notes in 2024 and a reduction in the current‑portion balance, while the 1.375 % notes remained a stable, non‑current component of the overall debt structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly incorrect long-term debt figures. Ground truth states long-term debt was $6,484 million in 2022 and $5,794 million in 2024. LLM claims $6.59 billion (2022) and $5.92 billion (2024), which are materially different from the ground truth values. The 2022 figure is off by ~$106 million and the 2024 figure is off by ~$126 million. These are not minor rounding differences but represent substantial discrepancies. (2) CLASSIFICATION ERROR - The LLM incorrectly states that 'a modest ~$100 million slice is disclosed as the current portion because it matures within the next fiscal year.' The ground truth explicitly states the 1.375% notes due June 2027 'remained consistently valued at $1,250 million' and were 'never moved to current liabilities.' The notes were NOT reclassified to current portion during this period. The reclassification mentioned in ground truth involved the 2.750% Senior Notes due May 2024, not the 1.375% notes. (3) MULTI-HOP REASONING - While the LLM correctly identifies that the 1.375% notes remained stable at ~$1.25 billion and that overall long-term debt declined, it fundamentally misunderstands the composition change. The ground truth clearly attributes the decline to reclassification of the 2.750% notes from long-term to current portion, not to repayment in 2024 as the LLM suggests. (4) SEMANTIC ISSUES - The statement about the notes being 'never moved to current liabilities, although a modest ~$100 million slice is disclosed as the current portion' is internally contradictory and factually incorrect. The ground truth shows no such reclassification occurred for these notes. (5) ENTITY ACCURACY - Correct identification of Costco and the specific note instruments, but incorrect application of their treatment and classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 502,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe shifted its free online self‑service learning from a stand‑alone training option to a strategic element of its broader learning‑and‑enablement portfolio, explicitly linking it to enterprise customer‑success outcomes. The company now integrates solution‑specific skills assessments and Customer Success Manager engagement so that the free modules are tailored to each client’s business objectives and feed into higher‑touch consulting, professional‑services and subscription enablement, ensuring that self‑service learning directly drives adoption, value realization and measurable ROI for enterprise customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2022-2024) and the core subject (Adobe's free online self-service learning). (2) No factual errors regarding dates or entities - Adobe is correctly identified. (3) The LLM captures the general trajectory of evolution from standalone to integrated offering. (4) Quantitative accuracy is strong - no numbers are provided in either answer, so no calculation errors exist.\n\nWEAKNESSES: (1) SPECIFICITY DEFICIT: The LLM answer introduces specific claims not present in the ground truth, such as 'Customer Success Manager engagement' and 'solution-specific skills assessments' being explicitly linked to enterprise outcomes. While the ground truth mentions skills assessments, it does not emphasize CSM engagement as a specific mechanism. (2) OVERSTATED INTEGRATION: The LLM claims the free modules are 'tailored to each client's business objectives' and 'feed into higher-touch consulting, professional-services and subscription enablement' - these claims go beyond what the ground truth supports. The ground truth states integration 'appears to have matured' and mentions 'aligning it more closely' but doesn't claim explicit feeding into paid services. (3) MISSING NUANCE: The ground truth emphasizes 'democratizing product knowledge' as a strategic commitment, which the LLM answer omits. (4) YEAR-BY-YEAR PROGRESSION: The ground truth provides specific details about 2022 (introduction as part of broader strategy), 2023 (reinforcement on learning.adobe.com), and 2024 (maintained structure with closer alignment). The LLM answer treats this as a general 2022-2024 shift without acknowledging the year-by-year evolution documented in the ground truth. (5) TONE DIFFERENCE: The LLM answer is more prescriptive and claims stronger integration than the ground truth's more measured 'appears to have matured' language.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis but makes inferential leaps beyond the source material. The connection between free learning and 'measurable ROI' is asserted but not explicitly supported in the ground truth.\n\nSEMANTIC EQUIVALENCE: While both answers discuss evolution and integration, the LLM's specific mechanisms (CSM engagement, direct ROI linkage) are not equivalent to the ground truth's more cautious framing of 'maturing approach.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 626,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes due 2031 have shown essentially no change in outstanding principal from 2022 through 2024 – the debt‑maturity tables in the 2022 (pp. 78‑82), 2023 (pp. 65‑69) and 2024 (pp. 70‑74) filings all list a carrying amount of roughly **$1.25 billion** for that series.  This steady exposure indicates that, as the company’s AI‑driven revenue has accelerated, NVIDIA is deliberately maintaining a stable, low‑cost long‑term debt profile rather than expanding leverage, using the fixed‑rate 2031 notes as a reliable funding pillar while preserving balance‑sheet flexibility for future growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the carrying amount was 'roughly $1.25 billion' consistently across 2022-2024, but the ground truth shows: 2022: $1.20 billion, 2023: $1.057 billion, 2024: $1.25 billion. The LLM incorrectly states there was 'essentially no change' when there was actually a $143 million decrease from 2022 to 2023 (12% reduction) and a $193 million increase from 2023 to 2024 (18% increase). These are material fluctuations, not 'essentially no change.' (2) MULTI-HOP REASONING FAILURE: The LLM's interpretation of the debt management strategy is fundamentally wrong. The ground truth identifies a deliberate three-phase pattern: initial reduction (2022→2023), then increase (2023→2024), suggesting dynamic optimization and refinancing opportunities. The LLM mischaracterizes this as 'steady exposure' and 'deliberately maintaining a stable' position, which contradicts the actual volatility in the numbers. (3) MISSING KEY INSIGHT: The ground truth correctly identifies that the 2023 reduction 'possibly to optimize capital structure or take advantage of refinancing opportunities' represents strategic debt management. The LLM completely misses this nuance by claiming stability. (4) SEMANTIC MISALIGNMENT: While the LLM correctly identifies the 2031 notes as a 'reliable funding pillar,' it fundamentally misinterprets the pattern as static when it is actually dynamic. The answer demonstrates a failure to synthesize the actual numerical progression across the three years and draws an incorrect conclusion about NVIDIA's debt strategy. The claim of 'steady exposure' is factually wrong given the documented fluctuations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 483,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from announcing a multi‑year, enterprise‑wide program to integrate, simplify and standardize the finance‑shared‑service platform (and related HR, IT, procurement and supply‑chain processes) to actively expanding and refining that program each year, explicitly aligning the design and operation of its financial control environment with the new standardized processes. This progression shows that the company is making financial‑process standardization and a rigorously controlled, unified control framework a core strategic priority—using the shared‑service initiative to embed stronger, repeatable controls rather than reacting to deficiencies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the multi-year initiative spanning 2022-2024 and accurate characterization of J&J's strategic focus. STRENGTHS: (1) Correctly identifies the timeframe (2022-2024) and the core initiative (enterprise-wide financial shared service enhancement); (2) Accurately captures the progression from announcement to active expansion and refinement; (3) Correctly emphasizes the proactive, non-reactive nature of the initiative; (4) Properly synthesizes the strategic intent around process standardization and control environment alignment; (5) No quantitative errors or date inaccuracies; (6) Appropriately expands scope to mention related functions (HR, IT, procurement, supply-chain) which adds relevant context. MINOR CONSIDERATIONS: (1) The LLM answer includes additional detail about related functions (HR, IT, procurement, supply-chain) that goes slightly beyond what the ground truth explicitly states, though this appears to be reasonable elaboration rather than factual error; (2) The ground truth emphasizes 'consistent messaging' and 'continuity' across three years, while the LLM answer emphasizes 'expanding and refining' - these are subtly different framings, though both are semantically compatible with the underlying narrative of sustained strategic focus; (3) The LLM answer uses slightly more assertive language ('core strategic priority') compared to the ground truth's more measured 'sustained strategic focus,' but this represents appropriate interpretation rather than factual error. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and properly connects the initiative's evolution to its strategic implications regarding control environment alignment. The reasoning is sound and logically coherent. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth - that J&J has maintained a consistent, proactive, multi-year initiative focused on financial process standardization and control enhancement, not reactive to deficiencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 562,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nCostco’s 10‑K filings consistently list BJ’s Wholesale Club—alongside Sam’s Club—as a warehouse‑club competitor (2022 p. 8; 2023 p. 9; 2024 p. 9), but the language around that rivalry does not change dramatically. What does evolve is the emphasis on Kirkland Signature: the 2022 filing merely notes that private‑label merchandise “helps lower costs and differentiates our offerings,” whereas the 2023 and 2024 filings explicitly describe Kirkland products as “high‑quality, priced lower than national brands” and state that the company “expects to continue to increase the sales penetration of our private‑label items,” positioning the brand as a core differentiator against BJ’s and other rivals.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate information but contains significant issues in completeness and accuracy relative to the ground truth. STRENGTHS: (1) Correctly identifies BJ's Wholesale Club as a named competitor across 2022-2024 filings; (2) Accurately notes that Kirkland Signature language evolved from general cost-lowering/differentiation language in 2022 to more explicit 'high-quality, priced lower than national brands' positioning in 2023-2024; (3) Correctly identifies the emphasis on increasing private-label sales penetration; (4) Page citations appear reasonable for 10-K competitive positioning sections. WEAKNESSES: (1) The LLM reverses the chronological accuracy - it claims 2022 filing 'merely notes' general language while 2023-2024 are more explicit, but the ground truth indicates 2022 already described Kirkland as 'high quality, offered at prices generally lower than national brands,' suggesting the LLM may have mischaracterized the 2022 baseline; (2) Missing the 2023 sustainability initiatives angle mentioned in ground truth, which represented an evolution in the competitive positioning narrative; (3) Fails to capture the ground truth's nuanced observation about 'growing emphasis on differentiation through private-label branding in response to competitive pressures' - the LLM notes evolution but doesn't fully articulate the strategic response dimension; (4) The LLM's characterization that 2022 'merely notes' general language while 2023-2024 are more explicit contradicts the ground truth's statement that 2022 already included the 'high quality, offered at prices generally lower than national brands' description; (5) Missing discussion of how the tone shifted toward 'differentiating our merchandise offerings' in increasingly competitive metropolitan markets (2024 evolution). The answer demonstrates partial understanding of the multi-hop synthesis required (comparing language across three years) but contains factual inaccuracies about what appeared in which year's filing, and omits important contextual elements about sustainability and market competitiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 566,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of Schwab’s U.S. state and municipal securities slipped slightly—from roughly $638 million in 2022 to about $579 million in 2023 and remaining at that low level in 2024—while still representing only a small slice of the total investment portfolio.  In each filing the company emphasizes that “substantially all” of its investment‑portfolio securities are investment‑grade, revealing a deliberate, conservative fixed‑income strategy that prioritizes credit quality and stability over higher‑yielding, riskier assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the timeline and values of Schwab's U.S. State and Municipal Securities holdings. According to the ground truth, the $638 million figure was disclosed in 2023, not 2022. The LLM incorrectly states 'roughly $638 million in 2022' when this amount actually appeared in 2023. Additionally, the LLM claims the value 'slipped' to $579 million in 2023 and 'remained at that low level in 2024,' but the ground truth does not provide a $579 million figure for 2023 or confirm specific values for 2024—it only states that 2024 'reaffirmed its focus on investment-grade quality.' The LLM has fabricated a declining trend ($638M → $579M → $579M) that is not supported by the ground truth. MULTI-HOP REASONING: The LLM failed to correctly synthesize the temporal evolution across the three-year period. The ground truth clearly indicates: 2022 (qualitative disclosure of investment-grade focus), 2023 (specific $638M quantification), 2024 (reaffirmation of investment-grade focus). The LLM reversed the chronology and invented intermediate values. QUALITATIVE ASSESSMENT: The LLM's characterization of the fixed income strategy as 'deliberate, conservative' and emphasizing 'credit quality and stability' is semantically aligned with the ground truth's conclusion about 'strategic preference for high-quality, lower-risk fixed income instruments.' However, this correct qualitative insight cannot offset the severe quantitative errors. COMPLETENESS: The LLM addressed the evolution question but provided incorrect data points, undermining the entire analysis. The emphasis on investment-grade quality was correctly identified but the numerical foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 477,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure fell modestly—from a maximum potential payment of about $288 million in 2022 to roughly $274 million by the end of 2024—while the portion of that exposure borne by its collaboration partners declined from $140 million in 2022 to $135 million in 2023 and $131 million in 2024.  This downward trend shows that RTX is transferring a smaller share of the risk to its partners and is therefore retaining a larger share of the guarantee liability itself, indicating a shift toward tighter internal risk retention rather than outsourcing it to collaborators.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key collaboration partners' share figures ($140M in 2022, $135M in 2023, $131M in 2024) and the downward trend. The answer correctly interprets this trend as indicating RTX is retaining a larger share of guarantee liability internally rather than outsourcing to collaborators. The LLM also provides additional context about total maximum potential payment exposure ($288M in 2022 declining to $274M in 2024), which adds useful detail not explicitly in the ground truth but appears consistent with the filing data. The reasoning about risk transfer strategy is sound and semantically equivalent to the ground truth's conclusion about 'increased internal risk retention.' However, the LLM answer omits one important element from the ground truth: the statement that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.' This omission represents a minor gap in completeness regarding the full risk management picture. The quantitative figures are all accurate, the multi-hop synthesis across years is correct, and the interpretation of the trend is logically sound. The answer is well-structured and directly addresses the question about how exposure evolved and what the trend indicates about risk transfer strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 401,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe expanded Frame.io from a video‑focused review tool into an end‑to‑end content‑production hub.  In 2022 it offered frame‑accurate commenting and Camera‑to‑Cloud upload for video with support for still images, design files and PDFs and integrated mainly with Premiere Pro and After Effects; by 2023 the integration grew to include Photoshop, Lightroom, Workfront and broader workflow stages such as casting and location‑scouting, and by 2024 it is embedded in Adobe GenStudio alongside Express and Firefly, supporting a wider array of file types (including AI‑generated assets) and serving as the central collaboration layer across Premiere Pro, After Effects, Photoshop, Lightroom, Express and other Creative Cloud applications.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant chronological and factual inaccuracies that contradict the ground truth. (1) CHRONOLOGICAL REVERSAL: The LLM states that in 2022 Frame.io offered 'Camera-to-Cloud upload' and integrated with 'Premiere Pro and After Effects,' but then claims that 'by 2023 the integration grew to include Photoshop, Lightroom, Workfront.' This directly contradicts the ground truth, which states these integrations (Photoshop, Lightroom, Workfront) occurred in 2024, not 2023. The 2023 description in ground truth is limited to Premiere Pro and After Effects integration. (2) MISPLACED DETAILS: The LLM incorrectly attributes 2024 features (GenStudio embedding, Express integration, AI-generated assets support) to a timeline that already contains 2023 integrations, creating confusion about when each capability was introduced. (3) INCOMPLETE 2022 CHARACTERIZATION: The ground truth indicates 2022 was primarily about trademark registration and acquisition branding alignment, not detailed feature descriptions. The LLM's detailed 2022 feature list (frame-accurate commenting, Camera-to-Cloud) appears to conflate 2022 with 2023 capabilities. (4) MISSING GROUND TRUTH ELEMENTS: The LLM fails to mention that 2022 was characterized by trademark registration and initial branding alignment, which is a key milestone in the evolution narrative. (5) ADDED UNSUPPORTED CLAIMS: The LLM introduces 'GenStudio,' 'Express,' and 'Firefly' integration details for 2024 that are not present in the ground truth, and mentions 'AI-generated assets' support without grounding in the source material. While the LLM correctly identifies the overall trajectory (expansion from video-focused to end-to-end content production), the specific timeline and feature attribution are substantially incorrect, making this answer misleading despite capturing the general narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 515,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s production focus on the VH‑92A shifted from an early, low‑rate “initial‑production” phase—mentioned in the 2022 Rotary‑and‑Mission‑Systems overview (pages 48‑52)—to a more visible, sustainment‑oriented effort highlighted in the 2023 Business Overview (pages 2‑6) where the VH‑92A was listed as a key Marine‑One transport platform and its backlog began to grow.  By 2024 the program still contributed to segment net sales and backlog (pages 38‑42) even though its volume was modest compared with the CH‑53K, signalling that the VH‑92A remains a strategic, long‑term priority for RMS as the firm continues to modernize the Marine‑One fleet and protect its Sikorsky helicopter portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer introduces specific claims NOT supported by the ground truth: it claims the VH-92A shifted from 'initial-production' phase in 2022 to 'sustainment-oriented' in 2023, with 'backlog began to grow' - none of these details appear in the ground truth. The ground truth simply states the VH-92A was 'listed among RMS's major helicopter programs' consistently across all three years. (2) PAGE REFERENCES - The LLM cites specific page numbers (48-52, 2-6, 38-42) which cannot be verified against the ground truth and appear to be fabricated details. (3) QUANTITATIVE CLAIMS - The LLM makes comparative statements ('modest compared with the CH-53K') that are not substantiated in the ground truth. (4) CORRECT ELEMENTS - The LLM does correctly identify: the three-year timeframe (2022-2024), the Rotary and Mission Systems segment, the VH-92A as a Marine-One platform, and the general conclusion about strategic importance and long-term commitment. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize a narrative progression, it does so by inventing details rather than synthesizing actual filing information. The ground truth emphasizes 'consistent mention' and 'stable, long-term commitment' without claiming phase transitions or backlog growth. The LLM's answer is more speculative and detailed than warranted by available evidence, introducing unsupported claims about production phases and backlog dynamics that contradict the ground truth's emphasis on consistency rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 429,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s sales‑ and media‑marketing restrictions moved from a relatively narrow, country‑by‑country focus to a far broader, EU‑wide and emerging‑market regime that is markedly stricter.  The 2022‑2024 “Regulation” sections note that, in addition to longstanding EU nutrient‑profile and hour‑based advertising limits, the firm now faces mandatory extended‑producer‑responsibility (EPR) obligations, plastic‑tax and single‑use‑plastic bans that are being rolled out not only across EU member states but also in emerging economies such as India, Vietnam and other Southeast‑Asian markets, and these requirements are increasingly enforced through formal legislation rather than voluntary industry agreements.  Consequently, the geographic scope of the restrictions expanded to include many more emerging markets, while the regulatory stringency grew—particularly in the EU—through tighter labeling, advertising caps and waste‑management rules that now apply across both developed and developing regions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the overall trajectory and correctly identifies the key regulatory developments affecting MDLZ from 2022-2024. The answer accurately captures: (1) the expansion from country-by-country to EU-wide and emerging market scope, (2) the specific regulatory mechanisms (EPR, plastic taxes, single-use plastic bans), (3) the geographic expansion to India, Vietnam, and Southeast Asia, and (4) the increasing stringency through formal legislation. The multi-hop synthesis across years and regions is sound and well-reasoned. However, there are quantitative accuracy issues: The ground truth specifies 'over 25 EU countries' had implemented EPR policies in 2022, which the LLM answer does not mention. The LLM also does not explicitly reference the 2024 EU Packaging and Packaging Waste Directive adoption, which is a key formal regulatory milestone in the ground truth. The LLM mentions 'longstanding EU nutrient-profile and hour-based advertising limits' which adds context not in the ground truth but is not contradictory. The answer is semantically equivalent in conveying the expansion and increasing stringency, but lacks the specific quantitative detail ('over 25 EU countries') and the explicit mention of the 2024 formal directive adoption. The reasoning about the shift from voluntary to mandatory/formal enforcement is well-articulated and aligns with the ground truth's characterization of increasing regulatory intensity. Overall, the answer captures the essential narrative correctly but misses some specific quantitative and temporal details that would strengthen factual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 449,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 3.700 % Notes due 2046 remain listed in the “Debt” footnote under the same indenture series (exhibit 4.14 in 2022, exhibit 4.14 in 2023 and exhibit 4.18 in 2024) and are consistently classified as long‑term liabilities with no current‑portion disclosure or early‑redemption activity.  The only changes are the addition of newer supplemental indentures that reference the 2046 tranche, indicating that Microsoft is maintaining this fixed‑rate, long‑dated debt as a stable component of its capital structure rather than refinancing or re‑classifying it.  This pattern reflects a long‑term debt strategy that emphasizes holding low‑cost, long‑maturity notes and supplementing them with new issuances rather than retiring existing long‑dated obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core facts and provides accurate information about Microsoft's treatment of the 3.700% Notes due 2046 across the three reporting years. STRENGTHS: (1) Correctly identifies the 3.700% interest rate and 2046 maturity date; (2) Accurately notes the consistent classification as long-term liabilities with no current-portion disclosure; (3) Correctly identifies the exhibit references (4.14 for 2022/2023, 4.18 for 2024); (4) Properly synthesizes the multi-hop information across three years; (5) Accurately characterizes the strategy as maintaining stable, fixed-rate, long-dated debt; (6) Correctly notes the addition of newer supplemental indentures. WEAKNESSES: (1) The LLM answer mentions 'exhibit 4.14' and 'exhibit 4.18' references which are specific details not explicitly confirmed in the ground truth, creating minor verification concerns; (2) The ground truth specifically references the 'Eleventh Supplemental Indenture dated August 8, 2016' which the LLM answer does not mention by name or date - this is a notable omission of a specific factual detail; (3) The LLM answer adds interpretive detail about 'low-cost' debt that, while reasonable, goes slightly beyond what the ground truth explicitly states. MULTI-HOP REASONING: The LLM correctly synthesizes information across all three years and draws appropriate conclusions about Microsoft's debt strategy. The reasoning is sound and logically connects the consistent treatment to strategic intent. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - both convey that Microsoft maintained these notes consistently across three years as a stable component of capital structure. The LLM's characterization of the strategy as 'emphasizing holding low-cost, long-maturity notes and supplementing them with new issuances' is semantically equivalent to the ground truth's description of 'maintaining stable, long-dated liabilities' and 'preference for predictable debt servicing costs.' The answer is substantively correct but lacks one specific factual reference (the Eleventh Supplemental Indenture date) that was in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 581,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nThe 2.000 % Notes due 2023 first appeared in Microsoft’s debt documentation with the **Fifteenth Supplemental Indenture (Exhibit 4.18) filed on 11 Nov 2023** in the 2023 Form 10‑K, which added a new 2.000 % tranche to the indenture and marked the inaugural issuance of that coupon. In the 2022 filing the only 2023‑maturing series referenced was the earlier **Sixth Supplemental Indenture (Exhibit 4.9)**, which had added 2.375 % Notes due 2023, so the 2.000 % notes were not yet part of the structure. By the 2024 filing the same 2.000 % tranche remained listed under the 2023 maturity bucket (still Exhibit 4.18), showing that the issuance had been fully integrated into Microsoft’s debt‑ladder and no further amendments to that series were made, reflecting a progression from higher‑coupon near‑term notes toward a lower‑coupon, longer‑dated maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. EXHIBIT NUMBERS: The LLM claims the 2.000% Notes due 2023 appeared in Exhibit 4.18 (Fifteenth Supplemental Indenture), but the ground truth states they were in Exhibit 4.14 across all three years (2022, 2023, 2024). This is a fundamental error in document identification.\n\n2. SUPPLEMENTAL INDENTURE IDENTIFICATION: The LLM incorrectly identifies the Fifteenth Supplemental Indenture as the source, when the ground truth clearly states the Eleventh Supplemental Indenture dated August 8, 2016 was the relevant document. The LLM also incorrectly references the Sixth Supplemental Indenture for 2.375% Notes in 2022.\n\n3. TIMELINE AND FIRST APPEARANCE: The LLM claims the 2.000% Notes first appeared in the 2023 filing (November 11, 2023), contradicting the ground truth which states they were present in the 2022 filing. This is a critical multi-hop error in tracking the debt instrument's evolution.\n\n4. CONSISTENCY ACROSS YEARS: The ground truth indicates the 2.000% Notes due 2023 were consistently referenced in all three years (2022, 2023, 2024) under the same exhibit structure. The LLM's narrative of a new issuance in 2023 contradicts this consistency.\n\n5. MATURITY STATUS IN 2024: While both answers acknowledge the notes appeared in 2024 filings despite the maturity year having passed, the LLM's explanation about integration into a debt ladder is speculative and doesn't align with the ground truth's more cautious interpretation about rollover, delayed maturity, or disclosure requirements.\n\n6. COUPON COMPARISON: The LLM's comparison between 2.000% and 2.375% notes, while potentially relevant context, is not supported by the ground truth and appears to be an inference rather than documented fact.\n\nThe LLM fundamentally misidentified the exhibit numbers, supplemental indentures, and timeline of the debt instrument's appearance across the three years, which are the core factual elements required to answer this multi-hop question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 557,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nThe company’s Non‑Employee RSU awards are anchored to two core incentive plans: the Amended and Restated 2013 Stock Award and Incentive Plan (the “2013 Plan”) and the newer 2021 Medtronic plc Long‑Term Incentive Plan. In the 2022, 2023 and 2024 Form 10‑K filings the RSU award language was updated and re‑issued as exhibits under these plans—2022 introduced the 2021 Long‑Term Incentive Plan with specific vesting schedules (e.g., 100 % after three years or ratable over four years), while 2023 and 2024 retained the same 2013‑Plan‑based “Non‑Employee Restricted Stock Unit Award Agreement” language but referenced the updated 2021 plan for the newer award forms. Thus, the evolution reflects a shift from generic RSU provisions in the 2013 plan to more detailed, plan‑specific agreements in the 2021 long‑term incentive framework, all still cited in each year’s filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) The LLM introduces a '2021 Medtronic plc Long-Term Incentive Plan' that is not mentioned in the ground truth across any of the three years (2022, 2023, 2024). The ground truth explicitly states that all three years referenced the 'Amended and Restated 2013 Stock Award and Incentive Plan' with no change in the foundational plan. (2) The LLM claims '2022 introduced the 2021 Long-Term Incentive Plan' which is chronologically problematic and not supported by the ground truth. (3) The LLM states that '2023 and 2024 retained the same 2013-Plan-based agreement but referenced the updated 2021 plan for newer award forms'—this is contradicted by the ground truth which shows consistent referencing of the 2013 Plan across all three years with no mention of a 2021 plan. (4) The ground truth emphasizes 'continuity in form and structure' and 'long-term stability' with the same Amended and Restated 2013 plan referenced in all three years. The LLM's narrative of evolution toward a '2021 long-term incentive framework' is entirely unsupported. (5) The LLM's claim about 'vesting schedules (e.g., 100% after three years or ratable over four years)' being introduced in 2022 is not corroborated by the ground truth. The answer fundamentally misrepresents the evolution of these agreements by introducing a non-existent plan and creating a false narrative of transition from the 2013 Plan to a 2021 Plan. The ground truth clearly indicates the 2013 Plan remained the consistent underlying plan across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 442,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the proportion of buy‑in annuity policies in MDLZ’s non‑U.S. pension portfolio was roughly 17 % in 2022, held steady at about 16 % in 2023, and then surged to ≈ 75 % of plan assets in 2024.  This jump reflects a deliberate shift toward a liability‑driven investment approach, using annuity purchases to transfer and lock‑in future pension obligations, thereby reducing long‑term funding risk and balance‑sheet exposure for its international plans.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims buy-in annuity policies 'surged to ≈ 75% of plan assets in 2024,' but the ground truth states they were 'effectively discontinued by 2024.' This is a massive discrepancy - the LLM reports a 59 percentage point increase (from 16% to 75%) when the actual trend was discontinuation. (2) DIRECTIONAL ERROR: The LLM describes an upward trend (17% → 16% → 75%) when the ground truth shows a downward trend (17% → 16% → discontinued/0%). This is the opposite of what actually occurred. (3) STRATEGIC INTERPRETATION ERROR: The LLM interprets the trend as 'a deliberate shift toward a liability-driven investment approach' and 'using annuity purchases to transfer and lock-in future pension obligations,' which contradicts the ground truth's interpretation that the company shifted 'away from insurer-backed annuities toward more direct liability management.' The LLM's narrative suggests increased reliance on annuities when the actual strategy involved moving away from them. (4) METHODOLOGY ERROR: The ground truth indicates the company 'shifted to fair value estimation methods' in 2024, suggesting a change in accounting/valuation approach rather than an increase in annuity holdings. The LLM completely misses this critical detail. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year evolution, producing numbers that are internally inconsistent with the documented trend. The answer demonstrates a fundamental misunderstanding of the pension strategy and provides factually incorrect data that would mislead stakeholders about MDLZ's pension management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 474,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nAcross fiscal 2022 the $2.5 bn of 2.000 % notes maturing in 2023 remained outstanding and were carried as a current liability; in fiscal 2023 Microsoft refinanced this tranche by issuing a new 2.000 % series with a later maturity (2025/2026) and retiring the 2023 notes; and in fiscal 2024 the company continued to roll the 2.000 % program into even longer‑dated securities. This roll‑forward reveals Microsoft’s deliberate strategy of extending debt maturities and maintaining a diversified, low‑cost funding profile to support long‑term liquidity and growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. QUANTITATIVE ERRORS: The LLM claims \"$2.5 bn of 2.000% notes maturing in 2023\" but provides no source for this specific dollar amount. The ground truth does not mention a $2.5 billion figure for these notes.\n\n2. MAJOR FACTUAL CONTRADICTION: The LLM states that \"in fiscal 2023 Microsoft refinanced this tranche by issuing a new 2.000% series with a later maturity (2025/2026) and retiring the 2023 notes.\" This directly contradicts the ground truth, which explicitly states: \"This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.\" The ground truth confirms the notes remained on the books through 2024 with no refinancing.\n\n3. INCORRECT NARRATIVE: The LLM describes a \"roll-forward\" strategy where Microsoft continuously extended maturities (2023→2025/2026→longer-dated in 2024). The ground truth indicates the opposite: the same 2.000% Notes due in 2023 were consistently referenced across all three years without refinancing or retirement.\n\n4. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the information across the three fiscal years. Instead of recognizing the consistency and stability of the debt instrument across years, it invented a refinancing narrative that has no basis in the ground truth.\n\n5. EXHIBIT REFERENCE MISSING: The ground truth specifically references Exhibit 4.14 and the Eleventh Supplemental Indenture dated August 8, 2016. The LLM provides no such documentary evidence.\n\n6. SEMANTIC CONTRADICTION: While the LLM's conclusion about \"extending debt maturities\" might sound reasonable as a general debt strategy, it is factually incorrect for this specific instrument, which was NOT refinanced or extended according to the ground truth.\n\nThe answer demonstrates fundamental misunderstanding of the actual debt evolution and invents details not supported by the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 562,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nAcross the three filings Microsoft consistently presented the 4.000% Notes due 2021 as part of the same indenture package that began with the 2009 Base Indenture and was first expanded by the Third Supplemental Indenture (Feb 8 2011, Exhibit 4.6); the 2022 10‑K merely reiterated that the notes remained governed by that 2011 supplement, while the 2023 10‑K added later supplemental indentures (e.g., the Dec 6 2013 Seventh Supplemental Indenture) that introduced additional series but left the 2021 notes untouched, emphasizing that the indenture structure was being continuously amended rather than replaced. In the 2024 10‑K Microsoft disclosed a Fifteenth Supplemental Indenture dated Nov 6 2023 (Exhibit 4.18) that updated the overall indenture terms and confirmed that the 4.000% 2021 notes continue to be governed by the amended indenture, reflecting a shift from simply referencing the original supplement to documenting ongoing amendments that are filed as new supplemental indentures within the broader debt‑instrument framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 4.000% Notes due 2021 remained consistently governed by the Third Supplemental Indenture (Feb 8, 2011) across all three years. The dates provided (Feb 8, 2011 for Third Supplemental; Dec 6, 2013 for Seventh Supplemental; Nov 6, 2023 for Fifteenth Supplemental) appear plausible and are not contradicted by the ground truth. The core insight that the notes remained unchanged while new supplemental indentures were introduced is correct.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces information about a 'Fifteenth Supplemental Indenture dated Nov 6 2023 (Exhibit 4.18)' in the 2024 10-K that is NOT mentioned in the ground truth answer. This represents potential hallucination or unverified detail. (2) The LLM references the '2009 Base Indenture' which is not mentioned in the ground truth, suggesting the model may be adding contextual information not confirmed by the source documents. (3) The ground truth explicitly states the notes appeared in 'Exhibit 4.6' across all three years, but the LLM claims the 2024 filing shows them in 'Exhibit 4.18' - this is a discrepancy that suggests either the LLM is confusing exhibits or the ground truth is incomplete. (4) The LLM's characterization of a 'shift from simply referencing the original supplement to documenting ongoing amendments' is interpretive and goes beyond what the ground truth establishes.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years and connect the evolution of supplemental indentures, which is appropriate for the question. However, the introduction of unverified details (Fifteenth Supplemental Indenture, Exhibit 4.18) undermines the reliability of this synthesis.\n\nFACTUAL VERIFICATION: The ground truth confirms: (1) Third Supplemental Indenture Feb 8, 2011 - CORRECT; (2) Notes in Exhibit 4.6 across all years - CONTRADICTED by LLM's claim of Exhibit 4.18 in 2024; (3) Consistent treatment across years - CORRECT; (4) New debt instruments introduced - CORRECT but examples differ slightly (LLM mentions 2.375% Notes due 2023 and 2.125% Notes due 2022, which align with ground truth examples).\n\nThe core answer is directionally correct but contains unverified details and at least one potential exhibit number discrepancy that raises concerns about accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 621,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nMedtronic’s 10‑K filings for fiscal 2022, 2023 and 2024 each state that the 40,000 authorized Euro‑Deferred Shares (par €1) were **issued and outstanding = 0**, and that no Preferred or A‑Preferred Shares were issued at any of those year‑ends. The repeated disclosure of a zero balance shows that the company does not rely on these special share classes for financing; its capital structure is built on ordinary shares, with cash‑generated funds and share‑repurchase programs used to return capital rather than issuing new equity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key numeric facts are accurate - correctly identifies 40,000 authorized Euro Deferred Shares with €1 par value, zero issued and outstanding across fiscal 2022-2024. (2) Correctly identifies the three fiscal years covered. (3) Accurately synthesizes the multi-hop information showing consistency across all three years. (4) Provides sound reasoning about capital structure strategy implications. (5) Appropriately extends analysis to mention Preferred/A-Preferred Shares and capital return mechanisms (share repurchases, cash generation). MINOR WEAKNESSES: (1) The LLM answer goes slightly beyond the ground truth by introducing information about Preferred/A-Preferred Shares and share-repurchase programs, which while contextually relevant and likely accurate, are not explicitly mentioned in the original answer. This represents a modest expansion rather than an error. (2) The phrasing 'issued and outstanding = 0' is slightly more technical than the ground truth's 'no Euro Deferred Shares were issued or outstanding,' but this is a semantic variation, not an error. (3) The ground truth uses more cautious language ('potentially signaling') while the LLM is more definitive ('does not rely on'), though both interpretations are reasonable given the consistent zero balances. QUANTITATIVE VERIFICATION: All numbers check out - 40,000 shares, €1 par value, zero balances across all three years. MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and draws appropriate conclusions about capital structure strategy. The answer demonstrates sound understanding of how consistent non-utilization of a financial instrument reveals strategic preferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 480,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 remain disclosed only as part of the original series of supplemental indentures (first created by the Third Supplemental Indenture of Feb 8 2011 and thereafter referenced in later supplemental indentures such as the 12th, 13th, 14th and 15th).  No new amendment, refinancing or change in terms is reported—each year the same exhibit numbers and descriptions are reproduced.  This consistent filing indicates that Microsoft treats the 4.000% 2021 notes as a stable, long‑term liability that has not been altered, reinforcing their status as a fixed component of the company’s capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The date of February 8, 2011 for the Third Supplemental Indenture is accurate; (2) The 4.000% interest rate is correct; (3) The observation that the notes were due in 2021 is accurate; (4) The core finding that there was consistency in disclosure across 2022, 2023, and 2024 filings matches the ground truth. PROBLEMATIC ELEMENTS: (1) The LLM introduces references to '12th, 13th, 14th and 15th' supplemental indentures without verification from the ground truth, which only mentions the Third Supplemental Indenture under Exhibit 4.6. This appears to be an unsupported elaboration that may be factually incorrect; (2) The LLM characterizes the notes as a 'stable, long-term liability that has not been altered' and a 'fixed component of the company's capital structure,' but the ground truth explicitly states the notes 'were matured or fully accounted for,' suggesting they were no longer active liabilities. This is a significant semantic and factual error—a matured debt is fundamentally different from an active long-term liability; (3) The LLM's interpretation misses the key implication from the ground truth that the consistent disclosure despite maturity indicates the notes were fully accounted for with no further actions required. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022, 2023, 2024) and identifies the consistency pattern. However, it fails to properly interpret what that consistency means in the context of a matured debt instrument. QUANTITATIVE ACCURACY: The specific dates and percentages are correct, though the introduction of additional supplemental indentures without ground truth support is concerning. QUALITATIVE ACCURACY: The reasoning about consistency is sound, but the interpretation of what that consistency indicates about the debt's status is fundamentally flawed—treating a matured debt as an active long-term liability is a material error in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 546,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nLockheed Martin’s pension‑risk‑transfer activity expanded modestly from 2022 through 2024, with roughly $2.6 billion of defined‑benefit obligations transferred in 2022, about $3.1 billion in 2023 and approximately $3.3 billion in 2024 (as disclosed in the 2022, 2023 and 2024 Form 10‑K filings).  This upward trend reflects a deliberate strategy to off‑load long‑term pension liabilities to insurers, thereby reducing exposure to PBGC premiums and earnings volatility and signaling a shift toward managing pension risk through external risk‑transfer rather than retaining those obligations on the company’s balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims $2.6B transferred in 2022, $3.1B in 2023, and $3.3B in 2024. However, the ground truth states that as of 2022, Lockheed Martin had cumulatively transferred approximately $11.6 billion in pension obligations since December 2018 - not $2.6B in 2022 alone. The LLM appears to have fabricated year-by-year transfer amounts that are not supported by the source documents. The annual figures ($2.6B, $3.1B, $3.3B) sum to $9B, which is inconsistent with the cumulative $11.6B figure disclosed. (2) MISSING KEY INFORMATION: The LLM failed to mention the $69 million in annual PBGC premium savings disclosed in 2022, which is a material detail about the financial impact of these transactions. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the strategic intent (reducing liabilities and volatility), it fails to properly synthesize the actual transaction amounts across the three-year period. The ground truth indicates a cumulative approach with ongoing evaluation and reaffirmation of intent, not discrete annual transfers of the amounts claimed. (4) REASONING FLAW: The LLM's conclusion about an 'upward trend' is based on fabricated numbers rather than actual disclosed data. The ground truth suggests a sustained, multi-year strategy with a cumulative $11.6B transferred by 2022 and continued commitment through 2024, not a year-by-year escalation. (5) SEMANTIC ISSUE: The LLM mischaracterizes the nature of the disclosures - the ground truth emphasizes cumulative transfers and strategic intent, while the LLM presents false annual breakdowns. This represents a fundamental misunderstanding or hallucination of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 494,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\nIn each of the 2022, 2023 and 2024 Form 10‑K filings the company lists the 0.125 % Notes due 2029 in the Exhibit Index (e.g., Exhibit 4.23 in the 2022 filing, Exhibit 4.31 in the 2023 filing and again as Exhibit 4.23 in the 2024 filing) and repeats the identical “Form of Note for 0.125 % Notes due 2029” language that references the same 1991 indenture and its supplements. This unchanged presentation shows that Coca‑Cola has kept a consistent debt‑instrument structuring and disclosure practice for this series of notes across the three reporting periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing the general theme of consistency. CRITICAL ERRORS: (1) Exhibit number inconsistency - The LLM states 'Exhibit 4.23 in the 2022 filing, Exhibit 4.31 in the 2023 filing and again as Exhibit 4.23 in the 2024 filing' but the ground truth indicates the note appeared in Exhibit 4.23 AND 4.31 in BOTH 2022 and 2023, not alternating between them. This is a material factual error in exhibit numbering across years. (2) Missing critical source documentation - The ground truth explicitly references that the notes cite 'Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021' as the underlying documentation. The LLM completely omits these specific Form 8-K references and dates, instead vaguely referencing 'the same 1991 indenture and its supplements' without the precision of the ground truth. (3) Incomplete disclosure pattern - The ground truth shows the note was listed in BOTH Exhibit 4.23 AND 4.31 in each year (2022, 2023, 2024), indicating dual disclosure. The LLM's exhibit numbering pattern suggests alternation rather than consistent dual listing. (4) Lack of specific documentation citations - The LLM fails to mention the September 2020 and March 2021 Form 8-K filings that are central to understanding the debt instrument's documentation trail. WHAT WAS CORRECT: The LLM correctly identifies (a) the 0.125% Notes due 2029, (b) that they appear across all three years (2022, 2023, 2024), (c) the general theme of consistent structuring and disclosure, and (d) that the same form language is repeated. However, the execution contains material errors in exhibit numbering sequences and omits key documentary evidence. The answer demonstrates partial understanding but fails on precision of factual details that are essential for evaluating consistency of debt instrument treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 513,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe disclosed “service and product warranties and product‑performance guarantees” schedule shows that RTX’s accrued liability for these obligations was **$1.06 bn at the end of 2022**, **rose to $1.16 bn at the end of 2023**, and then **declined to $0.99 bn at the end of 2024** (see RTX 10‑K 2022 p. 111; RTX 10‑K 2023 p. 101; RTX 10‑K 2024 p. 103).  \n\nThe increase through 2023 reflects higher accruals for long‑term engine warranty and operating‑cost guarantees, while the drop in 2024 indicates that settlements and claim payouts exceeded new guarantees issued, suggesting that the company’s exposure to sustained product‑performance risk peaked in 2023 and has been easing, though a sizable liability still remains.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides completely different numbers than the ground truth, indicating a fundamental factual error. Ground truth shows collaboration partners' share of financing guarantees at $141M (2022), $135M (2023), and $131M (2024). The LLM answer instead cites total accrued liabilities of $1.06B (2022), $1.16B (2023), and $0.99B (2024) - numbers that are approximately 7-8x larger than the ground truth figures. While the LLM's numbers may come from a different line item in the 10-K (possibly total warranty and guarantee liabilities across all business segments rather than just the performance and operating cost guarantees for commercial aerospace), this represents a significant misalignment with the specific question asked about 'liabilities for performance and operating cost guarantees.' The question specifically asks about RTX's exposure in commercial aerospace, and the ground truth provides precise figures for the collaboration partners' share. The LLM's interpretation of the trend (increase through 2023, decline in 2024) is directionally similar to the ground truth's characterization of 'relatively stable' with slight decreases, but the magnitude and specific focus are wrong. The LLM provides page references to 10-K filings, suggesting sourcing from actual documents, but the numbers cited do not match the ground truth data. This is a quantitative accuracy failure on the primary metric requested - the evolution of specific liability figures from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 416,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic has kept using the Black‑Scholes model for non‑qualified‑option valuations but has progressively updated its key inputs from 2022 to 2024: volatility rose modestly from ≈23 % to ≈24.3 %, the risk‑free rate increased from ≈0.9 % to ≈4.2 %, and the dividend‑yield assumption grew from ≈2 % to ≈3.2 %, while the expected life stayed near six years. These adjustments—especially the higher volatility and higher cost‑of‑capital assumptions—signal a more conservative view of equity‑compensation risk, reflecting the company’s effort to align its option‑pricing inputs with current market conditions rather than any fundamental change in methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical values (volatility ~23% to ~24.3%, risk-free rate ~0.9% to ~4.2%, dividend yield ~2% to ~3.2%, expected life ~6 years) that cannot be verified against the ground truth, which does not provide these specific quantitative metrics. This is a critical issue: the LLM appears to have fabricated precise numerical data that was not present in the original answer. The ground truth focuses on qualitative evolution of disclosure practices and methodology transparency (Black-Scholes consistency, explicit mention of market-traded options for implied volatility starting in 2023), not on specific parameter values. The LLM's answer does correctly identify that Black-Scholes was used consistently across the period, which aligns with the ground truth. However, the LLM fundamentally misinterprets the question's focus: the original answer emphasizes the EVOLUTION OF DISCLOSURE AND TRANSPARENCY around volatility assumptions (moving from implicit to explicit mention of market-traded options), while the LLM answer shifts focus to alleged changes in actual parameter values. The LLM's characterization of these changes as reflecting 'a more conservative view' and 'higher cost-of-capital assumptions' cannot be verified and may be incorrect. The LLM fails to address the key insight from the ground truth: that the meaningful evolution was in how Medtronic DISCLOSED its volatility assumptions (adding transparency about market-traded options), not necessarily in the underlying methodology or risk modeling approach. The answer demonstrates poor multi-hop reasoning by inventing quantitative details rather than synthesizing the actual disclosed information about methodology evolution. The claim about 'aligning with current market conditions' is somewhat aligned with the ground truth's mention of 'market-informed approach,' but the specific numerical support is fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 517,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nThe 2022 10‑K (Exhibit 4.26) records the initial $1 bn issuance of 1.000 % notes maturing in 2028; the 2023 filing shows a second tranche of the same series, raising the aggregate amount outstanding to roughly $2 bn, and the 2024 filing adds a third tranche, pushing total issuance to about $3 bn.  This step‑wise buildup indicates that Coca‑Cola is deliberately expanding a low‑cost, long‑dated fixed‑rate debt pillar—issuing incremental 1.000 % 2028 notes each year to lock in favorable rates and fund its long‑term financing needs while maintaining a stable, predictable debt structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer makes specific quantitative claims that directly contradict the ground truth and cannot be verified from standard SEC filings. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims three tranches of 1.000% Notes due 2028 were issued in 2022, 2023, and 2024, totaling approximately $3 billion ($1bn + $1bn + $1bn). The ground truth states the company 'consistently referenced' these notes across all three years but does NOT indicate multiple tranches or a step-wise buildup to $3bn. The LLM provides specific dollar amounts ($1bn, $2bn, $3bn) without evidence from the filings. (2) FACTUAL CONTRADICTION: The ground truth explicitly states the 1.000% Notes due 2028 'remained part of the company's long-term debt structure' but emphasizes that in 2024, KO 'introduced significantly higher-yielding notes (5.000% Notes due 2034 and 5.300% Notes due 2054),' suggesting a strategic SHIFT away from low-rate borrowing. The LLM interprets this as deliberate expansion of the 1.000% instrument, which contradicts the ground truth's characterization of a shift toward higher-interest debt. (3) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key insight from the ground truth—that while the 1.000% Notes remained visible, the company's 2024 strategy shifted toward MORE AGGRESSIVE borrowing terms with higher yields. Instead, the LLM frames the 1.000% Notes as an intentional expansion strategy. (4) UNSUPPORTED CLAIMS: The LLM cites 'Exhibit 4.26' and makes specific tranche claims that cannot be independently verified and contradict the ground truth's more cautious language about 'consistent referencing' rather than new issuances. The ground truth does not support the claim of incremental annual issuances. (5) MISSING CONTEXT: The LLM completely omits the critical 2024 strategic shift toward higher-yielding instruments (5.000% and 5.300% notes), which is central to understanding KO's debt strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 527,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nMicrosoft’s 2.125 % senior notes have been issued consistently under the same master indenture (the May 18 2009 Base Indenture) with The Bank of New York Mellon Trust Company, N.A. acting as trustee. In the 2022 filing the notes appear in the 2012 Fourth Supplemental Indenture that originally created the 2.125 % Notes due 2022; the 2023 filing adds a later supplemental indenture (the November 6 2023 Fifteenth Supplemental Indenture) that refinances that series and bundles it with other note tranches, and the 2024 filing repeats the same structure—only updating the exhibit list with the newest supplemental indenture—while the trustee arrangement and overall indenture framework remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) CRITICAL DATE ERROR: The LLM states the 2.125% Notes were 'due 2022' in the 2022 filing, but the ground truth clearly indicates they were 'due 2021' - this is a fundamental misidentification of the instrument. (2) SUPPLEMENTAL INDENTURE MISMATCH: The LLM claims the 2022 filing references the '2012 Fourth Supplemental Indenture' and that the 2023 filing introduces a 'November 6 2023 Fifteenth Supplemental Indenture,' but the ground truth states the 2022 filing disclosed the 'Seventh Supplemental Indenture' - the LLM has cited incorrect supplemental indenture numbers. (3) STRUCTURAL CHANGE CLAIM: The LLM asserts that the 2023 filing 'adds a later supplemental indenture...that refinances that series and bundles it with other note tranches,' suggesting a structural change. However, the ground truth explicitly states 'the structure remained consistent' across all three years with 'no changes in the structure or administration.' (4) TRUSTEE ACCURACY: The trustee identification (The Bank of New York Mellon Trust Company, N.A.) is correct, and the base indenture reference appears reasonable, but these correct elements cannot offset the major errors in instrument identification and supplemental indenture citations. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution (or lack thereof) across the three-year period, incorrectly suggesting structural changes when the ground truth indicates consistency. The answer demonstrates a fundamental misunderstanding of which debt instrument was being tracked and how it was documented across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 455,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share interest stayed essentially unchanged – about 57 % in IAE and about 51 % in IAE LLC from 2022 through 2024 (the figures are after the sub‑collaborator allocations are applied).  This steady, controlling economic stake shows that RTX is deliberately maintaining a dominant position in the V2500 (IAE) and PW1100G‑JM (IAE LLC) engine collaborations, ensuring influence over their development and after‑market economics while sharing risk with its partners.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023-2024 net program share percentages (57% for IAE and 51% for IAE LLC) and accurately notes these are after sub-collaborator allocations. The interpretation about RTX maintaining a dominant position and strategic control is reasonable and contextually appropriate. The connection to V2500 and PW1100G-JM programs is correct.\n\nCRITICAL ERRORS: The LLM makes a significant factual error by claiming the figures 'stayed essentially unchanged...from 2022 through 2024.' The ground truth explicitly states that in 2022, the program share interest was 61% for IAE and 59% for IAE LLC (before sub-collaborator adjustments), which then decreased to 57% and 51% respectively by 2023. This represents a material change (4 percentage points for IAE, 8 percentage points for IAE LLC), not stability. The LLM conflates the 2023-2024 stabilization with a 2022-2024 trend, missing the important 2022-2023 evolution that the question specifically asks about.\n\nMULTI-HOP REASONING: The LLM fails to properly synthesize the temporal progression across all three years. It correctly identifies the 2023-2024 plateau but misses the 2022-2023 decline, which is a key part of understanding 'how...evolve from 2022 to 2024.' The ground truth emphasizes this evolution as a 'strategic recalibration,' while the LLM presents it as unchanged, fundamentally misrepresenting the progression.\n\nQUANTITATIVE ACCURACY: The percentages cited (57% and 51%) are correct for 2023-2024, but the claim of no change from 2022 is factually wrong. The LLM should have noted the 2022 figures (61% and 59%) and the subsequent decrease.\n\nCONTEXTUAL RELEVANCE: The strategic interpretation is sound and relevant, but it's based on an incomplete/incorrect understanding of the actual data progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 491,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s expense for its defined‑contribution (401(k)) plans rose from **$402 million in 2022** to **$468 million in 2023**, then slipped slightly to **about $443 million in 2024** (as disclosed in Note 7 of the 2023 and 2024 10‑K filings).  This upward trajectory—with a modest pull‑back in 2024 but still above the 2022 level—indicates that the company has been steadily increasing its financial commitment to employee benefits, using higher contributions to signal a strategic investment in attracting and retaining talent over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's contributions were $402 million in 2022, but the ground truth clearly shows $299 million in 2022. This is a significant discrepancy of $103 million (34% overstatement). The 2023 ($468 million) and 2024 ($443 million) figures are correct. IMPACT ON ANALYSIS: This error fundamentally distorts the trajectory analysis. The ground truth shows a dramatic 56% increase from 2022 to 2023 ($299M to $468M), followed by a 5% decline to 2024. The LLM's incorrect 2022 figure makes the 2023 increase appear much smaller (16% instead of 56%), significantly understating the magnitude of the 2023 investment surge. The LLM's characterization of 'steady increasing' is misleading given the actual sharp jump in 2023. CORRECT ELEMENTS: The 2023 and 2024 figures are accurate. The general narrative about employee benefits investment is reasonable, though based on incorrect baseline data. The citation to Note 7 of 10-K filings is appropriate. REASONING QUALITY: The multi-hop synthesis approach is sound (comparing across three years, drawing conclusions about strategic priorities), but the foundation is compromised by the wrong 2022 number. The conclusion about 'steadily increasing' is not well-supported by the actual data pattern (sharp spike then modest decline). QUANTITATIVE ACCURACY: 2/10 due to the major 2022 error despite correct 2023-2024 figures. QUALITATIVE ACCURACY: 5/10 because reasoning structure is present but conclusions are based on flawed data. CONTEXTUAL RELEVANCE: 6/10 because the answer addresses the question but with a fundamental factual error that undermines the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 450,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nAcross the 2022‑2024 filings Coca‑Cola kept the 3.000 % Notes due 2051 on its books and repeatedly listed the same instrument in its exhibits, while also adding newer long‑dated debt issues (e.g., 3.125 % Notes due 2032, 5.000 % Notes due 2034, 5.300 % Notes due 2054). This shows the company is deliberately extending the maturity of its fixed‑rate borrowing and using a laddered series of long‑term notes to lock in low‑cost capital, reflecting a capital‑structure strategy that emphasizes stability, low leverage and a conservative mix of short‑ and very‑long‑dated debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Coca-Cola maintained the 3.000% Notes due 2051 across 2022-2024 filings, matching the ground truth. (2) The LLM correctly identifies new debt instruments introduced (5.000% Notes due 2034, 5.300% Notes due 2054), which aligns with the original answer. (3) The reasoning about capital structure strategy (laddered debt, maturity extension, stability focus) is sound and semantically equivalent to the ground truth's conclusion about 'balancing long-term obligations with current market interest rate conditions.' (4) The multi-hop synthesis across three years is logically structured.\n\nWEAKNESSES: (1) FACTUAL ERROR: The LLM introduces the '3.125% Notes due 2032' as a new instrument added during 2022-2024, but this instrument is NOT mentioned in the original answer's list of new instruments. The ground truth only mentions '5.000% Notes due 2034' and '5.300% Notes due 2054' as new higher-coupon instruments introduced by 2024. This is a significant factual inaccuracy that cannot be verified against the ground truth. (2) The LLM characterizes the strategy as emphasizing 'low leverage' and 'conservative mix,' which goes beyond what the ground truth states. The ground truth focuses on 'diversifying with higher-yielding instruments' and 'balancing obligations with market conditions,' not explicitly on leverage reduction. (3) The LLM's characterization of 'locking in low-cost capital' is somewhat contradictory to the introduction of higher-coupon instruments (5.000%, 5.300%), which suggests responding to rising rate environments rather than locking in low costs.\n\nQUANTITATIVE ACCURACY: The percentages and years mentioned (3.000%, 2051, 5.000%, 2034, 5.300%, 2054) are correct where they appear in both answers. However, the introduction of the 3.125% Notes due 2032 is an unsupported addition that reduces quantitative accuracy.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression pattern. However, the introduction of an unverified instrument weakens the multi-hop synthesis quality.\n\nOVERALL: The answer captures the core narrative (maintaining 3.000% Notes while adding higher-coupon debt) but introduces a factual error regarding the 3.125% Notes that is not in the ground truth, and makes some interpretive leaps about leverage and conservatism that exceed the original answer's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 645,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle repeatedly tapped the medium‑term note market to add to and refinance its 2.875 % Notes due 2031—first disclosing an updated officers’ certificate and a new tranche in the 2022 Form 10‑K, issuing additional 2.875 % 2031 notes in the 2023 filing, and in the 2024 filing confirming a further amendment and larger aggregate issuance of the same series.  This progression shows Oracle’s intent to build a sizable, long‑dated, low‑coupon debt pillar, locking in inexpensive financing for its multi‑year growth strategy while reducing reliance on shorter‑term borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ACCURACY: The LLM claims Oracle issued 'additional 2.875% 2031 notes in the 2023 filing' and 'further amendment and larger aggregate issuance' in 2024, but the ground truth indicates the 2.875% Notes were simply reaffirmed/continued in filings, not newly issued or increased in aggregate amounts. The LLM provides no specific dollar amounts or issuance details, making unsubstantiated claims about 'larger aggregate issuance.' (2) FACTUAL ERRORS: The LLM incorrectly suggests Oracle was actively issuing additional tranches of the same 2.875% series across years, when the ground truth shows the notes were consistently listed but not newly issued each year. (3) MISSING CRITICAL CONTEXT: The LLM completely omits the key strategic insight from the ground truth—that by 2024, Oracle was issuing NEWER, HIGHER-YIELDING notes (4.500% due 2028, 4.900% due 2033) alongside the 2.875% notes. This diversification toward higher-coupon debt is central to understanding Oracle's debt strategy evolution and market conditions, but the LLM answer ignores it entirely. (4) REASONING FLAW: The LLM's conclusion that Oracle was 'building a sizable, long-dated, low-coupon debt pillar' by repeatedly issuing the same 2.875% notes contradicts the actual strategy shown in the ground truth—maintaining the 2.875% as stable while ADDING higher-cost debt instruments. (5) SEMANTIC MISALIGNMENT: The LLM's narrative of 'repeated issuance' and 'larger aggregate issuance' does not match the ground truth's narrative of 'continuity' and 'reaffirmation' with strategic diversification into higher-yielding instruments. The answer demonstrates incomplete multi-hop synthesis and misinterprets the progression of Oracle's debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 500,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s repeated, explicit reference to the 2.000 % Notes due 2023 in each of its 2022, 2023 and 2024 10‑K filings shows that the company deliberately surfaces this upcoming maturity each year.  By doing so, it signals a transparent, disciplined approach to long‑term debt management—keeping investors fully aware of the timing and size of a key obligation and reinforcing confidence in its overall capital‑structure strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft's 2.000% Notes due 2023 were disclosed across 2022, 2023, and 2024 10-K filings, and this reflects a transparent debt management approach. All numeric values (2.000%, the three years) are accurate. The reasoning about transparency and investor confidence is sound and semantically equivalent to the ground truth. However, the LLM answer is notably less comprehensive than the ground truth. Specifically: (1) The LLM omits important contextual details such as the Eleventh Supplemental Indenture dated August 8, 2016, which provides historical context for the instrument; (2) The LLM does not mention that the filing details remained 'unchanged' across all three years, which is a key indicator of consistency; (3) The LLM does not reference the trustee or other specific filing details that reinforce the consistency narrative; (4) The ground truth explicitly connects this to 'predictable financial stewardship' and 'favorable credit ratings,' while the LLM only mentions 'confidence in its overall capital-structure strategy.' The LLM's interpretation that the company 'deliberately surfaces this upcoming maturity each year' is reasonable but slightly shifts the emphasis from the consistency of the instrument itself to the strategic timing of disclosure. This is a minor interpretive difference rather than an error. Overall, the answer is factually correct on core points but lacks the depth and specific supporting details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 418,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nFrom 2022 through 2024 the contingent flight‑hour payments to Rolls‑Royce—recorded in the “Other commercial aerospace commitments” line of RTX’s commercial‑aerospace commitment schedule—were roughly **$0.7 bn in 2022, about $1.05 bn in 2023 and roughly $0.75 bn in 2024**. These payments are triggered by flight‑hour usage of V2500‑powered aircraft under the 2012 IAE acquisition agreement and are capitalized as collaboration intangible assets when settled, with the obligation extending through **June 2027**.  Consequently, RTX’s exposure to Rolls‑Royce remains multi‑year and material, as the company will continue to recognize and settle these hour‑based commitments over the remaining horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($0.7bn in 2022, $1.05bn in 2023, $0.75bn in 2024) that are NOT present in the ground truth answer. The ground truth explicitly does NOT quantify these contingent payments with specific dollar figures—it only describes the qualitative evolution and accounting treatment. The LLM appears to have fabricated precise financial numbers without evidence from the source material. This is a severe factual error that undermines the entire response's credibility. CORRECT ELEMENTS: (1) The LLM correctly identifies the payments as being in 'Other commercial aerospace commitments' (2) Correctly notes the V2500-powered aircraft connection (3) Correctly identifies the June 2027 end date (4) Correctly describes the capitalization and amortization treatment (5) Appropriately characterizes the exposure as 'multi-year and material.' MISSING ELEMENTS: The LLM fails to capture the important evolution in disclosure/accounting treatment across the three years—specifically that 2022 showed expected capitalization, 2023 clarified actual capitalization and amortization to cost of sales, and 2024 maintained consistency. The ground truth emphasizes this progression as indicating 'stable long-term financial exposure,' which the LLM mentions only generically. QUANTITATIVE ACCURACY FAILURE: The invented dollar amounts are completely unsupported by the ground truth and represent a fundamental breach of factual accuracy. Even if these numbers appeared in the actual 10-K filings, they are not validated by the ground truth knowledge graph provided, making their inclusion inappropriate and misleading. The answer reads plausibly but is built on false quantitative foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 471,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nThermo Fisher’s domestic pension plan held **$89 million** in U.S.‑equity funds in 2022, **$93 million** in 2023, and **$91 million** in 2024.  Because total domestic‑plan assets were $937 million (2022), $947 million (2023) and $895 million (2024), the U.S.‑equity share rose from roughly **9.5 %** of the portfolio in 2022 to about **10 %** in 2024 (peaking at ~9.8 % in 2023).  \n\nThis modest but consistent upward trend indicates that the company is **gradually increasing its exposure to U.S. equities** within its domestic pension assets, reflecting a strategic shift toward a slightly higher equity allocation while still maintaining a large fixed‑income, liability‑hedging core.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth across all three years:\n\n(1) QUANTITATIVE ACCURACY FAILURES:\n- 2022: LLM states $89M, Ground Truth states $125M (ERROR: -$36M or -28.8%)\n- 2023: LLM states $93M, Ground Truth states $89M (ERROR: +$4M or +4.5%)\n- 2024: LLM states $91M, Ground Truth states $93M (ERROR: -$2M or -2.1%)\n\nThe LLM has essentially inverted the 2022 and 2023 values, placing them in the wrong years. This is a critical factual error that cascades through all subsequent analysis.\n\n(2) CALCULATION ERRORS:\nThe percentage calculations are based on incorrect base numbers. While the mathematical operations appear sound (89/937 ≈ 9.5%), they are applied to wrong data points, making the percentages meaningless.\n\n(3) DIRECTIONAL ANALYSIS COMPLETELY REVERSED:\n- Ground Truth: Allocation DECREASED from $125M (2022) → $89M (2023), then slightly INCREASED to $93M (2024). This shows a cautious reduction with modest rebound.\n- LLM Answer: Claims allocation INCREASED from $89M → $93M → $91M, suggesting \"gradually increasing exposure to U.S. equities.\"\n\nThe LLM's conclusion is the opposite of what the data actually shows. The ground truth indicates a strategic reduction in U.S. equity exposure, while the LLM incorrectly characterizes it as an increase.\n\n(4) MULTI-HOP REASONING:\nThe LLM failed at the fundamental data synthesis step. Rather than correctly identifying the three-year trajectory, it misaligned the annual figures, leading to an entirely incorrect strategic interpretation.\n\n(5) SEMANTIC MEANING:\nThe semantic meaning is fundamentally wrong. The question asks about a change from 2022 to 2024 showing a \"3-year trajectory.\" The ground truth shows a decline followed by partial recovery. The LLM shows a steady increase, which is factually incorrect and leads to opposite strategic conclusions.\n\nThis is a complete failure on the primary metric of factual accuracy for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 542,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2023 Coca‑Cola’s long‑term debt strategy focused on maintaining a diversified ladder of low‑coupon obligations—most notably the 1.000 % Notes due 2041 that had been issued in 2021 and remained on the books—while gradually extending maturities and keeping overall funding costs modest.  \n\nIn 2024 the company shifted its approach, deliberately entering the market with higher‑yielding debt to capitalize on the rising‑rate environment; the 2024 10‑K filing lists new issuances such as 5.000 % Notes due 2034, 5.300 % Notes due 2054 and 5.400 % Notes due 2064 (plus other mid‑term notes with coupons above 3 %), signaling a strategic move toward higher‑yielding, longer‑dated financing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Coca-Cola's debt strategy evolution and correctly identifies the key instruments and the strategic shift. STRENGTHS: (1) All specific coupon rates and maturity years are accurate (1.000% due 2041, 5.000% due 2034, 5.300% due 2054, 5.400% due 2064). (2) The core narrative is correct—low-coupon focus in 2022-2023, shift to higher-yielding instruments in 2024. (3) The reasoning about market conditions and strategic recalibration is sound and matches the ground truth interpretation. (4) The multi-hop synthesis across three years is properly executed. WEAKNESSES: (1) The LLM mentions the 1.000% Notes were 'issued in 2021' which is an inference not explicitly stated in the ground truth (which only confirms they were referenced in 2022, 2023, and 2024). (2) The answer omits specific reference to the 0.400% Notes due 2030 (2022) and 0.950% Notes due 2036 (2023) that the ground truth explicitly mentions as examples of earlier lower-yielding instruments. This is a minor omission of supporting detail. (3) The answer doesn't explicitly mention the exhibit references (Exhibit 4.33) that appear in the ground truth, though this is a minor documentation detail. (4) The phrase 'plus other mid-term notes with coupons above 3%' is somewhat vague compared to the ground truth's specific instrument citations. QUANTITATIVE VERIFICATION: All coupon percentages and years are correct. No calculation errors. MULTI-HOP REASONING: Successfully synthesizes information across 2022, 2023, and 2024 to show the evolution. The logical flow from low-coupon to high-coupon strategy is properly established. SEMANTIC EQUIVALENCE: The answer conveys the essential information and strategic shift accurately, though with less granular detail than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 489,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle has kept the 1.650 % Notes due 2026 on its balance sheet in each of the fiscal‑year filings for 2022, 2023 and 2024, reaffirming the same low‑cost tranche across the three years.  This persistence stands in contrast to the company’s recent practice of issuing newer notes with higher coupons (e.g., 2.5 %–4.5 % issues in 2022‑2024), indicating that Oracle’s debt‑financing strategy relies on a stable, inexpensive long‑dated pillar while using higher‑rate issuances only to broaden maturities and meet specific funding needs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Oracle maintained the 1.650% Notes due 2026 across fiscal years 2022, 2023, and 2024, and recognizes the dual strategy of maintaining low-cost debt while issuing higher-rate notes. However, there are significant quantitative accuracy issues: (1) The LLM states newer notes had 'e.g., 2.5%-4.5% issues in 2022-2024' which is vague and imprecise. The ground truth specifically identifies the 5.800% Notes due 2025 (issued in 2023) and 4.500% Notes due 2028 (issued in 2024). The LLM's range of 2.5%-4.5% is incomplete and doesn't capture the 5.800% rate mentioned in the ground truth, which is a material omission. (2) The LLM fails to cite the specific exhibit references (4.16 for 2022, 4.14 for 2023 and 2024) that ground the ground truth answer. (3) The reasoning about 'broadening maturities and meeting specific funding needs' is somewhat speculative compared to the ground truth's more precise characterization of 'preserving liquidity through favorable borrowing terms.' The multi-hop synthesis is partially correct—the LLM does connect the persistence of low-cost debt with the introduction of higher-rate instruments—but the specific financial data supporting this synthesis is incomplete and inaccurate. The answer demonstrates understanding of the strategic concept but fails on precision of the quantitative details that are central to evaluating debt financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 394,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated listing of Exhibit 4.6—the third supplemental indenture that contains the 4.000% Notes due 2021—in the 2022, 2023 and 2024 Form 10‑K filings shows that it treats that indenture as the active legal framework for its long‑term debt. Rather than retiring or rewriting the original agreement, the company updates it through newer supplemental indentures (e.g., 4.15‑4.18), indicating a strategy of incremental refinancing and documentation refreshes that preserve the existing note series while adding new tranches.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 4.000% Notes due 2021 were ALREADY DUE in 2021 and their continued inclusion in Exhibit 4.6 across 2022-2024 is notable precisely because they appear AFTER their maturity date. The LLM answer incorrectly characterizes this as 'the active legal framework for its long-term debt' and suggests these are ongoing active notes, when the ground truth indicates they are historical/reference items that remained in documentation even after maturity. SPECIFIC ERRORS: (1) The LLM misinterprets the significance of the notes' continued presence - the ground truth emphasizes this is unusual/notable because the notes were already due in 2021, yet still listed in subsequent years. The LLM treats them as current active debt. (2) The LLM introduces unsupported claims about 'newer supplemental indentures (e.g., 4.15-4.18)' and 'incremental refinancing' that are not mentioned in the ground truth and appear to be fabricated. (3) The LLM's interpretation of 'incremental refinancing and documentation refreshes' contradicts the ground truth's explicit statement that 'Microsoft did not actively restructure this portion of its debt.' WHAT WAS CORRECT: The LLM correctly identifies that the notes appear consistently across 2022, 2023, and 2024, and correctly notes the trustee name update in 2024. The quantitative facts about the note percentage (4.000%) and years are accurate. MISSING ELEMENTS: The LLM fails to address the key insight from the ground truth - that the continued inclusion of already-matured debt in documentation indicates administrative/reference maintenance rather than active refinancing. The ground truth's nuanced point about 'absence of refinancing disclosures' is completely missed. REASONING QUALITY: The multi-hop synthesis is flawed because it draws incorrect conclusions about what the consistent inclusion means. The ground truth interprets it as stable reference/administrative maintenance; the LLM interprets it as active ongoing debt management with refinancing activity - these are contradictory interpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 585,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure declined over the period – the “maximum potential payment” fell from about **$322 million in 2022 to $288 million in 2023 and $274 million in 2024** – while the portion that is shared with collaboration partners shrank from **$142 million (2022) to $135 million (2023) to $131 million (2024)**.  This downward trend in partners’ share indicates that RTX is **retaining a larger slice of the risk itself**, i.e., it is transferring less of the guarantee exposure to its collaborators and absorbing more of the potential loss internally.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All collaboration partners' share figures are correct ($142M→$135M→$131M for 2022-2024). (2) The LLM correctly identifies the downward trend and accurately interprets it as RTX retaining more risk internally rather than transferring to partners. (3) The reasoning about risk transfer strategy is sound and logically derived from the data. (4) Number formatting is consistent and clear. (5) The multi-hop synthesis correctly connects the declining partner share to RTX's strategic shift. WEAKNESSES: (1) The LLM introduces additional data about 'maximum potential payment' ($322M→$288M→$274M) that, while potentially accurate, is not explicitly mentioned in the original ground truth answer. This represents additional context that goes beyond what was provided in the original answer. (2) The original answer mentions that 'RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves,' which the LLM answer omits entirely. This is a material detail about RTX's confidence in underlying asset values. (3) The LLM answer doesn't address the full scope of the original answer regarding the company's assessment of asset values supporting these arrangements. QUANTITATIVE VERIFICATION: All three collaboration partner share figures ($142M, $135M, $131M) are correct. The maximum potential payment figures appear reasonable but cannot be verified against the ground truth provided. REASONING ASSESSMENT: The core interpretation is sound - declining partner share = increased RTX risk retention. However, the answer is incomplete because it omits the asset valuation confidence statement from the original answer. The additional maximum potential payment data, while potentially valuable context, shifts focus slightly from the core question about the trend in collaboration partners' share.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 503,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 the 3.950% Notes due 2056 remained a $13 billion component of Microsoft’s long‑term debt, appearing unchanged in the long‑term‑debt tables of each year’s Notes to Financial Statements.  This steady, multi‑year presence shows that Microsoft’s capital strategy relies on a large, long‑dated fixed‑rate debt tranche to fund sustained growth while maintaining a predictable, low‑cost financing base.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - UNVERIFIED QUANTITATIVE CLAIM: The LLM answer introduces a specific dollar amount ($13 billion) that is NOT present in the ground truth answer. The ground truth explicitly states the Notes were 'consistently referenced' and 'remained present' across the three years with 'no changes to the terms or status,' but makes NO mention of a $13 billion principal amount. This is a significant factual error that cannot be verified against the provided ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies the 3.950% Notes due 2056 across fiscal years 2022, 2023, and 2024; (2) Correctly notes the Notes appeared unchanged in long-term debt tables; (3) Correctly identifies this as part of Microsoft's capital structure across all three years; (4) The reasoning about steady financing strategy and predictable low-cost financing is semantically aligned with the ground truth's conclusion about 'stable inclusion' and 'steady long-term financing strategy.' REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connected the presence of the Notes across three years to draw conclusions about capital strategy consistency. However, the introduction of the unsubstantiated $13 billion figure undermines the answer's credibility. MISSING ELEMENTS: The LLM does not mention the Eleventh Supplemental Indenture dated August 8, 2016, which the ground truth specifically references as the disclosure mechanism. OVERALL ASSESSMENT: While the qualitative reasoning about capital strategy is reasonable and the multi-year pattern identification is correct, the introduction of an unverified quantitative claim ($13 billion) represents a material factual error that significantly reduces the answer's reliability. The answer goes beyond what can be confirmed in the ground truth by adding specific financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 499,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 through 2023 the Missiles & Fire‑Control (MFC) segment enjoyed modest sales growth and stable operating profit as production ramped up on tactical and strike‑missile programs such as GMLRS, JASSM and PAC‑3, with backlog expanding and profit‑booking adjustments staying positive. In 2024 sales jumped about 13 % on the same programs, but operating profit plunged 73 % to $413 million because the segment absorbed a $1.4 billion classified‑program loss and a sharp drop in profit‑booking rates. That steep profit decline shaved roughly $1.1 billion from consolidated operating profit, turning the modest gains of 2022‑23 into an overall ~20 % drop in the company’s operating profit over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some key facts but contains significant quantitative discrepancies and incomplete synthesis of the multi-hop question. STRENGTHS: (1) Correctly identifies the 73% operating profit decline in 2024, (2) Correctly cites the $1.4 billion classified program loss in 2024, (3) Correctly notes the $1.1 billion impact on consolidated operating profit, (4) Correctly identifies key programs (GMLRS, JASSM, LRASM, PAC-3), (5) Appropriately characterizes the overall trend of production growth masking profit deterioration. WEAKNESSES: (1) MISSING CRITICAL DATA: The ground truth specifies precise year-by-year increases ($215M in 2022, $145M in 2023, $1.2B in 2024), but the LLM only mentions '13% sales jump in 2024' without providing the specific dollar amounts or 2022-2023 increases. (2) INCOMPLETE 2022-2023 ANALYSIS: Ground truth details $45M in losses on classified program in 2023, which the LLM completely omits. (3) VAGUE CHARACTERIZATION: LLM describes 2022-2023 as 'modest sales growth and stable operating profit' but ground truth shows operating profit actually declined in 2023 due to the $45M classified program loss. (4) MISSING PROFIT BOOKING DETAIL: Ground truth specifies '$1.2 billion in lower profit booking rate adjustments' in 2024, while LLM only vaguely references 'sharp drop in profit-booking rates.' (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about trajectory evolution from 2022-2024, but LLM doesn't provide year-by-year progression of both production and profit metrics. (6) OVERALL OPERATING PROFIT CLAIM: LLM states '~20% drop in the company's operating profit over the three-year period' but doesn't provide the baseline numbers to verify this calculation. The answer demonstrates understanding of the key narrative (production up, profit down) but fails to provide the detailed quantitative evidence that grounds truth requires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 511,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nIn the 2022 10‑K the only Executive Change‑In‑Control Retention Agreement on file was the one for CEO Marc N. Casper, with the latest amendment (the second amendment) dated March 16 2018. The 2023 10‑K added a separate, stand‑alone form of such agreement for other senior officers (listed as Exhibit 10.17), thereby extending Change‑In‑Control protection beyond Casper. The 2024 10‑K retains that officer‑agreement without further amendment, merely restating related compensation plans, so the 2023 expansion constituted the key evolution of the company’s Change‑In‑Control arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of the evolution but contains several factual discrepancies when compared to the ground truth: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the 2023 officer agreement was listed as Exhibit 10.17, but the ground truth indicates it was Exhibit 10.7. This is a specific, verifiable factual error. (2) PARTIAL ACCURACY ON 2022: The LLM correctly identifies that 2022 had only Casper's agreement and mentions the March 16, 2018 amendment date (not contradicted by ground truth), but the ground truth explicitly states that 2022 introduced 'a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper' - suggesting the form existed in 2022, not just 2023. The LLM's claim that 2023 'added' this form may misrepresent the timeline. (3) MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize across three years and identify the key evolution (2023 expansion), which shows reasonable multi-hop reasoning. However, the characterization of when the officer form was introduced appears inconsistent with ground truth. (4) COMPLETENESS: The LLM addresses all three years (2022, 2023, 2024) and discusses both Casper's agreement and the officer form, meeting the basic requirements. However, it may have mischaracterized the 2022 status. (5) TONE AND STRUCTURE: The LLM provides clear narrative progression and identifies 2023 as the key evolution point, which aligns with ground truth's emphasis on 'consistent structure and ongoing commitment.' The core insight about expansion beyond Casper is correct, but the specific timing and exhibit numbers contain errors that undermine confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 461,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLMT expanded its use of variable‑rate interest‑rate swaps from a $500 million notional amount disclosed in the 2022 filing (covering 2021) to $1.3 billion at the end of 2023, and it kept that $1.3 billion level through 2024.  The increase shows that the company deliberately broadened its hedge coverage to protect a larger portion of its fixed‑rate debt (and related variable‑rate exposures) from rising interest‑rate volatility, and the subsequent plateau indicates that the hedge size was calibrated to the company’s overall debt profile and no longer being aggressively expanded.  In short, LMT’s interest‑rate risk management strategy shifted from a modest hedge to a more substantial, stabilized swapping program to lock in or offset interest‑rate movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative facts are correct: $500 million notional amount in 2021 (disclosed in 2022 filing), $1.3 billion in 2023, and $1.3 billion in 2024. The multi-hop synthesis is sound—the answer correctly traces the evolution across three time periods and identifies the key strategic shift. The reasoning about the doubling of exposure and subsequent stabilization is logically sound and matches the ground truth interpretation. The LLM appropriately characterizes the shift from 'modest hedge' to 'more substantial, stabilized swapping program' and correctly infers the strategic intent (managing interest rate risk amid rising debt/volatility). Minor differences from ground truth: (1) The LLM uses slightly different phrasing ('protect a larger portion of its fixed-rate debt and related variable-rate exposures') versus ground truth's 'managing interest rate risk amid rising borrowing levels or market uncertainty'—both are semantically equivalent and reasonable interpretations. (2) The LLM adds the phrase 'to lock in or offset interest-rate movements' which is a reasonable inference but not explicitly stated in ground truth. (3) The LLM's explanation of 'calibrated to the company's overall debt profile' is a reasonable inference about why the plateau occurred. All core facts are accurate, calculations are correct (the doubling from $500M to $1.3B is properly characterized), and the multi-hop reasoning correctly synthesizes information across 2022, 2023, and 2024 filings. The answer fully addresses the question's two main components: (1) how use evolved, and (2) what the changes indicate about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 459,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s defined‑contribution plan expense was **$402 million in 2022**, **$468 million in 2023**, and **$443 million in 2024**. This shows a clear upward trajectory—peaking in 2023 and remaining well above the 2022 level—indicating that the company has been steadily increasing its investment in employee retirement benefits over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: All financial figures are correct ($402M in 2022, $468M in 2023, $443M in 2024). The LLM accurately identified the company (Thermo Fisher Scientific/TMO), the metric (defined contribution plan expenses), and all three fiscal years. Number formatting is appropriate and consistent. WEAKNESSES: The LLM's interpretation of the trend contains a significant logical error. The ground truth states the 2024 figure 'remained flat at $443 million,' but the LLM claims the amount 'remained well above the 2022 level' and describes a 'steady increase' over the three-year period. While technically $443M is above $402M, this characterization misses the key insight from the ground truth: the trend shows an INCREASE from 2022 to 2023, followed by a DECREASE from 2023 to 2024. The ground truth explicitly notes this represents 'a slight reduction in 2024, suggesting a potential stabilization or recalibration.' The LLM's conclusion that the company has been 'steadily increasing' its investment is misleading because it ignores the 2024 decline ($468M to $443M, a $25M or 5.3% decrease). The LLM should have noted the peak in 2023 and the subsequent pullback in 2024, which suggests a different narrative than continuous steady growth. MULTI-HOP REASONING: The LLM correctly synthesized the three-year data but failed to properly interpret the directional changes and their implications for company strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 392,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept valuing its non‑public equity stakes with the “estimates of sales‑proceeds” approach—primarily discounted‑cash‑flow and comparable‑company models—but it increasingly tied those estimates to observable market trends and required a quarterly test for other‑than‑temporary declines. The 2022 disclosure that the $87 million excess of carrying value over fair value for the Japan bottler was judged temporary, and the lack of any subsequent impairment, demonstrates management’s confidence that the Japanese market would recover, a view it reaffirmed in the 2023 and 2024 filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $87 million excess of carrying value over fair value for the Japan bottler investment in 2022. (2) The numeric value is accurate and properly formatted. (3) The LLM correctly notes that management deemed the decline temporary and did not subsequently impair the investment, demonstrating confidence in recovery. (4) The answer correctly identifies the time period (2022-2024) and the company (Coca-Cola). (5) The LLM appropriately references the use of valuation methodologies including discounted cash flow and comparable company models.\n\nWEAKNESSES: (1) The LLM introduces specific methodological details (\"discounted-cash-flow and comparable-company models\" and \"quarterly test for other-than-temporary declines\") that are not explicitly confirmed in the ground truth and may represent unsupported specificity. (2) The ground truth emphasizes an important evolution: increasing emphasis on \"assumptions a market participant would use\" and \"external market perspectives and macroeconomic risks,\" particularly in emerging/developing markets. The LLM mentions \"observable market trends\" but does not capture the nuanced shift toward market participant perspectives that the ground truth highlights. (3) The ground truth notes the evolution became \"more attuned to external market perspectives and macroeconomic risks,\" suggesting a meaningful shift in management's approach over the period. The LLM's framing of \"reaffirmed\" confidence is somewhat static and doesn't fully capture this evolution. (4) The ground truth provides context about the 18% decline ($87M relative to total carrying value), which the LLM omits. (5) The LLM's statement about \"lack of any subsequent impairment\" is reasonable inference but goes slightly beyond what the ground truth explicitly states about the evolution of reliance on estimates.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years (2022-2024) and connect valuation methodology to management confidence, which is appropriate. However, it misses the key insight about the evolution toward market participant perspectives, which is central to the ground truth's explanation of what the changing disclosures reveal.\n\nSEMANTIC ISSUES: The LLM's answer is somewhat narrower in scope than the ground truth. While it addresses the Japan investment and management confidence, it doesn't fully capture the broader evolution in how the company approached valuation assumptions across the three-year period, particularly the shift toward external market perspectives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 687,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nAcross the FY 2022 (Exhibit 4.16, pp. 112‑116), FY 2023 (Exhibit 4.16, pp. 108‑112) and FY 2024 (Exhibit 4.16, pp. 109‑113) filings Oracle repeatedly listed the 2.300 % Notes due 2028 as part of the senior unsecured series originally issued in March 2021, merely re‑stating the instrument and, in the 2024 filing, adding updated tranche language. This consistent re‑presentation shows that Oracle’s debt‑financing strategy was to maintain a diversified ladder of long‑dated fixed‑rate notes, using the 2028 maturity as a stable, low‑cost pillar of its overall financing structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2.300% Notes due 2028 as a consistent instrument across FY 2022, 2023, and 2024. (2) The original issuance date of March 2021 is accurate. (3) The characterization of these notes as 'senior unsecured' and 'fixed-rate' is correct. (4) The general concept that Oracle maintained this instrument while issuing newer debt is sound. (5) Exhibit references and page numbers appear plausible for SEC filings.\n\nWEAKNESSES: (1) The LLM answer FAILS to mention the newer, higher-rate instruments that are central to the ground truth's multi-year pattern analysis. Specifically, it omits: (a) the 4.500% Notes due 2028 issued in 2023, and (b) the 5.800% Notes due 2025 issued in 2024. These are critical to understanding Oracle's debt financing strategy evolution. (2) The LLM's conclusion focuses narrowly on the 2028 notes as a 'stable, low-cost pillar' but misses the broader strategic narrative about managing refinancing needs amid rising interest rates. (3) The answer doesn't synthesize the multi-hop pattern across years—it treats the 2028 notes in isolation rather than comparing them to newer issuances. (4) The phrase 'merely re-stating the instrument' and 'consistent re-presentation' suggests passive repetition rather than active strategic positioning alongside new debt instruments.\n\nMULTI-HOP REASONING: The question requires synthesizing information about: (a) the 2.300% Notes across three fiscal years, (b) comparison with other debt instruments issued in those years, and (c) inference about broader strategy. The LLM partially succeeds on (a) but fails on (b) and (c). The ground truth explicitly connects the pattern of maintaining old low-cost debt while issuing new higher-cost debt to a strategic response to rising interest rates. The LLM misses this critical synthesis.\n\nQUANTITATIVE ACCURACY: The interest rate (2.300%) and maturity date (2028) are correct. The issuance date (March 2021) is correct. However, the LLM omits the quantitative data on newer instruments (4.500%, 5.800%) that are essential to answering the question about multi-year evolution.\n\nSEMANTIC EQUIVALENCE: While the LLM's characterization of the 2028 notes as a 'stable, low-cost pillar' is semantically reasonable, it diverges from the ground truth's emphasis on the strategic interplay between old and new debt instruments in response to market conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 640,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nApple’s outstanding balance of Floating‑Rate Notes that matured in 2019 dropped from the amount reported in the 2022 filing (the 2022 10‑K notes the notes were still part of the company’s $2.5 billion floating‑rate indenture) to zero by the end of 2023, and the 2024 filing contains no reference to a 2019‑maturity tranche. This roll‑forward shows that Apple is actively retiring its near‑term floating‑rate debt and replacing it with newer floating‑rate issuances that extend to 2026‑2033, indicating a short‑term debt‑management strategy focused on continuously refinancing near‑term exposure into longer‑dated instruments to preserve liquidity and reduce rollover risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL CONTRADICTION: The ground truth explicitly states that Floating Rate Notes due 2019 appeared consistently across 2022, 2023, and 2024 filings with no modifications. The LLM claims these notes 'dropped from the amount reported in the 2022 filing...to zero by the end of 2023' and that '2024 filing contains no reference' - this directly contradicts the ground truth's statement of 'repeated appearance...in each year's 10-K filing.' (2) QUANTITATIVE ERRORS: The LLM references a '$2.5 billion floating-rate indenture' with no basis in the ground truth, and claims the notes matured/were retired by 2023, which is factually incorrect per the ground truth. (3) REASONING FAILURE: The LLM's multi-hop synthesis is flawed - it assumes a retirement/refinancing pattern that did not occur. The ground truth indicates stability and consistency, not active retirement and replacement. (4) ENTITY/TIMELINE CONFUSION: The LLM conflates the 2019 maturity date (when the notes were due) with their actual status in 2022-2024, incorrectly assuming they were retired. The ground truth clarifies these notes were issued in 2014 and continued to be disclosed through 2024. (5) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'actively retiring near-term floating-rate debt' and 'continuously refinancing' is the opposite of what the ground truth indicates - a 'stable, rather than active, management approach.' The answer demonstrates fundamental misunderstanding of the question and provides false information about Apple's debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 452,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe 4.000 % Senior Note due 2047 appears in the exhibit lists of the 2022, 2023 and 2024 10‑K filings, indicating that PepsiCo continues to regard this long‑dated, fixed‑rate issuance as a permanent pillar of its capital structure. By contrast, the 2.150 % Senior Note due 2024 and the 0.750 % Senior Note due 2027 are only disclosed as legacy short‑term instruments, reflecting a strategy that relies on periodic refinancing or retirement of near‑term debt rather than maintaining a lasting short‑term position.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key facts about the 4.000% Senior Note due 2047 appearing consistently across 2022, 2023, and 2024 filings, and accurately names the shorter-dated instruments (2.150% due 2024 and 0.750% due 2027). However, there are significant issues with completeness and reasoning: (1) MISSING CRITICAL CONTEXT: The LLM fails to mention the 2.500% Senior Note due 2022 that matured by 2023, which is explicitly highlighted in the ground truth as evidence of the 'dynamic nature of short-term debt versus persistent long-term obligations.' This omission weakens the comparative analysis. (2) CHARACTERIZATION ERROR: The LLM describes the 2.150% and 0.750% notes as 'legacy short-term instruments,' which is imprecise. The ground truth indicates these notes 'appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities'—not necessarily that they are 'legacy' instruments. The 0.750% note was 'introduced in 2024,' suggesting it's new, not legacy. (3) INCOMPLETE REASONING: While the LLM correctly identifies the long-term strategy focus, it doesn't fully explain the strategic implications articulated in the ground truth: that PepsiCo is 'leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.' (4) QUANTITATIVE ACCURACY: All percentages and dates are correct (4.000%, 2.150%, 0.750%, 2047, 2024, 2027). (5) MULTI-HOP SYNTHESIS: The answer partially synthesizes information across filings but misses the temporal progression that demonstrates the contrast between persistent long-term debt and rotating short-term obligations. The core insight about long-term debt strategy is present but incompletely developed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 481,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple keeps the 0.45 % Notes due 2016 in the footnotes of its 2022‑2024 filings even though the securities actually matured in 2016.  This practice shows that the company wants to retain a complete, auditable record of its historic capital‑structure items, ensuring full transparency and giving investors a clear picture of any lingering legacy obligations that could affect future financing decisions.  In effect, Apple’s strategy is to treat the matured notes as a permanent reference in its disclosures—preserving visibility for regulators, auditors and the market while signaling that no active debt remains, but the historical entry is retained for completeness and future‑reference purposes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative elements: correctly identifies the 0.45% Notes due 2016, accurately notes their 2016 maturity date, and properly references their continued disclosure in 2022-2024 filings. All numeric values and dates are correct with no calculation errors.\n\nThe reasoning is generally sound and addresses the multi-hop synthesis required: the answer correctly identifies that Apple maintains these disclosures despite maturity and interprets this as a deliberate strategy for transparency and historical record-keeping. The LLM appropriately synthesizes information across multiple years (2022, 2023, 2024) and connects the maturity date to the disclosure pattern.\n\nHowever, there are some qualitative differences from the ground truth:\n\n1. The LLM introduces the concept of \"lingering legacy obligations that could affect future financing decisions,\" which is not explicitly supported by the ground truth and could be slightly misleading—the notes have fully matured and settled, not lingering.\n\n2. The LLM states the strategy is to \"treat the matured notes as a permanent reference\" and emphasizes \"no active debt remains,\" which adds interpretive layers not present in the original answer. The ground truth is more cautious, suggesting the pattern \"possibly\" reflects a conservative approach rather than definitively stating the strategy.\n\n3. The ground truth specifically mentions the Officer's Certificate dated May 3, 2013 being consistently referenced, which the LLM answer omits. This detail supports the \"deliberate and consistent approach\" claim.\n\n4. The LLM's framing of \"preserving visibility for regulators, auditors and the market\" is reasonable but goes slightly beyond what the ground truth explicitly states about the company's intent.\n\nThe answer is substantively correct and demonstrates good understanding of the question's multi-hop nature, but makes some interpretive leaps beyond the ground truth's more measured assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 548,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nLockheed Martin’s pension‑risk‑transfer program, which started with the 2021 purchase of $4.9 billion of group‑annuity contracts, was expanded through 2022‑2024 so that roughly $11.6 billion of defined‑benefit obligations covering about 95,000 retirees have been moved off the company’s books, dramatically reducing the remaining pension liability and eliminating ongoing funding volatility.  The firm now expects to continue these transfers in future years, noting that each additional transaction could generate a non‑cash settlement charge that would affect earnings, but the overall effect is to smooth and stabilize pension‑related earnings by removing the risk‑driven fluctuations of the defined‑benefit plans.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Strengths: (1) Correctly identifies the $4.9 billion GAC transaction in 2021, (2) Accurately states the cumulative $11.6 billion in pension obligation transfers since December 2018, (3) Properly notes the approximately 95,000 retirees covered, (4) Correctly characterizes the noncash settlement charges and their impact on earnings, (5) Accurately describes the ongoing strategy through 2022-2024 with expectations for future transactions. Minor weaknesses: (1) The answer does not explicitly mention the $1.7 billion noncash pension settlement charge from the 2021 transaction, which was specifically disclosed in the 2022 filing and is part of the ground truth answer, (2) The phrasing 'started with the 2021 purchase' could be slightly clearer about the timing relative to 2022 disclosure, (3) The answer emphasizes the earnings smoothing benefit but could more explicitly state that future transactions 'could result in additional noncash settlement charges' as the ground truth specifies. The multi-hop reasoning is sound - the answer correctly synthesizes information about the evolution from 2022 through 2024, the cumulative impact, and the forward-looking strategy. The characterization of the approach as 'proactive de-risking' aligns with the ground truth's description of a 'consistent, proactive approach.' Quantitative accuracy is high with all dollar amounts and retiree counts correct. The omission of the specific $1.7 billion charge prevents a perfect score, though this is a relatively minor gap in an otherwise comprehensive answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 456,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nThe 2022 Form 10‑K (pp. 44‑48) disclosed the original 2009 Change‑in‑Control Retention Agreement for Marc N. Casper and, for the first time, attached a generic “Executive Change‑in‑Control Retention Agreement for Officers (other than Casper)” (Exhibit 10.18). The 2023 Form 10‑K (pp. 74‑78) revised that template (Exhibit 10.17) and clarified that the agreement now applies to additional senior roles such as the CFO, COO and other officers, not just Casper. In the 2024 filing (pp. 75‑79) the company further amended the form—updating trigger‑event definitions, notice periods and payment amounts—and explicitly listed a broader set of officer titles, thereby extending the retention‑agreement coverage to executives beyond Marc N. Casper.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of the general evolution of Thermo Fisher's Executive Change In Control Retention Agreements from 2022-2024, correctly identifying the progression from Casper-specific agreements to broader officer coverage. However, there are significant quantitative accuracy issues that undermine the response: (1) The LLM cites specific page numbers (2022: pp. 44-48, 2023: pp. 74-78, 2024: pp. 75-79) and exhibit numbers (Exhibit 10.18 for 2022, Exhibit 10.17 for 2023) that cannot be verified against the ground truth and appear to be hallucinated details. The ground truth does not provide these specific page or exhibit references. (2) The LLM claims the 2024 filing 'further amended the form—updating trigger-event definitions, notice periods and payment amounts' with 'explicitly listed a broader set of officer titles,' but the ground truth only states the company 'reaffirmed the existence of these agreements' and 'reiterating the form filed in 2023,' suggesting continuation rather than further amendment. This is a material factual discrepancy. (3) The ground truth specifies the 2018 form date (March 16, 2018) and 2023 form date (April 1, 2023), which the LLM does not mention. (4) The LLM's claim about the 2022 disclosure being 'for the first time' attaching a generic form cannot be verified against ground truth. The qualitative reasoning about expansion of coverage is sound and aligns with the ground truth narrative, and the contextual relevance is appropriate to the question. However, the fabricated specifics and the mischaracterization of 2024 as involving further amendments rather than reaffirmation represent significant accuracy problems.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 462,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo’s repeated reference to the 2.750 % Senior Note due 2051 in its 2022‑2024 filings—first recorded in the 2021 8‑K and then re‑affirmed in the 2023 and 2024 board‑resolution exhibits—shows that the company is deliberately maintaining a long‑dated, low‑coupon tranche of fixed‑rate debt as a cornerstone of its capital structure.  At the same time, the same filings disclose a parallel program of newer, higher‑coupon and floating‑rate issuances (e.g., 4.650 % 2027, 4.550 % 2029, floating‑rate 2026 notes), indicating that PepsiCo is balancing the stability of that legacy note with fresh funding that can adapt to higher market rates.  Overall, the company’s strategy in a rising‑rate environment is to lock in long‑term, low‑cost financing where possible while continuously refreshing its debt‑issuance pipeline to preserve flexibility and manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of PepsiCo's long-term debt strategy and correctly identifies the core insight about maintaining low-coupon legacy debt while issuing newer, higher-yielding notes. However, there are significant issues with quantitative accuracy and factual verification:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM introduces specific coupon rates (4.650% 2027, 4.550% 2029, floating-rate 2026) that are NOT mentioned in the original answer or ground truth. These appear to be fabricated details not supported by the provided context.\n   - The original answer mentions a 5.250% Senior Note due 2054 as an example of newer, higher-yielding notes, but the LLM provides different note details (4.650%, 4.550%, floating-rate) without source verification.\n   - This represents a critical failure in quantitative accuracy as specific financial instruments are cited without grounding in the provided evidence.\n\n2. ENTITY AND REFERENCE ACCURACY:\n   - The LLM correctly identifies the 2.750% Senior Note due 2051 and the time period (2022-2024).\n   - However, the reference to \"board-resolution exhibits\" is not explicitly mentioned in the ground truth, which refers to \"exhibit index\" references.\n   - The mention of a \"2021 Form 8-K filing\" is correct and matches the original answer.\n\n3. MULTI-HOP REASONING:\n   - The LLM correctly synthesizes the multi-hop concept: maintaining legacy low-coupon debt while issuing new higher-coupon debt in a rising rate environment.\n   - The reasoning about balancing stability with flexibility is sound and aligns with the original answer's conclusion.\n   - However, the introduction of unsupported specific coupon rates undermines the credibility of this reasoning.\n\n4. SEMANTIC EQUIVALENCE:\n   - The core message about PepsiCo's strategy (lock in long-term, low-cost financing while refreshing the debt pipeline) matches the original answer's conclusion.\n   - The characterization of the 2.750% note as a \"cornerstone\" and \"legacy note\" is semantically consistent with the original's description of \"consistent approach\" and \"stable long-term capital strategy.\"\n\n5. COMPLETENESS:\n   - The LLM addresses the question about long-term debt strategy in a rising interest rate environment.\n   - It covers the 2022-2024 period and the treatment of the specific note.\n   - However, it adds unsupported details rather than strictly adhering to the ground truth.\n\nKEY PROBLEM: The introduction of specific coupon rates (4.650%, 4.550%, floating-rate) without verification against the source documents is a significant factual error. While the original answer mentions the 5.250% Senior Note due 2054, the LLM provides different instruments. This suggests either hallucination or reliance on information not present in the provided context, which is a critical failure in financial analysis where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 768,
        "total_tokens": 2240
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nApple continued to carry its original 4.45 % Notes due 2044—first issued in 2014—through the 2022, 2023 and 2024 filings, but each year it added new multi‑year fixed‑rate issuances (e.g., the 2023 $1.5 bn 4.85 % Notes due 2053 and the 2024 follow‑on tranche of similar long‑dated bonds) while leaving the 2044 series outstanding.  This rolling ladder of long‑term debt shows that Apple’s capital strategy is to continuously tap the bond market with staggered maturities and coupons, using fresh long‑dated issuances to fund growth and shareholder returns while managing interest‑rate exposure and extending the average life of its debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims Apple issued '$1.5 bn 4.85% Notes due 2053' in 2023 and 'follow-on tranche of similar long-dated bonds' in 2024, but the ground truth makes no mention of these specific issuances. These appear to be fabricated numbers and dates not supported by the knowledge graph. (2) The ground truth explicitly states that Apple 'maintained this liability without redemption or restructuring during the observed period' - meaning the 4.45% Notes due 2044 remained outstanding unchanged. The LLM's characterization of a 'rolling ladder' of continuous new issuances contradicts this. (3) The LLM introduces unsupported claims about 'fresh long-dated issuances to fund growth and shareholder returns' without evidence from the filings. (4) While the LLM correctly identifies that the 4.45% Notes due 2044 were first issued in 2014 and remained outstanding through 2022-2024, it then adds unverified details about additional bond issuances. WHAT WAS CORRECT: The core fact that Apple carried the 4.45% Notes due 2044 through all three years (2022, 2023, 2024) is accurate. WHAT WAS INCORRECT: The specific dollar amounts ($1.5 bn), coupon rates (4.85%), maturity dates (2053), and the claim of 'follow-on tranches' in 2024 are not supported by the ground truth and appear to be hallucinated. The ground truth's emphasis on consistency and lack of restructuring is fundamentally different from the LLM's narrative of continuous new issuances. The LLM failed to accurately synthesize the multi-hop information and instead introduced unsupported financial details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 455,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nFrom 2022 through 2023 the pension plan’s allocation to “Collective Trust and Other Funds” fell sharply – the 2022 NAV table lists $ 498 million, while the 2023 NAV table shows $ 370 million, a reduction of about $ 128 million (≈ 26 %).  \n\nThe 2024 filing clarifies that these funds are valued at the net‑asset‑value of their underlying publicly‑traded securities, using readily observable market prices; therefore they are marked‑to‑market on a Level 1 basis and are essentially passively managed, with valuation driven by the performance of the underlying index‑style holdings rather than internal pricing models.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM provides significantly incorrect dollar amounts for the Collective Trust and Other Funds allocation. Ground truth states $756 million (2022) and $382 million (2023), but LLM claims $498 million (2022) and $370 million (2023). This is a critical quantitative error - the 2022 figure is off by $258 million (34% understatement) and the 2023 figure is off by $12 million. The calculated reduction of $128 million (26%) is therefore based on wrong numbers; the correct reduction is $374 million (49%). VALUATION METHODOLOGY MISCHARACTERIZATION: The LLM incorrectly describes these investments as 'marked-to-market on a Level 1 basis' with 'readily observable market prices' and 'index-style holdings.' The ground truth states they are valued using NAV (net asset value) derived from shares/units in commingled funds and LLCs - not Level 1 fair value measurements. This is a fundamental misunderstanding of the valuation approach. The LLM's claim about 'passively managed' and 'underlying index-style holdings' is not supported by the ground truth, which mentions 'global stock funds and short-term investments' without characterizing them as passive index funds. MISSING CONTEXT: The LLM fails to address the ground truth's important insight that the reduction may reflect 'deliberate rebalancing or risk management decision' and the significance of NAV-based measurement for transparency. PARTIAL CREDIT: The LLM correctly identifies that there was a reduction in allocation from 2022 to 2023 and attempts to address the 2024 disclosure about valuation methodology, showing some understanding of the multi-hop nature of the question. However, the fundamental numerical errors and mischaracterization of the valuation methodology severely undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 489,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple keeps the Officer’s Certificate for the 1.05 % Notes due 2017 in the exhibit sections of its 2022, 2023 and 2024 Form 10‑K filings. By retaining that certificate in each annual report, the company preserves the original debt‑issuance documentation as a permanent audit trail, ensuring that the terms of a matured security remain part of the public record. This practice reflects a deliberate, conservative approach to capital‑structure disclosure—maintaining complete, historical debt documentation so that investors, analysts and regulators can always reference the full evolution of Apple’s financing structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric and date references are correct—the 1.05% interest rate, the 2017 maturity date, and the three fiscal years (2022, 2023, 2024) are all accurately stated. The May 6, 2014 certificate date is not explicitly mentioned in the LLM answer, but this is a minor omission rather than an error. ENTITY ACCURACY: Apple is correctly identified, the debt instrument (1.05% Notes due 2017) is correctly specified, and all three fiscal years are properly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes the key insight that Apple retained documentation for a matured debt instrument across multiple years, and correctly interprets this as reflecting deliberate disclosure practices. The reasoning about maintaining historical context and providing an audit trail is sound and logically connected. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that Apple's retention of the Officer's Certificate across three years reflects a deliberate, conservative approach to capital structure disclosure and historical documentation preservation. The phrase 'permanent audit trail' and 'full evolution of Apple's financing structure' effectively capture the ground truth's emphasis on 'completeness and historical continuity.' MINOR DIFFERENCES: The LLM answer emphasizes the 'exhibit sections' and 'permanent audit trail' framing, which adds helpful specificity about where and how the documentation is maintained. The ground truth emphasizes 'documentation retention and disclosure strategy' and 'investor and regulatory transparency,' while the LLM emphasizes 'conservative approach' and 'public record'—both framings are semantically equivalent and appropriate. The LLM does not explicitly mention the May 6, 2014 date of the certificate, which is a minor detail omission but does not affect the core correctness of the answer. Overall, the LLM answer is factually accurate, logically sound, and appropriately addresses the multi-part question about documentation retention practices and their implications for capital structure disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 592,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Union Pacific trimmed the equity portion of its pension plan from a target of 45‑55 % of assets to a 20‑30 % range, and the actual corporate‑stock holding dropped from roughly 5 % of total plan assets in 2022 to under 3 % by 2024.  This systematic de‑risking reflects a strategic shift toward a higher‑quality, longer‑duration debt portfolio and a more conservative equity stance, prioritizing capital preservation over growth in the pension fund’s investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to match the ground truth data. QUANTITATIVE ERRORS: (1) The LLM provides percentage allocations (45-55% target declining to 20-30%, and 5% actual declining to under 3%) that are NOT present in the ground truth answer. The ground truth provides specific dollar amounts: $1,990M (2022), $181M (2023), and $1,116M (2024). (2) The LLM's percentages cannot be verified against the provided ground truth and appear to be fabricated or from different sources. (3) The LLM claims a decline from 5% to under 3%, but the ground truth shows absolute dollar amounts that tell a different story: a 90%+ drop from 2022-2023, then a partial rebound in 2024. COMPLETENESS ISSUES: (1) The LLM completely omits the specific dollar amounts that are central to the ground truth answer ($1,990M, $181M, $1,116M). (2) The ground truth explicitly mentions the 90%+ decline between 2022-2023 and the partial rebound in 2024, which the LLM does not capture with the same precision. REASONING ISSUES: (1) While the LLM correctly identifies the strategic shift toward de-risking and more conservative positioning, it does so using different metrics than the ground truth. (2) The LLM's interpretation about 'higher-quality, longer-duration debt portfolio' aligns with the ground truth's mention of 'fixed income instruments, particularly bonds and federal securities,' but this is presented without the supporting dollar figures. ENTITY ACCURACY: Union Pacific is correctly identified, and the time period (2022-2024) is correct. However, the specific financial metrics used are fundamentally different from the ground truth. The answer demonstrates understanding of the strategic direction but fails on the critical quantitative accuracy required for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 493,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nPrevymis sales grew from $428 million in 2022 to $605 million in 2023 and then to $785 million in 2024—a roughly 41 % increase from 2022 to 2023 and a further 29 % rise in 2024. This accelerating growth signals expanding market adoption and highlights the product’s rising strategic importance within Merck’s Hospital Acute Care segment, positioning it as a key driver of the company’s pharmaceutical portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All dollar amounts are correct ($428M in 2022, $605M in 2023, $785M in 2024). The percentage calculations are accurate: 2022-2023 increase is ($605M-$428M)/$428M = 41.4% (rounded to 41%), and 2023-2024 increase is ($785M-$605M)/$605M = 29.8% (rounded to 29%). (2) COMPLETENESS: The answer addresses all aspects of the multi-part question—sales evolution across the three-year period, market adoption trajectory, and strategic importance within the Hospital Acute Care segment. (3) ENTITY ACCURACY: Correctly identifies MRK/Merck, Prevymis product, Hospital Acute Care segment, and all relevant fiscal years. (4) REASONING QUALITY: The LLM goes beyond the ground truth by adding calculated percentage growth rates and explicitly characterizing the growth pattern as 'accelerating' (41% then 29%), which is a reasonable interpretation of the data trajectory. The synthesis correctly links sales growth to market adoption and strategic importance. (5) SEMANTIC EQUIVALENCE: The answer conveys identical factual information to the ground truth while providing additional analytical insight through percentage calculations and characterization of growth dynamics. The only minor distinction is that the LLM provides more detailed analytical commentary, which enhances rather than detracts from the answer quality. No factual errors, calculation errors, or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 406,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nIn the 2022 and 2023 Form 10‑Ks the 3.000% Senior Note due 2027 appears in the Exhibits list as an “outstanding” series (incorporated by reference), whereas the 2024 filing no longer presents it as an active issuance and instead references it only in a historical context—effectively indicating that the note had been retired or refinanced.  This shift shows that PepsiCo is actively retiring legacy fixed‑rate debt and replacing it with newer, longer‑dated or lower‑cost obligations, reflecting a strategic focus on optimizing its long‑term capital structure and reducing overall leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 3.000% Senior Note due 2027 was 'consistently included in PepsiCo's annual filings across 2022, 2023, and 2024' and was 'again included' in 2023 and 'continued to be referenced' in 2024. The LLM answer claims the opposite: that the note 'no longer presents it as an active issuance' in 2024 and 'references it only in a historical context—effectively indicating that the note had been retired or refinanced.' This is a direct contradiction of the ground truth. The ground truth provides specific exhibit references (Exhibit 4.22 for 2022, Exhibit 4.19 for 2023, Exhibit 4.17 for 2024) showing the note's continued presence. The LLM's characterization of the note as retired or refinanced by 2024 is factually incorrect. Additionally, the LLM fails to address the key insight from the ground truth about how the note's context evolved—from being presented alongside 2022-2024 maturity instruments in 2022, to longer-dated instruments in 2023, to newer short-term notes in 2024. The LLM's conclusion about 'retiring legacy fixed-rate debt' misses the actual strategy revealed in the ground truth: maintaining certain fixed-rate liabilities while introducing newer instruments to reflect market conditions. The answer demonstrates poor multi-hop reasoning by failing to synthesize the exhibit information across the three years correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 405,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nAcross the three fiscal years Adobe has deepened Frame.io’s role inside Creative Cloud. In 2022 it was introduced as a cloud‑native collaboration service tightly linked to a handful of core apps (Premiere Pro, After Effects, Photoshop, Lightroom and Workfront), offering real‑time, frame‑accurate review and “Camera‑to‑Cloud” uploads. By 2023 the narrative shifted to a more central hub, highlighting expanded, AI‑enhanced capabilities and broader integration with the full Creative Cloud suite, positioning Frame.io as the collaborative backbone for end‑to‑end content creation. In 2024 the integration has matured further, embedding Frame.io across all Creative Cloud desktop, web and mobile applications and coupling it with generative‑AI workflows (e.g., Firefly), so that frame‑accurate commenting, approvals and asset management are now a seamless, real‑time layer throughout the entire Creative Cloud ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN CHRONOLOGICAL ACCURACY: The LLM answer contains a fundamental factual error regarding the timeline of Frame.io's integration. According to the ground truth, in 2022 Frame.io was merely listed as part of Adobe's trademark portfolio (indicating recent acquisition), NOT already 'tightly linked to a handful of core apps' with 'Camera-to-Cloud uploads' and integration with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront. This detailed integration narrative belongs to 2023, not 2022. The LLM has incorrectly backdated capabilities that were introduced in 2023 to 2022. SPECIFIC ERRORS: (1) 2022 description is inaccurate - the ground truth states Frame.io was 'listed as part of Adobe's trademark portfolio' in 2022, suggesting early-stage positioning, not the mature integration the LLM describes. (2) The LLM attributes 'Camera-to-Cloud uploads' to 2022, but ground truth places detailed feature descriptions (real-time upload, review, approval) in 2023. (3) The LLM mentions Photoshop and Lightroom integration in 2022, but ground truth indicates these were emphasized in 2024 as part of expanded capabilities. (4) The 2023 description in the LLM is somewhat accurate but lacks the specific detail about 'still images, design files, and PDFs' support mentioned in ground truth. (5) The 2024 description correctly identifies GenStudio positioning and Firefly/Substance 3D integration, which aligns with ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the chronological progression across the three years. It conflated 2022 and 2023 capabilities, creating an inaccurate narrative of Frame.io's evolution. The ground truth shows a clear progression from trademark listing (2022) → detailed feature introduction (2023) → enterprise-scale positioning with GenStudio (2024), but the LLM presents a different timeline. SEMANTIC ISSUES: While the LLM's general framing about deepening integration is conceptually sound, the specific factual errors about which capabilities existed in which year undermine the answer's reliability. The answer reads plausibly but contains material factual inaccuracies that would mislead someone researching Frame.io's actual development timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 597,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 as a long‑term borrowing in its 2022 10‑K, classifying the entire issue as non‑current. When the notes approached maturity, the 2023 filing re‑classified the remaining balance to the current portion of long‑term debt and disclosed that Apple intended to refinance the obligation, reflecting an active rollover strategy. By the 2024 filing the 2.40 % 2023 notes were no longer outstanding—having been retired or replaced by newer issuances—showing that Apple manages its debt‑maturity wall by issuing new bonds ahead of existing maturities and retiring maturing issues with cash flow, thereby maintaining a staggered, laddered maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) CLASSIFICATION ERROR: The LLM claims the notes were classified as 'non-current' in 2022, but the ground truth indicates they were listed as outstanding debt instruments without specifying classification details. More critically, the LLM asserts reclassification to 'current portion of long-term debt' in 2023, which is not mentioned in the ground truth. (2) REFINANCING CLAIM: The LLM states Apple 'disclosed that Apple intended to refinance the obligation,' but the ground truth explicitly states 'showing no early retirement or restructuring action' in 2023. This is a direct contradiction. (3) DEBT MANAGEMENT STRATEGY: The LLM describes an 'active rollover strategy' and claims Apple 'issuing new bonds ahead of existing maturities and retiring maturing issues with cash flow,' but the ground truth clearly indicates 'a strategy of holding debt until maturity rather than refinancing or repurchasing it early.' This is the opposite of what the LLM claims. (4) MULTI-HOP REASONING: While the LLM correctly identifies the three-year progression (2022-2024) and the ultimate retirement of the notes, it fundamentally mischaracterizes Apple's debt management approach. The ground truth shows a passive hold-to-maturity strategy; the LLM describes an active refinancing/laddering strategy. (5) NUMERIC ACCURACY: The 2.40% rate is correct, and the 2023 due date is correct, but these are the only accurate elements. The LLM fabricates details about reclassification, refinancing intentions, and debt management tactics that are not supported by the ground truth and directly contradict it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 466,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nUnion Pacific’s Multiple‑Purpose Locomotive fleet fell from **7,242 units (6,204 owned + 1,038 leased) with an average age of 22.5 years in 2022** to **6,893 units (5,973 owned + 920 leased) with an average age of 25.2 years in 2023‑2024** (see UNP_10k_2022.pdf pp. 22‑26; UNP_10k_2023.pdf pp. 17‑21; UNP_10k_2024.pdf pp. 17‑21).  This multi‑year shift—smaller fleet size combined with a higher average age—reflects a deliberate asset‑management strategy of right‑sizing the locomotive pool, extending the service life of core units, and deferring new acquisitions while maintaining sufficient capacity through a buffer/surge fleet for operational flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the overall fleet decline from 7,242 to 6,893 units and the breakdown of owned/leased components (6,204→5,973 owned; 1,038→920 leased). (2) The starting average age of 22.5 years in 2022 is correct. (3) The qualitative interpretation about asset management strategy (right-sizing, extending service life, deferring acquisitions) is reasonable and well-reasoned. (4) Multi-hop synthesis across three years of 10-K filings is properly attempted. (5) Contextual relevance is high—the answer directly addresses the question about fleet composition, age profile, and strategic implications.\n\nCRITICAL ERRORS: (1) MAJOR QUANTITATIVE ERROR: The LLM states the average age reached 25.2 years in '2023-2024' but conflates the timeline. According to ground truth: 2022 age was 22.5 years, 2023 age was 24.3 years, and 2024 age was 25.2 years. The LLM omits the 2023 intermediate data point (24.3 years), presenting only the 2022 and 2024 endpoints. This is a significant omission of the multi-year progression that the question specifically asks about. (2) The phrasing '2023-2024' is ambiguous and suggests a single combined figure rather than showing the year-by-year progression (22.5→24.3→25.2). (3) The answer does not explicitly show the intermediate 2023 data, which is essential for demonstrating the 'multi-year progression' requested in the question.\n\nCALCULATION VERIFICATION: Fleet decline = 7,242 - 6,893 = 349 units (correct). Owned decline = 6,204 - 5,973 = 231 units (correct). Leased decline = 1,038 - 920 = 118 units (correct). Age progression should show: 2022: 22.5 years → 2023: 24.3 years → 2024: 25.2 years. The LLM only shows endpoints.\n\nMULTI-HOP REASONING: The synthesis across three years is attempted but incomplete. The answer successfully combines fleet composition data with age profile data, but fails to fully capture the three-year temporal progression that is central to the question's request for 'multi-year progression.'\n\nJUSTIFICATION: The core numbers are correct, but the omission of the 2023 intermediate age figure (24.3 years) represents a material gap in answering the specific request for multi-year progression analysis. This is not merely a wording issue—it's an incomplete presentation of the required data series. The qualitative interpretation is sound, but the quantitative presentation is deficient.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 637,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Merck moved MK‑8591A – the once‑daily doravirine + islatravir combination – from a Phase 2/3 bridge study in virologically suppressed patients into a registrational Phase 3 trial in treatment‑naïve adults, while the programme remained under the partial FDA clinical hold that was first imposed on the islatravir IND in December 2021; the company continued to enroll the Phase 3 cohort in 2023, submitted updated IND/NDA sections for the lower‑dose regimen, and in October 2024 launched a new Phase 3 arm (MK‑8591D) that pairs islatravir with lenacapavir, reflecting ongoing dose‑optimization and regulatory interaction with the Agency.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about MK-8591A's development trajectory but contains several factual discrepancies with the ground truth:\n\nCORRECT ELEMENTS:\n- MK-8591A is correctly identified as doravirine + islatravir combination\n- MK-8591D correctly identified as islatravir + lenacapavir\n- October 2024 entry of MK-8591D into Phase 3 is correct\n- FDA clinical hold context is mentioned\n- Multi-hop synthesis across 2022-2024 is attempted\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. PHASE DESIGNATION ERROR: LLM states MK-8591A moved from \"Phase 2/3 bridge study\" into \"registrational Phase 3 trial.\" Ground truth indicates it was in Phase 3 in 2022 (with entry date February 2020), not Phase 2/3. This is a significant phase classification error.\n\n2. CLINICAL HOLD TIMELINE DISCREPANCY: LLM states the partial hold \"was first imposed on the islatravir IND in December 2021\" and remained through the period. Ground truth states that in 2024, \"the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir.\" The LLM fails to mention the 2024 lifting of the clinical hold, which is a key regulatory development.\n\n3. INCOMPLETE REGULATORY TRAJECTORY: Ground truth emphasizes that by 2023 MK-8591A \"remained in Phase 3 and was under review, indicating no major regulatory advancements.\" The LLM doesn't clearly distinguish the lack of progression in 2023.\n\n4. MISSING KEY DETAIL: Ground truth specifies the partial hold remained specifically for \"higher doses of islatravir,\" which the LLM mentions but doesn't emphasize as a key distinction.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years and connect the clinical hold context to ongoing development, which is appropriate. However, the failure to capture the 2024 lifting of the clinical hold represents incomplete synthesis of the regulatory trajectory.\n\nQUANTITATIVE ACCURACY: The date \"October 2024\" for MK-8591D Phase 3 entry is correct. The December 2021 date for initial hold is mentioned but the critical 2024 regulatory change (lifting of hold) is missing.\n\nOVERALL: While the answer demonstrates knowledge of the programs and attempts multi-hop synthesis, the phase classification error and omission of the 2024 clinical hold lifting are significant factual gaps that undermine the accuracy of the regulatory trajectory narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 640,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nIn 2022 Merck added MK‑1308A—a quavonlimab + pembrolizumab co‑formulation—to its oncology pipeline as an investigational CTLA‑4 blockade for renal cell carcinoma. By 2023 the program advanced into pivotal clinical testing and earned Breakthrough‑Therapy designation, and in 2024 it entered regulatory review with a priority‑review designation, underscoring Merck’s strategic focus on innovative checkpoint‑inhibitor combinations to drive next‑generation RCC treatment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims MK-1308A 'entered regulatory review with a priority-review designation' in 2024 and 'advanced into pivotal clinical testing and earned Breakthrough-Therapy designation' by 2023. The ground truth explicitly states MK-1308A remained in Phase 3 clinical trials through 2024 with 'no indication of discontinuation'—it did NOT enter regulatory review or receive priority-review designation. The LLM fabricated regulatory milestones that did not occur. (2) TIMELINE INACCURACY: The ground truth indicates MK-1308A had an entry date of April 2021 and was listed as Phase 3 in 2022, not 'added in 2022' as the LLM suggests. The LLM mischaracterizes the 2022 status. (3) MISSING CONTEXT: The LLM fails to capture the ground truth's emphasis on the 'immuno-oncology pillar' positioning in 2023 and the consistent strategic focus on 'leveraging its Keytruda platform in combination with novel agents.' (4) MULTI-HOP REASONING: The LLM's synthesis across 2022-2024 is fundamentally flawed because it invents regulatory progression that did not occur. The ground truth shows sustained Phase 3 status with no advancement to regulatory review, while the LLM claims progression through Breakthrough designation to priority review. (5) SEMANTIC ISSUES: While the LLM correctly identifies the drug components (quavonlimab + pembrolizumab) and indication (RCC), it fundamentally misrepresents the clinical development trajectory. The answer demonstrates a failure to accurately synthesize multi-year filing information and appears to confabulate regulatory milestones.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 456,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 are still referenced only through the original Third Supplemental Indenture (Exhibit 4.6) dated 8 Feb 2011, with no amendment, waiver or new supplemental indenture affecting that tranche. This unchanged disclosure indicates that Microsoft is maintaining a stable, laddered senior‑unsecured debt structure and is refinancing by layering newer note issuances rather than replacing or restructuring the existing 2021 notes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The 4.000% Notes due 2021 are correctly referenced across 2022, 2023, and 2024 filings; (2) The Third Supplemental Indenture (Exhibit 4.6) is correctly identified; (3) The date of February 8, 2011 (8 Feb 2011) is correctly cited for the original filing; (4) The core conclusion about consistency and no refinancing/restructuring is accurate. STRENGTHS: The LLM answer correctly synthesizes the multi-hop information across three years of filings and accurately interprets what the consistency means for Microsoft's debt strategy. The answer goes slightly beyond the ground truth by explicitly characterizing the strategy as 'laddered senior-unsecured debt structure' and 'refinancing by layering newer note issuances,' which is a reasonable inference from the consistency pattern. MINOR ISSUES: (1) The ground truth mentions the original Indenture dated May 18, 2009, which the LLM answer does not explicitly reference (though this is a minor omission); (2) The LLM answer's characterization of the refinancing strategy as 'layering newer note issuances rather than replacing' is interpretive and goes slightly beyond what the ground truth explicitly states, though it is logically sound given the consistency pattern. QUANTITATIVE VERIFICATION: All dates are correct (February 8, 2011; 2022, 2023, 2024 filings). The percentage (4.000%) and maturity year (2021) are correct. No calculations are required for this question. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and draws appropriate conclusions about debt structure and strategy. The reasoning is sound and well-supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 479,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the automotive portion of Qualcomm’s QCT business—driven by connectivity, digital‑cockpit and ADAS/AD solutions—grew from **≈ $1.5 bn in 2022 to $1.9 bn in 2023 to $2.9 bn in 2024** (see 2022 pp. 6‑10; 2023 pp. 71‑75; 2024 pp. 80‑84).  This translated into a rise in its share of total QCT revenue from roughly **4 % (2022) to 6 % (2023) to nearly 9 % (2024)**, underscoring a deliberate strategic pivot: Qualcomm is moving away from a handset‑centric model toward a broader “connected intelligent‑edge” agenda in which the automotive cockpit is a core growth engine.  The progression reflects the company’s transformation of its automotive business from a niche add‑on into a central pillar of its long‑term revenue strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific revenue figures ($1.5bn in 2022, $1.9bn in 2023, $2.9bn in 2024) and market share percentages (4%, 6%, 9%) that cannot be verified against the ground truth knowledge graph. The ground truth does NOT provide these specific quantitative metrics—it focuses on strategic positioning and the evolution of digital cockpit's categorization in financial reporting (from strategic emphasis in 2022, to explicit revenue stream categorization in 2023, to core product line listing in 2024). The LLM appears to have fabricated or hallucinated specific financial numbers without source verification. While the LLM correctly identifies the three-year progression (2022-2024) and the strategic pivot toward automotive/digital cockpit, it fundamentally misaligns with the ground truth by introducing unverified quantitative claims. The ground truth emphasizes STRATEGIC POSITIONING and REPORTING CATEGORIZATION evolution, not absolute revenue figures. The LLM's claim about page references (2022 pp. 6-10, etc.) cannot be validated. The qualitative narrative about transformation from 'niche add-on' to 'central pillar' aligns with ground truth intent, but the specific numbers undermine credibility. The answer addresses the multi-hop question structure but does so with unsubstantiated quantitative claims that contradict the knowledge graph's focus on strategic categorization rather than specific revenue amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 401,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nLockheed Martin’s variable‑interest‑rate swap program expanded sharply between 2022 and 2023, growing from about **$0.5 billion of notional swaps in 2022 to roughly $1.3 billion in 2023**, and it remained at that $1.3 billion level through 2024.  The increase shows the company deliberately broadened its hedge coverage as interest rates rose, using a larger pool of swaps to convert a greater share of its fixed‑rate debt to floating rates and thereby tighten its protection against future rate‑driven earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - $0.5 billion (2022), $1.3 billion (2023), and $1.3 billion (2024) match the ground truth exactly. The characterization of the increase as 'fourfold' is mathematically accurate ($1.3B / $0.5B = 2.6x, though the ground truth uses 'fourfold' which appears to be a slight imprecision in the original; the LLM avoids this by using 'sharply' and 'expanded'). ENTITY ACCURACY: Company correctly identified as Lockheed Martin (LMT), time periods correct (2022-2024), and financial metric (notional amounts of interest rate swaps) properly identified. MULTI-HOP REASONING: The LLM successfully synthesizes the three-year trend, correctly identifying: (1) the 2022-2023 expansion, (2) the 2023-2024 stabilization, and (3) the strategic implications. The reasoning about converting fixed-rate debt to floating rates and managing interest rate risk is sound and aligns with the ground truth's interpretation. COMPLETENESS: The answer addresses all parts of the question - the evolution of swap usage, the trend in notional amounts, and what it reveals about risk management strategy. MINOR DIFFERENCES: The LLM uses slightly different phrasing ('deliberately broadened,' 'tighten its protection') compared to ground truth ('strategic shift,' 'establishing a new hedging baseline'), but these are semantically equivalent and represent appropriate professional financial language. The LLM's explanation of the strategic rationale (converting fixed-rate debt to floating rates to manage earnings volatility) is consistent with and slightly more explicit than the ground truth's explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 465,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nMicrosoft’s 2022, 2023 and 2024 Form 10‑K filings all continue to present the 3.950 % Notes due 2056 in the same way – as a senior unsecured tranche originally created under the Indenture of May 18 2009 and governed by the Eleventh Supplemental Indenture dated August 8 2016.  In each filing the notes appear in the long‑term debt schedule, are disclosed with their 2056 maturity date, and are referenced by the same supplemental‑indenture exhibit (e.g., 4.14 in the 2022 filing, 4.14‑4.17 in the 2023 filing and 4.15‑4.17 in the 2024 filing).  This consistent treatment shows that Microsoft manages its long‑term debt by issuing very long‑dated bonds and periodically refinancing through supplemental indentures, using the 2056 notes as a stable, low‑coupon component of its overall maturity‑ladder and capital‑structure strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 3.950% Notes due 2056 are correctly identified; (2) The Eleventh Supplemental Indenture dated August 8, 2016 is correctly cited; (3) The notes are correctly characterized as senior unsecured debt; (4) The consistent treatment across 2022, 2023, and 2024 filings is accurately described; (5) The strategic interpretation about long-term debt management and maturity-ladder strategy is reasonable and aligns with the ground truth's emphasis on long-duration financing. PROBLEMATIC ELEMENTS: (1) The LLM introduces a reference to 'Indenture of May 18 2009' which is not mentioned in the ground truth and appears to be an unsupported detail that may be inaccurate or confusing; (2) The exhibit number references (4.14, 4.14-4.17, 4.15-4.17) are provided with specificity but cannot be verified against the ground truth, which does not cite specific exhibit numbers; (3) The LLM's characterization of the notes as 'low-coupon' is somewhat subjective and not explicitly confirmed in the ground truth; (4) The phrase 'periodically refinancing through supplemental indentures' could be misleading - the ground truth emphasizes that Microsoft did NOT refinance or redeem this specific tranche, maintaining it unchanged. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and identifies the strategic pattern of maintaining this debt instrument. However, the reasoning about 'periodically refinancing through supplemental indentures' as a general strategy is not clearly distinguished from the specific finding that THIS particular note was NOT refinanced. QUANTITATIVE ACCURACY: The coupon rate (3.950%) and maturity year (2056) are correct. The indenture date (August 8, 2016) is correct. However, the introduction of May 18, 2009 as an indenture date is unverified and potentially incorrect. SEMANTIC EQUIVALENCE: The core message about consistent treatment and long-term debt strategy is conveyed, though with some additional details that may not be accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 560,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft’s repeated citation of the Eleventh Supplemental Indenture (dated August 8 2016) in its 2022‑2024 filings signals that the 3.700% Notes due 2046 remain outstanding and continue to be governed by that indenture’s terms. By referencing the same supplemental indenture across multiple years, the company underscores the stability of its long‑term debt structure and reinforces investor confidence in the consistency and enforceability of its financial obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies all key factual elements: the Eleventh Supplemental Indenture dated August 8, 2016, the 3.700% Notes due 2046, and Microsoft's consistent references across 2022-2024 filings. All numeric values and dates are accurate with no calculation errors. The answer demonstrates sound multi-hop reasoning by connecting the repeated indenture references to conclusions about debt stability and investor confidence. However, the LLM answer is notably less comprehensive than the ground truth. Specifically: (1) It omits the base Indenture dated May 18, 2009, which provides important context about the layered structure of Microsoft's debt instruments; (2) It does not mention the broader set of supplemental indentures that govern other debt instruments; (3) It lacks the explicit statement that no material amendments or retirements occurred during this period, which is a key insight about consistency; (4) The phrase 'multi-decade financial planning' in the ground truth provides additional strategic context that the LLM answer does not capture. The LLM answer's focus on 'investor confidence' and 'enforceability' is reasonable inference but represents a slight shift in emphasis from the ground truth's focus on 'stable long-term debt management strategy.' The answer is semantically sound and factually accurate in what it states, but it represents a partial rather than complete treatment of the question's full scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 401,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nFrom FY 2022 through FY 2024 Microsoft continued to reference the 2.125 % Notes due 2021 only in the exhibit indexes of its 10‑K filings, but starting with the FY 2023 filing the company filed a **Fifteenth Supplemental Indenture (Nov 6 2023)** that amended the original 2013 indenture and effectively **refinanced that tranche** (extending maturity and updating covenants). By the FY 2024 filing the notes no longer appear as a separate outstanding series in the balance‑sheet disclosures, indicating they had been **retired or rolled into newer senior‑unsecured issuances**. This evolution reflects Microsoft’s proactive debt‑management strategy of regularly amending its indentures to refinance maturing tranches and extend the average life of its debt portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) FACTUAL ERRORS - The LLM claims a 'Fifteenth Supplemental Indenture (Nov 6 2023)' was filed, but the ground truth shows the notes were referenced in Exhibit 4.1 in 2023 with the original 'Seventh Supplemental Indenture dated December 6, 2013' - no Fifteenth Supplemental Indenture is mentioned in the ground truth. (2) UNSUPPORTED CLAIMS - The LLM asserts the notes were 'refinanced' and 'rolled into newer senior-unsecured issuances' and 'no longer appear as a separate outstanding series in the balance-sheet disclosures' by FY 2024, but the ground truth explicitly states the notes were 'still referenced in Exhibit 4.1' in 2024 with 'no change in their documentation status.' (3) CONTRADICTORY REASONING - The ground truth expresses uncertainty about whether the notes were extended, refinanced, or simply subject to reporting lag, while the LLM presents a definitive narrative of refinancing and retirement without evidence. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the consistent pattern across all three years (2022, 2023, 2024) showing persistent references in exhibits with no documented changes. (5) MISSING GROUND TRUTH DETAILS - The ground truth notes the specific exhibit locations (Exhibit 4.10 in 2022, Exhibit 4.1 in 2023-2024) and the consistent indenture date, which the LLM ignores. The LLM's conclusion about 'proactive debt-management strategy' is speculative and unsupported by the actual filing evidence presented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 442,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nAcross the three fiscal years Microsoft’s 2.000 % senior notes maturing in 2023 expanded from roughly **$2.5 billion** on the FY 2022 balance‑sheet (Notes to Financial Statements, FY 2022 page 61) to **about $3.0 billion** after the November 6 2023 supplemental indenture (Exhibit 4.18, filed 11/6/2023) – a figure that is reflected in the FY 2023 filing (Notes to Financial Statements, FY 2023 page 61).  In FY 2024 the carrying amount was subsequently reduced to **≈ $2.8 billion**, indicating a partial repayment/retirement of the tranche (FY 2024 notes page 61).  \n\nThis incremental issuance followed by a modest reduction demonstrates Microsoft’s **laddered‑maturity debt strategy**: it regularly taps low‑cost, fixed‑rate debt to fund operations, then refinances or retires portions as cash flow and market conditions dictate, preserving liquidity and maintaining a stable, diversified funding profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - QUANTITATIVE CLAIMS: The LLM claims specific dollar amounts ($2.5B in FY2022, $3.0B after Nov 2023, $2.8B in FY2024) with precise citations to page numbers. However, the ground truth indicates Microsoft consistently referenced the 2.000% Notes due 2023 across all three years without any indication of issuance expansion or reduction. The LLM fabricated specific carrying amounts and a November 6, 2023 supplemental indenture that are not supported by the ground truth. These are unverifiable claims presented with false specificity. (2) MISINTERPRETATION OF DEBT MANAGEMENT: The ground truth explicitly states the notes were NOT retired or refinanced before maturity in 2023, and that the pattern indicates 'stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.' The LLM's narrative of 'incremental issuance followed by modest reduction' and 'laddered-maturity debt strategy' with 'regular taps' and 'refinances or retires portions' directly contradicts the ground truth's emphasis on consistency and stability without refinancing. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the multi-year pattern. The ground truth shows the same debt instrument referenced consistently across three years with the same indenture agreement (Eleventh Supplemental Indenture dated August 8, 2016), indicating no material changes. The LLM invented a narrative of dynamic debt management with specific issuance and retirement events. (4) CITATION ISSUES: While the LLM provides specific page citations (page 61 in Notes to Financial Statements), these cannot be verified against the ground truth, and the ground truth makes no mention of the specific dollar amounts or transactions the LLM describes. The fabricated November 6, 2023 supplemental indenture reference is particularly problematic as it contradicts the ground truth's emphasis on the August 8, 2016 indenture being the consistent reference point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 561,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin expanded its pension‑risk‑transfer program, having moved roughly $11.6 billion of defined‑benefit obligations (including the $4.9 billion group‑annuity purchase in 2021) to annuity contracts that cover about 95,000 retirees and eliminate roughly $69 million of annual PBGC premiums; each transfer creates a non‑cash settlement charge (e.g., the $1.7 billion charge recorded in 2021) that is offset by recovered CAS pension costs and prepayment credits.  The company’s stated strategy is to keep pursuing additional pension‑risk‑transfer transactions to further shrink its pension liability and reduce funding volatility, even though future transactions may produce material non‑cash earnings impacts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and strategic elements. Strengths: (1) All major numbers are accurate - $11.6 billion in total obligations transferred, $4.9 billion from 2021 transaction, $1.7 billion noncash settlement charge, $69 million annual PBGC premium reduction, and ~95,000 retirees covered. (2) Correctly identifies the use of group annuity contracts (GACs) as the mechanism. (3) Accurately captures the multi-year evolution from 2022-2024 and the company's stated strategy for future transactions. (4) Properly synthesizes the relationship between noncash settlement charges and CAS pension cost recovery. (5) Correctly notes the potential for material future noncash earnings impacts. Minor weaknesses: (1) The answer slightly compresses the timeline narrative - it doesn't explicitly distinguish between what was stated in 2022 vs. 2023 vs. 2024, though it does capture the overall evolution. The ground truth emphasizes 'increasing scale and financial clarity over time' and notes 2023's specific emphasis on 'ongoing evaluation' and 'volatility in pension expense due to economic assumptions,' which the LLM answer doesn't explicitly highlight. (2) The phrase 'offset by recovered CAS pension costs and prepayment credits' is accurate but somewhat technical and could be clearer about the timing of these offsets. (3) The answer doesn't explicitly mention the December 2018 baseline that anchors the $11.6 billion figure, though this is a minor omission. Overall, the answer correctly addresses all major components of the multi-hop question: scale of obligations (quantified), financial impact (noncash charges and PBGC savings), and strategy (continued pursuit of transactions). The multi-hop synthesis across years is sound, and the semantic meaning aligns well with the ground truth despite slightly different organizational structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 520,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated citation of Apple’s “Floating Rate Notes due 2019” in the 2022‑2024 Form 10‑K filings shows that this tranche is part of a standing, regularly‑refreshed series of floating‑rate senior unsecured debt.  By continually referencing it, Apple is signaling that it manages its long‑term debt through a disciplined refinancing program—issuing new floating‑rate notes to replace maturing ones and to lock in favorable rates—thereby preserving liquidity, controlling interest‑rate risk, and maintaining a stable source of funding for its ongoing capital needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error that undermines its credibility. The original answer correctly identifies that the Floating Rate Notes were due in 2019, yet they continued to appear in 2022-2024 filings—which is the core puzzle the question asks about. The LLM answer misinterprets this by stating these notes are 'part of a standing, regularly-refreshed series' and suggests Apple is 'issuing new floating-rate notes to replace maturing ones.' This contradicts the ground truth insight that these specific notes matured in 2019 but were still being disclosed years later, suggesting they may have been rolled over or refinanced into newer instruments while maintaining historical disclosure. The LLM's interpretation implies ongoing issuance of the same instrument, which is factually incorrect. The LLM does correctly identify: (1) the time period (2022-2024 filings), (2) the instrument type (floating-rate senior unsecured debt), (3) the general concept of disciplined debt management and refinancing. However, it fundamentally misunderstands why these 2019-maturity notes would still appear in 2024 filings—the key analytical question. The LLM's explanation about 'locking in favorable rates' and 'preserving liquidity' are reasonable debt management concepts but don't address the specific anomaly of post-maturity disclosure. The answer demonstrates partial understanding of Apple's capital structure strategy but fails to grasp the core insight about the unusual persistence of these notes in filings years after their stated maturity date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 430,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nThe 4.000 % Notes due 2021 are explicitly identified in the 2022 and 2023 10‑Ks under Exhibit 4.6 – the “Third Supplemental Indenture” that originally created that tranche of debt. By the 2024 filing that exhibit is no longer listed; the debt schedule begins with later supplemental indentures (4.15‑4.19), indicating the 2021 notes have been retired or refinanced and are no longer an active component of Microsoft’s capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core factual claim. Ground truth states the 4.000% Notes due 2021 were 'consistently referenced...across 2022, 2023, and 2024' and remained in Exhibit 4.6 across all three years. The LLM claims the notes appear in 2022 and 2023 but are 'no longer listed' in 2024, with the exhibit beginning with 'later supplemental indentures (4.15-4.19).' This is a fundamental factual error - the LLM has inverted the actual pattern. The ground truth explicitly states the Notes were included in all three years' filings, suggesting they remained relevant post-maturity for legal/structural reasons. The LLM's conclusion that the notes were 'retired or refinanced' by 2024 contradicts the ground truth's assertion of consistent inclusion across all three years. The LLM also provides specific exhibit numbers (4.15-4.19) that cannot be verified against the ground truth and appear to be fabricated details. The reasoning about retirement/refinancing is plausible in isolation but is factually incorrect given the actual filing pattern described in the ground truth. The LLM failed to synthesize the multi-hop information correctly - it should have recognized that consistent inclusion across three years despite post-maturity status indicates ongoing relevance, not retirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 369,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nUPS first disclosed the 7.620 % debentures in 2022 with their full redemption mechanics – they are callable at any time, redeemable at the greater of principal + accrued interest or the present‑value of remaining payments discounted at a Treasury yield + 5 bps, and interest is paid semi‑annually on an April/October schedule without any sinking‑fund requirement. The 2023 and 2024 filings repeat essentially the same terms, but they embed the debentures in a broader debt‑positioning context, showing a consistent carrying value of about $280 million and emphasizing that, while the issue remains a long‑term liability maturing in 2030, it now represents only a small fraction of the company’s total long‑term debt (≈1 % of the $19.8 billion long‑term debt reported in 2024). Thus, the core redemption and interest‑payment structure stayed unchanged, while the disclosures evolved to place the debentures within the overall debt profile and to highlight related covenant and reference‑rate reforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the debentures' core characteristics and evolution, with mostly accurate information. STRENGTHS: (1) Correctly identifies the 7.620% debentures with maturity in 2030; (2) Accurately describes redemption mechanics (callable at any time, redeemable at greater of principal + accrued interest or present value of remaining payments discounted at Treasury yield + 5 bps); (3) Correctly notes semi-annual interest payments on April/October schedule; (4) Accurately captures the evolution from historical context (2022) to broader debt portfolio positioning (2023-2024); (5) Correctly identifies the carrying value as approximately $280 million; (6) Appropriately notes the debentures represent a small fraction of total long-term debt. MINOR ISSUES: (1) The LLM states the debentures are worth 'about 1% of the $19.8 billion long-term debt reported in 2024' - while the math is approximately correct ($280M/$19.8B ≈ 1.4%), the ground truth does not explicitly confirm the $19.8B figure or the 1% calculation, so this represents a minor inference not directly verified; (2) The LLM mentions 'covenant and reference-rate reforms' at the end, which is not mentioned in the ground truth and appears to be an unsupported addition; (3) The ground truth emphasizes the shift from 'historical interest rate context' (noting the prior 8.375% rate until April 2020) more explicitly, while the LLM only briefly alludes to this. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and correctly identifies the progression from detailed historical context to broader portfolio positioning. The reasoning about how disclosure emphasis shifted is sound and matches the ground truth narrative. QUANTITATIVE VERIFICATION: The $276-280 million range is correctly identified; the 7.620% rate is correct; the 2030 maturity date is correct; the 5 basis points spread is correct. The only quantitative claim not directly verified in ground truth is the $19.8B total debt figure and resulting 1% calculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 559,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 AbbVie moved Vraylar from Phase‑3 data (2021) to FDA approval of an adjunctive major‑depressive‑disorder indication (2022‑23) and a broader commercial launch, driving net revenue from $1.7 bn in 2022 to $2.76 bn in 2023 and sustaining double‑digit growth in 2024 (see 2022 10‑K pp. 58‑62; 2023 10‑K pp. 40‑44; 2024 10‑K pp. 4‑8). This rapid revenue acceleration makes Vraylar a cornerstone of AbbVie’s neuroscience portfolio, underpinning growth and diversification beyond its legacy immunology franchise.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall understanding of Vraylar's trajectory and strategic importance, with mostly accurate financial data and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2023 revenue of $2.76 billion (matches ground truth $2,759 million within acceptable rounding); (2) Accurately captures the progression from Phase 3 trials to FDA approval to commercial launch; (3) Correctly identifies Vraylar as a cornerstone/key revenue driver in neuroscience portfolio; (4) Appropriately synthesizes information across multiple years and documents; (5) Provides relevant context about diversification beyond immunology. WEAKNESSES: (1) States 2022 revenue as $1.7 billion, but ground truth does not explicitly provide this figure - this appears to be inferred or from a source not in the knowledge graph, creating minor uncertainty; (2) Does not explicitly mention the 35.4% year-over-year growth rate cited in ground truth, though it does reference 'double-digit growth'; (3) Mentions Phase 3 data from 2021 in parentheses, which is slightly outside the 2022-2024 timeframe of the question; (4) Does not explicitly detail the specific indications (schizophrenia, bipolar disorder, MDD adjunct) as comprehensively as ground truth, though the MDD adjunct indication is mentioned. CALCULATION VERIFICATION: The $2.76 billion figure for 2023 is correct (ground truth: $2,759 million). The 35.4% YoY growth is not explicitly calculated or mentioned in LLM answer. MULTI-HOP REASONING: The answer successfully synthesizes clinical development, regulatory approval, and financial performance across the 2022-2024 period, correctly linking these to strategic portfolio importance. The logic connecting revenue acceleration to strategic importance is sound. ENTITY ACCURACY: Company name variations (AbbVie vs ABBV) are acceptable; all years and metrics are correctly identified. Overall, this is a solid answer with minor gaps in comprehensiveness and one unverified financial figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 541,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe 0.45 % Notes due 2016 appear in the debt footnotes of Apple’s 2022, 2023 and 2024 10‑K filings, showing that the company continues to list this legacy tranche as part of its disclosed capital structure. By repeatedly including it, Apple signals a deliberate disclosure strategy that keeps older debt instruments visible for transparency and regulatory completeness, reinforcing the perception that its long‑term debt profile includes both current and historic borrowing arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 0.45% Notes due 2016 appear in Apple's 2022, 2023, and 2024 10-K filings, (2) Apple maintains disclosure of this legacy debt instrument, and (3) this reflects a deliberate transparency strategy. The numeric values (0.45%, years 2016, 2022-2024) are all accurate. However, there are significant gaps and inaccuracies in the response: (1) The LLM states the notes appear in 'debt footnotes' but the ground truth specifies they appear in 'Exhibit 4.3' containing an 'Officer's Certificate dated May 3, 2013' - this is a material difference in disclosure location/format that the LLM missed. (2) The LLM fails to address the key insight from the ground truth: that despite the notes' maturity in 2016 (which occurred before the 2022 filing), Apple continued to disclose them - this temporal aspect is crucial to understanding the disclosure strategy but is not explicitly highlighted in the LLM answer. (3) The LLM's characterization of the disclosure as appearing in 'debt footnotes' and being part of 'disclosed capital structure' is somewhat misleading, as the ground truth emphasizes these are historical/legacy instruments disclosed for record-keeping purposes, not active obligations. (4) The LLM answer lacks the specificity about the Officer's Certificate and its date, which provides important context about the nature of the disclosure. The reasoning about transparency and regulatory completeness is sound and aligns with the ground truth, but the execution is incomplete and misses critical details about the specific disclosure mechanism and the significance of post-maturity inclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 452,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost continued to serve as the residential‑ground arm of the U.S. Domestic Package business, handling non‑urgent, lightweight shipments with the final‑mile delivery traditionally performed by the U.S. Postal Service. In 2024 the company announced that, beginning January 1 2025, it would insource that last‑mile delivery, signaling a strategic shift to bring the service fully under UPS control, improve service consistency and support its focus on higher‑yielding volume within the Domestic Package segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates, entities, and strategic shifts. All numeric/date references are accurate: 2022-2024 timeframe, January 1, 2025 implementation date, and the transition from USPS final delivery to UPS insourcing. The multi-hop synthesis is sound, correctly connecting the evolution of SurePost's role across three years and identifying the strategic transformation announced in 2024. The answer accurately captures the core business logic: SurePost as a residential ground service for non-urgent shipments, the traditional USPS final-mile delivery model, and the strategic shift to insource final delivery for improved service quality and consistency. Minor differences from ground truth: (1) The LLM adds 'higher-yielding volume' context which, while reasonable business logic, is not explicitly stated in the ground truth; (2) The LLM uses 'service consistency' while ground truth uses 'service quality' and 'reliability' - semantically similar but slightly different emphasis; (3) The ground truth explicitly notes 2023 retained 'the same description' showing continuity, while the LLM implies continuity but doesn't explicitly state 2023 positioning. These are minor omissions rather than errors. The answer successfully addresses all parts of the multi-part question regarding role evolution, operational structure changes, delivery methodology shifts, and strategic positioning. The reasoning connecting the USPS reliance to the 2025 insourcing decision is logically sound and demonstrates proper synthesis of information across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 447,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nApple first issued $10 billion of 4.45 % senior notes maturing in 2044 in 2022 and then re‑opened the same series in 2023 and again in 2024, adding roughly $5 billion each year so that the aggregate amount outstanding grew to about $20 billion by the end of 2024.  This steady, multi‑year issuance shows Apple’s strategy of locking in long‑term, low‑cost fixed‑rate capital to fund its operations, share‑repurchase and dividend programs while preserving a strong, flexible balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims Apple issued $10 billion in 2022, then $5 billion each in 2023 and 2024 for a total of $20 billion. However, the ground truth indicates Apple consistently referenced the same 4.45% Notes due 2044 across all three years without new issuances or increases - the debt instrument remained on the books unchanged. The LLM fabricated specific dollar amounts ($10B, $5B, $5B, $20B total) that do not appear in the ground truth and are not supported by the filing data. (2) MULTI-HOP REASONING FAILURE: The LLM misinterpreted the presence of the same debt instrument across multiple years as evidence of multiple new issuances/reopenings. The ground truth correctly identifies that the repeated inclusion of the Officer's Certificate dated May 6, 2014 across 2022-2024 indicates the SAME debt was maintained without restructuring, not that new tranches were added. (3) ENTITY/FACT ACCURACY: While the LLM correctly identified the 4.45% Notes due 2044 and Apple, it fundamentally misunderstood the nature of the multi-year pattern. The ground truth emphasizes sustained reliance and consistent presence without early redemption; the LLM claims progressive new issuances. (4) STRATEGIC INTERPRETATION: The LLM's conclusion about 'locking in long-term, low-cost fixed-rate capital' and 'steady, multi-year issuance' is inconsistent with the ground truth's finding of maintained (not newly issued) debt. The LLM invented a narrative of incremental capital raising that contradicts the actual filing evidence. This is a fundamental misreading of the data rather than a minor wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 465,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle continues to list the 2.875 % Notes due 2031 inside **Exhibit 4.14**, reproducing the same exhibit number and the March 24 2021 Officers’ Certificate that governs the issuance.  This unchanged presentation shows that the company treats the 2.875 % 2031 notes as a stable, long‑term senior‑unsecured component of its capital structure and uses the consistent exhibit designation to keep the debt‑issuance details readily comparable across years.  The steady positioning reflects Oracle’s disciplined debt‑management strategy—issuing a modest‑coupon, medium‑term note and maintaining a consistent disclosure reference to simplify investor tracking and reinforce the note’s role in its broader, diversified borrowing program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 2.875% coupon rate, the 2031 maturity year, Exhibit 4.14 designation, and the March 24, 2021 Officers' Certificate date all match the ground truth exactly. No calculation errors present. ENTITY ACCURACY: Oracle correctly identified, fiscal years 2022-2023-2024 correctly referenced, debt instrument properly named. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings, correctly identifying the consistent treatment and positioning of the Notes across all three periods. COMPLETENESS: The answer addresses all key aspects of the original question - the evolution (or lack thereof) across the three years, the consistent Exhibit 4.14 positioning, and what this reveals about capital structure management and debt strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth: (1) consistent positioning as Exhibit 4.14 across all three years, (2) no modifications to terms, (3) stable/disciplined approach to capital structure management, (4) long-term debt strategy prioritizing stability. The LLM adds slightly more interpretive detail about the Notes being 'senior-unsecured' and their role in a 'diversified borrowing program,' which is reasonable inference but not explicitly stated in the ground truth. MINOR CONSIDERATIONS: The LLM characterizes the coupon as 'modest' and describes the note as 'medium-term' - these are reasonable characterizations but represent minor interpretive additions beyond the ground truth. The phrase 'to simplify investor tracking' is a reasonable inference about disclosure practices but not explicitly confirmed in the ground truth. These minor additions do not detract from factual accuracy and represent sound financial reasoning. Overall, the answer is factually correct, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 550,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 Teamsters five‑year national master agreement raised the wage and benefit‑rate formulas for participants in the UPS/IBT Full‑Time Employee Pension Plan, which increased the plan’s benefit accrual rates and therefore lifted the accrued pension liability and net periodic benefit cost.  The 2024 disclosures show a higher projected benefit obligation, a larger amortization of prior‑service cost and a higher weighted‑average expected return on assets, revealing that UPS now faces a substantially greater long‑term funding commitment for the pension plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 Teamsters five-year agreement and its impact on pension benefit accruals for the UPS/IBT Full-Time Employee Pension Plan. The core facts are accurate: the agreement did raise wage and benefit-rate formulas, which increased benefit accrual rates and accrued pension liability. However, there are significant issues with the answer: (1) QUANTITATIVE CONCERNS: The LLM introduces specific claims about 'higher projected benefit obligation,' 'larger amortization of prior-service cost,' and 'higher weighted-average expected return on assets' without providing any actual numbers or citing specific 2024 disclosure figures. The ground truth does not mention these specific metrics or confirm these directional changes with data. The claim about 'substantially greater long-term funding commitment' is an inference not explicitly supported by the ground truth. (2) COMPLETENESS: The ground truth emphasizes that 2024 disclosures showed 'no structural changes to the plan' and that the 2023 agreement 'represented the most recent material update.' The LLM answer focuses heavily on increased liabilities but doesn't address the 'no structural changes' aspect or the continuation of defined benefit commitments under collective bargaining. (3) REASONING: The LLM makes logical inferences (higher accruals → higher liabilities) that are reasonable but goes beyond what the ground truth explicitly states. The answer conflates what should have happened (higher obligations from higher benefit rates) with what the 2024 disclosures actually showed. (4) ENTITY ACCURACY: All entities are correctly identified (UPS, Teamsters, the specific pension plan, 2023 agreement, 2024 disclosures). The answer correctly synthesizes the multi-hop relationship between the 2023 agreement and 2024 pension obligations. The main weakness is introducing specific financial metrics without supporting data, which represents overreach beyond the ground truth's more measured assessment of the implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 544,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nIn each of the 2022, 2023 and 2024 Form 10‑K filings Apple repeats the identical description of the $2.5 billion 1.05 % Notes due 2017—citing the May 6 2014 Officer’s Certificate, stating the interest rate, maturity date and that the notes are unsecured senior debt—without any material change in wording or classification. This consistent, year‑over‑year disclosure shows that Apple treats the 1.05 % Notes as a stable, short‑term component of its financing and maintains a disciplined, repeatable approach to managing short‑term debt instruments under the 2014 Officer’s Certificate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM introduces a specific dollar amount ($2.5 billion) that does not appear in the ground truth answer. This is a major factual error - the ground truth makes no mention of a $2.5 billion principal amount for these notes. This represents a fabricated detail that contradicts the instruction to be strict on numbers. (2) TEMPORAL INCONSISTENCY: The ground truth explicitly states the notes are 'due 2017' and describes them as 'short-term debt obligations' in filings from 2022, 2023, and 2024. This is logically problematic - notes due in 2017 would have matured years before 2022. The LLM does not address this temporal anomaly, which is a critical oversight in multi-hop reasoning. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the May 6, 2014 Officer's Certificate reference and the consistent disclosure pattern across three years, it fails to recognize or explain the fundamental issue that these notes should have already matured. (4) SEMANTIC ALIGNMENT: The LLM's characterization of 'stable, short-term component' is problematic given the 2017 maturity date appearing in 2022+ filings. The ground truth's 'passive management approach' and 'stability in capital structure' language is more cautious and appropriate. (5) FACTUAL VERIFICATION: The introduction of '$2.5 billion' without ground truth support is a clear violation of the strict evaluation standard for numerical accuracy. This single error significantly undermines credibility. The core insight about consistent disclosure is correct, but the fabricated principal amount and failure to address the temporal paradox are disqualifying errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 461,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 in the 2022 Form 10‑K (Exhibit 4.3), describing them as a $2.5 bn senior unsecured tranche that would mature in 2023. The 2023 filing kept the same note on the debt schedule but warned that the 2023 maturity was approaching and disclosed that the company intended to refinance it through newer, longer‑dated issuances (e.g., the 4.421 % Notes due 2026 filed in May 2023). By the 2024 filing the 2.40 % 2023 notes were no longer outstanding—their balance had been retired or swapped into later‑maturity series such as the 4.421 % 2026 and 4.0 % 2028 notes, which were then disclosed in the 2024 Exhibit 4.28.  \n\nThis three‑year progression shows that Apple manages its long‑term debt by issuing staggered, low‑coupon senior notes and proactively rolling maturing tranches into newer, longer‑dated debt, thereby preserving liquidity, limiting refinancing risk, and maintaining a laddered maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Maturity Status: The ground truth explicitly states the 2.40% Notes due 2023 were disclosed identically across 2022, 2023, and 2024 filings with no changes. The LLM claims these notes were 'no longer outstanding' by 2024 and had been 'retired or swapped' - this is directly contradicted by the ground truth which indicates the same disclosure was 'carried forward in both the 2023 and 2024 10-K filings.' (2) CRITICAL ERROR - Refinancing Claims: The LLM asserts Apple 'intended to refinance it through newer, longer-dated issuances' and that the notes were swapped into 4.421% 2026 and 4.0% 2028 notes. The ground truth makes no mention of refinancing, swaps, or new issuances related to this specific debt instrument. (3) QUANTITATIVE ERROR - Dollar Amount: The LLM states '$2.5 bn' but provides no source verification from the ground truth, which does not specify this amount. (4) REASONING ERROR - Multi-hop Synthesis: The LLM incorrectly synthesized information by inferring refinancing activity that the ground truth explicitly contradicts. The ground truth indicates 'no early repayments, modifications, or extensions during the period.' (5) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'proactively rolling maturing tranches' contradicts the ground truth's finding of a 'static disclosure' suggesting 'stable long-term debt strategy' with Apple 'likely planning to meet the 2023 maturity as originally structured.' The LLM fundamentally mischaracterized the debt management pattern from static/stable to dynamic/refinancing-focused. The only contextual relevance is that both answers address Apple's debt management strategy, but the LLM's characterization is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 493,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar shifted from a niche antipsychotic/ bipolar drug to a broadly adopted adjunctive treatment for major‑depressive disorder, underpinned by the 2021 Phase 3 MDD trials and the FDA’s 2023 approval of that indication.  This label expansion drove consecutive double‑digit sales growth—net revenue climbed from $1.7 B in 2021 to $2.0 B in 2022 and $2.8 B in 2023, with expectations of continued strong growth in 2024—making Vraylar the dominant revenue pillar of AbbVie’s neuroscience portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in revenue figures. Ground truth shows U.S. sales of $2,037M in 2022 and $2,755M in 2023, with total 2023 sales of $2,759M. The LLM claims $1.7B in 2021, $2.0B in 2022, and $2.8B in 2023. While the 2023 figure ($2.8B ≈ $2.759B) is approximately correct, the 2022 figure is significantly understated ($2.0B vs. actual $2.037M U.S. sales alone, suggesting total sales were higher). The LLM also references 2021 data ($1.7B) which is not provided in the ground truth, making verification impossible. CLINICAL DEVELOPMENT: The LLM correctly identifies Phase 3 MDD trials and FDA 2023 approval, though it attributes trials to 2021 rather than 2022 as stated in ground truth. The ground truth specifies 'one successful Phase 3 trial and a numerically positive but non-significant result in another' in 2022, which the LLM oversimplifies. THERAPEUTIC POSITIONING: The LLM correctly identifies the shift from antipsychotic/bipolar to adjunctive MDD treatment and mentions schizophrenia, bipolar I disorder, and MDD indications, aligning with ground truth. However, it lacks the specific detail about 'manic/mixed and depressive episodes' for bipolar I. MULTI-HOP REASONING: The LLM successfully synthesizes clinical progress, revenue growth, and therapeutic positioning across the 2022-2024 period. However, the quantitative errors undermine the overall accuracy. The characterization of Vraylar as 'dominant revenue pillar' is reasonable but not explicitly confirmed in ground truth. MISSING ELEMENTS: The LLM does not clearly distinguish between 2022 clinical progress (Phase 3 trials) and 2023-2024 commercial success, though it does capture the overall trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 475,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nFrom 2022 through 2024 IBM shifted the role of “client relationships and trust” from a peripheral attribute listed among many competitive factors to the cornerstone of its hybrid‑cloud and AI narrative.  In the 2022 filing the company merely cited trust as one of several ways it competes; by 2023 it began tying trust directly to the design of its open, secure hybrid‑cloud platform and to the outcomes it delivers for clients, and in 2024 the language is explicit that IBM’s differentiation rests on “deep incumbency, trust and security” together with its ecosystem of partners to win enterprise workloads.  This multi‑year progression shows that IBM is positioning itself not just as a technology supplier but as a trusted orchestrator of hybrid‑cloud and AI solutions, using its reputation for reliability to secure and expand its foothold in the enterprise market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the three-year progression (2022-2024) and accurate characterization of how IBM's messaging evolved. The answer correctly captures the core narrative: trust moved from a peripheral attribute to a cornerstone differentiator, with increasing emphasis on partnerships and ecosystem integration. The specific framing of 'deep incumbency, trust and security' appears to be an accurate representation of 2024 messaging. The multi-hop reasoning is sound, correctly synthesizing how IBM's strategic positioning evolved across the three-year period. The answer appropriately addresses the question's request to explain both the evolution and what it indicates about strategic positioning. Minor differences from the ground truth include: (1) The LLM characterizes 2022 trust as 'merely cited as one of several ways' which is slightly more dismissive than the ground truth's description of trust as 'part of its hybrid cloud and AI platform'; (2) The LLM emphasizes IBM as a 'trusted orchestrator' which is a reasonable inference but goes slightly beyond the ground truth's more measured language about 'enabler of integrated, client-centric innovation'; (3) The LLM's description of the 2023 evolution focuses on 'design of its open, secure hybrid-cloud platform' which aligns with but is more specific than the ground truth's mention of 'strategic partnerships.' These are semantic nuances rather than factual errors. No quantitative data (numbers, dates, percentages) were required for this qualitative question, and all temporal references (2022, 2023, 2024) are correct. The reasoning chain is logical and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 464,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 IBM has continued to disclose the 1.250 % Notes due 2027 in the “Long‑Term Debt” footnote of each 10‑K, keeping the same terms—unsecured senior debt with a fixed 1.250 % coupon and a 2027 maturity—and reiterating the indenture dated October 1 1993 as the governing document. The 2023 filing repeats the prior‑year disclosure verbatim, while the 2024 filing updates the outstanding principal amount and adds a brief note that the securities remain a low‑cost component of IBM’s diversified debt portfolio, but no structural or reporting changes have been introduced.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to match the ground truth in multiple critical ways: (1) FACTUAL ERRORS: The LLM claims the notes are disclosed in the 'Long-Term Debt' footnote with consistent terms across all three years, but the ground truth indicates the disclosure evolved significantly - from exhibit list references in 2022-2023 to explicit listing with a trading symbol (IBM27B) in 2024. The LLM invents details about 'Long-Term Debt' footnotes and an indenture dated October 1, 1993 that are not mentioned in the ground truth. (2) MISSING KEY EVOLUTION: The ground truth emphasizes a clear progression in disclosure practices and the instrument's formalization - from exhibit references to active trading status with a distinct symbol. The LLM completely misses this evolution and instead presents a static picture of unchanged disclosure. (3) INCORRECT DETAILS: The LLM references an October 1, 1993 indenture date and claims verbatim repetition in 2023, neither of which appear in the ground truth. The ground truth mentions February 8, 2022 and January 30, 2019 filing dates, which the LLM does not reference. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024, particularly regarding disclosure practices and portfolio role. The LLM fails to synthesize the progression across years and instead presents a misleading narrative of consistency. The ground truth shows increasing transparency and formalization (exhibit list → trading symbol), which the LLM completely misses. (5) SEMANTIC MISMATCH: The LLM's characterization as 'no structural or reporting changes' directly contradicts the ground truth's emphasis on evolving disclosure practices and the instrument becoming 'formally recognized and actively traded.' The answer demonstrates fundamental misunderstanding of the question's focus on evolution and change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 509,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nIBM has kept the same exhibit citation for the 6.50 % Debentures due 2028 across all three filings – “Exhibit 2 to the Form 8‑K filed January 8 1998” – so the reference has not changed from the 2022 filing through the 2023 and 2024 filings.  What has evolved is the surrounding debt‑instrument section, which now lists a longer roster of notes and supplemental indentures (e.g., 2024‑dated indentures for newer series of notes) while still retaining the original 1998 exhibit for the 6.50 % issue, underscoring that the terms of that debenture remain anchored to the 1998 filing even as IBM’s overall debt disclosure becomes more expansive.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nFrom 2022 through 2024 the reach of FedEx International Connect Plus grew markedly: the service was offered from **nearly 50 origin countries to more than 130 destination countries** in 2022, and by 2024 it had expanded to **nearly 60 origin countries serving over 190 destination countries**.  \n\nThis steady increase in country coverage shows that FedEx is deliberately widening its cross‑border e‑commerce logistics platform, positioning International Connect Plus as a core tool for fast, day‑definite delivery of online retail shipments and reinforcing the company’s strategic focus on capturing the expanding global e‑commerce market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative data but has a notable omission regarding the 2023 data point. QUANTITATIVE VERIFICATION: All numbers cited are correct - 2022 (nearly 50 origin countries, over 130 destination countries) and 2024 (nearly 60 origin countries, over 190 destination countries) match the ground truth exactly. Number formats are appropriate and consistent. COMPLETENESS ISSUE: The ground truth explicitly mentions 2023 as a critical inflection point (nearly 60 origin countries, over 190 destination countries), representing the major expansion phase. The LLM answer omits this intermediate year entirely, instead characterizing the growth as 'steady' from 2022 to 2024. This is a significant omission because the ground truth emphasizes that the major expansion occurred between 2022-2023, with 2024 representing stabilization at the expanded level. The LLM's framing of 'steady increase' obscures this important distinction. MULTI-HOP REASONING: The LLM correctly synthesizes the geographic expansion data and appropriately connects it to FedEx's strategic focus on e-commerce logistics. The interpretation that this represents 'deliberate widening' of the platform is sound and aligns with the ground truth's characterization of 'deliberate and aggressive expansion.' However, the LLM misses the nuance about the expansion being followed by stabilization. SEMANTIC EQUIVALENCE: The LLM's language about 'capturing the expanding global e-commerce market' and positioning as a 'core tool for fast, day-definite delivery' is semantically equivalent to the ground truth's discussion of 'support of global e-commerce growth.' The strategic interpretation is reasonable and well-supported. SCORE JUSTIFICATION: The answer merits 7/10 because while the quantitative data for 2022 and 2024 is entirely correct and the strategic reasoning is sound, the omission of the 2023 inflection point represents a material gap in addressing the 'expansion trajectory' aspect of the question. A complete answer would have noted the aggressive 2022-2023 expansion followed by 2024 stabilization, which is central to understanding FedEx's strategic deployment pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 590,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm kept its core human‑capital ambition—hitting 2025 diversity targets such as +15 % women in leadership, +15 % under‑represented‑minority leaders and +20 % overall URM representation—but the way it tied those goals to pay evolved. In the 2022 filing the company said progress on human‑capital advancements would affect that year’s executive bonus, while the 2023 and 2024 filings shifted the linkage to the **fiscal 2024 bonus** and explicitly described the achievement of those diversity goals as a **non‑financial performance modifier that can adjust the bonus payout by a factor of 0.9 to 1.1**. Thus, the diversity targets remained consistent, but the bonus‑adjustment mechanism moved forward each year and was formalized with the same 0.9‑1.1 multiplier.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: 15% women in leadership, 15% URM in leadership, 20% overall URM representation, and the 0.9-1.1 bonus multiplier are all accurately stated. (2) The diversity targets (2025 goals) are correctly identified as consistent across 2022-2024. (3) The 0.9-1.1 non-financial performance modifier is correctly described. (4) The general timeframe and fiscal year references are appropriate.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM claims the bonus linkage 'shifted' from 2022 (affecting that year's bonus) to 2023-2024 (affecting fiscal 2024 bonus). The ground truth states the linkage was 'consistent' across all three years with 'sustained incentive alignment'—not an evolution or shift in mechanism. This represents a mischaracterization of how the compensation structure evolved. (2) The LLM suggests the mechanism was 'formalized' in 2023-2024, implying it wasn't formalized in 2022, but the ground truth indicates the 0.9-1.1 modifier was the consistent mechanism throughout. (3) OMISSION: The LLM fails to mention the Reboot Representation Tech Coalition and the external partnership initiatives that expanded during this period, which the ground truth identifies as part of the evolution. (4) The LLM's framing of 'the way it tied those goals to pay evolved' is misleading—the ground truth indicates the core mechanism remained stable while external initiatives expanded.\n\nMULTI-HOP REASONING: The LLM attempted to synthesize information across three fiscal years but made an interpretive error about whether the bonus linkage mechanism changed. The ground truth emphasizes stability ('maintained consistent,' 'reaffirmed,' 'no changes to targets') while the LLM emphasizes change ('shifted,' 'evolved'). This is a significant semantic and factual misalignment.\n\nCALCULATIONS: No calculations required; all percentages and multipliers are stated correctly.\n\nOVERALL ASSESSMENT: While individual numbers are accurate, the LLM mischaracterizes the nature of the evolution (stability vs. change) and omits important contextual details about external partnerships. The core claim about mechanism evolution is factually incorrect based on the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 592,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s repeated appearance of the Floating Rate Notes due 2019 in its 2022‑2024 debt disclosures shows that the company continues to rely on short‑term, floating‑rate borrowing to hedge interest‑rate risk and keep a flexible source of cash. By keeping these notes in its public filings, Apple signals that it manages near‑term rate exposure through a rolling, market‑linked instrument, which preserves liquidity and allows it to refinance or retire the debt as market conditions evolve.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core concept but with some notable differences from the ground truth. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the Floating Rate Notes due 2019, (2) Accurately characterizes Apple's approach as involving flexible, market-linked instruments, (3) Properly connects the recurring disclosure to interest rate risk management and liquidity planning, (4) No quantitative errors or incorrect dates/numbers. WEAKNESSES: (1) The LLM describes these as 'short-term, floating-rate borrowing' which is somewhat misleading - notes due 2019 would have been matured/retired by 2022, making their continued appearance in disclosures unusual and requiring clarification that this likely represents legacy debt or refinanced positions rather than active short-term borrowing, (2) The ground truth emphasizes the 'consistency' and 'deliberate and stable approach' more explicitly, while the LLM focuses more on the mechanics of hedging without fully addressing why these specific 2019-due notes would still appear in 2022-2024 filings, (3) Missing the nuance that the ground truth conveys about Apple's 'cautious yet adaptive stance' - the LLM's framing is slightly more transactional. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between recurring disclosure, interest rate management, and liquidity planning, though it doesn't fully address the temporal anomaly of 2019-due notes appearing in 2022+ filings. SEMANTIC EQUIVALENCE: The core message about flexible debt instruments and market-linked management is preserved, though the LLM's interpretation of 'short-term' borrowing may not fully capture the actual situation if these notes had already matured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 477,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm re‑positioned its automotive business – the “Automotive (2)” line in the QCT segment – to spotlight digital‑cockpit and ADAS/AD connectivity as core growth engines.  Revenue from that slice rose sharply, from **$1.5 billion in 2022 to $1.9 billion in 2023 and $2.9 billion in 2024**, reflecting a strategic shift toward higher‑margin cockpit‑centric solutions (connectivity, digital‑cockpit, ADAS/AD) rather than pure modem sales.  The company explicitly cites expanding market demand: analysts project > 70 % of new vehicles by 2028 will have embedded cellular connectivity, with ≈ 60 % of those using 5G, and digital‑cockpit/ADAS features are expected to proliferate across vehicle tiers, making automotive a key pillar of Qualcomm’s future growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides specific revenue figures ($1.5B in 2022, $1.9B in 2023, $2.9B in 2024) that cannot be verified against the ground truth knowledge graph. The ground truth does not provide these specific dollar amounts for automotive segment revenue, making these numbers potentially fabricated or incorrect. This is a major factual error. (2) PERCENTAGE DISCREPANCY - The LLM states '>70% of new vehicles by 2028 will have embedded cellular connectivity' while the ground truth indicates 'over 60% of new vehicles would feature 5G connectivity by 2028.' These are different metrics (embedded cellular vs. 5G specifically) and different percentages (70% vs. 60%), representing a factual inaccuracy. (3) PARTIAL ALIGNMENT - The LLM correctly identifies the evolution trajectory (2022 positioning → 2023 revenue generation → 2024 integration) and correctly names the segments (digital cockpit, ADAS/AD, QCT segment), which aligns with ground truth. (4) MISSING CONTEXT - The LLM adds specific revenue numbers not present in ground truth, which could indicate hallucination rather than synthesis from actual filings. The ground truth emphasizes the conceptual-to-commercial evolution without providing specific revenue figures. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize across years and connect market demand to business strategy, the unsupported numerical claims undermine the credibility of the synthesis. The reasoning structure is sound but built on potentially false data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 425,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitment to private‑real‑estate (and other private) funds declined steadily—from about **$569 million at the end of 2022**, to **$555 million in 2023**, and **$540 million by the end of 2024**—a reduction of roughly $20‑30 million each year.  This consistent pull‑back indicates that the company is deliberately reducing its exposure to illiquid alternative‑asset commitments, likely to manage liquidity risk and reallocate capital as those funds mature.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the three key data points ($569M in 2022, $555M in 2023, $540M in 2024) and the overall downward trend. The qualitative interpretation about de-risking and liquidity management is sound and aligns with the ground truth. The company name (Abbott) and asset class (private real estate/illiquid alternatives) are correctly identified. CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY ISSUE - The LLM states the reduction is 'roughly $20-30 million each year,' which is INCORRECT. The ground truth clearly shows a consistent $15 million per year decline (2022→2023: $14M reduction; 2023→2024: $15M reduction). The LLM's characterization of '$20-30 million each year' overstates the annual reduction by 33-100%. (2) MISSING CONTEXT - The LLM omits the important detail about liquidation periods (2025-2034 by 2024), which is explicitly mentioned in the ground truth as evidence that Abbott is 'not exiting the space entirely but managing exposure more cautiously.' This is a material omission that weakens the completeness of the answer. (3) WORDING IMPRECISION - The phrase 'about $569 million' and 'roughly $20-30 million' introduces unnecessary vagueness when precise figures are available and important. REASONING QUALITY: The multi-hop synthesis is adequate—the LLM correctly connects the numerical trend to strategic implications (de-risking, liquidity management, capital reallocation). However, the calculation error undermines confidence in the analysis. The conclusion about deliberate reduction and liquidity risk management is reasonable but would be stronger with the liquidation period context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 448,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nAcross the three filings the balance of Apple’s 0.45 % senior notes due 2016 fell to zero: the 2022 10‑K (p. 55) still listed a $2.5 bn tranche of those notes, the 2023 10‑K (p. 56) showed the balance reduced to $0 million, and the 2024 10‑K (p. 57) no longer presented a separate line item for them.  This pattern demonstrates Apple’s disciplined, laddered debt‑management approach—issuing low‑coupon fixed‑rate notes, retiring them as they mature, and rolling the proceeds into newer, longer‑dated issuances to maintain a stable, low‑cost long‑term capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - DEBT MATURITY CONFUSION: The ground truth explicitly states the notes were 'due 2016,' meaning they matured in 2016, well before the 2022-2024 period being analyzed. The LLM incorrectly claims the notes had a $2.5 billion balance in 2022 that was retired by 2023. This is logically impossible since notes due in 2016 would have already matured and been paid off years before 2022. (2) QUANTITATIVE INACCURACY: The LLM provides specific page numbers (p. 55, 56, 57) and a $2.5 billion figure for 2022 that cannot be verified against the ground truth and appear to be fabricated. The ground truth makes no mention of any balance amounts. (3) CONTRADICTORY NARRATIVE: The ground truth indicates the 0.45% Notes due 2016 were consistently disclosed across all three years (2022, 2023, 2024) as historical debt instruments, suggesting they were already retired before this period. The LLM's narrative of active retirement during 2022-2023 contradicts this. (4) MISUNDERSTANDING OF DEBT STRUCTURE: The LLM misinterprets 'due 2016' as an active debt instrument during 2022-2024, when it should be understood as a historical reference to notes that matured in 2016. The ground truth's mention of consistent disclosure likely refers to historical debt schedules or footnote disclosures, not active balances. (5) REASONING FAILURE: While the LLM's general concept of debt laddering and retirement is reasonable debt management strategy, it is applied to the wrong instrument and time period, making the entire analysis factually incorrect. The multi-hop synthesis fails because it misidentifies the fundamental nature of the debt instrument being analyzed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 479,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nFrom 2022 through 2024 IBM repeatedly listed “client relationships and trust” as a principal competitive method, but each successive filing deepened that theme by tying it directly to its hybrid‑cloud and AI strategy. The progression shows IBM is leveraging its long‑standing client confidence to position IBM Cloud and Watson AI as the trusted, open platform for mission‑critical workloads, using trust and security as a differentiator against pure‑play cloud competitors.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of IBM's evolution but has significant gaps in completeness and reasoning quality. STRENGTHS: (1) Correctly identifies the core theme of 'client relationships and trust' as a consistent competitive differentiator across 2022-2024; (2) Accurately notes the progression deepened the connection to hybrid cloud and AI strategy; (3) Properly identifies IBM Cloud and Watson AI as key platforms; (4) No quantitative errors or incorrect dates. WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth reveals a three-stage evolution (2022: trust as part of broader portfolio → 2023: explicit link to consulting and mission-critical infrastructure → 2024: strategic partnerships as enablers), but the LLM answer collapses this into a generic 'deepening' without capturing the specific strategic shifts in each year; (2) MISSING KEY INSIGHT: The ground truth emphasizes that by 2024, trust became 'increasingly integrated with ecosystem collaboration and innovation leadership' - the LLM mentions partnerships but doesn't capture this as a strategic evolution or maturation; (3) REASONING QUALITY: The LLM's explanation focuses on competitive positioning against 'pure-play cloud competitors' which is reasonable but doesn't reflect the ground truth's emphasis on how the framing itself evolved year-to-year; (4) LACKS NUANCE: The ground truth distinguishes between trust as a 'standalone differentiator' versus 'integrated with ecosystem collaboration' - the LLM doesn't make this distinction clear. The answer is directionally correct but oversimplifies the multi-year progression and misses the strategic maturation narrative that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 465,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nThe 2022 filing first set up the August 13 2020 pass‑through trust and its revolving‑credit facility as the primary source of liquidity for the 4.250 % Note due 2030.  In the 2023 and 2024 10‑Ks FedEx added Amendment No. 1 to that facility (dated May 22 2023, Exhibit 4.44), which increased the commitment and extended maturities while preserving the inter‑creditor structure.  Together, these updates show that FedEx is proactively refining and strengthening the credit‑support mechanisms backing the note, ensuring ample liquidity and flexibility as the obligation approaches maturity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but also introduces unsupported claims and mischaracterizations. CORRECT ELEMENTS: (1) The foundational Revolving Credit Agreement dated August 13, 2020 is correctly identified; (2) Amendment No. 1 dated May 22, 2023 is correctly cited; (3) The 4.250% Note due 2030 is correctly referenced; (4) The general timeline of 2022-2024 is accurate. PROBLEMATIC ELEMENTS: (1) The LLM claims Amendment No. 1 'increased the commitment and extended maturities' - the ground truth does not specify these details, and the LLM appears to be inferring or fabricating specific amendment details not confirmed in the source material; (2) The LLM states the amendment was 'added' in both 2023 and 2024, but the ground truth indicates it was filed in 2023 with 'no further amendments noted' in 2024, suggesting the LLM may have misunderstood the temporal progression; (3) The characterization of FedEx 'proactively refining and strengthening' the mechanisms is interpretive language not explicitly supported by the ground truth, which more neutrally states the arrangement 'remained in place'; (4) The reference to 'pass-through trust' is not mentioned in the ground truth and appears to be an unsupported addition. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but overstates the nature of changes. The ground truth emphasizes consistency with a single modification, while the LLM emphasizes proactive strengthening without clear evidentiary support. QUANTITATIVE ACCURACY: Dates are correct (August 13, 2020; May 22, 2023), but the LLM adds unverified details about commitment increases and maturity extensions. The core factual framework is present but embellished with unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 478,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nApple’s 4.45 % Notes due 2044 were first issued under the May 6 2014 indenture and remained listed in the company’s 2022, 2023 and 2024 Form 10‑K filings, confirming that the securities were still outstanding throughout the three‑year period.  In each subsequent year Apple added new long‑dated bond tranches—most notably the May 10 2023 issuance of 4.421 % notes maturing 2026‑2053—while continuing to reference the original 2014 indenture for the 4.45 % 2044 notes, indicating a rolling, laddered approach to long‑term financing.  This multi‑year pattern shows that Apple’s long‑term debt strategy is to maintain a diversified, low‑cost bond ladder, regularly tapping the capital markets to replace maturing debt and lock in favorable rates while preserving a stable base of very‑long‑dated obligations such as the 4.45 % Notes due 2044.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more comprehensive detail than the ground truth. Key strengths: (1) All numeric values are accurate - the 4.45% rate, 2044 maturity date, May 6 2014 issuance date, May 10 2023 issuance date, 4.421% rate, and 2026-2053 maturity range are all correct. (2) The multi-hop synthesis is sound - the answer correctly identifies that the 4.45% Notes remained outstanding across all three years (2022, 2023, 2024) while also documenting new issuances. (3) Entity identification is accurate - Apple is correctly identified, fiscal years are correct, and debt instruments are properly characterized. (4) The reasoning about Apple's 'rolling, laddered approach' and 'diversified, low-cost bond ladder' strategy is logically sound and represents a more nuanced interpretation than the ground truth's simpler 'consistency' framing. Minor considerations: The LLM answer goes beyond the ground truth by adding information about the May 2023 issuance and the laddered strategy concept. While this additional detail is accurate and relevant, it slightly exceeds what the ground truth explicitly states. However, this represents enhancement rather than error - the core claim that the 4.45% Notes remained consistent across the three years is confirmed, and the additional strategic insight about the laddered approach is factually supported and contextually appropriate. The answer fully addresses the multi-year pattern question and provides sound reasoning about financing strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 422,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 through 2024 FedEx International Connect Plus grew its network markedly: the service moved from “nearly 50 origin countries to over 130 destinations” (2022) to “nearly 60 origin countries to over 190 destinations” (2024), adding new origin markets—particularly in the Asia‑Pacific, Europe and the Middle East—and expanding coverage to many additional destination nations.  \n\nThis expansion shows that FedEx is deliberately widening its contractual e‑commerce shipping footprint, positioning International Connect Plus as a core growth lever to capture the surge in cross‑border online retail and to deepen its role in the global e‑commerce logistics ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - TEMPORAL ACCURACY ERROR: The LLM answer conflates 2022 and 2024 data. It states the service moved from '~50 origin countries to over 130 destinations (2022)' to '~60 origin countries to over 190 destinations (2024)' - but this omits the crucial 2023 data point that is central to the ground truth answer. The ground truth explicitly shows: 2022 (50 origin, 130 destination) → 2023 (60 origin, 190 destination) → 2024 (60 origin, 190 destination - stabilized). The LLM's phrasing '2022 through 2024' and '(2024)' for the expanded figures is misleading because it suggests the expansion occurred over the full 2022-2024 period, when in fact the major expansion happened 2022-2023, with 2024 showing stabilization. This is a significant multi-hop reasoning error - the question specifically asks about evolution 'from 2022 to 2024,' which requires tracking the year-by-year progression. POSITIVE ASPECTS: (1) All individual numbers are correct (50, 130, 60, 190). (2) Geographic regions mentioned (Asia-Pacific, Europe, Middle East) are reasonable inferences. (3) Strategic interpretation about e-commerce logistics capture is sound and aligns with ground truth. (4) The qualitative analysis of FedEx's strategic focus is appropriate. NEGATIVE ASPECTS: (1) Failed to explicitly identify the 2023 inflection point and 2024 stabilization. (2) The temporal framing obscures the actual expansion trajectory. (3) Missing the key insight that expansion was followed by consolidation/optimization phase. The answer is partially correct on facts but fails on the critical multi-hop temporal synthesis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 447,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % Notes that were originally issued with a 2017 maturity had been fully retired before the end of fiscal 2022, and consequently they do not appear as outstanding indebtedness in the FY 2023 or FY 2024 balance‑sheet excerpts.  Nevertheless, the company continues to list those notes in the “Maturity of Debt” tables and in the footnote disclosures for each of the three years, using them only as a historical reference to illustrate the composition of its prior‑year debt and to show the schedule of upcoming maturities.  This practice reflects Apple’s disciplined approach to managing maturing debt—it retires older tranches well before they become due and then re‑issues new financing, thereby keeping the overall maturity profile under active control.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the notes 'were fully retired before the end of fiscal 2022' and 'do not appear as outstanding indebtedness in the FY 2023 or FY 2024 balance-sheet excerpts.' However, the ground truth explicitly states these notes were referenced consistently in Exhibit 4.4 across all three fiscal years (2022, 2023, 2024), indicating they continued to appear in disclosures. (2) FACTUAL CONTRADICTION - The LLM states the notes appear 'only as a historical reference' in 'Maturity of Debt' tables, but the ground truth indicates they were listed in Exhibit 4.4 (Officer's Certificate), not balance sheet or maturity tables. (3) MISCHARACTERIZATION OF DISCLOSURE PATTERN - The ground truth emphasizes that the notes were referenced 'consistently' with 'identical language' and 'no change in disclosure strategy,' suggesting standardized historical documentation. The LLM incorrectly interprets this as an active debt management practice of retiring and re-issuing debt. (4) UNSUPPORTED INFERENCE - The LLM's conclusion about Apple's 'disciplined approach' to retiring debt 'well before maturity' and 're-issuing new financing' is not supported by the ground truth, which makes no such claims about retirement timing or refinancing activities. (5) QUANTITATIVE ACCURACY - While the notes' maturity date (2017) is correct, the LLM's characterization of their status and disclosure treatment is fundamentally wrong. The ground truth indicates these were historical references retained for continuity, not active debt management examples. The LLM fundamentally misunderstands the nature of the disclosure pattern and provides an incorrect interpretation of Apple's debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 490,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm shifted its 5G strategy from early‑stage rollout to “5G Advanced” (Releases 16‑18), directing heavier R&D and capital spending toward 5G‑enabled automotive, IoT and edge‑computing platforms while expanding its licensing portfolio to more than 200 5G‑related agreements.  Licensing revenue grew modestly—driven by higher per‑unit royalties and a broader base of 5G standard‑essential patent licensees—but was pressured by geopolitical constraints, notably the 2024 U.S. export‑license revocation for Huawei and China’s “Made‑in‑China 2025” policies that limited sales to Chinese OEMs.  Consequently, the company’s financial commitment to 5G remained robust, yet its exposure to U.S./China trade tensions and the risk of key customers vertically integrating (e.g., Apple, Samsung) kept geopolitical risk a material head‑wind for future 5G revenue.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer introduces specific claims not supported by the ground truth: (1) '5G Advanced' (Releases 16-18) - not mentioned in ground truth; (2) 'more than 200 5G-related agreements' - not in ground truth; (3) 'higher per-unit royalties' - not substantiated; (4) 'China's Made-in-China 2025 policies' - not mentioned in ground truth. CORRECT ELEMENTS: The answer correctly identifies (1) the Huawei export license revocation in 2024; (2) the $560 million Huawei contribution prior to ban (implied by context); (3) 5G-enabled automotive, IoT, and edge computing focus; (4) geopolitical risks as a material headwind; (5) the progression from early-stage to advanced 5G. MISSING KEY GROUND TRUTH DETAILS: (1) The specific '27 billion IoT devices by 2026' projection from fiscal 2022; (2) The explicit statement about 'majority of QTL revenues derived from OFDMA-based (including 5G) devices'; (3) Qualcomm Ventures' strategic investments mentioned in ground truth; (4) The emphasis on 5G intellectual property leadership. MULTI-HOP REASONING: The LLM synthesizes information across the three fiscal years and addresses licensing revenue, investment in new applications, and geopolitical risks. However, it introduces unsupported specifics (Releases 16-18, 200+ agreements) that appear fabricated rather than derived from the knowledge graph. The reasoning about trade tensions and vertical integration risks (Apple, Samsung) is logical but not grounded in the provided ground truth. The answer demonstrates reasonable understanding of the question's multi-part structure but fails on factual accuracy by adding details not in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 461,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the domestic pension plan’s asset mix moved only modestly: U.S.‑equity holdings stayed around $90 million (≈ 10 % of assets), international‑equity holdings hovered near $90 million (≈ 10 %), while fixed‑income fell from $739 million (≈ 79 % of the portfolio in 2022) to $692 million (≈ 77 % in 2024).  Consequently, the combined equity share rose from roughly 19 % to 20 % of total assets and the fixed‑income share slipped from about 79 % to 77 %.  This slight tilt toward equities reflects Thermo Fisher’s evolving strategy of maintaining a liability‑hedging core while gradually increasing exposure to growth‑oriented assets to improve long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three asset categories and years:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - U.S. Equity: LLM states \"around $90 million\" for 2022-2024, but ground truth shows $125M (2022), $89M (2023), $93M (2024). The 2022 figure is significantly understated.\n   - International Equity: LLM states \"near $90 million\" throughout, but ground truth shows $126M (2022), $91M (2023), $93M (2024). Again, 2022 is substantially wrong.\n   - Fixed Income: LLM claims it \"fell from $739 million in 2022 to $692 million in 2024,\" but ground truth shows $1,001M (2022), $739M (2023), $739M (2024). The 2022 figure is off by $262M (26% error), and the claim of decline to $692M is completely fabricated.\n   - Total Assets: LLM's implied totals (~$919M in 2022, ~$875M in 2024) don't match ground truth ($1,267M in 2022, $947M in 2024).\n\n2. PERCENTAGE CALCULATIONS:\n   - LLM claims fixed income was \"79% of portfolio in 2022\" but ground truth shows $1,001M/$1,267M = 79% (this happens to be correct by coincidence).\n   - LLM's other percentages are based on incorrect dollar amounts, making them unreliable.\n   - The claim that equity share rose from \"19% to 20%\" contradicts the ground truth narrative of reduced equity exposure in 2023.\n\n3. MULTI-HOP REASONING FAILURE:\n   - LLM completely misses the critical 2023 transition year where total assets dropped from $1,267M to $937M (26% reduction).\n   - LLM fails to capture the strategic shift toward stability and reduced equity exposure in 2023.\n   - LLM's conclusion about \"gradually increasing exposure to growth-oriented assets\" contradicts the ground truth pattern of initial reduction followed by stabilization.\n\n4. MISSING CRITICAL INFORMATION:\n   - No mention of the significant 2022-2023 asset reduction ($330M decline).\n   - No discussion of the 2023-2024 stabilization pattern.\n   - Fails to address the three-year evolution properly by omitting the middle year's dramatic changes.\n\n5. SEMANTIC MISALIGNMENT:\n   - Ground truth reveals a \"strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.\"\n   - LLM claims the opposite: \"slight tilt toward equities\" and \"gradually increasing exposure to growth-oriented assets.\"\n   - This is a fundamental mischaracterization of the investment strategy.\n\nThe answer demonstrates poor data retrieval, calculation errors, and incorrect synthesis of multi-year trends. The fabricated 2024 fixed income figure ($692M vs. actual $739M) and the inverted strategic narrative are particularly problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 719,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Qualcomm moved its edge‑networking strategy from a handset‑centric, volume‑driven model toward a higher‑value, technology‑leadership role that leans on 5G‑Advanced, Wi‑Fi 6/6E‑7 and on‑device AI for fixed‑wireless and edge‑computing platforms.  The company highlighted new design wins for edge‑networking chips (mobile‑broadband and wireless‑access‑point products) and expanded its “connected intelligent edge” roadmap—emphasizing multimode 5G/NR‑U, Wi‑Fi 7 and AI‑accelerated system‑on‑chip solutions for industrial, consumer and automotive edge applications.  This shift is reflected in the revenue data: while total IoT revenue (which includes edge‑networking) fell from $7.35 bn in 2022 to $5.42 bn in 2024, the share of edge‑networking‑related sales grew as a proportion of QCT’s portfolio, underscoring a strategic pivot to higher‑margin, next‑generation edge technologies rather than pure volume growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific revenue figures ($7.35bn in 2022, $5.42bn in 2024 for IoT) that are NOT present in the ground truth and cannot be verified. These appear to be fabricated numbers. The ground truth makes NO mention of specific revenue figures for edge networking or IoT segments. (2) STRATEGIC NARRATIVE MISMATCH: The LLM constructs an elaborate narrative about 'handset-centric to higher-value pivot,' 5G-Advanced, Wi-Fi 6/6E/7, on-device AI, NR-U, and 'connected intelligent edge' roadmap. The ground truth is much simpler: edge networking was identified in 2022, explicitly listed as a revenue contributor in 2023, and continued in 2024 with mobile broadband and wireless access points. The LLM's detailed technical specifications (Wi-Fi 7, NR-U, AI-accelerated SoCs) are NOT mentioned in the ground truth. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize across 2022-2024, it does so by introducing information not supported by the ground truth. The ground truth shows consistent, straightforward positioning; the LLM invents a more complex 'strategic pivot' narrative. (4) ENTITY ACCURACY: Correctly identifies Qualcomm and the 2022-2024 timeframe, but incorrectly attributes specific product technologies and revenue metrics. (5) HALLUCINATION RISK: The specific revenue decline ($7.35bn to $5.42bn) and the detailed technical roadmap elements appear to be hallucinated details that sound plausible but are not grounded in the provided ground truth. The ground truth explicitly states edge networking was 'explicitly listed as a key revenue contributor' but does NOT provide quantitative revenue data or the technical pivot narrative the LLM describes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 473,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple’s 10‑K filings for 2022, 2023 and 2024 each list the same “0.45 % Notes due 2016” among the company’s outstanding debt disclosures. By repeatedly highlighting this fixed‑rate tranche, Apple signals that it deliberately staggers its debt maturities and locks in low‑cost financing, which helps maintain a predictable interest expense and reduces refinancing risk. This consistent reference reflects a capital‑structure strategy that emphasizes stability, liquidity management, and a disciplined, long‑term approach to managing fixed‑rate obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental misunderstanding of the ground truth. The original answer explicitly states that 'the 0.45% Notes due 2016 are no longer outstanding' and that their 'repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking.' However, the LLM answer incorrectly interprets this as evidence that these notes are 'among the company's outstanding debt disclosures' and that Apple is 'deliberately stagger[ing] its debt maturities' with these notes. This is factually wrong - notes due in 2016 would have matured years before 2022-2024 filings and would not be outstanding debt. The LLM fundamentally mischaracterizes the nature of the disclosure. The quantitative accuracy is acceptable (dates and percentages are correct: 0.45%, 2016, 2022-2024), but the qualitative reasoning is severely flawed. The LLM incorrectly suggests these notes represent active debt management strategy when they actually represent historical disclosure of matured obligations. The answer demonstrates a failure to synthesize the key insight from the ground truth: that the consistent inclusion reflects transparency and historical tracking of capital structure evolution, not active management of outstanding debt. This is a multi-hop reasoning failure where the model misinterpreted the significance of the repeated disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 392,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nFrom the 10‑K filings, Caterpillar’s dealer network for the EMD brand covered **193 countries in 2022**, fell to **187 countries in 2023**, and rose again to **191 countries in 2024**.  Thus, between 2022 and 2024 the geographic reach was essentially flat with a net reduction of **two countries** over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key numeric facts. Ground truth states EMD brand distribution covered 130 countries in 2022, remained at 130 in 2023, and declined to 109 in 2024 (a 21-country decrease). The LLM claims 193 countries in 2022, 187 in 2023, and 191 in 2024 - all numbers are completely wrong and do not match the ground truth data. The LLM's calculation of a 2-country net reduction is based on these incorrect figures. The magnitude of error is severe: the LLM overstates 2022 coverage by 63 countries (193 vs 130), 2023 by 57 countries (187 vs 130), and 2024 by 82 countries (191 vs 109). The LLM correctly identifies this as a multi-year comparison question and attempts to provide year-by-year data with calculations, but every single numeric value is factually incorrect. The reasoning structure is sound (comparing years, calculating net change), but it is applied to completely wrong data. This represents a total failure in quantitative accuracy - the most critical aspect of a financial question requiring specific numeric data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 310,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes carried a carrying amount of roughly **$682 million at the end of 2022**, rose modestly to **$700 million by year‑end 2023** and remained at **$700 million through 2024**. This small increase followed by a flat profile shows that Thermo Fisher is maintaining a steady mid‑term debt position—using the 7‑year senior note as a reliable financing building block to fund its R&D, acquisitions and expansion in the healthcare sector while keeping overall leverage stable and preserving flexibility in its broader capital‑structure strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 figure. The ground truth clearly states that TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes in 2022, but the LLM claims the carrying amount was 'roughly $682 million at the end of 2022.' This is a material discrepancy of $18 million (approximately 2.6% difference). The LLM then states the figure 'rose modestly to $700 million by year-end 2023,' which contradicts the ground truth that shows the value remained unchanged at $700 million from 2022 to 2023. The 2024 figure of $700 million is correct. MULTI-HOP REASONING: The LLM correctly identifies the three-year period (2022-2024) and attempts to synthesize the progression, but the incorrect 2022 baseline and the false claim of an increase from 2022 to 2023 undermine the core analysis. The ground truth indicates a completely stable pattern with no changes across all three years, whereas the LLM suggests a modest increase occurred. QUALITATIVE ASSESSMENT: The LLM's interpretation about TMO's debt strategy (maintaining steady mid-term debt, funding R&D and acquisitions, preserving flexibility) is reasonable and contextually appropriate for the healthcare sector, but this qualitative reasoning cannot compensate for the quantitative errors. The semantic framing about capital structure strategy is sound, but it's built on incorrect numerical premises. ENTITY ACCURACY: TMO and the specific note instrument (1.750% 7-Year Senior Notes due October 15, 2028) are correctly identified. The years 2022-2024 are correct. OVERALL ASSESSMENT: The answer fails on the primary metric of factual accuracy regarding the 2022 baseline figure and the progression narrative. The claim of a 'modest' increase from 2022 to 2023 is factually incorrect and represents a fundamental misreading of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 512,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nCaterpillar’s hedging program moved from a LIBOR‑centric structure in 2022—where it disclosed the need to replace LIBOR‑based floating‑rate contracts and began piloting SOFR‑linked instruments—to a fully SOFR‑driven approach by 2024, expanding the use of SOFR‑referenced derivatives and embedding a cross‑functional risk‑assessment team to manage the transition. This evolution shows the company’s proactive alignment with global market reforms, converting potential regulatory and market‑disruption risks into a disciplined, diversified hedging strategy that safeguards its financing costs and liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Caterpillar's LIBOR-to-SOFR transition and captures the core narrative of strategic adaptation. Strengths: (1) Correctly identifies the 2022-2024 timeline and the progression from LIBOR-centric to SOFR-driven approach; (2) Accurately references the cross-functional risk-assessment team mentioned in ground truth; (3) Properly characterizes the transition as proactive alignment with regulatory changes; (4) Correctly notes the shift from LIBOR-based floating-rate contracts to SOFR-referenced derivatives. Minor weaknesses: (1) The LLM mentions 'piloting SOFR-linked instruments' in 2022, which is not explicitly stated in the ground truth (ground truth indicates 2022 was about acknowledging LIBOR phase-out uncertainty, with SOFR emphasis emerging in 2023); (2) The phrase 'no longer referenced LIBOR at all' in 2024 is correctly captured by the LLM's statement that it moved to 'fully SOFR-driven approach,' though the LLM doesn't explicitly state the complete discontinuation of LIBOR references; (3) The LLM could have been more specific about the June 30, 2023 USD LIBOR phase-out date mentioned in ground truth, though this omission is minor given the focus on the broader evolution. The multi-hop reasoning is sound—the LLM successfully synthesizes information across three years and connects regulatory changes to Caterpillar's strategic response. The characterization of converting 'potential regulatory and market-disruption risks into a disciplined, diversified hedging strategy' is a reasonable inference supported by the ground truth narrative. No quantitative errors detected (no specific dollar amounts or percentages were provided in either answer to verify). The answer appropriately addresses the question's core inquiry about evolution, management, and strategic adaptation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 500,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher shifted from having separate, CEO‑only change‑in‑control agreements to a single, standardized Executive Change‑in‑Control Retention Agreement that is applied to all officers other than the CEO.  The company continued to reference the same form (shown as Exhibit 10.18 in the 2022 10‑K and carried forward as Exhibit 10.17 in the 2023 and 2024 filings), updating it only through routine amendments, thereby extending the retention terms uniformly across the entire executive team.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the form was 'Exhibit 10.18 in the 2022 10-K' but the ground truth clearly identifies it as 'Exhibit 10.12' for the CEO agreement in 2022 and 'Exhibit 10.17' for the standardized form introduced in 2023. The LLM's claim about Exhibit 10.18 in 2022 is factually incorrect. (2) INCOMPLETE CHARACTERIZATION: The ground truth specifies that in 2022, there was a CEO-specific agreement (Exhibit 10.12) with amendments dated March 16, 2018 (Exhibit 10.17). The LLM fails to distinguish between the CEO-specific agreement and the later standardized form, conflating the exhibit numbers. (3) MISSING KEY DETAIL: The ground truth notes the amendments were dated through March 16, 2018, which provides important temporal context that the LLM omits. (4) PARTIAL ACCURACY: The LLM correctly identifies the general evolution from CEO-only to standardized agreements across officers, and correctly notes the continuation through 2024. However, the exhibit number errors and incomplete synthesis of the 2022 baseline significantly undermine accuracy. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution across three years, the incorrect exhibit references suggest the model did not properly track the specific documents across years. The core narrative of standardization is correct, but the documentary evidence cited is wrong, which is critical for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 402,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a roadmap concept to a concrete node‑level feature: it was first slated for the Intel 20A process (announced in 2021 and still on track for 2023‑2024) and then refined as the key back‑end‑of‑line technology for the next‑generation Intel 18A node, which is planned for high‑volume manufacturing in 2025.  The company repeatedly highlighted that PowerVia’s backside‑power delivery—combined with RibbonFET—will deliver roughly 15 % performance‑per‑watt gains and enable denser, higher‑performance chips, positioning it as a cornerstone of Intel’s advanced‑process roadmap and of its IDM 2.0/foundry strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several correct elements but contains significant factual errors and omissions that reduce its accuracy:\n\nCORRECT ELEMENTS:\n- PowerVia was indeed positioned alongside RibbonFET as a breakthrough technology\n- PowerVia was initially slated for Intel 20A\n- Intel 18A retained PowerVia as a core component\n- 2025 is correct for high-volume manufacturing timeline\n- The answer correctly identifies backside-power delivery as PowerVia's key function\n- The connection to IDM 2.0/foundry strategy is appropriate\n\nCRITICAL ERRORS:\n1. QUANTITATIVE ACCURACY ISSUE: The LLM states \"roughly 15% performance-per-watt gains\" - this specific percentage is not mentioned in the ground truth and cannot be verified from the provided context. This is a factual claim that appears unsupported.\n\n2. TIMELINE INCONSISTENCY: The LLM states Intel 20A was \"announced in 2021 and still on track for 2023-2024.\" The ground truth indicates Intel 20A was canceled in favor of Intel 18A by 2024, which the LLM does mention but downplays the significance of this strategic shift.\n\n3. INCOMPLETE SYNTHESIS: The ground truth emphasizes that the 2024 cancellation of Intel 20A in favor of Intel 18A represents a \"strategic shift to prioritize a more refined version of the technology for greater efficiency and execution focus.\" The LLM treats this as a simple refinement rather than a significant strategic pivot.\n\n4. MISSING CONTEXT: The ground truth explicitly states this was a shift \"for greater efficiency and execution focus,\" indicating Intel's strategic recalibration. The LLM doesn't capture this nuance about why the change occurred.\n\nMULTI-HOP REASONING: The LLM does synthesize information across the 2022-2024 period and correctly traces PowerVia's evolution, though it misses the strategic implications of the 20A cancellation.\n\nSEMANTIC ISSUES: The phrase \"announced in 2021\" for Intel 20A is not confirmed in the ground truth, which begins discussion in 2022. This represents a potential factual error about the timeline.\n\nOVERALL: The answer demonstrates understanding of PowerVia's role and evolution but introduces unsupported claims (the 15% figure) and misses the strategic significance of the 20A cancellation, reducing overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 610,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nApple’s 1.05 % senior unsecured notes due 2017 are listed in the same “Long‑Term Debt”/Exhibit 4.4 section of each 10‑K—2022, 2023 and 2024—with only the filing‑date reference updated. The wording describing the issuance, coupon, and maturity remains unchanged across the three reports.  \n\nThis repeated inclusion shows that Apple treats the 1.05 % 2017 notes as a permanent, disclosed component of its overall debt profile, maintaining full transparency about all outstanding bond series regardless of age. It reflects a deliberate debt‑management practice of issuing multiple fixed‑rate tranches and continuously reporting the entire suite of obligations to investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 1.05% Notes due 2017 appear in the same Exhibit 4.4 section across 2022, 2023, and 2024 10-K filings, with only filing-date references updated. The percentage (1.05%) and maturity year (2017) are accurate. The LLM correctly notes the repeated inclusion across all three years and recognizes this as a deliberate reporting practice.\n\nWEAKNESSES: (1) The LLM's interpretation diverges significantly from the ground truth regarding what the repeated inclusion suggests. The ground truth explicitly states the notes were due in 2017 and their post-maturity persistence suggests Apple 'may have either rolled over the debt into a new instrument or maintained it in some form,' indicating uncertainty about the actual status. The LLM instead claims Apple treats these as 'permanent, disclosed components' and 'outstanding bond series,' which contradicts the fact that these notes matured in 2017. (2) The LLM fails to acknowledge the critical temporal issue: the notes were due in 2017, yet appear in 2022, 2023, and 2024 filings. This is a significant anomaly that the ground truth correctly identifies as noteworthy. (3) The LLM's explanation that this reflects 'continuously reporting the entire suite of obligations' is misleading—if the notes matured in 2017, they should not appear as outstanding obligations in 2022+ filings unless rolled over or refinanced. (4) The LLM provides no acknowledgment of the Officer's Certificate dated May 6, 2014 mentioned in the ground truth.\n\nMULTI-HOP REASONING: The LLM fails to synthesize the critical multi-hop insight: (a) notes due 2017 + (b) appearing in 2022/2023/2024 filings = (c) post-maturity persistence requiring explanation. The ground truth correctly identifies this as unusual and suggests possible rollover/refinancing. The LLM misses this entirely.\n\nFACTUAL ACCURACY: Numbers and dates are correct (1.05%, 2017, three years), but the interpretation of what these facts mean is substantially incorrect. The LLM's characterization of these as 'outstanding' obligations is factually problematic given the 2017 maturity date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 571,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel expanded and refined the equity awards it grants under the 2006 Equity Incentive Plan. In 2022 the company issued standard time‑based RSUs, performance‑based RSUs and RSUs with retirement‑vesting language to certain executives, and it began granting RSUs to non‑employee directors. In 2023 it added performance‑stock‑units that combine financial‑performance and market‑price targets and updated the vesting clauses to include double‑trigger acceleration on a change‑of‑control. By 2024 the plan introduced new grant agreements with cliff‑and‑graded three‑year schedules and revised retirement‑vesting provisions that allow partial vesting once service‑age criteria are met, reflecting a shift toward more performance‑driven and flexible vesting structures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Intel 'began granting RSUs to non-employee directors' in 2022, but the ground truth indicates non-employee directors were already referenced in 2022. The LLM also introduces specific details about 'double-trigger acceleration on a change-of-control' in 2023 and 'cliff-and-graded three-year schedules' in 2024 that are not mentioned in the ground truth. (2) MISSING KEY INFORMATION: The LLM fails to mention the critical May 11, 2023 amendment and restatement of the plan, which is a major structural change highlighted in the ground truth. The ground truth specifically notes the introduction of 'retirement vesting terms' and 'non-retirement vesting terms' in 2023, which the LLM conflates or misrepresents. (3) INACCURATE CHARACTERIZATION: The ground truth emphasizes 'strategic growth performance-based RSUs and stock options' in 2022, but the LLM only mentions RSUs and omits stock options entirely. The ground truth notes 'grandfathered and non-grandfathered executives' distinctions in 2023-2024, which the LLM does not capture. (4) UNSUPPORTED CLAIMS: The specific vesting mechanics described in the LLM answer (cliff-and-graded schedules, service-age criteria) are not present in the ground truth and appear to be fabricated details. (5) EVOLUTION NARRATIVE: While both answers attempt to describe evolution, the LLM's narrative diverges significantly from the documented progression. The ground truth emphasizes consolidation and documentation structure changes in 2024, while the LLM claims introduction of new features. The answer demonstrates partial understanding of the general topic but fails on factual accuracy and introduces unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 497,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nMedtronic continued to authorize a pool of **40,000 Euro Deferred Shares (€1 par value)** in each of the fiscal years 2022, 2023 and 2024, but each year’s filing explicitly states that **no Euro‑Deferred Shares were issued or outstanding** at the reporting date.  The uninterrupted absence of any issuance—despite the authorization remaining unchanged—shows that the company is not using this equity reserve as a financing tool; instead it is preserving the shares for potential future use while relying on other mechanisms (e.g., ordinary‑share repurchases, debt) to manage its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 40,000 Euro Deferred Shares, €1 par value, fiscal years 2022-2023-2024, and zero issuance/outstanding shares in each year. No calculation errors present. ENTITY ACCURACY: Medtronic correctly identified, fiscal years properly specified (2022, 2023, 2024), and financial metrics (authorized shares, par value, issuance status) accurately stated. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to establish the pattern of consistent non-issuance, then correctly interprets this pattern to draw conclusions about financing strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth - that despite authorization, no shares were issued, suggesting preference for alternative capital management tools. The LLM explicitly mentions 'ordinary-share repurchases, debt' while ground truth mentions 'ordinary share repurchases and dividend policies' - both are reasonable characterizations of alternative financing mechanisms, though the LLM's inclusion of debt is slightly broader. MINOR DIFFERENCES: The LLM uses slightly different phrasing ('preserving the shares for potential future use') compared to ground truth's 'did not utilize Euro Deferred Shares as a financing instrument,' but these are semantically equivalent interpretations of the same underlying fact. The LLM's answer is actually more comprehensive in explicitly noting the authorization remained 'unchanged' across the period. No factual errors detected. The answer fully addresses both parts of the multi-part question: (1) how disclosures evolved (answer: they remained consistent), and (2) what the absence suggests about strategy (answer: preference for other tools).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 506,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nIntel’s Advanced‑Packaging strategy moved from a research‑intensive, capacity‑building phase in 2022 to a commercial‑scale push in 2023‑24, with the company securing multiple design wins on its 18A node and expanding the IFS ecosystem (e.g., ARM and Synopsys agreements) that rely on its 2‑D/3‑D packaging technologies.  However, the shift to disaggregated designs and new packaging nodes introduced substantial manufacturing‑yield and supply‑chain complexity, driving R&D outlays of roughly $16 billion in 2024 and prompting non‑cash impairments and accelerated depreciation of about $3.1 billion in 2024—evidence that the financial payoff of these bets remains uncertain despite growing packaging‑related revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $3.1 billion non-cash impairments figure for 2024, matching the ground truth exactly. (2) The answer appropriately references the shift from research-intensive to commercial-scale phases across the 2022-2024 period. (3) The mention of disaggregated designs and manufacturing complexity aligns with ground truth themes. (4) The acknowledgment that 'financial payoff remains uncertain' captures the core narrative arc. WEAKNESSES: (1) MISSING KEY CONTEXT: The LLM fails to mention Intel 4 and 10nm process delays cited in 2022, which were explicitly part of the ground truth's 2022 positioning. (2) INCOMPLETE TEMPORAL ANALYSIS: While the LLM discusses 2023-24, it doesn't adequately address the 2022 baseline or the progression of risks from 2022→2023→2024 as the ground truth does. (3) UNVERIFIED CLAIMS: The LLM states 'R&D outlays of roughly $16 billion in 2024' - this specific figure is not present in the ground truth and cannot be verified. This is a potential factual error or unsupported claim. (4) MISSING STRATEGIC ELEMENTS: The ground truth explicitly mentions UCIe (Universal Chiplet Interconnect Express) demonstration in silicon in 2023 - the LLM does not reference this technical milestone. (5) INCOMPLETE FINANCIAL NARRATIVE: The ground truth mentions 'delays in global manufacturing projects' casting doubt on scalability - the LLM mentions supply-chain complexity but doesn't capture the manufacturing project delays or their strategic implications. (6) ENTITY PRECISION: The LLM mentions 'ARM and Synopsys agreements' and 'IFS ecosystem' which are reasonable inferences but not explicitly confirmed in the ground truth provided. QUANTITATIVE ASSESSMENT: The $3.1 billion figure is correct (7/10 for quantitative accuracy). However, the $16 billion R&D figure is unverified and potentially incorrect, reducing confidence. QUALITATIVE ASSESSMENT: The LLM demonstrates understanding of the strategic evolution but misses key technical milestones (UCIe) and specific 2022 context (Intel 4/10nm delays). The reasoning about manufacturing complexity is sound but incomplete. OVERALL: The answer captures the general narrative arc and key financial figures but lacks the comprehensive temporal progression and specific technical/operational details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 623,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIn the 2022 10‑K (pp. 5‑9) Intel first introduced PowerVia as the industry‑first back‑side power‑delivery scheme to be combined with the RibbonFET GAAFET architecture for future process nodes.  The 2023 roadmap update (pp. 12‑16) placed PowerVia on the Intel 20A node and targeted high‑volume manufacturing in 2024, but later shifted the focus to the Intel 18A node as the platform for commercial deployment.  The 2024 filing (pp. 8‑12) confirms that PowerVia will be ready for high‑volume production with the Intel 18A process in 2025 (e.g., Panther Lake), marking its first commercial use for external foundry customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of PowerVia across the three time periods but contains significant quantitative inaccuracies and omissions that prevent a higher score. STRENGTHS: (1) Correctly identifies PowerVia as an industry-first backside power delivery solution introduced in 2022; (2) Accurately notes the shift from Intel 20A to Intel 18A as the deployment platform; (3) Correctly identifies 2025 as the high-volume manufacturing target for Intel 18A; (4) Properly synthesizes the multi-hop evolution across 2022-2024; (5) Appropriately contextualizes the technology within Intel's broader roadmap. CRITICAL ERRORS: (1) The LLM states PowerVia was 'targeted for high-volume manufacturing in 2024' in the 2023 roadmap, but the ground truth indicates the 2023 roadmap positioned PowerVia for Intel 20A with no specific 2024 HVM date mentioned - this is a factual error; (2) MAJOR OMISSION: The LLM completely fails to mention the '15% performance-per-watt improvement over Intel 3' metric that was explicitly stated in the 2023 roadmap update according to the ground truth. This is a significant quantitative detail that should have been included; (3) The LLM mentions 'Panther Lake' as an example of first commercial use, which adds specificity not in the ground truth but is not contradicted. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces the evolution from 2022 introduction through 2023 roadmap refinement to 2024 manufacturing readiness. However, the incomplete capture of technical specifications (missing the 15% performance metric) and the apparent dating error regarding 2024 HVM targets weaken the overall accuracy. The answer demonstrates good understanding of the progression but lacks precision in quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 485,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nYes. The FY 2022, FY 2023 and FY 2024 10‑K filings each disclose a revised “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” under the 2021 Long‑Term Incentive Plan (see MDT_10k_2022.pdf pp. 112‑116 *10.54‑*10.65; MDT_10k_2023.pdf pp. 112‑116 *10.78‑*10.82; MDT_10k_2024.pdf pp. 112‑116 *10.86‑*10.90). The updated agreements replace the older RSU language with new vesting triggers—including a three‑year 100 % vesting option and ratable four‑year vesting—and introduce performance‑metric performance‑share units, while retaining the overall equity‑award framework. This consistency indicates that Medtronic is refining its equity compensation strategy to make it more performance‑driven and retention‑focused rather than overhauling the program entirely.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. (1) CORE FACTUAL ERROR: The ground truth states that Medtronic has NOT updated its U.S. employee RSU agreements from FY2022-FY2024, maintaining the same Form first filed on August 27, 2013 under the 2013 Stock Award and Incentive Plan. The LLM answer claims the opposite—that agreements WERE revised and now reference the 2021 Long-Term Incentive Plan with new vesting triggers and performance metrics. This is a direct contradiction of the ground truth. (2) ENTITY ACCURACY ISSUES: The LLM incorrectly identifies the underlying plan as the '2021 Long-Term Incentive Plan' when the ground truth clearly states it is the '2013 Stock Award and Incentive Plan.' This is a significant error in entity identification. (3) QUANTITATIVE CLAIMS: The LLM introduces specific vesting details ('three-year 100% vesting option and ratable four-year vesting') and references to performance-share units that are not supported by the ground truth and appear to be fabricated. The page references cited (pp. 112-116 with exhibit numbers *10.54-*10.65, etc.) cannot be verified against the ground truth provided. (4) REASONING FAILURE: The LLM's conclusion that the updates indicate a 'more performance-driven and retention-focused' strategy directly contradicts the ground truth's conclusion that the absence of modifications suggests 'a stable and consistent equity compensation strategy' with 'no structural changes.' (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize information across the three fiscal years (FY2022, FY2023, FY2024), instead fabricating a narrative of updates rather than consistency. The answer demonstrates a fundamental misunderstanding or hallucination of the filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 488,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel kept using the 2006 Equity Incentive Plan as the legal vehicle for executive awards, but the way it structured **performance‑based RSUs** changed each year.  \n\n* **2022** – The company issued two parallel RSU agreements: one for “grandfathered” executives (Exhibit 10.1.5) and a separate one for non‑grandfathered executives (Exhibit 10.1.6). Both included a **retirement‑vesting clause** that would accelerate vesting if the executive’s service ended before the award fully vested.  \n\n* **2023** – The language of those agreements was refined and a **new non‑employee director RSU form** (Exhibit 10.1.7) was added. The performance criteria were clarified to tie vesting to specific financial and strategic metrics, while the retirement‑vesting provision remained.  \n\n* **2024** – Intel consolidated the executive awards into an updated performance‑based RSU agreement for non‑grandfathered executives (still Exhibit 10.1.6) that emphasized achievement of defined performance targets and retained the retirement‑vesting trigger, reflecting a more streamlined, performance‑focused approach.  \n\nThus, while the underlying 2006 Plan remained unchanged, the **form and performance conditions of the RSU grants evolved from separate, grandfathered‑vs‑non‑grandfathered agreements in 2022 to a refined, unified performance‑target structure by 2024**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) EXHIBIT REFERENCES: The LLM cites specific exhibit numbers (10.1.5, 10.1.6, 10.1.7) with detailed descriptions of 'grandfathered vs. non-grandfathered' agreements and 'retirement-vesting clauses' that are not mentioned in the ground truth. These specific structural claims cannot be verified and appear to be fabricated details. (2) STRUCTURAL EVOLUTION CLAIMS: The LLM asserts a detailed year-by-year evolution involving parallel agreements in 2022, refined language and new director forms in 2023, and consolidation in 2024. The ground truth provides no such granular structural details—it only confirms consistent use of the 2006 Plan across all three years with performance-based conditions. (3) MISSING KEY FACTS: The LLM fails to mention the S-8 registration filed on September 26, 2023, which is explicitly noted in the ground truth as supporting continued use of the plan. (4) RETIREMENT-VESTING PROVISION: The repeated emphasis on 'retirement-vesting clauses' and 'retirement-vesting triggers' is not substantiated in the ground truth and appears to be an invention. (5) CONSOLIDATION CLAIM: The assertion that awards were 'consolidated' from separate grandfathered/non-grandfathered forms into a unified structure is not supported by the ground truth, which indicates the company 'continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives' in 2023. The LLM's narrative of evolution toward a 'unified performance-target structure by 2024' contradicts the ground truth's emphasis on consistency. The answer demonstrates poor multi-hop reasoning by inventing structural details rather than synthesizing actual filing information. While the core fact that the 2006 Plan was used throughout is correct, the specific claims about how it evolved are largely unsupported and potentially misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 548,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 to 2024 Intel progressed from building and risk‑testing advanced‑packaging and disaggregated‑design concepts (2022) to formalizing an ecosystem of EDA, IP and design‑service partners and logging multiple 18A design wins—including AI‑focused chiplets (2023) to accelerating commercial deployment, securing five new AI‑centric packaging design wins and multi‑year agreements with ARM and Synopsys that embed chiplet packaging as a core capability of its IDM 2.0 strategy (2024). This trajectory shows that Intel is increasingly able to stitch together disparate process technologies into a single packaged device, leveraging advanced packaging to meet the performance and integration demands of AI workloads, even though cost and capacity constraints remain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer demonstrates significant factual inaccuracies and omissions compared to the ground truth. CRITICAL ERRORS: (1) The LLM completely fails to mention the $16.5 billion R&D investment in 2024 or the $3.1 billion in charges related to non-cash impairments and accelerated depreciation—these are key quantitative facts that directly address the question about Intel's investment evolution and execution challenges. (2) The LLM claims 'multiple 18A design wins' and 'five new AI-centric packaging design wins' in 2023-2024, but these specific numbers do not appear in the ground truth and cannot be verified. (3) The LLM mentions 'multi-year agreements with ARM and Synopsys' which are not mentioned in the ground truth answer. (4) The ground truth explicitly notes 'persistent execution challenges and the high financial stakes' and 'ongoing execution risks and financial pressures,' but the LLM's tone is more optimistic, stating Intel is 'increasingly able to stitch together disparate process technologies' without adequately conveying the financial pressures and impairment charges. PARTIAL CREDIT: The LLM correctly identifies the progression from 2022 (risk-testing) through 2023 (progress with UCIe-like concepts) to 2024 (commercial deployment), and correctly references the disaggregated design strategy and AI-driven market context. However, the answer lacks the critical financial data points that are essential to answering how the investment 'evolved' and what it 'reveals about the company's ability to execute.' The omission of the $3.1 billion impairment charge is particularly problematic as it directly contradicts the optimistic tone and is central to understanding execution challenges. The LLM answer reads more like a marketing narrative than a balanced assessment grounded in actual financial data from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 500,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nAcross the three fiscal years Intel repeatedly amended the 2006 Equity Incentive Plan and replaced its RSU‑grant templates to reflect new vesting rules and share‑reserve limits. In the 2022 10‑K (pp. 112‑116) the company added a fresh share‑reserve amendment and introduced two new RSU agreement forms—one for performance‑based RSUs granted to non‑grandfathered executives (Exhibit 10.1.6) and one for non‑employee‑director RSUs (Exhibit 10.1.7). The 2023 10‑K (pp. 99‑103) incorporated a further amendment that added retirement‑vesting language and issued updated RSU grant agreements for both grandfathered and non‑grandfathered executives (Exhibits 10.1.3‑10.1.5). Finally, the 2024 10‑K (pp. 104‑108) restated the entire 2006 plan with an increased share reserve, adopted the 2024 ESPP amendment, and filed the latest RSU‑grant agreement forms (including the 2024‑dated director RSU agreement), marking the most recent evolution of the plan’s structure and award documentation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. MAJOR ISSUES: (1) FABRICATED DETAILS: The LLM cites specific page numbers (pp. 112-116 for 2022, pp. 99-103 for 2023, pp. 104-108 for 2024) and exhibit numbers (10.1.6, 10.1.7, 10.1.3-10.1.5, 2024-dated director RSU agreement) that cannot be verified against the ground truth and appear to be hallucinated. (2) UNSUPPORTED CLAIMS: The LLM asserts 'repeatedly amended the 2006 Equity Incentive Plan and replaced its RSU-grant templates' and claims 'fresh share-reserve amendment' in 2022, but the ground truth only confirms an 'amended and restated version' in 2023 (effective May 11, 2023). The 2022 activity is described in ground truth as 'referenced multiple grant agreements' not amendments. (3) INCORRECT CHARACTERIZATION OF 2024: The LLM claims the 2024 10-K shows a 'restated the entire 2006 plan with an increased share reserve' and 'adopted the 2024 ESPP amendment,' but ground truth indicates 2024 showed 'ongoing use of standardized RSU grant agreements' with 'sustained reliance on the plan' - not a major restatement. (4) MISSING KEY FACT: The ground truth explicitly states the formal amendment occurred in 2023 (May 11, 2023), which the LLM mentions but downplays by suggesting multiple amendments across all three years. (5) EXHIBIT CITATIONS: The specific exhibit numbers and page references in the LLM answer lack corroboration in the ground truth and appear fabricated. The ground truth does not provide these specific exhibit citations. WHAT WAS CORRECT: The LLM correctly identifies that RSU grant agreements were used across all three years and that there was evolution in the plan's application. The mention of retirement vesting terms in 2023 aligns with ground truth. However, the overall narrative of 'repeated amendments' and specific structural changes claimed for 2022 and 2024 are not supported by the ground truth, which emphasizes a single formal amendment in 2023 with sustained reliance thereafter.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 553,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm continued to place wireless‑access‑point and broader edge‑networking revenues inside its **QCT IoT** reporting line – the same revenue‑classification that had been used in the 2022 filing.  However, the **strategic emphasis shifted**: while in 2022 the company highlighted edge‑networking (mobile‑broadband and Wi‑Fi access points) as a growth trend, by 2023‑24 it was explicitly promoting **Wi‑Fi 6/6E and 5G fixed‑wireless access‑point solutions** as core components of its “connected intelligent edge” agenda, positioning edge networking as a primary growth pillar alongside automotive and consumer IoT even as the absolute IoT revenue declined (from $7.35 B in FY22 to $5.42 B in FY24).  Thus, the **financial categorization stayed the same (IoT = edge networking), but the narrative and market‑positioning focus evolved toward edge‑networking as a strategic, high‑growth opportunity.**",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides specific revenue figures ($7.35B in FY22 and $5.42B in FY24) that are NOT present in the ground truth answer. The ground truth explicitly states 'exact revenue figures for wireless access points alone are not disclosed.' This is a major factual error introducing unverified numbers. (2) CATEGORIZATION CLAIM - The LLM claims wireless access points were in 'QCT IoT' reporting in 2022, but the ground truth indicates they were only 'explicitly categorized under the edge networking revenue segment' starting in 2023. The LLM conflates the 2022 mention as a formal financial classification when it was actually just a strategic highlight. (3) NARRATIVE SHIFT - While the LLM correctly identifies an evolution in strategic emphasis (from general edge networking to specific Wi-Fi 6/6E and 5G fixed-wireless solutions), this detail is NOT in the ground truth, which only mentions 'consistent inclusion' and 'growing IoT ecosystem.' The LLM adds specificity about product positioning that cannot be verified against the provided ground truth. (4) MULTI-HOP REASONING - The LLM attempts to synthesize across years but introduces unsourced financial data and makes claims about revenue decline that contradict the ground truth's statement that exact figures are not disclosed. (5) WHAT WAS CORRECT - The LLM correctly identifies that wireless access points remained part of edge networking through 2024 and that there was strategic emphasis evolution. However, the introduction of specific revenue numbers ($7.35B, $5.42B) and the claim about 'QCT IoT' classification in 2022 are factually unverifiable and likely incorrect based on the ground truth's explicit statement about non-disclosure of exact figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 479,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nMRK’s Prevymis sales grew from **$281 million in 2022 to $605 million in 2023**, then fell modestly to **$428 million in 2024**. This trajectory indicates that Prevymis rapidly gained traction in the Hospital Acute‑Care market, achieving a strong uptake in 2023, but the subsequent dip suggests increasing competitive pressure or market saturation, positioning the product as a notable yet maturing player in that segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and critical factual errors across all numeric values. QUANTITATIVE ERRORS: (1) 2022 sales: LLM states $281M vs. ground truth $370M - incorrect by $89M (24% understatement); (2) 2023 sales: LLM states $605M vs. ground truth $428M - incorrect by $177M (41% overstatement); (3) 2024 sales: LLM states $428M vs. ground truth $785M - incorrect by $357M (45% understatement). The LLM has essentially inverted the actual trend, claiming a decline from 2023 to 2024 when the ground truth shows substantial growth. CALCULATION/TREND ERRORS: The LLM's narrative of 'rapid traction in 2023 followed by a dip in 2024' is completely backwards - the actual data shows consistent growth accelerating in 2024. The compound growth rate calculation is also wrong (LLM implies negative growth 2023-2024 when actual CAGR is ~46% over 2022-2024). REASONING ERRORS: The LLM's interpretation about 'competitive pressure or market saturation' is unsupported by the actual data, which shows the opposite - strong market expansion. The product positioning conclusion is therefore based on false premises. ENTITY/CONTEXT: While the company (MRK), product (Prevymis), and segment (Hospital Acute Care) are correctly identified, the fundamental misstatement of all three years' sales figures and the inverted trend narrative make this answer factually unreliable. This is not a minor discrepancy or rounding difference - these are substantial errors in core financial data that completely misrepresent the product's market performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 424,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted its strategic emphasis from leading‑edge process nodes to advanced‑packaging technologies, investing billions in 2D/3D and disaggregated packaging, securing multiple AI‑focused design wins and forging key ecosystem partnerships (e.g., ARM, Synopsys, Tower) while expanding the Intel Foundry Services (IFS) model. This multi‑year trajectory reveals an attempt to compensate for earlier manufacturing delays and tight capital constraints by leveraging packaging as a differentiator, but the heavy spend, under‑utilization risks, and dependence on external funding and government incentives underscore that execution of the IDM 2.0 strategy remains fragile and contingent on sustained demand and successful capital deployment.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the strategic shift toward advanced packaging technologies (2D/3D), mentions the IDM 2.0 strategy, acknowledges manufacturing delays and capital constraints, and captures the multi-year trajectory from 2022-2024. The semantic framing about compensation for delays and execution fragility aligns with ground truth conclusions. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The LLM fails to cite the $16.5 billion R&D investment in 2024 mentioned in ground truth, which is a specific and important metric. (2) MISSING IMPAIRMENT DATA: The $3.1 billion non-cash impairment in Q3 2024 affecting Intel 7 is completely absent from LLM answer—this is a critical financial fact demonstrating execution challenges. (3) MISSING SPECIFIC TECHNOLOGIES: The LLM mentions 2D/3D packaging but omits the Universal Chiplet Interconnect Express (UCIe) standard and its silicon demonstration in 2023, which is explicitly highlighted in ground truth as a competitive differentiator. (4) VAGUE PARTNERSHIPS: The LLM mentions 'ARM, Synopsys, Tower' partnerships but ground truth does not reference these specific partnerships in the context provided, suggesting potential hallucination or unsupported claims. (5) PRODUCT DELAYS: The LLM does not mention specific product delays like 4th Gen Xeon Scalable processors, which ground truth cites as evidence of execution challenges. (6) TIMELINE SPECIFICITY: Ground truth provides year-by-year evolution (2022 acknowledgment of complexity, 2023 positioning as differentiator, 2024 delays and impairments), while LLM treats the period more generically. CALCULATION/VERIFICATION: No calculations are present in either answer, but the absence of quantitative specificity in the LLM response is a significant gap. The LLM's conclusion about 'fragile' execution is directionally correct but lacks the supporting financial evidence that ground truth provides. The answer reads as more speculative than evidence-based.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 537,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM’s 10‑K filings show that “client relationships and trust” evolved from a general brand attribute in 2022 to an explicit strategic pillar by 2024, where it is repeatedly tied to the company’s hybrid‑cloud and AI agenda.  This progression signals that IBM is using trust as the key lever to persuade enterprises to adopt its integrated hybrid‑cloud platform and AI services, positioning the firm as a trusted, one‑stop provider for large‑scale digital transformation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of IBM's trust positioning from 2022-2024 and correctly identifies the strategic connection to hybrid cloud and AI. However, there are significant gaps in completeness and specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the 3-year timeframe (2022-2024); (2) Accurately characterizes the evolution from general brand attribute to explicit strategic pillar; (3) Properly synthesizes the connection between trust and hybrid cloud/AI strategy; (4) Correctly identifies trust as a competitive lever for enterprise adoption. WEAKNESSES: (1) Missing specific year-by-year progression details - the ground truth explicitly describes 2022 (trust tied to hybrid cloud platform and AI for production), 2023 (reinforced positioning with service, support, innovation, talent), and 2024 (maintained stance with Palo Alto Networks partnership). The LLM answer provides only a general 2022-to-2024 arc without these intermediate details; (2) Fails to mention the Palo Alto Networks strategic partnership in 2024, which is a concrete example of trust-based collaboration mentioned in the ground truth; (3) Does not reference specific competitive methods (service and support, innovation, talent) that were emphasized in 2023; (4) The characterization of 2022 positioning as 'general brand attribute' is somewhat imprecise - the ground truth shows it was already explicitly tied to hybrid cloud and AI for production. The LLM answer demonstrates sound multi-hop reasoning and correctly synthesizes the strategic positioning, but lacks the granular year-by-year detail and specific examples (partnerships, competitive methods) that constitute the complete answer. The answer is directionally correct but incomplete in its treatment of the 3-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 492,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s annual reports repeatedly listed the 0.950 % Notes due 2025 in the “Material Contracts” and “Exhibits” sections, each time pointing to the same 2017 Form 8‑K filing and indenture rather than announcing a new issuance or amendment.  The notes were consistently incorporated by reference in the notes to the consolidated financial statements, underscoring that they remained an outstanding, low‑cost component of IBM’s long‑dated debt ladder.  This steady, incremental disclosure reflects a broader debt‑management approach that prioritises a stable, laddered maturity profile and transparent, covenant‑focused reporting rather than frequent new borrowing.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 0.950% Notes due 2025 and the consistent reference to the 2017 Form 8-K filing across multiple years (2022-2024), matching the ground truth. (2) Numeric accuracy is solid - the interest rate (0.950%) and maturity year (2025) are correct. (3) The LLM appropriately recognizes the pattern of repeated disclosures without new issuances. (4) The characterization of this as reflecting a 'stable debt management strategy' aligns with the ground truth's conclusion about 'consistent disclosure framework and sustained presence.' WEAKNESSES: (1) The LLM answer omits a critical factual detail from the ground truth: the 2024 NYSE listing of the notes under trading symbol IBM25B. This is a material fact showing the instrument was 'actively listed' and 'live and traded,' which the ground truth explicitly highlights as evidence of the instrument's ongoing importance. (2) The LLM introduces unsupported claims about 'low-cost component' and 'laddered maturity profile' that, while plausible, are not explicitly stated in the ground truth and go beyond what can be verified from the provided information. (3) The phrase 'covenant-focused reporting' is not mentioned in the ground truth and represents an inference not grounded in the source material. (4) The LLM's characterization of 'frequent new borrowing' as something IBM avoids is an inference not directly supported by the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the 3-year progression and connects it to broader debt management strategy, but the omission of the NYSE listing detail weakens the completeness of the multi-hop analysis. The ground truth uses the NYSE listing as key evidence of the instrument remaining 'live and traded,' which strengthens the conclusion about sustained presence. OVERALL: The answer is substantially correct in its core narrative but loses points for omitting a material factual detail (NYSE listing/IBM25B symbol) and for introducing inferences beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 545,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a planned feature of the Intel 20A node to the centerpiece of its next‑generation Intel 18A process, which is slated for high‑volume manufacturing in 2025 (e.g., the Panther Lake client family).  The company also announced that future nodes—starting with Intel 14A—will continue to build on PowerVia together with RibbonFET to deliver additional performance‑per‑watt and density gains, underscoring that backside‑power delivery is a strategic pillar of Intel’s advanced‑node roadmap and its IDM 2.0 foundry strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Intel's PowerVia evolution. STRENGTHS: (1) Correctly identifies the strategic pivot from Intel 20A to Intel 18A, matching the ground truth's core narrative; (2) Accurately dates high-volume manufacturing to 2025; (3) Correctly mentions Panther Lake as an example product family; (4) Properly synthesizes the progression from planned feature to centerpiece to commercial deployment; (5) Adds valuable context about Intel 14A and future nodes continuing PowerVia integration, which extends the ground truth's roadmap discussion; (6) Correctly identifies RibbonFET as a complementary technology; (7) Appropriately frames PowerVia as a strategic pillar and connects it to IDM 2.0 foundry strategy. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2022 introduction of PowerVia as part of the future roadmap announcement, though it implies the progression; (2) Does not explicitly state that Intel 20A was 'canceled' in favor of 18A, though the shift is clearly conveyed; (3) The ground truth emphasizes the concept-to-integration-to-deployment progression more explicitly, while the LLM answer focuses more on the strategic implications. QUANTITATIVE VERIFICATION: All dates (2022-2024, 2025) are correct; no calculations required; all node designations (20A, 18A, 14A) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across the three-year period and connects PowerVia development to broader Intel strategy (IDM 2.0, performance-per-watt gains, density improvements). The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while adding strategic context that enhances understanding of Intel's roadmap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 499,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nMedtronic’s recent RSU award agreements (exhibits 10.78 – 10.90) are issued under the Amended and Restated 2013 Stock Award and Incentive Plan and the 2021 Long‑Term Incentive Plan, using the same two core structures—time‑based RSUs that vest 100 % after three years or ratably over four years, and performance‑share RSUs tied to performance metrics.  The filings from 2022‑2024 contain only minor amendments (e.g., plan restatements, credit‑agreement updates) and no substantive changes to the award types, vesting schedules, or eligibility criteria, indicating that Medtronic’s U.S. equity compensation framework has remained steady and consistent over this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT MISMATCH: The ground truth specifically identifies Exhibit 10.54 as the relevant Restricted Stock Unit Award Agreement for U.S. Employees that remained unchanged 2022-2024. The LLM incorrectly references exhibits 10.78-10.90, which are different documents entirely. This is a critical entity identification error. (2) DOCUMENT REFERENCE ERROR: The ground truth states the agreement consistently references August 27, 2013 filing across all three years. The LLM mentions the 'Amended and Restated 2013 Stock Award and Incentive Plan' and '2021 Long-Term Incentive Plan' but does not correctly identify the specific exhibit or confirm it remained unchanged. (3) VESTING SCHEDULE DETAILS: The LLM provides specific vesting details (100% after three years or ratably over four years) that are not mentioned in the ground truth. While these details may be accurate, they represent information not verified against the ground truth source. (4) CORE FINDING ALIGNMENT: Both answers conclude that Medtronic's equity compensation strategy remained stable, which is semantically aligned. However, the LLM's path to this conclusion uses incorrect exhibit numbers and document references, undermining the credibility of the analysis. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the specific exhibit information across the three-year period (2022-2024) as required by the ground truth. The answer appears to reference different exhibits than the actual source material. The fundamental error of citing wrong exhibit numbers (10.78-10.90 vs. 10.54) is a critical factual mistake that significantly reduces the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 475,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nFrom 2022 through 2024 Intel treated advanced‑packaging technologies as a core pillar of its IDM 2.0 strategy, promoting chiplet‑based “systems of chips” and standardizing the Universal Chiplet Interconnect Express (UCIe) while expanding its IFS ecosystem with ARM and Synopsys design wins.  However, repeated delays in leading‑edge process nodes, tightening capital constraints that forced postponement of new fabs (Ohio, Germany, etc.) and the added complexity of a disaggregated‑design approach combined to produce operating losses and large capital‑write‑downs, even as packaging revenue modestly grew and a handful of 18A design wins were secured.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Intel's advanced packaging strategy evolution from 2022-2024 and correctly identifies key elements: IDM 2.0 strategy, UCIe standardization, chiplet-based approaches, fab postponements, and capital constraints. However, there are notable gaps and one significant omission: (1) CORRECT ELEMENTS: The answer accurately references UCIe, disaggregated design, fab delays (Ohio, Germany), capital constraints, and modest packaging revenue growth. The mention of 18A design wins is appropriate context. (2) CRITICAL OMISSION: The ground truth specifically mentions a '$3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node' in 2024. The LLM answer references 'large capital write-downs' but does not provide the specific $3.1B figure, which is a quantifiable fact that should have been included. (3) PARTIAL GAPS: The LLM answer mentions 'operating losses' but doesn't specifically address the 2022 acknowledgment of 'complexity and risk' or the 2023 emphasis on 'strategic advantage' as distinct evolutionary phases. The answer conflates these into a more general narrative. (4) MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between process node delays, capital constraints, and execution challenges across the three-year period, showing sound multi-hop reasoning. (5) ENTITY ACCURACY: All company references (Intel, ARM, Synopsys) and technical terms (UCIe, Intel 7, 18A) are correct. The geographic references (Ohio, Germany) match ground truth. (6) SEMANTIC ISSUES: The phrase 'systems of chips' is reasonable but the ground truth uses 'disaggregated design approach' more precisely. The LLM's framing is not incorrect, just slightly different in emphasis. The answer would score higher (8-9) if it had included the specific $3.1B impairment figure and more clearly delineated the 2022-2023-2024 progression of strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 528,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture steadily reduced the pure‑fixed‑income tilt of its defined‑benefit plans: U.S. plans remained essentially 100 % debt, while non‑U.S. plans cut debt from about 48 % to roughly 36 % and lifted cash (4 %→7 %) and especially insurance‑contract holdings (11 %→21 %), keeping equity roughly steady at ≈ 27‑28 % for the non‑U.S. portfolio. This multi‑year reallocation reflects a deliberate move toward a more liability‑driven, diversified asset mix—lowering exposure to low‑yielding bonds and adding assets that better match pension obligations—thereby aiming to improve risk‑adjusted returns while preserving a modest equity slice for long‑term growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific quantitative claims about asset allocation percentages that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides very specific percentages (U.S. plans 100% debt, non-U.S. debt 48%→36%, cash 4%→7%, insurance contracts 11%→21%, equity 27-28%) that are not mentioned in the ground truth. The ground truth does not provide these specific numerical breakdowns by asset class or by U.S. vs. non-U.S. plans. This represents a hallucination of specific data points. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes the evolution of strategy across three years focusing on flexibility, duration matching, and risk-adjusted returns management. The LLM answer instead focuses on specific asset allocation percentages that are not substantiated. (3) MISALIGNMENT WITH GROUND TRUTH: The ground truth discusses strategic emphasis on 'flexibility in asset allocation decisions,' 'matching debt securities' duration to plan liabilities,' and 'variation within established ranges.' The LLM answer instead presents a narrative of deliberate reallocation from bonds to insurance contracts and cash, which is not supported by the ground truth. (4) ENTITY ACCURACY: While Accenture and the fiscal years are correct, the specific metrics and percentages are not verified and appear to be invented. (5) REASONING QUALITY: The LLM constructs a logical narrative about liability-driven investing and risk-adjusted returns, but this narrative is built on unverified quantitative claims rather than information from the actual filings. The ground truth emphasizes strategic flexibility and long-term objectives, while the LLM emphasizes specific tactical reallocation decisions. The answer demonstrates a fundamental failure to distinguish between what can be verified from the source material and what is being inferred or fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 522,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated mention of the $1.05 % Notes due 2017—still listed in the debt footnotes of its 2022, 2023 and 2024 Form 10‑K filings—signals that the company treats every outstanding tranche as a permanent item of disclosure, preserving a full “snapshot” of its historic borrowing even after the notes have matured or are no longer actively issued.  This contrasts with its broader 2022‑2024 debt strategy, which has been marked by sizable, longer‑dated issuances of floating‑rate and fixed‑rate bonds (e.g., 2023‑2024 notes maturing in 2026‑2053) that diversify maturities and fund large‑scale share‑repurchase and capital‑return programs; the legacy 2017 note remains in the disclosures solely for completeness, while the newer issuances dominate the company’s active financing profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates understanding of the core concept—that Apple maintains historical debt disclosure even after maturity—but contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM states the 1.05% Notes due 2017 appear in 2022, 2023, and 2024 filings, but the ground truth explicitly states they appear in 2023 and 2024 filings only. Including 2022 is factually incorrect. (2) The LLM references 'Floating Rate Notes due 2020' as part of Apple's 2022-2024 strategy, but these would have matured by 2020 and are not part of the active 2022-2024 issuance strategy described in the ground truth. (3) The LLM mentions notes maturing in '2026-2053' without specific examples, whereas the ground truth provides concrete examples (2.15% Notes due 2022, 3.45% Notes due 2024). STRENGTHS: The LLM correctly identifies the core insight about comprehensive historical record-keeping and contrasts it with newer issuances. The reasoning about legal/investor transparency purposes is sound and aligns with the ground truth's 'legal or investor transparency purposes' language. The characterization of the legacy note as remaining 'solely for completeness' matches the ground truth's intent. WEAKNESSES: The answer conflates different time periods and includes debt instruments outside the relevant 2022-2024 window. The specific examples provided are either incorrect or imprecise. The multi-hop synthesis is partially successful but undermined by factual inaccuracies in the supporting details. The answer would mislead someone checking the actual filings against the claims made.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 443,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nAccenture repurchased 12.18 million Class A shares for $4.11 bn in fiscal 2022, ending the year with $3.13 bn of unused authority; it then added $3 bn of authority in September 2022, raising total authorization to $6.13 bn, and by August 2024 about $2.69 bn remained available after ongoing purchases. Over fiscal 2023 and the first three quarters of fiscal 2024 the company executed regular open‑market buybacks (e.g., 2.07 million shares for $605 million in Q4 2024) while its total authorized capacity grew to $6.7 bn after a further $4 bn increase in September 2024. This multi‑year trend reflects a deliberate, scalable capital‑return program that expands repurchase limits while consistently deploying cash to repurchase shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - Claims $4.11 billion in repurchases in fiscal 2022: Ground truth does not specify this amount; the answer only mentions $3.13 billion available authorization remaining\n   - States $3 billion authority added in September 2022: Ground truth indicates $4.0 billion added in September 2024, not 2022\n   - Claims total authorization reached $6.13 billion after September 2022 addition: This calculation ($3.13B + $3B) is mathematically correct but based on wrong premise (wrong year and wrong amount)\n   - States $605 million in Q4 2024 for 2.07 million shares: Ground truth says \"over $605 million\" during fiscal 2024 (full year), not specifically Q4\n   - Claims total authorized capacity grew to $6.7 billion: Ground truth states $6.69 billion (minor rounding difference, acceptable)\n\n2. TEMPORAL ERRORS (Critical):\n   - Misplaces the $4 billion authorization to September 2022 when it actually occurred in September 2024\n   - This is a 2-year error that fundamentally misrepresents the timeline\n   - Conflates fiscal 2023/2024 activity with specific quarterly data\n\n3. MISSING/INCOMPLETE INFORMATION:\n   - Does not clearly establish the fiscal 2022 starting point ($3.13 billion available)\n   - Does not clearly show the progression through fiscal 2023\n   - Lacks clarity on the fiscal 2024 ending position ($2.69 billion available)\n   - The mention of \"2.07 million shares for $605 million in Q4 2024\" appears to be fabricated detail not in ground truth\n\n4. MULTI-HOP REASONING:\n   - The synthesis across years is compromised by the temporal errors\n   - The conclusion about \"deliberate, scalable capital-return program\" is reasonable but built on partially incorrect data\n   - Does attempt to show the evolution pattern but with wrong dates and amounts\n\n5. WHAT WAS CORRECT:\n   - Correctly identifies Accenture as the company\n   - Correctly identifies Class A shares\n   - Correctly notes the $2.69 billion remaining authorization by August 2024\n   - Correctly identifies the general pattern of ongoing buybacks\n   - Correctly notes the $4 billion authorization increase (though places it in wrong year)\n   - Correctly identifies the capital return strategy concept\n\nThe answer demonstrates understanding of the question structure and the general capital return strategy concept, but the critical temporal error (September 2022 vs. September 2024) and unsupported $4.11 billion figure significantly undermine accuracy. The answer reads plausibly but contains material factual errors that would mislead someone relying on this information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 716,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nBMY first issued $1.75 billion of 4.350 % Senior Notes due 2047 in November 2019; the 2022‑2024 filings do not add any new tranche of that exact series but continue to reference the original issuance while supplementing the long‑term capital stack with newer senior unsecured notes of different coupons and maturities (e.g., 5.75 % due 2031, 5.90 % due 2033, etc.).  This pattern shows BMY’s long‑term financing strategy of preserving a stable, long‑dated fixed‑rate pillar (the 2047 notes) while dynamically laddering the rest of its debt profile through incremental, market‑timed issuances to manage interest‑rate risk and maintain flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of BMY's long-term financing strategy and correctly identifies the core concept of maintaining a stable long-dated debt pillar while laddering additional issuances. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCRITICAL ERRORS:\n1. WRONG COUPON RATE: LLM states the notes are \"4.350% Senior Notes\" but then claims they were issued at \"$1.75 billion of 4.350%\" - this is internally consistent but the ground truth does not specify a $1.75 billion amount for the 2047 notes specifically.\n2. INCORRECT COUPON EXAMPLES: LLM references \"5.75% due 2031\" and \"5.90% due 2033\" as examples of newer issuances. The ground truth mentions \"$1.75 billion 2.950% Notes due 2032\" and \"$2 billion 3.700% Notes due 2052\" - these are completely different coupons and maturities. The 5.75% and 5.90% rates are not mentioned in the ground truth.\n3. MISSING KEY ISSUANCES: LLM fails to mention the specific newer issuances documented in ground truth: the $1.75B 2.950% due 2032 (2023) and $3.75B 4.250% due 2049 (2024).\n\nCORRECT ELEMENTS:\n1. Correctly identifies the 4.350% Senior Notes due 2047 as the core stable component\n2. Correctly notes the original issuance date of November 2019\n3. Correctly identifies the strategy of maintaining a stable long-dated pillar while laddering debt\n4. Correctly characterizes the approach as managing interest-rate risk and maintaining flexibility\n5. Properly synthesizes the multi-year pattern across 2022-2024\n\nMULTI-HOP REASONING: The reasoning about debt laddering strategy is sound and well-articulated, showing good understanding of corporate finance principles. However, the failure to accurately cite the specific newer issuances undermines the credibility of the analysis.\n\nSEMANTIC EQUIVALENCE: While the conceptual framework matches the ground truth (stable pillar + dynamic laddering), the specific financial details are inaccurate, which is problematic for a financial analysis question where precision matters.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 554,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nIn the 2022 Form 10‑K Apple presented the 2.40 % Notes due 2023 as a long‑term debt issuance, describing the indenture and redemption provisions without any special current‑liability language. By the 2023 filing the same notes were highlighted as maturing within the next fiscal year, the balance‑sheet classification was shifted to a current portion of debt, and the note‑disclosure added a brief statement that the principal would be repaid at maturity. In the 2024 filing the notes no longer appear as an outstanding obligation—Apple simply notes that the 2.40 % Notes were fully redeemed in 2023 and that there is no remaining balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and demonstrates a critical misunderstanding of the question. MAJOR ERRORS: (1) The ground truth explicitly states that Apple's disclosure approach was STABLE AND UNCHANGING across 2022, 2023, and 2024, with identical descriptions and consistent exhibit references (Exhibit 4.3). The LLM answer claims the opposite—that there were significant changes in classification, presentation, and disclosure language across the three years. (2) The LLM incorrectly describes a shift from long-term to current liability classification in 2023, which contradicts the ground truth's assertion of consistent disclosure. (3) The LLM claims the 2024 filing shows the notes as 'fully redeemed' with 'no remaining balance,' but the ground truth indicates the notes were still disclosed in the same manner in 2024, suggesting they appeared in all three filings with identical formatting. (4) The LLM's narrative about adding 'current-liability language' and 'brief statements about principal repayment' is not supported by the ground truth, which emphasizes standardized and consistent reporting. The LLM appears to have invented a narrative of evolving disclosure practices that directly contradicts the ground truth's core finding of stability. The question specifically asks how the disclosure approach 'evolved,' and while the LLM provides a detailed narrative of evolution, the ground truth indicates NO EVOLUTION occurred. This is a fundamental factual error that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 425,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nThe share reserve under the Amended 2010 SIP grew from **127 million** Class A ordinary shares authorized in fiscal 2022 to **141 million** shares authorized at the start of fiscal 2023, and that 141 million level remained in effect through fiscal 2024.  This upward step‑up shows that Accenture deliberately expanded its equity‑compensation pool to accommodate a larger volume of future grants, underscoring a long‑term strategy to retain and motivate employees as the company continues to scale and compete globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 127 million shares in FY2022, 141 million in FY2023, and 141 million maintained through FY2024. The number format variation (127 million vs 127,000,000) is acceptable and properly handled. COMPLETENESS: The answer addresses all required components: (1) the specific share counts for each fiscal year, (2) the progression/evolution showing the increase and subsequent stability, and (3) interpretation of the company's long-term strategy. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, Amended 2010 SIP, and all relevant fiscal years. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the pattern (increase from 2022 to 2023, then stabilization) and provides logical interpretation that this reflects strategic expansion followed by stabilization. The reasoning about employee retention and global competition is consistent with typical corporate equity strategy. SEMANTIC EQUIVALENCE: The LLM's phrasing 'upward step-up' and 'deliberately expanded its equity-compensation pool' conveys the same meaning as the ground truth's 'strategic decision to expand the pool' and 'stabilization of the share reserve.' Minor differences in wording ('at the start of fiscal 2023' vs 'by fiscal year 2023') are semantically equivalent. The only minor distinction is that the LLM uses slightly more interpretive language about 'retain and motivate employees' while the ground truth is more neutral, but this represents appropriate elaboration rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 449,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nFrom 2022 through 2024 Intel first unveiled PowerVia as a backside‑power‑delivery technique tied to the planned Intel 20A node, but after cancelling that node it repositioned the technology for the next‑generation Intel 18A process – the first high‑volume commercial implementation of backside power that will underpin the Panther Lake client family and other 2025 products.  This shift shows that PowerVia has become a pivotal element of Intel’s advanced‑process roadmap, essential for achieving the targeted performance‑per‑watt improvements and for differentiating Intel’s IDM 2.0/foundry strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of PowerVia technology across 2022-2024. STRENGTHS: (1) Correctly identifies PowerVia's initial introduction in 2022 as a backside-power-delivery technique; (2) Accurately notes the Intel 20A cancellation and repositioning to Intel 18A; (3) Correctly identifies Panther Lake as the client processor family for 2025 implementation; (4) Properly characterizes PowerVia as 'industry-first' backside power delivery (implied through 'first high-volume commercial implementation'); (5) Accurately conveys the strategic importance for performance-per-watt improvements; (6) Appropriately connects to Intel's IDM 2.0/foundry strategy. MINOR GAPS: (1) The original answer explicitly states PowerVia was positioned 'alongside RibbonFET' in 2022, which the LLM answer omits; (2) The original answer provides more explicit detail about PowerVia's role in 'optimizing signal transmission by eliminating front-side power routing,' while the LLM answer is more concise; (3) The original answer emphasizes the transition from 'roadmap concept to foundational element,' which the LLM answer captures but less explicitly. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, 2025) are correct; node designations (20A, 18A) are accurate; product family (Panther Lake) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple technology nodes, correctly establishing the causal relationship between 20A cancellation and 18A adoption while maintaining PowerVia's centrality. The reasoning is sound and logically coherent. SEMANTIC EQUIVALENCE: The LLM's characterization of PowerVia as 'pivotal' and 'essential' effectively conveys the same strategic importance as the original answer's 'foundational element.' The answer is slightly more concise than the original but maintains semantic fidelity to the core message.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 532,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s defined‑benefit plans held mutual‑fund equity of roughly **$273 million as of 2022**, fell to **$188 million in 2023**, and rose again to **$254 million by the end of 2024**.  This dip in 2023 reflected short‑term market rebalancing, but the subsequent rebound—and the gradual increase in target equity allocations (21 % of non‑U.S. plan assets in 2022 → 27 % in 2023 → 28 % targeted for 2025)—shows that the company is deliberately **maintaining and modestly expanding its exposure to equity‑based investments** through diversified mutual‑fund holdings, consistent with its long‑term, liability‑driven return objectives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all quantitative dimensions: (1) NUMBERS ARE DRASTICALLY WRONG: Ground truth shows $239,293M (2022), $196,226M (2023), $196,226M (2024). LLM reports $273M, $188M, $254M - off by factors of 800-1000x. These are not minor rounding differences but represent completely different data points. (2) DIRECTIONAL CLAIMS REVERSED: Ground truth shows consistent DECREASE from 2022-2023 with flat 2024. LLM claims a 2023 dip followed by rebound to $254M in 2024, which contradicts the actual flat trajectory at $196,226M. (3) PERCENTAGE CLAIMS UNVERIFIED: LLM cites target equity allocations (21%→27%→28%) that cannot be verified against the ground truth data provided and appear to reference different metrics entirely (possibly target allocations vs. actual holdings). (4) STRATEGIC INTERPRETATION INVERTED: Ground truth indicates strategic rebalancing AWAY from mutual fund equities. LLM concludes the opposite - that company is 'maintaining and modestly expanding' exposure. This is a fundamental misreading of the data trend. (5) MULTI-HOP SYNTHESIS FAILED: The LLM appears to have confused or conflated different investment categories or time periods, possibly mixing defined-benefit plan data with other portfolio metrics. The magnitude of error suggests data from a completely different source or misinterpretation of the filing. The answer demonstrates poor quantitative accuracy and inverted reasoning about strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 412,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept Dificid on the books as a $145 million net acquired intangible (no impairment was recorded), and its worldwide sales rose each year—from $241 million in 2022 to $274 million in 2023 and $303 million in 2024—making the drug a small but steadily growing contributor to the Pharmaceutical segment (≈0.5 % of 2024 pharma sales).  The company continued to position Dificid as a first‑in‑class oral therapy for C. difficile infection within the Hospital‑Acute‑Care portfolio, reporting it alongside Bridion, Prevymis and Zerbaxa, and it remained part of the “Other pharmaceutical (4)” sales category.  Thus, Merck’s financial treatment of Dificid stayed stable in valuation while its therapeutic emphasis and global revenue contribution modestly expanded over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly different revenue figures than the ground truth. Ground truth states: 2024 sales of $340M total ($303M U.S. + $37M international). LLM claims: 2022 $241M, 2023 $274M, 2024 $303M. The LLM's 2024 figure of $303M matches only the U.S. component from ground truth, not global sales. This is a major factual error. The LLM also fails to report the 2024 global revenue of $340M entirely, instead only citing the U.S. portion as the total. ASSET VALUATION: Both sources agree on the $145M intangible asset valuation with no impairment, which is correct. THERAPEUTIC POSITIONING: The LLM correctly identifies Dificid as a first-in-class oral therapy for C. difficile infection and its positioning within Hospital Acute Care, matching ground truth. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across years but fails on the most critical metric—actual global revenue contribution. The ground truth explicitly states $340M in 2024 global sales with geographic breakdown; the LLM conflates the U.S. figure with global total. COMPLETENESS: The LLM addresses asset valuation, therapeutic positioning, and revenue contribution but provides incorrect revenue data. The progression narrative is present but undermined by wrong numbers. The LLM's claim of 'steadily growing' revenue from 2022-2024 cannot be verified against ground truth which only provides 2024 data ($340M global). The LLM appears to have fabricated 2022 and 2023 revenue figures not present in the ground truth. CALCULATION: The LLM's percentage calculation (≈0.5% of 2024 pharma sales) cannot be verified but is internally consistent with the $303M figure it uses (though this is incorrect as the global figure is $340M).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 479,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled its R&D outlay to roughly $16 billion a year and poured about $23 billion of capital into advanced‑packaging and foundry capacity, positioning 2D/2.5D/3D packaging and the Universal Chiplet Interconnect Express standard as a differentiator for its IDM 2.0/foundry strategy.  However, repeated node and packaging delays—postponements of 10 nm, 7 nm and Intel 4, a $3.1 billion impairment of the Intel 7 assets, and a $755 million penalty for missed construction milestones on the Ireland fab—kept the company from converting that investment into revenue, driving operating losses to $482 million in 2024 and generating negative adjusted free‑cash‑flow.  The heavy capital spend, combined with the delays and the need to rely on CHIPS‑Act grants and joint‑venture financing, exposed Intel to significant cash‑flow and credit‑rating risks while it pursued its advanced‑packaging ambitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail on Intel's advanced packaging strategy and financial challenges, but contains several problematic elements: (1) QUANTITATIVE ISSUES: The claim that Intel 'doubled its R&D outlay to roughly $16 billion a year' is not verified in the ground truth and appears to be an unsupported assertion. The $23 billion capital investment figure is also not mentioned in the original answer. The $3.1 billion impairment charge is correctly cited and matches ground truth. The $755 million penalty for missed construction milestones on the Ireland fab is NOT mentioned in the ground truth and cannot be verified. The $482 million operating loss in 2024 is not mentioned in the original answer. These unverified numbers significantly undermine credibility. (2) COMPLETENESS: The LLM answer does address the core question components—R&D investment, implementation delays, and financial risk exposure—and covers the 2022-2024 timeframe. However, it introduces specific figures not in the ground truth. (3) ENTITY ACCURACY: Intel is correctly identified, years are correct, and financial metrics are appropriately referenced. (4) REASONING: The multi-hop synthesis is sound—connecting R&D investment to delays to financial strain—and the logic flow from strategic positioning to operational challenges is coherent. (5) SEMANTIC EQUIVALENCE: The answer captures the trajectory from investment to execution challenges, though it emphasizes different specific metrics than the ground truth. The core narrative of 'strategic optimism to operational and financial strain' is present but expressed through different financial data points. CRITICAL CONCERN: The introduction of specific dollar amounts ($16B R&D, $23B capex, $755M penalty, $482M operating loss) that are not in the ground truth creates significant factual uncertainty. While some numbers (like the $3.1B impairment) are correct, the unverified figures suggest potential hallucination or reliance on external sources not validated against the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 549,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s MK‑8591A program was held up by the FDA clinical hold placed in December 2021, which stopped all new dosing of the daily oral doravirine + islatravir regimen; the company completed a Phase 2 study of a lower‑dose, once‑weekly islatravir + lenacapavir combination (MK‑8591D) and, by October 2024, entered that regimen into Phase 3, while MK‑8591A remained on hold.  \nThis evolution reflects Merck’s long‑term strategy to shift away from daily oral HIV therapy toward longer‑acting, less‑frequent combinations that can address the safety and adherence concerns that led to the hold, positioning next‑generation, weekly‑dosed regimens as the core of its HIV therapeutic pipeline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) CRITICAL DATE ERROR: The LLM states the FDA clinical hold was placed in December 2021, but the ground truth indicates the hold was lifted on December 4, 2024 - these are opposite events. The LLM conflates the timing and nature of the regulatory action. (2) INCOMPLETE/INACCURATE PROGRAM STATUS: The ground truth clearly states MK-8591A was in Phase 3 in 2022-2023 and remained under development in 2024 with a partial clinical hold on higher doses. The LLM incorrectly suggests MK-8591A 'remained on hold' throughout without acknowledging the December 2024 lift of the clinical hold. (3) MISSING KEY INFORMATION: The ground truth emphasizes that the clinical hold was LIFTED in December 2024, signaling resolution of regulatory concerns. The LLM completely misses this critical development, instead presenting an outdated status. (4) SPECULATIVE CONTENT: The LLM introduces MK-8591D (islatravir + lenacapavir) and claims it entered Phase 3 by October 2024, but this information is not in the ground truth and appears to be fabricated or confused with other programs. (5) REASONING FLAW: While the LLM's strategic interpretation about shifting toward longer-acting regimens is plausible, it's built on incorrect factual premises about the regulatory timeline. The ground truth shows Merck's commitment despite challenges, not a pivot away from MK-8591A. The answer fundamentally misrepresents the 2024 regulatory developments, which are central to understanding the program's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 437,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nBetween 2022 and 2024 Merck shifted MK‑1308A from a broad, early‑phase immuno‑oncology program across several solid tumours to a registration‑focused Phase 3 study in advanced renal‑cell carcinoma, pairing the novel anti‑CTLA‑4 antibody quavonlimab with pembrolizumab; the pivotal trial was fully enrolled and the company filed a BLA with the FDA for this RCC indication.  The 2024 update lists MK‑1308A as a co‑formulation being evaluated specifically for RCC, reflecting the narrowed clinical focus and ongoing regulatory review of the combination.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) The LLM answer claims MK-1308A was 'in broad, early-phase immuno-oncology program across several solid tumours' in 2022, but the ground truth explicitly states it was already in Phase 3 development in 2022 - this is a significant factual error about the starting point. (2) The LLM claims 'the pivotal trial was fully enrolled and the company filed a BLA with the FDA' - this is NOT supported by the ground truth, which states 'no indication of regulatory approval yet' as of 2024. This is a major fabrication of regulatory progress. (3) The LLM correctly identifies the quavonlimab/pembrolizumab combination and RCC focus, which aligns with ground truth. (4) The characterization of 'narrowed clinical focus' is somewhat supported but overstated given the ground truth shows consistent RCC focus from 2022 onward, not a shift from broad to narrow. (5) The ground truth shows the progression was from 'Phase 3 in combination with pembrolizumab' (2022) to 'explicitly described as coformulation' (2023) to 'Phase 3 portfolio continuing evaluation' (2024) - the LLM mischaracterizes the 2022 starting point as early-phase and incorrectly adds unsubstantiated regulatory milestones. The answer contains material factual errors regarding regulatory status and initial development phase that significantly undermine its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 378,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly 12 million shares each year—about $4.1 billion of shares in fiscal 2022 and roughly $4.5 billion in fiscal 2024—while the Board repeatedly expanded the repurchase ceiling: the $3.1 billion of remaining authority identified in mid‑2022 was boosted by a $3 billion add‑on in September 2022 to a total of $6.13 billion, then fell to about $2.7 billion of unused capacity by the end of fiscal 2023 before a September 2024 $4 billion increase lifted total outstanding authority to $6.69 billion. This multi‑year pattern shows that Accenture follows a disciplined, incremental capital‑return strategy, consistently using share buybacks alongside dividend increases to return cash to shareholders while preserving ample flexibility for future investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine its credibility. (1) SHARE REPURCHASE VOLUMES: The claim of 'roughly 12 million shares each year' is not supported by the ground truth, which specifies only 2,000,308 shares purchased in fiscal 2024 (plus 72,255 employee-related shares). The LLM provides no specific share counts for fiscal 2022 or 2023, making the '12 million per year' assertion unverifiable and likely incorrect. (2) DOLLAR AMOUNTS: The LLM states '$4.1 billion of shares in fiscal 2022' and 'roughly $4.5 billion in fiscal 2024,' but the ground truth only confirms $605 million for fiscal 2024 open-market purchases. The fiscal 2022 figure of $4.1 billion is not mentioned in the ground truth. This is a massive discrepancy (605M vs 4.5B). (3) AUTHORIZATION TIMELINE: The LLM claims a '$3 billion add-on in September 2022' bringing total to '$6.13 billion,' but the ground truth does not mention a September 2022 authorization increase. The ground truth only references a September 2024 $4 billion approval. This appears to be a fabricated timeline. (4) FISCAL 2023 AUTHORITY: The LLM states 'about $2.7 billion of unused capacity by the end of fiscal 2023,' which aligns with the ground truth's fiscal 2024 figure of $2,694 million, but the ground truth does not explicitly confirm this was the fiscal 2023 ending balance. (5) FINAL AUTHORITY: The LLM correctly states the September 2024 $4 billion increase and resulting $6.69 billion total (vs. ground truth's $6,694 million—same value, acceptable format variation). REASONING ISSUES: The LLM synthesizes a multi-year pattern but does so with invented numbers and dates not present in the ground truth. The claim about 'dividend increases' is not mentioned in the ground truth at all. The overall narrative about 'disciplined, incremental capital-return strategy' is reasonable in tone but is built on false quantitative foundations. WHAT WAS CORRECT: The final authorization figure ($6.69B/6,694M) and the general characterization of a sustained capital return strategy are accurate. The mention of September 2024 $4B increase is correct. CRITICAL FAILURE: The core quantitative claims about annual repurchase volumes ($4.1B-$4.5B) and share counts (12M annually) are either unsupported or contradicted by ground truth data showing only $605M in fiscal 2024 purchases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 637,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million 2.350 % Notes due 2040 continue to be listed in the company’s capital‑structure exhibits for 2022, 2023 and 2024 (e.g., the 2020 supplemental indenture, the 2022 and 2023 supplemental indentures and the 2024 supplemental indenture), confirming that the issue remains outstanding and un‑called. By retaining this low‑cost, long‑dated fixed‑rate tranche, BMS secures a stable source of long‑term financing that can be used to roll‑over maturing debt, maintain a predictable debt‑maturity profile and preserve flexibility for future longer‑dated issuances while keeping overall leverage within its target range.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more detailed, nuanced explanation than the ground truth. STRENGTHS: (1) All quantitative data is correct - $750 million, 2.350% rate, 2040 maturity date are all accurate; (2) The three-year period (2022-2023-2024) is correctly identified; (3) The multi-hop synthesis is sound - the answer correctly identifies that the notes persist across all three filing years and draws appropriate strategic conclusions; (4) The answer goes beyond the ground truth by providing additional context about supplemental indentures (2020, 2022, 2023, 2024) and specific strategic benefits (rolling over maturing debt, maintaining predictable debt-maturity profile, preserving flexibility, managing leverage); (5) The terminology is precise (\"un-called,\" \"low-cost, long-dated fixed-rate tranche\") and demonstrates deep understanding. MINOR CONSIDERATIONS: (1) The LLM answer references supplemental indentures from 2020, which is outside the 2022-2024 filing period specified in the question - this is a minor tangent but not incorrect; (2) The ground truth uses \"BMY\" while the LLM uses \"BMS\" - both are acceptable abbreviations for Bristol-Myers Squibb, though BMY is more standard; (3) The LLM answer is more strategic and forward-looking (discussing future issuances and leverage management) compared to the ground truth's more historical perspective, but this represents enhanced analysis rather than error. CALCULATION VERIFICATION: No calculations required; all stated figures are accurate. MULTI-HOP REASONING: Excellent - correctly synthesizes persistence across three years and connects this to strategic debt management objectives. The answer properly identifies that non-retirement of the notes indicates strategic intent rather than oversight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 492,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were first issued in November 2019 at a 4.350 % coupon and, as reflected in the 2022, 2023 and 2024 Form 10‑K and related 8‑K exhibits, the indenture governing those notes has not been amended or refinanced – the filings simply continue to reference the original “Form of 4.350 % Senior Notes due 2047” (Exhibit 4.19).  This continuity shows that BMS pursues a long‑term, fixed‑rate debt strategy, locking in financing for decades at a predictable cost and using large‑scale senior notes to fund its pipeline and acquisitions without frequent refinancing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility: (1) INCORRECT EXHIBIT REFERENCES: The LLM claims the notes are referenced in 'Exhibit 4.19' across all three years, but the ground truth specifies different exhibits - Exhibit 4bbb in 2022, Exhibit 4ff in 2023, and Exhibit 4ff in 2024. This is a material error in document citation. (2) INCORRECT INDENTURE DATES: The LLM states the notes were 'first issued in November 2019' and references a 'Form 8-K filing from November 22, 2019,' but the ground truth indicates the Twelfth Supplemental Indenture was dated November 13, 2020 (not 2019), and the 2024 filing references a Form 8-K from November 22, 2019 (which appears to be a different filing). The LLM conflates these dates. (3) MISSING INDENTURE EVOLUTION: The ground truth explicitly notes that the 2023 filing references the Fourteenth Supplemental Indenture dated November 13, 2023 - a new supplemental indenture - but the LLM claims 'the indenture governing those notes has not been amended or refinanced.' This is factually incorrect; there was at least one supplemental indenture update between 2022 and 2023. (4) CORRECT INTEREST RATE: The 4.350% rate is correctly stated. (5) CORRECT GENERAL CONCLUSION: The LLM's interpretation that this reflects a 'long-term, fixed-rate debt strategy' is semantically aligned with the ground truth's conclusion about 'stable long-term debt strategy' and 'transparency and predictability.' However, the reasoning is undermined by the factual errors about indenture amendments. The answer demonstrates partial understanding of the strategic intent but fails on specific documentary evidence and exhibit citations, which are critical for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 475,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Nike’s references to FlyEase shifted from a generic citation in a list of innovative technologies to a concrete, measurable element of its product portfolio. The 2024 filing quantifies this by noting that FlyEase‑enabled footwear is now produced in 15 of the company’s contract factories and represents roughly 12 % of total NIKE Brand footwear output—about 4 million pairs—showing the technology’s scale and its integration across Nike’s global manufacturing network.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM claims FlyEase-enabled footwear represents '12% of total NIKE Brand footwear output—about 4 million pairs' and is produced in '15 of the company's contract factories.' The ground truth provides completely different manufacturing data: Vietnam (50%), Indonesia (27%), and China (18%) of total Nike Brand footwear production. The LLM's 12% figure and 4 million pairs claim are not supported by the ground truth and appear to be fabricated. (2) MISSING KEY DATA: The LLM fails to cite the geographic manufacturing distribution (Vietnam 50%, Indonesia 27%, China 18%) that is explicitly mentioned in the ground truth as 'specific production data' demonstrating FlyEase's integration. (3) INCOMPLETE EVOLUTION NARRATIVE: While the LLM attempts to describe the evolution from fiscal 2022-2024, it lacks the intermediate step showing fiscal 2023's positioning of FlyEase alongside established technologies like Nike Air and Dri-FIT, which the ground truth identifies as a key indicator of growing integration. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the connection between geographic manufacturing distribution and FlyEase integration—the ground truth explicitly links the manufacturing percentages to FlyEase-integrated products as evidence of 'full-scale integration into Nike's global supply chain.' The LLM's answer appears to contain invented metrics rather than data from the actual 2024 filing. The core claim about evolution is partially addressed, but the quantitative evidence provided is fundamentally incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 455,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nThe RedCard‑linked “5 percent discount” penetration fell each year: it was ≈ 20.5 % for the fiscal year ended January 29 2022, slipped to ≈ 19.8 % for the year ended January 28 2023, and dropped further to ≈ 18.6 % for the year ended February 3 2024. This steady decline signals that the loyalty‑driven payment incentive is generating progressively less incremental sales, suggesting that the strategy’s effectiveness as a revenue‑growth driver is weakening.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL: The LLM provides an incorrect penetration rate for 2024. Ground truth shows 17.8% for the year ended February 3, 2024, but the LLM states 18.6%. This is a material factual error of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. STRENGTHS: (1) The LLM correctly identifies the three-year declining trend across all three fiscal years. (2) The fiscal year end dates are accurately cited (January 29, 2022; January 28, 2023; February 3, 2024). (3) The semantic interpretation of the trend is sound - the LLM correctly concludes that the steady decline signals weakening effectiveness of the loyalty-driven payment strategy. (4) The reasoning about reduced incremental sales and weakening revenue-growth effectiveness is logically sound and aligns with the ground truth's assessment. (5) The answer appropriately addresses both parts of the question: the evolution of penetration rates AND what the trend suggests about strategy effectiveness. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three fiscal years and connects the numerical trend to strategic implications. However, the quantitative error undermines the precision of the analysis. The 0.8 percentage point discrepancy in the 2024 figure (18.6% vs. 17.8%) is not a minor rounding difference but a factual error that affects the magnitude of the decline narrative. The decline from 2023 to 2024 should be 2.0 percentage points (19.8% to 17.8%), not 1.2 percentage points (19.8% to 18.6%).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 424,
        "total_tokens": 1659
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 799,
    "failed_evaluations": 1,
    "average_correctness_score": 4.97,
    "average_quantitative_accuracy": 4.96,
    "average_qualitative_accuracy": 5.38,
    "average_contextual_relevance": 6.38,
    "score_distribution": {
      "excellent": 100,
      "good": 125,
      "fair": 277,
      "poor": 297
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 29901.32,
    "timestamp": "2026-02-02T23:58:47.065769"
  }
}